analog_libid,name_analog,parent_drug_libid,delta_mass,analog_mgf_scan,chemical_source,name_connected_compound,pharmacologic_class,therapeutic_area,therapeutic_indication,mechanism_of_action,inchikey
CCMSLIB00012722361,related spectra of 'benzimidazole (delta mass:1.0)',CCMSLIB00010143329,1,1,Drug_analog,benzimidazole,no_match,no_match,no_match,no_match,HYZJCKYKOHLVJF-UHFFFAOYSA-N
CCMSLIB00012722362,related spectra of 'thioguanine (delta mass:-27.05)',CCMSLIB00003137276,-27.05,2,Drug_analog,thioguanine,antimetabolite,hematologic malignancy,acute myeloid leukemia (AML),purine antagonist,UYTPUPDQBNUYGX-UHFFFAOYSA-N
CCMSLIB00012722363,related spectra of 'hydroquinone (delta mass:15.99)',CCMSLIB00000425063,15.99,3,Drug_analog,hydroquinone,melanin synthesis inhibitor,dermatology,dyschromia,melanin inhibitor,QIGBRXMKCJKVMJ-UHFFFAOYSA-N
CCMSLIB00012722364,related spectra of 'paracetamol (delta mass:1.0)',CCMSLIB00006113948,1,4,Drug_analog,paracetamol,other analgesics and antipyretics,neurology/psychiatry|endocrinology,pain relief|fever,cyclooxygenase inhibitor,RZVAJINKPMORJF-UHFFFAOYSA-N
CCMSLIB00012722365,related spectra of 'hymecromone (delta mass:-21.98)',CCMSLIB00000220779|CCMSLIB00000222870|CCMSLIB00000565034|CCMSLIB00000568353|CCMSLIB00005726695|CCMSLIB00005757745,-21.98,5,Drug_analog,hymecromone,other drugs for bile therapy,gastroenterology,biliary spasms,HA synthesis inhibitor,HSHNITRMYYLLCV-UHFFFAOYSA-N
CCMSLIB00012722366,related spectra of 'hymecromone (delta mass:-14.02)',CCMSLIB00000220779|CCMSLIB00000222870|CCMSLIB00000565034|CCMSLIB00000568353|CCMSLIB00005726695|CCMSLIB00005757745,-14.02,6,Drug_analog,hymecromone,other drugs for bile therapy,gastroenterology,biliary spasms,HA synthesis inhibitor,HSHNITRMYYLLCV-UHFFFAOYSA-N
CCMSLIB00012722367,related spectra of '1400w (delta mass:-15.01)',CCMSLIB00010138799|CCMSLIB00010138800,-15.01,7,Drug_analog,1400w,no_match,NA,NA,nitric oxide synthase inhibitor,RODUKNYOEVZQPR-UHFFFAOYSA-N
CCMSLIB00012722368,related spectra of 'rimantadine (delta mass:-16.03)',CCMSLIB00000566331|CCMSLIB00000566351|CCMSLIB00000574056|CCMSLIB00005731441|CCMSLIB00005731570|CCMSLIB00005733302|CCMSLIB00005735868|CCMSLIB00010131280|CCMSLIB00010131281|CCMSLIB00010131282|CCMSLIB00010131284|CCMSLIB00010131285,-16.03,8,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-UHFFFAOYSA-N|UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722369,related spectra of 'rimantadine (delta mass:-16.03)',CCMSLIB00000566331|CCMSLIB00000566351|CCMSLIB00000574056|CCMSLIB00005731441|CCMSLIB00005731570|CCMSLIB00005733302|CCMSLIB00005735868|CCMSLIB00010131280|CCMSLIB00010131281|CCMSLIB00010131282|CCMSLIB00010131284|CCMSLIB00010131285,-16.03,9,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-UHFFFAOYSA-N|UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722370,related spectra of 'rimantadine (delta mass:-16.03)',CCMSLIB00000566351|CCMSLIB00000574056|CCMSLIB00005731441|CCMSLIB00010131280|CCMSLIB00010131281|CCMSLIB00010131284,-16.03,10,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-UHFFFAOYSA-N|UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722371,related spectra of 'rimantadine (delta mass:-16.03)',CCMSLIB00000566351|CCMSLIB00000574056|CCMSLIB00005731441|CCMSLIB00010131280|CCMSLIB00010131281|CCMSLIB00010131284,-16.03,11,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-UHFFFAOYSA-N|UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722372,"related spectra of 'methylenedioxyethamphetamine (delta mass:-43.04)', 'tenamfetamine (delta mass:-15.01)'",CCMSLIB00000568514|CCMSLIB00000569789|CCMSLIB00000570211|CCMSLIB00005732682|CCMSLIB00005732727|CCMSLIB00005734389,-43.04|-15.01,12,Drug_analog,methylenedioxyethamphetamine|tenamfetamine,central nervous system stimulant,drug of abuse,psychostimulant,monoamine releasing agent,PVXVWWANJIWJOO-UHFFFAOYSA-N|NGBBVGZWCFBOGO-UHFFFAOYSA-N
CCMSLIB00012722373,related spectra of 'artemisinin (delta mass:-116.06)',CCMSLIB00005767817,-116.06,13,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012722374,related spectra of 'artemisinin (delta mass:-116.06)',CCMSLIB00005767817,-116.06,14,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012722375,related spectra of 'artemisinin (delta mass:-116.06)',CCMSLIB00005767817,-116.06,15,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012722376,"related spectra of 'midomafetamine (delta mass:-26.02)', 'methylenedioxyethamphetamine (delta mass:-40.03)', 'tenamfetamine (delta mass:-12.0)'",CCMSLIB00000568423|CCMSLIB00000568514|CCMSLIB00000568798|CCMSLIB00000568971|CCMSLIB00000570211|CCMSLIB00000570392|CCMSLIB00005730097|CCMSLIB00005732682|CCMSLIB00005732727|CCMSLIB00005733535|CCMSLIB00005734234|CCMSLIB00005735101,-26.02|-40.03|-12.00,16,Drug_analog,midomafetamine|methylenedioxyethamphetamine|tenamfetamine,central nervous system stimulant,drug of abuse,psychostimulant,monoamine releasing agent,SHXWCVYOXRDMCX-UHFFFAOYSA-N|PVXVWWANJIWJOO-UHFFFAOYSA-N|NGBBVGZWCFBOGO-UHFFFAOYSA-N
CCMSLIB00012722377,related spectra of 'rimantadine (delta mass:-12.0)',CCMSLIB00000563621|CCMSLIB00000566331|CCMSLIB00000566347|CCMSLIB00000566351|CCMSLIB00000574056|CCMSLIB00005731441|CCMSLIB00005731570|CCMSLIB00005732527|CCMSLIB00005733302|CCMSLIB00010131282|CCMSLIB00010131285,-12,17,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-UHFFFAOYSA-N|UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722378,related spectra of 'gabapentin (delta mass:-2.02)',CCMSLIB00000223777,-2.02,18,Drug_analog|Low_confidence,gabapentin,antiepileptic drug (AED),neurology/psychiatry,neuropathic pain|shingles|seizures|restless leg syndrome,calcium channel blocker,UGJMXCAKCUNAIE-UHFFFAOYSA-N
CCMSLIB00012722379,related spectra of 'gabapentin (delta mass:-0.98)',CCMSLIB00000209572|CCMSLIB00000209574|CCMSLIB00000209578|CCMSLIB00000209584|CCMSLIB00000209586|CCMSLIB00000209588|CCMSLIB00000209590|CCMSLIB00005755116|CCMSLIB00005755138|CCMSLIB00005775299|CCMSLIB00010132423|CCMSLIB00010132425|CCMSLIB00010132426|CCMSLIB00010132428|CCMSLIB00010132429|CCMSLIB00010137479|CCMSLIB00010137480|CCMSLIB00010137481|CCMSLIB00010137482,-0.98,19,Drug_analog|Low_confidence,gabapentin,antiepileptic drug (AED),neurology/psychiatry,neuropathic pain|shingles|seizures|restless leg syndrome,calcium channel blocker,UGJMXCAKCUNAIE-UHFFFAOYSA-N
CCMSLIB00012722380,related spectra of 'tranexamic acid (delta mass:14.02)',CCMSLIB00006681788|CCMSLIB00006682727,14.02,20,Drug_analog,tranexamic acid,antifibrinolytic,hematology,hemophilia|heavy menstrual bleeding,antifibrinolytic|plasminogen activator inhibitor,GYDJEQRTZSCIOI-UHFFFAOYSA-N
CCMSLIB00012722381,related spectra of 'gabapentin (delta mass:0.98)',CCMSLIB00000223777|CCMSLIB00003137913,0.98,21,Drug_analog|Low_confidence,gabapentin,antiepileptic drug (AED),neurology/psychiatry,neuropathic pain|shingles|seizures|restless leg syndrome,calcium channel blocker,UGJMXCAKCUNAIE-UHFFFAOYSA-N
CCMSLIB00012722382,related spectra of 'oxandrolone (delta mass:-132.08)',CCMSLIB00005723841,-132.08,22,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012722383,related spectra of 'gabapentin (delta mass:1.0)',CCMSLIB00000209572|CCMSLIB00000209574|CCMSLIB00000209576|CCMSLIB00000209578|CCMSLIB00000209584|CCMSLIB00000209586|CCMSLIB00000209588|CCMSLIB00000209590|CCMSLIB00005755116|CCMSLIB00005755138|CCMSLIB00005775299|CCMSLIB00010132423|CCMSLIB00010132425|CCMSLIB00010132426|CCMSLIB00010132428|CCMSLIB00010132429|CCMSLIB00010137479|CCMSLIB00010137480|CCMSLIB00010137481|CCMSLIB00010137482,1,23,Drug_analog|Low_confidence,gabapentin,antiepileptic drug (AED),neurology/psychiatry,neuropathic pain|shingles|seizures|restless leg syndrome,calcium channel blocker,UGJMXCAKCUNAIE-UHFFFAOYSA-N
CCMSLIB00012722384,related spectra of 'methoxsalen (delta mass:-40.03)',CCMSLIB00004694993,-40.03,24,Drug_analog,methoxsalen,photoactivated radical generator|psoralen,dermatology,psoriasis,DNA synthesis inhibitor,QXKHYNVANLEOEG-UHFFFAOYSA-N
CCMSLIB00012722385,related spectra of 'methoxsalen (delta mass:-40.03)',CCMSLIB00004694993,-40.03,25,Drug_analog,methoxsalen,photoactivated radical generator|psoralen,dermatology,psoriasis,DNA synthesis inhibitor,QXKHYNVANLEOEG-UHFFFAOYSA-N
CCMSLIB00012722386,related spectra of 'valproic acid (delta mass:29.97)',CCMSLIB00006679577,29.97,26,Drug_analog,valproic acid,antiepileptic drug (AED)|mood stabilizer,neurology/psychiatry,epilepsy|seizures,benzodiazepine receptor agonist|HDAC inhibitor,NIJJYAXOARWZEE-UHFFFAOYSA-N
CCMSLIB00012722387,related spectra of 'memantine (delta mass:-4.03)',CCMSLIB00006115995|CCMSLIB00006116000|CCMSLIB00006116002,-4.03,27,Drug_analog,memantine,N-methyl-D-aspartate (NMDA) receptor antagonist,neurology/psychiatry,Alzheimer's disease|senile dementia,glutamate receptor antagonist,BUGYDGFZZOZRHP-UHFFFAOYSA-N
CCMSLIB00012722388,related spectra of 'rimantadine (delta mass:-4.03)',CCMSLIB00010131280|CCMSLIB00010131281|CCMSLIB00010131284,-4.03,28,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722389,related spectra of 'memantine (delta mass:-4.03)',CCMSLIB00000567558|CCMSLIB00005732225,-4.03,29,Drug_analog,memantine,N-methyl-D-aspartate (NMDA) receptor antagonist,neurology/psychiatry,Alzheimer's disease|senile dementia,glutamate receptor antagonist,BUGYDGFZZOZRHP-UHFFFAOYSA-N
CCMSLIB00012722390,related spectra of 'memantine (delta mass:-4.03)',CCMSLIB00006115995|CCMSLIB00006116000|CCMSLIB00006116002,-4.03,30,Drug_analog,memantine,N-methyl-D-aspartate (NMDA) receptor antagonist,neurology/psychiatry,Alzheimer's disease|senile dementia,glutamate receptor antagonist,BUGYDGFZZOZRHP-UHFFFAOYSA-N
CCMSLIB00012722391,related spectra of 'levamisole (delta mass:-27.05)',CCMSLIB00005772378,-27.05,31,Drug_analog,levamisole,imidazothiazole derivatives|veterinary,infectious disease,gastrointestinal parasites,acetylcholine receptor agonist,HLFSDGLLUJUHTE-SNVBAGLBSA-N
CCMSLIB00012722392,related spectra of 'phenacetin (delta mass:-2.02)',CCMSLIB00005777919,-2.02,32,Drug_analog,phenacetin,other analgesics and antipyretics,neurology/psychiatry,pain relief,cyclooxygenase inhibitor,CPJSUEIXXCENMM-UHFFFAOYSA-N
CCMSLIB00012722393,related spectra of 'memantine (delta mass:-2.02)',CCMSLIB00006115998,-2.02,33,Drug_analog,memantine,N-methyl-D-aspartate (NMDA) receptor antagonist,neurology/psychiatry,Alzheimer's disease|senile dementia,glutamate receptor antagonist,BUGYDGFZZOZRHP-UHFFFAOYSA-N
CCMSLIB00012722394,"related spectra of 'memantine (delta mass:-2.02)', 'memantine (delta mass:-2.01)'",CCMSLIB00006115983|CCMSLIB00010145982|CCMSLIB00010145983|CCMSLIB00010145986,-2.02,34,Drug_analog,memantine,N-methyl-D-aspartate (NMDA) receptor antagonist,neurology/psychiatry,Alzheimer's disease|senile dementia,glutamate receptor antagonist,BUGYDGFZZOZRHP-UHFFFAOYSA-N
CCMSLIB00012722395,related spectra of 'esculetin (delta mass:2.02)',CCMSLIB00000222756|CCMSLIB00005743726,2.02,35,Drug_analog,esculetin,no_match,NA,NA,antioxidant,ILEDWLMCKZNDJK-UHFFFAOYSA-N
CCMSLIB00012722396,related spectra of 'hymecromone (delta mass:2.0)',CCMSLIB00000220779|CCMSLIB00000222870|CCMSLIB00005757745,2,36,Drug_analog,hymecromone,other drugs for bile therapy,gastroenterology,biliary spasms,HA synthesis inhibitor,HSHNITRMYYLLCV-UHFFFAOYSA-N
CCMSLIB00012722397,related spectra of 'hymecromone (delta mass:4.03)',CCMSLIB00005760901,4.03,37,Drug_analog,hymecromone,other drugs for bile therapy,gastroenterology,biliary spasms,HA synthesis inhibitor,HSHNITRMYYLLCV-UHFFFAOYSA-N
CCMSLIB00012722398,related spectra of 'hymecromone (delta mass:2.02)',CCMSLIB00005761638|CCMSLIB00005762575|CCMSLIB00005765192|CCMSLIB00005765896,2.02,38,Drug_analog,hymecromone,other drugs for bile therapy,gastroenterology,biliary spasms,HA synthesis inhibitor,HSHNITRMYYLLCV-UHFFFAOYSA-N
CCMSLIB00012722399,related spectra of 'midomafetamine (delta mass:-15.01)',CCMSLIB00000568798|CCMSLIB00005734234,-15.01,39,Drug_analog,midomafetamine,central nervous system stimulant,drug of abuse,psychostimulant,monoamine releasing agent,SHXWCVYOXRDMCX-UHFFFAOYSA-N
CCMSLIB00012722400,related spectra of 'phenacetin (delta mass:-0.98)',CCMSLIB00005777919,-0.98,40,Drug_analog,phenacetin,other analgesics and antipyretics,neurology/psychiatry,pain relief,cyclooxygenase inhibitor,CPJSUEIXXCENMM-UHFFFAOYSA-N
CCMSLIB00012722401,related spectra of '4-methylbenzylidene camphor (delta mass:-76.03)',CCMSLIB00010132864|CCMSLIB00010132866,-76.03,41,Drug_analog,4-methylbenzylidene camphor,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-KAMYIIQDSA-N
CCMSLIB00012722402,related spectra of '4-methylbenzylidene camphor (delta mass:-76.03)',CCMSLIB00010132864,-76.03,42,Drug_analog,4-methylbenzylidene camphor,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-KAMYIIQDSA-N
CCMSLIB00012722403,related spectra of '4-methylbenzylidene camphor (delta mass:-76.03)',CCMSLIB00010132866,-76.03,43,Drug_analog,4-methylbenzylidene camphor,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-KAMYIIQDSA-N
CCMSLIB00012722404,related spectra of '4-methylbenzylidene camphor (delta mass:-76.03)',CCMSLIB00010132866,-76.03,44,Drug_analog,4-methylbenzylidene camphor,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-KAMYIIQDSA-N
CCMSLIB00012722405,related spectra of '4-methylbenzylidene camphor (delta mass:-76.03)',CCMSLIB00010132866,-76.03,45,Drug_analog,4-methylbenzylidene camphor,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-KAMYIIQDSA-N
CCMSLIB00012722406,related spectra of 'hymecromone (delta mass:3.99)',CCMSLIB00005764064,3.99,46,Drug_analog,hymecromone,other drugs for bile therapy,gastroenterology,biliary spasms,HA synthesis inhibitor,HSHNITRMYYLLCV-UHFFFAOYSA-N
CCMSLIB00012722407,related spectra of 'hymecromone (delta mass:3.99)',CCMSLIB00000220779|CCMSLIB00000222870|CCMSLIB00000565034|CCMSLIB00000568353|CCMSLIB00005726695|CCMSLIB00005757745,3.99,47,Drug_analog,hymecromone,other drugs for bile therapy,gastroenterology,biliary spasms,HA synthesis inhibitor,HSHNITRMYYLLCV-UHFFFAOYSA-N
CCMSLIB00012722408,related spectra of 'hymecromone (delta mass:3.99)',CCMSLIB00005764064,3.99,48,Drug_analog,hymecromone,other drugs for bile therapy,gastroenterology,biliary spasms,HA synthesis inhibitor,HSHNITRMYYLLCV-UHFFFAOYSA-N
CCMSLIB00012722409,related spectra of 'hymecromone (delta mass:3.99)',CCMSLIB00000220779|CCMSLIB00000222870|CCMSLIB00000565034|CCMSLIB00000568353|CCMSLIB00005726695|CCMSLIB00005757745,3.99,49,Drug_analog,hymecromone,other drugs for bile therapy,gastroenterology,biliary spasms,HA synthesis inhibitor,HSHNITRMYYLLCV-UHFFFAOYSA-N
CCMSLIB00012722410,related spectra of 'exemestane (delta mass:-116.08)',CCMSLIB00000208693|CCMSLIB00000208694|CCMSLIB00000208699|CCMSLIB00000208700,-116.08,50,Drug_analog,exemestane,aromatase inhibitor,oncology,breast cancer,aromatase inhibitor,BFYIZQONLCFLEV-UHFFFAOYSA-N
CCMSLIB00012722411,related spectra of 'exemestane (delta mass:-116.06)',CCMSLIB00000005322,-116.06,51,Drug_analog,exemestane,aromatase inhibitor,oncology,breast cancer,aromatase inhibitor,BFYIZQONLCFLEV-DAELLWKTSA-N
CCMSLIB00012722412,related spectra of 'exemestane (delta mass:-116.06)',CCMSLIB00000208693|CCMSLIB00000208699,-116.06,52,Drug_analog,exemestane,aromatase inhibitor,oncology,breast cancer,aromatase inhibitor,BFYIZQONLCFLEV-UHFFFAOYSA-N
CCMSLIB00012722413,related spectra of 'exemestane (delta mass:-116.06)',CCMSLIB00000208693|CCMSLIB00000208694|CCMSLIB00000208699|CCMSLIB00000208700,-116.06,53,Drug_analog,exemestane,aromatase inhibitor,oncology,breast cancer,aromatase inhibitor,BFYIZQONLCFLEV-UHFFFAOYSA-N
CCMSLIB00012722414,"related spectra of 'ethinyl estradiol (delta mass:-116.06)', 'ethinylestradiol (delta mass:-116.06)'",CCMSLIB00000566716|CCMSLIB00000572470|CCMSLIB00005731088|CCMSLIB00005731984,-116.06,54,Drug_analog|Low_confidence,ethinylestradiol|ethinyl estradiol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist|estrogenic hormone,BFPYWIDHMRZLRN-UHFFFAOYSA-N
CCMSLIB00012722415,related spectra of 'exemestane (delta mass:-116.06)',CCMSLIB00000005322,-116.06,55,Drug_analog,exemestane,aromatase inhibitor,oncology,breast cancer,aromatase inhibitor,BFYIZQONLCFLEV-DAELLWKTSA-N
CCMSLIB00012722416,related spectra of 'rimantadine (delta mass:0.98)',CCMSLIB00000563621|CCMSLIB00000566347|CCMSLIB00000566351|CCMSLIB00000574056|CCMSLIB00005731441|CCMSLIB00005732527|CCMSLIB00005733302|CCMSLIB00010131280|CCMSLIB00010131281|CCMSLIB00010131282|CCMSLIB00010131284|CCMSLIB00010131285,0.98,56,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-UHFFFAOYSA-N|UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722417,related spectra of 'pilocarpine (delta mass:-26.02)',CCMSLIB00005720174,-26.02,57,Drug_analog,pilocarpine,cholinergic agonist,ophthalmology|dental,glaucoma|dry mouth,acetylcholine receptor agonist,QCHFTSOMWOSFHM-WPRPVWTQSA-N
CCMSLIB00012722418,related spectra of 'pilocarpine (delta mass:-26.02)',CCMSLIB00005720174,-26.02,58,Drug_analog,pilocarpine,cholinergic agonist,ophthalmology|dental,glaucoma|dry mouth,acetylcholine receptor agonist,QCHFTSOMWOSFHM-WPRPVWTQSA-N
CCMSLIB00012722419,related spectra of 'methoxsalen (delta mass:-31.99)',CCMSLIB00010117636,-31.99,59,Drug_analog,methoxsalen,photoactivated radical generator|psoralen,dermatology,psoriasis,DNA synthesis inhibitor,QXKHYNVANLEOEG-UHFFFAOYSA-N
CCMSLIB00012722420,related spectra of 'amantadine (delta mass:34.01)',CCMSLIB00006680764|CCMSLIB00010131377,34.01,60,Drug_analog|Low_confidence,amantadine,influenza A M2 protein inhibitor,infectious disease|neurology/psychiatry,influenza A virus infection|Parkinson's Disease,glutamate receptor antagonist,DKNWSYNQZKUICI-UHFFFAOYSA-N|DKNWSYNQZKUICI-URIMCQPQSA-N
CCMSLIB00012722421,related spectra of 'pirfenidone (delta mass:1.0)',CCMSLIB00010142235|CCMSLIB00010142237,1,61,Drug_analog,pirfenidone,pyridone,pulmonary,idiopathic pulmonary fibrosis (IPF),TGF beta receptor inhibitor,ISWRGOKTTBVCFA-UHFFFAOYSA-N
CCMSLIB00012722422,related spectra of 'gabapentin (delta mass:15.97)',CCMSLIB00000223777,15.97,62,Drug_analog|Low_confidence,gabapentin,antiepileptic drug (AED),neurology/psychiatry,neuropathic pain|shingles|seizures|restless leg syndrome,calcium channel blocker,UGJMXCAKCUNAIE-UHFFFAOYSA-N
CCMSLIB00012722423,related spectra of 'terbutaline (delta mass:-38.02)',CCMSLIB00000206419|CCMSLIB00005771250,-38.02,63,Drug_analog,terbutaline,beta-2 adrenergic agonist,pulmonary|obstetrics/gynecology,bronchospasm|bronchitis|emphysema|asthma|premature labor,adrenergic receptor agonist,XWTYSIMOBUGWOL-UHFFFAOYSA-N
CCMSLIB00012722424,related spectra of '8-hydroxyquinoline (chimeric precursor selection) (delta mass:43.04)',CCMSLIB00010136909|CCMSLIB00010136910,43.04,64,Drug_analog,8-hydroxyquinoline (chimeric precursor selection),quinoline derivatives|antiseptics,dermatology|obstetrics/gynecology,cosmetic|restore vaginal pH,chelating agent,MCJGNVYPOGVAJF-UHFFFAOYSA-N
CCMSLIB00012722425,related spectra of 'drostanolone (delta mass:-116.08)',CCMSLIB00005723746,-116.08,65,Drug_analog|Low_confidence,drostanolone,no_match,no_match,no_match,no_match,FDGQIVOIHOIMNK-TZAHHXAYSA-N
CCMSLIB00012722426,related spectra of 'antipyrine (delta mass:1.98)',CCMSLIB00005753857,1.98,66,Drug_analog,antipyrine,other analgesics and antipyretics,neurology/psychiatry,pain relief,cyclooxygenase inhibitor,VEQOALNAAJBPNY-UHFFFAOYSA-N
CCMSLIB00012722427,related spectra of 'alpha-asarone (delta mass:-15.99)',CCMSLIB00010142288|CCMSLIB00010142289,-15.99,67,Drug_analog,alpha-asarone,no_match,NA,NA,cytochrome P450 inhibitor|HMGCR inhibitor,RKFAZBXYICVSKP-AATRIKPKSA-N
CCMSLIB00012722428,related spectra of 'hymecromone (delta mass:15.99)',CCMSLIB00005764064,15.99,68,Drug_analog,hymecromone,other drugs for bile therapy,gastroenterology,biliary spasms,HA synthesis inhibitor,HSHNITRMYYLLCV-UHFFFAOYSA-N
CCMSLIB00012722429,related spectra of 'hymecromone (delta mass:16.03)',CCMSLIB00005762575|CCMSLIB00005765192|CCMSLIB00005765896,16.03,69,Drug_analog|Low_confidence,hymecromone,other drugs for bile therapy,gastroenterology,biliary spasms,HA synthesis inhibitor,HSHNITRMYYLLCV-UHFFFAOYSA-N
CCMSLIB00012722430,related spectra of 'diethyltoluamide (delta mass:0.98)',CCMSLIB00005772290,0.98,70,Drug_analog,diethyltoluamide,other insecticides and repellents,NA,NA,ionotropic receptor IR40a activator,MMOXZBCLCQITDF-UHFFFAOYSA-N
CCMSLIB00012722431,related spectra of 'mirogabalin (delta mass:-17.03)',CCMSLIB00010148398,-17.03,71,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722432,related spectra of 'mirogabalin (delta mass:-17.03)',CCMSLIB00010149219,-17.03,72,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722433,related spectra of 'mirogabalin (delta mass:-17.03)',CCMSLIB00010148396|CCMSLIB00010148397|CCMSLIB00010149217|CCMSLIB00010149218|CCMSLIB00010149219,-17.03,73,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722434,related spectra of 'mirogabalin (delta mass:-17.03)',CCMSLIB00010148396|CCMSLIB00010149217,-17.03,74,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722435,related spectra of 'mirogabalin (delta mass:-17.03)',CCMSLIB00010149219,-17.03,75,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722436,related spectra of 'mirogabalin (delta mass:-17.03)',CCMSLIB00010149219,-17.03,76,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722437,related spectra of 'diethyltoluamide (delta mass:1.0)',CCMSLIB00005772290|CCMSLIB00006718072,1,77,Drug_analog,diethyltoluamide,other insecticides and repellents,NA,NA,ionotropic receptor IR40a activator,MMOXZBCLCQITDF-UHFFFAOYSA-N
CCMSLIB00012722438,related spectra of 'desvenlafaxine (delta mass:-70.08)',CCMSLIB00000209431|CCMSLIB00000209443,-70.08,78,Drug_analog,desvenlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression,serotonin and norepinephrine reuptake inhibitor (SNRI),KYYIDSXMWOZKMP-UHFFFAOYSA-N
CCMSLIB00012722439,related spectra of 'rimantadine (delta mass:13.98)',CCMSLIB00000566331|CCMSLIB00000566351|CCMSLIB00000574056|CCMSLIB00005731441|CCMSLIB00005731570|CCMSLIB00005733302|CCMSLIB00005735868|CCMSLIB00010131279|CCMSLIB00010131280|CCMSLIB00010131281|CCMSLIB00010131282|CCMSLIB00010131284|CCMSLIB00010131285,13.98,79,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-UHFFFAOYSA-N|UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722440,related spectra of 'rimantadine (delta mass:14.02)',CCMSLIB00005733302|CCMSLIB00005735868|CCMSLIB00010131282|CCMSLIB00010131285,14.02,80,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-UHFFFAOYSA-N|UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722441,related spectra of 'memantine (delta mass:14.96)',CCMSLIB00006115983|CCMSLIB00010145982|CCMSLIB00010145983|CCMSLIB00010145986,14.96,81,Drug_analog,memantine,N-methyl-D-aspartate (NMDA) receptor antagonist,neurology/psychiatry,Alzheimer's disease|senile dementia,glutamate receptor antagonist,BUGYDGFZZOZRHP-UHFFFAOYSA-N
CCMSLIB00012722442,related spectra of 'memantine (delta mass:14.96)',CCMSLIB00006115995|CCMSLIB00006115997|CCMSLIB00006116000|CCMSLIB00006116002,14.96,82,Drug_analog,memantine,N-methyl-D-aspartate (NMDA) receptor antagonist,neurology/psychiatry,Alzheimer's disease|senile dementia,glutamate receptor antagonist,BUGYDGFZZOZRHP-UHFFFAOYSA-N
CCMSLIB00012722443,related spectra of 'rimantadine (delta mass:14.96)',CCMSLIB00000563621|CCMSLIB00000566331|CCMSLIB00000566347|CCMSLIB00000566351|CCMSLIB00000574056|CCMSLIB00005731441|CCMSLIB00005731570|CCMSLIB00005732527|CCMSLIB00005733302|CCMSLIB00005735868|CCMSLIB00010131280|CCMSLIB00010131281|CCMSLIB00010131282|CCMSLIB00010131284|CCMSLIB00010131285,14.96,83,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-UHFFFAOYSA-N|UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722444,related spectra of 'rimantadine (delta mass:14.96)',CCMSLIB00010131280|CCMSLIB00010131281|CCMSLIB00010131284,14.96,84,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722445,related spectra of 'rimantadine (delta mass:14.96)',CCMSLIB00000566331|CCMSLIB00000566351|CCMSLIB00000574056|CCMSLIB00005731441|CCMSLIB00005731570|CCMSLIB00005733302|CCMSLIB00005735868|CCMSLIB00010131280|CCMSLIB00010131281|CCMSLIB00010131282|CCMSLIB00010131284|CCMSLIB00010131285,14.96,85,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-UHFFFAOYSA-N|UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722446,related spectra of 'rimantadine (delta mass:14.96)',CCMSLIB00000566331|CCMSLIB00000566351|CCMSLIB00000574056|CCMSLIB00005731441|CCMSLIB00005731570|CCMSLIB00005733302|CCMSLIB00005735868|CCMSLIB00010131280|CCMSLIB00010131281|CCMSLIB00010131282|CCMSLIB00010131284|CCMSLIB00010131285,14.96,86,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-UHFFFAOYSA-N|UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722447,related spectra of 'rimantadine (delta mass:14.96)',CCMSLIB00010131280|CCMSLIB00010131281|CCMSLIB00010131284,14.96,87,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722448,related spectra of 'memantine (delta mass:14.96)',CCMSLIB00006116000|CCMSLIB00006116002,14.96,88,Drug_analog,memantine,N-methyl-D-aspartate (NMDA) receptor antagonist,neurology/psychiatry,Alzheimer's disease|senile dementia,glutamate receptor antagonist,BUGYDGFZZOZRHP-UHFFFAOYSA-N
CCMSLIB00012722449,related spectra of 'rimantadine (delta mass:14.96)',CCMSLIB00000563621|CCMSLIB00000566331|CCMSLIB00000566347|CCMSLIB00000566351|CCMSLIB00000574056|CCMSLIB00005731441|CCMSLIB00005731570|CCMSLIB00005732527|CCMSLIB00005733302|CCMSLIB00005735868|CCMSLIB00010131280|CCMSLIB00010131281|CCMSLIB00010131282|CCMSLIB00010131284|CCMSLIB00010131285,14.96,89,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-UHFFFAOYSA-N|UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722450,related spectra of 'rimantadine (delta mass:14.96)',CCMSLIB00010131279,14.96,90,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722451,related spectra of 'rimantadine (delta mass:14.96)',CCMSLIB00010131279,14.96,91,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722452,related spectra of 'rimantadine (delta mass:14.96)',CCMSLIB00010131280|CCMSLIB00010131281|CCMSLIB00010131284,14.96,92,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722453,related spectra of 'rimantadine (delta mass:14.96)',CCMSLIB00010131279,14.96,93,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722454,related spectra of 'memantine (delta mass:15.98)',CCMSLIB00000568321|CCMSLIB00005735445|CCMSLIB00010145981,15.97,94,Drug_analog,memantine,N-methyl-D-aspartate (NMDA) receptor antagonist,neurology/psychiatry,Alzheimer's disease|senile dementia,glutamate receptor antagonist,BUGYDGFZZOZRHP-UHFFFAOYSA-N
CCMSLIB00012722455,related spectra of 'rimantadine (delta mass:16.03)',CCMSLIB00000563621|CCMSLIB00000566347|CCMSLIB00005732527,16.03,95,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-UHFFFAOYSA-N
CCMSLIB00012722456,related spectra of 'baclofen (delta mass:1.0)',CCMSLIB00003136604,1,96,Drug_analog,baclofen,gamma-aminobutyric acid (GABA)-ergic agonist,neurology/psychiatry,multiple sclerosis|spasms,GABA receptor agonist,KPYSYYIEGFHWSV-UHFFFAOYSA-N
CCMSLIB00012722457,related spectra of 'baclofen (delta mass:1.0)',CCMSLIB00003136604,1,97,Drug_analog,baclofen,gamma-aminobutyric acid (GABA)-ergic agonist,neurology/psychiatry,multiple sclerosis|spasms,GABA receptor agonist,KPYSYYIEGFHWSV-UHFFFAOYSA-N
CCMSLIB00012722458,related spectra of 'metyrosine (delta mass:0.98)',CCMSLIB00010150043|CCMSLIB00010150044,0.98,98,Drug_analog,metyrosine,catecholamine synthesis inhibitor,cardiology,hypertension,tyrosine hydroxylase inhibitor,NHTGHBARYWONDQ-JTQLQIEISA-N
CCMSLIB00012722459,related spectra of 'baclofen (delta mass:2.02)',CCMSLIB00003136604,2.02,99,Drug_analog,baclofen,gamma-aminobutyric acid (GABA)-ergic agonist,neurology/psychiatry,multiple sclerosis|spasms,GABA receptor agonist,KPYSYYIEGFHWSV-UHFFFAOYSA-N
CCMSLIB00012722460,related spectra of 'memantine (delta mass:18.01)',CCMSLIB00000568321|CCMSLIB00005735445|CCMSLIB00010145981,18.01,100,Drug_analog,memantine,N-methyl-D-aspartate (NMDA) receptor antagonist,neurology/psychiatry,Alzheimer's disease|senile dementia,glutamate receptor antagonist,BUGYDGFZZOZRHP-UHFFFAOYSA-N
CCMSLIB00012722461,related spectra of 'oxandrolone (delta mass:-88.05)',CCMSLIB00005723842,-88.05,101,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012722462,related spectra of 'rimantadine (delta mass:18.99)',CCMSLIB00000563621|CCMSLIB00000566347|CCMSLIB00005732527|CCMSLIB00010131280|CCMSLIB00010131281|CCMSLIB00010131284,18.99,102,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-UHFFFAOYSA-N|UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722463,related spectra of 'uridine triacetate (delta mass:-43.01)',CCMSLIB00006124693|CCMSLIB00006124694|CCMSLIB00006124706,-43.01,103,Drug_analog,uridine triacetate,various alimentary tract and metabolism products,genetics|critical care,orotic aciduria|fluorouracil overdose|capecitabine overdose,pyrimidine analog,DRTQHJPVMGBUCF-XVFCMESISA-N
CCMSLIB00012722464,related spectra of 'gabapentin (delta mass:28.03)',CCMSLIB00000209572|CCMSLIB00000209574|CCMSLIB00000209576|CCMSLIB00000209578|CCMSLIB00000209584|CCMSLIB00000209586|CCMSLIB00000209588|CCMSLIB00000209590|CCMSLIB00005755116|CCMSLIB00005755138|CCMSLIB00010132425|CCMSLIB00010132426|CCMSLIB00010132428|CCMSLIB00010132429|CCMSLIB00010137481|CCMSLIB00010137482,28.03,104,Drug_analog|Low_confidence,gabapentin,antiepileptic drug (AED),neurology/psychiatry,neuropathic pain|shingles|seizures|restless leg syndrome,calcium channel blocker,UGJMXCAKCUNAIE-UHFFFAOYSA-N
CCMSLIB00012722465,related spectra of 'dobesilic acid (delta mass:12.04)',CCMSLIB00005759977,12.04,105,Drug_analog,dobesilic acid,other systemic hemostatics,hematology,hemorrhage,hemostatic agent,IKQCSJBQLWJEPU-UHFFFAOYSA-N
CCMSLIB00012722466,related spectra of 'antipyrine (delta mass:12.0)',CCMSLIB00005754770,12,106,Drug_analog,antipyrine,other analgesics and antipyretics,neurology/psychiatry,pain relief,cyclooxygenase inhibitor,VEQOALNAAJBPNY-UHFFFAOYSA-N
CCMSLIB00012722467,related spectra of 'atipamezole (delta mass:-12.0)',CCMSLIB00010151046|CCMSLIB00010151047|CCMSLIB00010151049,-12,107,Drug_analog,atipamezole,veterinary,neurology/psychiatry,reverse sedative,adrenergic receptor antagonist,HSWPZIDYAHLZDD-UHFFFAOYSA-N
CCMSLIB00012722468,related spectra of 'methoxsalen (delta mass:-13.98)',CCMSLIB00010117636|CCMSLIB00010117637,-13.98,108,Drug_analog,methoxsalen,photoactivated radical generator|psoralen,dermatology,psoriasis,DNA synthesis inhibitor,QXKHYNVANLEOEG-UHFFFAOYSA-N
CCMSLIB00012722469,related spectra of 'antipyrine (delta mass:13.98)',CCMSLIB00005773370,13.98,109,Drug_analog,antipyrine,other analgesics and antipyretics,neurology/psychiatry,pain relief,cyclooxygenase inhibitor,VEQOALNAAJBPNY-UHFFFAOYSA-N
CCMSLIB00012722470,related spectra of 'nomifensine (delta mass:-36.02)',CCMSLIB00005763582|CCMSLIB00005765830|CCMSLIB00005766022|CCMSLIB00005767139,-36.02,110,Drug_analog,nomifensine,other antidepressants,NA,NA,dopamine reuptake inhibitor|noradrenaline uptake inhibitor,XXPANQJNYNUNES-UHFFFAOYSA-N
CCMSLIB00012722471,related spectra of 'ethylestrenol (delta mass:-68.06)',CCMSLIB00005723752,-68.06,111,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012722472,related spectra of 'ethylestrenol (delta mass:-68.06)',CCMSLIB00005723752,-68.06,112,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012722473,related spectra of 'ethylestrenol (delta mass:-68.06)',CCMSLIB00005723752,-68.06,113,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012722474,related spectra of 'parthenolide (delta mass:-27.05)',CCMSLIB00000855424,-27.05,114,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-SLXBATTESA-N
CCMSLIB00012722475,related spectra of '2-acetamido-2-deoxy-d-mannopyranose (delta mass:0.98)',CCMSLIB00010131505,0.98,115,Drug_analog,2-acetamido-2-deoxy-d-mannopyranose,no_match,NA,NA,NA,OVRNDRQMDRJTHS-ZTVVOAFPSA-N
CCMSLIB00012722476,related spectra of '2-acetamido-2-deoxy-d-mannopyranose (delta mass:0.98)',CCMSLIB00010131504,0.98,116,Drug_analog,2-acetamido-2-deoxy-d-mannopyranose,no_match,NA,NA,NA,OVRNDRQMDRJTHS-ZTVVOAFPSA-N
CCMSLIB00012722477,related spectra of '2-acetamido-2-deoxy-d-mannopyranose (delta mass:0.98)',CCMSLIB00010131504,0.98,117,Drug_analog,2-acetamido-2-deoxy-d-mannopyranose,no_match,NA,NA,NA,OVRNDRQMDRJTHS-ZTVVOAFPSA-N
CCMSLIB00012722478,related spectra of 'tolimidone (delta mass:1.99)',CCMSLIB00010147324,2,118,Drug_analog,tolimidone,no_match,NA,NA,SRC activator,HJQILFPVRNHTIG-UHFFFAOYSA-N
CCMSLIB00012722479,related spectra of 'antipyrine (delta mass:15.98)',CCMSLIB00005753800|CCMSLIB00005754305|CCMSLIB00005754332,15.97,119,Drug_analog,antipyrine,other analgesics and antipyretics,neurology/psychiatry,pain relief,cyclooxygenase inhibitor,VEQOALNAAJBPNY-UHFFFAOYSA-N
CCMSLIB00012722480,related spectra of 'ipriflavone (delta mass:-17.99)',CCMSLIB00004718106|CCMSLIB00005745607|CCMSLIB00005765302,-17.99,120,Drug_analog,ipriflavone,other drugs affecting bone structure and mineralization,endocrinology,osteoporosis,bone resorption inhibitor,VHBFFQKBGNRLFZ-UHFFFAOYSA-N
CCMSLIB00012722481,related spectra of '2-acetamido-2-deoxy-d-mannopyranose (delta mass:1.0)',CCMSLIB00010131505,1,121,Drug_analog,2-acetamido-2-deoxy-d-mannopyranose,no_match,NA,NA,NA,OVRNDRQMDRJTHS-ZTVVOAFPSA-N
CCMSLIB00012722482,related spectra of 'tolimidone (delta mass:2.0)',CCMSLIB00010147324,2,122,Drug_analog,tolimidone,no_match,NA,NA,SRC activator,HJQILFPVRNHTIG-UHFFFAOYSA-N
CCMSLIB00012722483,related spectra of '2-acetamido-2-deoxy-d-mannopyranose (delta mass:1.0)',CCMSLIB00010131504,1,123,Drug_analog,2-acetamido-2-deoxy-d-mannopyranose,no_match,NA,NA,NA,OVRNDRQMDRJTHS-ZTVVOAFPSA-N
CCMSLIB00012722484,related spectra of '1-methyl-l-tryptophan (delta mass:-14.02)',CCMSLIB00010134131,-14.02,124,Drug_analog,1-methyl-l-tryptophan,no_match,NA,NA,"indoleamine 2,3-dioxygenase inhibitor",ZADWXFSZEAPBJS-JTQLQIEISA-N
CCMSLIB00012722485,related spectra of 'parthenolide (delta mass:-26.02)',CCMSLIB00010120238|CCMSLIB00010120978,-26.02,125,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722486,related spectra of 'parthenolide (delta mass:-26.02)',CCMSLIB00010120978,-26.02,126,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722487,related spectra of 'parthenolide (delta mass:-26.02)',CCMSLIB00010108898|CCMSLIB00010120238|CCMSLIB00010120978,-26.02,127,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722488,related spectra of 'parthenolide (delta mass:-26.02)',CCMSLIB00010120238|CCMSLIB00010120978,-26.02,128,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722489,related spectra of 'parthenolide (delta mass:-26.02)',CCMSLIB00010120238|CCMSLIB00010120978,-26.02,129,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722490,related spectra of 'parthenolide (delta mass:-26.02)',CCMSLIB00010120238|CCMSLIB00010120978,-26.02,130,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722491,related spectra of 'parthenolide (delta mass:-26.02)',CCMSLIB00010120238|CCMSLIB00010120978,-26.02,131,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722492,related spectra of 'parthenolide (delta mass:-44.03)',CCMSLIB00004692440,-44.03,132,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722493,related spectra of '2-acetamido-2-deoxy-d-mannopyranose (delta mass:2.02)',CCMSLIB00010131506,2.02,133,Drug_analog,2-acetamido-2-deoxy-d-mannopyranose,no_match,NA,NA,NA,OVRNDRQMDRJTHS-ZTVVOAFPSA-N
CCMSLIB00012722494,related spectra of 'pindolol (delta mass:-42.05)',CCMSLIB00005774021,-42.05,134,Drug_analog,pindolol,beta-adrenergic receptor inhibitor,cardiology,hypertension,adrenergic receptor antagonist,JZQKKSLKJUAGIC-UHFFFAOYSA-N
CCMSLIB00012722495,related spectra of 'pindolol (delta mass:-42.05)',CCMSLIB00005774021,-42.05,135,Drug_analog,pindolol,beta-adrenergic receptor inhibitor,cardiology,hypertension,adrenergic receptor antagonist,JZQKKSLKJUAGIC-UHFFFAOYSA-N
CCMSLIB00012722496,related spectra of 'artemisinin (delta mass:-76.03)',CCMSLIB00005769004,-76.03,136,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012722497,"related spectra of 'ethinyl estradiol (delta mass:-90.05)', 'ethinylestradiol (delta mass:-90.05)'",CCMSLIB00000566716|CCMSLIB00005731088,-90.05,137,Drug_analog|Low_confidence,ethinylestradiol|ethinyl estradiol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist|estrogenic hormone,BFPYWIDHMRZLRN-UHFFFAOYSA-N
CCMSLIB00012722498,related spectra of 'exemestane (delta mass:-90.05)',CCMSLIB00000208699,-90.05,138,Drug_analog,exemestane,aromatase inhibitor,oncology,breast cancer,aromatase inhibitor,BFYIZQONLCFLEV-UHFFFAOYSA-N
CCMSLIB00012722499,related spectra of 'exemestane (delta mass:-90.05)',CCMSLIB00000208693,-90.05,139,Drug_analog,exemestane,aromatase inhibitor,oncology,breast cancer,aromatase inhibitor,BFYIZQONLCFLEV-UHFFFAOYSA-N
CCMSLIB00012722500,related spectra of 'ethinylestradiol (delta mass:-90.05)',CCMSLIB00000004895,-90.05,140,Drug_analog|Low_confidence,ethinylestradiol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist|estrogenic hormone,BFPYWIDHMRZLRN-SLHNCBLASA-N
CCMSLIB00012722501,related spectra of 'exemestane (delta mass:-90.05)',CCMSLIB00000208693,-90.05,141,Drug_analog,exemestane,aromatase inhibitor,oncology,breast cancer,aromatase inhibitor,BFYIZQONLCFLEV-UHFFFAOYSA-N
CCMSLIB00012722502,related spectra of 'ethinylestradiol (delta mass:-90.05)',CCMSLIB00000004895,-90.05,142,Drug_analog|Low_confidence,ethinylestradiol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist|estrogenic hormone,BFPYWIDHMRZLRN-SLHNCBLASA-N
CCMSLIB00012722503,related spectra of 'exemestane (delta mass:-90.05)',CCMSLIB00000208693,-90.05,143,Drug_analog,exemestane,aromatase inhibitor,oncology,breast cancer,aromatase inhibitor,BFYIZQONLCFLEV-UHFFFAOYSA-N
CCMSLIB00012722504,related spectra of 'rimantadine (delta mass:27.99)',CCMSLIB00000563621|CCMSLIB00000566347|CCMSLIB00000566351|CCMSLIB00000574056|CCMSLIB00005731441|CCMSLIB00005732527,27.99,144,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-UHFFFAOYSA-N
CCMSLIB00012722505,related spectra of 'cantharidin (delta mass:12.0)',CCMSLIB00010125871,12,145,Drug_analog,cantharidin,no_match,dermatology,blisters|molluscum contagiosum,protein phosphatase inhibitor,DHZBEENLJMYSHQ-UHFFFAOYSA-N
CCMSLIB00012722506,related spectra of 'lobeline (delta mass:-129.08)',CCMSLIB00004716721|CCMSLIB00006565753,-129.08,146,Drug_analog|Low_confidence,lobeline,no_match,neurology/psychiatry,smoking cessation,acetylcholine receptor antagonist,MXYUKLILVYORSK-HBMCJLEFSA-N
CCMSLIB00012722507,related spectra of 'methylenedioxyethamphetamine (delta mass:1.94)',CCMSLIB00000568563|CCMSLIB00005731477,1.94,147,Drug_analog,methylenedioxyethamphetamine,central nervous system stimulant,drug of abuse,psychostimulant,monoamine releasing agent,PVXVWWANJIWJOO-UHFFFAOYSA-N
CCMSLIB00012722508,related spectra of 'mirogabalin (delta mass:0.98)',CCMSLIB00010148395|CCMSLIB00010148396|CCMSLIB00010148398|CCMSLIB00010149216|CCMSLIB00010149217|CCMSLIB00010149219,0.98,148,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722509,related spectra of 'mirogabalin (delta mass:0.98)',CCMSLIB00010148395|CCMSLIB00010148396|CCMSLIB00010148398|CCMSLIB00010149216|CCMSLIB00010149217|CCMSLIB00010149219,0.98,149,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722510,related spectra of 'mirogabalin (delta mass:0.98)',CCMSLIB00010148396|CCMSLIB00010148398|CCMSLIB00010149217|CCMSLIB00010149219,0.98,150,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722511,related spectra of 'mirogabalin (delta mass:0.98)',CCMSLIB00010149219,0.98,151,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722512,"related spectra of 'n,o-didesmethylvenlafaxine (delta mass:-39.01)'",CCMSLIB00000578724,-39.01,152,Drug_analog,"n,o-didesmethylvenlafaxine",serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MMSWXJSQCAEDLK-UHFFFAOYSA-N
CCMSLIB00012722513,related spectra of 'rimantadine (delta mass:31.99)',CCMSLIB00000563621|CCMSLIB00000566347|CCMSLIB00005732527,31.99,153,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-UHFFFAOYSA-N
CCMSLIB00012722514,"related spectra of 'ketorolac (delta mass:-42.01)', '(s)-ketorolac (delta mass:-42.01)'",CCMSLIB00010141179|CCMSLIB00010143678,-42.01,154,Drug_analog,ketorolac|ketorolac,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,rheumatoid arthritis|osteoarthritis|dysmenorrhea|muscle pain,cyclooxygenase inhibitor,OZWKMVRBQXNZKK-UHFFFAOYSA-N|OZWKMVRBQXNZKK-NSHDSACASA-N
CCMSLIB00012722515,related spectra of 'dethiobiotin (delta mass:-0.98)',CCMSLIB00010139695|CCMSLIB00010139696,-0.98,155,Drug_analog|Low_confidence,dethiobiotin,no_match,no_match,no_match,no_match,AUTOLBMXDDTRRT-JGVFFNPUSA-N
CCMSLIB00012722516,related spectra of 'hydroxyprogesterone caproate (delta mass:-116.08)',CCMSLIB00005765522,-116.08,156,Drug_analog|Low_confidence,hydroxyprogesterone caproate,progestin,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DBPWSSGDRRHUNT-CEGNMAFCSA-N
CCMSLIB00012722517,related spectra of 'pseudoephedrine (delta mass:13.98)',CCMSLIB00006557197,13.98,157,Drug_analog,pseudoephedrine,alpha adrenergic agonist,otolaryngology,nasal congestion,adrenergic receptor agonist,KWGRBVOPPLSCSI-WCBMZHEXSA-N
CCMSLIB00012722518,related spectra of 'methyldopa (delta mass:4.03)',CCMSLIB00010151354|CCMSLIB00010151357,4.03,158,Drug_analog|Low_confidence,methyldopa,central alpha-2 adrenergic agonist,cardiology,hypertension,adrenergic receptor agonist,CJCSPKMFHVPWAR-JTQLQIEISA-N
CCMSLIB00012722519,related spectra of 'parthenolide (delta mass:-14.02)',CCMSLIB00010120238|CCMSLIB00010120978,-14.02,159,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722520,related spectra of 'parthenolide (delta mass:-14.02)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238|CCMSLIB00010120978,-14.02,160,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722521,related spectra of 'parthenolide (delta mass:-14.02)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238,-14.02,161,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722522,related spectra of 'parthenolide (delta mass:-14.02)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238|CCMSLIB00010120978,-14.02,162,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722523,related spectra of 'parthenolide (delta mass:-13.98)',CCMSLIB00010120238,-13.98,163,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722524,related spectra of 'parthenolide (delta mass:-13.98)',CCMSLIB00010120238|CCMSLIB00010120978,-13.98,164,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722525,related spectra of 'enzacamene (delta mass:-38.02)',CCMSLIB00005775624,-38.02,165,Drug_analog,enzacamene,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-UHFFFAOYSA-N
CCMSLIB00012722526,related spectra of 'parthenolide (delta mass:-13.98)',CCMSLIB00010120238|CCMSLIB00010120978,-13.98,166,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722527,related spectra of 'parthenolide (delta mass:-13.98)',CCMSLIB00010120238|CCMSLIB00010120978,-13.98,167,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722528,related spectra of 'mesterolone (delta mass:-88.05)',CCMSLIB00005723783,-88.05,168,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012722529,related spectra of '2-acetamido-2-deoxy-d-mannopyranose (delta mass:14.02)',CCMSLIB00010131504|CCMSLIB00010131506,14.02,169,Drug_analog,2-acetamido-2-deoxy-d-mannopyranose,no_match,NA,NA,NA,OVRNDRQMDRJTHS-ZTVVOAFPSA-N
CCMSLIB00012722530,related spectra of '2-acetamido-2-deoxy-d-mannopyranose (delta mass:14.02)',CCMSLIB00010131504|CCMSLIB00010131506,14.02,170,Drug_analog,2-acetamido-2-deoxy-d-mannopyranose,no_match,NA,NA,NA,OVRNDRQMDRJTHS-ZTVVOAFPSA-N
CCMSLIB00012722531,related spectra of '2-acetamido-2-deoxy-d-mannopyranose (delta mass:14.02)',CCMSLIB00010131504,14.02,171,Drug_analog,2-acetamido-2-deoxy-d-mannopyranose,no_match,NA,NA,NA,OVRNDRQMDRJTHS-ZTVVOAFPSA-N
CCMSLIB00012722532,related spectra of 'enoxolone (delta mass:-15.97)',CCMSLIB00000567316,-15.97,172,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012722533,related spectra of 'methoxsalen (delta mass:2.02)',CCMSLIB00005766988,2.02,173,Drug_analog,methoxsalen,photoactivated radical generator|psoralen,dermatology,psoriasis,DNA synthesis inhibitor,QXKHYNVANLEOEG-UHFFFAOYSA-N
CCMSLIB00012722534,related spectra of 'parthenolide (delta mass:-12.04)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120978,-12.04,174,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722535,related spectra of 'parthenolide (delta mass:-12.04)',CCMSLIB00010108898,-12.04,175,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722536,related spectra of 'parthenolide (delta mass:-12.04)',CCMSLIB00010108898|CCMSLIB00010120978,-12.04,176,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722537,related spectra of 'parthenolide (delta mass:-12.04)',CCMSLIB00010108898|CCMSLIB00010120978,-12.04,177,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722538,related spectra of 'parthenolide (delta mass:-12.04)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238|CCMSLIB00010120978,-12.04,178,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722539,related spectra of 'nalidixic acid (delta mass:-13.98)',CCMSLIB00003136966,-13.98,179,Drug_analog,nalidixic acid,quinolone antimicrobial,infectious disease,urinary tract infections,bacterial DNA gyrase inhibitor,MHWLWQUZZRMNGJ-UHFFFAOYSA-N
CCMSLIB00012722540,related spectra of 'parthenolide (delta mass:-12.04)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238|CCMSLIB00010120978,-12.04,180,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722541,related spectra of 'parthenolide (delta mass:-12.04)',CCMSLIB00010120978,-12.04,181,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722542,related spectra of 'parthenolide (delta mass:-12.04)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120978,-12.04,182,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722543,related spectra of 'parthenolide (delta mass:-12.04)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120978,-12.04,183,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722544,related spectra of 'parthenolide (delta mass:-12.04)',CCMSLIB00010120978,-12.04,184,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722545,related spectra of 'parthenolide (delta mass:-12.04)',CCMSLIB00010120978,-12.04,185,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722546,related spectra of 'nalidixic acid (delta mass:-13.98)',CCMSLIB00003136966,-13.98,186,Drug_analog,nalidixic acid,quinolone antimicrobial,infectious disease,urinary tract infections,bacterial DNA gyrase inhibitor,MHWLWQUZZRMNGJ-UHFFFAOYSA-N
CCMSLIB00012722547,related spectra of 'parthenolide (delta mass:-12.0)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238|CCMSLIB00010120978,-12,187,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722548,related spectra of 'parthenolide (delta mass:-12.0)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120978,-12,188,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722549,related spectra of 'parthenolide (delta mass:-12.0)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120978,-12,189,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722550,related spectra of 'parthenolide (delta mass:-12.0)',CCMSLIB00010120978,-12,190,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722551,related spectra of 'parthenolide (delta mass:-12.0)',CCMSLIB00010108898,-12,191,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722552,related spectra of 'parthenolide (delta mass:-12.0)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120978,-12,192,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722553,related spectra of 'parthenolide (delta mass:-12.0)',CCMSLIB00010120978,-12,193,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722554,related spectra of 'parthenolide (delta mass:-12.0)',CCMSLIB00010120978,-12,194,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722555,related spectra of 'parthenolide (delta mass:-12.0)',CCMSLIB00010108898|CCMSLIB00010109636,-12,195,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722556,related spectra of 'parthenolide (delta mass:-12.0)',CCMSLIB00010108898|CCMSLIB00010120978,-12,196,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722557,related spectra of 'parthenolide (delta mass:-12.0)',CCMSLIB00010108898,-12,197,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722558,related spectra of 'parthenolide (delta mass:-12.0)',CCMSLIB00010108898,-12,198,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722559,related spectra of 'parthenolide (delta mass:-11.96)',CCMSLIB00010108898|CCMSLIB00010120978,-11.96,199,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722560,related spectra of 'parthenolide (delta mass:-11.96)',CCMSLIB00010108898,-11.96,200,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722561,related spectra of 'parthenolide (delta mass:-11.96)',CCMSLIB00010108898,-11.96,201,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722562,related spectra of 'kinetin (delta mass:4.03)',CCMSLIB00000222331,4.03,202,Drug_analog|Low_confidence,kinetin,no_match,NA,NA,cell division inducer,QANMHLXAZMSUEX-UHFFFAOYSA-N
CCMSLIB00012722563,related spectra of '93413-77-5 (delta mass:-30.01)',CCMSLIB00000210056|CCMSLIB00000210058|CCMSLIB00000210069|CCMSLIB00005772429,-30.01,203,Drug_analog,"n,n-didesmethylvenlafaxine",serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,SUQHIQRIIBKNOR-UHFFFAOYSA-N
CCMSLIB00012722564,related spectra of 'methsuximide (delta mass:18.01)',CCMSLIB00000565859|CCMSLIB00000567962|CCMSLIB00005730706,18.01,204,Drug_analog,methsuximide,antiepileptic drug (AED),neurology/psychiatry,seizures,T-type calcium channel blocker,AJXPJJZHWIXJCJ-UHFFFAOYSA-N
CCMSLIB00012722565,related spectra of 'ethopabate (delta mass:-13.98)',CCMSLIB00005776729,-13.98,205,Drug_analog,ethopabate,other antiprotozoal agents|veterinary,infectious disease,coccidiosis,antiprotozoal agent,GOVWOKSKFSBNGD-UHFFFAOYSA-N
CCMSLIB00012722566,related spectra of 'methyldopa (delta mass:12.04)',CCMSLIB00005761328,12.04,206,Drug_analog|Low_confidence,methyldopa,central alpha-2 adrenergic agonist,cardiology,hypertension,adrenergic receptor agonist,CJCSPKMFHVPWAR-JTQLQIEISA-N
CCMSLIB00012722567,related spectra of 'oxymatrine (delta mass:-43.04)',CCMSLIB00006516978|CCMSLIB00006516997|CCMSLIB00006517018,-43.04,207,Drug_analog,oxymatrine,no_match,NA,NA,NA,XVPBINOPNYFXID-LHDUFFHYSA-N
CCMSLIB00012722568,"related spectra of 'albuterol (delta mass:-18.01)', 'salbutamol (delta mass:-18.01)'",CCMSLIB00000206003|CCMSLIB00000211876|CCMSLIB00000211878|CCMSLIB00000211880|CCMSLIB00000211889|CCMSLIB00000211891|CCMSLIB00005771532|CCMSLIB00010150054,-18.01,208,Drug_analog,albuterol|salbutamol,beta-2 adrenergic agonist,pulmonary,asthma,adrenergic receptor agonist,NDAUXUAQIAJITI-UHFFFAOYSA-N
CCMSLIB00012722569,related spectra of 'bamethan (delta mass:12.0)',CCMSLIB00010118732,12,209,Drug_analog,bamethan,no_match,no_match,no_match,no_match,RDUHXGIIUDVSHR-UHFFFAOYSA-N
CCMSLIB00012722570,related spectra of 'bucetin (delta mass:-1.98)',CCMSLIB00005766017|CCMSLIB00010132858|CCMSLIB00010132859|CCMSLIB00010132860,-1.98,210,Drug_analog,bucetin|bucetin,no_match,NA,NA,analgesic agent,LIAWQASKBFCRNR-UHFFFAOYSA-N
CCMSLIB00012722571,related spectra of 'bamethan (delta mass:12.0)',CCMSLIB00010107397|CCMSLIB00010118732,12,211,Drug_analog,bamethan,no_match,no_match,no_match,no_match,RDUHXGIIUDVSHR-UHFFFAOYSA-N
CCMSLIB00012722572,related spectra of 'mirogabalin (delta mass:12.04)',CCMSLIB00010148397|CCMSLIB00010149218,12.04,212,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722573,related spectra of 'meptazinol (delta mass:-12.0)',CCMSLIB00000565906|CCMSLIB00000567833|CCMSLIB00005735309,-12,213,Drug_analog,meptazinol,opioid agonist,neurology/psychiatry,pain relief,opioid receptor agonist,JLICHNCFTLFZJN-UHFFFAOYSA-N
CCMSLIB00012722574,related spectra of 'albuterol (delta mass:-17.03)',CCMSLIB00000211878|CCMSLIB00000211880|CCMSLIB00000211889|CCMSLIB00000211891,-17.03,214,Drug_analog,albuterol,beta-2 adrenergic agonist,pulmonary,asthma,adrenergic receptor agonist,NDAUXUAQIAJITI-UHFFFAOYSA-N
CCMSLIB00012722575,"related spectra of 'n,o-didesmethylvenlafaxine (delta mass:-27.05)'",CCMSLIB00000210046|CCMSLIB00000578723,-27.05,215,Drug_analog,"n,o-didesmethylvenlafaxine",serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MMSWXJSQCAEDLK-UHFFFAOYSA-N
CCMSLIB00012722576,related spectra of 'memantine (delta mass:43.05)',CCMSLIB00000084751|CCMSLIB00000085515,43.04,216,Drug_analog,memantine,N-methyl-D-aspartate (NMDA) receptor antagonist,neurology/psychiatry,Alzheimer's disease|senile dementia,glutamate receptor antagonist,BUGYDGFZZOZRHP-WSVSKBAQSA-N|BUGYDGFZZOZRHP-UHFFFAOYSA-N
CCMSLIB00012722577,"related spectra of 'l-buthionine sulfoximine (delta mass:1.98)', '5072-26-4 (delta mass:1.98)'",CCMSLIB00010135341|CCMSLIB00010135342|CCMSLIB00010135344|CCMSLIB00010135345|CCMSLIB00010146398,1.98,217,Drug_analog,5072-26-4|l-buthionine sulfoximine,no_match,NA,NA,glutathione transferase inhibitor,KJQFBVYMGADDTQ-UHFFFAOYSA-N|KJQFBVYMGADDTQ-CVSPRKDYSA-N
CCMSLIB00012722578,related spectra of 'cantharidin (delta mass:28.03)',CCMSLIB00010125871,28.03,218,Drug_analog,cantharidin,no_match,dermatology,blisters|molluscum contagiosum,protein phosphatase inhibitor,DHZBEENLJMYSHQ-UHFFFAOYSA-N
CCMSLIB00012722579,related spectra of 'minoxidil (delta mass:15.01)',CCMSLIB00000085945,15.01,219,Drug_analog,minoxidil,arteriolar vasodilator,cardiology|dermatology,androgenetic alopecia|hypertension,KATP activator|Kir6 channel (KATP) activator|vasodilator,IHGXBAMAHRLAOP-UHFFFAOYSA-N
CCMSLIB00012722580,related spectra of 'artemisinin (delta mass:-58.01)',CCMSLIB00005768223,-58.01,220,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012722581,related spectra of 'pilocarpine (delta mass:16.03)',CCMSLIB00005768827|CCMSLIB00005768859|CCMSLIB00005769999|CCMSLIB00006113280,16.03,221,Drug_analog,pilocarpine,cholinergic agonist,ophthalmology|dental,glaucoma|dry mouth,acetylcholine receptor agonist,QCHFTSOMWOSFHM-WPRPVWTQSA-N|QCHFTSOMWOSFHM-UHFFFAOYSA-N
CCMSLIB00012722582,related spectra of 'pilocarpine (delta mass:16.03)',CCMSLIB00006113280,16.03,222,Drug_analog,pilocarpine,cholinergic agonist,ophthalmology|dental,glaucoma|dry mouth,acetylcholine receptor agonist,QCHFTSOMWOSFHM-UHFFFAOYSA-N
CCMSLIB00012722583,related spectra of 'dydrogesterone (delta mass:-88.05)',CCMSLIB00005774596,-88.05,223,Drug_analog,dydrogesterone,progestin,obstetrics/gynecology,infertility,progesterone receptor agonist,JGMOKGBVKVMRFX-HQZYFCCVSA-N
CCMSLIB00012722584,related spectra of 'varenicline (delta mass:14.02)',CCMSLIB00000568880|CCMSLIB00000569001|CCMSLIB00005730384|CCMSLIB00005731000,14.02,224,Drug_analog,varenicline,nicotinic receptor partial agonist|cholinergic agonist,neurology/psychiatry|ophthalmology,smoking cessation|dry eye disease,acetylcholine receptor agonist,JQSHBVHOMNKWFT-UHFFFAOYSA-N
CCMSLIB00012722585,related spectra of 'memantine (delta mass:45.99)',CCMSLIB00006115995|CCMSLIB00006115997|CCMSLIB00006116000|CCMSLIB00006116002,45.99,225,Drug_analog,memantine,N-methyl-D-aspartate (NMDA) receptor antagonist,neurology/psychiatry,Alzheimer's disease|senile dementia,glutamate receptor antagonist,BUGYDGFZZOZRHP-UHFFFAOYSA-N
CCMSLIB00012722586,related spectra of 'uridine triacetate (delta mass:-18.01)',CCMSLIB00010102925|CCMSLIB00010126540,-18.01,226,Drug_analog,uridine triacetate,various alimentary tract and metabolism products,genetics|critical care,orotic aciduria|fluorouracil overdose|capecitabine overdose,pyrimidine analog,DRTQHJPVMGBUCF-XVFCMESISA-N
CCMSLIB00012722587,related spectra of 'ritodrine (delta mass:-61.05)',CCMSLIB00010151676|CCMSLIB00010151679,-61.05,227,Drug_analog,ritodrine,"sympathomimetics, labour repressants",obstetrics/gynecology,premature labor,adrenergic receptor agonist,IOVGROKTTNBUGK-SJCJKPOMSA-N
CCMSLIB00012722588,related spectra of 'terbutaline (delta mass:0.98)',CCMSLIB00000206419|CCMSLIB00005771250,0.98,228,Drug_analog,terbutaline,beta-2 adrenergic agonist,pulmonary|obstetrics/gynecology,bronchospasm|bronchitis|emphysema|asthma|premature labor,adrenergic receptor agonist,XWTYSIMOBUGWOL-UHFFFAOYSA-N
CCMSLIB00012722589,related spectra of 'artemisinin (delta mass:-56.03)',CCMSLIB00005768072|CCMSLIB00005770754,-56.03,229,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012722590,related spectra of 'parthenolide (delta mass:-4.0)',CCMSLIB00010108898|CCMSLIB00010109636,-3.99,230,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722591,related spectra of 'methyltestosterone (delta mass:-76.03)',CCMSLIB00005775092,-76.03,231,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012722592,related spectra of 'methyltestosterone (delta mass:-76.03)',CCMSLIB00005775092,-76.03,232,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012722593,related spectra of 'cetrimonium (delta mass:-56.06)',CCMSLIB00010147046,-56.06,233,Drug_analog,cetrimonium,antiseptics and disinfectants,NA,cosmetic,preservative|antiseptic,RLGQACBPNDBWTB-UHFFFAOYSA-N
CCMSLIB00012722594,related spectra of 'higenamine (delta mass:-43.04)',CCMSLIB00006439515,-43.04,234,Drug_analog,higenamine,no_match,NA,NA,adrenergic receptor agonist,WZRCQWQRFZITDX-UHFFFAOYSA-N
CCMSLIB00012722595,related spectra of 'apr-246 (delta mass:28.99)',CCMSLIB00010147821,28.99,235,Drug_analog,apr-246,no_match,NA,NA,p53 activator,BGBNULCRKBVAKL-UHFFFAOYSA-N
CCMSLIB00012722596,related spectra of 'parthenolide (delta mass:-2.02)',CCMSLIB00010108898|CCMSLIB00010120238|CCMSLIB00010120978,-2.02,236,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722597,related spectra of 'parthenolide (delta mass:-2.02)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120978,-2.02,237,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722598,related spectra of 'mirogabalin (delta mass:18.99)',CCMSLIB00010148395|CCMSLIB00010148396|CCMSLIB00010148398|CCMSLIB00010149216|CCMSLIB00010149217|CCMSLIB00010149219,18.99,238,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722599,related spectra of 'mirogabalin (delta mass:18.99)',CCMSLIB00010148396|CCMSLIB00010148398|CCMSLIB00010149217|CCMSLIB00010149219,18.99,239,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722600,related spectra of 'dethiobiotin (delta mass:14.02)',CCMSLIB00010139695|CCMSLIB00010139696,14.02,240,Drug_analog|Low_confidence,dethiobiotin,no_match,no_match,no_match,no_match,AUTOLBMXDDTRRT-JGVFFNPUSA-N
CCMSLIB00012722601,related spectra of 'dethiobiotin (delta mass:14.02)',CCMSLIB00010139695|CCMSLIB00010139696,14.02,241,Drug_analog|Low_confidence,dethiobiotin,no_match,no_match,no_match,no_match,AUTOLBMXDDTRRT-JGVFFNPUSA-N
CCMSLIB00012722602,related spectra of 'parthenolide (delta mass:-1.98)',CCMSLIB00010120238,-1.98,242,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722603,related spectra of 'parthenolide (delta mass:-1.98)',CCMSLIB00010120238,-1.98,243,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722604,related spectra of 'testosterone propionate (delta mass:-116.08)',CCMSLIB00005763640,-116.08,244,Drug_analog|Low_confidence,testosterone propionate,androgen,endocrinology,hypogonadism,androgen receptor agonist,PDMMFKSKQVNJMI-BLQWBTBKSA-N
CCMSLIB00012722605,related spectra of 'oxybenzone (delta mass:1.0)',CCMSLIB00003135866|CCMSLIB00003137818,1,245,Drug_analog,oxybenzone,no_match,dermatology,sunscreen lotion,lipase inhibitor,DXGLGDHPHMLXJC-UHFFFAOYSA-N
CCMSLIB00012722606,"related spectra of 'levomilnacipran (delta mass:-17.03)', 'milnacipran (delta mass:-17.03)'",CCMSLIB00010138305|CCMSLIB00010138306|CCMSLIB00010142030|CCMSLIB00010142033|CCMSLIB00010142035,-17.03,246,Drug_analog,levomilnacipran|milnacipran,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry|rheumatology,depression|fibromyalgia,serotonin and norepinephrine reuptake inhibitor (SNRI),GJJFMKBJSRMPLA-DZGCQCFKSA-N|GJJFMKBJSRMPLA-HIFRSBDPSA-N
CCMSLIB00012722607,related spectra of 'vardenafil (delta mass:-14.02)',CCMSLIB00000079077,-14.02,247,Drug_analog,vardenafil,phosphodiesterase-5 (PDE-5) inhibitor,urology,erectile dysfunction,phosphodiesterase inhibitor,SECKRCOLJRRGGV-UHFFFAOYSA-N
CCMSLIB00012722608,related spectra of 'vardenafil (delta mass:-14.02)',CCMSLIB00000079077,-14.02,248,Drug_analog,vardenafil,phosphodiesterase-5 (PDE-5) inhibitor,urology,erectile dysfunction,phosphodiesterase inhibitor,SECKRCOLJRRGGV-UHFFFAOYSA-N
CCMSLIB00012722609,related spectra of 'vabicaserin (delta mass:1.94)',CCMSLIB00010146626,1.94,249,Drug_analog,vabicaserin,no_match,no_match,no_match,no_match,NPTIPEQJIDTVKR-STQMWFEESA-N
CCMSLIB00012722610,related spectra of 'norethindrone (delta mass:-68.06)',CCMSLIB00000564963,-68.06,250,Drug_analog,norethindrone,progestin,obstetrics/gynecology,endometriosis|contraceptive,progesterone receptor agonist,VIKNJXKGJWUCNN-XGXHKTLJSA-N
CCMSLIB00012722611,related spectra of 'drostanolone (delta mass:-56.06)',CCMSLIB00005723747,-56.06,251,Drug_analog|Low_confidence,drostanolone,no_match,no_match,no_match,no_match,FDGQIVOIHOIMNK-TZAHHXAYSA-N
CCMSLIB00012722612,related spectra of 'ethylestrenol (delta mass:-58.04)',CCMSLIB00005723751,-58.04,252,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012722613,"related spectra of 'n,o-didesmethylvenlafaxine (delta mass:-18.01)'",CCMSLIB00000210027|CCMSLIB00000210029|CCMSLIB00000210031|CCMSLIB00000210039|CCMSLIB00000210042|CCMSLIB00000210044|CCMSLIB00000210046|CCMSLIB00000578722|CCMSLIB00000578723|CCMSLIB00000578726,-18.01,253,Drug_analog,"n,o-didesmethylvenlafaxine",serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MMSWXJSQCAEDLK-UHFFFAOYSA-N
CCMSLIB00012722614,related spectra of 'enoxolone (delta mass:-1.98)',CCMSLIB00000567316,-1.98,254,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012722615,"related spectra of 'methoxsalen (delta mass:15.99)', 'methoxsalen (delta mass:16.0)'",CCMSLIB00000005191|CCMSLIB00004695005|CCMSLIB00005762664|CCMSLIB00005763985|CCMSLIB00006417000|CCMSLIB00006417008|CCMSLIB00006417016|CCMSLIB00006417040|CCMSLIB00006417048|CCMSLIB00006417056|CCMSLIB00006417064|CCMSLIB00006417072|CCMSLIB00006417080|CCMSLIB00006417088|CCMSLIB00006417103|CCMSLIB00006417123|CCMSLIB00006417137|CCMSLIB00006417144|CCMSLIB00006417152|CCMSLIB00006417167|CCMSLIB00006417175|CCMSLIB00006417183|CCMSLIB00006417191|CCMSLIB00006417198|CCMSLIB00006417206|CCMSLIB00006417214|CCMSLIB00006417222|CCMSLIB00006417230|CCMSLIB00006417238|CCMSLIB00006417261|CCMSLIB00006417283|CCMSLIB00006417291|CCMSLIB00006417299|CCMSLIB00006417307|CCMSLIB00006417329|CCMSLIB00006417337|CCMSLIB00006417345|CCMSLIB00006417353|CCMSLIB00010117636|CCMSLIB00010117637,15.99,255,Drug_analog,methoxsalen,photoactivated radical generator|psoralen,dermatology,psoriasis,DNA synthesis inhibitor,QXKHYNVANLEOEG-UHFFFAOYSA-N
CCMSLIB00012722616,related spectra of 'parthenolide (delta mass:1.94)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238|CCMSLIB00010120978,1.94,256,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722617,related spectra of 'parthenolide (delta mass:1.94)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238|CCMSLIB00010120978,1.94,257,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722618,related spectra of 'parthenolide (delta mass:1.94)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120978,1.94,258,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722619,related spectra of 'parthenolide (delta mass:1.94)',CCMSLIB00010108898|CCMSLIB00010109636,1.94,259,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722620,related spectra of 'benzyl benzoate (delta mass:-17.97)',CCMSLIB00004692056,-17.97,260,Drug_analog,benzyl benzoate,"other ectoparasiticides, incl. scabicides",infectious disease,lice|mites|scabies,lipase inhibitor,SESFRYSPDFLNCH-UHFFFAOYSA-N
CCMSLIB00012722621,related spectra of 'parthenolide (delta mass:1.94)',CCMSLIB00010120238|CCMSLIB00010120978,1.94,261,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722622,related spectra of 'parthenolide (delta mass:1.94)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238|CCMSLIB00010120978,1.94,262,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722623,related spectra of 'masoprocol (delta mass:-70.08)',CCMSLIB00006555764,-70.08,263,Drug_analog,masoprocol,other antineoplastic agents,dermatology,actinic keratosis (AK),lipoxygenase inhibitor,HCZKYJDFEPMADG-UHFFFAOYSA-N
CCMSLIB00012722624,related spectra of 'parthenolide (delta mass:1.94)',CCMSLIB00010108898,1.94,264,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722625,related spectra of 'parthenolide (delta mass:1.94)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238|CCMSLIB00010120978,1.94,265,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722626,related spectra of 'parthenolide (delta mass:1.94)',CCMSLIB00010108898|CCMSLIB00010120238|CCMSLIB00010120978,1.94,266,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722627,related spectra of 'oxybenzone (delta mass:3.99)',CCMSLIB00003135866,3.99,267,Drug_analog,oxybenzone,no_match,dermatology,sunscreen lotion,lipase inhibitor,DXGLGDHPHMLXJC-UHFFFAOYSA-N
CCMSLIB00012722628,related spectra of 'parthenolide (delta mass:1.94)',CCMSLIB00010109636|CCMSLIB00010120978,1.94,268,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722629,related spectra of 'parthenolide (delta mass:1.98)',CCMSLIB00010108898|CCMSLIB00010109636,1.98,269,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722630,related spectra of 'pindolol (delta mass:-16.03)',CCMSLIB00005774021,-16.03,270,Drug_analog|Low_confidence,pindolol,beta-adrenergic receptor inhibitor,cardiology,hypertension,adrenergic receptor antagonist,JZQKKSLKJUAGIC-UHFFFAOYSA-N
CCMSLIB00012722631,related spectra of 'parthenolide (delta mass:2.0)',CCMSLIB00010108898|CCMSLIB00010120978,2,271,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722632,related spectra of 'parthenolide (delta mass:2.02)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238,2.02,272,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722633,related spectra of 'parthenolide (delta mass:2.02)',CCMSLIB00010108898|CCMSLIB00010120978,2.02,273,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722634,related spectra of 'parthenolide (delta mass:2.02)',CCMSLIB00010108898,2.02,274,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722635,related spectra of 'parthenolide (delta mass:2.02)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238|CCMSLIB00010120978,2.02,275,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722636,"related spectra of 'n,o-didesmethylvenlafaxine (delta mass:-17.03)'",CCMSLIB00000210031|CCMSLIB00000210033|CCMSLIB00000210044|CCMSLIB00000210046|CCMSLIB00000578722|CCMSLIB00000578723|CCMSLIB00000578724|CCMSLIB00000578725,-17.03,276,Drug_analog,"n,o-didesmethylvenlafaxine",serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MMSWXJSQCAEDLK-UHFFFAOYSA-N
CCMSLIB00012722637,related spectra of 'physostigmine (delta mass:-43.01)',CCMSLIB00005763991|CCMSLIB00006569404|CCMSLIB00006569418|CCMSLIB00006569432|CCMSLIB00006569446|CCMSLIB00006569460|CCMSLIB00006569474|CCMSLIB00006569488,-43.01,277,Drug_analog,physostigmine,cholinesterase inhibitor,neurology/psychiatry|ophthalmology,glaucoma|anticholinergic toxicity,acetylcholinesterase inhibitor|cholinesterase inhibitor,PIJVFDBKTWXHHD-HIFRSBDPSA-N
CCMSLIB00012722638,related spectra of '2-acetamido-2-deoxy-d-mannopyranose (delta mass:30.01)',CCMSLIB00010131505,30.01,278,Drug_analog,2-acetamido-2-deoxy-d-mannopyranose,no_match,NA,NA,NA,OVRNDRQMDRJTHS-ZTVVOAFPSA-N
CCMSLIB00012722639,related spectra of 'metaxalone (delta mass:12.0)',CCMSLIB00000566558|CCMSLIB00000566663|CCMSLIB00005732441|CCMSLIB00005733214,12,279,Drug_analog,metaxalone,muscle relaxants,neurology/psychiatry,muscle pain|spasm,muscle relaxant,IMWZZHHPURKASS-UHFFFAOYSA-N
CCMSLIB00012722640,"related spectra of 'edta (delta mass:--58.01)', 'edetic acid (delta mass:-58.0)', 'edetic acid (delta mass:--58.01)'",CCMSLIB00003135454|CCMSLIB00003135498|CCMSLIB00005435779|CCMSLIB00006113816|CCMSLIB00006113818|CCMSLIB00006113819|CCMSLIB00006113821|CCMSLIB00006113822|CCMSLIB00010145114,-58.01,280,Drug_analog|Background/QAQC,edta,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N
CCMSLIB00012722641,related spectra of 'l-canavanine (delta mass:58.01)',CCMSLIB00010134906|CCMSLIB00010134907|CCMSLIB00010134909,58.01,281,Drug_analog,l-canavanine,no_match,no_match,no_match,no_match,FSBIGDSBMBYOPN-VKHMYHEASA-N
CCMSLIB00012722642,related spectra of 'parthenolide (delta mass:3.99)',CCMSLIB00010109636,3.99,282,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722643,related spectra of 'parthenolide (delta mass:3.99)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238|CCMSLIB00010120978,3.99,283,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722644,related spectra of 'parthenolide (delta mass:3.99)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238|CCMSLIB00010120978,3.99,284,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722645,"related spectra of 'n,o-didesmethylvenlafaxine (delta mass:-15.01)'",CCMSLIB00000210031|CCMSLIB00000210044|CCMSLIB00000210046|CCMSLIB00000578722|CCMSLIB00000578723,-15.01,285,Drug_analog,"n,o-didesmethylvenlafaxine",serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MMSWXJSQCAEDLK-UHFFFAOYSA-N
CCMSLIB00012722646,"related spectra of 'n,o-didesmethylvenlafaxine (delta mass:-15.01)'",CCMSLIB00000210031|CCMSLIB00000210044|CCMSLIB00000210046|CCMSLIB00000578722|CCMSLIB00000578723,-15.01,286,Drug_analog,"n,o-didesmethylvenlafaxine",serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MMSWXJSQCAEDLK-UHFFFAOYSA-N
CCMSLIB00012722647,related spectra of 'parthenolide (delta mass:4.03)',CCMSLIB00010120238,4.03,287,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722648,related spectra of 'parthenolide (delta mass:4.03)',CCMSLIB00010120978,4.03,288,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722649,related spectra of 'parthenolide (delta mass:4.03)',CCMSLIB00010120978,4.03,289,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722650,related spectra of 'meptazinol (delta mass:0.98)',CCMSLIB00000085774,0.98,290,Drug_analog,meptazinol,opioid agonist,neurology/psychiatry,pain relief,opioid receptor agonist,JLICHNCFTLFZJN-UHFFFAOYSA-N
CCMSLIB00012722651,"related spectra of 'n,o-didesmethylvenlafaxine (delta mass:-15.01)'",CCMSLIB00000210044|CCMSLIB00000210046|CCMSLIB00000578723,-15.01,291,Drug_analog,"n,o-didesmethylvenlafaxine",serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MMSWXJSQCAEDLK-UHFFFAOYSA-N
CCMSLIB00012722652,related spectra of 'perhexiline (delta mass:-43.04)',CCMSLIB00010145792|CCMSLIB00010145795,-43.04,292,Drug_analog|Low_confidence,perhexiline,other non-selective calcium channel blockers,cardiology,angina pectoris,carnitine palmitoyltransferase inhibitor,CYXKNKQEMFBLER-UHFFFAOYSA-N
CCMSLIB00012722653,related spectra of 'n-desmethylvenlafaxine (delta mass:-28.03)',CCMSLIB00000209369|CCMSLIB00000209382|CCMSLIB00000209383,-28.03,293,Drug_analog,n-desmethylvenlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MKAFOJAJJMUXLW-UHFFFAOYSA-N
CCMSLIB00012722654,related spectra of 'riluzole (delta mass:1.98)',CCMSLIB00003137619|CCMSLIB00003138461,1.98,294,Drug_analog,riluzole,benzothiazole,neurology/psychiatry,amyotrophic lateral sclerosis (ALS),glutamate inhibitor,FTALBRSUTCGOEG-UHFFFAOYSA-N
CCMSLIB00012722655,related spectra of 'morpholinylmercaptobenzothiazole (delta mass:-15.01)',CCMSLIB00005773523,-15.01,295,Drug_analog,morpholinylmercaptobenzothiazole,no_match,NA,NA,NA,MHKLKWCYGIBEQF-UHFFFAOYSA-N
CCMSLIB00012722656,related spectra of 'bupropion (delta mass:-2.02)',CCMSLIB00000078995|CCMSLIB00005775551|CCMSLIB00005775972|CCMSLIB00006122678|CCMSLIB00006122683,-2.02,296,Drug_analog,bupropion,aminoketone,neurology/psychiatry,depression,dopamine-norepinephrine reuptake inhibitor,SNPPWIUOZRMYNY-UHFFFAOYSA-N
CCMSLIB00012722657,related spectra of 'bupropion (delta mass:-2.02)',CCMSLIB00005772629,-2.02,297,Drug_analog,bupropion,aminoketone,neurology/psychiatry,depression,dopamine-norepinephrine reuptake inhibitor,SNPPWIUOZRMYNY-UHFFFAOYSA-N
CCMSLIB00012722658,related spectra of 'mirogabalin (delta mass:27.99)',CCMSLIB00010148399|CCMSLIB00010149220,27.99,298,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722659,related spectra of 'rimantadine (delta mass:58.0)',CCMSLIB00000563621|CCMSLIB00000566331|CCMSLIB00000566347|CCMSLIB00000566351|CCMSLIB00000574056|CCMSLIB00005731441|CCMSLIB00005731570|CCMSLIB00005732527|CCMSLIB00005733302|CCMSLIB00005735868|CCMSLIB00010131280|CCMSLIB00010131281|CCMSLIB00010131282|CCMSLIB00010131284|CCMSLIB00010131285,58.01,299,Drug_analog|Low_confidence,rimantadine,influenza A M2 protein inhibitor,infectious disease,influenza A virus infection,antiviral|RNA synthesis inhibitor,UBCHPRBFMUDMNC-UHFFFAOYSA-N|UBCHPRBFMUDMNC-ULCLOTFOSA-N
CCMSLIB00012722660,related spectra of 'carbamazepine (delta mass:1.94)',CCMSLIB00010131213,1.94,300,Drug_analog,carbamazepine,mood stabilizer,neurology/psychiatry,seizures|trigeminal neuralgia,carboxamide antiepileptic,FFGPTBGBLSHEPO-UHFFFAOYSA-N
CCMSLIB00012722661,related spectra of 'yohimbine (delta mass:-116.08)',CCMSLIB00005740107|CCMSLIB00005742488|CCMSLIB00005745210|CCMSLIB00005747147|CCMSLIB00005767875|CCMSLIB00005768187|CCMSLIB00005769686|CCMSLIB00005769877,-116.08,301,Drug_analog,yohimbine,drugs used in erectile dysfunction,urology,erectile dysfunction,adrenergic receptor antagonist,BLGXFZZNTVWLAY-UHFFFAOYSA-N|BLGXFZZNTVWLAY-SCYLSFHTSA-N
CCMSLIB00012722662,related spectra of 'ketamine (delta mass:1.98)',CCMSLIB00000211647,1.98,302,Drug_analog,ketamine,general anesthetic,neurology/psychiatry,anesthesia,NMDA receptor antagonist,YQEZLKZALYSWHR-UHFFFAOYSA-N
CCMSLIB00012722663,related spectra of 'ketamine (delta mass:2.0)',CCMSLIB00000211647|CCMSLIB00000211650|CCMSLIB00000211658|CCMSLIB00000211660,2,303,Drug_analog,ketamine,general anesthetic,neurology/psychiatry,anesthesia,NMDA receptor antagonist,YQEZLKZALYSWHR-UHFFFAOYSA-N
CCMSLIB00012722664,"related spectra of 'radafaxine (chimeric precursor selection) (delta mass:2.0)', 'radafaxine (delta mass:2.0)'",CCMSLIB00010131549|CCMSLIB00010131550|CCMSLIB00010131552|CCMSLIB00010131580|CCMSLIB00010131582|CCMSLIB00010131583|CCMSLIB00010131585|CCMSLIB00010131586|CCMSLIB00010131657|CCMSLIB00010131659|CCMSLIB00010131660,2,304,Drug_analog,hydroxybupropion,no_match,NA,NA,dopamine-norepinephrine reuptake inhibitor,RCOBKSKAZMVBHT-TVQRCGJNSA-N
CCMSLIB00012722665,related spectra of 'ketamine (delta mass:2.02)',CCMSLIB00000211647|CCMSLIB00000211660,2.02,305,Drug_analog,ketamine,general anesthetic,neurology/psychiatry,anesthesia,NMDA receptor antagonist,YQEZLKZALYSWHR-UHFFFAOYSA-N
CCMSLIB00012722666,"related spectra of 'radafaxine (chimeric precursor selection) (delta mass:2.02)', 'radafaxine (delta mass:2.02)'",CCMSLIB00010131545|CCMSLIB00010131546|CCMSLIB00010131547|CCMSLIB00010131548|CCMSLIB00010131549|CCMSLIB00010131550|CCMSLIB00010131551|CCMSLIB00010131552|CCMSLIB00010131579|CCMSLIB00010131580|CCMSLIB00010131581|CCMSLIB00010131582|CCMSLIB00010131583|CCMSLIB00010131584|CCMSLIB00010131585|CCMSLIB00010131586|CCMSLIB00010131656|CCMSLIB00010131657|CCMSLIB00010131658|CCMSLIB00010131659|CCMSLIB00010131660,2.02,306,Drug_analog,hydroxybupropion,no_match,NA,NA,dopamine-norepinephrine reuptake inhibitor,RCOBKSKAZMVBHT-TVQRCGJNSA-N
CCMSLIB00012722667,related spectra of 'uridine triacetate (delta mass:-1.98)',CCMSLIB00005464337|CCMSLIB00006124703|CCMSLIB00006124704|CCMSLIB00006124705|CCMSLIB00006124706|CCMSLIB00006124707|CCMSLIB00006679633|CCMSLIB00010102471|CCMSLIB00010114425|CCMSLIB00010125753|CCMSLIB00010126086,-1.98,307,Drug_analog,uridine triacetate,various alimentary tract and metabolism products,genetics|critical care,orotic aciduria|fluorouracil overdose|capecitabine overdose,pyrimidine analog,DRTQHJPVMGBUCF-XVFCMESISA-N
CCMSLIB00012722668,related spectra of 'acadesine (delta mass:-18.01)',CCMSLIB00006122902|CCMSLIB00006122905|CCMSLIB00006679593,-18.01,308,Drug_analog,acadesine,no_match,NA,NA,AMPK activator,RTRQQBHATOEIAF-UUOKFMHZSA-N
CCMSLIB00012722669,related spectra of 'cantharidin (delta mass:44.02)',CCMSLIB00010125871,44.03,309,Drug_analog,cantharidin,no_match,dermatology,blisters|molluscum contagiosum,protein phosphatase inhibitor,DHZBEENLJMYSHQ-UHFFFAOYSA-N
CCMSLIB00012722670,related spectra of 'telbivudine (delta mass:-1.98)',CCMSLIB00003139902,-1.98,310,Drug_analog|Low_confidence,telbivudine,HBV nucleoside analog reverse transcriptase inhibitor (HBV-NRTI),infectious disease,hepatitis B,DNA polymerase inhibitor,IQFYYKKMVGJFEH-XLPZGREQSA-N
CCMSLIB00012722671,related spectra of 'enzacamene (delta mass:-14.02)',CCMSLIB00005777228,-14.02,311,Drug_analog,enzacamene,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-UHFFFAOYSA-N
CCMSLIB00012722672,related spectra of 'canrenone (delta mass:-100.02)',CCMSLIB00005775230,-100.02,312,Drug_analog,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012722673,related spectra of 'parthenolide (delta mass:12.0)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120978,12,313,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722674,related spectra of 'parthenolide (delta mass:12.04)',CCMSLIB00010108898,12.04,314,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722675,related spectra of 'parthenolide (delta mass:12.04)',CCMSLIB00010109636,12.04,315,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722676,related spectra of 'oxandrolone (delta mass:-44.02)',CCMSLIB00005723842,-44.03,316,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012722677,"related spectra of 'uridine triacetate (delta mass:1.01)', 'uridine triacetate (delta mass:1.0)'",CCMSLIB00005464337|CCMSLIB00006124693|CCMSLIB00006124694|CCMSLIB00006124695|CCMSLIB00006124696|CCMSLIB00006124697|CCMSLIB00006124698|CCMSLIB00006124700|CCMSLIB00006124712,1,317,Drug_analog,uridine triacetate,various alimentary tract and metabolism products,genetics|critical care,orotic aciduria|fluorouracil overdose|capecitabine overdose,pyrimidine analog,DRTQHJPVMGBUCF-XVFCMESISA-N
CCMSLIB00012722678,related spectra of 'oxybenzone (delta mass:16.03)',CCMSLIB00003135866,16.03,318,Drug_analog,oxybenzone,no_match,dermatology,sunscreen lotion,lipase inhibitor,DXGLGDHPHMLXJC-UHFFFAOYSA-N
CCMSLIB00012722679,related spectra of 'naproxen (delta mass:14.02)',CCMSLIB00005774179,14.02,319,Drug_analog,naproxen,nonsteroidal anti-inflammatory drug,neurology/psychiatry|rheumatology,pain relief|rheumatoid arthritis|headache|toothache|backache|muscle pain|common cold|fever,cyclooxygenase inhibitor,CMWTZPSULFXXJA-UHFFFAOYSA-N
CCMSLIB00012722680,related spectra of 'cortisone acetate (delta mass:-116.06)',CCMSLIB00000566981|CCMSLIB00000570072|CCMSLIB00004704962|CCMSLIB00004719904|CCMSLIB00005730548|CCMSLIB00005734900|CCMSLIB00005768231|CCMSLIB00005768751|CCMSLIB00005769455|CCMSLIB00006117786|CCMSLIB00006117788|CCMSLIB00006117790|CCMSLIB00006117792|CCMSLIB00006117794|CCMSLIB00006684959,-116.06,320,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012722681,related spectra of 'cortisone acetate (delta mass:-116.06)',CCMSLIB00005463901,-116.06,321,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012722682,related spectra of 'cortisone acetate (delta mass:-116.06)',CCMSLIB00000570072|CCMSLIB00004719904|CCMSLIB00005734900|CCMSLIB00005768231|CCMSLIB00005768751|CCMSLIB00005769455,-116.06,322,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012722683,related spectra of 'cortisone acetate (delta mass:-116.06)',CCMSLIB00004704962|CCMSLIB00005768231,-116.06,323,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012722684,related spectra of 'cortisone acetate (delta mass:-116.06)',CCMSLIB00006117790,-116.06,324,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012722685,related spectra of 'cortisone acetate (delta mass:-116.06)',CCMSLIB00005768231,-116.06,325,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012722686,related spectra of 'cortisone acetate (delta mass:-116.06)',CCMSLIB00000570072|CCMSLIB00004719904|CCMSLIB00005734900|CCMSLIB00005768751|CCMSLIB00005769455|CCMSLIB00006117786|CCMSLIB00006117788|CCMSLIB00006117790|CCMSLIB00006117792|CCMSLIB00006117794,-116.06,326,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012722687,related spectra of 'cortisone acetate (delta mass:-116.06)',CCMSLIB00004691594|CCMSLIB00005734864|CCMSLIB00005769009,-116.06,327,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012722688,related spectra of 'cortisone acetate (delta mass:-116.06)',CCMSLIB00000570072|CCMSLIB00004719904|CCMSLIB00005734900|CCMSLIB00005768751|CCMSLIB00005769455,-116.06,328,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012722689,related spectra of 'cortisone acetate (delta mass:-116.06)',CCMSLIB00000570072|CCMSLIB00004691594|CCMSLIB00004704961|CCMSLIB00004704962|CCMSLIB00004719904|CCMSLIB00005726279|CCMSLIB00005726418|CCMSLIB00005726583|CCMSLIB00005734864|CCMSLIB00005734900|CCMSLIB00005768231|CCMSLIB00005768751|CCMSLIB00005769009|CCMSLIB00005769455|CCMSLIB00006117786|CCMSLIB00006117788|CCMSLIB00006117790|CCMSLIB00006117792|CCMSLIB00006117794|CCMSLIB00006684959,-116.06,329,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012722690,related spectra of 'cortisone acetate (delta mass:-116.06)',CCMSLIB00000570072|CCMSLIB00004719904|CCMSLIB00005734864|CCMSLIB00005734900|CCMSLIB00005768231|CCMSLIB00005768751|CCMSLIB00005769455|CCMSLIB00006117786|CCMSLIB00006117788|CCMSLIB00006117790|CCMSLIB00006117792|CCMSLIB00006117794,-116.06,330,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012722691,related spectra of 'cortisone acetate (delta mass:-116.06)',CCMSLIB00004691594|CCMSLIB00004704961|CCMSLIB00006117788|CCMSLIB00006117790|CCMSLIB00006117794,-116.06,331,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012722692,related spectra of 'cortisone acetate (delta mass:-116.06)',CCMSLIB00004704962,-116.06,332,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012722693,related spectra of 'cortisone acetate (delta mass:-116.06)',CCMSLIB00004704962,-116.06,333,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012722694,"related spectra of 'parthenolide (delta mass:14.01)', 'parthenolide (delta mass:14.02)'",CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238|CCMSLIB00010120978,14.02,334,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722695,related spectra of 'parthenolide (delta mass:14.02)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238|CCMSLIB00010120978,14.02,335,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722696,related spectra of 'parthenolide (delta mass:14.02)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238|CCMSLIB00010120978,14.02,336,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722697,related spectra of 'parthenolide (delta mass:14.02)',CCMSLIB00010120238|CCMSLIB00010120978,14.02,337,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722698,related spectra of 'icaridin (delta mass:15.01)',CCMSLIB00010140813|CCMSLIB00010140814,15.01,338,Drug_analog,icaridin,no_match,no_match,no_match,no_match,QLHULAHOXSSASE-UHFFFAOYSA-N
CCMSLIB00012722699,related spectra of 'ethylestrenol (delta mass:-26.02)',CCMSLIB00005723752,-26.02,339,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012722700,related spectra of 'mirogabalin (delta mass:36.02)',CCMSLIB00010149219,36.02,340,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722701,"related spectra of '93413-77-5 (delta mass:-3.99)', 'n-desmethylvenlafaxine (delta mass:-18.01)', '93413-77-5 (delta mass:-4.0)'",CCMSLIB00000209369|CCMSLIB00000209371|CCMSLIB00000209373|CCMSLIB00000209380|CCMSLIB00000209382|CCMSLIB00000209383|CCMSLIB00000209386|CCMSLIB00000210054|CCMSLIB00000210056|CCMSLIB00000210058|CCMSLIB00000210060|CCMSLIB00000210066|CCMSLIB00000210069|CCMSLIB00000210071|CCMSLIB00000210073|CCMSLIB00000210075|CCMSLIB00000578720|CCMSLIB00000578721,-3.99|-18.01,341,Drug_analog,"n-desmethylvenlafaxine|n,n-didesmethylvenlafaxine",serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MKAFOJAJJMUXLW-UHFFFAOYSA-N|SUQHIQRIIBKNOR-UHFFFAOYSA-N
CCMSLIB00012722702,related spectra of 'meptazinol (delta mass:12.0)',CCMSLIB00000565906|CCMSLIB00000567833|CCMSLIB00005735309,12,342,Drug_analog,meptazinol,opioid agonist,neurology/psychiatry,pain relief,opioid receptor agonist,JLICHNCFTLFZJN-UHFFFAOYSA-N
CCMSLIB00012722703,related spectra of 'edetic acid (delta mass:-43.99)',CCMSLIB00006114112|CCMSLIB00006114113|CCMSLIB00006114114|CCMSLIB00006114116|CCMSLIB00006114117|CCMSLIB00006114119|CCMSLIB00006114121|CCMSLIB00006114123|CCMSLIB00006114125,-43.99,343,Drug_analog|Background/QAQC,edta,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N
CCMSLIB00012722704,related spectra of 'antipyrine (delta mass:58.01)',CCMSLIB00010140525,58.01,344,Drug_analog,antipyrine,other analgesics and antipyretics,neurology/psychiatry,pain relief,cyclooxygenase inhibitor,VEQOALNAAJBPNY-UHFFFAOYSA-N
CCMSLIB00012722705,related spectra of 'parthenolide (delta mass:15.99)',CCMSLIB00010120978,15.99,345,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722706,related spectra of 'parthenolide (delta mass:15.99)',CCMSLIB00010109636,15.99,346,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722707,related spectra of 'parthenolide (delta mass:16.03)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120978,16.03,347,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722708,related spectra of 'parthenolide (delta mass:16.03)',CCMSLIB00010120238|CCMSLIB00010120978,16.03,348,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722709,related spectra of 'parthenolide (delta mass:16.03)',CCMSLIB00010120238,16.03,349,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722710,related spectra of 'ritodrine (delta mass:-40.03)',CCMSLIB00000085949|CCMSLIB00010151676|CCMSLIB00010151679,-40.03,350,Drug_analog,ritodrine,"sympathomimetics, labour repressants",obstetrics/gynecology,premature labor,adrenergic receptor agonist,IOVGROKTTNBUGK-SJCJKPOMSA-N
CCMSLIB00012722711,related spectra of 'nateglinide (delta mass:-68.06)',CCMSLIB00000567977|CCMSLIB00005732012|CCMSLIB00006118532|CCMSLIB00006118535|CCMSLIB00006118537|CCMSLIB00006118539|CCMSLIB00006118541|CCMSLIB00006118554|CCMSLIB00006118556|CCMSLIB00006118562,-68.06,351,Drug_analog,nateglinide,glinide,endocrinology,type 2 diabetes mellitus,insulin secretagogue,OELFLUMRDSZNSF-OFLPRAFFSA-N
CCMSLIB00012722712,related spectra of 'physostigmine (delta mass:-28.03)',CCMSLIB00005720159|CCMSLIB00006569488,-28.03,352,Drug_analog,physostigmine,cholinesterase inhibitor,neurology/psychiatry|ophthalmology,glaucoma|anticholinergic toxicity,acetylcholinesterase inhibitor|cholinesterase inhibitor,PIJVFDBKTWXHHD-HIFRSBDPSA-N
CCMSLIB00012722713,related spectra of '93413-77-5 (delta mass:-2.02)',CCMSLIB00000210060|CCMSLIB00000210071|CCMSLIB00000210073|CCMSLIB00000210075,-2.02,353,Drug_analog,"n,n-didesmethylvenlafaxine",serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,SUQHIQRIIBKNOR-UHFFFAOYSA-N
CCMSLIB00012722714,related spectra of 'uridine triacetate (delta mass:4.03)',CCMSLIB00006403979,4.03,354,Drug_analog,uridine triacetate,various alimentary tract and metabolism products,genetics|critical care,orotic aciduria|fluorouracil overdose|capecitabine overdose,pyrimidine analog,DRTQHJPVMGBUCF-XVFCMESISA-N
CCMSLIB00012722715,related spectra of 'uridine triacetate (delta mass:4.03)',CCMSLIB00006403979,4.03,355,Drug_analog,uridine triacetate,various alimentary tract and metabolism products,genetics|critical care,orotic aciduria|fluorouracil overdose|capecitabine overdose,pyrimidine analog,DRTQHJPVMGBUCF-XVFCMESISA-N
CCMSLIB00012722716,related spectra of 'physostigmine (delta mass:-27.05)',CCMSLIB00000084944|CCMSLIB00006400030|CCMSLIB00006400055|CCMSLIB00006400132|CCMSLIB00006400159|CCMSLIB00006400235,-27.05,356,Drug_analog,physostigmine,cholinesterase inhibitor,neurology/psychiatry|ophthalmology,glaucoma|anticholinergic toxicity,acetylcholinesterase inhibitor|cholinesterase inhibitor,PIJVFDBKTWXHHD-HIFRSBDPSA-N
CCMSLIB00012722717,related spectra of 'physostigmine (delta mass:-27.05)',CCMSLIB00000084944|CCMSLIB00005744745|CCMSLIB00006399807|CCMSLIB00006399835|CCMSLIB00006399863|CCMSLIB00006399919|CCMSLIB00006399947|CCMSLIB00006399975|CCMSLIB00006400003,-27.05,357,Drug_analog,physostigmine,cholinesterase inhibitor,neurology/psychiatry|ophthalmology,glaucoma|anticholinergic toxicity,acetylcholinesterase inhibitor|cholinesterase inhibitor,PIJVFDBKTWXHHD-HIFRSBDPSA-N
CCMSLIB00012722718,related spectra of 'masoprocol (delta mass:-54.03)',CCMSLIB00006555788,-54.03,358,Drug_analog,masoprocol,other antineoplastic agents,dermatology,actinic keratosis (AK),lipoxygenase inhibitor,HCZKYJDFEPMADG-UHFFFAOYSA-N
CCMSLIB00012722719,related spectra of 'loxoprofen (delta mass:-14.02)',CCMSLIB00010140295,-14.02,359,Drug_analog,loxoprofen,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,inflammation|pain|joint disorders,cyclooxygenase inhibitor|prostanoid receptor antagonist,YMBXTVYHTMGZDW-UHFFFAOYSA-N
CCMSLIB00012722720,related spectra of 'emixustat (delta mass:4.03)',CCMSLIB00010144924,4.03,360,Drug_analog,emixustat,no_match,NA,NA,retinoid isomerohydrolase inhibitor,WJIGGYYSZBWCGC-MRXNPFEDSA-N
CCMSLIB00012722721,related spectra of 'artemisinin (delta mass:-31.99)',CCMSLIB00005768817|CCMSLIB00005770791,-31.99,361,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012722722,related spectra of 'artemisinin (delta mass:-31.99)',CCMSLIB00005768817|CCMSLIB00005770791,-31.99,362,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012722723,related spectra of 'artemisinin (delta mass:-31.99)',CCMSLIB00005768817|CCMSLIB00005770791,-31.99,363,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012722724,related spectra of 'artemisinin (delta mass:-31.99)',CCMSLIB00005767817,-31.99,364,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012722725,"related spectra of 'enzacamene (delta mass:-3.99)', '4-methylbenzylidene camphor (delta mass:-4.0)', '4-methylbenzylidene camphor (delta mass:-3.99)'",CCMSLIB00005777228|CCMSLIB00010132866,-3.99,365,Drug_analog,enzacamene|4-methylbenzylidene camphor,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-UHFFFAOYSA-N|HEOCBCNFKCOKBX-KAMYIIQDSA-N
CCMSLIB00012722726,related spectra of 'perhexiline (delta mass:-27.05)',CCMSLIB00010145792|CCMSLIB00010145795,-27.05,366,Drug_analog|Low_confidence,perhexiline,other non-selective calcium channel blockers,cardiology,angina pectoris,carnitine palmitoyltransferase inhibitor,CYXKNKQEMFBLER-UHFFFAOYSA-N
CCMSLIB00012722727,related spectra of 'mirogabalin (delta mass:42.01)',CCMSLIB00010148398,42.01,367,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722728,related spectra of 'mirogabalin (delta mass:42.01)',CCMSLIB00010148395|CCMSLIB00010148396|CCMSLIB00010148398|CCMSLIB00010149216|CCMSLIB00010149217|CCMSLIB00010149219,42.01,368,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722729,related spectra of 'mirogabalin (delta mass:42.01)',CCMSLIB00010148395|CCMSLIB00010148396|CCMSLIB00010148398|CCMSLIB00010148399|CCMSLIB00010149216|CCMSLIB00010149217|CCMSLIB00010149219|CCMSLIB00010149220,42.01,369,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722730,related spectra of 'mirogabalin (delta mass:42.01)',CCMSLIB00010148398|CCMSLIB00010149219,42.01,370,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722731,related spectra of 'mirogabalin (delta mass:42.01)',CCMSLIB00010148398|CCMSLIB00010149219,42.01,371,Drug_analog,mirogabalin,gabapentinoids,neurology/psychiatry,diabetic peripheral neuropathy|postherpetic neuralgia,calcium channel antagonist,FTBQORVNHOIASH-CKYFFXLPSA-N
CCMSLIB00012722732,related spectra of '93413-77-5 (delta mass:1.98)',CCMSLIB00000210054|CCMSLIB00000210056|CCMSLIB00000210069,1.98,372,Drug_analog,"n,n-didesmethylvenlafaxine",serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,SUQHIQRIIBKNOR-UHFFFAOYSA-N
CCMSLIB00012722733,related spectra of 'perhexiline (delta mass:-26.02)',CCMSLIB00010145792|CCMSLIB00010145795,-26.02,373,Drug_analog|Low_confidence,perhexiline,other non-selective calcium channel blockers,cardiology,angina pectoris,carnitine palmitoyltransferase inhibitor,CYXKNKQEMFBLER-UHFFFAOYSA-N
CCMSLIB00012722734,related spectra of 'lactulose (delta mass:-88.05)',CCMSLIB00006122286|CCMSLIB00006122288|CCMSLIB00006122290|CCMSLIB00006122293|CCMSLIB00006122295,-88.05,374,Drug_analog|Low_confidence,lactulose,osmotic laxative,gastroenterology,portal-systemic encephalopathy (PSE)|constipation,laxative,JCQLYHFGKNRPGE-FCVZTGTOSA-N
CCMSLIB00012722735,related spectra of 'diethylstilbestrol (delta mass:-16.03)',CCMSLIB00000565081|CCMSLIB00005726537|CCMSLIB00005726775,-16.03,375,Drug_analog,diethylstilbestrol,estrogen,NA,NA,estrogen receptor agonist,RGLYKWWBQGJZGM-ISLYRVAYSA-N
CCMSLIB00012722736,related spectra of 'iloprost (delta mass:-90.05)',CCMSLIB00010149637,-90.05,376,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012722737,"related spectra of '4-methylbenzylidene camphor (delta mass:-1.98)', 'enzacamene (delta mass:-1.98)'",CCMSLIB00005777228|CCMSLIB00010132866|CCMSLIB00010132867,-1.98,377,Drug_analog,enzacamene|4-methylbenzylidene camphor,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-UHFFFAOYSA-N|HEOCBCNFKCOKBX-KAMYIIQDSA-N
CCMSLIB00012722738,related spectra of 'dydrogesterone (delta mass:-60.02)',CCMSLIB00005774596,-60.02,378,Drug_analog,dydrogesterone,progestin,obstetrics/gynecology,infertility,progesterone receptor agonist,JGMOKGBVKVMRFX-HQZYFCCVSA-N
CCMSLIB00012722739,related spectra of 'cimetidine (delta mass:1.0)',CCMSLIB00000077008,1,379,Drug_analog,cimetidine,histamine-2 (H2) receptor antagonist,gastroenterology|hematologic malignancy|endocrinology,duodenal ulcer disease|peptic ulcer disease (PUD)|gastroesophageal reflux disease (GERD)|aggressive systemic mastocytosis (ASM)|Zollinger-Ellison syndrome|endocrine adenoma,histamine receptor antagonist,AQIXAKUUQRKLND-UHFFFAOYSA-N
CCMSLIB00012722740,related spectra of 'metoprolol (delta mass:-14.02)',CCMSLIB00005776676,-14.02,380,Drug_analog,metoprolol,beta-adrenergic receptor inhibitor,cardiology,hypertension|angina pectoris|myocardial infarction,adrenergic receptor antagonist,IUBSYMUCCVWXPE-UHFFFAOYSA-N
CCMSLIB00012722741,related spectra of 'ethylestrenol (delta mass:-17.03)',CCMSLIB00005723752,-17.03,381,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012722742,related spectra of '93413-77-5 (delta mass:4.03)',CCMSLIB00000210056|CCMSLIB00000210058|CCMSLIB00000210069,4.03,382,Drug_analog,"n,n-didesmethylvenlafaxine",serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,SUQHIQRIIBKNOR-UHFFFAOYSA-N
CCMSLIB00012722743,related spectra of 'danthron (delta mass:16.03)',CCMSLIB00004694633,16.03,383,Drug_analog,danthron,stimulant laxative,gastroenterology,constipation,laxative,QBPFLULOKWLNNW-UHFFFAOYSA-N
CCMSLIB00012722744,related spectra of 'benzyl benzoate (delta mass:4.03)',CCMSLIB00004692054,4.03,384,Drug_analog,benzyl benzoate,"other ectoparasiticides, incl. scabicides",infectious disease,lice|mites|scabies,lipase inhibitor,SESFRYSPDFLNCH-UHFFFAOYSA-N
CCMSLIB00012722745,"related spectra of 'sulfamethoxazole (delta mass:1.99)', 'sulfamethoxazole (delta mass:2.0)'",CCMSLIB00000078344|CCMSLIB00000208207|CCMSLIB00000208213|CCMSLIB00000562780|CCMSLIB00000579546|CCMSLIB00000841891|CCMSLIB00003135069|CCMSLIB00003136182|CCMSLIB00003137766|CCMSLIB00003137795|CCMSLIB00003137817|CCMSLIB00003140018|CCMSLIB00003140081|CCMSLIB00005753343|CCMSLIB00005753625|CCMSLIB00005753729|CCMSLIB00005754000|CCMSLIB00005754054|CCMSLIB00005754069|CCMSLIB00005754156|CCMSLIB00005754191|CCMSLIB00005754528|CCMSLIB00005754808|CCMSLIB00005754912|CCMSLIB00005772440,2,385,Drug_analog|Low_confidence,sulfamethoxazole,sulfonamide antimicrobial,infectious disease,pneumonia|enteritis|urinary tract infections,PABA antagonist,JLKIGFTWXXRPMT-UHFFFAOYSA-N
CCMSLIB00012722746,related spectra of '4-methylbenzylidene camphor (delta mass:1.01)',CCMSLIB00010132864|CCMSLIB00010132866,1,386,Drug_analog,4-methylbenzylidene camphor,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-KAMYIIQDSA-N
CCMSLIB00012722747,related spectra of 'lamotrigine (delta mass:0.98)',CCMSLIB00000210202|CCMSLIB00000210214,0.98,387,Drug_analog,lamotrigine,antiepileptic drug (AED)|mood stabilizer,neurology/psychiatry,epilepsy|bipolar disorder,serotonin receptor antagonist|sodium channel blocker,PYZRQGJRPPTADH-UHFFFAOYSA-N
CCMSLIB00012722748,related spectra of 'lamotrigine (delta mass:1.0)',CCMSLIB00000210202|CCMSLIB00000210204|CCMSLIB00000210214|CCMSLIB00000210216|CCMSLIB00005772670,1,388,Drug_analog,lamotrigine,antiepileptic drug (AED)|mood stabilizer,neurology/psychiatry,epilepsy|bipolar disorder,serotonin receptor antagonist|sodium channel blocker,PYZRQGJRPPTADH-UHFFFAOYSA-N
CCMSLIB00012722749,related spectra of 'methoxsalen (delta mass:2.02)',CCMSLIB00004694997,2.02,389,Drug_analog,methoxsalen,photoactivated radical generator|psoralen,dermatology,psoriasis,DNA synthesis inhibitor,QXKHYNVANLEOEG-UHFFFAOYSA-N
CCMSLIB00012722750,related spectra of 'uridine triacetate (delta mass:14.02)',CCMSLIB00006124693|CCMSLIB00006124694|CCMSLIB00006124710|CCMSLIB00006124712,14.02,390,Drug_analog,uridine triacetate,various alimentary tract and metabolism products,genetics|critical care,orotic aciduria|fluorouracil overdose|capecitabine overdose,pyrimidine analog,DRTQHJPVMGBUCF-XVFCMESISA-N
CCMSLIB00012722751,related spectra of 'enzacamene (delta mass:1.98)',CCMSLIB00005774462,1.98,391,Drug_analog,enzacamene,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-UHFFFAOYSA-N
CCMSLIB00012722752,related spectra of 'enzacamene (delta mass:2.02)',CCMSLIB00005775624|CCMSLIB00005777228,2.02,392,Drug_analog,enzacamene,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-UHFFFAOYSA-N
CCMSLIB00012722753,related spectra of 'enzacamene (delta mass:2.02)',CCMSLIB00005774462|CCMSLIB00005777228,2.02,393,Drug_analog,enzacamene,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-UHFFFAOYSA-N
CCMSLIB00012722754,related spectra of 'norethindrone (delta mass:-42.01)',CCMSLIB00005772887,-42.01,394,Drug_analog,norethindrone,progestin,obstetrics/gynecology,endometriosis|contraceptive,progesterone receptor agonist,VIKNJXKGJWUCNN-XGXHKTLJSA-N
CCMSLIB00012722755,"related spectra of 'enzacamene (delta mass:2.02)', '4-methylbenzylidene camphor (delta mass:2.02)'",CCMSLIB00005774462|CCMSLIB00010132867,2.02,395,Drug_analog,enzacamene|4-methylbenzylidene camphor,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-UHFFFAOYSA-N|HEOCBCNFKCOKBX-KAMYIIQDSA-N
CCMSLIB00012722756,related spectra of 'enzacamene (delta mass:2.02)',CCMSLIB00005774462,2.02,396,Drug_analog,enzacamene,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-UHFFFAOYSA-N
CCMSLIB00012722757,related spectra of 'lamotrigine (delta mass:2.0)',CCMSLIB00000210204|CCMSLIB00000210216|CCMSLIB00005726655,2,397,Drug_analog,lamotrigine,antiepileptic drug (AED)|mood stabilizer,neurology/psychiatry,epilepsy|bipolar disorder,serotonin receptor antagonist|sodium channel blocker,PYZRQGJRPPTADH-UHFFFAOYSA-N
CCMSLIB00012722758,related spectra of 'lamotrigine (delta mass:2.0)',CCMSLIB00000210200|CCMSLIB00000210202|CCMSLIB00000210214,2,398,Drug_analog,lamotrigine,antiepileptic drug (AED)|mood stabilizer,neurology/psychiatry,epilepsy|bipolar disorder,serotonin receptor antagonist|sodium channel blocker,PYZRQGJRPPTADH-UHFFFAOYSA-N
CCMSLIB00012722759,related spectra of 'sulfamethoxazole (delta mass:4.03)',CCMSLIB00000208207|CCMSLIB00000208208|CCMSLIB00000208213|CCMSLIB00000208214|CCMSLIB00005753378|CCMSLIB00005753514|CCMSLIB00005753601|CCMSLIB00005753824|CCMSLIB00005753832|CCMSLIB00005753849|CCMSLIB00005753964|CCMSLIB00005753990|CCMSLIB00005754144|CCMSLIB00005754399|CCMSLIB00005754400|CCMSLIB00005754473|CCMSLIB00005754499|CCMSLIB00005754931|CCMSLIB00005755088|CCMSLIB00005755137,4.03,399,Drug_analog|Low_confidence,sulfamethoxazole,sulfonamide antimicrobial,infectious disease,pneumonia|enteritis|urinary tract infections,PABA antagonist,JLKIGFTWXXRPMT-UHFFFAOYSA-N
CCMSLIB00012722760,related spectra of 'methocarbamol (delta mass:15.99)',CCMSLIB00005726139|CCMSLIB00005726383,15.99,400,Drug_analog,methocarbamol,muscle relaxant,neurology/psychiatry,acute musculoskeletal pain,muscle relaxant,GNXFOGHNGIVQEH-UHFFFAOYSA-N
CCMSLIB00012722761,related spectra of 'parthenolide (delta mass:28.03)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238|CCMSLIB00010120978,28.03,401,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722762,related spectra of 'parthenolide (delta mass:28.03)',CCMSLIB00010109636|CCMSLIB00010120238,28.03,402,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722763,related spectra of 'parthenolide (delta mass:28.03)',CCMSLIB00010120238|CCMSLIB00010120978,28.03,403,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722764,related spectra of 'parthenolide (delta mass:28.03)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238|CCMSLIB00010120978,28.03,404,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722765,related spectra of 'parthenolide (delta mass:28.03)',CCMSLIB00010120238|CCMSLIB00010120978,28.03,405,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722766,related spectra of 'parthenolide (delta mass:28.03)',CCMSLIB00010108898,28.03,406,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722767,related spectra of 'enzacamene (delta mass:4.0)',CCMSLIB00005774462,3.99,407,Drug_analog,enzacamene,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-UHFFFAOYSA-N
CCMSLIB00012722768,related spectra of 'parthenolide (delta mass:28.03)',CCMSLIB00010108898,28.03,408,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722769,related spectra of 'enzacamene (delta mass:4.03)',CCMSLIB00005774462|CCMSLIB00005777228,4.03,409,Drug_analog,enzacamene,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-UHFFFAOYSA-N
CCMSLIB00012722770,"related spectra of 'n-desmethylvenlafaxine (delta mass:-3.99)', 'n-desmethylvenlafaxine (delta mass:-4.0)'",CCMSLIB00000209371|CCMSLIB00000209373|CCMSLIB00000209383|CCMSLIB00000209386|CCMSLIB00000578721,-3.99,410,Drug_analog,n-desmethylvenlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MKAFOJAJJMUXLW-UHFFFAOYSA-N
CCMSLIB00012722771,"related spectra of 'desvenlafaxine (delta mass:14.02)', 'venlafaxine (delta mass:-18.01)'",CCMSLIB00000208593|CCMSLIB00000208594|CCMSLIB00000208595|CCMSLIB00000208600|CCMSLIB00000208601|CCMSLIB00000578975|CCMSLIB00005735475|CCMSLIB00010132018|CCMSLIB00010135604,14.02|-18.01,411,Drug_analog,venlafaxine|desvenlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor|serotonin and norepinephrine reuptake inhibitor (SNRI),PNVNVHUZROJLTJ-UHFFFAOYSA-N|KYYIDSXMWOZKMP-UHFFFAOYSA-N
CCMSLIB00012722772,related spectra of 'n-desmethylvenlafaxine (delta mass:-3.99)',CCMSLIB00000209382|CCMSLIB00000578720,-3.99,412,Drug_analog,n-desmethylvenlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MKAFOJAJJMUXLW-UHFFFAOYSA-N
CCMSLIB00012722773,related spectra of 'xylometazoline (delta mass:15.01)',CCMSLIB00000569943|CCMSLIB00005732573|CCMSLIB00005735671,15.01,413,Drug_analog,xylometazoline,"sympathomimetics, plain",otolaryngology,nasal congestion,adrenergic receptor agonist,HUCJFAOMUPXHDK-UHFFFAOYSA-N
CCMSLIB00012722774,related spectra of 'masoprocol (delta mass:-42.05)',CCMSLIB00000078777|CCMSLIB00000845349|CCMSLIB00003139237,-42.05,414,Drug_analog,masoprocol,other antineoplastic agents,dermatology,actinic keratosis (AK),lipoxygenase inhibitor,HCZKYJDFEPMADG-TXEJJXNPSA-N|HCZKYJDFEPMADG-UHFFFAOYSA-N
CCMSLIB00012722775,related spectra of 'parthenolide (delta mass:29.97)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120978,29.97,415,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722776,related spectra of 'parthenolide (delta mass:29.97)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120978,29.97,416,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722777,related spectra of 'parthenolide (delta mass:29.97)',CCMSLIB00010108898|CCMSLIB00010109636|CCMSLIB00010120238|CCMSLIB00010120978,29.97,417,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722778,related spectra of 'aminoglutethimide (delta mass:27.99)',CCMSLIB00000086180,27.99,418,Drug_analog,aminoglutethimide,adrenal steroid synthesis inhibitor,endocrinology|oncology,Cushing's syndrome|breast cancer,glucocorticoid receptor antagonist,ROBVIMPUHSLWNV-UHFFFAOYSA-N
CCMSLIB00012722779,related spectra of 'oxandrolone (delta mass:-28.03)',CCMSLIB00005723836,-28.03,419,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,QSLJIVKCVHQPLV-ZXOYHYBESA-N
CCMSLIB00012722780,related spectra of 'methyltestosterone (delta mass:-42.05)',CCMSLIB00005777031,-42.05,420,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012722781,related spectra of 'methyltestosterone (delta mass:-42.05)',CCMSLIB00005777031,-42.05,421,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012722782,related spectra of 'methyltestosterone (delta mass:-42.05)',CCMSLIB00005777031,-42.05,422,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012722783,related spectra of 'methyltestosterone (delta mass:-42.05)',CCMSLIB00005777031,-42.05,423,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012722784,related spectra of 'ethylestrenol (delta mass:-28.03)',CCMSLIB00005723751,-28.03,424,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012722785,related spectra of 'methyltestosterone (delta mass:-42.01)',CCMSLIB00005777031,-42.01,425,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012722786,"related spectra of 'hyoscyamine (delta mass:-28.03)', 'atropine (delta mass:-28.03)'",CCMSLIB00000077007|CCMSLIB00000078450|CCMSLIB00000078624,-28.03,426,Drug_analog,atropine|hyoscyamine,"anticholinergic|belladonna alkaloids, tertiary amines",ophthalmology|critical care|cardiology|gastroenterology|urology|neurology/psychiatry,cycloplegia|mydriasis|amblyopia|anticholinergic poisoning|bradycardia|peptic ulcer disease (PUD)|acute abdominal visceral spasm|ulcerative colitis|interstitial cystitis (IC)|enterocolitis|irritable bowel syndrome|tremors,acetylcholine receptor antagonist,RKUNBYITZUJHSG-PJPHBNEVSA-N|RKUNBYITZUJHSG-LGGPCSOHSA-N
CCMSLIB00012722787,related spectra of 'n-desmethylvenlafaxine (delta mass:-2.02)',CCMSLIB00000209369,-2.02,427,Drug_analog,n-desmethylvenlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MKAFOJAJJMUXLW-UHFFFAOYSA-N
CCMSLIB00012722788,related spectra of 'meptazinol (delta mass:28.03)',CCMSLIB00000565906|CCMSLIB00000567833|CCMSLIB00000568298|CCMSLIB00005735309|CCMSLIB00005736685,28.03,428,Drug_analog,meptazinol,opioid agonist,neurology/psychiatry,pain relief,opioid receptor agonist,JLICHNCFTLFZJN-UHFFFAOYSA-N
CCMSLIB00012722789,related spectra of 'mesterolone (delta mass:-42.05)',CCMSLIB00005723783,-42.05,429,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012722790,related spectra of 'oxandrolone (delta mass:-42.01)',CCMSLIB00005723841,-42.01,430,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012722791,related spectra of 'ethylestrenol (delta mass:-26.02)',CCMSLIB00005723751,-26.02,431,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012722792,related spectra of 'mesterolone (delta mass:-42.01)',CCMSLIB00005723783,-42.01,432,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012722793,related spectra of 'mesterolone (delta mass:-42.01)',CCMSLIB00005723783,-42.01,433,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012722794,related spectra of 'mesterolone (delta mass:-42.01)',CCMSLIB00005723783,-42.01,434,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012722795,related spectra of 'mesterolone (delta mass:-42.01)',CCMSLIB00005723783,-42.01,435,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012722796,"related spectra of 'n,o-didesmethylvenlafaxine (delta mass:14.02)'",CCMSLIB00000210033|CCMSLIB00000210046,14.02,436,Drug_analog,"n,o-didesmethylvenlafaxine",serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MMSWXJSQCAEDLK-UHFFFAOYSA-N
CCMSLIB00012722797,related spectra of 'mycophenolic acid (delta mass:-54.03)',CCMSLIB00004695857|CCMSLIB00004702358|CCMSLIB00005727222,-54.03,437,Drug_analog,mycophenolic acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-RUDMXATFSA-N
CCMSLIB00012722798,related spectra of 'artemisinin (delta mass:-18.01)',CCMSLIB00005768072|CCMSLIB00005770754,-18.01,438,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012722799,related spectra of 'masoprocol (delta mass:-38.02)',CCMSLIB00006555640,-38.02,439,Drug_analog,masoprocol,other antineoplastic agents,dermatology,actinic keratosis (AK),lipoxygenase inhibitor,HCZKYJDFEPMADG-UHFFFAOYSA-N
CCMSLIB00012722800,related spectra of 'desvenlafaxine (delta mass:0.98)',CCMSLIB00003136655,0.98,440,Drug_analog,desvenlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression,serotonin and norepinephrine reuptake inhibitor (SNRI),KYYIDSXMWOZKMP-UHFFFAOYSA-N
CCMSLIB00012722801,related spectra of 'nortriptyline (delta mass:1.0)',CCMSLIB00000568509|CCMSLIB00000569178|CCMSLIB00000569182|CCMSLIB00000570081|CCMSLIB00003135401|CCMSLIB00003136095|CCMSLIB00003138588|CCMSLIB00005730683|CCMSLIB00005734254|CCMSLIB00005734376|CCMSLIB00005735311|CCMSLIB00005736187|CCMSLIB00005772749|CCMSLIB00010138446|CCMSLIB00010138447|CCMSLIB00010138448|CCMSLIB00010138449,1,441,Drug_analog,nortriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression,tricyclic antidepressant,PHVGLTMQBUFIQQ-UHFFFAOYSA-N
CCMSLIB00012722802,related spectra of 'methyltestosterone (delta mass:-38.02)',CCMSLIB00005775092,-38.02,442,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012722803,related spectra of 'dansylamide (delta mass:15.0)',CCMSLIB00010151064,15,443,Drug_analog,dansylamide,no_match,no_match,no_match,no_match,TYNBFJJKZPTRKS-UHFFFAOYSA-N
CCMSLIB00012722804,related spectra of 'doxepin (delta mass:-14.02)',CCMSLIB00000569152|CCMSLIB00005735291|CCMSLIB00006116035|CCMSLIB00006116039|CCMSLIB00006116042|CCMSLIB00006116043|CCMSLIB00006116045|CCMSLIB00006116049|CCMSLIB00006116050|CCMSLIB00006116052|CCMSLIB00006116054|CCMSLIB00006116057|CCMSLIB00006116059|CCMSLIB00006116061|CCMSLIB00006116062|CCMSLIB00006116064|CCMSLIB00006116066,-14.02,444,Drug_analog,doxepin,tricyclic antidepressant (TCA),neurology/psychiatry,depression|anxiety,histamine receptor antagonist,ODQWQRRAPPTVAG-BOPFTXTBSA-N|ODQWQRRAPPTVAG-UHFFFAOYSA-N
CCMSLIB00012722805,related spectra of 'perhexiline (delta mass:-12.0)',CCMSLIB00010145792|CCMSLIB00010145795,-12,445,Drug_analog|Low_confidence,perhexiline,other non-selective calcium channel blockers,cardiology,angina pectoris,carnitine palmitoyltransferase inhibitor,CYXKNKQEMFBLER-UHFFFAOYSA-N
CCMSLIB00012722806,"related spectra of 'lactulose (delta mass:-58.0)', 'lactulose (delta mass:--58.01)'",CCMSLIB00003136571,-58.01,446,Drug_analog|Low_confidence,lactulose,osmotic laxative,gastroenterology,portal-systemic encephalopathy (PSE)|constipation,laxative,JCQLYHFGKNRPGE-FCVZTGTOSA-N
CCMSLIB00012722807,related spectra of 'lactulose (delta mass:-58.0)',CCMSLIB00003136571,-58.01,447,Drug_analog|Low_confidence,lactulose,osmotic laxative,gastroenterology,portal-systemic encephalopathy (PSE)|constipation,laxative,JCQLYHFGKNRPGE-FCVZTGTOSA-N
CCMSLIB00012722808,related spectra of 'artemisinin (delta mass:-16.03)',CCMSLIB00000214217|CCMSLIB00000215699,-16.03,448,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012722809,related spectra of 'ubenimex (delta mass:-42.05)',CCMSLIB00000078191,-42.05,449,Drug_analog,ubenimex,no_match,NA,NA,leukotriene synthesis inhibitor,VGGGPCQERPFHOB-RDBSUJKOSA-N
CCMSLIB00012722810,related spectra of 'h_295_6a_hydroxy_gestrinone (delta mass:-40.03)',CCMSLIB00005723776,-40.03,450,Drug_analog,h_295_6a_hydroxy_gestrinone,antigonadotropins and similar agents,obstetrics/gynecology,endometriosis,progesterone receptor antagonist,KQUWZIRAKHNAAC-TYKSMWHLSA-N
CCMSLIB00012722811,related spectra of 'iloprost (delta mass:-58.01)',CCMSLIB00010149632,-58.01,451,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012722812,related spectra of 'drospirenone (delta mass:-100.02)',CCMSLIB00005776034,-100.02,452,Drug_analog,drospirenone,progestin,obstetrics/gynecology,contraceptive,mineralocorticoid receptor antagonist|progesterone receptor agonist,METQSPRSQINEEU-HXCATZOESA-N
CCMSLIB00012722813,related spectra of 'iloprost (delta mass:-58.01)',CCMSLIB00010149630,-58.01,453,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012722814,related spectra of 'enzacamene (delta mass:12.04)',CCMSLIB00005775624,12.04,454,Drug_analog,enzacamene,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-UHFFFAOYSA-N
CCMSLIB00012722815,related spectra of 'mesterolone (delta mass:-38.02)',CCMSLIB00005723783,-38.02,455,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012722816,related spectra of 'atenolol (delta mass:1.0)',CCMSLIB00006113797|CCMSLIB00006113810,1,456,Drug_analog,atenolol,beta-adrenergic receptor inhibitor,cardiology,hypertension|angina pectoris|acute myocardial infarction,adrenergic receptor antagonist,METKIMKYRPQLGS-UHFFFAOYSA-N
CCMSLIB00012722817,related spectra of 'vidarabine (delta mass:0.98)',CCMSLIB00010140027|CCMSLIB00010140028,0.98,457,Drug_analog,vidarabine,adenosine receptor agonist,cardiology,Wolff-Parkinson-White Syndrome (WPW)|supraventricular tachycardia,adenosine receptor agonist,OIRDTQYFTABQOQ-UHTZMRCNSA-N
CCMSLIB00012722818,related spectra of 'artemisinin (delta mass:-14.02)',CCMSLIB00005768817|CCMSLIB00005770791,-14.02,458,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012722819,related spectra of '4-methylbenzylidene camphor (delta mass:13.98)',CCMSLIB00010132867,13.98,459,Drug_analog,4-methylbenzylidene camphor,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-KAMYIIQDSA-N
CCMSLIB00012722820,related spectra of 'artemisinin (delta mass:-13.98)',CCMSLIB00005768817|CCMSLIB00005770791,-13.98,460,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012722821,related spectra of 'artemisinin (delta mass:-13.98)',CCMSLIB00005768223,-13.98,461,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012722822,related spectra of 'artemisinin (delta mass:-13.98)',CCMSLIB00005768817|CCMSLIB00005770791,-13.98,462,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012722823,related spectra of 'artemisinin (delta mass:-13.98)',CCMSLIB00005768072|CCMSLIB00005770754,-13.98,463,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012722824,related spectra of 'mestranol (delta mass:-42.01)',CCMSLIB00003140010,-42.01,464,Drug_analog,mestranol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist,IMSSROKUHAOUJS-MJCUULBUSA-N
CCMSLIB00012722825,related spectra of 'hexestrol (delta mass:-1.98)',CCMSLIB00005767080,-1.98,465,Drug_analog,hexestrol,estrogen,NA,NA,synthetic estrogen,PBBGSZCBWVPOOL-HDICACEKSA-N
CCMSLIB00012722826,related spectra of 'hexestrol (delta mass:-1.98)',CCMSLIB00005767080,-1.98,466,Drug_analog,hexestrol,estrogen,NA,NA,synthetic estrogen,PBBGSZCBWVPOOL-HDICACEKSA-N
CCMSLIB00012722827,related spectra of 'enzacamene (delta mass:14.02)',CCMSLIB00005774462,14.02,467,Drug_analog,enzacamene,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-UHFFFAOYSA-N
CCMSLIB00012722828,related spectra of 'metoprolol (delta mass:1.0)',CCMSLIB00000207246|CCMSLIB00000207247|CCMSLIB00000207248|CCMSLIB00000207252|CCMSLIB00000207253|CCMSLIB00000207254|CCMSLIB00000223621|CCMSLIB00000562781|CCMSLIB00005755115|CCMSLIB00010139506|CCMSLIB00010139508|CCMSLIB00010139509|CCMSLIB00010139511|CCMSLIB00010139512,1,468,Drug_analog,metoprolol,beta-adrenergic receptor inhibitor,cardiology,hypertension|angina pectoris|myocardial infarction,adrenergic receptor antagonist,IUBSYMUCCVWXPE-UHFFFAOYSA-N
CCMSLIB00012722829,"related spectra of 'sulfamethoxazole (delta mass:16.0)', 'sulfamethoxazole (delta mass:15.99)'",CCMSLIB00000078344|CCMSLIB00000208207|CCMSLIB00000208213|CCMSLIB00000223672|CCMSLIB00000562780|CCMSLIB00000579546|CCMSLIB00000841891|CCMSLIB00003134748|CCMSLIB00003135069|CCMSLIB00003136182|CCMSLIB00003137766|CCMSLIB00003137795|CCMSLIB00003138001|CCMSLIB00003138040|CCMSLIB00003139117|CCMSLIB00003139738|CCMSLIB00003140081|CCMSLIB00005753343|CCMSLIB00005753368|CCMSLIB00005753503|CCMSLIB00005753514|CCMSLIB00005753529|CCMSLIB00005753588|CCMSLIB00005753601|CCMSLIB00005753625|CCMSLIB00005753729|CCMSLIB00005753814|CCMSLIB00005754000|CCMSLIB00005754005|CCMSLIB00005754054|CCMSLIB00005754069|CCMSLIB00005754156|CCMSLIB00005754191|CCMSLIB00005754210|CCMSLIB00005754528|CCMSLIB00005754808|CCMSLIB00005754900|CCMSLIB00005754912|CCMSLIB00005772440,15.99,469,Drug_analog|Low_confidence,sulfamethoxazole,sulfonamide antimicrobial,infectious disease,pneumonia|enteritis|urinary tract infections,PABA antagonist,JLKIGFTWXXRPMT-UHFFFAOYSA-N
CCMSLIB00012722830,related spectra of 'ranitidine n-oxide (delta mass:-61.05)',CCMSLIB00000210546|CCMSLIB00000210548|CCMSLIB00000210550|CCMSLIB00000210558|CCMSLIB00000210560|CCMSLIB00000210562|CCMSLIB00005774370,-61.05,470,Drug_analog,ranitidine n-oxide,histamine-2 (H2) receptor antagonist,gastroenterology,heartburn|Zollinger-Ellison syndrome|duodenal ulcer|gastric ulcer|erosive esophagitis|gastroesophageal reflux disease (GERD),histamine receptor antagonist,DFJVUWAHTQPQCV-MDWZMJQESA-N
CCMSLIB00012722831,related spectra of 'ranitidine n-oxide (delta mass:-61.05)',CCMSLIB00000210546|CCMSLIB00000210548|CCMSLIB00000210558|CCMSLIB00000210560,-61.05,471,Drug_analog,ranitidine n-oxide,histamine-2 (H2) receptor antagonist,gastroenterology,heartburn|Zollinger-Ellison syndrome|duodenal ulcer|gastric ulcer|erosive esophagitis|gastroesophageal reflux disease (GERD),histamine receptor antagonist,DFJVUWAHTQPQCV-MDWZMJQESA-N
CCMSLIB00012722832,related spectra of 'ranitidine n-oxide (delta mass:-61.05)',CCMSLIB00000210546|CCMSLIB00000210548|CCMSLIB00000210558|CCMSLIB00000210560|CCMSLIB00005774582,-61.05,472,Drug_analog,ranitidine n-oxide,histamine-2 (H2) receptor antagonist,gastroenterology,heartburn|Zollinger-Ellison syndrome|duodenal ulcer|gastric ulcer|erosive esophagitis|gastroesophageal reflux disease (GERD),histamine receptor antagonist,DFJVUWAHTQPQCV-MDWZMJQESA-N
CCMSLIB00012722833,related spectra of 'metoprolol (delta mass:1.94)',CCMSLIB00000223622|CCMSLIB00005726533,1.94,473,Drug_analog,metoprolol,beta-adrenergic receptor inhibitor,cardiology,hypertension|angina pectoris|myocardial infarction,adrenergic receptor antagonist,IUBSYMUCCVWXPE-UHFFFAOYSA-N
CCMSLIB00012722834,related spectra of 'methocarbamol (delta mass:28.03)',CCMSLIB00005726372|CCMSLIB00005726439|CCMSLIB00005726697,28.03,474,Drug_analog,methocarbamol,muscle relaxant,neurology/psychiatry,acute musculoskeletal pain,muscle relaxant,GNXFOGHNGIVQEH-UHFFFAOYSA-N
CCMSLIB00012722835,"related spectra of 'dtxsid40891595 (delta mass:15.0)', 'dtxsid90891580 (delta mass:15.0)'",CCMSLIB00000578689|CCMSLIB00000578695,15,475,Drug_analog,massbankeu:et110604 npe_255.1491_11.6|pheniramine formamide|phe_255.1497_11.6|massbankeu:et110704 npe_255.1491_11.0|n-acetyl-n-didemethylpheniramine|n-(3-phenyl-3-pyridin-2-ylpropyl)acetamide,substituted alkylamines,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,SXXHPCVDFDABHW-UHFFFAOYSA-N|ZMNXZIWMJCGGHP-UHFFFAOYSA-N
CCMSLIB00012722836,related spectra of 'promethazine (delta mass:-14.02)',CCMSLIB00000085454,-14.02,476,Drug_analog,promethazine,phenothiazine,neurology/psychiatry|allergy|gastroenterology,sedative|allergic rhinitis|motion sickness|nausea|vomiting|allergic conditions,histamine receptor antagonist,PWWVAXIEGOYWEE-UHFFFAOYSA-N
CCMSLIB00012722837,related spectra of 'mycophenolic-acid (delta mass:-49.99)',CCMSLIB00005778133,-49.99,477,Drug_analog,mycophenolic-acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-UHFFFAOYSA-N
CCMSLIB00012722838,related spectra of 'exemestane (delta mass:-26.02)',CCMSLIB00000079118|CCMSLIB00000208690,-26.02,478,Drug_analog,exemestane,aromatase inhibitor,oncology,breast cancer,aromatase inhibitor,BFYIZQONLCFLEV-DAELLWKTSA-N|BFYIZQONLCFLEV-UHFFFAOYSA-N
CCMSLIB00012722839,related spectra of 'hydroxyprogesterone caproate (delta mass:-60.02)',CCMSLIB00005761260|CCMSLIB00006116102|CCMSLIB00006116104|CCMSLIB00006116106|CCMSLIB00006116107|CCMSLIB00006116109,-60.02,479,Drug_analog|Low_confidence,hydroxyprogesterone caproate,progestin,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DBPWSSGDRRHUNT-CEGNMAFCSA-N|DBPWSSGDRRHUNT-SJFWLOONSA-N
CCMSLIB00012722840,related spectra of 'metoclopramide (delta mass:-28.03)',CCMSLIB00000211008|CCMSLIB00000211010|CCMSLIB00000211021|CCMSLIB00005753764|CCMSLIB00005753841|CCMSLIB00005754392|CCMSLIB00005754407|CCMSLIB00005754420|CCMSLIB00005754509|CCMSLIB00005754512|CCMSLIB00005754845|CCMSLIB00005754938,-28.03,480,Drug_analog,metoclopramide,dopamine-2 (D2) antagonist,gastroenterology,diabetic gastroparesis|nausea|vomiting|gastroesophageal reflux disease (GERD),dopamine receptor antagonist|serotonin receptor antagonist,TTWJBBZEZQICBI-UHFFFAOYSA-N
CCMSLIB00012722841,related spectra of 'propranolol (delta mass:12.0)',CCMSLIB00000207235|CCMSLIB00000207240|CCMSLIB00005733934|CCMSLIB00006118497|CCMSLIB00006118504,12,481,Drug_analog|Low_confidence,propranolol,beta-adrenergic receptor inhibitor,cardiology|neurology/psychiatry,hypertension|angina pectoris|migraine headache|essential tremor,adrenergic receptor antagonist,AQHHHDLHHXJYJD-UHFFFAOYSA-N
CCMSLIB00012722842,related spectra of 'propranolol (delta mass:12.0)',CCMSLIB00000207240|CCMSLIB00000579594|CCMSLIB00000841885|CCMSLIB00005733934|CCMSLIB00005734395|CCMSLIB00005764884,12,482,Drug_analog|Low_confidence,propranolol,beta-adrenergic receptor inhibitor,cardiology|neurology/psychiatry,hypertension|angina pectoris|migraine headache|essential tremor,adrenergic receptor antagonist,AQHHHDLHHXJYJD-UHFFFAOYSA-N
CCMSLIB00012722843,"related spectra of 'sulfamethizole (delta mass:2.0)', 'sulfamethizole (delta mass:1.99)', 'sulfamethizole (delta mass:1.98)'",CCMSLIB00000078357|CCMSLIB00003137228|CCMSLIB00003137765|CCMSLIB00003139855,2,483,Drug_analog|Background/QAQC,sulfamethizole,sulfonamide antimicrobial,infectious disease,urinary tract infections,bacterial antifolate,VACCAVUAMIDAGB-UHFFFAOYSA-N
CCMSLIB00012722844,"related spectra of 'sulfamethizole (delta mass:2.0)', 'sulfamethizole (delta mass:1.99)'",CCMSLIB00000562771|CCMSLIB00003138135|CCMSLIB00005774906,2,484,Drug_analog|Background/QAQC,sulfamethizole,sulfonamide antimicrobial,infectious disease,urinary tract infections,bacterial antifolate,VACCAVUAMIDAGB-UHFFFAOYSA-N
CCMSLIB00012722845,related spectra of 'sulfamethizole (delta mass:2.0)',CCMSLIB00003138135,2,485,Drug_analog|Background/QAQC,sulfamethizole,sulfonamide antimicrobial,infectious disease,urinary tract infections,bacterial antifolate,VACCAVUAMIDAGB-UHFFFAOYSA-N
CCMSLIB00012722846,"related spectra of 'sulfamethizole (delta mass:2.0)', 'sulfamethizole (delta mass:1.99)'",CCMSLIB00003137228|CCMSLIB00003137765|CCMSLIB00003138135|CCMSLIB00003139855|CCMSLIB00010136741|CCMSLIB00010136742,2,486,Drug_analog|Background/QAQC,sulfamethizole,sulfonamide antimicrobial,infectious disease,urinary tract infections,bacterial antifolate,VACCAVUAMIDAGB-UHFFFAOYSA-N
CCMSLIB00012722847,related spectra of 'parthenolide (delta mass:42.01)',CCMSLIB00010108898|CCMSLIB00010109636,42.01,487,Drug_analog|Low_confidence,parthenolide,no_match,NA,NA,NFkB pathway inhibitor,KTEXNACQROZXEV-PVLRGYAZSA-N
CCMSLIB00012722848,related spectra of 'enzacamene (delta mass:18.01)',CCMSLIB00005775624,18.01,488,Drug_analog,enzacamene,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-UHFFFAOYSA-N
CCMSLIB00012722849,related spectra of 'lovastatin (delta mass:-132.08)',CCMSLIB00000566933|CCMSLIB00004693622|CCMSLIB00005733700,-132.08,489,Drug_analog,lovastatin,HMG-CoA reductase inhibitor (statin),endocrinology|cardiology|neurology/psychiatry,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,PCZOHLXUXFIOCF-BXMDZJJMSA-N
CCMSLIB00012722850,"related spectra of 'dasotraline (delta mass:-17.03)', 'desmethylsertraline (delta mass:-17.03)'",CCMSLIB00005732907|CCMSLIB00005774419|CCMSLIB00005775476|CCMSLIB00010135530|CCMSLIB00010135576,-17.03,490,Drug_analog,desmethylsertraline|dasotraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry|NA,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder|NA,selective serotonin reuptake inhibitor (SSRI)|dopamine-norepinephrine-serotonin reuptake inhibitor,SRPXSILJHWNFMK-UHFFFAOYSA-N|SRPXSILJHWNFMK-ZBEGNZNMSA-N|SRPXSILJHWNFMK-MEDUHNTESA-N
CCMSLIB00012722851,"related spectra of 'dasotraline (delta mass:-17.03)', 'desmethylsertraline (delta mass:-17.03)'",CCMSLIB00005730505|CCMSLIB00005732907|CCMSLIB00005774419|CCMSLIB00005775476|CCMSLIB00010135530|CCMSLIB00010135576,-17.03,491,Drug_analog,desmethylsertraline|dasotraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry|NA,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder|NA,selective serotonin reuptake inhibitor (SSRI)|dopamine-norepinephrine-serotonin reuptake inhibitor,SRPXSILJHWNFMK-UHFFFAOYSA-N|SRPXSILJHWNFMK-ZBEGNZNMSA-N|SRPXSILJHWNFMK-MEDUHNTESA-N
CCMSLIB00012722852,related spectra of 'desmethylsertraline (delta mass:-17.03)',CCMSLIB00005775476,-17.03,492,Drug_analog,desmethylsertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),SRPXSILJHWNFMK-ZBEGNZNMSA-N
CCMSLIB00012722853,related spectra of 'desmethylsertraline (delta mass:-17.03)',CCMSLIB00005774419|CCMSLIB00005775476,-17.03,493,Drug_analog,desmethylsertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),SRPXSILJHWNFMK-ZBEGNZNMSA-N
CCMSLIB00012722854,related spectra of 'desmethylsertraline (delta mass:-17.03)',CCMSLIB00005775476,-17.03,494,Drug_analog,desmethylsertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),SRPXSILJHWNFMK-ZBEGNZNMSA-N
CCMSLIB00012722855,related spectra of 'sulfamethazine (delta mass:-4.03)',CCMSLIB00003135019,-4.03,495,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012722856,"related spectra of 'sulfamethazine (delta mass:-4.0)', 'sulfamethazine (delta mass:-3.99)', 'sulfadimidine (delta mass:-4.0)'",CCMSLIB00000562784|CCMSLIB00003135019|CCMSLIB00003136257|CCMSLIB00005776685|CCMSLIB00010143273,-3.99,496,Drug_analog|Background/QAQC,sulfamethazine|sulfadimidine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012722857,related spectra of 'sodium tetradecyl sulfate (delta mass:-42.05)',CCMSLIB00004716391|CCMSLIB00004716392,-42.05,497,Drug_analog,sodium tetradecyl sulfate,sclerosing agents for local injection,dermatology,varicose veins,sclerosing agent,URLJMZWTXZTZRR-UHFFFAOYSA-N
CCMSLIB00012722858,related spectra of 'sar407899 (delta mass:30.01)',CCMSLIB00010131726,30.01,498,Drug_analog,sar407899,no_match,NA,NA,rho associated kinase inhibitor,IPEXHQGMTHOKQV-UHFFFAOYSA-N
CCMSLIB00012722859,related spectra of 'trenbolone (delta mass:4.0)',CCMSLIB00005773429,3.99,499,Drug_analog,trenbolone,no_match,no_match,no_match,no_match,MEHHPFQKXOUFFV-FOIPXRHGSA-N
CCMSLIB00012722860,related spectra of 'hexestrol (delta mass:4.03)',CCMSLIB00005767080,4.03,500,Drug_analog,hexestrol,estrogen,NA,NA,synthetic estrogen,PBBGSZCBWVPOOL-HDICACEKSA-N
CCMSLIB00012722861,related spectra of 'methyltestosterone (delta mass:-28.03)',CCMSLIB00005777031,-28.03,501,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012722862,related spectra of 'oxandrolone (delta mass:-14.02)',CCMSLIB00005723836,-14.02,502,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,QSLJIVKCVHQPLV-ZXOYHYBESA-N
CCMSLIB00012722863,related spectra of 'oxandrolone (delta mass:-14.02)',CCMSLIB00005723836,-14.02,503,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,QSLJIVKCVHQPLV-ZXOYHYBESA-N
CCMSLIB00012722864,related spectra of 'cyclopentolate (delta mass:1.94)',CCMSLIB00010130529,1.94,504,Drug_analog,cyclopentolate,anticholinergic,ophthalmology,mydriasis|cycloplegia,acetylcholine receptor antagonist,SKYSRIRYMSLOIN-UHFFFAOYSA-N
CCMSLIB00012722865,"related spectra of 'oglufanide (delta mass:-58.0)', 'golotimod (delta mass:--58.01)', 'golotimod (delta mass:-58.0)'",CCMSLIB00010133731|CCMSLIB00010133732|CCMSLIB00010133733|CCMSLIB00010152308,-58.01,505,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012722866,"related spectra of 'oglufanide (delta mass:--58.01)', 'golotimod (delta mass:--58.01)', 'bnc210 (delta mass:-42.05)', 'golotimod (delta mass:-58.0)'",CCMSLIB00010131015|CCMSLIB00010133731|CCMSLIB00010133733|CCMSLIB00010152309|CCMSLIB00010152310,-58.01|-42.05,506,Drug_analog|Low_confidence,bnc210|golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,BVRPESWOSNFUCJ-LKTVYLICSA-N|CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012722867,related spectra of 'golotimod (delta mass:-58.01)',CCMSLIB00010133731,-58.01,507,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722868,related spectra of 'golotimod (delta mass:-58.01)',CCMSLIB00010133731,-58.01,508,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722869,"related spectra of 'oglufanide (delta mass:--58.01)', 'oglufanide (delta mass:-58.0)', 'golotimod (delta mass:--58.01)', 'golotimod (delta mass:-58.0)'",CCMSLIB00010133730|CCMSLIB00010133731|CCMSLIB00010133732|CCMSLIB00010152308,-58.01,509,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012722870,related spectra of 'golotimod (delta mass:-58.01)',CCMSLIB00010133731|CCMSLIB00010133733,-58.01,510,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722871,related spectra of 'golotimod (delta mass:-58.01)',CCMSLIB00010133731,-58.01,511,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722872,related spectra of 'golotimod (delta mass:-58.01)',CCMSLIB00010133731,-58.01,512,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722873,related spectra of 'golotimod (delta mass:-58.01)',CCMSLIB00010133731,-58.01,513,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722874,related spectra of 'golotimod (delta mass:-58.01)',CCMSLIB00010133731,-58.01,514,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722875,related spectra of 'golotimod (delta mass:-58.01)',CCMSLIB00010133731,-58.01,515,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722876,related spectra of 'golotimod (delta mass:-58.01)',CCMSLIB00010133731,-58.01,516,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722877,"related spectra of 'oglufanide (delta mass:--58.01)', 'golotimod (delta mass:-58.0)'",CCMSLIB00010133731|CCMSLIB00010152308,-58.01,517,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012722878,related spectra of 'golotimod (delta mass:-58.01)',CCMSLIB00010133731,-58.01,518,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722879,related spectra of 'golotimod (delta mass:-58.01)',CCMSLIB00010133731,-58.01,519,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722880,related spectra of 'golotimod (delta mass:-58.01)',CCMSLIB00010133731,-58.01,520,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722881,related spectra of 'golotimod (delta mass:-58.01)',CCMSLIB00010133731,-58.01,521,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722882,"related spectra of 'golotimod (delta mass:--58.01)', 'golotimod (delta mass:-58.0)'",CCMSLIB00010133731,-58.01,522,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722883,"related spectra of 'oglufanide (delta mass:--58.01)', 'oglufanide (delta mass:-58.0)', 'golotimod (delta mass:--58.01)', 'golotimod (delta mass:-58.0)'",CCMSLIB00010133731|CCMSLIB00010133733|CCMSLIB00010152308,-58.01,523,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012722884,"related spectra of 'golotimod (delta mass:--58.01)', 'golotimod (delta mass:-58.0)'",CCMSLIB00010133731|CCMSLIB00010133733,-58.01,524,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722885,"related spectra of 'golotimod (delta mass:--58.01)', 'golotimod (delta mass:-58.0)'",CCMSLIB00010133731|CCMSLIB00010133732,-58.01,525,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722886,related spectra of 'golotimod (delta mass:-58.0)',CCMSLIB00010133731,-58.01,526,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722887,related spectra of 'golotimod (delta mass:-58.0)',CCMSLIB00010133731,-58.01,527,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722888,related spectra of 'golotimod (delta mass:-58.0)',CCMSLIB00010133731,-58.01,528,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722889,related spectra of 'golotimod (delta mass:-58.0)',CCMSLIB00010133731,-58.01,529,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012722890,related spectra of 'dienogest (delta mass:-36.02)',CCMSLIB00000568045|CCMSLIB00000568305|CCMSLIB00005730684|CCMSLIB00005735367,-36.02,530,Drug_analog,dienogest,progestin,obstetrics/gynecology,contraceptive|endometriosis,progesterone receptor agonist,AZFLJNIPTRTECV-FUMNGEBKSA-N
CCMSLIB00012722891,related spectra of 'cyclopentolate (delta mass:2.0)',CCMSLIB00010130529,2,531,Drug_analog,cyclopentolate,anticholinergic,ophthalmology,mydriasis|cycloplegia,acetylcholine receptor antagonist,SKYSRIRYMSLOIN-UHFFFAOYSA-N
CCMSLIB00012722892,related spectra of 'cyclopentolate (delta mass:2.02)',CCMSLIB00010130529,2.02,532,Drug_analog,cyclopentolate,anticholinergic,ophthalmology,mydriasis|cycloplegia,acetylcholine receptor antagonist,SKYSRIRYMSLOIN-UHFFFAOYSA-N
CCMSLIB00012722893,related spectra of 'oxandrolone (delta mass:-28.03)',CCMSLIB00005723841,-28.03,533,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012722894,related spectra of 'exemestane (delta mass:-20.01)',CCMSLIB00000208693|CCMSLIB00000208694|CCMSLIB00000208699|CCMSLIB00000208700,-20.01,534,Drug_analog,exemestane,aromatase inhibitor,oncology,breast cancer,aromatase inhibitor,BFYIZQONLCFLEV-UHFFFAOYSA-N
CCMSLIB00012722895,related spectra of 'octinoxate (delta mass:-14.02)',CCMSLIB00006709940,-14.02,535,Drug_analog,octinoxate,no_match,dermatology,sunscreen lotion,NA,YBGZDTIWKVFICR-JLHYYAGUSA-N
CCMSLIB00012722896,related spectra of 'exemestane (delta mass:-20.01)',CCMSLIB00000208693,-20.01,536,Drug_analog,exemestane,aromatase inhibitor,oncology,breast cancer,aromatase inhibitor,BFYIZQONLCFLEV-UHFFFAOYSA-N
CCMSLIB00012722897,related spectra of 'octinoxate (delta mass:-14.02)',CCMSLIB00006709940,-14.02,537,Drug_analog,octinoxate,no_match,dermatology,sunscreen lotion,NA,YBGZDTIWKVFICR-JLHYYAGUSA-N
CCMSLIB00012722898,related spectra of 'd-617 (delta mass:-14.02)',CCMSLIB00000209973|CCMSLIB00000209975|CCMSLIB00000209985|CCMSLIB00000209987,-14.02,538,Drug_analog,d-617 (verapamil metabolite),nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris|arrhythmia,calcium channel blocker,WLOBUUJURNEQCL-UHFFFAOYSA-N
CCMSLIB00012722899,related spectra of 'd-617 (delta mass:-14.02)',CCMSLIB00000209975|CCMSLIB00000209987,-14.02,539,Drug_analog,d-617 (verapamil metabolite),nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris|arrhythmia,calcium channel blocker,WLOBUUJURNEQCL-UHFFFAOYSA-N
CCMSLIB00012722900,related spectra of 'd-617 (delta mass:-14.02)',CCMSLIB00000209973|CCMSLIB00000209981|CCMSLIB00000209985|CCMSLIB00000209991,-14.02,540,Drug_analog,d-617 (verapamil metabolite),nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris|arrhythmia,calcium channel blocker,WLOBUUJURNEQCL-UHFFFAOYSA-N
CCMSLIB00012722901,related spectra of 'oxandrolone (delta mass:-12.0)',CCMSLIB00005723836,-12,541,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,QSLJIVKCVHQPLV-ZXOYHYBESA-N
CCMSLIB00012722902,"related spectra of 'oxandrolone (delta mass:-28.0)', 'oxandrolone (delta mass:-27.99)'",CCMSLIB00005723841,-27.99,542,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012722903,related spectra of 'methyltestosterone (delta mass:-26.02)',CCMSLIB00005760099,-26.02,543,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012722904,related spectra of 'oxandrolone (delta mass:-28.0)',CCMSLIB00005723841,-27.99,544,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012722905,related spectra of 'amitriptyline (delta mass:-0.98)',CCMSLIB00003134977,-0.98,545,Drug_analog|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012722906,related spectra of 'ethylestrenol (delta mass:-12.04)',CCMSLIB00005723751,-12.04,546,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012722907,related spectra of 'mesterolone (delta mass:-28.03)',CCMSLIB00005723783,-28.03,547,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012722908,related spectra of 'mesterolone (delta mass:-28.03)',CCMSLIB00005723783,-28.03,548,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012722909,related spectra of 'oxandrolone (delta mass:-12.0)',CCMSLIB00005723836,-12,549,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,QSLJIVKCVHQPLV-ZXOYHYBESA-N
CCMSLIB00012722910,related spectra of 'ethylestrenol (delta mass:-12.04)',CCMSLIB00005723751,-12.04,550,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012722911,related spectra of 'mesterolone (delta mass:-28.03)',CCMSLIB00005723783,-28.03,551,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012722912,related spectra of 'ethylestrenol (delta mass:-12.04)',CCMSLIB00005723751,-12.04,552,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012722913,related spectra of 'ethylestrenol (delta mass:-12.04)',CCMSLIB00005723751,-12.04,553,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012722914,related spectra of 'drostanolone (delta mass:-28.03)',CCMSLIB00005723746,-28.03,554,Drug_analog|Low_confidence,drostanolone,no_match,no_match,no_match,no_match,FDGQIVOIHOIMNK-TZAHHXAYSA-N
CCMSLIB00012722915,related spectra of 'mesterolone (delta mass:-28.03)',CCMSLIB00005723783,-28.03,555,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012722916,related spectra of 'mesterolone (delta mass:-28.03)',CCMSLIB00005723783,-28.03,556,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012722917,related spectra of 'stanozolol-4b-oh (delta mass:-49.99)',CCMSLIB00005723881,-49.99,557,Drug_analog,stanozolol-4b-oh,androstan derivatives,genetics|dermatology,hereditary angioedema,androgen receptor agonist,OCUSYXNRARMJHS-JQPLYGKBSA-N
CCMSLIB00012722918,related spectra of 'stanozolol-4b-oh (delta mass:-49.99)',CCMSLIB00005723881,-49.99,558,Drug_analog,stanozolol-4b-oh,androstan derivatives,genetics|dermatology,hereditary angioedema,androgen receptor agonist,OCUSYXNRARMJHS-JQPLYGKBSA-N
CCMSLIB00012722919,related spectra of 'ethylestrenol (delta mass:-12.0)',CCMSLIB00005723751,-12,559,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012722920,related spectra of 'sulfamethazine (delta mass:-0.98)',CCMSLIB00003135019,-0.98,560,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012722921,related spectra of 'protriptyline (delta mass:14.02)',CCMSLIB00010137915,14.02,561,Drug_analog,protriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression,tricyclic antidepressant,BWPIARFWQZKAIA-UHFFFAOYSA-N
CCMSLIB00012722922,related spectra of 'protriptyline (delta mass:14.02)',CCMSLIB00010137915|CCMSLIB00010137918,14.02,562,Drug_analog,protriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression,tricyclic antidepressant,BWPIARFWQZKAIA-UHFFFAOYSA-N
CCMSLIB00012722923,related spectra of 'protriptyline (delta mass:14.02)',CCMSLIB00010137913,14.02,563,Drug_analog,protriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression,tricyclic antidepressant,BWPIARFWQZKAIA-UHFFFAOYSA-N
CCMSLIB00012722924,related spectra of 'artemisinin (delta mass:-4.0)',CCMSLIB00005769004,-3.99,564,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012722925,related spectra of 'mesterolone (delta mass:-26.02)',CCMSLIB00005723783,-26.02,565,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012722926,related spectra of 'sulfamethazine (delta mass:1.0)',CCMSLIB00010143276|CCMSLIB00010143279,1,566,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012722927,"related spectra of 'sulfamethazine (delta mass:1.01)', 'sulfadimidine (delta mass:1.0)', 'sulfamethazine (delta mass:1.0)'",CCMSLIB00000207274|CCMSLIB00000207275|CCMSLIB00000207280|CCMSLIB00000562784|CCMSLIB00003135019|CCMSLIB00003135048|CCMSLIB00003136955|CCMSLIB00003137995|CCMSLIB00005776263|CCMSLIB00005776685|CCMSLIB00010143272|CCMSLIB00010143273|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143278|CCMSLIB00010143279,1,567,Drug_analog|Background/QAQC,sulfamethazine|sulfadimidine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012722928,related spectra of 'sulfamethazine (delta mass:1.0)',CCMSLIB00000579538|CCMSLIB00000841836|CCMSLIB00010143279,1,568,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012722929,related spectra of 'sulfamethazine (delta mass:1.0)',CCMSLIB00000579538|CCMSLIB00000841836|CCMSLIB00003135048|CCMSLIB00010143279,1,569,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012722930,related spectra of 'sulfamethazine (delta mass:1.0)',CCMSLIB00000078582|CCMSLIB00003136257|CCMSLIB00005775958|CCMSLIB00005776263|CCMSLIB00010143276|CCMSLIB00010143279,1,570,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012722931,"related spectra of 'sulfamethazine (delta mass:1.01)', 'sulfamethazine (delta mass:1.0)'",CCMSLIB00000078582|CCMSLIB00000579538|CCMSLIB00000841836|CCMSLIB00003135019|CCMSLIB00003135048,1,571,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012722932,related spectra of 'sulfamethazine (delta mass:1.0)',CCMSLIB00000078582|CCMSLIB00003136257,1,572,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012722933,related spectra of 'sulfamethazine (delta mass:1.0)',CCMSLIB00005776263|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143279,1,573,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012722934,related spectra of 'sulfamethazine (delta mass:1.0)',CCMSLIB00010143279,1,574,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012722935,related spectra of 'sulfamethazine (delta mass:1.0)',CCMSLIB00000579538|CCMSLIB00000841836,1,575,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012722936,"related spectra of 'sulfamethazine (delta mass:1.01)', 'sulfamethazine (delta mass:1.0)', 'sulfadimidine (delta mass:1.01)'",CCMSLIB00000078582|CCMSLIB00000207274|CCMSLIB00000207275|CCMSLIB00000207276|CCMSLIB00000207280|CCMSLIB00000207281|CCMSLIB00000207282|CCMSLIB00000223720|CCMSLIB00000562784|CCMSLIB00000579538|CCMSLIB00000841836|CCMSLIB00003135048|CCMSLIB00003136257|CCMSLIB00003136955|CCMSLIB00003137995|CCMSLIB00003138861|CCMSLIB00005776263|CCMSLIB00005776685|CCMSLIB00010143273|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143278|CCMSLIB00010143279,1,576,Drug_analog|Background/QAQC,sulfamethazine|sulfadimidine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012722937,"related spectra of 'cyclobenzaprine (delta mass:3.99)', 'cyclobenzaprine (delta mass:4.0)'",CCMSLIB00000085940|CCMSLIB00003136482|CCMSLIB00003137759|CCMSLIB00003139608|CCMSLIB00010151698|CCMSLIB00010151699|CCMSLIB00010151700|CCMSLIB00010151703,3.99,577,Drug_analog,cyclobenzaprine,muscle relaxant,neurology/psychiatry,muscle spasms,adrenergic receptor agonist|serotonin receptor agonist,JURKNVYFZMSNLP-UHFFFAOYSA-N
CCMSLIB00012722938,"related spectra of 'cyclobenzaprine (delta mass:3.99)', 'cyclobenzaprine (delta mass:4.0)'",CCMSLIB00000085940|CCMSLIB00003136482|CCMSLIB00003137759|CCMSLIB00003139608|CCMSLIB00010151698|CCMSLIB00010151699|CCMSLIB00010151700|CCMSLIB00010151701|CCMSLIB00010151703|CCMSLIB00010151704,3.99,578,Drug_analog,cyclobenzaprine,muscle relaxant,neurology/psychiatry,muscle spasms,adrenergic receptor agonist|serotonin receptor agonist,JURKNVYFZMSNLP-UHFFFAOYSA-N
CCMSLIB00012722939,related spectra of 'cyclobenzaprine (delta mass:4.0)',CCMSLIB00000085940|CCMSLIB00003136482|CCMSLIB00003137759|CCMSLIB00003139608,3.99,579,Drug_analog,cyclobenzaprine,muscle relaxant,neurology/psychiatry,muscle spasms,adrenergic receptor agonist|serotonin receptor agonist,JURKNVYFZMSNLP-UHFFFAOYSA-N
CCMSLIB00012722940,"related spectra of 'n,o-didesmethylvenlafaxine (delta mass:30.01)'",CCMSLIB00000578724,30.01,580,Drug_analog,"n,o-didesmethylvenlafaxine",serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MMSWXJSQCAEDLK-UHFFFAOYSA-N
CCMSLIB00012722941,related spectra of 'perhexiline (delta mass:1.98)',CCMSLIB00010145792|CCMSLIB00010145795,1.98,581,Drug_analog|Low_confidence,perhexiline,other non-selective calcium channel blockers,cardiology,angina pectoris,carnitine palmitoyltransferase inhibitor,CYXKNKQEMFBLER-UHFFFAOYSA-N
CCMSLIB00012722942,related spectra of 'perhexiline (delta mass:1.98)',CCMSLIB00010145792|CCMSLIB00010145795,1.98,582,Drug_analog|Low_confidence,perhexiline,other non-selective calcium channel blockers,cardiology,angina pectoris,carnitine palmitoyltransferase inhibitor,CYXKNKQEMFBLER-UHFFFAOYSA-N
CCMSLIB00012722943,related spectra of 'perhexiline (delta mass:1.98)',CCMSLIB00010145792|CCMSLIB00010145795,1.98,583,Drug_analog|Low_confidence,perhexiline,other non-selective calcium channel blockers,cardiology,angina pectoris,carnitine palmitoyltransferase inhibitor,CYXKNKQEMFBLER-UHFFFAOYSA-N
CCMSLIB00012722944,related spectra of 'perhexiline (delta mass:1.98)',CCMSLIB00010145792|CCMSLIB00010145795,1.98,584,Drug_analog|Low_confidence,perhexiline,other non-selective calcium channel blockers,cardiology,angina pectoris,carnitine palmitoyltransferase inhibitor,CYXKNKQEMFBLER-UHFFFAOYSA-N
CCMSLIB00012722945,related spectra of 'perhexiline (delta mass:1.98)',CCMSLIB00010145792|CCMSLIB00010145795,1.98,585,Drug_analog|Low_confidence,perhexiline,other non-selective calcium channel blockers,cardiology,angina pectoris,carnitine palmitoyltransferase inhibitor,CYXKNKQEMFBLER-UHFFFAOYSA-N
CCMSLIB00012722946,related spectra of 'perhexiline (delta mass:1.98)',CCMSLIB00010145792|CCMSLIB00010145795,1.98,586,Drug_analog|Low_confidence,perhexiline,other non-selective calcium channel blockers,cardiology,angina pectoris,carnitine palmitoyltransferase inhibitor,CYXKNKQEMFBLER-UHFFFAOYSA-N
CCMSLIB00012722947,related spectra of 'perhexiline (delta mass:1.98)',CCMSLIB00010145792|CCMSLIB00010145795,1.98,587,Drug_analog|Low_confidence,perhexiline,other non-selective calcium channel blockers,cardiology,angina pectoris,carnitine palmitoyltransferase inhibitor,CYXKNKQEMFBLER-UHFFFAOYSA-N
CCMSLIB00012722948,related spectra of 'perhexiline (delta mass:1.98)',CCMSLIB00010145792|CCMSLIB00010145795,1.98,588,Drug_analog|Low_confidence,perhexiline,other non-selective calcium channel blockers,cardiology,angina pectoris,carnitine palmitoyltransferase inhibitor,CYXKNKQEMFBLER-UHFFFAOYSA-N
CCMSLIB00012722949,related spectra of 'perhexiline (delta mass:1.98)',CCMSLIB00010145792|CCMSLIB00010145795,1.98,589,Drug_analog|Low_confidence,perhexiline,other non-selective calcium channel blockers,cardiology,angina pectoris,carnitine palmitoyltransferase inhibitor,CYXKNKQEMFBLER-UHFFFAOYSA-N
CCMSLIB00012722950,related spectra of 'perhexiline (delta mass:1.98)',CCMSLIB00010145792|CCMSLIB00010145795,1.98,590,Drug_analog|Low_confidence,perhexiline,other non-selective calcium channel blockers,cardiology,angina pectoris,carnitine palmitoyltransferase inhibitor,CYXKNKQEMFBLER-UHFFFAOYSA-N
CCMSLIB00012722951,related spectra of 'perhexiline (delta mass:1.98)',CCMSLIB00010145792|CCMSLIB00010145795,1.98,591,Drug_analog|Low_confidence,perhexiline,other non-selective calcium channel blockers,cardiology,angina pectoris,carnitine palmitoyltransferase inhibitor,CYXKNKQEMFBLER-UHFFFAOYSA-N
CCMSLIB00012722952,related spectra of 'perhexiline (delta mass:2.02)',CCMSLIB00010145792|CCMSLIB00010145795,2.02,592,Drug_analog|Low_confidence,perhexiline,other non-selective calcium channel blockers,cardiology,angina pectoris,carnitine palmitoyltransferase inhibitor,CYXKNKQEMFBLER-UHFFFAOYSA-N
CCMSLIB00012722953,related spectra of 'uridine triacetate (delta mass:37.96)',CCMSLIB00005464337|CCMSLIB00006124703|CCMSLIB00006124704|CCMSLIB00006124705|CCMSLIB00006124706|CCMSLIB00006124707|CCMSLIB00006679633|CCMSLIB00010102471|CCMSLIB00010102817|CCMSLIB00010114425|CCMSLIB00010125753|CCMSLIB00010126086|CCMSLIB00010126432,37.96,593,Drug_analog,uridine triacetate,various alimentary tract and metabolism products,genetics|critical care,orotic aciduria|fluorouracil overdose|capecitabine overdose,pyrimidine analog,DRTQHJPVMGBUCF-XVFCMESISA-N
CCMSLIB00012722954,"related spectra of 'sulfamethazine (delta mass:2.0)', 'sulfamethazine (delta mass:1.99)'",CCMSLIB00005776263,2,594,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012722955,"related spectra of 'sulfamethazine (delta mass:2.0)', 'sulfamethazine (delta mass:1.99)', 'sulfadimidine (delta mass:1.99)'",CCMSLIB00000207275|CCMSLIB00000207276|CCMSLIB00000207281|CCMSLIB00000207282|CCMSLIB00000223720|CCMSLIB00000562784|CCMSLIB00000579538|CCMSLIB00000841836|CCMSLIB00003135019|CCMSLIB00003135048|CCMSLIB00003137995|CCMSLIB00003138861|CCMSLIB00005776263|CCMSLIB00005776685|CCMSLIB00010143272,2,595,Drug_analog|Background/QAQC,sulfamethazine|sulfadimidine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012722956,related spectra of 'diethylstilbestrol (delta mass:12.0)',CCMSLIB00000565081|CCMSLIB00005726537|CCMSLIB00005726775,12,596,Drug_analog,diethylstilbestrol,estrogen,NA,NA,estrogen receptor agonist,RGLYKWWBQGJZGM-ISLYRVAYSA-N
CCMSLIB00012722957,related spectra of 'diethylstilbestrol (delta mass:12.0)',CCMSLIB00000565081|CCMSLIB00005726537|CCMSLIB00005726775,12,597,Drug_analog,diethylstilbestrol,estrogen,NA,NA,estrogen receptor agonist,RGLYKWWBQGJZGM-ISLYRVAYSA-N
CCMSLIB00012722958,related spectra of 'diethylstilbestrol (delta mass:12.0)',CCMSLIB00000565081|CCMSLIB00005726537|CCMSLIB00005726775,12,598,Drug_analog,diethylstilbestrol,estrogen,NA,NA,estrogen receptor agonist,RGLYKWWBQGJZGM-ISLYRVAYSA-N
CCMSLIB00012722959,related spectra of 'diethylstilbestrol (delta mass:12.0)',CCMSLIB00000565081|CCMSLIB00005726537|CCMSLIB00005726775,12,599,Drug_analog,diethylstilbestrol,estrogen,NA,NA,estrogen receptor agonist,RGLYKWWBQGJZGM-ISLYRVAYSA-N
CCMSLIB00012722960,related spectra of 'canrenone (delta mass:-60.02)',CCMSLIB00005775230,-60.02,600,Drug_analog,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012722961,related spectra of 'methyltestosterone (delta mass:-21.99)',CCMSLIB00005775092,-21.98,601,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012722962,related spectra of 'methyltestosterone (delta mass:-21.98)',CCMSLIB00005775092,-21.98,602,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012722963,related spectra of 'oxymetholone (delta mass:-17.99)',CCMSLIB00005723848,-17.99,603,Drug_analog,oxymetholone,androstan derivatives,hematology,anemia,androgen receptor agonist,YKELUTWGCGLPTM-WBNQDIJOSA-N
CCMSLIB00012722964,related spectra of 'methyltestosterone (delta mass:-21.98)',CCMSLIB00005762182|CCMSLIB00005767206,-21.98,604,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012722965,related spectra of 'methyltestosterone (delta mass:-21.98)',CCMSLIB00005775092,-21.98,605,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012722966,related spectra of 'vidarabine (delta mass:14.02)',CCMSLIB00010140026|CCMSLIB00010140027|CCMSLIB00010140028,14.02,606,Drug_analog,vidarabine,adenosine receptor agonist,cardiology,Wolff-Parkinson-White Syndrome (WPW)|supraventricular tachycardia,adenosine receptor agonist,OIRDTQYFTABQOQ-UHTZMRCNSA-N
CCMSLIB00012722967,related spectra of 'esmolol (delta mass:-14.02)',CCMSLIB00000078947,-14.02,607,Drug_analog,esmolol,beta-adrenergic receptor inhibitor,cardiology,ventricular tachycardia (VT)|hypertension,adrenergic receptor antagonist,AQNDDEOPVVGCPG-UHFFFAOYSA-N
CCMSLIB00012722968,related spectra of 'esmolol (delta mass:-14.02)',CCMSLIB00000078947|CCMSLIB00000085836,-14.02,608,Drug_analog,esmolol,beta-adrenergic receptor inhibitor,cardiology,ventricular tachycardia (VT)|hypertension,adrenergic receptor antagonist,AQNDDEOPVVGCPG-UHFFFAOYSA-N
CCMSLIB00012722969,related spectra of 'metoprolol acid (delta mass:14.02)',CCMSLIB00005775931,14.02,609,Drug_analog,metoprolol acid,beta-adrenergic receptor inhibitor,cardiology,hypertension|angina pectoris|myocardial infarction,adrenergic receptor antagonist,PUQIRTNPJRFRCZ-UHFFFAOYSA-N
CCMSLIB00012722970,"related spectra of 'atenolol (delta mass:15.01)', '(r)-(+)-atenolol (delta mass:15.01)'",CCMSLIB00005755105|CCMSLIB00005772592|CCMSLIB00006678609|CCMSLIB00006679329|CCMSLIB00006679692|CCMSLIB00006682259|CCMSLIB00010135132|CCMSLIB00010135135|CCMSLIB00010144693|CCMSLIB00010144696,15.01,610,Drug_analog,atenolol|atenolol,beta-adrenergic receptor inhibitor,cardiology,hypertension|angina pectoris|acute myocardial infarction,adrenergic receptor antagonist,METKIMKYRPQLGS-UHFFFAOYSA-N|METKIMKYRPQLGS-GFCCVEGCSA-N
CCMSLIB00012722971,related spectra of 'dicyclomine (delta mass:-28.03)',CCMSLIB00010011924|CCMSLIB00010148639|CCMSLIB00010148642,-28.03,611,Drug_analog,dicyclomine,anticholinergic,gastroenterology,irritable bowel syndrome,acetylcholine receptor antagonist,CURUTKGFNZGFSE-UHFFFAOYSA-N
CCMSLIB00012722972,related spectra of 'perhexiline (delta mass:3.99)',CCMSLIB00010145792|CCMSLIB00010145795,3.99,612,Drug_analog|Low_confidence,perhexiline,other non-selective calcium channel blockers,cardiology,angina pectoris,carnitine palmitoyltransferase inhibitor,CYXKNKQEMFBLER-UHFFFAOYSA-N
CCMSLIB00012722973,related spectra of 'baicalein (delta mass:12.0)',CCMSLIB00006585024|CCMSLIB00010122263|CCMSLIB00010122265|CCMSLIB00010136231|CCMSLIB00010136232|CCMSLIB00010136234,12,613,Drug_analog,baicalein|baicalein,no_match,no_match,no_match,no_match,FXNFHKRTJBSTCS-UHFFFAOYSA-N
CCMSLIB00012722974,related spectra of 'trenbolone (delta mass:29.98)',CCMSLIB00005723896,29.97,614,Drug_analog,trenbolone,no_match,no_match,no_match,no_match,MEHHPFQKXOUFFV-HIEASXQVSA-N
CCMSLIB00012722975,related spectra of 'prednisolone (delta mass:-60.02)',CCMSLIB00010134091,-60.02,615,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012722976,related spectra of 'prednisolone (delta mass:-60.02)',CCMSLIB00010134091,-60.02,616,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012722977,related spectra of 'prednisolone (delta mass:-60.02)',CCMSLIB00010134089,-60.02,617,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012722978,related spectra of 'trenbolone (delta mass:12.04)',CCMSLIB00000842012|CCMSLIB00005765142|CCMSLIB00005772759|CCMSLIB00005773429,12.04,618,Drug_analog,trenbolone,no_match,no_match,no_match,no_match,MEHHPFQKXOUFFV-UHFFFAOYSA-N|MEHHPFQKXOUFFV-OWSLCNJRSA-N|MEHHPFQKXOUFFV-FOIPXRHGSA-N
CCMSLIB00012722979,related spectra of 'drostanolone (delta mass:-21.98)',CCMSLIB00005723746,-21.98,619,Drug_analog|Low_confidence,drostanolone,no_match,no_match,no_match,no_match,FDGQIVOIHOIMNK-TZAHHXAYSA-N
CCMSLIB00012722980,related spectra of 'bisoprolol (delta mass:-42.05)',CCMSLIB00000572544|CCMSLIB00000579596|CCMSLIB00000841913|CCMSLIB00005735825|CCMSLIB00005775224|CCMSLIB00010146744|CCMSLIB00010146745|CCMSLIB00010146747|CCMSLIB00010146750,-42.05,620,Drug_analog,bisoprolol|bisoprolol,beta-adrenergic receptor inhibitor,cardiology,hypertension,adrenergic receptor antagonist,VHYCDWMUTMEGQY-UHFFFAOYSA-N
CCMSLIB00012722981,related spectra of 'sulfamethizole (delta mass:14.02)',CCMSLIB00003138135,14.02,621,Drug_analog|Background/QAQC,sulfamethizole,sulfonamide antimicrobial,infectious disease,urinary tract infections,bacterial antifolate,VACCAVUAMIDAGB-UHFFFAOYSA-N
CCMSLIB00012722982,related spectra of 'uridine triacetate (delta mass:42.01)',CCMSLIB00006124693|CCMSLIB00006124694,42.01,622,Drug_analog,uridine triacetate,various alimentary tract and metabolism products,genetics|critical care,orotic aciduria|fluorouracil overdose|capecitabine overdose,pyrimidine analog,DRTQHJPVMGBUCF-XVFCMESISA-N
CCMSLIB00012722983,related spectra of 'uridine triacetate (delta mass:42.01)',CCMSLIB00006124696,42.01,623,Drug_analog,uridine triacetate,various alimentary tract and metabolism products,genetics|critical care,orotic aciduria|fluorouracil overdose|capecitabine overdose,pyrimidine analog,DRTQHJPVMGBUCF-XVFCMESISA-N
CCMSLIB00012722984,related spectra of 'norethisterone acetate (delta mass:-56.06)',CCMSLIB00010149572|CCMSLIB00010149575,-56.06,624,Drug_analog,norethisterone acetate,progestin,obstetrics/gynecology,endometriosis|contraceptive,progesterone receptor agonist,IMONTRJLAWHYGT-ZCPXKWAGSA-N
CCMSLIB00012722985,related spectra of 'trenbolone (delta mass:13.98)',CCMSLIB00005723890|CCMSLIB00005723895,13.98,625,Drug_analog,trenbolone,no_match,no_match,no_match,no_match,MEHHPFQKXOUFFV-OWSLCNJRSA-N|MEHHPFQKXOUFFV-HIEASXQVSA-N
CCMSLIB00012722986,related spectra of 'iloprost (delta mass:-40.03)',CCMSLIB00010149630,-40.03,626,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012722987,related spectra of 'exemestane (delta mass:-12.0)',CCMSLIB00000005322,-12,627,Drug_analog,exemestane,aromatase inhibitor,oncology,breast cancer,aromatase inhibitor,BFYIZQONLCFLEV-DAELLWKTSA-N
CCMSLIB00012722988,"related spectra of 'ethinylestradiol (delta mass:-11.96)', 'ethinyl estradiol (delta mass:-11.96)'",CCMSLIB00000572862|CCMSLIB00005732287|CCMSLIB00005735778,-11.96,628,Drug_analog|Low_confidence,ethinylestradiol|ethinyl estradiol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist|estrogenic hormone,BFPYWIDHMRZLRN-UHFFFAOYSA-N
CCMSLIB00012722989,related spectra of 'ethylestrenol (delta mass:13.98)',CCMSLIB00005723752,13.98,629,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012722990,related spectra of 'dydrogesterone (delta mass:-27.99)',CCMSLIB00005774596,-27.99,630,Drug_analog,dydrogesterone,progestin,obstetrics/gynecology,infertility,progesterone receptor agonist,JGMOKGBVKVMRFX-HQZYFCCVSA-N
CCMSLIB00012722991,related spectra of 'methyltestosterone (delta mass:-18.01)',CCMSLIB00005775092,-18.01,631,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012722992,related spectra of 'methyltestosterone (delta mass:-17.99)',CCMSLIB00005775092,-17.99,632,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012722993,related spectra of 'codeine (delta mass:-14.02)',CCMSLIB00005775049,-14.02,633,Drug_analog,codeine,opioid agonist,neurology/psychiatry|pulmonary,pain|cough,opioid receptor agonist,OROGSEYTTFOCAN-DNJOTXNNSA-N
CCMSLIB00012722994,"related spectra of 'higenamine (delta mass:14.02)', 'higenamine (chimeric precursor selection) (delta mass:14.02)'",CCMSLIB00010144239|CCMSLIB00010144240|CCMSLIB00010144242|CCMSLIB00010144243,14.02,634,Drug_analog,higenamine|higenamine (chimeric precursor selection),no_match,NA,NA,adrenergic receptor agonist,WZRCQWQRFZITDX-UHFFFAOYSA-N
CCMSLIB00012722995,"related spectra of 'quinine (delta mass:-39.01)', 'quinidine (delta mass:-39.01)'",CCMSLIB00000085673|CCMSLIB00000214060|CCMSLIB00000215543|CCMSLIB00000856116|CCMSLIB00003135463|CCMSLIB00005778090|CCMSLIB00006380677|CCMSLIB00006380775|CCMSLIB00006380851|CCMSLIB00006380876|CCMSLIB00006390980|CCMSLIB00006399955|CCMSLIB00006400191,-39.01,635,Drug_analog,quinine|quinidine,antimalarial|antiarrhythmic,infectious disease|cardiology,malaria|atrial fibrillation (AF)|ventricular arrhythmias,hemozoin biocrystallization inhibitor|sodium channel blocker,LOUPRKONTZGTKE-WZBLMQSHSA-N|LOUPRKONTZGTKE-FOEVPDMQSA-N|LOUPRKONTZGTKE-USWSZDBUSA-N|LOUPRKONTZGTKE-LHHVKLHASA-N|LOUPRKONTZGTKE-UHFFFAOYSA-N
CCMSLIB00012722996,related spectra of 'cyclizine (delta mass:18.99)',CCMSLIB00005753607|CCMSLIB00005753652|CCMSLIB00005754329|CCMSLIB00005754423,18.99,636,Drug_analog,cyclizine,histamine-1 (H1) inhibitor,gastroenterology|neurology/psychiatry,nausea|vomiting|vertigo|motion sickness,histamine receptor modulator,UVKZSORBKUEBAZ-UHFFFAOYSA-N
CCMSLIB00012722997,related spectra of 'oxandrolone (delta mass:-0.98)',CCMSLIB00005723842,-0.98,637,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012722998,"related spectra of 'sulfachloropyridazine (delta mass:1.98)', 'sulfachlorpyridazine (delta mass:1.98)'",CCMSLIB00005775887|CCMSLIB00010146860,1.98,638,Drug_analog|Background/QAQC,sulfachlorpyridazine|sulfachloropyridazine,sulfonamide antimicrobial|veterinary,infectious disease,urinary tract infections,bacterial antifolate,XOXHILFPRYWFOD-UHFFFAOYSA-N
CCMSLIB00012722999,related spectra of 'dapsone (delta mass:37.95)',CCMSLIB00010148428,37.95,639,Drug_analog,dapsone,sulfone,dermatology|infectious disease,dermatitis herpetiformis (DH)|leprosy,bacterial antifolate,MQJKPEGWNLWLTK-UHFFFAOYSA-N
CCMSLIB00012723000,related spectra of 'dapsone (delta mass:37.95)',CCMSLIB00010148428|CCMSLIB00010148430,37.95,640,Drug_analog,dapsone,sulfone,dermatology|infectious disease,dermatitis herpetiformis (DH)|leprosy,bacterial antifolate,MQJKPEGWNLWLTK-UHFFFAOYSA-N
CCMSLIB00012723001,"related spectra of 'hydroxyzine (delta mass:-88.05)', 'chlorcyclizine (delta mass:-14.02)'",CCMSLIB00000078630|CCMSLIB00000085591,-88.05|-14.02,641,Drug_analog,hydroxyzine|chlorcyclizine,histamine-1 (H1) inhibitor,neurology/psychiatry|allergy,anxiety|urticaria|itching|allergic rhinitis,histamine H1 receptor inverse agonist|histamine receptor antagonist,ZQDWXGKKHFNSQK-UHFFFAOYSA-N|WFNAKBGANONZEQ-UHFFFAOYSA-N
CCMSLIB00012723002,related spectra of 'hydroxyzine (delta mass:-88.05)',CCMSLIB00000078630,-88.05,642,Drug_analog,hydroxyzine,histamine-1 (H1) inhibitor,neurology/psychiatry|allergy,anxiety|urticaria|itching,histamine H1 receptor inverse agonist,ZQDWXGKKHFNSQK-UHFFFAOYSA-N
CCMSLIB00012723003,related spectra of 'iloprost (delta mass:-56.06)',CCMSLIB00010149636,-56.06,643,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723004,related spectra of 'enzacamene (delta mass:31.99)',CCMSLIB00005774462,31.99,644,Drug_analog,enzacamene,no_match,dermatology,sunscreen lotion,endocrine disruptor,HEOCBCNFKCOKBX-UHFFFAOYSA-N
CCMSLIB00012723005,related spectra of 'methyltestosterone (delta mass:-16.03)',CCMSLIB00005777031,-16.03,645,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012723006,related spectra of 'methyltestosterone (delta mass:-16.03)',CCMSLIB00005777031,-16.03,646,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012723007,related spectra of 'trenbolone (delta mass:16.03)',CCMSLIB00000842012|CCMSLIB00005765142,16.03,647,Drug_analog,trenbolone,no_match,no_match,no_match,no_match,MEHHPFQKXOUFFV-UHFFFAOYSA-N|MEHHPFQKXOUFFV-OWSLCNJRSA-N
CCMSLIB00012723008,related spectra of 'ethylestrenol (delta mass:15.99)',CCMSLIB00005723752,15.99,648,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012723009,related spectra of 'methyltestosterone (delta mass:-15.99)',CCMSLIB00005777031,-15.99,649,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012723010,related spectra of 'sulfachlorpyridazine (delta mass:3.0)',CCMSLIB00005775887,3,650,Drug_analog|Background/QAQC,sulfachlorpyridazine,sulfonamide antimicrobial|veterinary,infectious disease,urinary tract infections,bacterial antifolate,XOXHILFPRYWFOD-UHFFFAOYSA-N
CCMSLIB00012723011,"related spectra of 'hydrocodone (delta mass:-12.0)', 'dihydrocodeine (delta mass:-14.02)'",CCMSLIB00000568273|CCMSLIB00000569838|CCMSLIB00005731756|CCMSLIB00005735253|CCMSLIB00005772197|CCMSLIB00005772272|CCMSLIB00005773269,-12.00|-14.02,651,Drug_analog,dihydrocodeine|hydrocodone,opioid agonist,neurology/psychiatry|pulmonary,pain|cough,opioid receptor agonist,RBOXVHNMENFORY-DNJOTXNNSA-N|LLPOLZWFYMWNKH-CMKMFDCUSA-N
CCMSLIB00012723012,"related spectra of 'cinchocaine (delta mass:-56.06)', 'dibucaine (delta mass:-56.06)'",CCMSLIB00000567693|CCMSLIB00005730153|CCMSLIB00005754007|CCMSLIB00005754019|CCMSLIB00005754963,-56.06,652,Drug_analog,cinchocaine|dibucaine,amide local anesthetic,neurology/psychiatry,local anesthetic,sodium channel blocker,PUFQVTATUTYEAL-UHFFFAOYSA-N
CCMSLIB00012723013,related spectra of 'acitretin (delta mass:-38.02)',CCMSLIB00010130332,-38.02,653,Drug_analog,acitretin,retinoid,dermatology,psoriasis,retinoid receptor agonist,IHUNBGSDBOWDMA-AQFIFDHZSA-N
CCMSLIB00012723014,related spectra of 'lovastatin (delta mass:-116.08)',CCMSLIB00000566324|CCMSLIB00005736331,-116.08,654,Drug_analog,lovastatin,HMG-CoA reductase inhibitor (statin),endocrinology|cardiology|neurology/psychiatry,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,PCZOHLXUXFIOCF-BXMDZJJMSA-N
CCMSLIB00012723015,related spectra of 'nateglinide (delta mass:-26.02)',CCMSLIB00006118535|CCMSLIB00006118537|CCMSLIB00006118554|CCMSLIB00006118556|CCMSLIB00006118559,-26.02,655,Drug_analog,nateglinide,glinide,endocrinology,type 2 diabetes mellitus,insulin secretagogue,OELFLUMRDSZNSF-OFLPRAFFSA-N
CCMSLIB00012723016,related spectra of 'bimatoprost (delta mass:-90.05)',CCMSLIB00010147091|CCMSLIB00010147092|CCMSLIB00010147093,-90.05,656,Drug_analog,bimatoprost,prostaglandin analog,ophthalmology,intraocular pressure|glaucoma|ocular hypertension,prostanoid receptor agonist,AQOKCDNYWBIDND-FTOWTWDKSA-N
CCMSLIB00012723017,related spectra of 'bimatoprost (delta mass:-90.05)',CCMSLIB00010147091|CCMSLIB00010147092|CCMSLIB00010147093,-90.05,657,Drug_analog,bimatoprost,prostaglandin analog,ophthalmology,intraocular pressure|glaucoma|ocular hypertension,prostanoid receptor agonist,AQOKCDNYWBIDND-FTOWTWDKSA-N
CCMSLIB00012723018,related spectra of 'golotimod (delta mass:-43.01)',CCMSLIB00010133732,-43.01,658,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723019,related spectra of 'masoprocol (delta mass:-12.0)',CCMSLIB00006555588,-12,659,Drug_analog,masoprocol,other antineoplastic agents,dermatology,actinic keratosis (AK),lipoxygenase inhibitor,HCZKYJDFEPMADG-UHFFFAOYSA-N
CCMSLIB00012723020,related spectra of 'hydroxyprogesterone caproate (delta mass:-40.03)',CCMSLIB00005766828,-40.03,660,Drug_analog|Low_confidence,hydroxyprogesterone caproate,progestin,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DBPWSSGDRRHUNT-CEGNMAFCSA-N
CCMSLIB00012723021,related spectra of 'ethylestrenol (delta mass:1.94)',CCMSLIB00005723751,1.94,661,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012723022,related spectra of 'oxandrolone (delta mass:-14.02)',CCMSLIB00005723841,-14.02,662,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012723023,related spectra of 'oxandrolone (delta mass:4.0)',CCMSLIB00005723842,3.99,663,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012723024,related spectra of 'canrenone (delta mass:-49.99)',CCMSLIB00000564977|CCMSLIB00005726588,-49.99,664,Drug_analog,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-WNHSNXHDSA-N
CCMSLIB00012723025,related spectra of 'drostanolone (delta mass:4.0)',CCMSLIB00005723747,3.99,665,Drug_analog|Low_confidence,drostanolone,no_match,no_match,no_match,no_match,FDGQIVOIHOIMNK-TZAHHXAYSA-N
CCMSLIB00012723026,related spectra of 'mesterolone (delta mass:4.0)',CCMSLIB00005723784,3.99,666,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723027,related spectra of 'mesterolone (delta mass:4.03)',CCMSLIB00005723784,4.03,667,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723028,related spectra of '21312-10-7 (delta mass:-3.99)',CCMSLIB00000208221|CCMSLIB00000208227|CCMSLIB00006126852,-3.99,668,Drug_analog,acetylsulfamethoxazole,sulfonamide antimicrobial,infectious disease,pneumonia|enteritis|urinary tract infections,PABA antagonist,GXPIUNZCALHVBA-UHFFFAOYSA-N
CCMSLIB00012723029,"related spectra of 'golotimod (delta mass:-42.01)', 'oglufanide (delta mass:-42.01)'",CCMSLIB00010133731|CCMSLIB00010133732|CCMSLIB00010133733|CCMSLIB00010152307|CCMSLIB00010152308,-42.01,669,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723030,"related spectra of 'golotimod (delta mass:-42.01)', 'oglufanide (delta mass:-42.01)'",CCMSLIB00010133731|CCMSLIB00010133733|CCMSLIB00010152307,-42.01,670,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723031,related spectra of 'n-desmethylvenlafaxine (delta mass:27.99)',CCMSLIB00000209369,27.99,671,Drug_analog,n-desmethylvenlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MKAFOJAJJMUXLW-UHFFFAOYSA-N
CCMSLIB00012723032,related spectra of 'meptazinol (delta mass:58.01)',CCMSLIB00000565906|CCMSLIB00000567833|CCMSLIB00005735309,58.01,672,Drug_analog,meptazinol,opioid agonist,neurology/psychiatry,pain relief,opioid receptor agonist,JLICHNCFTLFZJN-UHFFFAOYSA-N
CCMSLIB00012723033,related spectra of 'amitriptyline (delta mass:14.02)',CCMSLIB00010131289,14.02,673,Drug_analog|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012723034,related spectra of 'tolnaftate (delta mass:-15.01)',CCMSLIB00000425486,-15.01,674,Drug_analog,tolnaftate,other antifungals for topical use,infectious disease,tinea pedis|tinea corporis,fungal squalene epoxidase inhibitor,FUSNMLFNXJSCDI-UHFFFAOYSA-N
CCMSLIB00012723035,related spectra of 'sulfamethazine (delta mass:14.02)',CCMSLIB00010143272,14.02,675,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012723036,"related spectra of 'ethinyl estradiol (delta mass:-4.03)', 'ethinylestradiol (delta mass:-4.03)'",CCMSLIB00000566716|CCMSLIB00000572470|CCMSLIB00000572685|CCMSLIB00005731088|CCMSLIB00005731984|CCMSLIB00005735265,-4.03,676,Drug_analog|Low_confidence,ethinylestradiol|ethinyl estradiol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist|estrogenic hormone,BFPYWIDHMRZLRN-UHFFFAOYSA-N
CCMSLIB00012723037,related spectra of 'octinoxate (delta mass:1.98)',CCMSLIB00006709940,1.98,677,Drug_analog,octinoxate,no_match,dermatology,sunscreen lotion,NA,YBGZDTIWKVFICR-JLHYYAGUSA-N
CCMSLIB00012723038,"related spectra of 'ethinylestradiol (delta mass:14.02)', 'ethinylestradiol (delta mass:14.01)', 'ethinyl estradiol (delta mass:14.02)'",CCMSLIB00006115937|CCMSLIB00006115939|CCMSLIB00010125662,14.02,678,Drug_analog|Low_confidence,ethinylestradiol|ethinyl estradiol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist|estrogenic hormone,BFPYWIDHMRZLRN-UHFFFAOYSA-N|BFPYWIDHMRZLRN-SLHNCBLASA-N
CCMSLIB00012723039,"related spectra of 'ethinyl estradiol (delta mass:-3.99)', 'ethinylestradiol (delta mass:-3.99)', 'ethinyl estradiol (delta mass:-3.98)', 'ethinylestradiol (delta mass:-3.98)'",CCMSLIB00000566716|CCMSLIB00000572470|CCMSLIB00000572685|CCMSLIB00005731088|CCMSLIB00005731984|CCMSLIB00005735265,-3.99,679,Drug_analog|Low_confidence,ethinylestradiol|ethinyl estradiol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist|estrogenic hormone,BFPYWIDHMRZLRN-UHFFFAOYSA-N
CCMSLIB00012723040,related spectra of 'gestodene (delta mass:-17.99)',CCMSLIB00000005052,-17.99,680,Drug_analog,gestodene,"progestogens and estrogens, fixed combinations",obstetrics/gynecology,contraceptive,contraceptive agent,SIGSPDASOTUPFS-XUDSTZEESA-N
CCMSLIB00012723041,related spectra of 'mesterolone (delta mass:-12.04)',CCMSLIB00005723783,-12.04,681,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723042,related spectra of 'hydroxyprogesterone caproate (delta mass:-38.02)',CCMSLIB00005765522,-38.02,682,Drug_analog|Low_confidence,hydroxyprogesterone caproate,progestin,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DBPWSSGDRRHUNT-CEGNMAFCSA-N
CCMSLIB00012723043,related spectra of 'mesterolone (delta mass:-12.04)',CCMSLIB00005723783,-12.04,683,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723044,related spectra of 'mesterolone (delta mass:-12.04)',CCMSLIB00005723783,-12.04,684,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723045,related spectra of 'mesterolone (delta mass:-12.04)',CCMSLIB00005723783,-12.04,685,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723046,related spectra of 'mesterolone (delta mass:-12.04)',CCMSLIB00005723783,-12.04,686,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723047,related spectra of 'mesterolone (delta mass:-12.04)',CCMSLIB00005723783,-12.04,687,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723048,related spectra of 'mesterolone (delta mass:-12.04)',CCMSLIB00005723783,-12.04,688,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723049,"related spectra of 'edetic acid (delta mass:1.0)', 'edta (delta mass:1.0)'",CCMSLIB00003134529|CCMSLIB00003135454|CCMSLIB00003135498|CCMSLIB00005435779|CCMSLIB00006113816|CCMSLIB00006113818|CCMSLIB00006113819|CCMSLIB00006113821|CCMSLIB00006113822|CCMSLIB00010145114|CCMSLIB00010145115,1,689,Drug_analog|Background/QAQC,edta,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N
CCMSLIB00012723050,related spectra of 'tolnaftate (delta mass:-13.98)',CCMSLIB00000425486,-13.98,690,Drug_analog,tolnaftate,other antifungals for topical use,infectious disease,tinea pedis|tinea corporis,fungal squalene epoxidase inhibitor,FUSNMLFNXJSCDI-UHFFFAOYSA-N
CCMSLIB00012723051,related spectra of 'n-desmethylvenlafaxine (delta mass:29.97)',CCMSLIB00000209371|CCMSLIB00000209382|CCMSLIB00000209383|CCMSLIB00000578721,29.97,691,Drug_analog,n-desmethylvenlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MKAFOJAJJMUXLW-UHFFFAOYSA-N
CCMSLIB00012723052,related spectra of 'cyclobenzaprine (delta mass:18.01)',CCMSLIB00010151698|CCMSLIB00010151701|CCMSLIB00010151702|CCMSLIB00010151704|CCMSLIB00010151705,18.01,692,Drug_analog,cyclobenzaprine,muscle relaxant,neurology/psychiatry,muscle spasms,adrenergic receptor agonist|serotonin receptor agonist,JURKNVYFZMSNLP-UHFFFAOYSA-N
CCMSLIB00012723053,related spectra of 'cyclobenzaprine (delta mass:18.01)',CCMSLIB00000085940|CCMSLIB00003136482|CCMSLIB00003137759|CCMSLIB00003139608|CCMSLIB00010151698|CCMSLIB00010151699|CCMSLIB00010151700|CCMSLIB00010151701|CCMSLIB00010151702|CCMSLIB00010151703|CCMSLIB00010151704|CCMSLIB00010151705,18.01,693,Drug_analog,cyclobenzaprine,muscle relaxant,neurology/psychiatry,muscle spasms,adrenergic receptor agonist|serotonin receptor agonist,JURKNVYFZMSNLP-UHFFFAOYSA-N
CCMSLIB00012723054,related spectra of 'nortriptyline (delta mass:30.01)',CCMSLIB00000568509|CCMSLIB00005734376|CCMSLIB00010138447,30.01,694,Drug_analog,nortriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression,tricyclic antidepressant,PHVGLTMQBUFIQQ-UHFFFAOYSA-N
CCMSLIB00012723055,related spectra of 'nortriptyline (delta mass:30.01)',CCMSLIB00000568509|CCMSLIB00000569182|CCMSLIB00005734376|CCMSLIB00005736187|CCMSLIB00010138446,30.01,695,Drug_analog,nortriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression,tricyclic antidepressant,PHVGLTMQBUFIQQ-UHFFFAOYSA-N
CCMSLIB00012723056,related spectra of 'cyclobenzaprine (delta mass:18.01)',CCMSLIB00010151698|CCMSLIB00010151699|CCMSLIB00010151700|CCMSLIB00010151703,18.01,696,Drug_analog,cyclobenzaprine,muscle relaxant,neurology/psychiatry,muscle spasms,adrenergic receptor agonist|serotonin receptor agonist,JURKNVYFZMSNLP-UHFFFAOYSA-N
CCMSLIB00012723057,"related spectra of 'doxepin (delta mass:14.02)', 'doxepin (delta mass:14.01)'",CCMSLIB00000569152|CCMSLIB00005730738|CCMSLIB00005735291|CCMSLIB00006116033|CCMSLIB00006116037|CCMSLIB00006679797|CCMSLIB00006682610|CCMSLIB00006682715|CCMSLIB00010144041|CCMSLIB00010144043|CCMSLIB00010144044|CCMSLIB00010144046,14.02,697,Drug_analog,doxepin,tricyclic antidepressant (TCA),neurology/psychiatry,depression|anxiety,histamine receptor antagonist,ODQWQRRAPPTVAG-BOPFTXTBSA-N|ODQWQRRAPPTVAG-UHFFFAOYSA-N|ODQWQRRAPPTVAG-GZTJUZNOSA-N
CCMSLIB00012723058,related spectra of 'nortriptyline (delta mass:30.01)',CCMSLIB00000568509|CCMSLIB00000569182|CCMSLIB00005734376|CCMSLIB00005736187,30.01,698,Drug_analog,nortriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression,tricyclic antidepressant,PHVGLTMQBUFIQQ-UHFFFAOYSA-N
CCMSLIB00012723059,related spectra of 'nortriptyline (delta mass:30.01)',CCMSLIB00000568509|CCMSLIB00005734376|CCMSLIB00010138447,30.01,699,Drug_analog,nortriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression,tricyclic antidepressant,PHVGLTMQBUFIQQ-UHFFFAOYSA-N
CCMSLIB00012723060,related spectra of 'venlafaxine (delta mass:15.97)',CCMSLIB00000208601|CCMSLIB00000578975|CCMSLIB00005735475,15.97,700,Drug_analog,venlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,PNVNVHUZROJLTJ-UHFFFAOYSA-N
CCMSLIB00012723061,"related spectra of 'n,o-didesmethylvenlafaxine (delta mass:44.03)'",CCMSLIB00000210031|CCMSLIB00000210033|CCMSLIB00000210044|CCMSLIB00000210046|CCMSLIB00000578722|CCMSLIB00000578723|CCMSLIB00000578724,44.03,701,Drug_analog,"n,o-didesmethylvenlafaxine",serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MMSWXJSQCAEDLK-UHFFFAOYSA-N
CCMSLIB00012723062,related spectra of 'sulfamethazine (delta mass:15.99)',CCMSLIB00003135048,15.99,702,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012723063,related spectra of 'edetic acid (delta mass:4.03)',CCMSLIB00006114127,4.03,703,Drug_analog|Background/QAQC,edta,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N
CCMSLIB00012723064,"related spectra of 'mycophenolic-acid (delta mass:-26.02)', 'mycophenolic acid (delta mass:-26.02)', 'mycophenolic acid (delta mass:-43.04)'",CCMSLIB00004695866|CCMSLIB00004695869|CCMSLIB00004702367|CCMSLIB00004702370|CCMSLIB00005774693|CCMSLIB00005777982|CCMSLIB00005778133,-26.02|-43.04,704,Drug_analog,mycophenolic acid|mycophenolic-acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-RUDMXATFSA-N|HPNSFSBZBAHARI-UHFFFAOYSA-N
CCMSLIB00012723065,related spectra of 'golotimod (delta mass:-39.01)',CCMSLIB00010133731|CCMSLIB00010133733,-39.01,705,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723066,related spectra of 'artemisinin (delta mass:12.0)',CCMSLIB00005768072|CCMSLIB00005770754,12,706,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723067,related spectra of 'ubenimex (delta mass:-14.02)',CCMSLIB00000078191|CCMSLIB00000079037,-14.02,707,Drug_analog,ubenimex,no_match,NA,NA,leukotriene synthesis inhibitor,VGGGPCQERPFHOB-RDBSUJKOSA-N
CCMSLIB00012723068,related spectra of 'oxandrolone (delta mass:-12.0)',CCMSLIB00005723835,-12,708,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,QSLJIVKCVHQPLV-ZXOYHYBESA-N
CCMSLIB00012723069,related spectra of 'prednisone (delta mass:-63.96)',CCMSLIB00000206340|CCMSLIB00005771430,-63.96,709,Drug_analog,prednisone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,XOFYZVNMUHMLCC-UHFFFAOYSA-N
CCMSLIB00012723070,related spectra of 'oxandrolone (delta mass:-12.0)',CCMSLIB00005723835,-12,710,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,QSLJIVKCVHQPLV-ZXOYHYBESA-N
CCMSLIB00012723071,related spectra of 'oxandrolone (delta mass:-12.0)',CCMSLIB00005723835,-12,711,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,QSLJIVKCVHQPLV-ZXOYHYBESA-N
CCMSLIB00012723072,related spectra of 'oxandrolone (delta mass:-12.0)',CCMSLIB00005723835,-12,712,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,QSLJIVKCVHQPLV-ZXOYHYBESA-N
CCMSLIB00012723073,related spectra of 'prednisone (delta mass:-63.96)',CCMSLIB00005764230|CCMSLIB00010147694,-63.96,713,Drug_analog,prednisone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,XOFYZVNMUHMLCC-ZPOLXVRWSA-N
CCMSLIB00012723074,related spectra of 'prednisone (delta mass:-63.96)',CCMSLIB00005731345,-63.96,714,Drug_analog,prednisone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,XOFYZVNMUHMLCC-ZPOLXVRWSA-N
CCMSLIB00012723075,related spectra of 'oxandrolone (delta mass:-12.0)',CCMSLIB00005723835,-12,715,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,QSLJIVKCVHQPLV-ZXOYHYBESA-N
CCMSLIB00012723076,related spectra of 'metoprolol acid (delta mass:27.99)',CCMSLIB00000208973|CCMSLIB00000208985,27.99,716,Drug_analog,metoprolol acid,beta-adrenergic receptor inhibitor,cardiology,hypertension|angina pectoris|myocardial infarction,adrenergic receptor antagonist,PUQIRTNPJRFRCZ-UHFFFAOYSA-N
CCMSLIB00012723077,related spectra of 'doxepin (delta mass:15.99)',CCMSLIB00000569152|CCMSLIB00005735291|CCMSLIB00006116039,15.99,717,Drug_analog,doxepin,tricyclic antidepressant (TCA),neurology/psychiatry,depression|anxiety,histamine receptor antagonist,ODQWQRRAPPTVAG-BOPFTXTBSA-N|ODQWQRRAPPTVAG-UHFFFAOYSA-N
CCMSLIB00012723078,related spectra of 'artemisinin (delta mass:13.98)',CCMSLIB00000214217|CCMSLIB00000215699,13.98,718,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723079,related spectra of 'acitretin (delta mass:-30.01)',CCMSLIB00010130334,-30.01,719,Drug_analog,acitretin,retinoid,dermatology,psoriasis,retinoid receptor agonist,IHUNBGSDBOWDMA-AQFIFDHZSA-N
CCMSLIB00012723080,"related spectra of 'yohimbine (delta mass:-58.0)', 'yohimbine (delta mass:--58.01)'",CCMSLIB00000854883|CCMSLIB00005769484,-58.01,720,Drug_analog,yohimbine,drugs used in erectile dysfunction,urology,erectile dysfunction,adrenergic receptor antagonist,BLGXFZZNTVWLAY-UHFFFAOYSA-N|BLGXFZZNTVWLAY-SCYLSFHTSA-N
CCMSLIB00012723081,related spectra of 'prednisolone (delta mass:-63.96)',CCMSLIB00000004492|CCMSLIB00006117497|CCMSLIB00006117499|CCMSLIB00010134095,-63.96,721,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723082,related spectra of 'prednisolone (delta mass:-63.96)',CCMSLIB00000004492|CCMSLIB00006117495|CCMSLIB00006117497|CCMSLIB00006117499|CCMSLIB00010134095,-63.96,722,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723083,related spectra of 'prednisolone (delta mass:-63.96)',CCMSLIB00006117501,-63.96,723,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723084,"related spectra of '21312-10-7 (delta mass:2.0)', '21312-10-7 (delta mass:1.99)'",CCMSLIB00000208218|CCMSLIB00000208220|CCMSLIB00000208226|CCMSLIB00000208231|CCMSLIB00000223789|CCMSLIB00000223790|CCMSLIB00005774339|CCMSLIB00005775725,2,724,Drug_analog,acetylsulfamethoxazole,sulfonamide antimicrobial,infectious disease,pneumonia|enteritis|urinary tract infections,PABA antagonist,GXPIUNZCALHVBA-UHFFFAOYSA-N
CCMSLIB00012723085,related spectra of 'vidarabine (delta mass:30.01)',CCMSLIB00010140027,30.01,725,Drug_analog,vidarabine,adenosine receptor agonist,cardiology,Wolff-Parkinson-White Syndrome (WPW)|supraventricular tachycardia,adenosine receptor agonist,OIRDTQYFTABQOQ-UHTZMRCNSA-N
CCMSLIB00012723086,related spectra of 'vidarabine (delta mass:30.01)',CCMSLIB00010140027|CCMSLIB00010140028,30.01,726,Drug_analog,vidarabine,adenosine receptor agonist,cardiology,Wolff-Parkinson-White Syndrome (WPW)|supraventricular tachycardia,adenosine receptor agonist,OIRDTQYFTABQOQ-UHTZMRCNSA-N
CCMSLIB00012723087,related spectra of 'codeine (delta mass:-2.02)',CCMSLIB00005775107,-2.02,727,Drug_analog,codeine,opioid agonist,neurology/psychiatry|pulmonary,pain|cough,opioid receptor agonist,OROGSEYTTFOCAN-DNJOTXNNSA-N
CCMSLIB00012723088,related spectra of 'metoprolol (delta mass:30.01)',CCMSLIB00000207244|CCMSLIB00000207246|CCMSLIB00000207257|CCMSLIB00000223623|CCMSLIB00000223624|CCMSLIB00005726154|CCMSLIB00010139509|CCMSLIB00010139512,30.01,728,Drug_analog,metoprolol,beta-adrenergic receptor inhibitor,cardiology,hypertension|angina pectoris|myocardial infarction,adrenergic receptor antagonist,IUBSYMUCCVWXPE-UHFFFAOYSA-N
CCMSLIB00012723089,related spectra of 'sulfamethizole (delta mass:27.99)',CCMSLIB00010136741|CCMSLIB00010136742,27.99,729,Drug_analog|Background/QAQC,sulfamethizole,sulfonamide antimicrobial,infectious disease,urinary tract infections,bacterial antifolate,VACCAVUAMIDAGB-UHFFFAOYSA-N
CCMSLIB00012723090,related spectra of 'sulfamethizole (delta mass:27.99)',CCMSLIB00010136742,27.99,730,Drug_analog|Background/QAQC,sulfamethizole,sulfonamide antimicrobial,infectious disease,urinary tract infections,bacterial antifolate,VACCAVUAMIDAGB-UHFFFAOYSA-N
CCMSLIB00012723091,related spectra of 'lactulose (delta mass:-42.01)',CCMSLIB00006684580,-42.01,731,Drug_analog|Low_confidence,lactulose,osmotic laxative,gastroenterology,portal-systemic encephalopathy (PSE)|constipation,laxative,JCQLYHFGKNRPGE-FCVZTGTOSA-N
CCMSLIB00012723092,related spectra of 'mestranol (delta mass:-12.04)',CCMSLIB00003140010,-12.04,732,Drug_analog,mestranol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist,IMSSROKUHAOUJS-MJCUULBUSA-N
CCMSLIB00012723093,related spectra of 'mestranol (delta mass:-12.04)',CCMSLIB00003140010,-12.04,733,Drug_analog,mestranol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist,IMSSROKUHAOUJS-MJCUULBUSA-N
CCMSLIB00012723094,related spectra of 'mestranol (delta mass:-12.04)',CCMSLIB00003140010,-12.04,734,Drug_analog,mestranol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist,IMSSROKUHAOUJS-MJCUULBUSA-N
CCMSLIB00012723095,related spectra of 'prednisolone (delta mass:-44.03)',CCMSLIB00010134089,-44.03,735,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723096,related spectra of 'exemestane (delta mass:2.0)',CCMSLIB00000208700,2,736,Drug_analog,exemestane,aromatase inhibitor,oncology,breast cancer,aromatase inhibitor,BFYIZQONLCFLEV-UHFFFAOYSA-N
CCMSLIB00012723097,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,737,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723098,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,738,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723099,related spectra of 'ethinylestradiol (delta mass:2.0)',CCMSLIB00000004896,2,739,Drug_analog|Low_confidence,ethinylestradiol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist|estrogenic hormone,BFPYWIDHMRZLRN-SLHNCBLASA-N
CCMSLIB00012723100,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,740,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723101,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,741,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723102,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,742,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723103,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,743,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723104,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,744,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723105,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005769004,16.03,745,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723106,related spectra of 'ethinylestradiol (delta mass:2.0)',CCMSLIB00000004896,2,746,Drug_analog|Low_confidence,ethinylestradiol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist|estrogenic hormone,BFPYWIDHMRZLRN-SLHNCBLASA-N
CCMSLIB00012723107,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,747,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723108,"related spectra of 'ethinylestradiol (delta mass:2.0)', 'ethinyl estradiol (delta mass:2.0)'",CCMSLIB00000572685|CCMSLIB00005735265,2,748,Drug_analog|Low_confidence,ethinylestradiol|ethinyl estradiol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist|estrogenic hormone,BFPYWIDHMRZLRN-UHFFFAOYSA-N
CCMSLIB00012723109,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,749,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723110,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,750,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723111,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,751,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723112,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,752,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723113,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,753,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723114,"related spectra of 'ethinylestradiol (delta mass:2.0)', 'ethinyl estradiol (delta mass:2.0)'",CCMSLIB00000572685|CCMSLIB00005735265,2,754,Drug_analog|Low_confidence,ethinylestradiol|ethinyl estradiol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist|estrogenic hormone,BFPYWIDHMRZLRN-UHFFFAOYSA-N
CCMSLIB00012723115,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,755,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723116,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,756,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723117,related spectra of 'ethinylestradiol (delta mass:2.0)',CCMSLIB00000004896,2,757,Drug_analog|Low_confidence,ethinylestradiol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist|estrogenic hormone,BFPYWIDHMRZLRN-SLHNCBLASA-N
CCMSLIB00012723118,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,758,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723119,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,759,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723120,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,760,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723121,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,761,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723122,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,762,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723123,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,763,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723124,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,764,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723125,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,765,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723126,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,766,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723127,related spectra of 'artemisinin (delta mass:16.03)',CCMSLIB00005768072|CCMSLIB00005770754,16.03,767,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723128,related spectra of 'ethinyl estradiol (delta mass:2.0)',CCMSLIB00005735778,2,768,Drug_analog|Low_confidence,ethinyl estradiol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist|estrogenic hormone,BFPYWIDHMRZLRN-UHFFFAOYSA-N
CCMSLIB00012723129,"related spectra of 'ethinylestradiol (delta mass:2.02)', 'ethinylestradiol (delta mass:2.01)', 'ethinyl estradiol (delta mass:2.01)'",CCMSLIB00000004896|CCMSLIB00000572470|CCMSLIB00005731984,2.02,769,Drug_analog|Low_confidence,ethinylestradiol|ethinyl estradiol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist|estrogenic hormone,BFPYWIDHMRZLRN-SLHNCBLASA-N|BFPYWIDHMRZLRN-UHFFFAOYSA-N
CCMSLIB00012723130,related spectra of 'oxandrolone (delta mass:12.0)',CCMSLIB00005723842,12,770,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012723131,related spectra of 'ethinylestradiol (delta mass:2.02)',CCMSLIB00000004896,2.02,771,Drug_analog|Low_confidence,ethinylestradiol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist|estrogenic hormone,BFPYWIDHMRZLRN-SLHNCBLASA-N
CCMSLIB00012723132,related spectra of 'dydrogesterone (delta mass:-14.02)',CCMSLIB00005774596,-14.02,772,Drug_analog,dydrogesterone,progestin,obstetrics/gynecology,infertility,progesterone receptor agonist,JGMOKGBVKVMRFX-HQZYFCCVSA-N
CCMSLIB00012723133,related spectra of 'ethinylestradiol (delta mass:2.02)',CCMSLIB00000004896,2.02,773,Drug_analog|Low_confidence,ethinylestradiol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist|estrogenic hormone,BFPYWIDHMRZLRN-SLHNCBLASA-N
CCMSLIB00012723134,related spectra of 'dydrogesterone (delta mass:-14.02)',CCMSLIB00005774596,-14.02,774,Drug_analog,dydrogesterone,progestin,obstetrics/gynecology,infertility,progesterone receptor agonist,JGMOKGBVKVMRFX-HQZYFCCVSA-N
CCMSLIB00012723135,related spectra of 'dydrogesterone (delta mass:-14.02)',CCMSLIB00005774596,-14.02,775,Drug_analog,dydrogesterone,progestin,obstetrics/gynecology,infertility,progesterone receptor agonist,JGMOKGBVKVMRFX-HQZYFCCVSA-N
CCMSLIB00012723136,related spectra of 'dydrogesterone (delta mass:-14.02)',CCMSLIB00005774596,-14.02,776,Drug_analog,dydrogesterone,progestin,obstetrics/gynecology,infertility,progesterone receptor agonist,JGMOKGBVKVMRFX-HQZYFCCVSA-N
CCMSLIB00012723137,related spectra of 'oxandrolone (delta mass:12.0)',CCMSLIB00005723842,12,777,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012723138,related spectra of 'iloprost (delta mass:-44.03)',CCMSLIB00010149637,-44.03,778,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723139,related spectra of 'treprostinil (delta mass:-56.03)',CCMSLIB00010144011,-56.03,779,Drug_analog,treprostinil,prostacycline vasodilator,pulmonary,pulmonary arterial hypertension (PAH),prostanoid receptor agonist,PAJMKGZZBBTTOY-ZFORQUDYSA-N
CCMSLIB00012723140,related spectra of 'dydrogesterone (delta mass:-14.02)',CCMSLIB00000086170,-14.02,780,Drug_analog,dydrogesterone,progestin,obstetrics/gynecology,infertility,progesterone receptor agonist,JGMOKGBVKVMRFX-HQZYFCCVSA-N
CCMSLIB00012723141,related spectra of 'hexestrol (delta mass:28.03)',CCMSLIB00005767080,28.03,781,Drug_analog,hexestrol,estrogen,NA,NA,synthetic estrogen,PBBGSZCBWVPOOL-HDICACEKSA-N
CCMSLIB00012723142,related spectra of 'dydrogesterone (delta mass:-14.02)',CCMSLIB00005774596,-14.02,782,Drug_analog,dydrogesterone,progestin,obstetrics/gynecology,infertility,progesterone receptor agonist,JGMOKGBVKVMRFX-HQZYFCCVSA-N
CCMSLIB00012723143,related spectra of 'gestodene (delta mass:-12.0)',CCMSLIB00000005052,-12,783,Drug_analog,gestodene,"progestogens and estrogens, fixed combinations",obstetrics/gynecology,contraceptive,contraceptive agent,SIGSPDASOTUPFS-XUDSTZEESA-N
CCMSLIB00012723144,related spectra of 'methyltestosterone (delta mass:-3.99)',CCMSLIB00005775092,-3.99,784,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012723145,related spectra of 'higenamine (delta mass:28.03)',CCMSLIB00006439374|CCMSLIB00006439446|CCMSLIB00006516701|CCMSLIB00006516718|CCMSLIB00006516756,28.03,785,Drug_analog,higenamine,no_match,NA,NA,adrenergic receptor agonist,WZRCQWQRFZITDX-UHFFFAOYSA-N
CCMSLIB00012723146,related spectra of 'enilconazole (delta mass:3.99)',CCMSLIB00005761372|CCMSLIB00005762391,3.99,786,Drug_analog,enilconazole,veterinary,infectious disease,dermatophytosis,sterol demethylase inhibitor,PZBPKYOVPCNPJY-UHFFFAOYSA-N
CCMSLIB00012723147,related spectra of 'aai101 (delta mass:-14.02)',CCMSLIB00010135569,-14.02,787,Drug_analog,aai101,no_match,NA,NA,lactamase inhibitor,HFZITXBUTWITPT-YWVKMMECSA-N
CCMSLIB00012723148,"related spectra of 'nocodazole (chimeric precursor selection) (delta mass:-0.98)', 'nocodazole (delta mass:-0.98)'",CCMSLIB00010150277|CCMSLIB00010150280,-0.98,788,Drug_analog,nocodazole (chimeric precursor selection)|nocodazole,no_match,NA,NA,tubulin polymerization inhibitor,KYRVNWMVYQXFEU-UHFFFAOYSA-N
CCMSLIB00012723149,related spectra of 'amlexanox (delta mass:2.02)',CCMSLIB00000078918,2.02,789,Drug_analog|Low_confidence,amlexanox,no_match,dermatology|allergy,aphthous ulcers|asthma|conjunctivitis|allergic rhinitis,histamine receptor modulator,SGRYPYWGNKJSDL-UHFFFAOYSA-N
CCMSLIB00012723150,related spectra of 'amlexanox (delta mass:2.02)',CCMSLIB00000078918,2.02,790,Drug_analog|Low_confidence,amlexanox,no_match,dermatology|allergy,aphthous ulcers|asthma|conjunctivitis|allergic rhinitis,histamine receptor modulator,SGRYPYWGNKJSDL-UHFFFAOYSA-N
CCMSLIB00012724571,related spectra of 'dolutegravir (delta mass:-27.995)',CCMSLIB00010136050|CCMSLIB00010136051|CCMSLIB00010136052|CCMSLIB00010136053|CCMSLIB00010136054|CCMSLIB00010136055|CCMSLIB00010136056|CCMSLIB00010136057|CCMSLIB00010140181|CCMSLIB00010140182|CCMSLIB00010140183|CCMSLIB00010140184|CCMSLIB00010140185,-27.99,2211,Drug_suspect,dolutegravir,HIV integrase strand transfer inhibitor (HIV INSTI),infectious disease,human immunodeficiency virus (HIV-1),HIV integrase inhibitor,RHWKPHLQXYSBKR-BMIGLBTASA-N
CCMSLIB00012723152,related spectra of 'papaverine (delta mass:-39.01)',CCMSLIB00000085463|CCMSLIB00000846611|CCMSLIB00003135451|CCMSLIB00003136879|CCMSLIB00003136905|CCMSLIB00003136938|CCMSLIB00003136967,-39.01,792,Drug_analog,papaverine,drugs used in erectile dysfunction|papaverine and derivatives,cardiology|gastroenterology|urology,myocardial infarction|angina pectoris|pulmonary embolism (PE)|colitis|vascular spasm|erectile dysfunction,phosphodiesterase inhibitor,XQYZDYMELSJDRZ-UHFFFAOYSA-N
CCMSLIB00012723153,related spectra of 'prednisolone (delta mass:-60.02)',CCMSLIB00005777127,-60.02,793,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723154,related spectra of 'prednisolone (delta mass:-42.01)',CCMSLIB00010134091,-42.01,794,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723155,related spectra of 'prednisolone (delta mass:-60.02)',CCMSLIB00005774987,-60.02,795,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723156,"related spectra of 'prednisolone (delta mass:-42.01)', 'prednisolone (delta mass:-60.02)'",CCMSLIB00000004492|CCMSLIB00006117495|CCMSLIB00006117497|CCMSLIB00006117501|CCMSLIB00010134091,-42.01|-60.02,796,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723157,related spectra of 'prednisolone (delta mass:-60.02)',CCMSLIB00005777127,-60.02,797,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723158,related spectra of 'prednisolone (delta mass:-60.02)',CCMSLIB00005777127,-60.02,798,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723159,related spectra of 'prednisolone (delta mass:-60.02)',CCMSLIB00000004492,-60.02,799,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723160,related spectra of 'ethinylestradiol (delta mass:4.0)',CCMSLIB00000004897,3.99,800,Drug_analog|Low_confidence,ethinylestradiol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist|estrogenic hormone,BFPYWIDHMRZLRN-SLHNCBLASA-N
CCMSLIB00012723161,related spectra of 'methyltestosterone (delta mass:-2.02)',CCMSLIB00005777031,-2.02,801,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012723162,related spectra of 'latanoprost (delta mass:-132.08)',CCMSLIB00010143083|CCMSLIB00010143086,-132.08,802,Drug_analog|Low_confidence,latanoprost,prostaglandin analog,ophthalmology,ocular hypertension|glaucoma,prostanoid receptor agonist,GGXICVAJURFBLW-CEYXHVGTSA-N
CCMSLIB00012723163,related spectra of 'latanoprost (delta mass:-132.08)',CCMSLIB00010143083|CCMSLIB00010143086,-132.08,803,Drug_analog|Low_confidence,latanoprost,prostaglandin analog,ophthalmology,ocular hypertension|glaucoma,prostanoid receptor agonist,GGXICVAJURFBLW-CEYXHVGTSA-N
CCMSLIB00012723164,related spectra of 'oxandrolone (delta mass:14.02)',CCMSLIB00005723842,14.02,804,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012723165,related spectra of 'latanoprost (delta mass:-132.08)',CCMSLIB00010143083|CCMSLIB00010143086,-132.08,805,Drug_analog|Low_confidence,latanoprost,prostaglandin analog,ophthalmology,ocular hypertension|glaucoma,prostanoid receptor agonist,GGXICVAJURFBLW-CEYXHVGTSA-N
CCMSLIB00012723166,related spectra of 'latanoprost (delta mass:-132.08)',CCMSLIB00010143083|CCMSLIB00010143086,-132.08,806,Drug_analog|Low_confidence,latanoprost,prostaglandin analog,ophthalmology,ocular hypertension|glaucoma,prostanoid receptor agonist,GGXICVAJURFBLW-CEYXHVGTSA-N
CCMSLIB00012723167,related spectra of 'latanoprost (delta mass:-132.08)',CCMSLIB00010143083|CCMSLIB00010143086,-132.08,807,Drug_analog|Low_confidence,latanoprost,prostaglandin analog,ophthalmology,ocular hypertension|glaucoma,prostanoid receptor agonist,GGXICVAJURFBLW-CEYXHVGTSA-N
CCMSLIB00012723168,related spectra of 'latanoprost (delta mass:-132.08)',CCMSLIB00010143083|CCMSLIB00010143086,-132.08,808,Drug_analog|Low_confidence,latanoprost,prostaglandin analog,ophthalmology,ocular hypertension|glaucoma,prostanoid receptor agonist,GGXICVAJURFBLW-CEYXHVGTSA-N
CCMSLIB00012723169,related spectra of 'tegaserod (delta mass:-0.98)',CCMSLIB00010136239,-0.98,809,Drug_analog,tegaserod,serotonin-4 (5-HT4) receptor agonist,gastroenterology,irritable bowel syndrome with constipation (IBS-C),serotonin receptor partial agonist,IKBKZGMPCYNSLU-RGVLZGJSSA-N
CCMSLIB00012723170,related spectra of 'hydroxybutorphanol (delta mass:-43.01)',CCMSLIB00000206201|CCMSLIB00005771585,-43.01,810,Drug_analog,hydroxybutorphanol,opioid agonist/antagonist,neurology/psychiatry,pain,opioid receptor agonist|opioid receptor antagonist,NCMXKIHJYUFTRL-UHFFFAOYSA-N
CCMSLIB00012723171,related spectra of 'latanoprost (delta mass:-132.08)',CCMSLIB00010143083|CCMSLIB00010143086,-132.08,811,Drug_analog|Low_confidence,latanoprost,prostaglandin analog,ophthalmology,ocular hypertension|glaucoma,prostanoid receptor agonist,GGXICVAJURFBLW-CEYXHVGTSA-N
CCMSLIB00012723172,related spectra of 'latanoprost (delta mass:-132.08)',CCMSLIB00010143083|CCMSLIB00010143086,-132.08,812,Drug_analog|Low_confidence,latanoprost,prostaglandin analog,ophthalmology,ocular hypertension|glaucoma,prostanoid receptor agonist,GGXICVAJURFBLW-CEYXHVGTSA-N
CCMSLIB00012723173,related spectra of 'oxymetholone (delta mass:-16.03)',CCMSLIB00005723847,-16.03,813,Drug_analog,oxymetholone,androstan derivatives,hematology,anemia,androgen receptor agonist,YKELUTWGCGLPTM-WBNQDIJOSA-N
CCMSLIB00012723174,related spectra of 'methyltestosterone (delta mass:-2.02)',CCMSLIB00005777031,-2.02,814,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012723175,related spectra of 'drostanolone (delta mass:31.99)',CCMSLIB00005723750,31.99,815,Drug_analog|Low_confidence,drostanolone,no_match,no_match,no_match,no_match,FDGQIVOIHOIMNK-TZAHHXAYSA-N
CCMSLIB00012723176,related spectra of 'ethylestrenol (delta mass:30.01)',CCMSLIB00005723752,30.01,816,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012723177,"related spectra of 'golotimod (delta mass:-31.99)', 'oglufanide (delta mass:-31.99)'",CCMSLIB00010133731|CCMSLIB00010133733|CCMSLIB00010152307,-31.99,817,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723178,related spectra of 'trilostane (delta mass:-28.03)',CCMSLIB00005762140,-28.03,818,Drug_analog,trilostane,anticorticosteroids|veterinary,endocrinology,Cushing's syndrome,3beta-hydroxy-delta5-steroid dehydrogenase inhibitor,KVJXBPDAXMEYOA-CXANFOAXSA-N
CCMSLIB00012723179,"related spectra of 'mycophenolic acid (delta mass:-18.01)', 'mycophenolic-acid (delta mass:-18.01)'",CCMSLIB00000078487|CCMSLIB00000079956|CCMSLIB00000211249|CCMSLIB00000211251|CCMSLIB00000211262|CCMSLIB00000211264|CCMSLIB00000478521|CCMSLIB00000579712|CCMSLIB00000841899|CCMSLIB00004695868|CCMSLIB00004702369|CCMSLIB00005777982|CCMSLIB00005778133|CCMSLIB00010117843|CCMSLIB00010145942,-18.01,819,Drug_analog,mycophenolic acid|mycophenolic-acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-RUDMXATFSA-N|HPNSFSBZBAHARI-UHFFFAOYSA-N
CCMSLIB00012723180,related spectra of 'canrenone (delta mass:-38.02)',CCMSLIB00005775230,-38.02,820,Drug_analog,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012723181,"related spectra of 'iloprost (delta mass:-21.98)', 'iloprost (delta mass:-21.99)'",CCMSLIB00010149631,-21.98,821,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723182,related spectra of 'mesterolone (delta mass:-2.02)',CCMSLIB00005723783,-2.02,822,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723183,related spectra of 'ethylestrenol (delta mass:31.99)',CCMSLIB00005723752,31.99,823,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012723184,related spectra of 'golotimod (delta mass:-30.01)',CCMSLIB00010133731,-30.01,824,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723185,"related spectra of 'oglufanide (delta mass:-29.98)', 'golotimod (delta mass:-29.98)', 'golotimod (delta mass:-29.97)'",CCMSLIB00010133730|CCMSLIB00010133731|CCMSLIB00010133732|CCMSLIB00010152308,-29.97,825,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723186,"related spectra of 'oglufanide (delta mass:-29.97)', 'golotimod (delta mass:-29.98)', 'golotimod (delta mass:-29.97)'",CCMSLIB00010133731|CCMSLIB00010133732|CCMSLIB00010152308,-29.97,826,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723187,"related spectra of 'oglufanide (delta mass:-29.97)', 'golotimod (delta mass:-29.97)'",CCMSLIB00010133731|CCMSLIB00010133732|CCMSLIB00010133733|CCMSLIB00010152308,-29.97,827,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723188,"related spectra of 'golotimod (delta mass:-29.97)', 'bnc210 (delta mass:-14.02)'",CCMSLIB00010131015|CCMSLIB00010133731|CCMSLIB00010133733,-29.97|-14.02,828,Drug_analog|Low_confidence,bnc210|golotimod,no_match,no_match,no_match,no_match,BVRPESWOSNFUCJ-LKTVYLICSA-N|CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723189,related spectra of 'golotimod (delta mass:-29.97)',CCMSLIB00010133731,-29.97,829,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723190,related spectra of 'oglufanide (delta mass:-29.97)',CCMSLIB00010152308,-29.97,830,Drug_analog|Low_confidence,oglufanide,no_match,NA,NA,VEGF antagonist,LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723191,related spectra of 'dolasetron (delta mass:-20.01)',CCMSLIB00003136568,-20.01,831,Drug_analog|Low_confidence,dolasetron,serotonin-3 (5-HT3) receptor antagonist,gastroenterology,nausea|vomiting,serotonin receptor antagonist,UKTAZPQNNNJVKR-AKJUYKBHSA-N
CCMSLIB00012723192,"related spectra of 'methyltestosterone (delta mass:1.98)', 'hydroxyprogesterone caproate (delta mass:-26.02)'",CCMSLIB00005762182|CCMSLIB00005765522|CCMSLIB00005765990|CCMSLIB00005766653|CCMSLIB00005775092|CCMSLIB00006116102|CCMSLIB00006116104|CCMSLIB00006116106|CCMSLIB00006116107|CCMSLIB00006116109,1.98|-26.02,832,Drug_analog|Low_confidence,methyltestosterone|hydroxyprogesterone caproate,androgen|progestin,endocrinology|oncology|obstetrics/gynecology,hypogonadism|breast cancer|spontaneous preterm birth,androgen receptor agonist|progesterone receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N|DBPWSSGDRRHUNT-CEGNMAFCSA-N|DBPWSSGDRRHUNT-SJFWLOONSA-N
CCMSLIB00012723193,related spectra of 'oxandrolone (delta mass:15.99)',CCMSLIB00005723836,15.99,833,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,QSLJIVKCVHQPLV-ZXOYHYBESA-N
CCMSLIB00012723194,related spectra of 'medroxyprogesterone (delta mass:-40.03)',CCMSLIB00005773103|CCMSLIB00006119382|CCMSLIB00006119397|CCMSLIB00006119398|CCMSLIB00006119400|CCMSLIB00006119402|CCMSLIB00010118137|CCMSLIB00010150390,-40.03,834,Drug_analog|Low_confidence,medroxyprogesterone,progestin,obstetrics/gynecology,contraceptive,progesterone receptor agonist,FRQMUZJSZHZSGN-HBNHAYAOSA-N
CCMSLIB00012723195,related spectra of 'methyltestosterone (delta mass:1.98)',CCMSLIB00005760099,1.98,835,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012723196,related spectra of 'testosterone propionate (delta mass:-40.03)',CCMSLIB00005763640,-40.03,836,Drug_analog|Low_confidence,testosterone propionate,androgen,endocrinology,hypogonadism,androgen receptor agonist,PDMMFKSKQVNJMI-BLQWBTBKSA-N
CCMSLIB00012723197,related spectra of 'benzalkonium (delta mass:1.0)',CCMSLIB00003135025,1,837,Drug_analog,benzalkonium,antiseptics and disinfectants,NA,antiseptic,antiseptic|preservative,CYDRXTMLKJDRQH-UHFFFAOYSA-N
CCMSLIB00012723198,related spectra of 'norcocaine (delta mass:15.99)',CCMSLIB00004721848,15.99,838,Drug_analog,norcocaine,central nervous system stimulant,drug of abuse,psychostimulant,monoamine transporter inhibitor,AYDBLCSLKNTEJL-RFQIPJPRSA-N
CCMSLIB00012723199,"related spectra of 'oglufanide (delta mass:-27.99)', 'golotimod (delta mass:-27.99)'",CCMSLIB00010133731|CCMSLIB00010133733|CCMSLIB00010152307,-27.99,839,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723200,"related spectra of 'bnc210 (delta mass:-12.04)', 'golotimod (delta mass:-27.99)'",CCMSLIB00010131014|CCMSLIB00010131015|CCMSLIB00010133731,-12.04|-27.99,840,Drug_analog|Low_confidence,bnc210|golotimod,no_match,no_match,no_match,no_match,BVRPESWOSNFUCJ-LKTVYLICSA-N|CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723201,related spectra of 'vildagliptin (delta mass:2.0)',CCMSLIB00000078549,2,841,Drug_analog,vildagliptin,dipeptidyl peptidase-4 (DPP-4) inhibitor,endocrinology,type 2 diabetes mellitus,dipeptidyl peptidase inhibitor,SYOKIDBDQMKNDQ-XWTIBIIYSA-N
CCMSLIB00012723202,related spectra of 'sulfamethazine (delta mass:27.99)',CCMSLIB00000207282,27.99,842,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012723203,related spectra of '100-90-3 (delta mass:-14.02)',CCMSLIB00000207738,-14.02,843,Drug_analog|Background/QAQC,n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723204,"related spectra of 'sulfamethazine (delta mass:27.99)', 'sulfadimidine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000562784|CCMSLIB00000579538|CCMSLIB00000841836|CCMSLIB00003135019|CCMSLIB00003135048|CCMSLIB00003137995|CCMSLIB00005775295|CCMSLIB00005776685|CCMSLIB00010143272|CCMSLIB00010143273,27.99|-14.02,844,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine|sulfadimidine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723205,related spectra of 'sulfamethazine (delta mass:27.99)',CCMSLIB00010143272,27.99,845,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012723206,related spectra of '100-90-3 (delta mass:-14.02)',CCMSLIB00005775295,-14.02,846,Drug_analog|Background/QAQC,n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723207,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)'",CCMSLIB00000207282|CCMSLIB00000207746,27.99|-14.02,847,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723208,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)'",CCMSLIB00000207282|CCMSLIB00000223720|CCMSLIB00005775295|CCMSLIB00010143273,27.99|-14.02,848,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723209,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)'",CCMSLIB00005775295|CCMSLIB00010143273,27.99|-14.02,849,Drug_analog|Background/QAQC,n-acetyl sulfamethazine|sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,LJKAKWDUZRJNPJ-UHFFFAOYSA-N|ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012723210,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000207282|CCMSLIB00003135019|CCMSLIB00005775295|CCMSLIB00010143273,27.99|-14.02,850,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723211,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000207282|CCMSLIB00000223720|CCMSLIB00003135019|CCMSLIB00005774684|CCMSLIB00005775295|CCMSLIB00010143272|CCMSLIB00010143273,27.99|-14.02,851,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723212,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000207280|CCMSLIB00000207282|CCMSLIB00003135019|CCMSLIB00003136955|CCMSLIB00005775295|CCMSLIB00010143272|CCMSLIB00010143273,27.99|-14.02,852,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723213,"related spectra of '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00003135019|CCMSLIB00005775295,-14.02|28.00,853,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723214,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000207282|CCMSLIB00000223720|CCMSLIB00003135019|CCMSLIB00005775295|CCMSLIB00010143272|CCMSLIB00010143273,27.99|-14.02,854,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723215,"related spectra of 'sulfamethazine (delta mass:27.99)', 'sulfadimidine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000562784|CCMSLIB00000579538|CCMSLIB00000841836|CCMSLIB00003137995|CCMSLIB00005774684|CCMSLIB00005775295|CCMSLIB00005776263|CCMSLIB00005776685|CCMSLIB00010143272|CCMSLIB00010143273|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143278|CCMSLIB00010143279,27.99|-14.02,855,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine|sulfadimidine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723216,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)'",CCMSLIB00000207282|CCMSLIB00000207738|CCMSLIB00000207744|CCMSLIB00000223720|CCMSLIB00003135048|CCMSLIB00010143272|CCMSLIB00010143273,27.99|-14.02,856,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723217,"related spectra of 'sulfamethazine (delta mass:27.99)', 'sulfadimidine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000207282|CCMSLIB00000223720|CCMSLIB00000562784|CCMSLIB00000579538|CCMSLIB00000841836|CCMSLIB00003135019|CCMSLIB00003137995|CCMSLIB00005775295|CCMSLIB00005776685|CCMSLIB00010143272|CCMSLIB00010143273|CCMSLIB00010143278,27.99|-14.02,857,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine|sulfadimidine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723218,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000207282|CCMSLIB00000223720|CCMSLIB00003135019|CCMSLIB00005775295|CCMSLIB00010143273,27.99|-14.02,858,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723219,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000207282|CCMSLIB00003135019|CCMSLIB00005775295|CCMSLIB00010143272|CCMSLIB00010143273,27.99|-14.02,859,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723220,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)'",CCMSLIB00000207282|CCMSLIB00005775295|CCMSLIB00010143272,27.99|-14.02,860,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723221,"related spectra of 'sulfamethazine (delta mass:27.99)', 'sulfadimidine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)'",CCMSLIB00000562784|CCMSLIB00000579538|CCMSLIB00000841836|CCMSLIB00003137995|CCMSLIB00005775295|CCMSLIB00005776263|CCMSLIB00005776685|CCMSLIB00010143273|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143278|CCMSLIB00010143279,27.99|-14.02,861,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine|sulfadimidine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723222,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)'",CCMSLIB00000207282|CCMSLIB00005775295|CCMSLIB00010143272,27.99|-14.02,862,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723223,"related spectra of 'sulfamethazine (delta mass:27.99)', 'sulfadimidine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000207282|CCMSLIB00000223720|CCMSLIB00000562784|CCMSLIB00000579538|CCMSLIB00000841836|CCMSLIB00003135019|CCMSLIB00003135048|CCMSLIB00003137995|CCMSLIB00005775295|CCMSLIB00005776263|CCMSLIB00005776685|CCMSLIB00010143272|CCMSLIB00010143273|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143278|CCMSLIB00010143279,27.99|-14.02,863,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine|sulfadimidine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723224,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)'",CCMSLIB00000223720|CCMSLIB00005775295,27.99|-14.02,864,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723225,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000207282|CCMSLIB00000223720|CCMSLIB00003135019|CCMSLIB00005775295|CCMSLIB00010143272|CCMSLIB00010143273,27.99|-14.02,865,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723226,"related spectra of 'sulfamethazine (delta mass:27.99)', 'sulfadimidine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000207281|CCMSLIB00000207282|CCMSLIB00000223720|CCMSLIB00000562784|CCMSLIB00000579538|CCMSLIB00000841836|CCMSLIB00003135019|CCMSLIB00003136257|CCMSLIB00003136955|CCMSLIB00003137995|CCMSLIB00005775295|CCMSLIB00005776263|CCMSLIB00005776685|CCMSLIB00010143273|CCMSLIB00010143275|CCMSLIB00010143278,27.99|-14.02,866,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine|sulfadimidine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723227,"related spectra of 'sulfamethazine (delta mass:27.99)', 'sulfadimidine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000207281|CCMSLIB00000223720|CCMSLIB00000562784|CCMSLIB00000579538|CCMSLIB00000841836|CCMSLIB00003135019|CCMSLIB00003135048|CCMSLIB00003137995|CCMSLIB00005775295|CCMSLIB00005776263|CCMSLIB00005776685|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143278|CCMSLIB00010143279,27.99|-14.02,867,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine|sulfadimidine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723228,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000207282|CCMSLIB00003135019|CCMSLIB00005775295|CCMSLIB00010143272|CCMSLIB00010143273,27.99|-14.02,868,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723229,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)'",CCMSLIB00003137995|CCMSLIB00005775295,27.99|-14.02,869,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723230,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)'",CCMSLIB00005775295|CCMSLIB00010143273,27.99|-14.02,870,Drug_analog|Background/QAQC,n-acetyl sulfamethazine|sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,LJKAKWDUZRJNPJ-UHFFFAOYSA-N|ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012723231,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)'",CCMSLIB00000207282|CCMSLIB00000223720|CCMSLIB00005775295|CCMSLIB00010143272|CCMSLIB00010143273,27.99|-14.02,871,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723232,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000207276|CCMSLIB00000207282|CCMSLIB00000207744|CCMSLIB00000223720|CCMSLIB00003135019|CCMSLIB00003135048|CCMSLIB00010143272,27.99|-14.02,872,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723233,"related spectra of 'sulfamethazine (delta mass:27.99)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000223720|CCMSLIB00003135019,27.99,873,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012723234,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000207282|CCMSLIB00000223720|CCMSLIB00003136257|CCMSLIB00003136955|CCMSLIB00003137995|CCMSLIB00003138861|CCMSLIB00005774974|CCMSLIB00005775295|CCMSLIB00010143272|CCMSLIB00010143273,27.99|-14.02,874,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723235,related spectra of 'sulfamethazine (delta mass:27.99)',CCMSLIB00000207282|CCMSLIB00000223720|CCMSLIB00010143273,27.99,875,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012723236,related spectra of '100-90-3 (delta mass:-14.02)',CCMSLIB00005775295,-14.02,876,Drug_analog|Background/QAQC,n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723237,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)'",CCMSLIB00005775295|CCMSLIB00010143273,27.99|-14.02,877,Drug_analog|Background/QAQC,n-acetyl sulfamethazine|sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,LJKAKWDUZRJNPJ-UHFFFAOYSA-N|ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012723238,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)'",CCMSLIB00000207274|CCMSLIB00000207738|CCMSLIB00000207744,27.99|-14.02,878,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723239,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000207282|CCMSLIB00003135019|CCMSLIB00005775295|CCMSLIB00010143272|CCMSLIB00010143273,27.99|-14.02,879,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723240,related spectra of 'sulfamethazine (delta mass:27.99)',CCMSLIB00000223720,27.99,880,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012723241,"related spectra of 'sulfamethazine (delta mass:27.99)', 'sulfadimidine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000207282|CCMSLIB00000223720|CCMSLIB00000562784|CCMSLIB00000579538|CCMSLIB00000841836|CCMSLIB00003135019|CCMSLIB00003137995|CCMSLIB00005775295|CCMSLIB00005776263|CCMSLIB00005776685|CCMSLIB00010143272|CCMSLIB00010143273|CCMSLIB00010143275|CCMSLIB00010143278,27.99|-14.02,881,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine|sulfadimidine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723242,related spectra of '100-90-3 (delta mass:-14.02)',CCMSLIB00005775295,-14.02,882,Drug_analog|Background/QAQC,n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723243,related spectra of '100-90-3 (delta mass:-14.02)',CCMSLIB00000207738|CCMSLIB00000207744,-14.02,883,Drug_analog|Background/QAQC,n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723244,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)'",CCMSLIB00005775295|CCMSLIB00010143272,27.99|-14.02,884,Drug_analog|Background/QAQC,n-acetyl sulfamethazine|sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,LJKAKWDUZRJNPJ-UHFFFAOYSA-N|ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012723245,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)'",CCMSLIB00000207282|CCMSLIB00005775295|CCMSLIB00010143272,27.99|-14.02,885,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723246,"related spectra of 'sulfamethazine (delta mass:27.99)', 'sulfadimidine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000223720|CCMSLIB00000562784|CCMSLIB00000579538|CCMSLIB00000841836|CCMSLIB00003135019|CCMSLIB00003137995|CCMSLIB00005775295|CCMSLIB00005776263|CCMSLIB00005776685|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143278|CCMSLIB00010143279,27.99|-14.02,886,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine|sulfadimidine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723247,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)'",CCMSLIB00000223720|CCMSLIB00005775295,27.99|-14.02,887,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723248,"related spectra of 'sulfadimidine (delta mass:28.0)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000562784|CCMSLIB00005775295|CCMSLIB00005776685|CCMSLIB00010143273,28.00|-14.02,888,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine|sulfadimidine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723249,related spectra of 'sulfamethazine (delta mass:27.99)',CCMSLIB00000207274|CCMSLIB00000207280,27.99,889,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012723250,"related spectra of 'sulfamethazine (delta mass:27.99)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000207282|CCMSLIB00005774684|CCMSLIB00005775295|CCMSLIB00010143272|CCMSLIB00010143273,27.99|-14.02,890,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723251,"related spectra of 'sulfadimidine (delta mass:28.0)', '100-90-3 (delta mass:-14.02)', 'sulfamethazine (delta mass:28.0)'",CCMSLIB00000562784|CCMSLIB00005775295|CCMSLIB00005776685,28.00|-14.02,891,Drug_analog|Background/QAQC,sulfamethazine|n-acetyl sulfamethazine|sulfadimidine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723252,related spectra of '100-90-3 (delta mass:-14.02)',CCMSLIB00005775295,-14.02,892,Drug_analog|Background/QAQC,n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723253,related spectra of 'sulfamethazine (delta mass:28.0)',CCMSLIB00000223720,27.99,893,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012723254,related spectra of '100-90-3 (delta mass:-14.02)',CCMSLIB00005775295,-14.02,894,Drug_analog|Background/QAQC,n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723255,related spectra of '100-90-3 (delta mass:-14.02)',CCMSLIB00000207738,-14.02,895,Drug_analog|Background/QAQC,n-acetyl sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,LJKAKWDUZRJNPJ-UHFFFAOYSA-N
CCMSLIB00012723256,related spectra of 'edetic acid (delta mass:14.02)',CCMSLIB00006113816|CCMSLIB00006113818|CCMSLIB00006113819|CCMSLIB00006113821|CCMSLIB00006113822,14.02,896,Drug_analog|Background/QAQC,edta,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N
CCMSLIB00012723257,"related spectra of 'dolasetron (delta mass:-17.99)', 'dolasetron (delta mass:-18.01)'",CCMSLIB00000079079|CCMSLIB00003136568,-18.01,897,Drug_analog|Low_confidence,dolasetron,serotonin-3 (5-HT3) receptor antagonist,gastroenterology,nausea|vomiting,serotonin receptor antagonist,UKTAZPQNNNJVKR-AKJUYKBHSA-N
CCMSLIB00012723258,related spectra of 'artesunate (delta mass:-100.02)',CCMSLIB00006558128|CCMSLIB00006558150,-100.02,898,Drug_analog,artesunate,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,FIHJKUPKCHIPAT-AHIGJZGOSA-N
CCMSLIB00012723259,related spectra of 'prednisolone (delta mass:-54.03)',CCMSLIB00005777127,-54.03,899,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723260,"related spectra of '(1s,2s,3ar,8br)-2,3,3a,8b-tetrahydro-2-hydroxy-1-[(e,3r)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]-1h-cyclopenta[b]benzofuran-5-butanoic acid (delta mass:-56.03)'",CCMSLIB00010147765,-56.03,900,Drug_analog,"2,3,3a,8b-tetrahydro-2-hydroxy-1-[(e,3r)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]-1h-cyclopenta[b]benzofuran-5-butanoic acid",no_match,no_match,no_match,no_match,CTPOHARTNNSRSR-PCEABUQKSA-N
CCMSLIB00012723261,related spectra of 'amitriptyline (delta mass:28.99)',CCMSLIB00000078599|CCMSLIB00000211525|CCMSLIB00000214322|CCMSLIB00000214324|CCMSLIB00000215809|CCMSLIB00000215811,28.99,901,Drug_analog|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012723262,related spectra of 'stanozolol-4b-oh (delta mass:-20.03)',CCMSLIB00005723881,-20.03,902,Drug_analog,stanozolol-4b-oh,androstan derivatives,genetics|dermatology,hereditary angioedema,androgen receptor agonist,OCUSYXNRARMJHS-JQPLYGKBSA-N
CCMSLIB00012723263,related spectra of 'mesterolone (delta mass:1.98)',CCMSLIB00005723783,1.98,903,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723264,related spectra of 'mesterolone (delta mass:1.98)',CCMSLIB00005723783,1.98,904,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723265,related spectra of 'mesterolone (delta mass:1.98)',CCMSLIB00005723783,1.98,905,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723266,related spectra of 'drostanolone (delta mass:1.98)',CCMSLIB00005723746,1.98,906,Drug_analog|Low_confidence,drostanolone,no_match,no_match,no_match,no_match,FDGQIVOIHOIMNK-TZAHHXAYSA-N
CCMSLIB00012723267,related spectra of 'ethylestrenol (delta mass:36.02)',CCMSLIB00005723752,36.02,907,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012723268,related spectra of 'ethylestrenol (delta mass:36.02)',CCMSLIB00005723752,36.02,908,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012723269,related spectra of 'mesterolone (delta mass:2.02)',CCMSLIB00005723783,2.02,909,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723270,related spectra of 'sertraline (delta mass:1.99)',CCMSLIB00000078642|CCMSLIB00000084936|CCMSLIB00003135311|CCMSLIB00005776039,2,910,Drug_analog,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012723271,related spectra of 'fluconazole (delta mass:1.0)',CCMSLIB00000077102|CCMSLIB00000078101|CCMSLIB00000085015|CCMSLIB00000208374|CCMSLIB00000208375|CCMSLIB00000208380|CCMSLIB00000208381|CCMSLIB00000579592|CCMSLIB00000841916|CCMSLIB00003135571|CCMSLIB00003136278|CCMSLIB00005760798|CCMSLIB00005763009|CCMSLIB00005772589|CCMSLIB00005773811|CCMSLIB00005775215|CCMSLIB00005776520|CCMSLIB00010133134|CCMSLIB00010133135|CCMSLIB00010133137|CCMSLIB00010133140,1,911,Drug_analog,fluconazole,azole antifungal,infectious disease,candidiasis|esophageal candidiasis|vaginal candidiasis|cryptococcal meningitis,sterol demethylase inhibitor,RFHAOTPXVQNOHP-UHFFFAOYSA-N
CCMSLIB00012723272,related spectra of 'oxaprozin (delta mass:14.02)',CCMSLIB00000078946,14.02,912,Drug_analog,oxaprozin,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis,cyclooxygenase inhibitor,OFPXSFXSNFPTHF-UHFFFAOYSA-N
CCMSLIB00012723273,related spectra of 'chloroquine (delta mass:-12.04)',CCMSLIB00010139364,-12.04,913,Drug_analog,chloroquine,antimalarial,infectious disease,malaria|amebiasis,antimalarial agent,WHTVZRBIWZFKQO-UHFFFAOYSA-N
CCMSLIB00012723274,related spectra of 'terbinafine (delta mass:15.99)',CCMSLIB00005736700|CCMSLIB00010137418|CCMSLIB00010137421,15.99,914,Drug_analog,terbinafine,allylamine antifungal,infectious disease,tinea pedis|tinea cruris|tinea corporis,fungal squalene epoxidase inhibitor,DOMXUEMWDBAQBQ-UHFFFAOYSA-N|DOMXUEMWDBAQBQ-WEVVVXLNSA-N
CCMSLIB00012723275,related spectra of '127-74-2 (delta mass:15.99)',CCMSLIB00000207753|CCMSLIB00000207759|CCMSLIB00005773222,15.99,915,Drug_analog,n-acetyl sulfadiazine,sulfonamide antibacterial,infectious disease,malaria|meningitis|urinary tract infections|conjunctivitis|trachoma|chancroid,bacterial antifolate,NJIZUWGMNCUKGU-UHFFFAOYSA-N
CCMSLIB00012723276,related spectra of 'sulfadoxine (delta mass:-1.98)',CCMSLIB00003135483,-1.98,916,Drug_analog|Background/QAQC,sulfadoxine,sulfonamide,infectious disease,malaria,dihydropteroate synthase inhibitor,PJSFRIWCGOHTNF-UHFFFAOYSA-N
CCMSLIB00012723277,"related spectra of 'edetic acid (delta mass:16.0)', 'edetic acid (delta mass:15.99)'",CCMSLIB00003134529|CCMSLIB00003135454|CCMSLIB00006113818|CCMSLIB00006113819|CCMSLIB00006113822,15.99,917,Drug_analog|Background/QAQC,edta,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N
CCMSLIB00012723278,related spectra of 'fursultiamine (delta mass:-90.05)',CCMSLIB00010141022|CCMSLIB00010141026,-90.05,918,Drug_analog,fursultiamine,"vitamin B1, plain",metabolism,thiamine deficiency,vitamin B1 derivate,JTLXCMOFVBXEKD-FOWTUZBSSA-N
CCMSLIB00012723279,related spectra of 'fursultiamine (delta mass:-90.05)',CCMSLIB00010141022|CCMSLIB00010141026,-90.05,919,Drug_analog,fursultiamine,"vitamin B1, plain",metabolism,thiamine deficiency,vitamin B1 derivate,JTLXCMOFVBXEKD-FOWTUZBSSA-N
CCMSLIB00012723280,related spectra of 'sulfadoxine (delta mass:-1.98)',CCMSLIB00003139177,-1.98,920,Drug_analog|Background/QAQC,sulfadoxine,sulfonamide,infectious disease,malaria,dihydropteroate synthase inhibitor,PJSFRIWCGOHTNF-UHFFFAOYSA-N
CCMSLIB00012723281,related spectra of 'ajmaline (delta mass:-18.01)',CCMSLIB00005744138|CCMSLIB00005748033,-18.01,921,Drug_analog,ajmaline,no_match,cardiology,Wolff-Parkinson-White Syndrome (WPW),sodium channel blocker,CJDRUOGAGYHKKD-UORGRDHFSA-N
CCMSLIB00012723282,related spectra of 'oxandrolone (delta mass:3.99)',CCMSLIB00005723841,3.99,922,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012723283,related spectra of 'oxandrolone (delta mass:4.0)',CCMSLIB00005723841,3.99,923,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012723284,related spectra of 'sulfadimethoxine (delta mass:1.0)',CCMSLIB00000573240|CCMSLIB00005730395|CCMSLIB00005730777|CCMSLIB00005735659,1,924,Drug_analog|Background/QAQC,sulfadimethoxine,sulfonamide antimicrobial|veterinary,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,dihydropteroate synthetase inhibitor,ZZORFUFYDOWNEF-UHFFFAOYSA-N
CCMSLIB00012723285,"related spectra of 'pramoxine (delta mass:15.99)', 'pramoxine (delta mass:16.0)', 'pramocaine (delta mass:15.99)'",CCMSLIB00005735097|CCMSLIB00010129896|CCMSLIB00010129899,15.99,925,Drug_analog,pramoxine|pramocaine,anesthetics for topical use,neurology/psychiatry,local anesthetic,topical anesthetic,DQKXQSGTHWVTAD-UHFFFAOYSA-N
CCMSLIB00012723286,related spectra of 'artemisinin (delta mass:27.05)',CCMSLIB00000214217|CCMSLIB00000215699,27.05,926,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723287,related spectra of 'betulinic acid (delta mass:-129.08)',CCMSLIB00010124192,-129.08,927,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012723288,related spectra of 'n(4)-acetylsulfadimethoxine (delta mass:-42.01)',CCMSLIB00000207725,-42.01,928,Drug_analog|Background/QAQC,n(4)-acetylsulfadimethoxine,sulfonamide antimicrobial|veterinary,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,dihydropteroate synthetase inhibitor,DQWIIKBKAIPUPY-UHFFFAOYSA-N
CCMSLIB00012723289,related spectra of 'sulfamethoxazole (delta mass:57.02)',CCMSLIB00003136182|CCMSLIB00003138040,57.02,929,Drug_analog|Low_confidence,sulfamethoxazole,sulfonamide antimicrobial,infectious disease,pneumonia|enteritis|urinary tract infections,PABA antagonist,JLKIGFTWXXRPMT-UHFFFAOYSA-N
CCMSLIB00012723290,related spectra of 'sulfamethoxazole (delta mass:57.02)',CCMSLIB00000579546|CCMSLIB00000841891|CCMSLIB00005753343|CCMSLIB00005754912,57.02,930,Drug_analog|Low_confidence,sulfamethoxazole,sulfonamide antimicrobial,infectious disease,pneumonia|enteritis|urinary tract infections,PABA antagonist,JLKIGFTWXXRPMT-UHFFFAOYSA-N
CCMSLIB00012723291,related spectra of 'sulfamethoxazole (delta mass:57.02)',CCMSLIB00005753529|CCMSLIB00005753712|CCMSLIB00005753814|CCMSLIB00005754900,57.02,931,Drug_analog|Low_confidence,sulfamethoxazole,sulfonamide antimicrobial,infectious disease,pneumonia|enteritis|urinary tract infections,PABA antagonist,JLKIGFTWXXRPMT-UHFFFAOYSA-N
CCMSLIB00012723292,related spectra of 'sulfamethoxazole (delta mass:57.02)',CCMSLIB00005753990|CCMSLIB00005754144|CCMSLIB00005754499,57.02,932,Drug_analog|Low_confidence,sulfamethoxazole,sulfonamide antimicrobial,infectious disease,pneumonia|enteritis|urinary tract infections,PABA antagonist,JLKIGFTWXXRPMT-UHFFFAOYSA-N
CCMSLIB00012723293,related spectra of 'sulfamethoxazole (delta mass:57.02)',CCMSLIB00000208207|CCMSLIB00000208213|CCMSLIB00000223672|CCMSLIB00000579546|CCMSLIB00000841891|CCMSLIB00003134960|CCMSLIB00005753378|CCMSLIB00005753514|CCMSLIB00005753529|CCMSLIB00005753601|CCMSLIB00005753625|CCMSLIB00005753712|CCMSLIB00005753814|CCMSLIB00005754000|CCMSLIB00005754054|CCMSLIB00005754069|CCMSLIB00005754528|CCMSLIB00005754884|CCMSLIB00005754900|CCMSLIB00005755088|CCMSLIB00005755137,57.02,933,Drug_analog|Low_confidence,sulfamethoxazole,sulfonamide antimicrobial,infectious disease,pneumonia|enteritis|urinary tract infections,PABA antagonist,JLKIGFTWXXRPMT-UHFFFAOYSA-N
CCMSLIB00012723294,related spectra of 'sulfamethazine (delta mass:31.99)',CCMSLIB00010143272,31.99,934,Drug_analog|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012723295,"related spectra of 'escitalopram (delta mass:-14.02)', 'citalopram (delta mass:-14.02)'",CCMSLIB00000085257|CCMSLIB00000085899|CCMSLIB00000212105|CCMSLIB00000212117|CCMSLIB00000223792,-14.02,935,Drug_analog,escitalopram|citalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-FQEVSTJZSA-N|WSEQXVZVJXJVFP-UHFFFAOYSA-N
CCMSLIB00012723296,"related spectra of 'escitalopram (delta mass:-14.02)', 'citalopram (delta mass:-14.02)'",CCMSLIB00000212105|CCMSLIB00000212107|CCMSLIB00000212115|CCMSLIB00000212117|CCMSLIB00000212119|CCMSLIB00000223792|CCMSLIB00010142218|CCMSLIB00010142223|CCMSLIB00010142661|CCMSLIB00010142663|CCMSLIB00010142664|CCMSLIB00010142666,-14.02,936,Drug_analog,citalopram|escitalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-UHFFFAOYSA-N|WSEQXVZVJXJVFP-FQEVSTJZSA-N
CCMSLIB00012723297,related spectra of 'citalopram (delta mass:-14.02)',CCMSLIB00000223792,-14.02,937,Drug_analog,citalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-UHFFFAOYSA-N
CCMSLIB00012723298,"related spectra of 'citalopram (delta mass:-14.02)', 'escitalopram (delta mass:-14.01)'",CCMSLIB00000085257|CCMSLIB00000085473,-14.02,938,Drug_analog,escitalopram|citalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-FQEVSTJZSA-N|WSEQXVZVJXJVFP-HXUWFJFHSA-N
CCMSLIB00012723299,related spectra of 'ethinylestradiol (delta mass:13.98)',CCMSLIB00000004895,13.98,939,Drug_analog|Low_confidence,ethinylestradiol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist|estrogenic hormone,BFPYWIDHMRZLRN-SLHNCBLASA-N
CCMSLIB00012723300,related spectra of 'labetalol (delta mass:-18.01)',CCMSLIB00000077054|CCMSLIB00000579598|CCMSLIB00000841584|CCMSLIB00005766008|CCMSLIB00005772236|CCMSLIB00005776124|CCMSLIB00005776670|CCMSLIB00010138605|CCMSLIB00010138609,-18.01,940,Drug_analog,labetalol,beta-adrenergic receptor inhibitor,cardiology,hypertension,adrenergic receptor antagonist,SGUAFYQXFOLMHL-UHFFFAOYSA-N
CCMSLIB00012723301,"related spectra of 'quinine (delta mass:-14.02)', 'quinidine (delta mass:-14.02)'",CCMSLIB00004720019|CCMSLIB00010115318|CCMSLIB00010115321|CCMSLIB00010143178|CCMSLIB00010148758,-14.02,941,Drug_analog,quinidine|quinine,antimalarial|antiarrhythmic,infectious disease|cardiology,malaria|atrial fibrillation (AF)|ventricular arrhythmias,sodium channel blocker|hemozoin biocrystallization inhibitor,LOUPRKONTZGTKE-LHHVKLHASA-N|LOUPRKONTZGTKE-WZBLMQSHSA-N
CCMSLIB00012723302,related spectra of 'prednisolone (delta mass:-31.99)',CCMSLIB00010134091,-31.99,942,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723303,related spectra of 'prednisolone (delta mass:-31.99)',CCMSLIB00010134090,-31.99,943,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723304,related spectra of 'prednisolone (delta mass:-31.99)',CCMSLIB00010134091,-31.99,944,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723305,related spectra of 'prednisolone (delta mass:-31.99)',CCMSLIB00010134091,-31.99,945,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723306,related spectra of 'prednisolone (delta mass:-31.99)',CCMSLIB00010134091,-31.99,946,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723307,related spectra of 'forskolin (delta mass:-100.02)',CCMSLIB00006555747,-100.02,947,Drug_analog,forskolin,no_match,NA,NA,adenylyl cyclase activator,OHCQJHSOBUTRHG-KGGHGJDLSA-N
CCMSLIB00012723308,related spectra of 'acitretin (delta mass:-15.97)',CCMSLIB00010130332,-15.97,948,Drug_analog,acitretin,retinoid,dermatology,psoriasis,retinoid receptor agonist,IHUNBGSDBOWDMA-AQFIFDHZSA-N
CCMSLIB00012723309,related spectra of 'exemestane (delta mass:15.01)',CCMSLIB00000208693|CCMSLIB00000208694|CCMSLIB00000208699|CCMSLIB00000208700,15.01,949,Drug_analog,exemestane,aromatase inhibitor,oncology,breast cancer,aromatase inhibitor,BFYIZQONLCFLEV-UHFFFAOYSA-N
CCMSLIB00012723310,related spectra of 'methoxsalen (delta mass:58.0)',CCMSLIB00004694997,58.01,950,Drug_analog,methoxsalen,photoactivated radical generator|psoralen,dermatology,psoriasis,DNA synthesis inhibitor,QXKHYNVANLEOEG-UHFFFAOYSA-N
CCMSLIB00012723311,related spectra of 'enilconazole (delta mass:15.99)',CCMSLIB00005776835,15.99,951,Drug_analog,enilconazole,veterinary,infectious disease,dermatophytosis,sterol demethylase inhibitor,PZBPKYOVPCNPJY-UHFFFAOYSA-N
CCMSLIB00012723312,related spectra of 'chlorsulfaquinoxaline (delta mass:-21.99)',CCMSLIB00010138816,-21.98,952,Drug_analog,chlorsulfaquinoxaline,no_match,NA,NA,NA,CTSNHMQGVWXIEG-UHFFFAOYSA-N
CCMSLIB00012723313,"related spectra of 'sulfadimethoxine (delta mass:2.0)', 'sulfadimethoxine (delta mass:2.01)', 'sulphadimethoxine (delta mass:2.01)'",CCMSLIB00000078360|CCMSLIB00000084763|CCMSLIB00000206398|CCMSLIB00000206399|CCMSLIB00003134657|CCMSLIB00003135842|CCMSLIB00003138091|CCMSLIB00005771117|CCMSLIB00005771399|CCMSLIB00005772673,2,953,Drug_analog|Background/QAQC,sulphadimethoxine|sulfadimethoxine,sulfonamide antimicrobial|veterinary,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,dihydropteroate synthetase inhibitor,ZZORFUFYDOWNEF-UHFFFAOYSA-N
CCMSLIB00012723314,"related spectra of 'sulfadimethoxine (delta mass:2.0)', 'sulfadimethoxine (delta mass:2.01)'",CCMSLIB00000206398|CCMSLIB00000207288|CCMSLIB00000207294|CCMSLIB00003135842|CCMSLIB00003137321|CCMSLIB00003137512|CCMSLIB00003138002|CCMSLIB00003138938|CCMSLIB00005771117|CCMSLIB00010137133|CCMSLIB00010137134|CCMSLIB00010141436|CCMSLIB00010141437,2,954,Drug_analog|Background/QAQC,sulfadimethoxine,sulfonamide antimicrobial|veterinary,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,dihydropteroate synthetase inhibitor,ZZORFUFYDOWNEF-UHFFFAOYSA-N
CCMSLIB00012723315,related spectra of 'masoprocol (delta mass:12.0)',CCMSLIB00004692492,12,955,Drug_analog,masoprocol,other antineoplastic agents,dermatology,actinic keratosis (AK),lipoxygenase inhibitor,HCZKYJDFEPMADG-UHFFFAOYSA-N
CCMSLIB00012723316,related spectra of 'prednisolone (delta mass:-30.01)',CCMSLIB00010134089|CCMSLIB00010134090,-30.01,956,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723317,related spectra of 'yohimbine (delta mass:-42.01)',CCMSLIB00004679943|CCMSLIB00004679968|CCMSLIB00004680042|CCMSLIB00004680087|CCMSLIB00005739305|CCMSLIB00005740107|CCMSLIB00005742333|CCMSLIB00005742488|CCMSLIB00005745210|CCMSLIB00005747147,-42.01,957,Drug_analog,yohimbine,drugs used in erectile dysfunction,urology,erectile dysfunction,adrenergic receptor antagonist,BLGXFZZNTVWLAY-FJDMERLMSA-N|BLGXFZZNTVWLAY-DKJBZYCGSA-N|BLGXFZZNTVWLAY-AECJZGCLSA-N|BLGXFZZNTVWLAY-SCYLSFHTSA-N|BLGXFZZNTVWLAY-UHFFFAOYSA-N
CCMSLIB00012723318,related spectra of 'mestranol (delta mass:2.02)',CCMSLIB00003140010,2.02,958,Drug_analog,mestranol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist,IMSSROKUHAOUJS-MJCUULBUSA-N
CCMSLIB00012723319,related spectra of 'stanozolol-4b-oh (delta mass:4.03)',CCMSLIB00005723884,4.03,959,Drug_analog,stanozolol-4b-oh,androstan derivatives,genetics|dermatology,hereditary angioedema,androgen receptor agonist,OCUSYXNRARMJHS-JQPLYGKBSA-N
CCMSLIB00012723320,related spectra of 'hispidulin (delta mass:14.02)',CCMSLIB00010143734|CCMSLIB00010143737,14.02,960,Drug_analog,hispidulin,no_match,no_match,no_match,no_match,IHFBPDAQLQOCBX-UHFFFAOYSA-N
CCMSLIB00012723321,related spectra of 'iloprost (delta mass:-28.03)',CCMSLIB00010149637,-28.03,961,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723322,related spectra of 'iloprost (delta mass:-28.03)',CCMSLIB00010149637,-28.03,962,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723323,related spectra of 'hydroxyprogesterone caproate (delta mass:-16.03)',CCMSLIB00005772150,-16.03,963,Drug_analog|Low_confidence,hydroxyprogesterone caproate,progestin,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DBPWSSGDRRHUNT-UHFFFAOYSA-N
CCMSLIB00012723324,related spectra of 'prednisolone (delta mass:-27.99)',CCMSLIB00010134091,-27.99,964,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723325,related spectra of 'hydroxyprogesterone caproate (delta mass:-16.03)',CCMSLIB00005772150,-16.03,965,Drug_analog|Low_confidence,hydroxyprogesterone caproate,progestin,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DBPWSSGDRRHUNT-UHFFFAOYSA-N
CCMSLIB00012723326,related spectra of 'mestranol (delta mass:4.03)',CCMSLIB00003140010,4.03,966,Drug_analog,mestranol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist,IMSSROKUHAOUJS-MJCUULBUSA-N
CCMSLIB00012723327,related spectra of 'mestranol (delta mass:4.03)',CCMSLIB00003140010,4.03,967,Drug_analog,mestranol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist,IMSSROKUHAOUJS-MJCUULBUSA-N
CCMSLIB00012723328,related spectra of 'hydroxyprogesterone caproate (delta mass:-15.99)',CCMSLIB00005772562,-15.99,968,Drug_analog|Low_confidence,hydroxyprogesterone caproate,progestin,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DBPWSSGDRRHUNT-UHFFFAOYSA-N
CCMSLIB00012723329,"related spectra of 'oglufanide (delta mass:-18.01)', 'golotimod (delta mass:-18.01)'",CCMSLIB00010133731|CCMSLIB00010133732|CCMSLIB00010133733|CCMSLIB00010133734|CCMSLIB00010152307|CCMSLIB00010152308|CCMSLIB00010152309|CCMSLIB00010152310,-18.01,969,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723330,"related spectra of 'oglufanide (delta mass:-18.01)', 'golotimod (delta mass:-18.01)'",CCMSLIB00010133733|CCMSLIB00010152308,-18.01,970,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723331,related spectra of 'golotimod (delta mass:-18.01)',CCMSLIB00010133733,-18.01,971,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723332,related spectra of 'golotimod (delta mass:-18.01)',CCMSLIB00010133733,-18.01,972,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723333,"related spectra of 'oglufanide (delta mass:-18.01)', 'golotimod (delta mass:-18.01)'",CCMSLIB00010133733|CCMSLIB00010152309|CCMSLIB00010152310,-18.01,973,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723334,related spectra of 'oglufanide (delta mass:-18.01)',CCMSLIB00010152308,-18.01,974,Drug_analog|Low_confidence,oglufanide,no_match,NA,NA,VEGF antagonist,LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723335,related spectra of 'golotimod (delta mass:-18.01)',CCMSLIB00010133733,-18.01,975,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723336,related spectra of 'oglufanide (delta mass:-18.01)',CCMSLIB00010152307|CCMSLIB00010152308,-18.01,976,Drug_analog|Low_confidence,oglufanide,no_match,NA,NA,VEGF antagonist,LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723337,"related spectra of 'oglufanide (delta mass:-18.01)', 'golotimod (delta mass:-18.01)'",CCMSLIB00010133733|CCMSLIB00010133734|CCMSLIB00010152307|CCMSLIB00010152309|CCMSLIB00010152310,-18.01,977,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723338,related spectra of 'oglufanide (delta mass:-18.01)',CCMSLIB00010152307|CCMSLIB00010152309|CCMSLIB00010152310,-18.01,978,Drug_analog|Low_confidence,oglufanide,no_match,NA,NA,VEGF antagonist,LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723339,related spectra of 'golotimod (delta mass:-18.01)',CCMSLIB00010133733,-18.01,979,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723340,related spectra of 'golotimod (delta mass:-18.01)',CCMSLIB00010133733,-18.01,980,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723341,related spectra of 'dibucaine (delta mass:-28.03)',CCMSLIB00005753333|CCMSLIB00005753398|CCMSLIB00005753791|CCMSLIB00005753871|CCMSLIB00005754007|CCMSLIB00005754379|CCMSLIB00005754885|CCMSLIB00005755068,-28.03,981,Drug_analog,dibucaine,amide local anesthetic,neurology/psychiatry,local anesthetic,sodium channel blocker,PUFQVTATUTYEAL-UHFFFAOYSA-N
CCMSLIB00012723342,related spectra of 'triclocarban (delta mass:2.0)',CCMSLIB00000213035|CCMSLIB00000213047|CCMSLIB00005774389,2,982,Drug_analog,triclocarban,no_match,NA,NA,antibacterial agent,ICUTUKXCWQYESQ-UHFFFAOYSA-N
CCMSLIB00012723343,related spectra of 'phenprocoumon (delta mass:36.02)',CCMSLIB00010142100,36.02,983,Drug_analog,phenprocoumon,vitamin K antagonist,hematology|cardiology,thrombosis|pulmonary embolism (PE),vitamin K antagonist,DQDAYGNAKTZFIW-UHFFFAOYSA-N
CCMSLIB00012723344,related spectra of 'quinine (delta mass:-29.97)',CCMSLIB00006381191,-29.97,984,Drug_analog,quinine,antimalarial,infectious disease,malaria,hemozoin biocrystallization inhibitor,LOUPRKONTZGTKE-WZBLMQSHSA-N
CCMSLIB00012723345,related spectra of 'quinine (delta mass:-29.97)',CCMSLIB00006559878,-29.97,985,Drug_analog,quinine,antimalarial,infectious disease,malaria,hemozoin biocrystallization inhibitor,LOUPRKONTZGTKE-UHFFFAOYSA-N
CCMSLIB00012723346,related spectra of 'quinine (delta mass:-29.97)',CCMSLIB00006381191,-29.97,986,Drug_analog,quinine,antimalarial,infectious disease,malaria,hemozoin biocrystallization inhibitor,LOUPRKONTZGTKE-WZBLMQSHSA-N
CCMSLIB00012723347,related spectra of 'quinine (delta mass:-29.97)',CCMSLIB00006381191,-29.97,987,Drug_analog,quinine,antimalarial,infectious disease,malaria,hemozoin biocrystallization inhibitor,LOUPRKONTZGTKE-WZBLMQSHSA-N
CCMSLIB00012723348,related spectra of 'treprostinil (delta mass:-38.02)',CCMSLIB00010144008|CCMSLIB00010144009|CCMSLIB00010144012,-38.02,988,Drug_analog,treprostinil,prostacycline vasodilator,pulmonary,pulmonary arterial hypertension (PAH),prostanoid receptor agonist,PAJMKGZZBBTTOY-ZFORQUDYSA-N
CCMSLIB00012723349,"related spectra of 'ingenol (delta mass:4.03)', 'ingenol mebutate (delta mass:-13.98)'",CCMSLIB00010122574|CCMSLIB00010152242,4.03|-13.98,989,Drug_analog,ingenol mebutate|ingenol,inducer of cell death,dermatology,keratosis,PKC activator,VEBVPUXQAPLADL-POYOOMFHSA-N
CCMSLIB00012723350,"related spectra of 'dydrogesterone (delta mass:4.0)', 'dydrogesterone (delta mass:3.99)'",CCMSLIB00005776432,3.99,990,Drug_analog,dydrogesterone,progestin,obstetrics/gynecology,infertility,progesterone receptor agonist,JGMOKGBVKVMRFX-HQZYFCCVSA-N
CCMSLIB00012723351,"related spectra of 'hydroxyprogesterone caproate (delta mass:-14.02)', 'testosterone propionate (delta mass:-28.03)', 'hydroxyprogesterone caproate (delta mass:-14.01)', 'methyltestosterone (delta mass:13.98)', 'desoxycorticosterone acetate (delta mass:-56.03)'",CCMSLIB00000206429|CCMSLIB00003139033|CCMSLIB00005463881|CCMSLIB00005761260|CCMSLIB00005763167|CCMSLIB00005763797|CCMSLIB00005765522|CCMSLIB00005765990|CCMSLIB00005766653|CCMSLIB00005771142|CCMSLIB00005775092|CCMSLIB00006116102|CCMSLIB00006116104|CCMSLIB00006116106|CCMSLIB00006116107|CCMSLIB00006116109|CCMSLIB00006680013|CCMSLIB00010106289|CCMSLIB00010106290|CCMSLIB00010117628|CCMSLIB00010117629|CCMSLIB00010138236|CCMSLIB00010138238,-14.02|-28.03|13.98|-56.03,991,Drug_analog|Low_confidence,testosterone propionate|hydroxyprogesterone caproate|desoxycorticosterone acetate|methyltestosterone,androgen|progestin|no_match,endocrinology|obstetrics/gynecology|NA|oncology,hypogonadism|spontaneous preterm birth|NA|breast cancer,androgen receptor agonist|progesterone receptor agonist|mineralocorticoid receptor agonist,PDMMFKSKQVNJMI-UHFFFAOYSA-N|DBPWSSGDRRHUNT-CEGNMAFCSA-N|VPGRYOFKCNULNK-ACXQXYJUSA-N|PDMMFKSKQVNJMI-BLQWBTBKSA-N|GCKMFJBGXUYNAG-HLXURNFRSA-N|DBPWSSGDRRHUNT-SJFWLOONSA-N
CCMSLIB00012723352,related spectra of 'oxandrolone (delta mass:12.0)',CCMSLIB00005723841,12,992,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012723353,related spectra of 'treprostinil (delta mass:-38.02)',CCMSLIB00010135676|CCMSLIB00010144009,-38.02,993,Drug_analog,treprostinil,prostacycline vasodilator,pulmonary,pulmonary arterial hypertension (PAH),prostanoid receptor agonist,PAJMKGZZBBTTOY-ZFORQUDYSA-N
CCMSLIB00012723354,related spectra of 'ethisterone (delta mass:3.99)',CCMSLIB00005723731,3.99,994,Drug_analog,ethisterone,progestin,obstetrics/gynecology,amenorrhea,progestogen hormone,CHNXZKVNWQUJIB-AYUYWISESA-N
CCMSLIB00012723355,related spectra of 'latanoprost (delta mass:-116.08)',CCMSLIB00010143083|CCMSLIB00010143086,-116.08,995,Drug_analog,latanoprost,prostaglandin analog,ophthalmology,ocular hypertension|glaucoma,prostanoid receptor agonist,GGXICVAJURFBLW-CEYXHVGTSA-N
CCMSLIB00012723356,related spectra of 'iloprost (delta mass:-26.02)',CCMSLIB00010149636,-26.02,996,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723357,related spectra of 'iloprost (delta mass:-26.02)',CCMSLIB00010149637,-26.02,997,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723358,related spectra of 'iloprost (delta mass:-26.02)',CCMSLIB00010149637,-26.02,998,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723359,related spectra of 'iloprost (delta mass:-26.02)',CCMSLIB00010149637,-26.02,999,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723360,related spectra of 'hydroxyprogesterone caproate (delta mass:-14.02)',CCMSLIB00005761260|CCMSLIB00005766828,-14.02,1000,Drug_analog|Low_confidence,hydroxyprogesterone caproate,progestin,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DBPWSSGDRRHUNT-CEGNMAFCSA-N
CCMSLIB00012723361,related spectra of 'treprostinil (delta mass:-38.02)',CCMSLIB00010144009,-38.02,1001,Drug_analog,treprostinil,prostacycline vasodilator,pulmonary,pulmonary arterial hypertension (PAH),prostanoid receptor agonist,PAJMKGZZBBTTOY-ZFORQUDYSA-N
CCMSLIB00012723362,related spectra of 'treprostinil (delta mass:-38.02)',CCMSLIB00010135676|CCMSLIB00010144009,-38.02,1002,Drug_analog,treprostinil,prostacycline vasodilator,pulmonary,pulmonary arterial hypertension (PAH),prostanoid receptor agonist,PAJMKGZZBBTTOY-ZFORQUDYSA-N
CCMSLIB00012723363,related spectra of 'treprostinil (delta mass:-38.02)',CCMSLIB00010144012,-38.02,1003,Drug_analog,treprostinil,prostacycline vasodilator,pulmonary,pulmonary arterial hypertension (PAH),prostanoid receptor agonist,PAJMKGZZBBTTOY-ZFORQUDYSA-N
CCMSLIB00012723364,related spectra of 'iloprost (delta mass:-26.02)',CCMSLIB00010149637,-26.02,1004,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723365,"related spectra of 'hydroxyprogesterone caproate (delta mass:-13.98)', 'medroxyprogesterone (delta mass:-27.99)', 'medroxyprogesterone (delta mass:-28.0)'",CCMSLIB00005765522|CCMSLIB00006119400|CCMSLIB00006119402|CCMSLIB00010118137,-13.98|-27.99,1005,Drug_analog|Low_confidence,hydroxyprogesterone caproate|medroxyprogesterone,progestin,obstetrics/gynecology,spontaneous preterm birth|contraceptive,progesterone receptor agonist,DBPWSSGDRRHUNT-CEGNMAFCSA-N|FRQMUZJSZHZSGN-HBNHAYAOSA-N
CCMSLIB00012723366,related spectra of 'methyltestosterone (delta mass:14.02)',CCMSLIB00005767206,14.02,1006,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012723367,related spectra of 'methyltestosterone (delta mass:14.02)',CCMSLIB00005766653,14.02,1007,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012723368,related spectra of 'testosterone propionate (delta mass:-27.99)',CCMSLIB00005763797|CCMSLIB00010138238,-27.99,1008,Drug_analog|Low_confidence,testosterone propionate,androgen,endocrinology,hypogonadism,androgen receptor agonist,PDMMFKSKQVNJMI-BLQWBTBKSA-N
CCMSLIB00012724581,related spectra of 'elvitegravir (gs-9137) (delta mass:13.98)',CCMSLIB00000078379,13.98,2221,Drug_suspect,elvitegravir,HIV integrase strand transfer inhibitor (HIV INSTI),infectious disease,human immunodeficiency virus (HIV-1),HIV integrase inhibitor,JUZYLCPPVHEVSV-LJQANCHMSA-N
CCMSLIB00012723370,"related spectra of 'nateglinide (delta mass:2.0)', 'nateglinide (delta mass:2.02)'",CCMSLIB00006118532|CCMSLIB00006118535|CCMSLIB00006118537|CCMSLIB00006118539|CCMSLIB00006118541|CCMSLIB00006118554|CCMSLIB00006118556|CCMSLIB00006118559|CCMSLIB00006118561|CCMSLIB00006118562,2.00|2.02,1010,Drug_analog,nateglinide,glinide,endocrinology,type 2 diabetes mellitus,insulin secretagogue,OELFLUMRDSZNSF-OFLPRAFFSA-N
CCMSLIB00012723371,related spectra of 'artemisinin (delta mass:36.02)',CCMSLIB00000214217|CCMSLIB00000215699,36.02,1011,Drug_analog,artemisinin,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,BLUAFEHZUWYNDE-NNWCWBAJSA-N
CCMSLIB00012723372,related spectra of 'oxymetholone (delta mass:1.98)',CCMSLIB00005723847,1.98,1012,Drug_analog,oxymetholone,androstan derivatives,hematology,anemia,androgen receptor agonist,YKELUTWGCGLPTM-WBNQDIJOSA-N
CCMSLIB00012723373,related spectra of 'oxandrolone (delta mass:14.02)',CCMSLIB00005723841,14.02,1013,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012723374,related spectra of 'oxymetholone (delta mass:1.98)',CCMSLIB00005723847,1.98,1014,Drug_analog,oxymetholone,androstan derivatives,hematology,anemia,androgen receptor agonist,YKELUTWGCGLPTM-WBNQDIJOSA-N
CCMSLIB00012723375,related spectra of 'oxymetholone (delta mass:1.98)',CCMSLIB00005723847,1.98,1015,Drug_analog,oxymetholone,androstan derivatives,hematology,anemia,androgen receptor agonist,YKELUTWGCGLPTM-WBNQDIJOSA-N
CCMSLIB00012723376,related spectra of 'oxymetholone (delta mass:1.98)',CCMSLIB00005723847,1.98,1016,Drug_analog,oxymetholone,androstan derivatives,hematology,anemia,androgen receptor agonist,YKELUTWGCGLPTM-WBNQDIJOSA-N
CCMSLIB00012723377,related spectra of 'oxymetholone (delta mass:1.98)',CCMSLIB00005723847,1.98,1017,Drug_analog,oxymetholone,androstan derivatives,hematology,anemia,androgen receptor agonist,YKELUTWGCGLPTM-WBNQDIJOSA-N
CCMSLIB00012723378,related spectra of 'oxymetholone (delta mass:1.98)',CCMSLIB00005723847,1.98,1018,Drug_analog,oxymetholone,androstan derivatives,hematology,anemia,androgen receptor agonist,YKELUTWGCGLPTM-WBNQDIJOSA-N
CCMSLIB00012723379,related spectra of 'canrenone (delta mass:-21.98)',CCMSLIB00005775230,-21.98,1019,Drug_analog,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012723380,related spectra of 'oxymetholone (delta mass:1.98)',CCMSLIB00005723847,1.98,1020,Drug_analog,oxymetholone,androstan derivatives,hematology,anemia,androgen receptor agonist,YKELUTWGCGLPTM-WBNQDIJOSA-N
CCMSLIB00012723381,related spectra of 'oxymetholone (delta mass:1.98)',CCMSLIB00005723847,1.98,1021,Drug_analog,oxymetholone,androstan derivatives,hematology,anemia,androgen receptor agonist,YKELUTWGCGLPTM-WBNQDIJOSA-N
CCMSLIB00012723382,related spectra of 'oxymetholone (delta mass:2.02)',CCMSLIB00005723847,2.02,1022,Drug_analog,oxymetholone,androstan derivatives,hematology,anemia,androgen receptor agonist,YKELUTWGCGLPTM-WBNQDIJOSA-N
CCMSLIB00012723383,related spectra of 'amoxicillin (delta mass:-43.99)',CCMSLIB00000572773|CCMSLIB00000572811|CCMSLIB00000574200|CCMSLIB00005434448|CCMSLIB00005730102|CCMSLIB00005732214|CCMSLIB00006118688|CCMSLIB00006118690|CCMSLIB00006118692|CCMSLIB00006118695|CCMSLIB00006118697|CCMSLIB00006118704|CCMSLIB00006118706|CCMSLIB00006118708|CCMSLIB00006118710|CCMSLIB00006118713,-43.99,1023,Drug_analog,amoxicillin,penicillin class antibacterial,infectious disease,skin infections|duodenal ulcer disease|gonorrhea|ear infections|throat infections|genitourinary tract infections|respiratory tract infections,penicillin binding protein inhibitor,LSQZJLSUYDQPKJ-NJBDSQKTSA-N|LSQZJLSUYDQPKJ-UHFFFAOYSA-N
CCMSLIB00012723384,"related spectra of 'oglufanide (delta mass:-14.02)', 'golotimod (delta mass:-14.02)'",CCMSLIB00010133731|CCMSLIB00010133732|CCMSLIB00010152308,-14.02,1024,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723385,"related spectra of 'oglufanide (delta mass:-14.02)', 'golotimod (delta mass:-14.02)'",CCMSLIB00010133731|CCMSLIB00010133732|CCMSLIB00010133733|CCMSLIB00010152308,-14.02,1025,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723386,related spectra of 'golotimod (delta mass:-14.02)',CCMSLIB00010133731|CCMSLIB00010133733,-14.02,1026,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723387,related spectra of 'golotimod (delta mass:-14.02)',CCMSLIB00010133731|CCMSLIB00010133733,-14.02,1027,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723388,"related spectra of 'oglufanide (delta mass:-14.02)', 'golotimod (delta mass:-14.02)'",CCMSLIB00010133731|CCMSLIB00010133733|CCMSLIB00010152309|CCMSLIB00010152310,-14.02,1028,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723389,"related spectra of 'oglufanide (delta mass:-14.02)', 'golotimod (delta mass:-14.02)'",CCMSLIB00010133731|CCMSLIB00010133733|CCMSLIB00010152307|CCMSLIB00010152309|CCMSLIB00010152310,-14.02,1029,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723390,related spectra of 'golotimod (delta mass:-14.02)',CCMSLIB00010133731|CCMSLIB00010133733,-14.02,1030,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723391,"related spectra of 'oglufanide (delta mass:-14.02)', 'golotimod (delta mass:-14.02)'",CCMSLIB00010133731|CCMSLIB00010133733|CCMSLIB00010152308,-14.02,1031,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723392,related spectra of 'golotimod (delta mass:-14.02)',CCMSLIB00010133731,-14.02,1032,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723393,related spectra of 'golotimod (delta mass:-14.02)',CCMSLIB00010133731|CCMSLIB00010133733,-14.02,1033,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723394,related spectra of 'golotimod (delta mass:-14.02)',CCMSLIB00010133731|CCMSLIB00010133733,-14.02,1034,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723395,related spectra of 'golotimod (delta mass:-14.02)',CCMSLIB00010133731,-14.02,1035,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723396,related spectra of 'golotimod (delta mass:-14.02)',CCMSLIB00010133733,-14.02,1036,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723397,related spectra of 'bisacodyl (delta mass:-42.01)',CCMSLIB00000078638,-42.01,1037,Drug_analog,bisacodyl,stimulant laxative,gastroenterology,constipation,laxative,KHOITXIGCFIULA-UHFFFAOYSA-N
CCMSLIB00012723398,"related spectra of 'cocaine (delta mass:15.99)', 'cocaine (delta mass:16.0)'",CCMSLIB00000080017|CCMSLIB00000211402|CCMSLIB00000211412|CCMSLIB00003137682,15.99,1038,Drug_analog,cocaine,central nervous system stimulant,drug of abuse,psychostimulant,monoamine transporter inhibitor,ZPUCINDJVBIVPJ-UHFFFAOYSA-N|ZPUCINDJVBIVPJ-LJISPDSOSA-N
CCMSLIB00012723399,related spectra of 'methyltestosterone (delta mass:18.01)',CCMSLIB00005775092,18.01,1039,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012723400,related spectra of 'methyltestosterone (delta mass:18.01)',CCMSLIB00005775092,18.01,1040,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012723401,related spectra of 'mesterolone (delta mass:16.0)',CCMSLIB00005723783,15.99,1041,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723402,related spectra of 'mesterolone (delta mass:16.03)',CCMSLIB00005723783,16.03,1042,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723403,related spectra of 'mesterolone (delta mass:16.03)',CCMSLIB00005723783,16.03,1043,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723404,related spectra of 'mesterolone (delta mass:16.03)',CCMSLIB00005723783,16.03,1044,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723405,"related spectra of 'chlorthalidone (delta mass:-17.03)', 'chlortalidone (delta mass:-17.03)'",CCMSLIB00000077136|CCMSLIB00000566305|CCMSLIB00000566978|CCMSLIB00003135287|CCMSLIB00005730324|CCMSLIB00005732393,-17.03,1045,Drug_analog,chlorthalidone|chlortalidone,thiazide-like diuretic,cardiology|nephrology,hypertension|edema,sodium and chloride reabsorption inhibitor,JIVPVXMEBJLZRO-UHFFFAOYSA-N
CCMSLIB00012723406,"related spectra of 'chlorthalidone (delta mass:-17.03)', 'chlortalidone (delta mass:-17.03)'",CCMSLIB00000077136|CCMSLIB00000085714|CCMSLIB00000566978|CCMSLIB00003135287|CCMSLIB00005730324,-17.03,1046,Drug_analog,chlorthalidone|chlortalidone,thiazide-like diuretic,cardiology|nephrology,hypertension|edema,sodium and chloride reabsorption inhibitor,JIVPVXMEBJLZRO-UHFFFAOYSA-N
CCMSLIB00012723407,related spectra of 'sertraline (delta mass:15.99)',CCMSLIB00003140022,15.99,1047,Drug_analog,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012723408,related spectra of 'mesterolone (delta mass:17.03)',CCMSLIB00005723783,17.03,1048,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723409,related spectra of 'perhexiline (delta mass:44.03)',CCMSLIB00010145792|CCMSLIB00010145795,44.03,1049,Drug_analog|Low_confidence,perhexiline,other non-selective calcium channel blockers,cardiology,angina pectoris,carnitine palmitoyltransferase inhibitor,CYXKNKQEMFBLER-UHFFFAOYSA-N
CCMSLIB00012723410,related spectra of 'cortisone acetate (delta mass:-38.02)',CCMSLIB00005767404|CCMSLIB00005769009|CCMSLIB00005772623|CCMSLIB00005773029,-38.02,1050,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012723411,related spectra of 'digoxigenin (delta mass:-68.06)',CCMSLIB00010151841,-68.06,1051,Drug_analog,digoxigenin,no_match,NA,NA,steroid,SHIBSTMRCDJXLN-KCZCNTNESA-N
CCMSLIB00012723412,related spectra of 'oxandrolone (delta mass:18.01)',CCMSLIB00005723841,18.01,1052,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012723413,related spectra of 'mesterolone (delta mass:18.01)',CCMSLIB00005723783,18.01,1053,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723414,related spectra of 'oxandrolone (delta mass:16.03)',CCMSLIB00005723835,16.03,1054,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,QSLJIVKCVHQPLV-ZXOYHYBESA-N
CCMSLIB00012723415,related spectra of 'mesterolone (delta mass:18.01)',CCMSLIB00005723783,18.01,1055,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723416,related spectra of 'testosterone propionate (delta mass:-21.98)',CCMSLIB00005760974,-21.98,1056,Drug_analog|Low_confidence,testosterone propionate,androgen,endocrinology,hypogonadism,androgen receptor agonist,PDMMFKSKQVNJMI-BLQWBTBKSA-N
CCMSLIB00012723417,related spectra of 'betulinic acid (delta mass:-116.06)',CCMSLIB00010124192,-116.06,1057,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012723418,related spectra of 'finasteride (delta mass:-49.99)',CCMSLIB00000223781,-49.99,1058,Drug_analog,finasteride,5-alpha reductase inhibitor,dermatology|urology,male androgenetic alopecia|benign prostatic hyperplasia,5 alpha reductase inhibitor,DBEPLOCGEIEOCV-WSBQPABSSA-N
CCMSLIB00012723419,related spectra of 'papaverine (delta mass:-16.03)',CCMSLIB00003135451|CCMSLIB00003136905|CCMSLIB00003136997|CCMSLIB00004692497|CCMSLIB00004692923|CCMSLIB00005769343|CCMSLIB00005769417|CCMSLIB00005769790|CCMSLIB00010115062,-16.03,1059,Drug_analog,papaverine,drugs used in erectile dysfunction|papaverine and derivatives,cardiology|gastroenterology|urology,myocardial infarction|angina pectoris|pulmonary embolism (PE)|colitis|vascular spasm|erectile dysfunction,phosphodiesterase inhibitor,XQYZDYMELSJDRZ-UHFFFAOYSA-N
CCMSLIB00012723420,"related spectra of 'pramoxine (delta mass:29.97)', 'pramocaine (delta mass:29.97)'",CCMSLIB00000566019|CCMSLIB00000566914|CCMSLIB00000568072|CCMSLIB00005731097|CCMSLIB00005732628|CCMSLIB00010129894|CCMSLIB00010129897|CCMSLIB00010129900,29.97,1060,Drug_analog,pramocaine|pramoxine|pramocaine,anesthetics for topical use,neurology/psychiatry,local anesthetic,topical anesthetic,DQKXQSGTHWVTAD-UHFFFAOYSA-N
CCMSLIB00012723421,related spectra of 'chloramphenicol (delta mass:3.99)',CCMSLIB00000572303|CCMSLIB00000572479|CCMSLIB00000572720|CCMSLIB00004691469|CCMSLIB00004691470|CCMSLIB00005733406|CCMSLIB00005733495|CCMSLIB00005736199|CCMSLIB00005765892|CCMSLIB00005766750|CCMSLIB00005776881,3.99,1061,Drug_analog,chloramphenicol,amphenicol class antibacterial,infectious disease,meningitis|cholera|bacterial conjunctivitis,bacterial 50S ribosomal subunit inhibitor,WIIZWVCIJKGZOK-RKDXNWHRSA-N|WIIZWVCIJKGZOK-UHFFFAOYSA-N
CCMSLIB00012723422,related spectra of 'chloramphenicol (delta mass:2.0)',CCMSLIB00005733888,2,1062,Drug_analog,chloramphenicol,amphenicol class antibacterial,infectious disease,meningitis|cholera|bacterial conjunctivitis,bacterial 50S ribosomal subunit inhibitor,WIIZWVCIJKGZOK-RKDXNWHRSA-N
CCMSLIB00012723423,"related spectra of 'sulfadimethoxine (delta mass:14.02)', 'sulphadimethoxine (delta mass:14.02)', 'sulfadimethoxine (delta mass:14.01)'",CCMSLIB00000078360|CCMSLIB00000206398|CCMSLIB00000207294|CCMSLIB00000207295|CCMSLIB00000579624|CCMSLIB00000841873|CCMSLIB00003137321|CCMSLIB00003137512|CCMSLIB00003138866|CCMSLIB00003138938|CCMSLIB00003138961|CCMSLIB00005771117|CCMSLIB00010137131|CCMSLIB00010137133|CCMSLIB00010137134|CCMSLIB00010141433|CCMSLIB00010141434|CCMSLIB00010141436|CCMSLIB00010141437,14.02,1063,Drug_analog|Background/QAQC,sulphadimethoxine|sulfadimethoxine,sulfonamide antimicrobial|veterinary,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,dihydropteroate synthetase inhibitor,ZZORFUFYDOWNEF-UHFFFAOYSA-N
CCMSLIB00012723424,"related spectra of 'sulfadimethoxine (delta mass:14.02)', 'sulfadimethoxine (delta mass:14.01)'",CCMSLIB00000206398|CCMSLIB00000207288|CCMSLIB00000207294|CCMSLIB00000207295|CCMSLIB00000579624|CCMSLIB00000841873|CCMSLIB00003137321|CCMSLIB00003137512|CCMSLIB00003138866|CCMSLIB00003138938|CCMSLIB00003138961|CCMSLIB00005771117|CCMSLIB00010137131|CCMSLIB00010137133|CCMSLIB00010137134|CCMSLIB00010141434|CCMSLIB00010141436|CCMSLIB00010141437,14.02,1064,Drug_analog|Background/QAQC,sulfadimethoxine,sulfonamide antimicrobial|veterinary,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,dihydropteroate synthetase inhibitor,ZZORFUFYDOWNEF-UHFFFAOYSA-N
CCMSLIB00012723425,related spectra of 'lactulose (delta mass:-15.99)',CCMSLIB00006122286|CCMSLIB00006122288|CCMSLIB00006122290|CCMSLIB00006122293|CCMSLIB00006122295,-15.99,1065,Drug_analog|Low_confidence,lactulose,osmotic laxative,gastroenterology,portal-systemic encephalopathy (PSE)|constipation,laxative,JCQLYHFGKNRPGE-FCVZTGTOSA-N
CCMSLIB00012723426,related spectra of 'canrenone (delta mass:-16.0)',CCMSLIB00005772583,-15.99,1066,Drug_analog,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012723427,related spectra of 'canrenone (delta mass:-15.99)',CCMSLIB00005775230,-15.99,1067,Drug_analog,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012723428,related spectra of 'drospirenone (delta mass:-42.01)',CCMSLIB00005773207,-42.01,1068,Drug_analog,drospirenone,progestin,obstetrics/gynecology,contraceptive,mineralocorticoid receptor antagonist|progesterone receptor agonist,METQSPRSQINEEU-HXCATZOESA-N
CCMSLIB00012723429,related spectra of 'clopidogrel carboxylic acid (delta mass:18.01)',CCMSLIB00000211930|CCMSLIB00000211931|CCMSLIB00000211942,18.01,1069,Drug_analog,clopidogrel carboxylic acid,P2Y12 platelet inhibitor,cardiology|neurology/psychiatry,myocardial infarction|stroke|peripheral artery disease (PAD)|acute coronary syndrome (ACS),purinergic receptor antagonist,DCASRSISIKYPDD-UHFFFAOYSA-N
CCMSLIB00012723430,related spectra of 'ca-074 (delta mass:-58.04)',CCMSLIB00010133647|CCMSLIB00010133650,-58.04,1070,Drug_analog,ca-074,no_match,no_match,no_match,no_match,ZEZGJKSEBRELAS-PEDHHIEDSA-N
CCMSLIB00012723431,"related spectra of 'escitalopram (delta mass:1.98)', 'citalopram (delta mass:1.98)'",CCMSLIB00000078645|CCMSLIB00000212111|CCMSLIB00000212121|CCMSLIB00005772827|CCMSLIB00006119357|CCMSLIB00006119361,1.98,1071,Drug_analog,escitalopram|citalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-FQEVSTJZSA-N|WSEQXVZVJXJVFP-UHFFFAOYSA-N
CCMSLIB00012723432,"related spectra of 'canrenone (delta mass:-14.02)', 'drospirenone (delta mass:-40.03)'",CCMSLIB00000005508|CCMSLIB00000564977|CCMSLIB00005726588,-14.02|-40.03,1072,Drug_analog,drospirenone|canrenone,progestin|aldosterone antagonist,obstetrics/gynecology|endocrinology|cardiology,contraceptive|hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist|progesterone receptor agonist,METQSPRSQINEEU-HXCATZOESA-N|UJVLDDZCTMKXJK-WNHSNXHDSA-N
CCMSLIB00012723433,related spectra of 'iloprost (delta mass:2.0)',CCMSLIB00010149632,2,1073,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723434,related spectra of 'canrenone (delta mass:-13.98)',CCMSLIB00000564977|CCMSLIB00005726588|CCMSLIB00006684961,-13.98,1074,Drug_analog,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-WNHSNXHDSA-N
CCMSLIB00012723435,related spectra of 'iloprost (delta mass:-16.0)',CCMSLIB00010149636,-15.99,1075,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723436,related spectra of 'medroxyprogesterone (delta mass:-18.01)',CCMSLIB00000579302|CCMSLIB00000579820|CCMSLIB00000842005|CCMSLIB00005773306|CCMSLIB00006119374|CCMSLIB00006119376|CCMSLIB00006119378|CCMSLIB00006119380|CCMSLIB00006119382|CCMSLIB00006119400|CCMSLIB00006119402|CCMSLIB00010106797|CCMSLIB00010118137|CCMSLIB00010150393|CCMSLIB00010150394,-18.01,1076,Drug_analog|Low_confidence,medroxyprogesterone,progestin,obstetrics/gynecology,contraceptive,progesterone receptor agonist,FRQMUZJSZHZSGN-UHFFFAOYSA-N|FRQMUZJSZHZSGN-HBNHAYAOSA-N
CCMSLIB00012723437,related spectra of 'iloprost (delta mass:-15.99)',CCMSLIB00010149637,-15.99,1077,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723438,related spectra of 'canrenone (delta mass:-13.98)',CCMSLIB00005775230,-13.98,1078,Drug_analog,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012723439,related spectra of 'canrenone (delta mass:-13.98)',CCMSLIB00005775230,-13.98,1079,Drug_analog,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012723440,related spectra of 'canrenone (delta mass:-13.98)',CCMSLIB00005775230,-13.98,1080,Drug_analog,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012723441,related spectra of 'hydroxyprogesterone caproate (delta mass:-3.99)',CCMSLIB00005777181,-3.99,1081,Drug_analog|Low_confidence,hydroxyprogesterone caproate,progestin,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DBPWSSGDRRHUNT-UHFFFAOYSA-N
CCMSLIB00012723442,related spectra of 'canrenone (delta mass:-13.98)',CCMSLIB00005772583,-13.98,1082,Drug_analog,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012723443,related spectra of 'canrenone (delta mass:-13.98)',CCMSLIB00005775230,-13.98,1083,Drug_analog,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012723444,related spectra of 'canrenone (delta mass:-13.98)',CCMSLIB00005775230,-13.98,1084,Drug_analog,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012723445,related spectra of 'hydroxyprogesterone caproate (delta mass:-3.99)',CCMSLIB00005777181,-3.99,1085,Drug_analog|Low_confidence,hydroxyprogesterone caproate,progestin,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DBPWSSGDRRHUNT-UHFFFAOYSA-N
CCMSLIB00012723446,related spectra of 'canrenone (delta mass:-13.98)',CCMSLIB00005775230,-13.98,1086,Drug_analog,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012723447,related spectra of 'mestranol (delta mass:16.03)',CCMSLIB00003140010,16.03,1087,Drug_analog,mestranol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist,IMSSROKUHAOUJS-MJCUULBUSA-N
CCMSLIB00012723448,related spectra of 'ca-074 (delta mass:-56.06)',CCMSLIB00010133647,-56.06,1088,Drug_analog,ca-074,no_match,no_match,no_match,no_match,ZEZGJKSEBRELAS-PEDHHIEDSA-N
CCMSLIB00012723449,"related spectra of 'hydroquinine (delta mass:1.0)', 'hydroquinidine (delta mass:1.0)'",CCMSLIB00003137724|CCMSLIB00004694142|CCMSLIB00004694143|CCMSLIB00004694569|CCMSLIB00006393499|CCMSLIB00006393591|CCMSLIB00006562765|CCMSLIB00010114941|CCMSLIB00010147559|CCMSLIB00010147562|CCMSLIB00010150479|CCMSLIB00010150482,1,1089,Drug_analog,hydroquinidine|hydroquinine,antiarrhythmic,cardiology,cardiac arrythmia,antiarrhythmic,LJOQGZACKSYWCH-LHHVKLHASA-N|LJOQGZACKSYWCH-WZBLMQSHSA-N
CCMSLIB00012723450,related spectra of 'tadalafil (delta mass:-61.05)',CCMSLIB00000078956,-61.05,1090,Drug_analog,tadalafil,phosphodiesterase-5 (PDE-5) inhibitor,urology,erectile dysfunction|benign prostatic hyperplasia|pulmonary arterial hypertension (PAH),phosphodiesterase inhibitor,WOXKDUGGOYFFRN-IIBYNOLFSA-N
CCMSLIB00012723451,related spectra of 'amoxapine (delta mass:15.01)',CCMSLIB00010134915,15.01,1091,Drug_analog,amoxapine,tricyclic antidepressant (TCA),neurology/psychiatry,depression,norepinephrine reputake inhibitor,QWGDMFLQWFTERH-UHFFFAOYSA-N
CCMSLIB00012723452,related spectra of 'clozapine (delta mass:2.0)',CCMSLIB00000211792|CCMSLIB00000211794|CCMSLIB00000211806,2,1092,Drug_analog,clozapine,atypical antipsychotic,neurology/psychiatry,schizophrenia,dopamine receptor antagonist|serotonin receptor antagonist,QZUDBNBUXVUHMW-UHFFFAOYSA-N
CCMSLIB00012724582,related spectra of 'elvitegravir (gs-9137) (delta mass:14.016)',CCMSLIB00000078379,14.02,2222,Drug_suspect,elvitegravir,HIV integrase strand transfer inhibitor (HIV INSTI),infectious disease,human immunodeficiency virus (HIV-1),HIV integrase inhibitor,JUZYLCPPVHEVSV-LJQANCHMSA-N
CCMSLIB00012723454,related spectra of 'ingenol mebutate (delta mass:-18.01)',CCMSLIB00010111236,-18.01,1094,Drug_analog,ingenol mebutate,inducer of cell death,dermatology,keratosis,PKC activator,VEBVPUXQAPLADL-POYOOMFHSA-N
CCMSLIB00012723455,related spectra of 'quinine (delta mass:-17.97)',CCMSLIB00006381955|CCMSLIB00006382098|CCMSLIB00006382148|CCMSLIB00006382242|CCMSLIB00006382266,-17.97,1095,Drug_analog,quinine,antimalarial,infectious disease,malaria,hemozoin biocrystallization inhibitor,LOUPRKONTZGTKE-WZBLMQSHSA-N
CCMSLIB00012723456,related spectra of 'dexamethasone (delta mass:-63.96)',CCMSLIB00000209890,-63.96,1096,Drug_analog,dexamethasone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,UREBDLICKHMUKA-CXSFZGCWSA-N
CCMSLIB00012723457,related spectra of 'oxymetholone (delta mass:12.0)',CCMSLIB00005723847,12,1097,Drug_analog,oxymetholone,androstan derivatives,hematology,anemia,androgen receptor agonist,YKELUTWGCGLPTM-WBNQDIJOSA-N
CCMSLIB00012723458,"related spectra of 'testosterone propionate (delta mass:-15.99)', 'desoxycorticosterone acetate (delta mass:-43.99)', 'hydroxyprogesterone caproate (delta mass:-1.98)', 'testosterone propionate (delta mass:-16.0)'",CCMSLIB00000206429|CCMSLIB00003139033|CCMSLIB00005463881|CCMSLIB00005763640|CCMSLIB00005763797|CCMSLIB00005765522|CCMSLIB00005765990|CCMSLIB00005771142|CCMSLIB00006116102|CCMSLIB00006116104|CCMSLIB00006116106|CCMSLIB00006116107|CCMSLIB00006116109|CCMSLIB00006680013|CCMSLIB00010106289|CCMSLIB00010106290,-15.99|-43.99|-1.98,1098,Drug_analog|Low_confidence,testosterone propionate|hydroxyprogesterone caproate|desoxycorticosterone acetate,androgen|progestin|no_match,endocrinology|obstetrics/gynecology|NA,hypogonadism|spontaneous preterm birth|NA,androgen receptor agonist|progesterone receptor agonist|mineralocorticoid receptor agonist,PDMMFKSKQVNJMI-UHFFFAOYSA-N|DBPWSSGDRRHUNT-CEGNMAFCSA-N|VPGRYOFKCNULNK-ACXQXYJUSA-N|PDMMFKSKQVNJMI-BLQWBTBKSA-N|DBPWSSGDRRHUNT-SJFWLOONSA-N
CCMSLIB00012723459,related spectra of 'dydrogesterone (delta mass:16.03)',CCMSLIB00005774596,16.03,1099,Drug_analog,dydrogesterone,progestin,obstetrics/gynecology,infertility,progesterone receptor agonist,JGMOKGBVKVMRFX-HQZYFCCVSA-N
CCMSLIB00012723460,related spectra of 'iloprost (delta mass:-13.98)',CCMSLIB00010149637,-13.98,1100,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723461,related spectra of 'ethylestrenol (delta mass:58.01)',CCMSLIB00005723752,58.01,1101,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012723462,related spectra of 'ergocalciferol (delta mass:-68.06)',CCMSLIB00010114654,-68.06,1102,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723463,"related spectra of 'nylidrin (delta mass:29.97)', 'isoxsuprine (delta mass:27.99)'",CCMSLIB00000206210|CCMSLIB00005754520|CCMSLIB00005755029|CCMSLIB00005771213,29.97|27.99,1103,Drug_analog,isoxsuprine|nylidrin,peripheral vasodilators,rheumatology|cardiology|neurology/psychiatry|obstetrics/gynecology,Raynaud's disease|peripheral vascular disease|cerebrovascular insufficiency|Buerger's disease|premature labor,adrenergic receptor agonist,BMUKKTUHUDJSNZ-UHFFFAOYSA-N|PTGXAUBQBSGPKF-UHFFFAOYSA-N
CCMSLIB00012723464,related spectra of 'isoxsuprine (delta mass:27.99)',CCMSLIB00000206210|CCMSLIB00005771213,27.99,1104,Drug_analog,isoxsuprine,peripheral vasodilators,rheumatology|cardiology|neurology/psychiatry|obstetrics/gynecology,Raynaud's disease|peripheral vascular disease|cerebrovascular insufficiency|Buerger's disease|premature labor,adrenergic receptor agonist,BMUKKTUHUDJSNZ-UHFFFAOYSA-N
CCMSLIB00012723465,related spectra of 'hyoscine butylbromide (delta mass:-30.01)',CCMSLIB00000084820|CCMSLIB00000085183|CCMSLIB00010107154,-30.01,1105,Drug_analog,hyoscine butylbromide,anticholinergic,gastroenterology,abdominal pain|abdominal cramps,cholinergic receptor antagonist,YBCNXCRZPWQOBR-MWGADRMYSA-N|YBCNXCRZPWQOBR-UHFFFAOYSA-N
CCMSLIB00012723466,related spectra of 'quinine (delta mass:-15.99)',CCMSLIB00006381191,-15.99,1106,Drug_analog,quinine,antimalarial,infectious disease,malaria,hemozoin biocrystallization inhibitor,LOUPRKONTZGTKE-WZBLMQSHSA-N
CCMSLIB00012723467,related spectra of 'quinine (delta mass:-15.99)',CCMSLIB00006381262,-15.99,1107,Drug_analog,quinine,antimalarial,infectious disease,malaria,hemozoin biocrystallization inhibitor,LOUPRKONTZGTKE-WZBLMQSHSA-N
CCMSLIB00012723468,related spectra of 'quinine (delta mass:-15.99)',CCMSLIB00006381262,-15.99,1108,Drug_analog,quinine,antimalarial,infectious disease,malaria,hemozoin biocrystallization inhibitor,LOUPRKONTZGTKE-WZBLMQSHSA-N
CCMSLIB00012723469,related spectra of 'iloprost (delta mass:-12.04)',CCMSLIB00010149637,-12.04,1109,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723470,related spectra of 'iloprost (delta mass:-12.04)',CCMSLIB00010149637,-12.04,1110,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723471,related spectra of 'iloprost (delta mass:-12.04)',CCMSLIB00010149637|CCMSLIB00010149638,-12.04,1111,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723472,related spectra of 'iloprost (delta mass:-12.04)',CCMSLIB00010149637|CCMSLIB00010149638,-12.04,1112,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723473,related spectra of 'iloprost (delta mass:-12.0)',CCMSLIB00010149638,-12,1113,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723474,related spectra of 'cortisone acetate (delta mass:-29.97)',CCMSLIB00000570329|CCMSLIB00004691593|CCMSLIB00004719903|CCMSLIB00005463901|CCMSLIB00005730069|CCMSLIB00005767404|CCMSLIB00005767915|CCMSLIB00005768751|CCMSLIB00005775173|CCMSLIB00006117786|CCMSLIB00006117788|CCMSLIB00006680084|CCMSLIB00006684982,-29.97,1114,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012723475,related spectra of 'budesonide (delta mass:-100.02)',CCMSLIB00000004382|CCMSLIB00005762258,-100.02,1115,Drug_analog,budesonide,corticosteroid,gastroenterology|pulmonary|allergy,Crohn's disease|asthma|COPD|allergic rhinitis,glucocorticoid receptor agonist,VOVIALXJUBGFJZ-KWVAZRHASA-N
CCMSLIB00012723476,related spectra of 'oxymetholone (delta mass:14.02)',CCMSLIB00005723847,14.02,1116,Drug_analog,oxymetholone,androstan derivatives,hematology,anemia,androgen receptor agonist,YKELUTWGCGLPTM-WBNQDIJOSA-N
CCMSLIB00012723477,related spectra of 'digoxigenin (delta mass:-59.98)',CCMSLIB00010151840|CCMSLIB00010151841,-59.98,1117,Drug_analog,digoxigenin,no_match,NA,NA,steroid,SHIBSTMRCDJXLN-KCZCNTNESA-N
CCMSLIB00012724583,related spectra of 'elvitegravir (gs-9137) (delta mass:15.995)',CCMSLIB00000078379,15.99,2223,Drug_suspect,elvitegravir,HIV integrase strand transfer inhibitor (HIV INSTI),infectious disease,human immunodeficiency virus (HIV-1),HIV integrase inhibitor,JUZYLCPPVHEVSV-LJQANCHMSA-N
CCMSLIB00012724584,related spectra of 'elvitegravir (gs-9137) (delta mass:30.01)',CCMSLIB00000078379,30.01,2224,Drug_suspect,elvitegravir,HIV integrase strand transfer inhibitor (HIV INSTI),infectious disease,human immunodeficiency virus (HIV-1),HIV integrase inhibitor,JUZYLCPPVHEVSV-LJQANCHMSA-N
CCMSLIB00012723369,related spectra of 'efavirenz (delta mass:2.0)',CCMSLIB00000079120|CCMSLIB00000567814|CCMSLIB00005735740|CCMSLIB00005776252|CCMSLIB00005776641,2,1009,Drug_analog,efavirenz,HIV non-nucleoside reverse transcriptase inhibitor (HIV NNRTI),infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,XPOQHMRABVBWPR-ZDUSSCGKSA-N|XPOQHMRABVBWPR-UHFFFAOYSA-N
CCMSLIB00012723478,related spectra of 'efavirenz (delta mass:15.99)',CCMSLIB00000079120|CCMSLIB00000579893|CCMSLIB00000841852|CCMSLIB00005776252|CCMSLIB00005776641,15.99,1118,Drug_analog,efavirenz,HIV non-nucleoside reverse transcriptase inhibitor (HIV NNRTI),infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,XPOQHMRABVBWPR-ZDUSSCGKSA-N|XPOQHMRABVBWPR-UHFFFAOYSA-N
CCMSLIB00012723482,related spectra of 'oxfendazole (delta mass:15.99)',CCMSLIB00000078305|CCMSLIB00005760054|CCMSLIB00005762990|CCMSLIB00005766270|CCMSLIB00005776977|CCMSLIB00005777017|CCMSLIB00010151567,15.99,1122,Drug_analog,oxfendazole|oxfendazole,benzimidazoles and related substances|veterinary,infectious disease,lungworms|tapeworm|gastrointestinal roundworms,anthelmintic agent,BEZZFPOZAYTVHN-UHFFFAOYSA-N
CCMSLIB00012723483,"related spectra of 'omeprazole (delta mass:-14.01)', 'omeprazole (delta mass:-14.02)', 'esomeprazole (delta mass:-14.02)'",CCMSLIB00000006486|CCMSLIB00000078131|CCMSLIB00000079070|CCMSLIB00004679253|CCMSLIB00005772836|CCMSLIB00005773533|CCMSLIB00005774401|CCMSLIB00006680003|CCMSLIB00010138456|CCMSLIB00010142823|CCMSLIB00010142826,-14.02,1123,Drug_analog,esomeprazole|omeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,SUBDBMMJDZJVOS-UHFFFAOYSA-N
CCMSLIB00012723484,related spectra of 'omeprazole (delta mass:-14.02)',CCMSLIB00000078131|CCMSLIB00000079070|CCMSLIB00005772836|CCMSLIB00006680003|CCMSLIB00010138456|CCMSLIB00010142823,-14.02,1124,Drug_analog,omeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,SUBDBMMJDZJVOS-UHFFFAOYSA-N
CCMSLIB00012723485,"related spectra of 'paroxetine (delta mass:2.01)', 'paroxetine (delta mass:2.02)'",CCMSLIB00000085281|CCMSLIB00000085582|CCMSLIB00000085975|CCMSLIB00000223641|CCMSLIB00000568754|CCMSLIB00000579650|CCMSLIB00000841884|CCMSLIB00003139692|CCMSLIB00005733736|CCMSLIB00005734387|CCMSLIB00005735959|CCMSLIB00005775993|CCMSLIB00005776798|CCMSLIB00005777158|CCMSLIB00006115670|CCMSLIB00006115671|CCMSLIB00006115673|CCMSLIB00006115675|CCMSLIB00006115678|CCMSLIB00006115679|CCMSLIB00006115681|CCMSLIB00006115683|CCMSLIB00006115685|CCMSLIB00006115686|CCMSLIB00006679986|CCMSLIB00010135142,2.02,1125,Drug_analog,paroxetine,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|generalized anxiety disorder (GAD)|panic disorders|posttraumatic stress disorder|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),AHOUBRCZNHFOSL-YOEHRIQHSA-N|AHOUBRCZNHFOSL-UHFFFAOYSA-N
CCMSLIB00012723486,related spectra of 'paroxetine (delta mass:2.02)',CCMSLIB00000223641|CCMSLIB00000568754|CCMSLIB00000579650|CCMSLIB00000841884|CCMSLIB00003139692|CCMSLIB00005733736|CCMSLIB00005734387|CCMSLIB00005735959|CCMSLIB00005777158|CCMSLIB00006115670|CCMSLIB00006115671|CCMSLIB00006115673|CCMSLIB00006115675|CCMSLIB00006115678|CCMSLIB00006115679|CCMSLIB00006115681|CCMSLIB00006115683|CCMSLIB00006115685|CCMSLIB00006115686|CCMSLIB00006679986|CCMSLIB00006684742|CCMSLIB00010135142|CCMSLIB00010135143|CCMSLIB00010135145|CCMSLIB00010135146,2.02,1126,Drug_analog,paroxetine,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|generalized anxiety disorder (GAD)|panic disorders|posttraumatic stress disorder|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),AHOUBRCZNHFOSL-UHFFFAOYSA-N|AHOUBRCZNHFOSL-YOEHRIQHSA-N
CCMSLIB00012723487,related spectra of 'oxybutynin (delta mass:-26.02)',CCMSLIB00000006548,-26.02,1127,Drug_analog,oxybutynin,anticholinergic,urology,urinary incontinence,acetylcholine receptor antagonist,XIQVNETUBQGFHX-UHFFFAOYSA-N
CCMSLIB00012723488,related spectra of 'bnc210 (delta mass:14.96)',CCMSLIB00010131015,14.96,1128,Drug_analog,bnc210,no_match,no_match,no_match,no_match,BVRPESWOSNFUCJ-LKTVYLICSA-N
CCMSLIB00012723489,related spectra of 'oglufanide (delta mass:-0.98)',CCMSLIB00010152307|CCMSLIB00010152309|CCMSLIB00010152310,-0.98,1129,Drug_analog|Low_confidence,oglufanide,no_match,NA,NA,VEGF antagonist,LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723490,"related spectra of 'golotimod (delta mass:-0.98)', 'oglufanide (delta mass:-0.98)'",CCMSLIB00010133731|CCMSLIB00010133733|CCMSLIB00010133734|CCMSLIB00010152307|CCMSLIB00010152308,-0.98,1130,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723491,related spectra of 'ilomastat (delta mass:-56.06)',CCMSLIB00010144088,-56.06,1131,Drug_analog,ilomastat,no_match,NA,NA,matrix metalloprotease inhibitor,NITYDPDXAAFEIT-DYVFJYSZSA-N
CCMSLIB00012723492,related spectra of 'ingenol mebutate (delta mass:2.0)',CCMSLIB00010122574,2,1132,Drug_analog,ingenol mebutate,inducer of cell death,dermatology,keratosis,PKC activator,VEBVPUXQAPLADL-POYOOMFHSA-N
CCMSLIB00012723493,related spectra of 'exemestane (delta mass:36.02)',CCMSLIB00000208693|CCMSLIB00000208694|CCMSLIB00000208699|CCMSLIB00000208700,36.02,1133,Drug_analog,exemestane,aromatase inhibitor,oncology,breast cancer,aromatase inhibitor,BFYIZQONLCFLEV-UHFFFAOYSA-N
CCMSLIB00012723494,related spectra of 'testosterone propionate (delta mass:-12.04)',CCMSLIB00000206429|CCMSLIB00005771142,-12.04,1134,Drug_analog|Low_confidence,testosterone propionate,androgen,endocrinology,hypogonadism,androgen receptor agonist,PDMMFKSKQVNJMI-UHFFFAOYSA-N
CCMSLIB00012723495,related spectra of 'oxandrolone (delta mass:27.99)',CCMSLIB00005723841,27.99,1135,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012723496,related spectra of 'drostanolone (delta mass:63.98)',CCMSLIB00005723750,63.98,1136,Drug_analog|Low_confidence,drostanolone,no_match,no_match,no_match,no_match,FDGQIVOIHOIMNK-TZAHHXAYSA-N
CCMSLIB00012723497,"related spectra of 'methyltestosterone (delta mass:29.97)', 'hydroxyprogesterone caproate (delta mass:1.98)', 'desoxycorticosterone acetate (delta mass:-40.03)'",CCMSLIB00005463881|CCMSLIB00005761260|CCMSLIB00005765522|CCMSLIB00005765990|CCMSLIB00005775092|CCMSLIB00006116102|CCMSLIB00006116104|CCMSLIB00006116106|CCMSLIB00006116107|CCMSLIB00006116109|CCMSLIB00006680013|CCMSLIB00006685047|CCMSLIB00010106289|CCMSLIB00010117628|CCMSLIB00010117629,29.97|1.98|-40.03,1137,Drug_analog|Low_confidence,desoxycorticosterone acetate|hydroxyprogesterone caproate|methyltestosterone,no_match|progestin|androgen,NA|obstetrics/gynecology|endocrinology|oncology,NA|spontaneous preterm birth|hypogonadism|breast cancer,mineralocorticoid receptor agonist|progesterone receptor agonist|androgen receptor agonist,VPGRYOFKCNULNK-ACXQXYJUSA-N|DBPWSSGDRRHUNT-CEGNMAFCSA-N|GCKMFJBGXUYNAG-HLXURNFRSA-N|DBPWSSGDRRHUNT-SJFWLOONSA-N
CCMSLIB00012723498,related spectra of 'oxymetholone (delta mass:15.96)',CCMSLIB00005723847,15.96,1138,Drug_analog,oxymetholone,androstan derivatives,hematology,anemia,androgen receptor agonist,YKELUTWGCGLPTM-WBNQDIJOSA-N
CCMSLIB00012723499,related spectra of 'testosterone propionate (delta mass:-12.0)',CCMSLIB00000206428|CCMSLIB00005763797|CCMSLIB00005766327|CCMSLIB00005771357,-12,1139,Drug_analog|Low_confidence,testosterone propionate,androgen,endocrinology,hypogonadism,androgen receptor agonist,PDMMFKSKQVNJMI-UHFFFAOYSA-N|PDMMFKSKQVNJMI-BLQWBTBKSA-N
CCMSLIB00012723500,"related spectra of 'hydroxyprogesterone caproate (delta mass:2.02)', 'hydroxyprogesterone caproate (delta mass:2.01)', 'testosterone propionate (delta mass:-12.0)', 'methyltestosterone (delta mass:30.01)'",CCMSLIB00000206428|CCMSLIB00003139033|CCMSLIB00005761260|CCMSLIB00005762182|CCMSLIB00005763167|CCMSLIB00005763640|CCMSLIB00005763797|CCMSLIB00005765522|CCMSLIB00005765990|CCMSLIB00005766327|CCMSLIB00005767206|CCMSLIB00005771357|CCMSLIB00005776268|CCMSLIB00006116102|CCMSLIB00006116104|CCMSLIB00006116106|CCMSLIB00006116107|CCMSLIB00006116109|CCMSLIB00010138236|CCMSLIB00010138238,2.02|-12.00|30.01,1140,Drug_analog|Low_confidence,testosterone propionate|hydroxyprogesterone caproate|methyltestosterone,androgen|progestin,endocrinology|obstetrics/gynecology|oncology,hypogonadism|spontaneous preterm birth|breast cancer,androgen receptor agonist|progesterone receptor agonist,PDMMFKSKQVNJMI-UHFFFAOYSA-N|DBPWSSGDRRHUNT-CEGNMAFCSA-N|GCKMFJBGXUYNAG-HLXURNFRSA-N|PDMMFKSKQVNJMI-BLQWBTBKSA-N|DBPWSSGDRRHUNT-UHFFFAOYSA-N|DBPWSSGDRRHUNT-SJFWLOONSA-N
CCMSLIB00012723501,related spectra of 'medroxyprogesterone (delta mass:-12.0)',CCMSLIB00006119397|CCMSLIB00006119398|CCMSLIB00006119400|CCMSLIB00006119402|CCMSLIB00006119405|CCMSLIB00010118137|CCMSLIB00010150390|CCMSLIB00010150391|CCMSLIB00010150392,-12,1141,Drug_analog|Low_confidence,medroxyprogesterone,progestin,obstetrics/gynecology,contraceptive,progesterone receptor agonist,FRQMUZJSZHZSGN-HBNHAYAOSA-N
CCMSLIB00012723502,related spectra of 'mesterolone (delta mass:27.99)',CCMSLIB00005723783,27.99,1142,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723503,"related spectra of 'hydroxyprogesterone caproate (delta mass:2.02)', 'testosterone propionate (delta mass:-12.0)'",CCMSLIB00000206429|CCMSLIB00005771142|CCMSLIB00006116106|CCMSLIB00006116109,2.02|-12.00,1143,Drug_analog|Low_confidence,testosterone propionate|hydroxyprogesterone caproate,androgen|progestin,endocrinology|obstetrics/gynecology,hypogonadism|spontaneous preterm birth,androgen receptor agonist|progesterone receptor agonist,PDMMFKSKQVNJMI-UHFFFAOYSA-N|DBPWSSGDRRHUNT-SJFWLOONSA-N
CCMSLIB00012723504,related spectra of 'dronabinol (delta mass:18.01)',CCMSLIB00005772180,18.01,1144,Drug_analog,dronabinol,cannabinoid,gastroenterology|neurology/psychiatry,anorexia|weight loss|nausea|vomiting,cannabinoid receptor agonist,CYQFCXCEBYINGO-UHFFFAOYSA-N
CCMSLIB00012723505,related spectra of 'mesterolone (delta mass:28.03)',CCMSLIB00005723783,28.03,1145,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723506,related spectra of 'meloxicam (delta mass:-15.98)',CCMSLIB00005763047|CCMSLIB00006117609|CCMSLIB00006117625,-15.98,1146,Drug_analog,meloxicam,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis,cyclooxygenase inhibitor,ZRVUJXDFFKFLMG-UHFFFAOYSA-N
CCMSLIB00012723507,related spectra of 'flumazenil (delta mass:30.01)',CCMSLIB00000078915|CCMSLIB00003138354,30.01,1147,Drug_analog,flumazenil,benzodiazepine antagonist,neurology/psychiatry,reverse sedative effects of benzodiazepines,benzodiazepine receptor antagonist,OFBIFZUFASYYRE-UHFFFAOYSA-N
CCMSLIB00012723508,"related spectra of 9-(4'-aminophenyl)-3,7-dihydroxy-2,4,6-trimethyl-9-oxo-nonoic acid (delta mass:-4.0), 9-(4'-aminophenyl)-3,7-dihydroxy-2,4,6-trimethyl-9-oxo-nonoic acid (delta mass:-3.99)",CCMSLIB00005463708,-3.99,1148,Drug_analog,"9-(4'-aminophenyl)-3,7-dihydroxy-2,4,6-trimethyl-9-oxo-nonoic acid",polyene antifungal,infectious disease,vulvovaginal candidiasis,fungal ergosterol inhibitor,UHZAKFDEIOBYGZ-UHFFFAOYSA-N
CCMSLIB00012723509,related spectra of 'benzododecinium (delta mass:29.97)',CCMSLIB00010152444,29.97,1149,Drug_analog,benzododecinium,no_match,no_match,no_match,no_match,CYDRXTMLKJDRQH-UHFFFAOYSA-N
CCMSLIB00012723510,related spectra of 'griseofulvin (delta mass:-15.99)',CCMSLIB00004692131,-15.99,1150,Drug_analog,griseofulvin,tubulin inhibiting agent,infectious disease,ringworm|tinea pedis|fungal infections,tubulin polymerization inhibitor,DDUHZTYCFQRHIY-RBHXEPJQSA-N
CCMSLIB00012723511,related spectra of 'griseofulvin (delta mass:-15.98)',CCMSLIB00004692131,-15.98,1151,Drug_analog,griseofulvin,tubulin inhibiting agent,infectious disease,ringworm|tinea pedis|fungal infections,tubulin polymerization inhibitor,DDUHZTYCFQRHIY-RBHXEPJQSA-N
CCMSLIB00012723512,"related spectra of 'golotimod (delta mass:0.98)', 'golotimod (delta mass:1.0)'",CCMSLIB00010133731|CCMSLIB00010133733|CCMSLIB00010133734,1,1152,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723513,related spectra of 'forskolin (delta mass:-76.03)',CCMSLIB00006555747,-76.03,1153,Drug_analog,forskolin,no_match,NA,NA,adenylyl cyclase activator,OHCQJHSOBUTRHG-KGGHGJDLSA-N
CCMSLIB00012723514,related spectra of 'forskolin (delta mass:-76.03)',CCMSLIB00006555747,-76.03,1154,Drug_analog,forskolin,no_match,NA,NA,adenylyl cyclase activator,OHCQJHSOBUTRHG-KGGHGJDLSA-N
CCMSLIB00012723515,related spectra of 'forskolin (delta mass:-76.03)',CCMSLIB00006555747,-76.03,1155,Drug_analog,forskolin,no_match,NA,NA,adenylyl cyclase activator,OHCQJHSOBUTRHG-KGGHGJDLSA-N
CCMSLIB00012723516,related spectra of 'ethylestrenol (delta mass:63.98)',CCMSLIB00005723752,63.98,1156,Drug_analog,ethylestrenol,no_match,no_match,no_match,no_match,GUBNWXDDDXQJOQ-VIVHBNLFSA-N
CCMSLIB00012723517,related spectra of 'mesterolone (delta mass:30.01)',CCMSLIB00005723783,30.01,1157,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723518,related spectra of 'mesterolone (delta mass:30.01)',CCMSLIB00005723783,30.01,1158,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723519,related spectra of 'mesterolone (delta mass:30.01)',CCMSLIB00005723783,30.01,1159,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723520,related spectra of 'oglufanide (delta mass:2.02)',CCMSLIB00010152307,2.02,1160,Drug_analog|Low_confidence,oglufanide,no_match,NA,NA,VEGF antagonist,LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723521,related spectra of 'golotimod (delta mass:2.0)',CCMSLIB00010133731|CCMSLIB00010133733,2,1161,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723522,related spectra of 'mycophenolic acid (delta mass:15.97)',CCMSLIB00000079956,15.97,1162,Drug_analog,mycophenolic acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-RUDMXATFSA-N
CCMSLIB00012723523,related spectra of 'acitretin (delta mass:-12.04)',CCMSLIB00006444164,-12.04,1163,Drug_analog,acitretin,retinoid,dermatology,psoriasis,retinoid receptor agonist,IHUNBGSDBOWDMA-AQFIFDHZSA-N
CCMSLIB00012723524,related spectra of 'yohimbine (delta mass:-18.01)',CCMSLIB00000084808|CCMSLIB00000085214|CCMSLIB00004702542|CCMSLIB00005740133|CCMSLIB00005742990|CCMSLIB00005746347|CCMSLIB00005748113|CCMSLIB00005748772|CCMSLIB00005749678|CCMSLIB00005749701,-18.01,1164,Drug_analog,yohimbine,drugs used in erectile dysfunction,urology,erectile dysfunction,adrenergic receptor antagonist,BLGXFZZNTVWLAY-DKJBZYCGSA-N|BLGXFZZNTVWLAY-SCYLSFHTSA-N|BLGXFZZNTVWLAY-UHFFFAOYSA-N
CCMSLIB00012723525,related spectra of 'methyltestosterone (delta mass:34.01)',CCMSLIB00005767206,34.01,1165,Drug_analog|Low_confidence,methyltestosterone,androgen,endocrinology|oncology,hypogonadism|breast cancer,androgen receptor agonist,GCKMFJBGXUYNAG-HLXURNFRSA-N
CCMSLIB00012723526,related spectra of 'enoxolone (delta mass:-116.06)',CCMSLIB00010118337,-116.06,1166,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723527,related spectra of 'enoxolone (delta mass:-116.06)',CCMSLIB00010118337,-116.06,1167,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723528,related spectra of 'boldenone undecylenate (delta mass:-116.06)',CCMSLIB00000206053|CCMSLIB00005771284,-116.06,1168,Drug_analog,boldenone undecylenate,no_match,no_match,no_match,no_match,AHMMSNQYOPMLSX-UHFFFAOYSA-N
CCMSLIB00012723529,related spectra of 'thiamphenicol (delta mass:-18.01)',CCMSLIB00000078520|CCMSLIB00000568422|CCMSLIB00005734116,-18.01,1169,Drug_analog,thiamphenicol,amphenicol class antibacterial|veterinary,infectious disease,gram-positive bacterial infections|gram-negative bacterial infections,bacterial 50S ribosomal subunit inhibitor,OTVAEFIXJLOWRX-NXEZZACHSA-N|OTVAEFIXJLOWRX-UHFFFAOYSA-N
CCMSLIB00012723530,"related spectra of 'fentanyl (delta mass:1.0)', 'fentanyl (delta mass:1.01)'",CCMSLIB00003135084|CCMSLIB00003135626|CCMSLIB00003136417|CCMSLIB00003139043|CCMSLIB00003140014,1,1170,Drug_analog,fentanyl,opioid agonist,neurology/psychiatry,analgesia|anesthesia|pain,opioid receptor agonist,PJMPHNIQZUBGLI-UHFFFAOYSA-N
CCMSLIB00012723531,related spectra of 'ampelopsin (delta mass:18.01)',CCMSLIB00005723303,18.01,1171,Drug_analog,ampelopsin,no_match,NA,NA,NA,KJXSIXMJHKAJOD-LSDHHAIUSA-N
CCMSLIB00012723532,related spectra of 'n(4)-acetylsulfadimethoxine (delta mass:-14.02)',CCMSLIB00000207724|CCMSLIB00005773542,-14.02,1172,Drug_analog|Background/QAQC,n(4)-acetylsulfadimethoxine,sulfonamide antimicrobial|veterinary,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,dihydropteroate synthetase inhibitor,DQWIIKBKAIPUPY-UHFFFAOYSA-N
CCMSLIB00012723533,related spectra of 'n(4)-acetylsulfadimethoxine (delta mass:-14.02)',CCMSLIB00005773542,-14.02,1173,Drug_analog|Background/QAQC,n(4)-acetylsulfadimethoxine,sulfonamide antimicrobial|veterinary,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,dihydropteroate synthetase inhibitor,DQWIIKBKAIPUPY-UHFFFAOYSA-N
CCMSLIB00012723534,related spectra of 'lactulose (delta mass:-1.98)',CCMSLIB00006122286|CCMSLIB00006122288|CCMSLIB00006122290|CCMSLIB00006122293|CCMSLIB00006122295,-1.98,1174,Drug_analog|Low_confidence,lactulose,osmotic laxative,gastroenterology,portal-systemic encephalopathy (PSE)|constipation,laxative,JCQLYHFGKNRPGE-FCVZTGTOSA-N
CCMSLIB00012723535,related spectra of 'citalopram (delta mass:14.02)',CCMSLIB00000212094|CCMSLIB00000212111|CCMSLIB00000212121|CCMSLIB00000223793|CCMSLIB00000223794|CCMSLIB00006119351|CCMSLIB00006119353|CCMSLIB00006119355|CCMSLIB00006119357|CCMSLIB00006119359|CCMSLIB00006119361|CCMSLIB00006119362|CCMSLIB00006119363,14.02,1175,Drug_analog,citalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-UHFFFAOYSA-N
CCMSLIB00012723536,related spectra of 'methylprednisolone (delta mass:-36.02)',CCMSLIB00000004249|CCMSLIB00000077142|CCMSLIB00000077143|CCMSLIB00000078262|CCMSLIB00000205977|CCMSLIB00000205978|CCMSLIB00000209912|CCMSLIB00000209914|CCMSLIB00000209925|CCMSLIB00000209927|CCMSLIB00003134513|CCMSLIB00005764487|CCMSLIB00005764667|CCMSLIB00005765301|CCMSLIB00005771125|CCMSLIB00005771350|CCMSLIB00005773160|CCMSLIB00005773360|CCMSLIB00005773492|CCMSLIB00005773815|CCMSLIB00005773963|CCMSLIB00005774455|CCMSLIB00005774642|CCMSLIB00005774986|CCMSLIB00005775546|CCMSLIB00005776619|CCMSLIB00010152455|CCMSLIB00010152457|CCMSLIB00010152458,-36.02,1176,Drug_analog,methylprednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,VHRSUDSXCMQTMA-PJHHCJLFSA-N|VHRSUDSXCMQTMA-UHFFFAOYSA-N
CCMSLIB00012723537,related spectra of 'exemestane (delta mass:42.01)',CCMSLIB00000208693|CCMSLIB00000208699,42.01,1177,Drug_analog,exemestane,aromatase inhibitor,oncology,breast cancer,aromatase inhibitor,BFYIZQONLCFLEV-UHFFFAOYSA-N
CCMSLIB00012723538,related spectra of 'methylprednisolone (delta mass:-36.02)',CCMSLIB00000205979|CCMSLIB00000209931|CCMSLIB00005760179|CCMSLIB00005771544|CCMSLIB00005774544|CCMSLIB00010152455|CCMSLIB00010152456,-36.02,1178,Drug_analog,methylprednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,VHRSUDSXCMQTMA-UHFFFAOYSA-N|VHRSUDSXCMQTMA-PJHHCJLFSA-N
CCMSLIB00012723539,related spectra of 'docosanol (delta mass:13.98)',CCMSLIB00004702726|CCMSLIB00004702727,13.98,1179,Drug_analog,docosanol,antivirals,infectious disease,cold sore|herpes labialis,lipase clearing factor inhibitor,NOPFSRXAKWQILS-UHFFFAOYSA-N
CCMSLIB00012723540,related spectra of 'florfenicol (delta mass:-18.01)',CCMSLIB00005730219,-18.01,1180,Drug_analog,florfenicol,amphenicol class antibacterial|veterinary,infectious disease,bovine respiratory disease (BRD),protein synthesis inhibitor,AYIRNRDRBQJXIF-UHFFFAOYSA-N
CCMSLIB00012723541,related spectra of 'famotidine (delta mass:2.0)',CCMSLIB00000078422,2,1181,Drug_analog,famotidine,histamine-2 (H2) receptor antagonist,gastroenterology,heartburn|gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|gastric ulcers,histamine receptor antagonist,XUFQPHANEAPEMJ-UHFFFAOYSA-N
CCMSLIB00012723542,"related spectra of 'canrenone (delta mass:1.0)', 'canrenone (delta mass:1.01)'",CCMSLIB00005774283,1,1182,Drug_analog,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012723543,"related spectra of 'hydroquinine (delta mass:13.98)', 'quinine (delta mass:15.99)', 'hydroquinidine (delta mass:13.98)'",CCMSLIB00000004259|CCMSLIB00004719333|CCMSLIB00010150477|CCMSLIB00010150480,13.98|15.99,1183,Drug_analog,quinine|hydroquinidine|hydroquinine,antimalarial|antiarrhythmic,infectious disease|cardiology,malaria|cardiac arrythmia,hemozoin biocrystallization inhibitor|antiarrhythmic,LOUPRKONTZGTKE-WZBLMQSHSA-N|LJOQGZACKSYWCH-LHHVKLHASA-N|LJOQGZACKSYWCH-WZBLMQSHSA-N
CCMSLIB00012723544,related spectra of 'perindopril (delta mass:-28.03)',CCMSLIB00000206310|CCMSLIB00005735037|CCMSLIB00005771323|CCMSLIB00006117810|CCMSLIB00006117825|CCMSLIB00006684872|CCMSLIB00010132745|CCMSLIB00010132747|CCMSLIB00010132750,-28.03,1184,Drug_analog,perindopril|perindopril,angiotensin converting enzyme inhibitor,cardiology,hypertension|myocardial infarction|coronary artery disease (CAD),angiotensin converting enzyme inhibitor,IPVQLZZIHOAWMC-UHFFFAOYSA-N|IPVQLZZIHOAWMC-QXKUPLGCSA-N
CCMSLIB00012723545,related spectra of 'perindopril (delta mass:-28.03)',CCMSLIB00000085419,-28.03,1185,Drug_analog,perindopril,angiotensin converting enzyme inhibitor,cardiology,hypertension|myocardial infarction|coronary artery disease (CAD),angiotensin converting enzyme inhibitor,IPVQLZZIHOAWMC-QXKUPLGCSA-N
CCMSLIB00012723546,related spectra of 'prednisolone (delta mass:-1.98)',CCMSLIB00010134090,-1.98,1186,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723547,related spectra of 'iloprost (delta mass:15.99)',CCMSLIB00010149631,15.99,1187,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723548,related spectra of 'prednisolone (delta mass:-1.98)',CCMSLIB00010134091,-1.98,1188,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723549,related spectra of 'prednisolone (delta mass:-1.98)',CCMSLIB00010134090,-1.98,1189,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723550,related spectra of 'exemestane (delta mass:44.03)',CCMSLIB00000208693|CCMSLIB00000208694|CCMSLIB00000208699|CCMSLIB00000208700,44.03,1190,Drug_analog,exemestane,aromatase inhibitor,oncology,breast cancer,aromatase inhibitor,BFYIZQONLCFLEV-UHFFFAOYSA-N
CCMSLIB00012723551,related spectra of 'mestranol (delta mass:30.01)',CCMSLIB00003140010,30.01,1191,Drug_analog,mestranol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist,IMSSROKUHAOUJS-MJCUULBUSA-N
CCMSLIB00012723552,related spectra of 'prednisolone (delta mass:-1.98)',CCMSLIB00010134091,-1.98,1192,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723553,related spectra of 'miridesap (delta mass:1.0)',CCMSLIB00010139111|CCMSLIB00010139112,1,1193,Drug_analog,miridesap,no_match,NA,NA,amyloid protein inhibitor,HZLAWYIBLZNRFZ-VXGBXAGGSA-N
CCMSLIB00012723554,related spectra of 'estradiol benzoate (delta mass:-15.98)',CCMSLIB00003138449,-15.98,1194,Drug_analog|Low_confidence,estradiol benzoate,estrogen,obstetrics/gynecology,contraceptive|menopause symptoms,estrogen receptor agonist,UYIFTLBWAOGQBI-BZDYCCQFSA-N
CCMSLIB00012723555,related spectra of 'estradiol benzoate (delta mass:-15.98)',CCMSLIB00003138449,-15.98,1195,Drug_analog|Low_confidence,estradiol benzoate,estrogen,obstetrics/gynecology,contraceptive|menopause symptoms,estrogen receptor agonist,UYIFTLBWAOGQBI-BZDYCCQFSA-N
CCMSLIB00012723556,"related spectra of 'levonorgestrel (delta mass:30.01)', 'norgestrel (delta mass:30.01)'",CCMSLIB00005761367|CCMSLIB00005765386,30.01,1196,Drug_analog,norgestrel|levonorgestrel,progestin|progestin-containing intrauterine device (IUD),obstetrics/gynecology,contraceptive,progesterone receptor agonist,WWYNJERNGUHSAO-CULCCENASA-N|WWYNJERNGUHSAO-XUDSTZEESA-N
CCMSLIB00012723557,"related spectra of 'testosterone propionate (delta mass:-2.01)', 'testosterone propionate (delta mass:-2.02)'",CCMSLIB00000206429|CCMSLIB00005763797|CCMSLIB00005771142|CCMSLIB00010138236|CCMSLIB00010138238,-2.02,1197,Drug_analog|Low_confidence,testosterone propionate,androgen,endocrinology,hypogonadism,androgen receptor agonist,PDMMFKSKQVNJMI-UHFFFAOYSA-N|PDMMFKSKQVNJMI-BLQWBTBKSA-N
CCMSLIB00012723558,"related spectra of 'levocetirizine (delta mass:-44.03)', 'cetirizine (delta mass:-44.02)', 'chlorcyclizine (delta mass:43.99)', 'levocetirizine (delta mass:-44.02)', 'cetirizine (delta mass:-44.03)'",CCMSLIB00000077127|CCMSLIB00000079138|CCMSLIB00000081597|CCMSLIB00000085591|CCMSLIB00005775156,-44.03|43.99,1198,Drug_analog,cetirizine|levocetirizine|chlorcyclizine,histamine-1 (H1) inhibitor|histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,ZKLPARSLTMPFCP-UHFFFAOYSA-N|ZKLPARSLTMPFCP-OAQYLSRUSA-N|WFNAKBGANONZEQ-UHFFFAOYSA-N
CCMSLIB00012723559,"related spectra of 'levocetirizine (delta mass:-44.02)', 'cetirizine (delta mass:-44.03)', 'levocetirizine (delta mass:-44.03)', 'cetirizine n-oxide (delta mass:-60.02)'",CCMSLIB00000077127|CCMSLIB00000078089|CCMSLIB00000079138|CCMSLIB00000081597|CCMSLIB00000568104|CCMSLIB00005730259|CCMSLIB00005775156,-44.03|-60.02,1199,Drug_analog,cetirizine|levocetirizine|cetirizine n-oxide,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,ZKLPARSLTMPFCP-UHFFFAOYSA-N|ZKLPARSLTMPFCP-OAQYLSRUSA-N|IVDOUUOLLFEMJQ-UHFFFAOYSA-N
CCMSLIB00012723560,"related spectra of 'prednisolone (delta mass:-16.0)', 'prednisolone (delta mass:-15.99)'",CCMSLIB00005772281|CCMSLIB00005775451|CCMSLIB00006117499,-15.99,1200,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723561,related spectra of 'cortisone acetate (delta mass:-15.99)',CCMSLIB00000570072|CCMSLIB00004719904|CCMSLIB00005734900|CCMSLIB00005768231|CCMSLIB00005769455,-15.99,1201,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012723562,related spectra of 'iloprost (delta mass:2.0)',CCMSLIB00010149637,2,1202,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723563,related spectra of 'dalcetrapib (delta mass:-45.02)',CCMSLIB00010133899|CCMSLIB00010133900,-45.02,1203,Drug_analog,dalcetrapib,no_match,NA,NA,cholesteryl ester transfer protein inhibitor,YZQLWPMZQVHJED-UHFFFAOYSA-N
CCMSLIB00012723564,"related spectra of 'hydroxyprogesterone caproate (delta mass:14.01)', 'hydroxyprogesterone caproate (delta mass:14.02)'",CCMSLIB00003139033,14.02,1204,Drug_analog|Low_confidence,hydroxyprogesterone caproate,progestin,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DBPWSSGDRRHUNT-CEGNMAFCSA-N
CCMSLIB00012723565,"related spectra of 'desoxycorticosterone acetate (delta mass:-27.99)', 'hydroxyprogesterone caproate (delta mass:14.02)'",CCMSLIB00005763167|CCMSLIB00005765990|CCMSLIB00006116104|CCMSLIB00006116106|CCMSLIB00006116109|CCMSLIB00006685047,-27.99|14.02,1205,Drug_analog|Low_confidence,hydroxyprogesterone caproate|desoxycorticosterone acetate,progestin|no_match,obstetrics/gynecology|NA,spontaneous preterm birth|NA,progesterone receptor agonist|mineralocorticoid receptor agonist,DBPWSSGDRRHUNT-CEGNMAFCSA-N|DBPWSSGDRRHUNT-SJFWLOONSA-N|VPGRYOFKCNULNK-ACXQXYJUSA-N
CCMSLIB00012723566,related spectra of 'hydroxyprogesterone caproate (delta mass:14.02)',CCMSLIB00005776268,14.02,1206,Drug_analog|Low_confidence,hydroxyprogesterone caproate,progestin,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DBPWSSGDRRHUNT-UHFFFAOYSA-N
CCMSLIB00012723567,related spectra of 'hydroxyprogesterone caproate (delta mass:14.02)',CCMSLIB00003139033,14.02,1207,Drug_analog|Low_confidence,hydroxyprogesterone caproate,progestin,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DBPWSSGDRRHUNT-CEGNMAFCSA-N
CCMSLIB00012723568,related spectra of 'hydroxyprogesterone caproate (delta mass:14.02)',CCMSLIB00006116109,14.02,1208,Drug_analog|Low_confidence,hydroxyprogesterone caproate,progestin,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DBPWSSGDRRHUNT-SJFWLOONSA-N
CCMSLIB00012723569,related spectra of 'hydroxyprogesterone caproate (delta mass:14.02)',CCMSLIB00005765990|CCMSLIB00006116102|CCMSLIB00006116104|CCMSLIB00006116106|CCMSLIB00006116107|CCMSLIB00006116109,14.02,1209,Drug_analog|Low_confidence,hydroxyprogesterone caproate,progestin,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DBPWSSGDRRHUNT-CEGNMAFCSA-N|DBPWSSGDRRHUNT-SJFWLOONSA-N
CCMSLIB00012723570,related spectra of 'hydroxyprogesterone caproate (delta mass:14.02)',CCMSLIB00003139033,14.02,1210,Drug_analog|Low_confidence,hydroxyprogesterone caproate,progestin,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DBPWSSGDRRHUNT-CEGNMAFCSA-N
CCMSLIB00012723571,"related spectra of 'enrofloxacin (delta mass:-14.01)', 'enrofloxacin (delta mass:-14.02)'",CCMSLIB00000078564|CCMSLIB00000079094,-14.02,1211,Drug_analog,enrofloxacin,fluoroquinolone antimicrobial|veterinary,infectious disease,gram-negative bacterial infections,bacterial DNA gyrase inhibitor,SPFYMRJSYKOXGV-UHFFFAOYSA-N
CCMSLIB00012723572,"related spectra of 'bnc210 (delta mass:27.99)', 'bnc210 (delta mass:28.0)', 'golotimod (delta mass:12.04)'",CCMSLIB00010131015|CCMSLIB00010133731,27.99|12.04,1212,Drug_analog|Low_confidence,bnc210|golotimod,no_match,no_match,no_match,no_match,BVRPESWOSNFUCJ-LKTVYLICSA-N|CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723573,related spectra of 'latanoprostene bunod (delta mass:-162.05)',CCMSLIB00010139230|CCMSLIB00010139231,-162.05,1213,Drug_analog,latanoprostene bunod,prostaglandin analogues,ophthalmology,intraocular pressure|glaucoma,prostaglandin receptor agonist,LOVMMUBRQUFEAH-UIEAZXIASA-N
CCMSLIB00012723574,related spectra of 'cortisone acetate (delta mass:-13.98)',CCMSLIB00000566981|CCMSLIB00005730548,-13.98,1214,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012723575,"related spectra of 'levonorgestrel (delta mass:34.01)', 'norgestrel (delta mass:34.01)'",CCMSLIB00005761367|CCMSLIB00005765386,34.01,1215,Drug_analog,norgestrel|levonorgestrel,progestin|progestin-containing intrauterine device (IUD),obstetrics/gynecology,contraceptive,progesterone receptor agonist,WWYNJERNGUHSAO-CULCCENASA-N|WWYNJERNGUHSAO-XUDSTZEESA-N
CCMSLIB00012723576,related spectra of 'cortisone acetate (delta mass:-13.98)',CCMSLIB00005768231|CCMSLIB00006117788|CCMSLIB00006117794|CCMSLIB00006684982,-13.98,1216,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012723577,related spectra of 'cortisone acetate (delta mass:-13.98)',CCMSLIB00004691593|CCMSLIB00004691594|CCMSLIB00004704960|CCMSLIB00004719902|CCMSLIB00004719903|CCMSLIB00005463901|CCMSLIB00005767404|CCMSLIB00005769009|CCMSLIB00005773029|CCMSLIB00005775173|CCMSLIB00006117786|CCMSLIB00006117788|CCMSLIB00006117790|CCMSLIB00006117792|CCMSLIB00006117794|CCMSLIB00006581899|CCMSLIB00006680084|CCMSLIB00006684982,-13.98,1217,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012723578,related spectra of 'methylprednisolone (delta mass:-27.99)',CCMSLIB00005772603,-27.99,1218,Drug_analog,methylprednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,VHRSUDSXCMQTMA-PJHHCJLFSA-N
CCMSLIB00012723579,related spectra of 'cephradine (delta mass:-2.02)',CCMSLIB00010114615|CCMSLIB00010125945,-2.02,1219,Drug_analog,cephradine,cephalosporin antibacterial,infectious disease,respiratory tract infections|otitis|skin infections|urinary tract infections|tonsillitis|pharyngitis|pneumonia,bacterial cell wall synthesis inhibitor,RDLPVSKMFDYCOR-UEKVPHQBSA-N
CCMSLIB00012723580,related spectra of 'cephradine (delta mass:-2.02)',CCMSLIB00010114615|CCMSLIB00010125945,-2.02,1220,Drug_analog,cephradine,cephalosporin antibacterial,infectious disease,respiratory tract infections|otitis|skin infections|urinary tract infections|tonsillitis|pharyngitis|pneumonia,bacterial cell wall synthesis inhibitor,RDLPVSKMFDYCOR-UEKVPHQBSA-N
CCMSLIB00012723581,related spectra of 'cephradine (delta mass:-2.02)',CCMSLIB00010114615|CCMSLIB00010125945,-2.02,1221,Drug_analog,cephradine,cephalosporin antibacterial,infectious disease,respiratory tract infections|otitis|skin infections|urinary tract infections|tonsillitis|pharyngitis|pneumonia,bacterial cell wall synthesis inhibitor,RDLPVSKMFDYCOR-UEKVPHQBSA-N
CCMSLIB00012723582,related spectra of 'cephradine (delta mass:-2.02)',CCMSLIB00010114615,-2.02,1222,Drug_analog,cephradine,cephalosporin antibacterial,infectious disease,respiratory tract infections|otitis|skin infections|urinary tract infections|tonsillitis|pharyngitis|pneumonia,bacterial cell wall synthesis inhibitor,RDLPVSKMFDYCOR-UEKVPHQBSA-N
CCMSLIB00012723583,"related spectra of 'ofloxacin (delta mass:-14.02)', 'levofloxacin (delta mass:-14.02)'",CCMSLIB00000005823|CCMSLIB00000005825|CCMSLIB00000076983|CCMSLIB00000078156|CCMSLIB00000084770|CCMSLIB00000085846|CCMSLIB00000223633|CCMSLIB00003135908|CCMSLIB00004722092|CCMSLIB00005732545|CCMSLIB00005734458|CCMSLIB00005734991|CCMSLIB00005775375|CCMSLIB00005775480|CCMSLIB00010142006,-14.02,1223,Drug_analog,levofloxacin|ofloxacin,fluoroquinolone antimicrobial,infectious disease,pneumonia|sinusitis|bronchitis|skin infections|prostatitis|urinary tract infections|pyelonephritis|anthrax|plague|gram-negative bacterial infections|gram-positive bacterial infections,bacterial DNA gyrase inhibitor,GSDSWSVVBLHKDQ-JTQLQIEISA-N|GSDSWSVVBLHKDQ-UHFFFAOYSA-N
CCMSLIB00012723584,"related spectra of 'golotimod (delta mass:14.02)', 'golotimod (delta mass:14.01)'",CCMSLIB00010133731|CCMSLIB00010133733|CCMSLIB00010133734,14.02,1224,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723585,related spectra of 'oxandrolone (delta mass:43.04)',CCMSLIB00005723841,43.04,1225,Drug_analog,oxandrolone,androstan derivatives,endocrinology,weight gain,androgen receptor agonist,CCCXHTHETXUUDU-REBFHUNPSA-N
CCMSLIB00012723586,related spectra of 'quinine (delta mass:1.94)',CCMSLIB00006381955,1.94,1226,Drug_analog,quinine,antimalarial,infectious disease,malaria,hemozoin biocrystallization inhibitor,LOUPRKONTZGTKE-WZBLMQSHSA-N
CCMSLIB00012723587,related spectra of 'sodium tetradecyl sulfate (delta mass:15.0)',CCMSLIB00004716402|CCMSLIB00004716403,15,1227,Drug_analog,sodium tetradecyl sulfate,sclerosing agents for local injection,dermatology,varicose veins,sclerosing agent,URLJMZWTXZTZRR-UHFFFAOYSA-N
CCMSLIB00012723588,related spectra of 'sodium tetradecyl sulfate (delta mass:15.0)',CCMSLIB00004716402|CCMSLIB00004716403,15,1228,Drug_analog,sodium tetradecyl sulfate,sclerosing agents for local injection,dermatology,varicose veins,sclerosing agent,URLJMZWTXZTZRR-UHFFFAOYSA-N
CCMSLIB00012723589,related spectra of 'cortisone acetate (delta mass:-12.0)',CCMSLIB00004704962,-12,1229,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012723590,related spectra of 'medroxyprogesterone (delta mass:4.03)',CCMSLIB00005772799|CCMSLIB00005774602,4.03,1230,Drug_analog|Low_confidence,medroxyprogesterone,progestin,obstetrics/gynecology,contraceptive,progesterone receptor agonist,FRQMUZJSZHZSGN-HBNHAYAOSA-N
CCMSLIB00012723591,related spectra of 'sertraline (delta mass:43.99)',CCMSLIB00003135311|CCMSLIB00003140022|CCMSLIB00005776039,43.99,1231,Drug_analog,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012723592,"related spectra of 'hydroxychloroquine (delta mass:13.98)', 'chloroquine (delta mass:29.97)'",CCMSLIB00005772675|CCMSLIB00005774546|CCMSLIB00005776717|CCMSLIB00006678621|CCMSLIB00006684827|CCMSLIB00010138313|CCMSLIB00010138314|CCMSLIB00010138315|CCMSLIB00010138316|CCMSLIB00010138318|CCMSLIB00010138319|CCMSLIB00010139363|CCMSLIB00010139364|CCMSLIB00010139365|CCMSLIB00010148903|CCMSLIB00010148904|CCMSLIB00010148905,13.98|29.97,1232,Drug_analog,hydroxychloroquine|chloroquine,antirheumatic|antimalarial,infectious disease|rheumatology,malaria|rheumatoid arthritis|lupus|amebiasis,antimalarial agent,XXSMGPRMXLTPCZ-UHFFFAOYSA-N|WHTVZRBIWZFKQO-UHFFFAOYSA-N
CCMSLIB00012723593,related spectra of 'chloroquine (delta mass:29.97)',CCMSLIB00010148904,29.97,1233,Drug_analog,chloroquine,antimalarial,infectious disease,malaria|amebiasis,antimalarial agent,WHTVZRBIWZFKQO-UHFFFAOYSA-N
CCMSLIB00012723594,"related spectra of 'hydroxychloroquine (delta mass:13.98)', 'chloroquine (delta mass:29.97)', 'chloroquine (delta mass:29.98)'",CCMSLIB00005772675|CCMSLIB00005774546|CCMSLIB00005776717|CCMSLIB00006678777|CCMSLIB00010138313|CCMSLIB00010138314|CCMSLIB00010138316|CCMSLIB00010138319|CCMSLIB00010139364|CCMSLIB00010148903|CCMSLIB00010148904,13.98|29.97,1234,Drug_analog,hydroxychloroquine|chloroquine,antirheumatic|antimalarial,infectious disease|rheumatology,malaria|rheumatoid arthritis|lupus|amebiasis,antimalarial agent,XXSMGPRMXLTPCZ-UHFFFAOYSA-N|WHTVZRBIWZFKQO-UHFFFAOYSA-N
CCMSLIB00012723595,"related spectra of 'chloroquine (delta mass:29.97)', 'chloroquine (delta mass:29.98)'",CCMSLIB00010139364|CCMSLIB00010148904,29.97,1235,Drug_analog,chloroquine,antimalarial,infectious disease,malaria|amebiasis,antimalarial agent,WHTVZRBIWZFKQO-UHFFFAOYSA-N
CCMSLIB00012723596,related spectra of 'golotimod (delta mass:17.03)',CCMSLIB00010133730|CCMSLIB00010133731,17.03,1236,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723597,related spectra of 'spectinomycin (delta mass:18.01)',CCMSLIB00000206373|CCMSLIB00005771428,18.01,1237,Drug_analog,spectinomycin,other antibacterials,infectious disease,gram-positive bacterial infections|gram-negative bacterial infections|gonorrhea,bacterial 30S ribosomal subunit inhibitor,UNFWWIHTNXNPBV-UHFFFAOYSA-N
CCMSLIB00012723598,related spectra of 'hydroxychloroquine (delta mass:15.98)',CCMSLIB00005772570,15.97,1238,Drug_analog,hydroxychloroquine,antirheumatic|antimalarial,infectious disease|rheumatology,malaria|rheumatoid arthritis|lupus,antimalarial agent,XXSMGPRMXLTPCZ-UHFFFAOYSA-N
CCMSLIB00012723599,"related spectra of 'donepezil (delta mass:-28.04)', 'donepezil (delta mass:-28.03)'",CCMSLIB00000084865|CCMSLIB00010145522|CCMSLIB00010145525|CCMSLIB00010145528|CCMSLIB00010148762|CCMSLIB00010148765|CCMSLIB00010148768,-28.03,1239,Drug_analog,donepezil,acetylcholinesterase inhibitor,neurology/psychiatry,Alzheimer's disease,acetylcholinesterase inhibitor,ADEBPBSSDYVVLD-UHFFFAOYSA-N
CCMSLIB00012723600,related spectra of 'sulfadoxine (delta mass:42.01)',CCMSLIB00000085245|CCMSLIB00000562756|CCMSLIB00005774153,42.01,1240,Drug_analog|Background/QAQC,sulfadoxine,sulfonamide,infectious disease,malaria,dihydropteroate synthase inhibitor,PJSFRIWCGOHTNF-UHFFFAOYSA-N
CCMSLIB00012723601,"related spectra of 'quinidine (delta mass:27.99)', 'quinine (delta mass:27.99)', 'quinine (delta mass:28.0)', 'quinidine (delta mass:28.0)'",CCMSLIB00004691123|CCMSLIB00004691189|CCMSLIB00004698847|CCMSLIB00004720018|CCMSLIB00004720019|CCMSLIB00005744890|CCMSLIB00005760509|CCMSLIB00006380604|CCMSLIB00006380654|CCMSLIB00006380945|CCMSLIB00006390780|CCMSLIB00006399815|CCMSLIB00006400011|CCMSLIB00006555534|CCMSLIB00006555560|CCMSLIB00006555586|CCMSLIB00006555638|CCMSLIB00006555664|CCMSLIB00006555690|CCMSLIB00006559564|CCMSLIB00006559591|CCMSLIB00006559618|CCMSLIB00006559645|CCMSLIB00006569297|CCMSLIB00010115318|CCMSLIB00010115321,27.99,1241,Drug_analog,quinidine|quinine,antimalarial|antiarrhythmic,infectious disease|cardiology,malaria|atrial fibrillation (AF)|ventricular arrhythmias,sodium channel blocker|hemozoin biocrystallization inhibitor,LOUPRKONTZGTKE-LHHVKLHASA-N|LOUPRKONTZGTKE-WZBLMQSHSA-N|LOUPRKONTZGTKE-USWSZDBUSA-N|LOUPRKONTZGTKE-VPCNSNALSA-N|LOUPRKONTZGTKE-UHFFFAOYSA-N
CCMSLIB00012723602,related spectra of 'doxapram (delta mass:-26.02)',CCMSLIB00000078631|CCMSLIB00000079081,-26.02,1242,Drug_analog,doxapram,respiratory stimulant,pulmonary|critical care,respiratory depression|central nervous system depression|acute hypercapnia (AHC),potassium channel blocker,XFDJYSQDBULQSI-UHFFFAOYSA-N
CCMSLIB00012723603,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149632,28.03,1243,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723604,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149632,28.03,1244,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723605,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149632,28.03,1245,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723606,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149632,28.03,1246,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723607,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149632,28.03,1247,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723608,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149632,28.03,1248,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723609,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149632,28.03,1249,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723610,related spectra of 'meloxicam (delta mass:2.0)',CCMSLIB00000078263,2,1250,Drug_analog,meloxicam,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis,cyclooxygenase inhibitor,ZRVUJXDFFKFLMG-UHFFFAOYSA-N
CCMSLIB00012723611,related spectra of 'famotidine (delta mass:15.99)',CCMSLIB00003136498,15.99,1251,Drug_analog,famotidine,histamine-2 (H2) receptor antagonist,gastroenterology,heartburn|gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|gastric ulcers,histamine receptor antagonist,XUFQPHANEAPEMJ-UHFFFAOYSA-N
CCMSLIB00012723612,related spectra of 'griseofulvin (delta mass:1.0)',CCMSLIB00004692138|CCMSLIB00004692139|CCMSLIB00004693977,1,1252,Drug_analog,griseofulvin,tubulin inhibiting agent,infectious disease,ringworm|tinea pedis|fungal infections,tubulin polymerization inhibitor,DDUHZTYCFQRHIY-RBHXEPJQSA-N
CCMSLIB00012723613,related spectra of 'itraconazole (delta mass:1.0)',CCMSLIB00000079018,1,1253,Drug_analog,itraconazole,azole antifungal,infectious disease,onychomycosis|histoplasmosis|blastomycosis|aspergillosis,lanosterol 14-alpha-demethylase inhibitor,VHVPQPYKVGDNFY-ZPGVKDDISA-N
CCMSLIB00012723614,related spectra of 'enilconazole (delta mass:58.0)',CCMSLIB00005761372|CCMSLIB00005762391|CCMSLIB00005763251|CCMSLIB00005765701|CCMSLIB00005776835,58.01,1254,Drug_analog,enilconazole,veterinary,infectious disease,dermatophytosis,sterol demethylase inhibitor,PZBPKYOVPCNPJY-UHFFFAOYSA-N
CCMSLIB00012723615,related spectra of 'griseofulvin (delta mass:2.0)',CCMSLIB00003136177|CCMSLIB00003138467|CCMSLIB00004692138|CCMSLIB00004692139|CCMSLIB00004693977|CCMSLIB00004693978|CCMSLIB00005727285|CCMSLIB00010107610|CCMSLIB00010118944|CCMSLIB00010120635,2,1255,Drug_analog,griseofulvin,tubulin inhibiting agent,infectious disease,ringworm|tinea pedis|fungal infections,tubulin polymerization inhibitor,DDUHZTYCFQRHIY-RBHXEPJQSA-N|DDUHZTYCFQRHIY-UHFFFAOYSA-N
CCMSLIB00012723616,related spectra of 'denatonium (delta mass:29.97)',CCMSLIB00010151223,29.97,1256,Drug_analog,denatonium,no_match,NA,NA,NA,ZFQMTVNLDNXRNQ-UHFFFAOYSA-O
CCMSLIB00012723617,related spectra of 'drospirenone (delta mass:-11.96)',CCMSLIB00005776034,-11.96,1257,Drug_analog,drospirenone,progestin,obstetrics/gynecology,contraceptive,mineralocorticoid receptor antagonist|progesterone receptor agonist,METQSPRSQINEEU-HXCATZOESA-N
CCMSLIB00012723618,related spectra of 'iloprost (delta mass:12.04)',CCMSLIB00010149637,12.04,1258,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723619,related spectra of 'iloprost (delta mass:12.04)',CCMSLIB00010149637,12.04,1259,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723620,related spectra of 'iloprost (delta mass:12.04)',CCMSLIB00010149637,12.04,1260,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723621,related spectra of 'enoxolone (delta mass:-116.08)',CCMSLIB00010118331,-116.08,1261,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723622,related spectra of 'iloprost (delta mass:12.04)',CCMSLIB00010149637,12.04,1262,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723623,related spectra of 'iloprost (delta mass:12.04)',CCMSLIB00010149637,12.04,1263,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723624,related spectra of 'enoxolone (delta mass:-116.06)',CCMSLIB00004704575,-116.06,1264,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723625,related spectra of 'enoxolone (delta mass:-116.06)',CCMSLIB00000566736|CCMSLIB00005736117,-116.06,1265,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723626,related spectra of 'quetiapine sulfoxide (delta mass:-44.03)',CCMSLIB00010135508,-44.03,1266,Drug_analog,quetiapine sulfoxide,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,FXJNLPUSSHEDON-UHFFFAOYSA-N
CCMSLIB00012723627,related spectra of 'isocorydine (delta mass:14.02)',CCMSLIB00010146655|CCMSLIB00010146656|CCMSLIB00010146658|CCMSLIB00010146661,14.02,1267,Drug_analog,isocorydine,no_match,no_match,no_match,no_match,QELDJEKNFOQJOY-ZDUSSCGKSA-N
CCMSLIB00012723628,related spectra of 'isocorydine (delta mass:14.02)',CCMSLIB00010146655|CCMSLIB00010146656|CCMSLIB00010146658|CCMSLIB00010146661,14.02,1268,Drug_analog,isocorydine,no_match,no_match,no_match,no_match,QELDJEKNFOQJOY-ZDUSSCGKSA-N
CCMSLIB00012723629,related spectra of 'isocorydine (delta mass:14.02)',CCMSLIB00010146655,14.02,1269,Drug_analog,isocorydine,no_match,no_match,no_match,no_match,QELDJEKNFOQJOY-ZDUSSCGKSA-N
CCMSLIB00012723630,related spectra of 'isocorydine (delta mass:14.02)',CCMSLIB00010146655,14.02,1270,Drug_analog,isocorydine,no_match,no_match,no_match,no_match,QELDJEKNFOQJOY-ZDUSSCGKSA-N
CCMSLIB00012723631,"related spectra of 'methylprednisolone acetate (delta mass:-60.02)', 'methylprednisolone (delta mass:-18.01)', 'methylprednisolone hemisuccinate (delta mass:-100.02)'",CCMSLIB00000004249|CCMSLIB00000077109|CCMSLIB00000077110|CCMSLIB00000077142|CCMSLIB00000077143|CCMSLIB00000078262|CCMSLIB00000085437|CCMSLIB00000085960|CCMSLIB00000205977|CCMSLIB00000205978|CCMSLIB00000209912|CCMSLIB00000209914|CCMSLIB00000209925|CCMSLIB00000209927|CCMSLIB00003134513|CCMSLIB00005764487|CCMSLIB00005764667|CCMSLIB00005771125|CCMSLIB00005771350|CCMSLIB00005773160|CCMSLIB00005773360|CCMSLIB00005773492|CCMSLIB00005773815|CCMSLIB00005773963|CCMSLIB00005774455|CCMSLIB00005774642|CCMSLIB00005774986|CCMSLIB00005775546|CCMSLIB00005776619|CCMSLIB00010130494|CCMSLIB00010142695|CCMSLIB00010152454|CCMSLIB00010152455|CCMSLIB00010152457|CCMSLIB00010152458,-60.02|-18.01|-100.02,1271,Drug_analog,methylprednisolone|methylprednisolone acetate|methylprednisolone hemisuccinate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,VHRSUDSXCMQTMA-PJHHCJLFSA-N|PLBHSZGDDKCEHR-LFYFAGGJSA-N|VHRSUDSXCMQTMA-UHFFFAOYSA-N|IMBXEJJVJRTNOW-XYMSELFBSA-N
CCMSLIB00012723632,"related spectra of 'levonorgestrel (delta mass:43.99)', 'cortisone acetate (delta mass:-4.0)', 'norgestrel (delta mass:43.99)'",CCMSLIB00000566981|CCMSLIB00005730548|CCMSLIB00005761367|CCMSLIB00005765386,43.99|-4.00,1272,Drug_analog,cortisone acetate|norgestrel|levonorgestrel,corticosteroid|progestin|progestin-containing intrauterine device (IUD),dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|obstetrics/gynecology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended|contraceptive,glucocorticoid receptor agonist|progesterone receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N|WWYNJERNGUHSAO-CULCCENASA-N|WWYNJERNGUHSAO-XUDSTZEESA-N
CCMSLIB00012723633,related spectra of 'iloprost (delta mass:13.98)',CCMSLIB00010149636,13.98,1273,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723634,related spectra of 'methylprednisolone (delta mass:-18.01)',CCMSLIB00005774231|CCMSLIB00005774737|CCMSLIB00005775365,-18.01,1274,Drug_analog,methylprednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,VHRSUDSXCMQTMA-PJHHCJLFSA-N
CCMSLIB00012723635,related spectra of 'methylprednisolone (delta mass:-18.01)',CCMSLIB00000205976|CCMSLIB00005771378|CCMSLIB00010152457,-18.01,1275,Drug_analog,methylprednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,VHRSUDSXCMQTMA-UHFFFAOYSA-N|VHRSUDSXCMQTMA-PJHHCJLFSA-N
CCMSLIB00012723636,"related spectra of 'methylprednisolone (delta mass:-18.01)', 'methylprednisolone hemisuccinate (delta mass:-100.02)'",CCMSLIB00000004249|CCMSLIB00000077142|CCMSLIB00000077143|CCMSLIB00000078262|CCMSLIB00000205977|CCMSLIB00000205978|CCMSLIB00000209912|CCMSLIB00000209925|CCMSLIB00000209927|CCMSLIB00003134513|CCMSLIB00005764667|CCMSLIB00005765301|CCMSLIB00005771125|CCMSLIB00005771350|CCMSLIB00005773492|CCMSLIB00005773815|CCMSLIB00005773963|CCMSLIB00005774231|CCMSLIB00005774455|CCMSLIB00005774642|CCMSLIB00005774737|CCMSLIB00005775365|CCMSLIB00005775546|CCMSLIB00010130494|CCMSLIB00010152457|CCMSLIB00010152458,-18.01|-100.02,1276,Drug_analog,methylprednisolone|methylprednisolone hemisuccinate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,VHRSUDSXCMQTMA-PJHHCJLFSA-N|VHRSUDSXCMQTMA-UHFFFAOYSA-N|IMBXEJJVJRTNOW-XYMSELFBSA-N
CCMSLIB00012723637,related spectra of 'rimexolone (delta mass:-13.98)',CCMSLIB00000085638,-13.98,1277,Drug_analog,rimexolone,corticosteroid,ophthalmology,anterior uveitis,glucocorticoid receptor agonist,QTTRZHGPGKRAFB-OOKHYKNYSA-N
CCMSLIB00012723638,related spectra of 'fursultiamine (delta mass:-40.03)',CCMSLIB00010141022,-40.03,1278,Drug_analog,fursultiamine,"vitamin B1, plain",metabolism,thiamine deficiency,vitamin B1 derivate,JTLXCMOFVBXEKD-FOWTUZBSSA-N
CCMSLIB00012723639,related spectra of 'cortisone acetate (delta mass:-2.02)',CCMSLIB00005768751|CCMSLIB00005769455,-2.02,1279,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012723640,"related spectra of 'prednisolone (delta mass:-1.98)', 'prednisolone (delta mass:16.03)'",CCMSLIB00000004492|CCMSLIB00006117499|CCMSLIB00010134090,-1.98|16.03,1280,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723641,related spectra of 'desoxycorticosterone acetate (delta mass:-14.02)',CCMSLIB00006685047,-14.02,1281,Drug_analog|Low_confidence,desoxycorticosterone acetate,no_match,NA,NA,mineralocorticoid receptor agonist,VPGRYOFKCNULNK-ACXQXYJUSA-N
CCMSLIB00012723642,related spectra of 'canrenone (delta mass:18.01)',CCMSLIB00005772583,18.01,1282,Drug_analog,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012723643,related spectra of 'iloprost (delta mass:16.03)',CCMSLIB00010149637,16.03,1283,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723644,related spectra of 'iloprost (delta mass:16.03)',CCMSLIB00010149637,16.03,1284,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723645,related spectra of 'iloprost (delta mass:16.03)',CCMSLIB00010149636,16.03,1285,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723646,related spectra of 'iloprost (delta mass:16.03)',CCMSLIB00010149636,16.03,1286,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723647,"related spectra of 'testosterone propionate (delta mass:14.02)', 'hydroxyprogesterone caproate (delta mass:28.03)', 'desoxycorticosterone acetate (delta mass:-13.98)'",CCMSLIB00003139033|CCMSLIB00005463881|CCMSLIB00006116102|CCMSLIB00006116104|CCMSLIB00006116106|CCMSLIB00006116107|CCMSLIB00006116109|CCMSLIB00006680013|CCMSLIB00006685047|CCMSLIB00010106289|CCMSLIB00010106290|CCMSLIB00010138236|CCMSLIB00010138238,14.02|28.03|-13.98,1287,Drug_analog|Low_confidence,hydroxyprogesterone caproate|desoxycorticosterone acetate|testosterone propionate,progestin|no_match|androgen,obstetrics/gynecology|NA|endocrinology,spontaneous preterm birth|NA|hypogonadism,progesterone receptor agonist|mineralocorticoid receptor agonist|androgen receptor agonist,DBPWSSGDRRHUNT-CEGNMAFCSA-N|VPGRYOFKCNULNK-ACXQXYJUSA-N|DBPWSSGDRRHUNT-SJFWLOONSA-N|PDMMFKSKQVNJMI-BLQWBTBKSA-N
CCMSLIB00012723648,related spectra of 'iloprost (delta mass:16.03)',CCMSLIB00010149636,16.03,1288,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723649,related spectra of 'bnc210 (delta mass:42.01)',CCMSLIB00010131015,42.01,1289,Drug_analog,bnc210,no_match,no_match,no_match,no_match,BVRPESWOSNFUCJ-LKTVYLICSA-N
CCMSLIB00012723650,"related spectra of 'cinchocaine (delta mass:16.0)', 'dibucaine (delta mass:16.0)', 'cinchocaine (delta mass:15.99)', 'dibucaine (delta mass:15.99)'",CCMSLIB00000078632|CCMSLIB00000085301|CCMSLIB00003135532|CCMSLIB00005753678|CCMSLIB00010138121|CCMSLIB00010138122|CCMSLIB00010143314,15.99,1290,Drug_analog,cinchocaine|dibucaine,amide local anesthetic,neurology/psychiatry,local anesthetic,sodium channel blocker,PUFQVTATUTYEAL-UHFFFAOYSA-N
CCMSLIB00012723651,related spectra of 'cetirizine n-oxide (delta mass:-44.03)',CCMSLIB00000567911|CCMSLIB00000568104|CCMSLIB00005730259|CCMSLIB00005731105|CCMSLIB00005773644,-44.03,1291,Drug_analog,cetirizine n-oxide,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,IVDOUUOLLFEMJQ-UHFFFAOYSA-N
CCMSLIB00012723652,related spectra of 'papaverine (delta mass:-0.98)',CCMSLIB00006401693,-0.98,1292,Drug_analog,papaverine,drugs used in erectile dysfunction|papaverine and derivatives,cardiology|gastroenterology|urology,myocardial infarction|angina pectoris|pulmonary embolism (PE)|colitis|vascular spasm|erectile dysfunction,phosphodiesterase inhibitor,XQYZDYMELSJDRZ-UHFFFAOYSA-N
CCMSLIB00012723653,related spectra of 'enrofloxacin (delta mass:1.0)',CCMSLIB00000078564|CCMSLIB00000079094,1,1293,Drug_analog,enrofloxacin,fluoroquinolone antimicrobial|veterinary,infectious disease,gram-negative bacterial infections,bacterial DNA gyrase inhibitor,SPFYMRJSYKOXGV-UHFFFAOYSA-N
CCMSLIB00012723654,related spectra of 'oxymetholone (delta mass:43.99)',CCMSLIB00005723847,43.99,1294,Drug_analog,oxymetholone,androstan derivatives,hematology,anemia,androgen receptor agonist,YKELUTWGCGLPTM-WBNQDIJOSA-N
CCMSLIB00012723655,related spectra of 'iloprost (delta mass:18.01)',CCMSLIB00010149637,18.01,1295,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723656,related spectra of 'desoxycorticosterone acetate (delta mass:-12.0)',CCMSLIB00006685047,-12,1296,Drug_analog|Low_confidence,desoxycorticosterone acetate,no_match,NA,NA,mineralocorticoid receptor agonist,VPGRYOFKCNULNK-ACXQXYJUSA-N
CCMSLIB00012723657,related spectra of 'lovastatin (delta mass:-44.03)',CCMSLIB00000565954|CCMSLIB00000566920|CCMSLIB00005736563,-44.03,1297,Drug_analog,lovastatin,HMG-CoA reductase inhibitor (statin),endocrinology|cardiology|neurology/psychiatry,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,PCZOHLXUXFIOCF-BXMDZJJMSA-N
CCMSLIB00012723658,"related spectra of 'hydrocortisone acetate (delta mass:-43.99)', 'canrenone (delta mass:20.03)'",CCMSLIB00005772742|CCMSLIB00005775230,-43.99|20.03,1298,Drug_analog,hydrocortisone acetate|canrenone,corticosteroid|aldosterone antagonist,dermatology|endocrinology|cardiology,corticosteroid-responsive dermatoses|hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,glucocorticoid receptor agonist|mineralocorticoid receptor antagonist,ALEXXDVDDISNDU-JZYPGELDSA-N|UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012723659,related spectra of 'iloprost (delta mass:18.01)',CCMSLIB00010149636,18.01,1299,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723660,related spectra of 'lovastatin (delta mass:-44.03)',CCMSLIB00000566933|CCMSLIB00005733700,-44.03,1300,Drug_analog,lovastatin,HMG-CoA reductase inhibitor (statin),endocrinology|cardiology|neurology/psychiatry,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,PCZOHLXUXFIOCF-BXMDZJJMSA-N
CCMSLIB00012723661,related spectra of 'hydrocortisone acetate (delta mass:-43.99)',CCMSLIB00005772742,-43.99,1301,Drug_analog,hydrocortisone acetate,corticosteroid,dermatology,corticosteroid-responsive dermatoses,glucocorticoid receptor agonist,ALEXXDVDDISNDU-JZYPGELDSA-N
CCMSLIB00012723662,related spectra of 'lovastatin (delta mass:-44.03)',CCMSLIB00000566933|CCMSLIB00004693622|CCMSLIB00005733700,-44.03,1302,Drug_analog,lovastatin,HMG-CoA reductase inhibitor (statin),endocrinology|cardiology|neurology/psychiatry,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,PCZOHLXUXFIOCF-BXMDZJJMSA-N
CCMSLIB00012723663,related spectra of 'hydrocortisone acetate (delta mass:-43.99)',CCMSLIB00005772742,-43.99,1303,Drug_analog,hydrocortisone acetate,corticosteroid,dermatology,corticosteroid-responsive dermatoses,glucocorticoid receptor agonist,ALEXXDVDDISNDU-JZYPGELDSA-N
CCMSLIB00012723664,related spectra of 'medroxyprogesterone (delta mass:16.03)',CCMSLIB00006119397|CCMSLIB00010150390,16.03,1304,Drug_analog|Low_confidence,medroxyprogesterone,progestin,obstetrics/gynecology,contraceptive,progesterone receptor agonist,FRQMUZJSZHZSGN-HBNHAYAOSA-N
CCMSLIB00012723665,"related spectra of 'omeprazole (delta mass:15.99)', 'omeprazole (delta mass:16.0)'",CCMSLIB00005773533|CCMSLIB00006680003|CCMSLIB00010142826,15.99,1305,Drug_analog,omeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,SUBDBMMJDZJVOS-UHFFFAOYSA-N
CCMSLIB00012723666,related spectra of 'mesterolone (delta mass:57.02)',CCMSLIB00005723783,57.02,1306,Drug_analog|Low_confidence,mesterolone,no_match,no_match,no_match,no_match,UXYRZJKIQKRJCF-ZRCUWBMESA-N
CCMSLIB00012723667,related spectra of 'cortisone acetate (delta mass:2.02)',CCMSLIB00000570072|CCMSLIB00000570329|CCMSLIB00004691593|CCMSLIB00004691594|CCMSLIB00004704960|CCMSLIB00004704961|CCMSLIB00004704962|CCMSLIB00004719902|CCMSLIB00004719903|CCMSLIB00004719904|CCMSLIB00005463901|CCMSLIB00005720592|CCMSLIB00005730069|CCMSLIB00005734864|CCMSLIB00005734900|CCMSLIB00005767404|CCMSLIB00005767915|CCMSLIB00005768751|CCMSLIB00005769009|CCMSLIB00005769455|CCMSLIB00005775173|CCMSLIB00006117786|CCMSLIB00006117788|CCMSLIB00006117790|CCMSLIB00006117792|CCMSLIB00006117794|CCMSLIB00006581899|CCMSLIB00006680084|CCMSLIB00006680090|CCMSLIB00006684982|CCMSLIB00006685085,2.02,1307,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012723668,related spectra of 'cortisone acetate (delta mass:2.02)',CCMSLIB00005463901|CCMSLIB00005767404,2.02,1308,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012723669,related spectra of 'hydrocortisone acetate (delta mass:-42.01)',CCMSLIB00005774590,-42.01,1309,Drug_analog,hydrocortisone acetate,corticosteroid,dermatology,corticosteroid-responsive dermatoses,glucocorticoid receptor agonist,ALEXXDVDDISNDU-JZYPGELDSA-N
CCMSLIB00012723670,related spectra of 'cortisone acetate (delta mass:2.02)',CCMSLIB00006117788|CCMSLIB00006117790|CCMSLIB00006117794,2.02,1310,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012723671,related spectra of 'cortisone acetate (delta mass:2.02)',CCMSLIB00000570072|CCMSLIB00004691593|CCMSLIB00004691594|CCMSLIB00004704960|CCMSLIB00004704961|CCMSLIB00004719904|CCMSLIB00005463901|CCMSLIB00005726279|CCMSLIB00005726418|CCMSLIB00005726583|CCMSLIB00005734864|CCMSLIB00005734900|CCMSLIB00005768751|CCMSLIB00005769455|CCMSLIB00005772623|CCMSLIB00005775173|CCMSLIB00006117788|CCMSLIB00006117790|CCMSLIB00006117792|CCMSLIB00006680084|CCMSLIB00006680090,2.02,1311,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012723672,related spectra of 'cortisone acetate (delta mass:2.02)',CCMSLIB00005769009,2.02,1312,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012723673,related spectra of 'boldenone undecylenate (delta mass:-90.05)',CCMSLIB00000206054|CCMSLIB00000206055|CCMSLIB00005771239|CCMSLIB00005771390|CCMSLIB00010145787,-90.05,1313,Drug_analog,boldenone undecylenate|boldenone undecylenate,no_match,no_match,no_match,no_match,AHMMSNQYOPMLSX-UHFFFAOYSA-N|AHMMSNQYOPMLSX-CNQKSJKFSA-N
CCMSLIB00012723674,related spectra of 'betulinic acid (delta mass:-76.03)',CCMSLIB00010124192,-76.03,1314,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012723675,related spectra of 'bezafibrate (delta mass:2.0)',CCMSLIB00005774494,2,1315,Drug_analog,bezafibrate,fibrates|peroxisome proliferator-activated receptor (PPAR) alpha agonist,cardiology|endocrinology,hypertriglyceridemia|hypercholesterolemia|hyperlipidemia,PPAR receptor agonist,IIBYAHWJQTYFKB-UHFFFAOYSA-N
CCMSLIB00012723676,related spectra of 'nifedipine (delta mass:17.03)',CCMSLIB00000078299|CCMSLIB00006116119|CCMSLIB00006116121|CCMSLIB00006116122|CCMSLIB00006116124|CCMSLIB00006116126|CCMSLIB00006116137|CCMSLIB00006116139|CCMSLIB00006679891|CCMSLIB00006684628,17.03,1316,Drug_analog,nifedipine,dihydropyridine calcium channel blocker,cardiology,vasospastic angina|chronic stable angina|hypertension,calcium channel blocker,HYIMSNHJOBLJNT-UHFFFAOYSA-N
CCMSLIB00012723677,related spectra of 'protirelin (delta mass:0.98)',CCMSLIB00010143639|CCMSLIB00010143640|CCMSLIB00010143642,0.98,1317,Drug_analog,protirelin,tests for thyreoidea function,radiology,thyroid function diagnostic,thyrotropin releasing hormone receptor agonist,XNSAINXGIQZQOO-SRVKXCTJSA-N
CCMSLIB00012723678,related spectra of 'protirelin (delta mass:2.02)',CCMSLIB00010143640,2.02,1318,Drug_analog,protirelin,tests for thyreoidea function,radiology,thyroid function diagnostic,thyrotropin releasing hormone receptor agonist,XNSAINXGIQZQOO-SRVKXCTJSA-N
CCMSLIB00012723679,related spectra of 'prednisolone (delta mass:4.03)',CCMSLIB00000004492,4.03,1319,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723680,related spectra of 'medroxyprogesterone (delta mass:20.03)',CCMSLIB00005772799|CCMSLIB00005773306|CCMSLIB00006119397|CCMSLIB00006119398|CCMSLIB00006119400|CCMSLIB00006119402|CCMSLIB00010118137,20.03,1320,Drug_analog|Low_confidence,medroxyprogesterone,progestin,obstetrics/gynecology,contraceptive,progesterone receptor agonist,FRQMUZJSZHZSGN-HBNHAYAOSA-N
CCMSLIB00012723681,related spectra of 'ampicillin (delta mass:15.99)',CCMSLIB00000206023|CCMSLIB00005771194|CCMSLIB00006120799,15.99,1321,Drug_analog,ampicillin,penicillin class antibacterial,infectious disease,respiratory tract infections|meningitis|bacterial septicemia|endocarditis|urinary tract infections|gastrointestinal infections,bacterial cell wall synthesis inhibitor,AVKUERGKIZMTKX-UHFFFAOYSA-N|AVKUERGKIZMTKX-NJBDSQKTSA-N
CCMSLIB00012723682,related spectra of 'bumetanide (delta mass:1.0)',CCMSLIB00000006153|CCMSLIB00000077072|CCMSLIB00000078087|CCMSLIB00010141470|CCMSLIB00010141472|CCMSLIB00010141475|CCMSLIB00010141495|CCMSLIB00010141496|CCMSLIB00010141498|CCMSLIB00010141501|CCMSLIB00010141562|CCMSLIB00010141564,1,1322,Drug_analog,bumetanide,loop diuretic,cardiology|nephrology,edema|congestive heart failure|renal impairment,solute carrier family member inhibitor,MAEIEVLCKWDQJH-UHFFFAOYSA-N
CCMSLIB00012723683,related spectra of '69227-93-6 (delta mass:-162.05)',CCMSLIB00010133714,-162.05,1323,Drug_analog,69227-93-6,no_match,no_match,no_match,no_match,NLEBIOOXCVAHBD-QKMCSOCLSA-N
CCMSLIB00012723684,related spectra of '69227-93-6 (delta mass:-162.05)',CCMSLIB00010133715|CCMSLIB00010133716,-162.05,1324,Drug_analog,69227-93-6,no_match,no_match,no_match,no_match,NLEBIOOXCVAHBD-QKMCSOCLSA-N
CCMSLIB00012723685,related spectra of '69227-93-6 (delta mass:-162.05)',CCMSLIB00010133715|CCMSLIB00010133716,-162.05,1325,Drug_analog,69227-93-6,no_match,no_match,no_match,no_match,NLEBIOOXCVAHBD-QKMCSOCLSA-N
CCMSLIB00012723686,"related spectra of 'meloxicam (delta mass:15.99)', 'meloxicam (delta mass:16.0)'",CCMSLIB00000085125|CCMSLIB00000085195|CCMSLIB00000085709|CCMSLIB00003135226|CCMSLIB00003136594,15.99,1326,Drug_analog,meloxicam,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis,cyclooxygenase inhibitor,ZRVUJXDFFKFLMG-UHFFFAOYSA-N
CCMSLIB00012723687,"related spectra of 'meloxicam (delta mass:15.99)', 'meloxicam (delta mass:16.0)'",CCMSLIB00000077137|CCMSLIB00000078263|CCMSLIB00000085125|CCMSLIB00003135226|CCMSLIB00003136594|CCMSLIB00005774340,15.99,1327,Drug_analog,meloxicam,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis,cyclooxygenase inhibitor,ZRVUJXDFFKFLMG-UHFFFAOYSA-N
CCMSLIB00012723688,related spectra of 'pantoprazole (delta mass:2.02)',CCMSLIB00010138629|CCMSLIB00010138632|CCMSLIB00010142390|CCMSLIB00010142393,2.02,1328,Drug_analog,pantoprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|erosive esophagitis (EE)|Zollinger-Ellison syndrome,ATPase inhibitor,IQPSEEYGBUAQFF-UHFFFAOYSA-N
CCMSLIB00012723689,"related spectra of 'lactulose (delta mass:27.99)', 'lactulose (delta mass:28.0)'",CCMSLIB00006122286|CCMSLIB00006122288|CCMSLIB00006122290|CCMSLIB00006122293|CCMSLIB00006122295,27.99,1329,Drug_analog|Low_confidence,lactulose,osmotic laxative,gastroenterology,portal-systemic encephalopathy (PSE)|constipation,laxative,JCQLYHFGKNRPGE-FCVZTGTOSA-N
CCMSLIB00012723690,"related spectra of 'mestranol (delta mass:58.0)', 'mestranol (delta mass:58.01)'",CCMSLIB00003140010,58.01,1330,Drug_analog,mestranol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist,IMSSROKUHAOUJS-MJCUULBUSA-N
CCMSLIB00012723691,related spectra of 'neoandrographolide (delta mass:-129.08)',CCMSLIB00010147145,-129.08,1331,Drug_analog,neoandrographolide,no_match,no_match,no_match,no_match,YGCYRQKJYWQXHG-RDNQFMDVSA-N
CCMSLIB00012723692,"related spectra of 'lactulose (delta mass:-16.0)', 'lactulose (delta mass:30.01)'",CCMSLIB00006122276|CCMSLIB00006122278|CCMSLIB00006122280|CCMSLIB00006122282|CCMSLIB00006122284|CCMSLIB00006122286|CCMSLIB00006122288|CCMSLIB00006122290|CCMSLIB00006122293|CCMSLIB00006122295|CCMSLIB00006679951|CCMSLIB00006684532,-15.99|30.01,1332,Drug_analog|Low_confidence,lactulose,osmotic laxative,gastroenterology,portal-systemic encephalopathy (PSE)|constipation,laxative,JCQLYHFGKNRPGE-FCVZTGTOSA-N
CCMSLIB00012723693,related spectra of 'iloprost (delta mass:27.99)',CCMSLIB00010149637,27.99,1333,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723694,"related spectra of 'desoxycorticosterone acetate (delta mass:-1.98)', 'hydroxyprogesterone caproate (delta mass:-58.04)'",CCMSLIB00005766981|CCMSLIB00006680013|CCMSLIB00006685047|CCMSLIB00010106290,-1.98|-58.04,1334,Drug_analog|Low_confidence,hydroxyprogesterone caproate|desoxycorticosterone acetate,no_match,obstetrics/gynecology|NA,spontaneous preterm birth|NA,progesterone receptor agonist|mineralocorticoid receptor agonist,DOMWKUIIPQCAJU-LJHIYBGHSA-N|VPGRYOFKCNULNK-ACXQXYJUSA-N
CCMSLIB00012723695,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1335,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723696,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1336,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723697,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1337,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723698,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1338,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723699,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1339,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723700,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1340,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723701,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1341,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723702,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1342,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723703,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1343,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723704,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1344,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723705,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1345,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723706,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1346,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723707,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1347,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723708,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1348,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723709,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1349,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723710,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1350,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723711,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1351,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723712,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1352,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723713,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1353,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723714,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1354,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723715,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1355,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723716,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1356,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723717,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1357,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723718,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1358,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723719,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1359,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723720,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637|CCMSLIB00010149638,28.03,1360,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723721,related spectra of 'hydroxyprogesterone caproate (delta mass:-58.04)',CCMSLIB00005764750,-58.04,1361,Drug_analog|Low_confidence,hydroxyprogesterone caproate,no_match,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DOMWKUIIPQCAJU-LJHIYBGHSA-N
CCMSLIB00012723722,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1362,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723723,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1363,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723724,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1364,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723725,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1365,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723726,related spectra of 'iloprost (delta mass:28.03)',CCMSLIB00010149637,28.03,1366,Drug_analog|Low_confidence,iloprost,prostacycline,pulmonary,pulmonary arterial hypertension (PAH),platelet aggregation inhibitor|prostanoid receptor agonist,HIFJCPQKFCZDDL-ACWOEMLNSA-N
CCMSLIB00012723727,related spectra of 'cortisone acetate (delta mass:12.0)',CCMSLIB00004704962,12,1367,Drug_analog,cortisone acetate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,MFYSYFVPBJMHGN-ZPOLXVRWSA-N
CCMSLIB00012723728,"related spectra of 'levonorgestrel (delta mass:59.98)', 'norgestrel (delta mass:59.98)'",CCMSLIB00005761367|CCMSLIB00005762795|CCMSLIB00005765386|CCMSLIB00005765387,59.98,1368,Drug_analog,norgestrel|levonorgestrel,progestin|progestin-containing intrauterine device (IUD),obstetrics/gynecology,contraceptive,progesterone receptor agonist,WWYNJERNGUHSAO-CULCCENASA-N|WWYNJERNGUHSAO-XUDSTZEESA-N
CCMSLIB00012723729,"related spectra of 'betamethasone (delta mass:-20.01)', 'dexamethasone (delta mass:-20.01)'",CCMSLIB00000077114|CCMSLIB00000214254|CCMSLIB00000215739|CCMSLIB00000841998|CCMSLIB00000842008|CCMSLIB00006112668|CCMSLIB00006112670|CCMSLIB00006112671|CCMSLIB00006112672|CCMSLIB00006680065|CCMSLIB00006680122,-20.01,1369,Drug_analog,dexamethasone|betamethasone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|otolaryngology|neurology/psychiatry|ophtalmology,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,UREBDLICKHMUKA-CXSFZGCWSA-N|UREBDLICKHMUKA-UHFFFAOYSA-N
CCMSLIB00012723730,related spectra of 'tamoxifen (delta mass:1.0)',CCMSLIB00005777055|CCMSLIB00006115749,1,1370,Drug_analog,tamoxifen,estrogen agonist/antagonist,oncology,breast cancer,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),NKANXQFJJICGDU-QPLCGJKRSA-N
CCMSLIB00012723731,related spectra of 'testosterone propionate (delta mass:28.03)',CCMSLIB00000206430|CCMSLIB00005771184,28.03,1371,Drug_analog|Low_confidence,testosterone propionate,androgen,endocrinology,hypogonadism,androgen receptor agonist,PDMMFKSKQVNJMI-UHFFFAOYSA-N
CCMSLIB00012723732,"related spectra of 'trimebutine (delta mass:-14.01)', 'trimebutine (delta mass:-14.02)'",CCMSLIB00000078427|CCMSLIB00000079022|CCMSLIB00000085393|CCMSLIB00000085943|CCMSLIB00010103930|CCMSLIB00010115263|CCMSLIB00010151014|CCMSLIB00010151015,-14.02,1372,Drug_analog,trimebutine,drugs for functional gastrointestinal disorders,gastroenterology,irritable bowel syndrome,opioid receptor agonist,LORDFXWUHHSAQU-UHFFFAOYSA-N
CCMSLIB00012723733,related spectra of 'prednisolone (delta mass:14.02)',CCMSLIB00000004492,14.02,1373,Drug_analog,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012723734,related spectra of 'terameprocol (delta mass:16.03)',CCMSLIB00003135755,16.03,1374,Drug_analog,terameprocol,no_match,NA,NA,lipoxygenase inhibitor,ORQFDHFZSMXRLM-IYBDPMFKSA-N
CCMSLIB00012723735,related spectra of 'finasteride (delta mass:2.0)',CCMSLIB00000223781,2,1375,Drug_analog,finasteride,5-alpha reductase inhibitor,dermatology|urology,male androgenetic alopecia|benign prostatic hyperplasia,5 alpha reductase inhibitor,DBEPLOCGEIEOCV-WSBQPABSSA-N
CCMSLIB00012723736,related spectra of 'golotimod (delta mass:42.01)',CCMSLIB00010133733,42.01,1376,Drug_analog|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012723737,"related spectra of 'alfuzosin (delta mass:-14.01)', 'alfuzosin (delta mass:-14.02)'",CCMSLIB00000569915|CCMSLIB00005730386|CCMSLIB00010142244|CCMSLIB00010142247|CCMSLIB00010142250|CCMSLIB00010151023|CCMSLIB00010151026,-14.02,1377,Drug_analog,alfuzosin,alpha adrenergic blocker,urology,benign prostatic hyperplasia (BPH),adrenergic receptor antagonist,WNMJYKCGWZFFKR-UHFFFAOYSA-N
CCMSLIB00012723738,related spectra of 'bimatoprost (delta mass:-21.98)',CCMSLIB00010147098,-21.98,1378,Drug_analog,bimatoprost,prostaglandin analog,ophthalmology,intraocular pressure|glaucoma|ocular hypertension,prostanoid receptor agonist,AQOKCDNYWBIDND-FTOWTWDKSA-N
CCMSLIB00012723739,related spectra of 'canrenone (delta mass:36.02)',CCMSLIB00005775230,36.02,1379,Drug_analog,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012723740,related spectra of 'latanoprost (chimeric precursor selection) (delta mass:-38.02)',CCMSLIB00010143078,-38.02,1380,Drug_analog,latanoprost (chimeric precursor selection),prostaglandin analog,ophthalmology,ocular hypertension|glaucoma,prostanoid receptor agonist,GGXICVAJURFBLW-CEYXHVGTSA-N
CCMSLIB00012723741,related spectra of 'finasteride (delta mass:4.0)',CCMSLIB00000223781,3.99,1381,Drug_analog,finasteride,5-alpha reductase inhibitor,dermatology|urology,male androgenetic alopecia|benign prostatic hyperplasia,5 alpha reductase inhibitor,DBEPLOCGEIEOCV-WSBQPABSSA-N
CCMSLIB00012723742,"related spectra of 'ramipril (delta mass:-38.02)', 'enalapril (delta mass:2.02)'",CCMSLIB00000084917|CCMSLIB00003135024,-38.02|2.02,1382,Drug_analog,enalapril|ramipril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,GBXSMTUPTTWBMN-XIRDDKMYSA-N|HDACQVRGBOVJII-JBDAPHQKSA-N
CCMSLIB00012723743,related spectra of 'octocrylene (delta mass:17.03)',CCMSLIB00000566191|CCMSLIB00000568347|CCMSLIB00000572752|CCMSLIB00000572801|CCMSLIB00000579921|CCMSLIB00000841551|CCMSLIB00005734462|CCMSLIB00005734697,17.03,1383,Drug_analog,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-LJQANCHMSA-N|FMJSMJQBSVNSBF-UHFFFAOYSA-N
CCMSLIB00012723744,"related spectra of 'octocrylene (delta mass:17.03)', 'octocrylene (delta mass:17.02)'",CCMSLIB00000077208|CCMSLIB00000579921|CCMSLIB00000841551|CCMSLIB00005775685|CCMSLIB00005775977,17.03,1384,Drug_analog,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-UHFFFAOYSA-N
CCMSLIB00012723745,"related spectra of 'octocrylene (delta mass:17.03)', 'octocrylene (delta mass:17.02)'",CCMSLIB00000077208|CCMSLIB00000572552|CCMSLIB00000579921|CCMSLIB00000841551|CCMSLIB00005733628|CCMSLIB00005775977,17.03,1385,Drug_analog,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-UHFFFAOYSA-N|FMJSMJQBSVNSBF-LJQANCHMSA-N
CCMSLIB00012723746,"related spectra of 'octocrylene (delta mass:17.03)', 'octocrylene (delta mass:17.02)'",CCMSLIB00000077208|CCMSLIB00000579921|CCMSLIB00000841551|CCMSLIB00005774938|CCMSLIB00005775977,17.03,1386,Drug_analog,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-UHFFFAOYSA-N
CCMSLIB00012723747,related spectra of 'octocrylene (delta mass:17.03)',CCMSLIB00000077208|CCMSLIB00000579921|CCMSLIB00000841551|CCMSLIB00005775977|CCMSLIB00005776664,17.03,1387,Drug_analog,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-UHFFFAOYSA-N
CCMSLIB00012723748,related spectra of 'octocrylene (delta mass:17.03)',CCMSLIB00000077208|CCMSLIB00000566191|CCMSLIB00000568347|CCMSLIB00000572752|CCMSLIB00000572801|CCMSLIB00000579921|CCMSLIB00000841551|CCMSLIB00005734462|CCMSLIB00005734697,17.03,1388,Drug_analog,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-UHFFFAOYSA-N|FMJSMJQBSVNSBF-LJQANCHMSA-N
CCMSLIB00012723749,related spectra of 'octocrylene (delta mass:17.03)',CCMSLIB00000566191|CCMSLIB00000568347|CCMSLIB00000572752|CCMSLIB00000572801|CCMSLIB00000579921|CCMSLIB00000841551|CCMSLIB00005734462|CCMSLIB00005734697,17.03,1389,Drug_analog,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-LJQANCHMSA-N|FMJSMJQBSVNSBF-UHFFFAOYSA-N
CCMSLIB00012723750,related spectra of 'octocrylene (delta mass:17.03)',CCMSLIB00005776664,17.03,1390,Drug_analog,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-UHFFFAOYSA-N
CCMSLIB00012723751,related spectra of 'ergocalciferol (delta mass:-18.01)',CCMSLIB00010114654,-18.01,1391,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723752,related spectra of 'famotidine (delta mass:42.01)',CCMSLIB00010131235,42.01,1392,Drug_analog,famotidine,histamine-2 (H2) receptor antagonist,gastroenterology,heartburn|gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|gastric ulcers,histamine receptor antagonist,XUFQPHANEAPEMJ-UHFFFAOYSA-N
CCMSLIB00012723753,related spectra of 'sulfasalazine (delta mass:-18.01)',CCMSLIB00005761266|CCMSLIB00005766836|CCMSLIB00010141136|CCMSLIB00010141137|CCMSLIB00010141138,-18.01,1393,Drug_analog,sulfasalazine,aminosalicylate,gastroenterology|rheumatology,ulcerative colitis|Crohn's disease|rheumatoid arthritis,cyclooxygenase inhibitor,NCEXYHBECQHGNR-UHFFFAOYSA-N
CCMSLIB00012723754,related spectra of 'meloxicam (delta mass:29.97)',CCMSLIB00000085125|CCMSLIB00000085195|CCMSLIB00000085709|CCMSLIB00003136594,29.97,1394,Drug_analog,meloxicam,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis,cyclooxygenase inhibitor,ZRVUJXDFFKFLMG-UHFFFAOYSA-N
CCMSLIB00012723755,related spectra of 'lactulose (delta mass:42.01)',CCMSLIB00006122286|CCMSLIB00006122288|CCMSLIB00006122290|CCMSLIB00006122293|CCMSLIB00006122295,42.01,1395,Drug_analog|Low_confidence,lactulose,osmotic laxative,gastroenterology,portal-systemic encephalopathy (PSE)|constipation,laxative,JCQLYHFGKNRPGE-FCVZTGTOSA-N
CCMSLIB00012723756,related spectra of 'ergocalciferol (delta mass:-14.02)',CCMSLIB00010125983,-14.02,1396,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723757,related spectra of 'betulinic acid (delta mass:-56.03)',CCMSLIB00010112869,-56.03,1397,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012723758,related spectra of 'pantoprazole (delta mass:18.01)',CCMSLIB00010138632|CCMSLIB00010142393,18.01,1398,Drug_analog,pantoprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|erosive esophagitis (EE)|Zollinger-Ellison syndrome,ATPase inhibitor,IQPSEEYGBUAQFF-UHFFFAOYSA-N
CCMSLIB00012723759,related spectra of 'pantoprazole (delta mass:18.01)',CCMSLIB00010138632|CCMSLIB00010142393,18.01,1399,Drug_analog,pantoprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|erosive esophagitis (EE)|Zollinger-Ellison syndrome,ATPase inhibitor,IQPSEEYGBUAQFF-UHFFFAOYSA-N
CCMSLIB00012723760,"related spectra of 'lactulose (delta mass:-1.98)', 'lactulose (delta mass:44.03)'",CCMSLIB00006122276|CCMSLIB00006122278|CCMSLIB00006122280|CCMSLIB00006122282|CCMSLIB00006122284|CCMSLIB00006122286|CCMSLIB00006122288|CCMSLIB00006122290|CCMSLIB00006122293|CCMSLIB00006122295|CCMSLIB00006679951|CCMSLIB00006684532,-1.98|44.03,1400,Drug_analog|Low_confidence,lactulose,osmotic laxative,gastroenterology,portal-systemic encephalopathy (PSE)|constipation,laxative,JCQLYHFGKNRPGE-FCVZTGTOSA-N
CCMSLIB00012723761,related spectra of 'perindopril (delta mass:15.99)',CCMSLIB00006117803|CCMSLIB00006117805|CCMSLIB00006117807|CCMSLIB00006117810|CCMSLIB00006117812|CCMSLIB00006117825|CCMSLIB00006117828|CCMSLIB00006117830|CCMSLIB00006684872|CCMSLIB00010132746|CCMSLIB00010132747|CCMSLIB00010132750,15.99,1401,Drug_analog,perindopril|perindopril,angiotensin converting enzyme inhibitor,cardiology,hypertension|myocardial infarction|coronary artery disease (CAD),angiotensin converting enzyme inhibitor,IPVQLZZIHOAWMC-QXKUPLGCSA-N
CCMSLIB00012723762,related spectra of 'desonide (delta mass:-31.99)',CCMSLIB00005774991|CCMSLIB00005777026,-31.99,1402,Drug_analog,desonide,corticosteroid,dermatology,corticosteroid-responsive dermatoses,glucocorticoid receptor agonist,WBGKWQHBNHJJPZ-LECWWXJVSA-N
CCMSLIB00012723763,related spectra of 'enoxolone (delta mass:-68.06)',CCMSLIB00010118337,-68.06,1403,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723764,related spectra of 'calpain inhibitor i (delta mass:1.98)',CCMSLIB00010136857|CCMSLIB00010136858|CCMSLIB00010136860|CCMSLIB00010136861,1.98,1404,Drug_analog,calpain inhibitor i,no_match,no_match,no_match,no_match,FMYKJLXRRQTBOR-BZSNNMDCSA-N
CCMSLIB00012723765,related spectra of 'fursultiamine (delta mass:-12.0)',CCMSLIB00010141022,-12,1405,Drug_analog,fursultiamine,"vitamin B1, plain",metabolism,thiamine deficiency,vitamin B1 derivate,JTLXCMOFVBXEKD-FOWTUZBSSA-N
CCMSLIB00012723766,related spectra of 'irbesartan (delta mass:-42.05)',CCMSLIB00000210860|CCMSLIB00000210873|CCMSLIB00000579827|CCMSLIB00000841582|CCMSLIB00006115781|CCMSLIB00006115783|CCMSLIB00006115784|CCMSLIB00006115786|CCMSLIB00006115788|CCMSLIB00006115798|CCMSLIB00006115800|CCMSLIB00006115805|CCMSLIB00006685011|CCMSLIB00010131633,-42.05,1406,Drug_analog,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012723767,related spectra of 'terameprocol (delta mass:27.99)',CCMSLIB00003135755,27.99,1407,Drug_analog,terameprocol,no_match,NA,NA,lipoxygenase inhibitor,ORQFDHFZSMXRLM-IYBDPMFKSA-N
CCMSLIB00012723768,related spectra of 'hydroxyprogesterone caproate (delta mass:-42.01)',CCMSLIB00005764750,-42.01,1408,Drug_analog|Low_confidence,hydroxyprogesterone caproate,no_match,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DOMWKUIIPQCAJU-LJHIYBGHSA-N
CCMSLIB00012723769,related spectra of 'trazodone (delta mass:15.99)',CCMSLIB00000078519|CCMSLIB00000079178,15.99,1409,Drug_analog,trazodone,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,PHLBKPHSAVXXEF-UHFFFAOYSA-N
CCMSLIB00012723770,related spectra of 'forskolin (delta mass:-44.03)',CCMSLIB00006555848,-44.03,1410,Drug_analog,forskolin,no_match,NA,NA,adenylyl cyclase activator,OHCQJHSOBUTRHG-KGGHGJDLSA-N
CCMSLIB00012723771,related spectra of 'methylprednisolone (delta mass:13.98)',CCMSLIB00000004249|CCMSLIB00000004250|CCMSLIB00000077142|CCMSLIB00000077143|CCMSLIB00000078262|CCMSLIB00000085960|CCMSLIB00000205977|CCMSLIB00000205978|CCMSLIB00000209912|CCMSLIB00000209914|CCMSLIB00000209916|CCMSLIB00000209925|CCMSLIB00000209927|CCMSLIB00000209929|CCMSLIB00003134513|CCMSLIB00005764487|CCMSLIB00005764667|CCMSLIB00005771125|CCMSLIB00005771350|CCMSLIB00005773160|CCMSLIB00005773360|CCMSLIB00005773492|CCMSLIB00005773815|CCMSLIB00005773963|CCMSLIB00005774455|CCMSLIB00005774544|CCMSLIB00005774986|CCMSLIB00005776619|CCMSLIB00010152455,13.98,1411,Drug_analog,methylprednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,VHRSUDSXCMQTMA-PJHHCJLFSA-N|VHRSUDSXCMQTMA-UHFFFAOYSA-N
CCMSLIB00012723772,related spectra of 'methylprednisolone (delta mass:13.98)',CCMSLIB00000004250|CCMSLIB00000077142|CCMSLIB00000077143|CCMSLIB00000078262|CCMSLIB00000085960|CCMSLIB00000205978|CCMSLIB00000209914|CCMSLIB00000209916|CCMSLIB00000209929|CCMSLIB00003134513|CCMSLIB00005764487|CCMSLIB00005771125|CCMSLIB00005772443|CCMSLIB00005772603|CCMSLIB00005773160|CCMSLIB00005773360|CCMSLIB00005773492|CCMSLIB00005773815|CCMSLIB00005773963|CCMSLIB00005774455|CCMSLIB00005774544|CCMSLIB00005774986|CCMSLIB00005776619|CCMSLIB00010152455|CCMSLIB00010152458,13.98,1412,Drug_analog,methylprednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,VHRSUDSXCMQTMA-PJHHCJLFSA-N|VHRSUDSXCMQTMA-UHFFFAOYSA-N
CCMSLIB00012723773,related spectra of 'digoxigenin (delta mass:-2.02)',CCMSLIB00010151840|CCMSLIB00010151841,-2.02,1413,Drug_analog,digoxigenin,no_match,NA,NA,steroid,SHIBSTMRCDJXLN-KCZCNTNESA-N
CCMSLIB00012723774,"related spectra of 'desoxycorticosterone acetate (delta mass:16.03)', 'hydroxyprogesterone caproate (delta mass:-40.03)', 'testosterone propionate (delta mass:44.03)'",CCMSLIB00000206429|CCMSLIB00005763640|CCMSLIB00005764750|CCMSLIB00005771142|CCMSLIB00006685047|CCMSLIB00006685065|CCMSLIB00010117628,16.03|-40.03|44.03,1414,Drug_analog|Low_confidence,testosterone propionate|hydroxyprogesterone caproate|desoxycorticosterone acetate,androgen|no_match,endocrinology|obstetrics/gynecology|NA,hypogonadism|spontaneous preterm birth|NA,androgen receptor agonist|progesterone receptor agonist|mineralocorticoid receptor agonist,PDMMFKSKQVNJMI-UHFFFAOYSA-N|PDMMFKSKQVNJMI-BLQWBTBKSA-N|DOMWKUIIPQCAJU-LJHIYBGHSA-N|VPGRYOFKCNULNK-ACXQXYJUSA-N
CCMSLIB00012723775,related spectra of 'hydroxyprogesterone caproate (delta mass:-40.03)',CCMSLIB00005764750,-40.03,1415,Drug_analog|Low_confidence,hydroxyprogesterone caproate,no_match,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DOMWKUIIPQCAJU-LJHIYBGHSA-N
CCMSLIB00012723776,"related spectra of 'cetirizine (delta mass:1.0)', 'levocetirizine (delta mass:1.0)'",CCMSLIB00000077127|CCMSLIB00000078089|CCMSLIB00000079138|CCMSLIB00000081597|CCMSLIB00005775156,1,1416,Drug_analog,cetirizine|levocetirizine,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,ZKLPARSLTMPFCP-UHFFFAOYSA-N|ZKLPARSLTMPFCP-OAQYLSRUSA-N
CCMSLIB00012723777,related spectra of 'nicardipine (delta mass:-90.05)',CCMSLIB00000085093,-90.05,1417,Drug_analog,nicardipine,dihydropyridine calcium channel blocker,cardiology,chronic stable angina|hypertension,calcium channel blocker,ZBBHBTPTTSWHBA-UHFFFAOYSA-N
CCMSLIB00012723778,related spectra of 'quinine (delta mass:43.99)',CCMSLIB00006559878,43.99,1418,Drug_analog,quinine,antimalarial,infectious disease,malaria,hemozoin biocrystallization inhibitor,LOUPRKONTZGTKE-UHFFFAOYSA-N
CCMSLIB00012723779,"related spectra of 'golotimod (delta mass:57.02)', 'oglufanide (delta mass:57.02)'",CCMSLIB00010133731|CCMSLIB00010133733|CCMSLIB00010152308,57.02,1419,Drug_analog|Low_confidence,golotimod|oglufanide,no_match,no_match|NA,no_match|NA,no_match|VEGF antagonist,CATMPQFFVNKDEY-YPMHNXCESA-N|LLEUXCDZPQOJMY-AAEUAGOBSA-N
CCMSLIB00012723780,related spectra of 'olmesartan (delta mass:-38.02)',CCMSLIB00010138702,-38.02,1420,Drug_analog,olmesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,VTRAEEWXHOVJFV-UHFFFAOYSA-N
CCMSLIB00012723781,related spectra of 'fluorometholone (delta mass:13.98)',CCMSLIB00005775727,13.98,1421,Drug_analog,fluorometholone,corticosteroid,ophthalmology,eye inflammation,glucocorticoid receptor agonist,FAOZLTXFLGPHNG-KNAQIMQKSA-N
CCMSLIB00012723782,"related spectra of 'enalapril (delta mass:14.01)', 'enalapril (delta mass:14.02)'",CCMSLIB00000006019|CCMSLIB00000077093|CCMSLIB00000078354|CCMSLIB00000084917|CCMSLIB00000206128|CCMSLIB00000579632|CCMSLIB00000841937|CCMSLIB00005771099|CCMSLIB00005772614|CCMSLIB00005777219|CCMSLIB00010134496|CCMSLIB00010134498|CCMSLIB00010134501,14.02,1422,Drug_analog,enalapril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,GBXSMTUPTTWBMN-XIRDDKMYSA-N|GBXSMTUPTTWBMN-UHFFFAOYSA-N
CCMSLIB00012723783,related spectra of 'fluorometholone (delta mass:14.02)',CCMSLIB00005762483,14.02,1423,Drug_analog,fluorometholone,corticosteroid,ophthalmology,eye inflammation,glucocorticoid receptor agonist,FAOZLTXFLGPHNG-KNAQIMQKSA-N
CCMSLIB00012723784,related spectra of 'tadalafil (delta mass:2.02)',CCMSLIB00000078956|CCMSLIB00010150670|CCMSLIB00010150672|CCMSLIB00010150673,2.02,1424,Drug_analog,tadalafil|tadalafil,phosphodiesterase-5 (PDE-5) inhibitor,urology,erectile dysfunction|benign prostatic hyperplasia|pulmonary arterial hypertension (PAH),phosphodiesterase inhibitor,WOXKDUGGOYFFRN-IIBYNOLFSA-N
CCMSLIB00012723785,"related spectra of '(s)-carvedilol (delta mass:-14.01)', 'carvedilol (delta mass:-14.01)', 'carvedilol (delta mass:-14.02)', '(r)-carvedilol (delta mass:-14.02)', '(r)-carvedilol (delta mass:-14.01)', '(s)-carvedilol (delta mass:-14.02)'",CCMSLIB00000078306|CCMSLIB00000078949|CCMSLIB00006117050|CCMSLIB00006117052|CCMSLIB00006117054|CCMSLIB00006117056|CCMSLIB00006117057|CCMSLIB00006117068|CCMSLIB00006117069|CCMSLIB00006117071|CCMSLIB00006117073|CCMSLIB00006117075|CCMSLIB00010130242|CCMSLIB00010130244|CCMSLIB00010130245|CCMSLIB00010130247|CCMSLIB00010130248|CCMSLIB00010143769|CCMSLIB00010143771|CCMSLIB00010143774|CCMSLIB00010152218|CCMSLIB00010152219|CCMSLIB00010152221|CCMSLIB00010152224,-14.02,1425,Drug_analog,carvedilol|carvedilol,alpha adrenergic blocker|beta-adrenergic receptor inhibitor,cardiology,myocardial infarction|hypertension,adrenergic receptor antagonist,OGHNVEJMJSYVRP-UHFFFAOYSA-N|OGHNVEJMJSYVRP-QGZVFWFLSA-N|OGHNVEJMJSYVRP-KRWDZBQOSA-N
CCMSLIB00012723786,related spectra of 'dovitinib (delta mass:1.01)',CCMSLIB00010136205|CCMSLIB00010136206|CCMSLIB00010136208|CCMSLIB00010148500|CCMSLIB00010148501|CCMSLIB00010148503,1,1426,Drug_analog,dovitinib,kinase inhibitor,NA,NA,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,PIQCTGMSNWUMAF-UHFFFAOYSA-N
CCMSLIB00012723787,related spectra of 'valsartan (delta mass:-42.05)',CCMSLIB00000078331|CCMSLIB00000079131|CCMSLIB00000209773|CCMSLIB00000209785|CCMSLIB00005772245|CCMSLIB00005773820|CCMSLIB00005774674|CCMSLIB00006116255|CCMSLIB00006116257|CCMSLIB00006680041|CCMSLIB00006685103|CCMSLIB00010140221|CCMSLIB00010147620,-42.05,1427,Drug_analog,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012723788,related spectra of 'protirelin (delta mass:31.99)',CCMSLIB00010143639|CCMSLIB00010143640|CCMSLIB00010143642,31.99,1428,Drug_analog,protirelin,tests for thyreoidea function,radiology,thyroid function diagnostic,thyrotropin releasing hormone receptor agonist,XNSAINXGIQZQOO-SRVKXCTJSA-N
CCMSLIB00012723789,related spectra of 'ergocalciferol (delta mass:-2.02)',CCMSLIB00010114654,-2.02,1429,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723790,related spectra of 'ergocalciferol (delta mass:-1.98)',CCMSLIB00010114654,-1.98,1430,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723791,"related spectra of 'benazepril (delta mass:-28.04)', 'benazepril (delta mass:-28.03)'",CCMSLIB00000005373|CCMSLIB00010133144|CCMSLIB00010133147,-28.03,1431,Drug_analog,benazepril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|myocardial infarction|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,XPCFTKFZXHTYIP-PMACEKPBSA-N
CCMSLIB00012723792,related spectra of 'benazepril (delta mass:-28.03)',CCMSLIB00000005373|CCMSLIB00010133144|CCMSLIB00010133147,-28.03,1432,Drug_analog,benazepril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|myocardial infarction|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,XPCFTKFZXHTYIP-PMACEKPBSA-N
CCMSLIB00012723793,related spectra of 'benazepril (delta mass:-28.03)',CCMSLIB00000005373|CCMSLIB00010133143|CCMSLIB00010133144|CCMSLIB00010133147,-28.03,1433,Drug_analog,benazepril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|myocardial infarction|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,XPCFTKFZXHTYIP-PMACEKPBSA-N
CCMSLIB00012723794,related spectra of 'benazepril (delta mass:-28.03)',CCMSLIB00000005373|CCMSLIB00010133142|CCMSLIB00010133143|CCMSLIB00010133144|CCMSLIB00010133147,-28.03,1434,Drug_analog,benazepril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|myocardial infarction|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,XPCFTKFZXHTYIP-PMACEKPBSA-N
CCMSLIB00012723795,related spectra of 'benazepril (delta mass:-28.03)',CCMSLIB00000005373|CCMSLIB00010133143|CCMSLIB00010133144|CCMSLIB00010133147,-28.03,1435,Drug_analog,benazepril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|myocardial infarction|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,XPCFTKFZXHTYIP-PMACEKPBSA-N
CCMSLIB00012723796,related spectra of 'benazepril (delta mass:-28.03)',CCMSLIB00000005373|CCMSLIB00010133143|CCMSLIB00010133144|CCMSLIB00010133147,-28.03,1436,Drug_analog,benazepril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|myocardial infarction|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,XPCFTKFZXHTYIP-PMACEKPBSA-N
CCMSLIB00012723797,related spectra of 'benazepril (delta mass:-28.03)',CCMSLIB00000005373|CCMSLIB00010133143|CCMSLIB00010133144|CCMSLIB00010133147,-28.03,1437,Drug_analog,benazepril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|myocardial infarction|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,XPCFTKFZXHTYIP-PMACEKPBSA-N
CCMSLIB00012723798,related spectra of 'benazepril (delta mass:-28.03)',CCMSLIB00000005373|CCMSLIB00010133143|CCMSLIB00010133144|CCMSLIB00010133147,-28.03,1438,Drug_analog,benazepril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|myocardial infarction|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,XPCFTKFZXHTYIP-PMACEKPBSA-N
CCMSLIB00012723799,related spectra of 'benazepril (delta mass:-28.03)',CCMSLIB00000005373|CCMSLIB00010133143|CCMSLIB00010133144|CCMSLIB00010133147,-28.03,1439,Drug_analog,benazepril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|myocardial infarction|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,XPCFTKFZXHTYIP-PMACEKPBSA-N
CCMSLIB00012723800,related spectra of 'hydroxyprogesterone caproate (delta mass:-31.99)',CCMSLIB00005764750|CCMSLIB00005766981,-31.99,1440,Drug_analog|Low_confidence,hydroxyprogesterone caproate,no_match,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DOMWKUIIPQCAJU-LJHIYBGHSA-N
CCMSLIB00012723801,related spectra of 'quetiapine (delta mass:13.98)',CCMSLIB00000084788|CCMSLIB00000085848|CCMSLIB00003140182,13.98,1441,Drug_analog,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012723802,related spectra of 'quetiapine (delta mass:13.98)',CCMSLIB00000078279|CCMSLIB00000079141|CCMSLIB00010139369|CCMSLIB00010145184,13.98,1442,Drug_analog,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012723803,related spectra of 'benazepril (delta mass:-28.03)',CCMSLIB00000005376,-28.03,1443,Drug_analog,benazepril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|myocardial infarction|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,XPCFTKFZXHTYIP-PMACEKPBSA-N
CCMSLIB00012723804,related spectra of 'benazepril (delta mass:-28.03)',CCMSLIB00000005376,-28.03,1444,Drug_analog,benazepril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|myocardial infarction|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,XPCFTKFZXHTYIP-PMACEKPBSA-N
CCMSLIB00012723805,related spectra of 'lactulose (delta mass:12.04)',CCMSLIB00006122276|CCMSLIB00006122278|CCMSLIB00006122280|CCMSLIB00006122282|CCMSLIB00006122284,12.04,1445,Drug_analog|Low_confidence,lactulose,osmotic laxative,gastroenterology,portal-systemic encephalopathy (PSE)|constipation,laxative,JCQLYHFGKNRPGE-FCVZTGTOSA-N
CCMSLIB00012723806,related spectra of 'desonide (delta mass:-18.01)',CCMSLIB00005774991|CCMSLIB00005775479,-18.01,1446,Drug_analog,desonide,corticosteroid,dermatology,corticosteroid-responsive dermatoses,glucocorticoid receptor agonist,WBGKWQHBNHJJPZ-LECWWXJVSA-N
CCMSLIB00012723807,related spectra of 'enoxolone (delta mass:-54.03)',CCMSLIB00010118337,-54.03,1447,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723808,related spectra of 'ergocalciferol (delta mass:1.98)',CCMSLIB00010125983,1.98,1448,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723809,related spectra of 'ergocalciferol (delta mass:1.98)',CCMSLIB00010125983,1.98,1449,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723810,related spectra of 'ergocalciferol (delta mass:1.98)',CCMSLIB00010125983,1.98,1450,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723811,related spectra of 'betulinic acid (delta mass:-40.03)',CCMSLIB00010124192,-40.03,1451,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012723812,related spectra of 'ergocalciferol (delta mass:1.98)',CCMSLIB00010125983,1.98,1452,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723813,related spectra of 'betulinic acid (delta mass:-40.03)',CCMSLIB00010112869,-40.03,1453,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012723814,related spectra of 'ergocalciferol (delta mass:1.98)',CCMSLIB00010125983,1.98,1454,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723815,related spectra of 'ergocalciferol (delta mass:1.98)',CCMSLIB00010125983,1.98,1455,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723816,related spectra of 'pantoprazole (delta mass:34.01)',CCMSLIB00010142393,34.01,1456,Drug_analog,pantoprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|erosive esophagitis (EE)|Zollinger-Ellison syndrome,ATPase inhibitor,IQPSEEYGBUAQFF-UHFFFAOYSA-N
CCMSLIB00012723817,related spectra of 'fursultiamine (delta mass:1.0)',CCMSLIB00010141022|CCMSLIB00010141026,1,1457,Drug_analog,fursultiamine,"vitamin B1, plain",metabolism,thiamine deficiency,vitamin B1 derivate,JTLXCMOFVBXEKD-FOWTUZBSSA-N
CCMSLIB00012723818,related spectra of 'quetiapine (delta mass:15.99)',CCMSLIB00000006403,15.99,1458,Drug_analog,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,ZNPNOVHKCAAQCG-UHFFFAOYSA-N
CCMSLIB00012723819,related spectra of 'diltiazem (delta mass:-14.02)',CCMSLIB00000078321|CCMSLIB00000572863|CCMSLIB00000572963|CCMSLIB00003135470|CCMSLIB00003135521|CCMSLIB00005735865|CCMSLIB00005736434|CCMSLIB00006116363|CCMSLIB00006684374,-14.02,1459,Drug_analog,diltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,HSUGRBWQSSZJOP-RTWAWAEBSA-N|HSUGRBWQSSZJOP-UHFFFAOYSA-N
CCMSLIB00012723820,related spectra of 'diltiazem (delta mass:-14.02)',CCMSLIB00000078321|CCMSLIB00000572753|CCMSLIB00000572863|CCMSLIB00000572963|CCMSLIB00003135470|CCMSLIB00003135521|CCMSLIB00005731766|CCMSLIB00005735865|CCMSLIB00005736434|CCMSLIB00006116363|CCMSLIB00006116366|CCMSLIB00006116368|CCMSLIB00006116369|CCMSLIB00006116371|CCMSLIB00006116373|CCMSLIB00006679906|CCMSLIB00006684335|CCMSLIB00006684374,-14.02,1460,Drug_analog,diltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,HSUGRBWQSSZJOP-RTWAWAEBSA-N|HSUGRBWQSSZJOP-UHFFFAOYSA-N
CCMSLIB00012723821,"related spectra of 'fursultiamine (delta mass:2.02)', 'fursultiamine (delta mass:2.0)'",CCMSLIB00010141022,2.02|2.00,1461,Drug_analog,fursultiamine,"vitamin B1, plain",metabolism,thiamine deficiency,vitamin B1 derivate,JTLXCMOFVBXEKD-FOWTUZBSSA-N
CCMSLIB00012723822,related spectra of 'irbesartan (delta mass:-28.03)',CCMSLIB00000078173|CCMSLIB00000079128|CCMSLIB00003136255|CCMSLIB00005772775|CCMSLIB00010131632,-28.03,1462,Drug_analog,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012723823,related spectra of 'ergocalciferol (delta mass:3.99)',CCMSLIB00010125983,3.99,1463,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723824,"related spectra of 'losartan carboxaldehyde (delta mass:-18.01)', 'losartan (delta mass:-20.03)'",CCMSLIB00000085308|CCMSLIB00003061262,-18.01|-20.03,1464,Drug_analog,losartan|losartan carboxaldehyde,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N|FQZSMTSTFMNWQF-UHFFFAOYSA-N
CCMSLIB00012723825,related spectra of 'losartan (delta mass:-18.01)',CCMSLIB00000572307|CCMSLIB00000572566|CCMSLIB00000579704|CCMSLIB00000841586|CCMSLIB00000841926|CCMSLIB00003061260|CCMSLIB00005732878|CCMSLIB00005736096,-18.01,1465,Drug_analog,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012723826,related spectra of 'nimodipine (delta mass:-14.02)',CCMSLIB00000078273|CCMSLIB00000079086,-14.02,1466,Drug_analog,nimodipine,dihydropyridine calcium channel blocker,neurology/psychiatry,subarachnoid hemorrhage|cerebral vasospasm,calcium channel blocker,UIAGMCDKSXEBJQ-UHFFFAOYSA-N
CCMSLIB00012723827,related spectra of 'ampicillin (delta mass:57.02)',CCMSLIB00006684585,57.02,1467,Drug_analog,ampicillin,penicillin class antibacterial,infectious disease,respiratory tract infections|meningitis|bacterial septicemia|endocarditis|urinary tract infections|gastrointestinal infections,bacterial cell wall synthesis inhibitor,AVKUERGKIZMTKX-NJBDSQKTSA-N
CCMSLIB00012723828,related spectra of 'treprostinil (delta mass:16.03)',CCMSLIB00010135684,16.03,1468,Drug_analog,treprostinil,prostacycline vasodilator,pulmonary,pulmonary arterial hypertension (PAH),prostanoid receptor agonist,PAJMKGZZBBTTOY-ZFORQUDYSA-N
CCMSLIB00012723829,related spectra of 'betulinic acid (delta mass:-31.99)',CCMSLIB00010112869,-31.99,1469,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012723830,"related spectra of 'griseofulvin (delta mass:58.0)', 'griseofulvin (delta mass:58.01)'",CCMSLIB00004692129,58.01,1470,Drug_analog,griseofulvin,tubulin inhibiting agent,infectious disease,ringworm|tinea pedis|fungal infections,tubulin polymerization inhibitor,DDUHZTYCFQRHIY-RBHXEPJQSA-N
CCMSLIB00012723831,"related spectra of 'enoxolone (delta mass:-44.03)', 'carbenoxolone (delta mass:-162.05)'",CCMSLIB00010118337|CCMSLIB00010134949,-44.03|-162.05,1471,Drug_analog,enoxolone|carbenoxolone,no_match,NA|gastroenterology|dental,NA|peptic ulcer disease (PUD)|mouth inflammation,gap junction modulator|11-beta hydroxysteroid dehydrogenase inhibitor,MPDGHEJMBKOTSU-YKLVYJNSSA-N|OBZHEBDUNPOCJG-WBXJDKIVSA-N
CCMSLIB00012723832,"related spectra of 'benazepril (delta mass:-14.01)', 'benazepril (delta mass:-14.02)'",CCMSLIB00000005371|CCMSLIB00000078084|CCMSLIB00000078919|CCMSLIB00003138869|CCMSLIB00003138892|CCMSLIB00010133143|CCMSLIB00010133145|CCMSLIB00010133148,-14.02,1472,Drug_analog,benazepril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|myocardial infarction|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,XPCFTKFZXHTYIP-PMACEKPBSA-N
CCMSLIB00012723833,related spectra of 'neoandrographolide (delta mass:-68.06)',CCMSLIB00004697637|CCMSLIB00004697638,-68.06,1473,Drug_analog,neoandrographolide,no_match,no_match,no_match,no_match,YGCYRQKJYWQXHG-RDNQFMDVSA-N
CCMSLIB00012723834,related spectra of 'neoandrographolide (delta mass:-68.06)',CCMSLIB00004697637|CCMSLIB00004697638,-68.06,1474,Drug_analog,neoandrographolide,no_match,no_match,no_match,no_match,YGCYRQKJYWQXHG-RDNQFMDVSA-N
CCMSLIB00012723835,related spectra of 'neoandrographolide (delta mass:-68.06)',CCMSLIB00004697638,-68.06,1475,Drug_analog,neoandrographolide,no_match,no_match,no_match,no_match,YGCYRQKJYWQXHG-RDNQFMDVSA-N
CCMSLIB00012723836,related spectra of 'neoandrographolide (delta mass:-68.06)',CCMSLIB00004697637|CCMSLIB00004697638,-68.06,1476,Drug_analog,neoandrographolide,no_match,no_match,no_match,no_match,YGCYRQKJYWQXHG-RDNQFMDVSA-N
CCMSLIB00012723837,related spectra of 'enoxolone (delta mass:-60.02)',CCMSLIB00000567526|CCMSLIB00005733345|CCMSLIB00010118331|CCMSLIB00010118332,-60.02,1477,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723838,related spectra of 'enoxolone (delta mass:-59.98)',CCMSLIB00004691638|CCMSLIB00004704573,-59.98,1478,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723839,related spectra of 'betulinic acid (delta mass:-27.99)',CCMSLIB00010124192,-27.99,1479,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012723840,related spectra of 'ergocalciferol (delta mass:14.02)',CCMSLIB00010125983,14.02,1480,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723841,related spectra of 'sulfasalazine (delta mass:14.02)',CCMSLIB00000078940|CCMSLIB00000206404|CCMSLIB00005771479,14.02,1481,Drug_analog,sulfasalazine,aminosalicylate,gastroenterology|rheumatology,ulcerative colitis|Crohn's disease|rheumatoid arthritis,cyclooxygenase inhibitor,NCEXYHBECQHGNR-UHFFFAOYSA-N|OQANPHBRHBJGNZ-UHFFFAOYSA-N
CCMSLIB00012723842,"related spectra of 'budesonide (delta mass:-17.99)', 'budesonide (delta mass:-18.01)', 'desonide (delta mass:-3.99)'",CCMSLIB00000004381|CCMSLIB00000004382|CCMSLIB00000078086|CCMSLIB00003138596|CCMSLIB00005466082|CCMSLIB00005762258|CCMSLIB00005772524|CCMSLIB00005773298|CCMSLIB00005775052|CCMSLIB00005775479|CCMSLIB00005776359|CCMSLIB00010147745|CCMSLIB00010147746,-18.01|-3.99,1482,Drug_analog,budesonide|desonide,corticosteroid,gastroenterology|pulmonary|allergy|dermatology,Crohn's disease|asthma|COPD|allergic rhinitis|corticosteroid-responsive dermatoses,glucocorticoid receptor agonist,VOVIALXJUBGFJZ-KWVAZRHASA-N|VOVIALXJUBGFJZ-VXKMTNQYSA-N|WBGKWQHBNHJJPZ-LECWWXJVSA-N
CCMSLIB00012723843,"related spectra of 'budesonide (delta mass:-18.01)', 'desonide (delta mass:-4.0)'",CCMSLIB00000004382|CCMSLIB00005762258|CCMSLIB00005772524|CCMSLIB00005774991|CCMSLIB00005775052|CCMSLIB00005776359,-18.01|-4.00,1483,Drug_analog,budesonide|desonide,corticosteroid,gastroenterology|pulmonary|allergy|dermatology,Crohn's disease|asthma|COPD|allergic rhinitis|corticosteroid-responsive dermatoses,glucocorticoid receptor agonist,VOVIALXJUBGFJZ-KWVAZRHASA-N|VOVIALXJUBGFJZ-VXKMTNQYSA-N|WBGKWQHBNHJJPZ-LECWWXJVSA-N
CCMSLIB00012723844,related spectra of 'calpain inhibitor i (delta mass:28.99)',CCMSLIB00010136858|CCMSLIB00010136860|CCMSLIB00010136861,28.99,1484,Drug_analog,calpain inhibitor i,no_match,no_match,no_match,no_match,FMYKJLXRRQTBOR-BZSNNMDCSA-N
CCMSLIB00012723845,related spectra of 'calpain inhibitor i (delta mass:28.99)',CCMSLIB00010136857|CCMSLIB00010136858|CCMSLIB00010136860|CCMSLIB00010136861,28.99,1485,Drug_analog,calpain inhibitor i,no_match,no_match,no_match,no_match,FMYKJLXRRQTBOR-BZSNNMDCSA-N
CCMSLIB00012723846,related spectra of 'ergocalciferol (delta mass:15.96)',CCMSLIB00010125983,15.96,1486,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723847,related spectra of 'ergocalciferol (delta mass:15.96)',CCMSLIB00010125983,15.96,1487,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723848,related spectra of 'ergocalciferol (delta mass:15.96)',CCMSLIB00010125983,15.96,1488,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723849,related spectra of 'latanoprost (delta mass:-1.98)',CCMSLIB00010143077,-1.98,1489,Drug_analog,latanoprost,prostaglandin analog,ophthalmology,ocular hypertension|glaucoma,prostanoid receptor agonist,GGXICVAJURFBLW-CEYXHVGTSA-N
CCMSLIB00012723850,related spectra of 'benzethonium (delta mass:1.0)',CCMSLIB00010129864,1,1490,Drug_analog,benzethonium,antiseptics and disinfectants,infectious disease,first-aid antiseptic,disruption of cell membranes,SIYLLGKDQZGJHK-UHFFFAOYSA-N
CCMSLIB00012723851,related spectra of 'betulinic acid (delta mass:-26.02)',CCMSLIB00010112869|CCMSLIB00010124192,-26.02,1491,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012723852,"related spectra of 'enoxolone (delta mass:--58.01)', 'enoxolone (delta mass:-58.0)'",CCMSLIB00000567526|CCMSLIB00004704575|CCMSLIB00005733345,-58.01,1492,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723853,related spectra of 'ergocalciferol (delta mass:16.03)',CCMSLIB00010125983,16.03,1493,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723854,related spectra of 'ergocalciferol (delta mass:16.03)',CCMSLIB00010125983,16.03,1494,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723855,related spectra of 'quetiapine sulfoxide (delta mass:13.98)',CCMSLIB00010135508|CCMSLIB00010135509|CCMSLIB00010135512,13.98,1495,Drug_analog,quetiapine sulfoxide,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,FXJNLPUSSHEDON-UHFFFAOYSA-N
CCMSLIB00012723856,"related spectra of 'fursultiamine (delta mass:16.0)', 'fursultiamine (delta mass:15.99)'",CCMSLIB00000086060|CCMSLIB00010141021|CCMSLIB00010141022|CCMSLIB00010141024|CCMSLIB00010141026|CCMSLIB00010141027,15.99,1496,Drug_analog,fursultiamine|fursultiamine,"vitamin B1, plain",metabolism,thiamine deficiency,vitamin B1 derivate,JTLXCMOFVBXEKD-FOWTUZBSSA-N
CCMSLIB00012723857,related spectra of 'tofogliflozin (delta mass:28.03)',CCMSLIB00010140095,28.03,1497,Drug_analog,tofogliflozin,sodium-glucose co-transporter 2 (SGLT2) inhibitor,endocrinology,NA,sodium/glucose cotransporter inhibitor,VWVKUNOPTJGDOB-BDHVOXNPSA-N
CCMSLIB00012723858,"related spectra of 'flunisolide (delta mass:-20.01)', 'triamcinolone acetonide (delta mass:-20.01)', 'triamcinolone (delta mass:20.03)'",CCMSLIB00000579631|CCMSLIB00000842002|CCMSLIB00005772498|CCMSLIB00010137581,-20.01|20.03,1498,Drug_analog,triamcinolone|flunisolide|triamcinolone acetonide,corticosteroid,dermatology|allergy|rheumatology|neurology/psychiatry|pulmonary,corticosteroid-responsive dermatoses|allergic reactions|multiple sclerosis (MS)|arthritis|alopecia areata|rheumatoid disorders|allergic rhinitis|asthma,glucocorticoid receptor agonist,GFNANZIMVAIWHM-OBYCQNJPSA-N|GFNANZIMVAIWHM-UHFFFAOYSA-N|XSFJVAJPIHIPKU-XWCQMRHXSA-N|YNDXUCZADRHECN-JNQJZLCISA-N
CCMSLIB00012723859,"related spectra of 'triamcinolone acetonide (delta mass:-20.01)', 'dexamethasone acetate (delta mass:-20.01)', 'triamcinolone-acetonide (delta mass:-20.01)'",CCMSLIB00000005221|CCMSLIB00005772418|CCMSLIB00005773454|CCMSLIB00005775776|CCMSLIB00005776885|CCMSLIB00010137581|CCMSLIB00010137582|CCMSLIB00010137585|CCMSLIB00010137588,-20.01,1499,Drug_analog,triamcinolone-acetonide|triamcinolone acetonide|dexamethasone acetate|triamcinolone acetonide,corticosteroid,dermatology|allergy|rheumatology|neurology/psychiatry|pulmonary|endocrinology|oncology|gastroenterology|hematologic malignancy|ophthalmology,corticosteroid-responsive dermatoses|allergic reactions|multiple sclerosis (MS)|arthritis|alopecia areata|rheumatoid disorders|serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,YNDXUCZADRHECN-JNQJZLCISA-N|AKUJBENLRBOFTD-RPRRAYFGSA-N
CCMSLIB00012723860,related spectra of 'rapastinel (delta mass:0.98)',CCMSLIB00010129977|CCMSLIB00010129978|CCMSLIB00010129980|CCMSLIB00010129983,0.98,1500,Drug_analog,rapastinel,no_match,NA,NA,glutamate receptor agonist,GIBQQARAXHVEGD-BSOLPCOYSA-N
CCMSLIB00012723861,related spectra of 'ergocalciferol (delta mass:18.01)',CCMSLIB00010125983,18.01,1501,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723862,related spectra of 'flecainide (delta mass:1.0)',CCMSLIB00000084819|CCMSLIB00000572935|CCMSLIB00005733059|CCMSLIB00005776715,1,1502,Drug_analog,flecainide,antiarrhythmic,cardiology,ventricular tachycardia (VT)|atrial fibrillation (AF)|ventricular arrhythmias,sodium channel blocker,DJBNUMBKLMJRSA-UHFFFAOYSA-N
CCMSLIB00012723863,"related spectra of 'isoconazole (delta mass:2.0)', 'isoconazole (delta mass:1.99)', 'miconazole (delta mass:2.0)'",CCMSLIB00000085023|CCMSLIB00000086157,2,1503,Drug_analog,isoconazole|miconazole,azole antifungal,infectious disease,gram-positive bacterial infections|fungal infections|yeast infection,fungal lanosterol demethylase inhibitor|bacterial cell wall synthesis inhibitor,MPIPASJGOJYODL-UHFFFAOYSA-N|BYBLEWFAAKGYCD-UHFFFAOYSA-N
CCMSLIB00012723864,related spectra of 'fursultiamine (delta mass:18.01)',CCMSLIB00010141021|CCMSLIB00010141022,18.01,1504,Drug_analog,fursultiamine,"vitamin B1, plain",metabolism,thiamine deficiency,vitamin B1 derivate,JTLXCMOFVBXEKD-FOWTUZBSSA-N
CCMSLIB00012723865,related spectra of 'enoxolone (delta mass:-54.03)',CCMSLIB00000567526|CCMSLIB00005733345,-54.03,1505,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723479,related spectra of 'efavirenz (delta mass:15.99)',CCMSLIB00000567533|CCMSLIB00000571797|CCMSLIB00000579893|CCMSLIB00000841852|CCMSLIB00005733992|CCMSLIB00005776252,15.99,1119,Drug_analog,efavirenz,HIV non-nucleoside reverse transcriptase inhibitor (HIV NNRTI),infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,XPOQHMRABVBWPR-ZDUSSCGKSA-N|XPOQHMRABVBWPR-UHFFFAOYSA-N
CCMSLIB00012723867,related spectra of 'valsartan (delta mass:-18.01)',CCMSLIB00005774674|CCMSLIB00005776368,-18.01,1507,Drug_analog,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012723868,related spectra of 'afimoxifene (delta mass:30.01)',CCMSLIB00005774055,30.01,1508,Drug_analog,afimoxifene,estrogen agonist/antagonist,oncology,breast cancer,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),TXUZVZSFRXZGTL-UHFFFAOYSA-N
CCMSLIB00012723869,related spectra of 'finasteride (delta mass:45.99)',CCMSLIB00000223781,45.99,1509,Drug_analog,finasteride,5-alpha reductase inhibitor,dermatology|urology,male androgenetic alopecia|benign prostatic hyperplasia,5 alpha reductase inhibitor,DBEPLOCGEIEOCV-WSBQPABSSA-N
CCMSLIB00012723870,"related spectra of 'perphenazine (delta mass:16.0)', 'perphenazine (delta mass:15.99)'",CCMSLIB00000076970|CCMSLIB00000085232|CCMSLIB00006116215|CCMSLIB00006116217|CCMSLIB00006116219|CCMSLIB00006116220|CCMSLIB00006116222|CCMSLIB00006116233|CCMSLIB00006116235|CCMSLIB00006116236|CCMSLIB00006116238|CCMSLIB00006116240|CCMSLIB00010140031|CCMSLIB00010140032|CCMSLIB00010140035|CCMSLIB00010140038,15.99,1510,Drug_analog,perphenazine,phenothiazine,neurology/psychiatry|gastroenterology,schizophrenia|nausea|vomiting,dopamine receptor antagonist,RGCVKNLCSQQDEP-UHFFFAOYSA-N
CCMSLIB00012723871,related spectra of 'terazosin (delta mass:31.99)',CCMSLIB00000078411|CCMSLIB00000079158|CCMSLIB00003135205,31.99,1511,Drug_analog,terazosin,alpha adrenergic blocker,urology|cardiology,benign prostatic hyperplasia (BPH)|hypertension,adrenergic receptor antagonist,VCKUSRYTPJJLNI-UHFFFAOYSA-N
CCMSLIB00012723872,related spectra of 'losartan (delta mass:-2.02)',CCMSLIB00000579704|CCMSLIB00000841586|CCMSLIB00000841926|CCMSLIB00010129985,-2.02,1512,Drug_analog,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012723873,"related spectra of 'hydroxyzine (delta mass:45.99)', 'meclizine (delta mass:29.97)'",CCMSLIB00000078630|CCMSLIB00000084907,45.99|29.97,1513,Drug_analog,hydroxyzine|meclizine,histamine-1 (H1) inhibitor|antiemetic,neurology/psychiatry|allergy|gastroenterology,anxiety|urticaria|itching|nausea|vomiting|motion sickness,histamine H1 receptor inverse agonist|constitutive androstane receptor (CAR) agonist|histamine H1 receptor antagonist,ZQDWXGKKHFNSQK-UHFFFAOYSA-N|OCJYIGYOJCODJL-UHFFFAOYSA-N
CCMSLIB00012723874,"related spectra of '(s)-carvedilol (delta mass:15.99)', 'carvedilol (delta mass:15.99)', '(r)-carvedilol (delta mass:15.99)'",CCMSLIB00006117050|CCMSLIB00006117054|CCMSLIB00006117056|CCMSLIB00006117057|CCMSLIB00006117073|CCMSLIB00010130241|CCMSLIB00010130242|CCMSLIB00010143768|CCMSLIB00010143769|CCMSLIB00010152218|CCMSLIB00010152219,15.99,1514,Drug_analog,carvedilol|carvedilol,alpha adrenergic blocker|beta-adrenergic receptor inhibitor,cardiology,myocardial infarction|hypertension,adrenergic receptor antagonist,OGHNVEJMJSYVRP-UHFFFAOYSA-N|OGHNVEJMJSYVRP-QGZVFWFLSA-N|OGHNVEJMJSYVRP-KRWDZBQOSA-N
CCMSLIB00012723875,"related spectra of '(r)-carvedilol (delta mass:16.0)', 'carvedilol (delta mass:16.0)', '(r)-carvedilol (delta mass:15.99)', '(s)-carvedilol (delta mass:16.0)', 'carvedilol (delta mass:15.99)', '(s)-carvedilol (delta mass:15.99)'",CCMSLIB00006117050|CCMSLIB00006117052|CCMSLIB00006117054|CCMSLIB00006117056|CCMSLIB00006117057|CCMSLIB00006117068|CCMSLIB00006117069|CCMSLIB00006117071|CCMSLIB00006117073|CCMSLIB00006117075|CCMSLIB00010130241|CCMSLIB00010130242|CCMSLIB00010130244|CCMSLIB00010130245|CCMSLIB00010130247|CCMSLIB00010130248|CCMSLIB00010143768|CCMSLIB00010143769|CCMSLIB00010143771|CCMSLIB00010143774|CCMSLIB00010152218|CCMSLIB00010152219|CCMSLIB00010152221|CCMSLIB00010152224,15.99,1515,Drug_analog,carvedilol|carvedilol,alpha adrenergic blocker|beta-adrenergic receptor inhibitor,cardiology,myocardial infarction|hypertension,adrenergic receptor antagonist,OGHNVEJMJSYVRP-UHFFFAOYSA-N|OGHNVEJMJSYVRP-QGZVFWFLSA-N|OGHNVEJMJSYVRP-KRWDZBQOSA-N
CCMSLIB00012723876,related spectra of 'carvedilol (delta mass:15.99)',CCMSLIB00000078306|CCMSLIB00000078949,15.99,1516,Drug_analog,carvedilol,alpha adrenergic blocker|beta-adrenergic receptor inhibitor,cardiology,myocardial infarction|hypertension,adrenergic receptor antagonist,OGHNVEJMJSYVRP-UHFFFAOYSA-N
CCMSLIB00012723877,related spectra of 'enoxolone (delta mass:-30.01)',CCMSLIB00010118337,-30.01,1517,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723878,related spectra of 'enoxolone (delta mass:-30.01)',CCMSLIB00010118337,-30.01,1518,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723879,related spectra of 'enoxolone (delta mass:-30.01)',CCMSLIB00010118337,-30.01,1519,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723880,related spectra of 'enoxolone (delta mass:-30.01)',CCMSLIB00010118337,-30.01,1520,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723881,related spectra of 'enoxolone (delta mass:-30.01)',CCMSLIB00010118337,-30.01,1521,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723882,related spectra of 'enoxolone (delta mass:-30.01)',CCMSLIB00010118337,-30.01,1522,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723883,related spectra of 'enoxolone (delta mass:-30.01)',CCMSLIB00010118337,-30.01,1523,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723884,"related spectra of 'enoxolone (delta mass:-29.97)', 'enoxolone (delta mass:-29.98)'",CCMSLIB00010106998,-29.97,1524,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723885,related spectra of 'betulinic acid (delta mass:-15.99)',CCMSLIB00010112869|CCMSLIB00010124192,-15.99,1525,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012723886,related spectra of 'betulinic acid (delta mass:-15.99)',CCMSLIB00010112869,-15.99,1526,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012723887,related spectra of 'losartan (delta mass:2.0)',CCMSLIB00000572307|CCMSLIB00000572566|CCMSLIB00000572884|CCMSLIB00000579704|CCMSLIB00000841586|CCMSLIB00000841926|CCMSLIB00003061260|CCMSLIB00005730404|CCMSLIB00005732878|CCMSLIB00005736096|CCMSLIB00005774648|CCMSLIB00005775154|CCMSLIB00005776014|CCMSLIB00005776443|CCMSLIB00010129985|CCMSLIB00010129986|CCMSLIB00010129988|CCMSLIB00010129989|CCMSLIB00010139536|CCMSLIB00010139537|CCMSLIB00010139539|CCMSLIB00010139540,2,1527,Drug_analog,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012723888,related spectra of 'enoxolone (delta mass:-28.03)',CCMSLIB00010118337,-28.03,1528,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723889,related spectra of 'akba (delta mass:-88.05)',CCMSLIB00010144080,-88.05,1529,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012723890,related spectra of 'akba (delta mass:-88.05)',CCMSLIB00010144080,-88.05,1530,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012723891,related spectra of 'akba (delta mass:-88.05)',CCMSLIB00010144080,-88.05,1531,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012723892,related spectra of 'betulinic acid (delta mass:-14.02)',CCMSLIB00010124192,-14.02,1532,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012723893,related spectra of 'enoxolone (delta mass:-27.99)',CCMSLIB00010118337,-27.99,1533,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723894,related spectra of 'calpain inhibitor i (delta mass:42.01)',CCMSLIB00010136857|CCMSLIB00010136858|CCMSLIB00010136860|CCMSLIB00010136861,42.01,1534,Drug_analog,calpain inhibitor i,no_match,no_match,no_match,no_match,FMYKJLXRRQTBOR-BZSNNMDCSA-N
CCMSLIB00012723895,"related spectra of 'irbesartan (delta mass:-2.01)', 'irbesartan (delta mass:-2.02)'",CCMSLIB00000078173|CCMSLIB00000079128|CCMSLIB00000210860|CCMSLIB00000210862|CCMSLIB00000210864|CCMSLIB00000210873|CCMSLIB00000210874|CCMSLIB00000210877|CCMSLIB00000579827|CCMSLIB00000841582|CCMSLIB00003136255|CCMSLIB00005772775|CCMSLIB00006115781|CCMSLIB00006115783|CCMSLIB00006115784|CCMSLIB00006115786|CCMSLIB00006115788|CCMSLIB00006115798|CCMSLIB00006115800|CCMSLIB00006115802|CCMSLIB00006115803|CCMSLIB00006115805|CCMSLIB00006685011|CCMSLIB00010131632|CCMSLIB00010131633|CCMSLIB00010131635|CCMSLIB00010131638,-2.02,1535,Drug_analog,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012723896,related spectra of 'enoxolone (delta mass:-44.03)',CCMSLIB00000566599|CCMSLIB00000567526|CCMSLIB00004691639|CCMSLIB00004704574|CCMSLIB00004704575|CCMSLIB00005733345|CCMSLIB00005735077|CCMSLIB00010118331|CCMSLIB00010118332,-44.03,1536,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723897,related spectra of 'enoxolone (delta mass:-44.03)',CCMSLIB00000567526|CCMSLIB00005733345,-44.03,1537,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723898,related spectra of 'enoxolone (delta mass:-26.02)',CCMSLIB00010118337,-26.02,1538,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723899,related spectra of 'enoxolone (delta mass:-44.03)',CCMSLIB00000567526|CCMSLIB00004691639|CCMSLIB00004704574|CCMSLIB00005733345|CCMSLIB00010118331|CCMSLIB00010118332,-44.03,1539,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723900,related spectra of 'ergocalciferol (delta mass:29.97)',CCMSLIB00010125983,29.97,1540,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723901,related spectra of 'enoxolone (delta mass:-44.03)',CCMSLIB00000567526|CCMSLIB00004691639|CCMSLIB00004704574|CCMSLIB00005733345|CCMSLIB00010118331|CCMSLIB00010118332,-44.03,1541,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723902,related spectra of 'enoxolone (delta mass:-44.03)',CCMSLIB00010118331|CCMSLIB00010118332,-44.03,1542,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723903,related spectra of 'ergocalciferol (delta mass:29.97)',CCMSLIB00010114654,29.97,1543,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723904,related spectra of 'betulinic acid (delta mass:-12.0)',CCMSLIB00010124192,-12,1544,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012723905,related spectra of 'ergocalciferol (delta mass:30.01)',CCMSLIB00010114654,30.01,1545,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723906,related spectra of 'fursultiamine (delta mass:28.99)',CCMSLIB00010141026,28.99,1546,Drug_analog,fursultiamine,"vitamin B1, plain",metabolism,thiamine deficiency,vitamin B1 derivate,JTLXCMOFVBXEKD-FOWTUZBSSA-N
CCMSLIB00012723907,related spectra of 'irbesartan (delta mass:-2.02)',CCMSLIB00000005541,-2.02,1547,Drug_analog,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012723908,related spectra of 'benzethonium (delta mass:15.99)',CCMSLIB00010129859|CCMSLIB00010129860,15.99,1548,Drug_analog,benzethonium,antiseptics and disinfectants,infectious disease,first-aid antiseptic,disruption of cell membranes,SIYLLGKDQZGJHK-UHFFFAOYSA-N
CCMSLIB00012723909,related spectra of 'lactulose (delta mass:42.01)',CCMSLIB00006122276|CCMSLIB00006122278|CCMSLIB00006122280|CCMSLIB00006122282|CCMSLIB00006122284,42.01,1549,Drug_analog|Low_confidence,lactulose,osmotic laxative,gastroenterology,portal-systemic encephalopathy (PSE)|constipation,laxative,JCQLYHFGKNRPGE-FCVZTGTOSA-N
CCMSLIB00012723910,related spectra of 'ranolazine (delta mass:1.0)',CCMSLIB00000078297|CCMSLIB00000078966|CCMSLIB00000085217|CCMSLIB00000085488,1,1550,Drug_analog,ranolazine,antianginal,cardiology,chronic stable angina,sodium channel blocker,XKLMZUWKNUAPSZ-UHFFFAOYSA-N
CCMSLIB00012723911,related spectra of 'ergocalciferol (delta mass:31.99)',CCMSLIB00010125983,31.99,1551,Drug_analog|Low_confidence,ergocalciferol,provitamin D2 compound,endocrinology,hypoparathyroidism|rickets|hypophosphatemia,vitamin analog,MECHNRXZTMCUDQ-RKHKHRCZSA-N
CCMSLIB00012723912,related spectra of 'carminic acid (delta mass:-59.98)',CCMSLIB00010113105|CCMSLIB00010113108,-59.98,1552,Drug_analog,carminic acid,no_match,no_match,no_match,no_match,DGQLVPJVXFOQEV-JNVSTXMASA-N
CCMSLIB00012723913,related spectra of 'mifepristone (delta mass:1.0)',CCMSLIB00008851494|CCMSLIB00010130669|CCMSLIB00010130673,1,1553,Drug_analog,mifepristone,progestin antagonist,endocrinology|obstetrics/gynecology,hyperglycemia|Cushing syndrome|pregnancy termination,glucocorticoid receptor antagonist|progesterone receptor antagonist,VKHAHZOOUSRJNA-GCNJZUOMSA-N
CCMSLIB00012723914,related spectra of 'enoxolone (delta mass:-40.03)',CCMSLIB00010118331|CCMSLIB00010118332,-40.03,1554,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723915,related spectra of 'enoxolone (delta mass:-40.03)',CCMSLIB00000567526|CCMSLIB00004704575|CCMSLIB00005733345,-40.03,1555,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723916,related spectra of 'enoxolone (delta mass:-40.03)',CCMSLIB00000566736|CCMSLIB00005736117,-40.03,1556,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723917,related spectra of 'isoquercetin (delta mass:-31.99)',CCMSLIB00005743053,-31.99,1557,Drug_analog,isoquercetin,no_match,NA,NA,aldose reductase inhibitor,OVSQVDMCBVZWGM-QSOFNFLRSA-N
CCMSLIB00012723918,related spectra of 'enoxolone (delta mass:-38.02)',CCMSLIB00000566736|CCMSLIB00005736117,-38.02,1558,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723919,"related spectra of 'valsartan (delta mass:-2.02)', 'valsartan (delta mass:-2.01)'",CCMSLIB00000078331|CCMSLIB00000079131|CCMSLIB00000209773|CCMSLIB00000209775|CCMSLIB00000209785|CCMSLIB00000209787|CCMSLIB00000579796|CCMSLIB00000841928|CCMSLIB00003138031|CCMSLIB00005772245|CCMSLIB00005773587|CCMSLIB00005773820|CCMSLIB00005774674|CCMSLIB00005775793|CCMSLIB00005776368|CCMSLIB00006116250|CCMSLIB00006116252|CCMSLIB00006116253|CCMSLIB00006116255|CCMSLIB00006116257|CCMSLIB00006116267|CCMSLIB00006116268|CCMSLIB00006116270|CCMSLIB00006116272|CCMSLIB00006116274|CCMSLIB00006680041|CCMSLIB00006685103|CCMSLIB00006685220|CCMSLIB00010140221|CCMSLIB00010140222|CCMSLIB00010140223|CCMSLIB00010147620|CCMSLIB00010147621|CCMSLIB00010147622|CCMSLIB00010147625|CCMSLIB00010147627,-2.02,1559,Drug_analog,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012723920,related spectra of 'isoquercetin (delta mass:-28.0)',CCMSLIB00005777828,-27.99,1560,Drug_analog,isoquercetin,no_match,NA,NA,aldose reductase inhibitor,OVSQVDMCBVZWGM-QSOFNFLRSA-N
CCMSLIB00012723921,related spectra of 'latanoprost (delta mass:2.02)',CCMSLIB00010143081|CCMSLIB00010143082|CCMSLIB00010143083|CCMSLIB00010143086,2.02,1561,Drug_analog,latanoprost,prostaglandin analog,ophthalmology,ocular hypertension|glaucoma,prostanoid receptor agonist,GGXICVAJURFBLW-CEYXHVGTSA-N
CCMSLIB00012723922,related spectra of 'enoxolone (delta mass:-36.02)',CCMSLIB00004691639|CCMSLIB00004704574|CCMSLIB00010118331|CCMSLIB00010118332,-36.02,1562,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723923,related spectra of 'boldenone undecylenate (delta mass:-17.97)',CCMSLIB00010145787,-17.97,1563,Drug_analog,boldenone undecylenate,no_match,no_match,no_match,no_match,AHMMSNQYOPMLSX-CNQKSJKFSA-N
CCMSLIB00012723924,"related spectra of 'losartan (delta mass:13.98)', 'losartan (delta mass:31.99)'",CCMSLIB00005774716|CCMSLIB00010129973|CCMSLIB00010129985|CCMSLIB00010129986|CCMSLIB00010139536|CCMSLIB00010139537,13.98|31.99,1564,Drug_analog,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012723925,related spectra of 'losartan (delta mass:13.98)',CCMSLIB00000572723|CCMSLIB00005730071|CCMSLIB00005775756,13.98,1565,Drug_analog,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012723926,related spectra of 'enoxolone (delta mass:-16.03)',CCMSLIB00010118337,-16.03,1566,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723927,related spectra of 'enoxolone (delta mass:-15.99)',CCMSLIB00010106998,-15.99,1567,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723928,"related spectra of 'losartan (delta mass:15.99)', 'losartan carboxaldehyde (delta mass:18.01)', 'losartan carboxylic acid (delta mass:2.02)', 'losartan (delta mass:16.0)', 'losartan carboxylic acid (delta mass:2.01)'",CCMSLIB00000579704|CCMSLIB00000841586|CCMSLIB00000841926|CCMSLIB00003061260|CCMSLIB00003061261|CCMSLIB00003061262|CCMSLIB00005774648|CCMSLIB00005776014,15.99|18.01|2.02,1568,Drug_analog,losartan|losartan carboxylic acid|losartan carboxaldehyde,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N|ZEUXAIYYDDCIRX-UHFFFAOYSA-N|FQZSMTSTFMNWQF-UHFFFAOYSA-N
CCMSLIB00012723929,related spectra of 'losartan (delta mass:15.98)',CCMSLIB00010129985|CCMSLIB00010129986|CCMSLIB00010139536|CCMSLIB00010139537,15.97,1569,Drug_analog,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012723930,"related spectra of 'losartan (delta mass:34.01)', 'losartan carboxylic acid (delta mass:2.0)', 'losartan (delta mass:15.99)', 'losartan carboxaldehyde (delta mass:18.01)', 'losartan carboxylic acid (delta mass:2.02)', 'losartan (delta mass:16.0)'",CCMSLIB00000085308|CCMSLIB00000579704|CCMSLIB00000841586|CCMSLIB00000841926|CCMSLIB00003061260|CCMSLIB00003061261|CCMSLIB00003061262|CCMSLIB00005774648|CCMSLIB00005775756|CCMSLIB00005776014|CCMSLIB00010129972|CCMSLIB00010129985|CCMSLIB00010129986|CCMSLIB00010139536|CCMSLIB00010139537,34.01|15.99|18.01|2.02,1570,Drug_analog,losartan|losartan carboxylic acid|losartan carboxaldehyde,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N|ZEUXAIYYDDCIRX-UHFFFAOYSA-N|FQZSMTSTFMNWQF-UHFFFAOYSA-N
CCMSLIB00012723931,related spectra of 'losartan (delta mass:15.99)',CCMSLIB00000572723|CCMSLIB00005730071|CCMSLIB00005775756|CCMSLIB00010129985|CCMSLIB00010129986|CCMSLIB00010139536|CCMSLIB00010139537,15.99,1571,Drug_analog,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012723932,"related spectra of 'losartan (delta mass:15.99)', 'losartan carboxaldehyde (delta mass:18.01)', 'losartan carboxylic acid (delta mass:2.02)', 'losartan (delta mass:16.0)', 'losartan carboxylic acid (delta mass:2.01)'",CCMSLIB00000085308|CCMSLIB00000572307|CCMSLIB00000572884|CCMSLIB00000579704|CCMSLIB00000841586|CCMSLIB00000841926|CCMSLIB00003061260|CCMSLIB00003061261|CCMSLIB00003061262|CCMSLIB00005730404|CCMSLIB00005736096|CCMSLIB00010129989|CCMSLIB00010139539,15.99|18.01|2.02,1572,Drug_analog,losartan|losartan carboxylic acid|losartan carboxaldehyde,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N|ZEUXAIYYDDCIRX-UHFFFAOYSA-N|FQZSMTSTFMNWQF-UHFFFAOYSA-N
CCMSLIB00012723933,"related spectra of 'losartan (delta mass:15.99)', 'losartan carboxaldehyde (delta mass:18.01)', 'losartan carboxylic acid (delta mass:2.02)', 'losartan (delta mass:16.0)', 'losartan carboxylic acid (delta mass:2.01)'",CCMSLIB00003061261|CCMSLIB00003061262|CCMSLIB00005774648|CCMSLIB00005776014,15.99|18.01|2.02,1573,Drug_analog,losartan carboxylic acid|losartan carboxaldehyde|losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,ZEUXAIYYDDCIRX-UHFFFAOYSA-N|FQZSMTSTFMNWQF-UHFFFAOYSA-N|PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012723934,related spectra of 'losartan carboxaldehyde (delta mass:18.01)',CCMSLIB00003061262,18.01,1574,Drug_analog,losartan carboxaldehyde,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,FQZSMTSTFMNWQF-UHFFFAOYSA-N
CCMSLIB00012723935,related spectra of 'losartan carboxylic acid (delta mass:2.02)',CCMSLIB00003061261,2.02,1575,Drug_analog,losartan carboxylic acid,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,ZEUXAIYYDDCIRX-UHFFFAOYSA-N
CCMSLIB00012723936,related spectra of 'enoxolone (delta mass:-14.02)',CCMSLIB00010106998|CCMSLIB00010118337,-14.02,1576,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723937,related spectra of 'enoxolone (delta mass:-14.02)',CCMSLIB00010106998,-14.02,1577,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723938,related spectra of 'enoxolone (delta mass:-31.99)',CCMSLIB00000566599|CCMSLIB00004691639|CCMSLIB00004704574|CCMSLIB00005735077|CCMSLIB00010106992|CCMSLIB00010106993,-31.99,1578,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723939,related spectra of 'enoxolone (delta mass:-31.99)',CCMSLIB00000566599|CCMSLIB00004691639|CCMSLIB00004704574|CCMSLIB00005735077|CCMSLIB00010118331|CCMSLIB00010118332,-31.99,1579,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723940,related spectra of 'enoxolone (delta mass:-31.99)',CCMSLIB00010118331|CCMSLIB00010118332,-31.99,1580,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723941,related spectra of 'betulinic acid (delta mass:1.0)',CCMSLIB00010112869|CCMSLIB00010124192,1,1581,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012723942,related spectra of 'betulinic acid (delta mass:1.0)',CCMSLIB00010112869|CCMSLIB00010124192,1,1582,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012723943,related spectra of 'lovastatin (delta mass:36.02)',CCMSLIB00000077133|CCMSLIB00000566315|CCMSLIB00005435737|CCMSLIB00005733502|CCMSLIB00005772125|CCMSLIB00005773354|CCMSLIB00005775228|CCMSLIB00006116679|CCMSLIB00006116681|CCMSLIB00006116683|CCMSLIB00006116685,36.02,1583,Drug_analog,lovastatin,HMG-CoA reductase inhibitor (statin),endocrinology|cardiology|neurology/psychiatry,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,PCZOHLXUXFIOCF-BXMDZJJMSA-N
CCMSLIB00012723944,related spectra of 'calpain inhibitor i (delta mass:57.02)',CCMSLIB00010136857|CCMSLIB00010136858|CCMSLIB00010136860|CCMSLIB00010136861,57.02,1584,Drug_analog,calpain inhibitor i,no_match,no_match,no_match,no_match,FMYKJLXRRQTBOR-BZSNNMDCSA-N
CCMSLIB00012723945,related spectra of 'enoxolone (delta mass:-30.01)',CCMSLIB00000567526|CCMSLIB00004704575|CCMSLIB00005733345,-30.01,1585,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723946,related spectra of 'enoxolone (delta mass:-30.01)',CCMSLIB00010118331,-30.01,1586,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723947,related spectra of 'enoxolone (delta mass:-30.01)',CCMSLIB00010118331,-30.01,1587,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723948,related spectra of 'enoxolone (delta mass:-30.01)',CCMSLIB00010118331|CCMSLIB00010118332,-30.01,1588,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723949,related spectra of 'enoxolone (delta mass:-30.01)',CCMSLIB00000567526|CCMSLIB00005733345,-30.01,1589,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723950,related spectra of 'enoxolone (delta mass:-30.01)',CCMSLIB00000567526|CCMSLIB00005733345,-30.01,1590,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723951,related spectra of 'enoxolone (delta mass:-12.0)',CCMSLIB00010118337,-12,1591,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723952,related spectra of 'enoxolone (delta mass:-30.01)',CCMSLIB00010118332,-30.01,1592,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723953,related spectra of 'enoxolone (delta mass:-30.01)',CCMSLIB00000567526|CCMSLIB00005733345|CCMSLIB00010118331,-30.01,1593,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723954,related spectra of 'enoxolone (delta mass:-29.98)',CCMSLIB00004691638|CCMSLIB00004704573|CCMSLIB00010106993,-29.97,1594,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723955,"related spectra of 'enoxolone (delta mass:-29.97)', 'enoxolone (delta mass:-29.98)'",CCMSLIB00004691638|CCMSLIB00004704573|CCMSLIB00010106992|CCMSLIB00010106993,-29.97,1595,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723956,"related spectra of 'enoxolone (delta mass:-29.97)', 'enoxolone (delta mass:-29.98)'",CCMSLIB00010106993,-29.97,1596,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723957,"related spectra of 'enoxolone (delta mass:-29.97)', 'enoxolone (delta mass:-29.98)'",CCMSLIB00004691638|CCMSLIB00004704573,-29.97,1597,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723958,"related spectra of 'enoxolone (delta mass:-29.97)', 'enoxolone (delta mass:-29.98)'",CCMSLIB00010106993,-29.97,1598,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723959,"related spectra of 'enoxolone (delta mass:-29.97)', 'enoxolone (delta mass:-29.98)'",CCMSLIB00004691638|CCMSLIB00004704573,-29.97,1599,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723960,related spectra of 'betulinic acid (delta mass:2.02)',CCMSLIB00010124192,2.02,1600,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012723961,related spectra of 'enoxolone (delta mass:-29.97)',CCMSLIB00004691639|CCMSLIB00004704574|CCMSLIB00010106993,-29.97,1601,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723962,related spectra of 'enoxolone (delta mass:-29.97)',CCMSLIB00000567526|CCMSLIB00004704575|CCMSLIB00005733345|CCMSLIB00010118332,-29.97,1602,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723963,related spectra of 'enoxolone (delta mass:-29.97)',CCMSLIB00004691638|CCMSLIB00010106993,-29.97,1603,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723964,related spectra of 'enoxolone (delta mass:-29.97)',CCMSLIB00000566599|CCMSLIB00004691639|CCMSLIB00004704574|CCMSLIB00005735077,-29.97,1604,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723965,related spectra of 'enoxolone (delta mass:-29.97)',CCMSLIB00010106992|CCMSLIB00010106993,-29.97,1605,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723966,related spectra of 'enoxolone (delta mass:-29.97)',CCMSLIB00004691638,-29.97,1606,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723967,related spectra of 'enoxolone (delta mass:-29.97)',CCMSLIB00010106993,-29.97,1607,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723968,related spectra of 'enoxolone (delta mass:-29.97)',CCMSLIB00010106993,-29.97,1608,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723969,related spectra of 'tasosartan (delta mass:29.98)',CCMSLIB00010138546|CCMSLIB00010138547|CCMSLIB00010138691|CCMSLIB00010138692,29.97,1609,Drug_analog,tasosartan,angiotensin II receptor blocker,cardiology,hypertension,angiotensin receptor antagonist,ADXGNEYLLLSOAR-UHFFFAOYSA-N
CCMSLIB00012723970,related spectra of 'tasosartan (delta mass:29.98)',CCMSLIB00010138546|CCMSLIB00010138547|CCMSLIB00010138691|CCMSLIB00010138692,29.97,1610,Drug_analog,tasosartan,angiotensin II receptor blocker,cardiology,hypertension,angiotensin receptor antagonist,ADXGNEYLLLSOAR-UHFFFAOYSA-N
CCMSLIB00012723971,related spectra of 'bardoxolone methyl (delta mass:-63.96)',CCMSLIB00010135024,-63.96,1611,Drug_analog,bardoxolone methyl,no_match,NA,NA,nuclear factor erythroid derived|like (NRF2) activator,WPTTVJLTNAWYAO-KPOXMGGZSA-N
CCMSLIB00012723972,related spectra of 'n-desmethylclindamycin sulfoxide (delta mass:15.99)',CCMSLIB00005716878,15.99,1612,Drug_analog,n-desmethylclindamycin sulfoxide,lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,RKZYQAJFAZGGKD-UHFFFAOYSA-N
CCMSLIB00012723973,related spectra of 'n-desmethylclindamycin sulfoxide (delta mass:15.99)',CCMSLIB00005716878,15.99,1613,Drug_analog,n-desmethylclindamycin sulfoxide,lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,RKZYQAJFAZGGKD-UHFFFAOYSA-N
CCMSLIB00012723974,related spectra of 'enoxolone (delta mass:-28.03)',CCMSLIB00000567526|CCMSLIB00005733345|CCMSLIB00010118331|CCMSLIB00010118332,-28.03,1614,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723975,related spectra of 'enoxolone (delta mass:-28.03)',CCMSLIB00000566736|CCMSLIB00000567526|CCMSLIB00004704575|CCMSLIB00005733345|CCMSLIB00005736117|CCMSLIB00010118331|CCMSLIB00010118332,-28.03,1615,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723976,related spectra of 'enoxolone (delta mass:-28.03)',CCMSLIB00004704575,-28.03,1616,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723977,related spectra of 'enoxolone (delta mass:-27.99)',CCMSLIB00000566599|CCMSLIB00004691639|CCMSLIB00004704574|CCMSLIB00005735077|CCMSLIB00010106992|CCMSLIB00010106993,-27.99,1617,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723978,related spectra of 'enoxolone (delta mass:-27.99)',CCMSLIB00004704575|CCMSLIB00010118331|CCMSLIB00010118332,-27.99,1618,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723979,related spectra of 'rapastinel (delta mass:30.01)',CCMSLIB00010129977|CCMSLIB00010129979|CCMSLIB00010129982,30.01,1619,Drug_analog,rapastinel,no_match,NA,NA,glutamate receptor agonist,GIBQQARAXHVEGD-BSOLPCOYSA-N
CCMSLIB00012723980,"related spectra of 'ranolazine (delta mass:16.0)', 'ranolazine (delta mass:15.99)'",CCMSLIB00000004290|CCMSLIB00000004291|CCMSLIB00000006033|CCMSLIB00000006034|CCMSLIB00000078297|CCMSLIB00000078966|CCMSLIB00000078967|CCMSLIB00000085217,15.99,1620,Drug_analog,ranolazine,antianginal,cardiology,chronic stable angina,sodium channel blocker,XKLMZUWKNUAPSZ-UHFFFAOYSA-N
CCMSLIB00012723981,related spectra of 'enoxolone (delta mass:-27.05)',CCMSLIB00000566736|CCMSLIB00005736117,-27.05,1621,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723982,"related spectra of 'irbesartan (delta mass:15.99)', 'irbesartan (delta mass:16.0)'",CCMSLIB00000005547|CCMSLIB00000078173|CCMSLIB00000079128|CCMSLIB00000210860|CCMSLIB00000210862|CCMSLIB00000210873|CCMSLIB00000210874|CCMSLIB00000579827|CCMSLIB00000841582|CCMSLIB00003136255|CCMSLIB00005772775|CCMSLIB00006115781|CCMSLIB00006115783|CCMSLIB00006115784|CCMSLIB00006115786|CCMSLIB00006115788|CCMSLIB00006115798|CCMSLIB00006115800|CCMSLIB00006115802|CCMSLIB00006115803|CCMSLIB00006115805|CCMSLIB00006685011|CCMSLIB00010131632|CCMSLIB00010131633|CCMSLIB00010131635|CCMSLIB00010131638,15.99,1622,Drug_analog,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012723983,related spectra of 'irbesartan (delta mass:15.99)',CCMSLIB00000210860|CCMSLIB00000210862|CCMSLIB00000210873|CCMSLIB00000210874|CCMSLIB00000579827|CCMSLIB00000841582|CCMSLIB00006115781|CCMSLIB00006115783|CCMSLIB00006115784|CCMSLIB00006115786|CCMSLIB00006115788|CCMSLIB00006115798|CCMSLIB00006115800|CCMSLIB00006115802|CCMSLIB00006115803|CCMSLIB00006115805|CCMSLIB00006685011|CCMSLIB00010131633|CCMSLIB00010131635|CCMSLIB00010131638,15.99,1623,Drug_analog,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012723984,related spectra of 'enoxolone (delta mass:-26.02)',CCMSLIB00000567526|CCMSLIB00005733345,-26.02,1624,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723985,related spectra of 'docusate sodium (delta mass:1.0)',CCMSLIB00003136961|CCMSLIB00003139039,1,1625,Drug_analog,docusate sodium,"softeners, emollients",gastroenterology,constipation,laxative,HNSDLXPSAYFUHK-UHFFFAOYSA-N
CCMSLIB00012723986,related spectra of 'aripiprazole (delta mass:2.0)',CCMSLIB00000085956,2,1626,Drug_analog,aripiprazole,atypical antipsychotic,neurology/psychiatry,depression|schizophrenia|bipolar disorder,D2 and 5-HT1A receptor partial agonist|5-HT2A receptor antagonist,CEUORZQYGODEFX-UHFFFAOYSA-N
CCMSLIB00012723987,related spectra of 'valsartan (delta mass:13.98)',CCMSLIB00003138031|CCMSLIB00006116252|CCMSLIB00006116253|CCMSLIB00006116267|CCMSLIB00006116268|CCMSLIB00006116270|CCMSLIB00006116272|CCMSLIB00006116274|CCMSLIB00006685103|CCMSLIB00010140222|CCMSLIB00010147620|CCMSLIB00010147621,13.98,1627,Drug_analog,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012723988,"related spectra of 'valsartan (delta mass:14.02)', 'valsartan (delta mass:14.01)'",CCMSLIB00000209775|CCMSLIB00000209787|CCMSLIB00003138031|CCMSLIB00006116250|CCMSLIB00006116252|CCMSLIB00006116253|CCMSLIB00006116267|CCMSLIB00006116268|CCMSLIB00006116270|CCMSLIB00006116272|CCMSLIB00006116274|CCMSLIB00010140222|CCMSLIB00010147620|CCMSLIB00010147621,14.02,1628,Drug_analog,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012723989,related spectra of 'enoxolone (delta mass:-20.03)',CCMSLIB00000566736|CCMSLIB00005736117,-20.03,1629,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012723990,"related spectra of 'valsartan (delta mass:15.99)', 'valsartan (delta mass:16.0)'",CCMSLIB00000005789|CCMSLIB00000209775|CCMSLIB00000209777|CCMSLIB00000209787|CCMSLIB00000209789|CCMSLIB00003138031|CCMSLIB00005773587|CCMSLIB00005773739|CCMSLIB00005776368|CCMSLIB00006116267|CCMSLIB00006116270|CCMSLIB00006116272|CCMSLIB00006116274|CCMSLIB00006685220|CCMSLIB00010140223|CCMSLIB00010147622|CCMSLIB00010147625,15.99,1630,Drug_analog,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012723991,"related spectra of 'valsartan (delta mass:15.96)', 'valsartan (delta mass:15.97)'",CCMSLIB00000005789|CCMSLIB00000209775|CCMSLIB00000209787|CCMSLIB00003138031|CCMSLIB00005773587,15.96,1631,Drug_analog,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012723992,related spectra of 'miltefosine (delta mass:43.99)',CCMSLIB00010132195|CCMSLIB00010132196|CCMSLIB00010132197,43.99,1632,Drug_analog|Low_confidence,miltefosine,antileishmanial drug,infectious disease,leishmaniasis,membrane integrity inhibitor,PQLXHQMOHUQAKB-UHFFFAOYSA-N
CCMSLIB00012723993,related spectra of 'miltefosine (delta mass:43.99)',CCMSLIB00010132197,43.99,1633,Drug_analog|Low_confidence,miltefosine,antileishmanial drug,infectious disease,leishmaniasis,membrane integrity inhibitor,PQLXHQMOHUQAKB-UHFFFAOYSA-N
CCMSLIB00012723994,"related spectra of 'fipronil sulfone (delta mass:1.99)', 'fipronil sulfone (delta mass:2.0)'",CCMSLIB00005772351|CCMSLIB00005776236,2,1634,Drug_analog,fipronil sulfone,ectoparaciticide|veterinary,infectious disease,flea control,chloride channel blocker|GABA gated chloride channel blocker,LGHZJDKSVUTELU-UHFFFAOYSA-N
CCMSLIB00012723995,related spectra of 'aztreonam (delta mass:17.03)',CCMSLIB00000078170,17.03,1635,Drug_analog,aztreonam,monobactam antibacterial,infectious disease,urinary tract infections|respiratory tract infections|bacterial septicemia|skin infections|intra-abdominal infections|gynecologic infections,bacterial cell wall synthesis inhibitor,WZPBZJONDBGPKJ-DZIOLEBDSA-N
CCMSLIB00012723996,"related spectra of 'rivaroxaban (delta mass:17.03)', '5-r-rivaroxaban (delta mass:17.03)'",CCMSLIB00010130929|CCMSLIB00010130930|CCMSLIB00010147172|CCMSLIB00010147173|CCMSLIB00010147175,17.03,1636,Drug_analog,rivaroxaban|5-r-rivaroxaban,factor Xa inhibitor,hematology|cardiology|neurology/psychiatry,stroke|systemic embolism|atrial fibrillation (AF)|deep vein thrombosis (DVT)|pulmonary embolism (PE),coagulation factor inhibitor,KGFYHTZWPPHNLQ-AWEZNQCLSA-N|KGFYHTZWPPHNLQ-CQSZACIVSA-N
CCMSLIB00012723997,"related spectra of 'losartan (delta mass:29.97)', 'losartan (delta mass:29.98)'",CCMSLIB00000085308|CCMSLIB00000572723|CCMSLIB00005730071|CCMSLIB00005775756|CCMSLIB00010129985|CCMSLIB00010129986|CCMSLIB00010129987|CCMSLIB00010139536|CCMSLIB00010139537|CCMSLIB00010139538,29.97,1637,Drug_analog,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012723998,related spectra of 'losartan (delta mass:29.97)',CCMSLIB00005775756,29.97,1638,Drug_analog,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012723999,"related spectra of 'valsartan (delta mass:17.02)', 'valsartan (delta mass:17.03)'",CCMSLIB00000005787|CCMSLIB00000005788|CCMSLIB00000078331|CCMSLIB00000079131|CCMSLIB00000209771|CCMSLIB00000209773|CCMSLIB00000209783|CCMSLIB00000209785|CCMSLIB00000579796|CCMSLIB00000841928|CCMSLIB00005750091|CCMSLIB00005750126|CCMSLIB00005772245|CCMSLIB00005772329|CCMSLIB00005773820|CCMSLIB00005773889|CCMSLIB00005774674|CCMSLIB00005776559|CCMSLIB00005777054|CCMSLIB00006116250|CCMSLIB00006116252|CCMSLIB00006116253|CCMSLIB00006116257|CCMSLIB00006680041|CCMSLIB00006685103|CCMSLIB00006685115|CCMSLIB00010140221|CCMSLIB00010140222|CCMSLIB00010140224|CCMSLIB00010147621|CCMSLIB00010147623|CCMSLIB00010147624|CCMSLIB00010147626|CCMSLIB00010147627,17.03,1639,Drug_analog,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012724000,related spectra of 'valsartan (delta mass:17.03)',CCMSLIB00000209773|CCMSLIB00000209785|CCMSLIB00005773587|CCMSLIB00006685103,17.03,1640,Drug_analog,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012724001,related spectra of 'valsartan (delta mass:17.03)',CCMSLIB00000078331|CCMSLIB00005776368|CCMSLIB00006116255|CCMSLIB00006116257,17.03,1641,Drug_analog,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012724002,related spectra of 'akba (delta mass:-60.02)',CCMSLIB00010144080,-60.02,1642,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724003,related spectra of 'betulinic acid (delta mass:13.98)',CCMSLIB00010112869|CCMSLIB00010124192,13.98,1643,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012724004,related spectra of 'akba (delta mass:-60.02)',CCMSLIB00010144080,-60.02,1644,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724005,related spectra of 'akba (delta mass:-60.02)',CCMSLIB00010144080,-60.02,1645,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724006,related spectra of 'akba (delta mass:-60.02)',CCMSLIB00010144080,-60.02,1646,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724007,related spectra of 'akba (delta mass:-60.02)',CCMSLIB00010144080,-60.02,1647,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724008,related spectra of 'betulinic acid (delta mass:14.02)',CCMSLIB00010112869|CCMSLIB00010124192,14.02,1648,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012724009,related spectra of 'enoxolone (delta mass:1.0)',CCMSLIB00010106998,1,1649,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724010,related spectra of 'enoxolone (delta mass:-16.03)',CCMSLIB00000566736|CCMSLIB00005736117,-16.03,1650,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724011,related spectra of 'enoxolone (delta mass:-16.03)',CCMSLIB00004704575|CCMSLIB00010118331|CCMSLIB00010118332,-16.03,1651,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724012,related spectra of 'enoxolone (delta mass:1.98)',CCMSLIB00010118337,1.98,1652,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724013,"related spectra of 'enoxolone (delta mass:1.98)', 'enoxolone (delta mass:-16.03)'",CCMSLIB00000567526|CCMSLIB00005733345|CCMSLIB00010118337,1.98|-16.03,1653,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724014,"related spectra of 'akba (delta mass:-58.04)', 'enoxolone (delta mass:-16.03)'",CCMSLIB00004704575|CCMSLIB00010118331|CCMSLIB00010118332|CCMSLIB00010144080,-58.04|-16.03,1654,Drug_analog,enoxolone|akba,no_match,NA,NA,gap junction modulator|lipoxygenase inhibitor,MPDGHEJMBKOTSU-YKLVYJNSSA-N|HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724015,related spectra of 'enoxolone (delta mass:-16.03)',CCMSLIB00000566736|CCMSLIB00004704575|CCMSLIB00005736117,-16.03,1655,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724016,related spectra of 'enoxolone (delta mass:-16.03)',CCMSLIB00010118331|CCMSLIB00010118332,-16.03,1656,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724017,related spectra of 'akba (delta mass:-58.04)',CCMSLIB00010144080,-58.04,1657,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724018,related spectra of 'betulinic acid (delta mass:15.99)',CCMSLIB00010124192,15.99,1658,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012724019,related spectra of 'betulinic acid (delta mass:15.99)',CCMSLIB00010124192,15.99,1659,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012724020,"related spectra of 'enoxolone (delta mass:-16.0)', 'enoxolone (delta mass:-15.99)'",CCMSLIB00000567526|CCMSLIB00004704575|CCMSLIB00005733345|CCMSLIB00010118331|CCMSLIB00010118332,-15.99,1660,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724021,related spectra of 'enoxolone (delta mass:2.02)',CCMSLIB00010118337,2.02,1661,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724022,related spectra of 'enoxolone (delta mass:-16.0)',CCMSLIB00000567526|CCMSLIB00005733345|CCMSLIB00010118331|CCMSLIB00010118332,-15.99,1662,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724023,related spectra of 'enoxolone (delta mass:-16.0)',CCMSLIB00000566599|CCMSLIB00004691639|CCMSLIB00004704574|CCMSLIB00005735077,-15.99,1663,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724024,related spectra of 'enoxolone (delta mass:-15.99)',CCMSLIB00004691639|CCMSLIB00004704574,-15.99,1664,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724025,related spectra of 'enoxolone (delta mass:-15.99)',CCMSLIB00010106993|CCMSLIB00010118331|CCMSLIB00010118332,-15.99,1665,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724026,related spectra of 'enoxolone (delta mass:-15.99)',CCMSLIB00004691638|CCMSLIB00010106992,-15.99,1666,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724027,related spectra of 'enoxolone (delta mass:-15.99)',CCMSLIB00000566599|CCMSLIB00004691639|CCMSLIB00004704574|CCMSLIB00005735077|CCMSLIB00010106992|CCMSLIB00010106993,-15.99,1667,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724028,related spectra of 'enoxolone (delta mass:-15.99)',CCMSLIB00000566599|CCMSLIB00004691639|CCMSLIB00004704574|CCMSLIB00005735077,-15.99,1668,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724029,"related spectra of 'enoxolone (delta mass:2.02)', 'enoxolone (delta mass:-15.99)'",CCMSLIB00004704575|CCMSLIB00010118337,2.02|-15.99,1669,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724030,related spectra of 'enoxolone (delta mass:-15.99)',CCMSLIB00010118331|CCMSLIB00010118332,-15.99,1670,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724031,related spectra of 'enoxolone (delta mass:-15.99)',CCMSLIB00004691639|CCMSLIB00004704574,-15.99,1671,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724032,related spectra of 'enoxolone (delta mass:-15.99)',CCMSLIB00004691638,-15.99,1672,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724033,related spectra of 'enoxolone (delta mass:-15.99)',CCMSLIB00000566599|CCMSLIB00004691638|CCMSLIB00004704573|CCMSLIB00004704574|CCMSLIB00005735077|CCMSLIB00010106992|CCMSLIB00010106993,-15.99,1673,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724034,related spectra of 'enoxolone (delta mass:-15.99)',CCMSLIB00000566599|CCMSLIB00004691639|CCMSLIB00004704574|CCMSLIB00005735077|CCMSLIB00010118331|CCMSLIB00010118332,-15.99,1674,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724035,related spectra of 'enoxolone (delta mass:-14.02)',CCMSLIB00000567526|CCMSLIB00004704575|CCMSLIB00005733345|CCMSLIB00010118331|CCMSLIB00010118332,-14.02,1675,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724036,"related spectra of 'akba (delta mass:-56.03)', 'enoxolone (delta mass:-14.02)'",CCMSLIB00000567526|CCMSLIB00005733345|CCMSLIB00010118331|CCMSLIB00010118332|CCMSLIB00010144080,-56.03|-14.02,1676,Drug_analog,enoxolone|akba,no_match,NA,NA,gap junction modulator|lipoxygenase inhibitor,MPDGHEJMBKOTSU-YKLVYJNSSA-N|HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724037,related spectra of 'enoxolone (delta mass:-14.02)',CCMSLIB00000567526|CCMSLIB00005733345|CCMSLIB00010118331|CCMSLIB00010118332,-14.02,1677,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724038,related spectra of 'akba (delta mass:-56.03)',CCMSLIB00010144080,-56.03,1678,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724039,"related spectra of 'akba (delta mass:-56.03)', 'enoxolone (delta mass:-14.02)'",CCMSLIB00000567526|CCMSLIB00005733345|CCMSLIB00010118331|CCMSLIB00010118332|CCMSLIB00010144080,-56.03|-14.02,1679,Drug_analog,enoxolone|akba,no_match,NA,NA,gap junction modulator|lipoxygenase inhibitor,MPDGHEJMBKOTSU-YKLVYJNSSA-N|HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724040,related spectra of 'enoxolone (delta mass:-14.02)',CCMSLIB00010118331,-14.02,1680,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724041,related spectra of 'akba (delta mass:-56.03)',CCMSLIB00010144080,-56.03,1681,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724042,"related spectra of 'enoxolone (delta mass:3.99)', 'akba (delta mass:-56.03)'",CCMSLIB00010118337|CCMSLIB00010144080,3.99|-56.03,1682,Drug_analog,enoxolone|akba,no_match,NA,NA,gap junction modulator|lipoxygenase inhibitor,MPDGHEJMBKOTSU-YKLVYJNSSA-N|HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724043,related spectra of 'enoxolone (delta mass:-14.02)',CCMSLIB00010118331|CCMSLIB00010118332,-14.02,1683,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724044,related spectra of 'enoxolone (delta mass:-14.02)',CCMSLIB00000567526|CCMSLIB00005733345,-14.02,1684,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724045,related spectra of 'enoxolone (delta mass:-14.02)',CCMSLIB00000567526|CCMSLIB00005733345|CCMSLIB00010118331|CCMSLIB00010118332,-14.02,1685,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724046,related spectra of 'enoxolone (delta mass:-13.98)',CCMSLIB00004691638,-13.98,1686,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724047,related spectra of 'enoxolone (delta mass:-13.98)',CCMSLIB00000567526|CCMSLIB00004704575|CCMSLIB00005733345|CCMSLIB00010118331|CCMSLIB00010118332,-13.98,1687,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724048,related spectra of 'betulinic acid (delta mass:18.01)',CCMSLIB00010112869|CCMSLIB00010124192,18.01,1688,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012724049,related spectra of 'enoxolone (delta mass:-13.98)',CCMSLIB00004704573,-13.98,1689,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724050,related spectra of 'enoxolone (delta mass:-13.98)',CCMSLIB00004691638|CCMSLIB00004704573|CCMSLIB00010106992|CCMSLIB00010106993,-13.98,1690,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724051,related spectra of 'enoxolone (delta mass:-13.98)',CCMSLIB00004691638|CCMSLIB00004704573,-13.98,1691,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724052,related spectra of 'enoxolone (delta mass:-13.98)',CCMSLIB00010118331|CCMSLIB00010118332,-13.98,1692,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724053,related spectra of 'enoxolone (delta mass:-13.98)',CCMSLIB00004691638|CCMSLIB00010106992|CCMSLIB00010106993,-13.98,1693,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724054,related spectra of '69227-93-6 (delta mass:-70.08)',CCMSLIB00010133712|CCMSLIB00010133713|CCMSLIB00010133714|CCMSLIB00010133715|CCMSLIB00010133716,-70.08,1694,Drug_analog,69227-93-6,no_match,no_match,no_match,no_match,NLEBIOOXCVAHBD-QKMCSOCLSA-N
CCMSLIB00012724055,related spectra of 'neoandrographolide (delta mass:-40.03)',CCMSLIB00010147145,-40.03,1695,Drug_analog,neoandrographolide,no_match,no_match,no_match,no_match,YGCYRQKJYWQXHG-RDNQFMDVSA-N
CCMSLIB00012724056,related spectra of 'olmesartan (delta mass:30.01)',CCMSLIB00010138555,30.01,1696,Drug_analog,olmesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,VTRAEEWXHOVJFV-UHFFFAOYSA-N
CCMSLIB00012724057,related spectra of 'enoxolone (delta mass:-12.04)',CCMSLIB00010118331|CCMSLIB00010118332,-12.04,1697,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724058,related spectra of 'enoxolone (delta mass:-12.0)',CCMSLIB00010118331|CCMSLIB00010118332,-12,1698,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724059,related spectra of 'enoxolone (delta mass:-12.0)',CCMSLIB00010118332,-12,1699,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724060,related spectra of 'enoxolone (delta mass:-12.0)',CCMSLIB00010118332,-12,1700,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724061,related spectra of 'enoxolone (delta mass:-12.0)',CCMSLIB00010118331|CCMSLIB00010118332,-12,1701,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724062,related spectra of 'enoxolone (delta mass:-12.0)',CCMSLIB00010118331|CCMSLIB00010118332,-12,1702,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724063,related spectra of 'enoxolone (delta mass:-12.0)',CCMSLIB00010118331,-12,1703,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724064,related spectra of 'enoxolone (delta mass:-12.0)',CCMSLIB00010118331,-12,1704,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724065,related spectra of 'ranolazine (delta mass:31.99)',CCMSLIB00000078966|CCMSLIB00010138425|CCMSLIB00010152272|CCMSLIB00010152275|CCMSLIB00010152278,31.99,1705,Drug_analog,ranolazine|ranolazine,antianginal,cardiology,chronic stable angina,sodium channel blocker,XKLMZUWKNUAPSZ-UHFFFAOYSA-N
CCMSLIB00012724066,related spectra of 'sildenafil (delta mass:-14.02)',CCMSLIB00000085187,-14.02,1706,Drug_analog,sildenafil,phosphodiesterase-5 (PDE-5) inhibitor,urology|cardiology,erectile dysfunction|pulmonary arterial hypertension (PAH),phosphodiesterase inhibitor,BNRNXUUZRGQAQC-UHFFFAOYSA-N
CCMSLIB00012724067,"related spectra of 'glipizide (delta mass:16.0)', 'glipizide (delta mass:15.99)'",CCMSLIB00000006553|CCMSLIB00000078250|CCMSLIB00010148883|CCMSLIB00010148886,15.99,1707,Drug_analog,glipizide,sulfonylurea,endocrinology,type 2 diabetes mellitus,insulin secretagogue,ZJJXGWJIGJFDTL-UHFFFAOYSA-N
CCMSLIB00012724068,"related spectra of 'hydrocortisone valerate (delta mass:15.96)', 'hydrocortisone butyrate (delta mass:29.97)'",CCMSLIB00010107006|CCMSLIB00010107634,15.96|29.97,1708,Drug_analog,hydrocortisone butyrate|hydrocortisone valerate,corticosteroid,dermatology,corticosteroid-responsive dermatoses|eczema,glucocorticoid receptor agonist,BMCQMVFGOVHVNG-TUFAYURCSA-N|FZCHYNWYXKICIO-FZNHGJLXSA-N
CCMSLIB00012724069,related spectra of 'aripiprazole (delta mass:15.99)',CCMSLIB00006119218|CCMSLIB00006119219|CCMSLIB00006119221|CCMSLIB00006119233|CCMSLIB00006119235|CCMSLIB00006119237|CCMSLIB00006119239,15.99,1709,Drug_analog,aripiprazole,atypical antipsychotic,neurology/psychiatry,depression|schizophrenia|bipolar disorder,D2 and 5-HT1A receptor partial agonist|5-HT2A receptor antagonist,CEUORZQYGODEFX-UHFFFAOYSA-N
CCMSLIB00012724070,related spectra of 'enoxolone (delta mass:12.04)',CCMSLIB00010118337,12.04,1710,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724071,related spectra of 'isoquercetin (delta mass:1.01)',CCMSLIB00005738836|CCMSLIB00005747028,1,1711,Drug_analog,isoquercetin,no_match,NA,NA,aldose reductase inhibitor,OVSQVDMCBVZWGM-QSOFNFLRSA-N
CCMSLIB00012724072,"related spectra of 'miltefosine (delta mass:58.0)', 'miltefosine (delta mass:58.01)'",CCMSLIB00010132196|CCMSLIB00010132197,58.01,1712,Drug_analog|Low_confidence,miltefosine,antileishmanial drug,infectious disease,leishmaniasis,membrane integrity inhibitor,PQLXHQMOHUQAKB-UHFFFAOYSA-N
CCMSLIB00012724073,related spectra of 'enoxolone (delta mass:-4.03)',CCMSLIB00000567526|CCMSLIB00005733345,-4.03,1713,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724074,related spectra of 'enoxolone (delta mass:-4.03)',CCMSLIB00000567526|CCMSLIB00004704575|CCMSLIB00005733345,-4.03,1714,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724075,related spectra of 'enoxolone (delta mass:-4.03)',CCMSLIB00000566736|CCMSLIB00005736117,-4.03,1715,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724076,related spectra of 'enoxolone (delta mass:-4.03)',CCMSLIB00000566736|CCMSLIB00000567526|CCMSLIB00004704575|CCMSLIB00005733345|CCMSLIB00005736117,-4.03,1716,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724077,related spectra of 'betulinic acid (delta mass:28.03)',CCMSLIB00010124192,28.03,1717,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012724078,"related spectra of 'doxazosin (delta mass:15.99)', 'doxazosin (delta mass:16.0)'",CCMSLIB00000004422|CCMSLIB00000078096|CCMSLIB00000085267|CCMSLIB00000085981|CCMSLIB00000567935|CCMSLIB00003138850|CCMSLIB00005731983,15.99,1718,Drug_analog,doxazosin,alpha adrenergic blocker,urology|cardiology,benign prostatic hyperplasia (BPH)|hypertension,adrenergic receptor antagonist,RUZYUOTYCVRMRZ-UHFFFAOYSA-N|RUZYUOTYCVRMRZ-HXUWFJFHSA-N
CCMSLIB00012724079,related spectra of 'latanoprostene bunod (delta mass:-4.03)',CCMSLIB00010139223,-4.03,1719,Drug_analog,latanoprostene bunod,prostaglandin analogues,ophthalmology,intraocular pressure|glaucoma,prostaglandin receptor agonist,LOVMMUBRQUFEAH-UIEAZXIASA-N
CCMSLIB00012724080,related spectra of 'tobramycin 1-n- or 3- n-formyl (delta mass:-27.99)',CCMSLIB00003142424,-27.99,1720,Drug_analog,tobramycin 1-n- or 3- n-formyl,aminoglycoside antibacterial,infectious disease,bacterial septicemia|respiratory tract infections|meningitis|skin infections|urinary tract infections,bacterial 30S ribosomal subunit inhibitor,WRKRRZYETOSMBY-ZMYKPOSGSA-N
CCMSLIB00012724081,"related spectra of 'enoxolone (delta mass:15.99)', 'enoxolone (delta mass:-2.02)'",CCMSLIB00000566599|CCMSLIB00004691639|CCMSLIB00004704574|CCMSLIB00005735077|CCMSLIB00010118337,15.99|-2.02,1721,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724082,"related spectra of 'enoxolone (delta mass:15.99)', 'akba (delta mass:-44.03)'",CCMSLIB00010118337|CCMSLIB00010144080,15.99|-44.03,1722,Drug_analog,enoxolone|akba,no_match,NA,NA,gap junction modulator|lipoxygenase inhibitor,MPDGHEJMBKOTSU-YKLVYJNSSA-N|HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724083,related spectra of 'enoxolone (delta mass:-2.02)',CCMSLIB00005736395|CCMSLIB00010106992|CCMSLIB00010106993,-2.02,1723,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724084,related spectra of 'enoxolone (delta mass:-2.02)',CCMSLIB00000566599|CCMSLIB00004691639|CCMSLIB00004704574|CCMSLIB00005735077|CCMSLIB00010106992,-2.02,1724,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724085,related spectra of 'enoxolone (delta mass:-2.02)',CCMSLIB00004704573|CCMSLIB00010106992|CCMSLIB00010106993,-2.02,1725,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724086,"related spectra of 'boldenone undecylenate (delta mass:15.99)', 'enoxolone (delta mass:15.99)'",CCMSLIB00000206055|CCMSLIB00005771239|CCMSLIB00010118337,15.99,1726,Drug_analog,boldenone undecylenate|enoxolone,no_match,no_match|NA,no_match|NA,no_match|gap junction modulator,AHMMSNQYOPMLSX-UHFFFAOYSA-N|MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724087,related spectra of 'enoxolone (delta mass:-2.02)',CCMSLIB00000566736|CCMSLIB00005736117|CCMSLIB00010118331,-2.02,1727,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724088,related spectra of 'akba (delta mass:-44.03)',CCMSLIB00010144080,-44.03,1728,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724089,related spectra of 'enoxolone (delta mass:-2.02)',CCMSLIB00010106992,-2.02,1729,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724090,related spectra of 'enoxolone (delta mass:-2.02)',CCMSLIB00010106993,-2.02,1730,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724091,related spectra of 'enoxolone (delta mass:-2.02)',CCMSLIB00000566599|CCMSLIB00004691639|CCMSLIB00004704574|CCMSLIB00005735077|CCMSLIB00010106992,-2.02,1731,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724092,related spectra of 'enoxolone (delta mass:-2.02)',CCMSLIB00010106992|CCMSLIB00010106993,-2.02,1732,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724093,related spectra of 'enoxolone (delta mass:-2.02)',CCMSLIB00010106992|CCMSLIB00010106993,-2.02,1733,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724094,related spectra of 'akba (delta mass:-44.02)',CCMSLIB00010144080,-44.03,1734,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724095,related spectra of 'enoxolone (delta mass:16.03)',CCMSLIB00010118337,16.03,1735,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724096,related spectra of 'boldenone undecylenate (delta mass:16.03)',CCMSLIB00000206054|CCMSLIB00000206055|CCMSLIB00005771239|CCMSLIB00005771390,16.03,1736,Drug_analog,boldenone undecylenate,no_match,no_match,no_match,no_match,AHMMSNQYOPMLSX-UHFFFAOYSA-N
CCMSLIB00012724097,related spectra of 'betulinic acid (delta mass:30.01)',CCMSLIB00010124192,30.01,1737,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012724098,related spectra of 'iloperidone (delta mass:43.99)',CCMSLIB00000078160,43.99,1738,Drug_analog,iloperidone,atypical antipsychotic,neurology/psychiatry,schizophrenia,dopamine receptor antagonist|serotonin receptor antagonist,XMXHEBAFVSFQEX-UHFFFAOYSA-N
CCMSLIB00012724099,related spectra of 'akba (delta mass:-42.05)',CCMSLIB00010144080,-42.05,1739,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724100,related spectra of 'akba (delta mass:-42.05)',CCMSLIB00010144080,-42.05,1740,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724101,related spectra of 'akba (delta mass:-42.05)',CCMSLIB00010144080,-42.05,1741,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724102,related spectra of 'akba (delta mass:-42.05)',CCMSLIB00010144080,-42.05,1742,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724103,related spectra of 'akba (delta mass:-42.05)',CCMSLIB00010144080,-42.05,1743,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724104,related spectra of 'akba (delta mass:-42.05)',CCMSLIB00010144080,-42.05,1744,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724105,related spectra of 'akba (delta mass:-42.05)',CCMSLIB00010144080,-42.05,1745,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724106,related spectra of 'betulinic acid (delta mass:31.99)',CCMSLIB00010112869|CCMSLIB00010124192,31.99,1746,Drug_analog,betulinic acid,no_match,NA,NA,apoptosis stimulant|NFkB pathway inhibitor,QGJZLNKBHJESQX-FZFNOLFKSA-N
CCMSLIB00012724107,related spectra of 'akba (delta mass:-42.01)',CCMSLIB00010144080,-42.01,1747,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724108,related spectra of 'akba (delta mass:-42.01)',CCMSLIB00010144080,-42.01,1748,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724109,related spectra of 'akba (delta mass:-42.01)',CCMSLIB00010144080,-42.01,1749,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724110,related spectra of 'akba (delta mass:-42.01)',CCMSLIB00010144080,-42.01,1750,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724111,related spectra of 'akba (delta mass:-42.01)',CCMSLIB00010144080,-42.01,1751,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724112,related spectra of 'enoxolone (delta mass:18.01)',CCMSLIB00010118337,18.01,1752,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724113,related spectra of '69227-93-6 (delta mass:-56.06)',CCMSLIB00010133712|CCMSLIB00010133713|CCMSLIB00010133715|CCMSLIB00010133716,-56.06,1753,Drug_analog,69227-93-6,no_match,no_match,no_match,no_match,NLEBIOOXCVAHBD-QKMCSOCLSA-N
CCMSLIB00012724114,related spectra of 'enoxolone (delta mass:1.0)',CCMSLIB00000566599|CCMSLIB00004691638|CCMSLIB00004691639|CCMSLIB00004704573|CCMSLIB00004704574|CCMSLIB00005735077|CCMSLIB00005736395|CCMSLIB00010106992|CCMSLIB00010106993,1,1754,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724115,related spectra of 'enoxolone (delta mass:1.0)',CCMSLIB00010118331,1,1755,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724116,related spectra of 'akba (delta mass:-40.03)',CCMSLIB00010144080,-40.03,1756,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724117,"related spectra of 'enoxolone (delta mass:1.98)', 'akba (delta mass:-40.03)'",CCMSLIB00004704575|CCMSLIB00010144080,1.98|-40.03,1757,Drug_analog,enoxolone|akba,no_match,NA,NA,gap junction modulator|lipoxygenase inhibitor,MPDGHEJMBKOTSU-YKLVYJNSSA-N|HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724118,related spectra of 'enoxolone (delta mass:1.98)',CCMSLIB00010118332,1.98,1758,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724119,related spectra of 'enoxolone (delta mass:2.0)',CCMSLIB00010118332,2,1759,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724120,"related spectra of 'enoxolone (delta mass:20.03)', 'enoxolone (delta mass:2.02)'",CCMSLIB00004704575|CCMSLIB00010118332|CCMSLIB00010118337,20.03|2.02,1760,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724121,related spectra of 'enoxolone (delta mass:2.02)',CCMSLIB00010118331,2.02,1761,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724122,related spectra of 'enoxolone (delta mass:2.02)',CCMSLIB00010118332,2.02,1762,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724123,related spectra of 'enoxolone (delta mass:2.02)',CCMSLIB00010118331,2.02,1763,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724124,related spectra of 'isoquercetin (delta mass:12.0)',CCMSLIB00005463735|CCMSLIB00005778041|CCMSLIB00006126935,12,1764,Drug_analog,isoquercetin,no_match,NA,NA,aldose reductase inhibitor,OVSQVDMCBVZWGM-QSOFNFLRSA-N
CCMSLIB00012724125,"related spectra of 'enoxolone (delta mass:3.99)', 'akba (delta mass:-38.02)', 'enoxolone (delta mass:4.0)'",CCMSLIB00000566736|CCMSLIB00000567526|CCMSLIB00004704575|CCMSLIB00005733345|CCMSLIB00005736117|CCMSLIB00010118331|CCMSLIB00010118332|CCMSLIB00010144080,3.99|-38.02,1765,Drug_analog,enoxolone|akba,no_match,NA,NA,gap junction modulator|lipoxygenase inhibitor,MPDGHEJMBKOTSU-YKLVYJNSSA-N|HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724126,related spectra of 'enoxolone (delta mass:3.99)',CCMSLIB00000566736|CCMSLIB00005736117,3.99,1766,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724127,related spectra of 'enoxolone (delta mass:4.03)',CCMSLIB00010118331|CCMSLIB00010118332,4.03,1767,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724128,"related spectra of 'isoquercetin (delta mass:14.02)', 'isoquercetin (delta mass:14.01)'",CCMSLIB00000213819|CCMSLIB00000215303|CCMSLIB00005739117,14.02,1768,Drug_analog,isoquercetin,no_match,NA,NA,aldose reductase inhibitor,OVSQVDMCBVZWGM-QSOFNFLRSA-N
CCMSLIB00012724129,related spectra of 'betamethasone valerate (delta mass:4.03)',CCMSLIB00005773981,4.03,1769,Drug_analog,betamethasone valerate,corticosteroid,dermatology,corticosteroid-responsive dermatoses|eczema|psoriasis,glucocorticoid receptor agonist,SNHRLVCMMWUAJD-UHFFFAOYSA-N
CCMSLIB00012724130,"related spectra of 'enoxolone (delta mass:28.03)', 'akba (delta mass:-31.99)'",CCMSLIB00010118337|CCMSLIB00010144080,28.03|-31.99,1770,Drug_analog,enoxolone|akba,no_match,NA,NA,gap junction modulator|lipoxygenase inhibitor,MPDGHEJMBKOTSU-YKLVYJNSSA-N|HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724131,related spectra of 'akba (delta mass:-31.99)',CCMSLIB00010144080,-31.99,1771,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724132,related spectra of 'atorvastatin (delta mass:-76.03)',CCMSLIB00000211306|CCMSLIB00000211319|CCMSLIB00005760128|CCMSLIB00005762161|CCMSLIB00005772295|CCMSLIB00005776181,-76.03,1772,Drug_analog,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724133,related spectra of 'acarbose (delta mass:-162.05)',CCMSLIB00003135828|CCMSLIB00005723219|CCMSLIB00006119764|CCMSLIB00006119765|CCMSLIB00006119767|CCMSLIB00006119769|CCMSLIB00006119776|CCMSLIB00006119778|CCMSLIB00006119779|CCMSLIB00006680052|CCMSLIB00006680140|CCMSLIB00006680143|CCMSLIB00006685104|CCMSLIB00006685177|CCMSLIB00006685319|CCMSLIB00010146081|CCMSLIB00010146082|CCMSLIB00010146084|CCMSLIB00010146087,-162.05,1773,Drug_analog,acarbose,alpha glucosidase inhibitor,endocrinology,type 2 diabetes mellitus,glucosidase inhibitor,XUFXOAAUWZOOIT-UGEKTDRHSA-N
CCMSLIB00012724134,related spectra of 'fexofenadine (delta mass:-18.01)',CCMSLIB00000572914|CCMSLIB00000572952|CCMSLIB00005735276|CCMSLIB00005736225|CCMSLIB00010147972|CCMSLIB00010147975,-18.01,1774,Drug_analog,fexofenadine,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,RWTNPBWLLIMQHL-UHFFFAOYSA-N
CCMSLIB00012724135,"related spectra of '69227-93-6 (delta mass:-44.03)', '69227-93-6 (delta mass:-44.02)'",CCMSLIB00010133715|CCMSLIB00010133716,-44.03,1775,Drug_analog,69227-93-6,no_match,no_match,no_match,no_match,NLEBIOOXCVAHBD-QKMCSOCLSA-N
CCMSLIB00012724136,related spectra of '69227-93-6 (delta mass:-44.03)',CCMSLIB00010133715|CCMSLIB00010133716,-44.03,1776,Drug_analog,69227-93-6,no_match,no_match,no_match,no_match,NLEBIOOXCVAHBD-QKMCSOCLSA-N
CCMSLIB00012724137,related spectra of 'amcinonide (delta mass:-18.01)',CCMSLIB00006115889|CCMSLIB00006115891|CCMSLIB00006115893,-18.01,1777,Drug_analog,amcinonide,corticosteroid,dermatology,corticosteroid-responsive dermatoses,glucocorticoid receptor agonist,ILKJAFIWWBXGDU-MOGDOJJUSA-N
CCMSLIB00012724138,related spectra of 'betamethasone dipropionate (delta mass:-20.01)',CCMSLIB00005775067,-20.01,1778,Drug_analog,betamethasone dipropionate,corticosteroid,dermatology,corticosteroid-responsive dermatoses|eczema|psoriasis,glucocorticoid receptor agonist,CIWBQSYVNNPZIQ-UHFFFAOYSA-N
CCMSLIB00012724139,"related spectra of 'akba (delta mass:-28.04)', 'akba (delta mass:-28.03)'",CCMSLIB00010144080,-28.03,1779,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724140,"related spectra of 'akba (delta mass:-28.03)', 'enoxolone (delta mass:13.98)'",CCMSLIB00000566736|CCMSLIB00005736117|CCMSLIB00010144080,-28.03|13.98,1780,Drug_analog,enoxolone|akba,no_match,NA,NA,gap junction modulator|lipoxygenase inhibitor,MPDGHEJMBKOTSU-YKLVYJNSSA-N|HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724141,related spectra of 'akba (delta mass:-28.03)',CCMSLIB00010144080,-28.03,1781,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724142,related spectra of 'akba (delta mass:-27.99)',CCMSLIB00010144080,-27.99,1782,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724143,related spectra of '69227-93-6 (delta mass:-42.05)',CCMSLIB00010133713|CCMSLIB00010133715|CCMSLIB00010133716,-42.05,1783,Drug_analog,69227-93-6,no_match,no_match,no_match,no_match,NLEBIOOXCVAHBD-QKMCSOCLSA-N
CCMSLIB00012724144,related spectra of 'akba (delta mass:-26.02)',CCMSLIB00010144080,-26.02,1784,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724145,related spectra of 'akba (delta mass:-26.02)',CCMSLIB00010144080,-26.02,1785,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724146,related spectra of 'akba (delta mass:-26.02)',CCMSLIB00010144080,-26.02,1786,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724147,related spectra of 'akba (delta mass:-26.02)',CCMSLIB00010144080,-26.02,1787,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724148,"related spectra of 'akba (delta mass:-26.02)', 'enoxolone (delta mass:15.99)'",CCMSLIB00000567526|CCMSLIB00004704575|CCMSLIB00005733345|CCMSLIB00010144080,-26.02|15.99,1788,Drug_analog,enoxolone|akba,no_match,NA,NA,gap junction modulator|lipoxygenase inhibitor,MPDGHEJMBKOTSU-YKLVYJNSSA-N|HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724149,"related spectra of 'akba (delta mass:-26.02)', 'enoxolone (delta mass:16.0)', 'enoxolone (delta mass:15.99)'",CCMSLIB00000567526|CCMSLIB00004704575|CCMSLIB00005733345|CCMSLIB00010144080,-26.02|15.99,1789,Drug_analog,enoxolone|akba,no_match,NA,NA,gap junction modulator|lipoxygenase inhibitor,MPDGHEJMBKOTSU-YKLVYJNSSA-N|HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724150,related spectra of 'enoxolone (delta mass:15.99)',CCMSLIB00000567738|CCMSLIB00005733598,15.99,1790,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724151,"related spectra of 'enoxolone (delta mass:15.99)', 'boldenone undecylenate (delta mass:34.01)'",CCMSLIB00000206055|CCMSLIB00000567738|CCMSLIB00005733598|CCMSLIB00005771239,15.99|34.01,1791,Drug_analog,boldenone undecylenate|enoxolone,no_match,no_match|NA,no_match|NA,no_match|gap junction modulator,AHMMSNQYOPMLSX-UHFFFAOYSA-N|MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724152,related spectra of 'akba (delta mass:-26.02)',CCMSLIB00010144080,-26.02,1792,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724153,related spectra of 'akba (delta mass:-26.02)',CCMSLIB00010144080,-26.02,1793,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724154,related spectra of 'tezacaftor (delta mass:-30.01)',CCMSLIB00010132686,-30.01,1794,Drug_analog,tezacaftor,cystic fibrosis transmembrane conductance regulator (CFTR) corrector,pulmonary|genetics,cystic fibrosis,CFTR channel agonist,MJUVRTYWUMPBTR-MRXNPFEDSA-N
CCMSLIB00012724155,related spectra of 'akba (delta mass:-21.98)',CCMSLIB00010144080,-21.98,1795,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724156,"related spectra of 'silibinin (delta mass:14.02)', 'silymarin (delta mass:14.02)'",CCMSLIB00004701954|CCMSLIB00004701955|CCMSLIB00004702842|CCMSLIB00004702843|CCMSLIB00004719272|CCMSLIB00004719273|CCMSLIB00006120904|CCMSLIB00006120906|CCMSLIB00006120908|CCMSLIB00006120910|CCMSLIB00006120912|CCMSLIB00006120925|CCMSLIB00010111793|CCMSLIB00010123126,14.02,1796,Drug_analog,silymarin|silibinin,liver therapy,gastroenterology,hepatic cirrhosis,cytochrome P450 inhibitor,SEBFKMXJBCUCAI-HKTJVKLFSA-N
CCMSLIB00012724157,related spectra of 'rosuvastatin (delta mass:14.02)',CCMSLIB00000211134|CCMSLIB00000211136|CCMSLIB00000211138|CCMSLIB00000211147|CCMSLIB00000211149|CCMSLIB00000211151,14.02,1797,Drug_analog,rosuvastatin,HMG-CoA reductase inhibitor (statin),endocrinology|cardiology|neurology/psychiatry,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,BPRHUIZQVSMCRT-YXWZHEERSA-N
CCMSLIB00012724158,related spectra of 'enoxolone (delta mass:27.05)',CCMSLIB00000566736|CCMSLIB00000567526|CCMSLIB00004704575|CCMSLIB00005733345|CCMSLIB00005736117,27.05,1798,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724159,related spectra of 'enoxolone (delta mass:28.03)',CCMSLIB00010118331|CCMSLIB00010118332,28.03,1799,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724160,related spectra of 'enoxolone (delta mass:28.03)',CCMSLIB00010118331|CCMSLIB00010118332,28.03,1800,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724161,related spectra of 'enoxolone (delta mass:28.03)',CCMSLIB00010118331|CCMSLIB00010118332,28.03,1801,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724162,related spectra of '69227-93-6 (delta mass:-28.03)',CCMSLIB00010133712|CCMSLIB00010133713|CCMSLIB00010133715|CCMSLIB00010133716,-28.03,1802,Drug_analog,69227-93-6,no_match,no_match,no_match,no_match,NLEBIOOXCVAHBD-QKMCSOCLSA-N
CCMSLIB00012724163,related spectra of 'akba (delta mass:-12.04)',CCMSLIB00010144080,-12.04,1803,Drug_analog,akba,no_match,NA,NA,lipoxygenase inhibitor,HMMGKOVEOFBCAU-BCDBGHSCSA-N
CCMSLIB00012724164,related spectra of 'enoxolone (delta mass:30.01)',CCMSLIB00000567738|CCMSLIB00004704575|CCMSLIB00005733598,30.01,1804,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724165,"related spectra of 'fexofenadine (delta mass:1.0)', 'fexofenadine (delta mass:0.99)'",CCMSLIB00000085849|CCMSLIB00000565955|CCMSLIB00000572914|CCMSLIB00000572954|CCMSLIB00005731408|CCMSLIB00005735276|CCMSLIB00010147970|CCMSLIB00010147972|CCMSLIB00010147973|CCMSLIB00010147975,1,1805,Drug_analog,fexofenadine,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,RWTNPBWLLIMQHL-UHFFFAOYSA-N
CCMSLIB00012723480,related spectra of 'efavirenz (delta mass:15.99)',CCMSLIB00005776252,15.99,1120,Drug_analog,efavirenz,HIV non-nucleoside reverse transcriptase inhibitor (HIV NNRTI),infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,XPOQHMRABVBWPR-UHFFFAOYSA-N
CCMSLIB00012723481,related spectra of 'efavirenz (delta mass:15.99)',CCMSLIB00000079120|CCMSLIB00000579893|CCMSLIB00000841852|CCMSLIB00005776252,15.99,1121,Drug_analog,efavirenz,HIV non-nucleoside reverse transcriptase inhibitor (HIV NNRTI),infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,XPOQHMRABVBWPR-ZDUSSCGKSA-N|XPOQHMRABVBWPR-UHFFFAOYSA-N
CCMSLIB00012724168,"related spectra of 'chlorhexidine (delta mass:2.01)', 'chlorhexidine (delta mass:2.0)', 'chlorhexidine (delta mass:1.99)'",CCMSLIB00000084869|CCMSLIB00003134813|CCMSLIB00003140196,2,1808,Drug_analog,chlorhexidine,antiseptic and disinfectant,dental|infectious disease,periodontitis|topical antiseptic|gingivitis,membrane integrity inhibitor,GHXZTYHSJHQHIJ-UHFFFAOYSA-N
CCMSLIB00012724169,"related spectra of 'glimepiride (delta mass:16.0)', 'glimepiride (delta mass:15.99)'",CCMSLIB00000005741|CCMSLIB00000078108|CCMSLIB00000079243|CCMSLIB00000579842|CCMSLIB00000841843|CCMSLIB00005772154|CCMSLIB00005772575|CCMSLIB00005773098|CCMSLIB00006116308|CCMSLIB00006116310|CCMSLIB00006116312|CCMSLIB00006116314|CCMSLIB00006116316,15.99,1809,Drug_analog,glimepiride,sulfonylurea,endocrinology,type 2 diabetes mellitus,insulin secretagogue,WIGIZIANZCJQQY-UHFFFAOYSA-N
CCMSLIB00012724170,"related spectra of 'glimepiride (delta mass:16.0)', 'glimepiride (delta mass:15.99)'",CCMSLIB00000005741|CCMSLIB00000085185|CCMSLIB00005772575|CCMSLIB00005773098|CCMSLIB00005775472|CCMSLIB00006116308|CCMSLIB00006116310|CCMSLIB00006116312|CCMSLIB00006116314|CCMSLIB00006116316,15.99,1810,Drug_analog,glimepiride,sulfonylurea,endocrinology,type 2 diabetes mellitus,insulin secretagogue,WIGIZIANZCJQQY-UHFFFAOYSA-N
CCMSLIB00012724171,"related spectra of 'glyburide (delta mass:15.99)', 'glibenclamide (delta mass:15.99)', 'glyburide (delta mass:16.0)'",CCMSLIB00000077074|CCMSLIB00000078252|CCMSLIB00003136409|CCMSLIB00005774932|CCMSLIB00005775065|CCMSLIB00005776675|CCMSLIB00006117113,15.99,1811,Drug_analog,glyburide|glibenclamide,sulfonylurea,endocrinology,type 2 diabetes mellitus,ATP channel blocker|insulin secretagogue,ZNNLBTZKUZBEKO-UHFFFAOYSA-N
CCMSLIB00012724172,"related spectra of 'silibinin (delta mass:30.01)', 'silymarin (delta mass:30.01)'",CCMSLIB00004701954|CCMSLIB00004701955|CCMSLIB00004702842|CCMSLIB00004702843|CCMSLIB00004719271|CCMSLIB00004719272|CCMSLIB00004719273|CCMSLIB00006120904|CCMSLIB00006120906|CCMSLIB00006120908|CCMSLIB00006120910|CCMSLIB00006120912|CCMSLIB00006120925|CCMSLIB00010111793|CCMSLIB00010123126,30.01,1812,Drug_analog,silymarin|silibinin,liver therapy,gastroenterology,hepatic cirrhosis,cytochrome P450 inhibitor,SEBFKMXJBCUCAI-HKTJVKLFSA-N
CCMSLIB00012724173,related spectra of 'enoxolone (delta mass:42.01)',CCMSLIB00000566599|CCMSLIB00004691638|CCMSLIB00004691639|CCMSLIB00004704573|CCMSLIB00004704574|CCMSLIB00005735077|CCMSLIB00005736395|CCMSLIB00010106992|CCMSLIB00010106993|CCMSLIB00010118331|CCMSLIB00010118332,42.01,1813,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724174,related spectra of 'enoxolone (delta mass:42.01)',CCMSLIB00004704573|CCMSLIB00005736395,42.01,1814,Drug_analog,enoxolone,no_match,NA,NA,gap junction modulator,MPDGHEJMBKOTSU-YKLVYJNSSA-N
CCMSLIB00012724175,related spectra of 'carbenoxolone (delta mass:-58.0)',CCMSLIB00010134948,-58.01,1815,Drug_analog,carbenoxolone,no_match,gastroenterology|dental,peptic ulcer disease (PUD)|mouth inflammation,11-beta hydroxysteroid dehydrogenase inhibitor,OBZHEBDUNPOCJG-WBXJDKIVSA-N
CCMSLIB00012724176,related spectra of 'orlistat (delta mass:17.03)',CCMSLIB00000579874|CCMSLIB00000841872|CCMSLIB00003136466,17.03,1816,Drug_analog,orlistat,intestinal lipase inhibitor,endocrinology,weight-loss aid,lipase inhibitor,AHLBNYSZXLDEJQ-FWEHEUNISA-N
CCMSLIB00012724177,related spectra of '69227-93-6 (delta mass:-14.02)',CCMSLIB00010133715|CCMSLIB00010133716,-14.02,1817,Drug_analog,69227-93-6,no_match,no_match,no_match,no_match,NLEBIOOXCVAHBD-QKMCSOCLSA-N
CCMSLIB00012724178,related spectra of 'deferoxamine (delta mass:-44.03)',CCMSLIB00005435927,-44.03,1818,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724179,related spectra of 'oleandrin (delta mass:-58.01)',CCMSLIB00010145609,-58.01,1819,Drug_analog,oleandrin,no_match,NA,NA,Na/K-ATPase inhibitor,JLPDBLFIVFSOCC-XYXFTTADSA-N
CCMSLIB00012724180,related spectra of 'fosinopril (delta mass:-43.99)',CCMSLIB00005777129,-43.99,1820,Drug_analog,fosinopril,angiotensin converting enzyme inhibitor,cardiology|endocrinology,hypertension|congestive heart failure|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,BIDNLKIUORFRQP-FKDWWROVSA-N
CCMSLIB00012724181,related spectra of 'lodenafil (delta mass:15.98)',CCMSLIB00010135727|CCMSLIB00010135730,15.97,1821,Drug_analog,lodenafil,no_match,no_match,no_match,no_match,NEYKRKVLEWKOBI-UHFFFAOYSA-N
CCMSLIB00012724182,"related spectra of 'glimepiride (delta mass:29.98)', 'glimepiride (delta mass:29.97)'",CCMSLIB00000005741|CCMSLIB00000005742|CCMSLIB00000085185|CCMSLIB00000579842|CCMSLIB00000841843|CCMSLIB00005772575|CCMSLIB00005773098|CCMSLIB00005775472|CCMSLIB00006116308|CCMSLIB00006116310|CCMSLIB00006116312|CCMSLIB00006116314|CCMSLIB00006116316|CCMSLIB00006116327|CCMSLIB00006116329|CCMSLIB00006116330|CCMSLIB00006116332|CCMSLIB00010129742|CCMSLIB00010129743|CCMSLIB00010129744|CCMSLIB00010129747,29.97,1822,Drug_analog,glimepiride,sulfonylurea,endocrinology,type 2 diabetes mellitus,insulin secretagogue,WIGIZIANZCJQQY-UHFFFAOYSA-N|WIGIZIANZCJQQY-RUCARUNLSA-N
CCMSLIB00012724183,"related spectra of 'calcimycin (delta mass:1.01)', 'calcimycin (delta mass:1.0)'",CCMSLIB00000085751,1,1823,Drug_analog,calcimycin,no_match,no_match,no_match,no_match,HIYAVKIYRIFSCZ-CYEMHPAKSA-N
CCMSLIB00012724184,related spectra of 'doxorubicin (delta mass:-18.01)',CCMSLIB00000206118|CCMSLIB00005771429,-18.01,1824,Drug_analog,doxorubicin,anthracycline topoisomerase inhibitor,hematologic malignancy|oncology,acute lymphoblastic leukemia (ALL)|acute myeloid leukemia (AML)|Wilm's tumor|breast cancer|ovarian cancer|Hodgkin's lymphoma|bladder cancer|multiple myeloma,topoisomerase inhibitor,AOJJSUZBOXZQNB-UHFFFAOYSA-N
CCMSLIB00012724185,related spectra of 'epirubicin (delta mass:-18.01)',CCMSLIB00010125175|CCMSLIB00010140653,-18.01,1825,Drug_analog,epirubicin|epirubicin,anthracycline topoisomerase inhibitor,hematologic malignancy|oncology,acute lymphoblastic leukemia (ALL)|acute myeloid leukemia (AML)|Wilm's tumor|breast cancer|ovarian cancer|Hodgkin's lymphoma|bladder cancer|multiple myeloma,topoisomerase inhibitor,AOJJSUZBOXZQNB-SNFLSGHGSA-N|AOJJSUZBOXZQNB-VTZDEGQISA-N
CCMSLIB00012724186,"related spectra of 'epirubicin (delta mass:-18.01)', 'doxorubicin (delta mass:-18.01)'",CCMSLIB00010113850|CCMSLIB00010131409|CCMSLIB00010131411|CCMSLIB00010131412,-18.01,1826,Drug_analog,epirubicin|doxorubicin,anthracycline topoisomerase inhibitor,hematologic malignancy|oncology,acute lymphoblastic leukemia (ALL)|acute myeloid leukemia (AML)|Wilm's tumor|breast cancer|ovarian cancer|Hodgkin's lymphoma|bladder cancer|multiple myeloma,topoisomerase inhibitor,AOJJSUZBOXZQNB-SNFLSGHGSA-N|AOJJSUZBOXZQNB-TZSSRYMLSA-N
CCMSLIB00012724187,related spectra of 'piperacillin (delta mass:17.03)',CCMSLIB00010151523,17.03,1827,Drug_analog,piperacillin,penicillin class antibacterial,infectious disease,intra-abdominal infections|skin infections|pelvic inflammatory disease|pneumonia|gram-positive bacterial infections|gram-negative bacterial infections,bacterial cell wall synthesis inhibitor,IVBHGBMCVLDMKU-GXNBUGAJSA-N
CCMSLIB00012724188,related spectra of 'atorvastatin (delta mass:-18.01)',CCMSLIB00000211306|CCMSLIB00000211309|CCMSLIB00000211311|CCMSLIB00000211319|CCMSLIB00005760128|CCMSLIB00005760904|CCMSLIB00005762161|CCMSLIB00005763959|CCMSLIB00005772295,-18.01,1828,Drug_analog,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724189,related spectra of 'atorvastatin (delta mass:-18.01)',CCMSLIB00000579838|CCMSLIB00000841911|CCMSLIB00005762821|CCMSLIB00005775046,-18.01,1829,Drug_analog,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724190,related spectra of 'ergoloid (delta mass:-42.05)',CCMSLIB00000206150|CCMSLIB00005771229,-42.05,1830,Drug_analog,ergoloid,no_match,no_match,no_match,no_match,YLXBZBPHTNJZQE-UHFFFAOYSA-N
CCMSLIB00012724191,related spectra of 'atorvastatin (delta mass:-2.02)',CCMSLIB00000211304|CCMSLIB00000211317|CCMSLIB00000211319|CCMSLIB00000579838|CCMSLIB00000841911|CCMSLIB00005762821|CCMSLIB00005766072|CCMSLIB00005772295|CCMSLIB00005772364|CCMSLIB00005776109|CCMSLIB00005776181,-2.02,1831,Drug_analog,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724192,related spectra of 'elacridar (delta mass:-2.02)',CCMSLIB00010148780|CCMSLIB00010148781|CCMSLIB00010148783|CCMSLIB00010148784|CCMSLIB00010148786|CCMSLIB00010149547|CCMSLIB00010149548|CCMSLIB00010149550,-2.02,1832,Drug_analog,elacridar,no_match,NA,NA,P glycoprotein inhibitor,OSFCMRGOZNQUSW-UHFFFAOYSA-N
CCMSLIB00012724577,related spectra of 'efavirenz (delta mass:15.995)',CCMSLIB00000079120,15.99,2217,Drug_suspect,efavirenz,HIV non-nucleoside reverse transcriptase inhibitor (HIV NNRTI),infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,XPOQHMRABVBWPR-ZDUSSCGKSA-N
CCMSLIB00012724194,"related spectra of 'deferoxamine (delta mass:0.98)', 'deferoxamine (delta mass:0.99)'",CCMSLIB00000079678|CCMSLIB00000223884|CCMSLIB00000848497|CCMSLIB00003134607|CCMSLIB00003135047,1,1834,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724195,"related spectra of 'deferoxamine (delta mass:0.99)', 'deferoxamine (delta mass:1.0)'",CCMSLIB00003134607|CCMSLIB00003135712,1,1835,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724196,"related spectra of 'deferoxamine (delta mass:0.98)', 'deferoxamine (delta mass:0.99)'",CCMSLIB00003135712,1,1836,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724197,"related spectra of 'deferoxamine (delta mass:0.98)', 'deferoxamine (delta mass:0.99)', 'deferoxamine (delta mass:1.0)'",CCMSLIB00001059065|CCMSLIB00003134607|CCMSLIB00003135712|CCMSLIB00003136339|CCMSLIB00003139590,1,1837,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724198,"related spectra of 'deferoxamine (delta mass:0.98)', 'deferoxamine (delta mass:0.99)', 'deferoxamine (delta mass:1.0)'",CCMSLIB00001059065|CCMSLIB00003135712|CCMSLIB00003139590,1,1838,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724199,"related spectra of 'deferoxamine (delta mass:0.98)', 'deferoxamine (delta mass:0.99)', 'deferoxamine (delta mass:1.0)'",CCMSLIB00001059065|CCMSLIB00003135712|CCMSLIB00003139590,1,1839,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724200,related spectra of 'deferoxamine (delta mass:0.98)',CCMSLIB00003135712,0.98,1840,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724201,"related spectra of 'deferoxamine (delta mass:0.98)', 'deferoxamine (delta mass:1.0)'",CCMSLIB00003135712|CCMSLIB00003139590,1,1841,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724202,"related spectra of 'deferoxamine (delta mass:0.99)', 'deferoxamine (delta mass:1.0)'",CCMSLIB00003134607|CCMSLIB00003135712,1,1842,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724203,"related spectra of 'deferoxamine (delta mass:0.98)', 'deferoxamine (delta mass:0.99)', 'deferoxamine (delta mass:1.0)'",CCMSLIB00001059065|CCMSLIB00003135712,1,1843,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724204,"related spectra of 'deferoxamine (delta mass:0.98)', 'deferoxamine (delta mass:1.0)'",CCMSLIB00001059065|CCMSLIB00003135712|CCMSLIB00003136339|CCMSLIB00003139590,1,1844,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724205,"related spectra of 'deferoxamine (delta mass:0.98)', 'deferoxamine (delta mass:1.0)'",CCMSLIB00001059065|CCMSLIB00003135712|CCMSLIB00003139590,1,1845,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724206,related spectra of 'deferoxamine (delta mass:1.0)',CCMSLIB00001059065|CCMSLIB00003139590,1,1846,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724207,"related spectra of 'deferoxamine (delta mass:0.98)', 'deferoxamine (delta mass:1.0)'",CCMSLIB00003135712|CCMSLIB00003136339,1,1847,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724208,"related spectra of 'deferoxamine (delta mass:0.98)', 'deferoxamine (delta mass:0.99)', 'deferoxamine (delta mass:1.0)'",CCMSLIB00001059065|CCMSLIB00003135712|CCMSLIB00003136339|CCMSLIB00003139590,1,1848,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724209,"related spectra of 'deferoxamine (delta mass:0.98)', 'deferoxamine (delta mass:1.0)'",CCMSLIB00001059065|CCMSLIB00003135712|CCMSLIB00003136339|CCMSLIB00003139590,1,1849,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724210,"related spectra of 'deferoxamine (delta mass:0.98)', 'deferoxamine (delta mass:1.0)'",CCMSLIB00001059065|CCMSLIB00003135712,1,1850,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724211,"related spectra of 'deferoxamine (delta mass:0.98)', 'deferoxamine (delta mass:0.99)', 'deferoxamine (delta mass:1.0)'",CCMSLIB00001059065|CCMSLIB00003135712|CCMSLIB00003139590,1,1851,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724212,related spectra of 'deferoxamine (delta mass:1.0)',CCMSLIB00001059065,1,1852,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724213,"related spectra of 'deferoxamine (delta mass:0.98)', 'deferoxamine (delta mass:0.99)', 'deferoxamine (delta mass:1.0)'",CCMSLIB00001059065|CCMSLIB00003134607|CCMSLIB00003135712|CCMSLIB00003136339|CCMSLIB00003139590,1,1853,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724214,related spectra of 'deferoxamine (delta mass:1.0)',CCMSLIB00003136339,1,1854,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724215,"related spectra of 'deferoxamine (delta mass:0.98)', 'deferoxamine (delta mass:0.99)', 'deferoxamine (delta mass:1.0)'",CCMSLIB00001059065|CCMSLIB00003134607|CCMSLIB00003135712|CCMSLIB00003136339|CCMSLIB00003139590,1,1855,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724216,related spectra of 'deferoxamine (delta mass:1.0)',CCMSLIB00003135563|CCMSLIB00003136339,1,1856,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724217,"related spectra of 'deferoxamine (delta mass:0.98)', 'deferoxamine (delta mass:1.0)'",CCMSLIB00001059065|CCMSLIB00003135712,1,1857,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724218,related spectra of 'deferoxamine (delta mass:0.98)',CCMSLIB00003135712,0.98,1858,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724219,related spectra of 'deferoxamine (delta mass:0.99)',CCMSLIB00003135712,1,1859,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724220,related spectra of 'deferoxamine (delta mass:0.99)',CCMSLIB00003135712,1,1860,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724221,related spectra of 'deferoxamine (delta mass:0.99)',CCMSLIB00003135712,1,1861,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724222,"related spectra of 'deferoxamine (delta mass:0.99)', 'deferoxamine (delta mass:1.0)'",CCMSLIB00003135712,1,1862,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724223,related spectra of 'deferoxamine (delta mass:0.99)',CCMSLIB00003135712,1,1863,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724224,"related spectra of 'fusidic acid (delta mass:1.99)', 'fusidic acid (delta mass:2.0)'",CCMSLIB00006484332,2,1864,Drug_analog|Low_confidence,fusidic acid,steroid antibacterials,infectious disease,skin infections|impetigo|gram-positive bacterial infections,bacterial 30S ribosomal subunit inhibitor,IECPWNUMDGFDKC-MZJAQBGESA-N
CCMSLIB00012724225,related spectra of 'oleandrin (delta mass:-14.02)',CCMSLIB00010145612,-14.02,1865,Drug_analog,oleandrin,no_match,NA,NA,Na/K-ATPase inhibitor,JLPDBLFIVFSOCC-XYXFTTADSA-N
CCMSLIB00012724820,"related spectra of 'massbank:au235703 efavirenz|6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2h-3,1-benzoxazin-2-one|6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1h-3,1-benzoxazin-2-one (delta mass:2.004)'",CCMSLIB00005776641,2,2460,Drug_suspect,efavirenz,HIV non-nucleoside reverse transcriptase inhibitor (HIV NNRTI),infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,XPOQHMRABVBWPR-UHFFFAOYSA-N
CCMSLIB00012724821,"related spectra of 'massbank:au235703 efavirenz|6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2h-3,1-benzoxazin-2-one|6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1h-3,1-benzoxazin-2-one (delta mass:15.995)'",CCMSLIB00005776641,15.99,2461,Drug_suspect,efavirenz,HIV non-nucleoside reverse transcriptase inhibitor (HIV NNRTI),infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,XPOQHMRABVBWPR-UHFFFAOYSA-N
CCMSLIB00012724958,"related spectra of 'massbank:eq329201 efavirenz|(4s)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1h-3,1-benzoxazin-2-one (delta mass:15.995)'",CCMSLIB00005734748,15.99,2598,Drug_suspect,efavirenz,HIV non-nucleoside reverse transcriptase inhibitor (HIV NNRTI),infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,XPOQHMRABVBWPR-ZDUSSCGKSA-N
CCMSLIB00012724229,related spectra of 'lasalocid (delta mass:-43.99)',CCMSLIB00010139461|CCMSLIB00010148198|CCMSLIB00010148201,-43.99,1869,Drug_analog,lasalocid,other antibiotic|veterinary,infectious disease,coccidiosis,bacterial permeability inducer,BBMULGJBVDDDNI-OWKLGTHSSA-N
CCMSLIB00012723151,related spectra of 'abacavir (delta mass:13.98)',CCMSLIB00000078595|CCMSLIB00010134211|CCMSLIB00010142710|CCMSLIB00010142711,13.98,791,Drug_analog,abacavir,HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI),infectious disease,human immunodeficiency virus (HIV-1),nucleoside reverse transcriptase inhibitor,MCGSCOLBFJQGHM-SCZZXKLOSA-N
CCMSLIB00012723453,related spectra of 'abacavir (delta mass:42.01)',CCMSLIB00010134211,42.01,1093,Drug_analog,abacavir,HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI),infectious disease,human immunodeficiency virus (HIV-1),nucleoside reverse transcriptase inhibitor,MCGSCOLBFJQGHM-SCZZXKLOSA-N
CCMSLIB00012724232,related spectra of 'atorvastatin (delta mass:13.98)',CCMSLIB00000211304|CCMSLIB00000211317|CCMSLIB00005766072,13.98,1872,Drug_analog,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724233,related spectra of 'atorvastatin (delta mass:13.98)',CCMSLIB00000211317|CCMSLIB00000211319|CCMSLIB00000579838|CCMSLIB00000841911|CCMSLIB00005760128|CCMSLIB00005762161|CCMSLIB00005762821|CCMSLIB00005766072|CCMSLIB00005772295,13.98,1873,Drug_analog,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724234,related spectra of 'atorvastatin (delta mass:13.98)',CCMSLIB00000211319|CCMSLIB00000579838|CCMSLIB00000841911|CCMSLIB00005762821|CCMSLIB00005766072,13.98,1874,Drug_analog,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724235,related spectra of 'atorvastatin (delta mass:14.02)',CCMSLIB00000211319|CCMSLIB00005772295|CCMSLIB00005776181,14.02,1875,Drug_analog,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724236,related spectra of 'atorvastatin (delta mass:14.02)',CCMSLIB00000211319|CCMSLIB00005772295|CCMSLIB00005776181,14.02,1876,Drug_analog,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724237,related spectra of 'bq-123 (delta mass:-38.02)',CCMSLIB00010152016|CCMSLIB00010152017,-38.02,1877,Drug_analog,bq-123,no_match,NA,NA,endothelin receptor antagonist,VYCMAAOURFJIHD-PJNXIOHISA-N
CCMSLIB00012724238,"related spectra of 'atorvastatin (delta mass:15.99)', 'atorvastatin (delta mass:15.97)'",CCMSLIB00000211304|CCMSLIB00000211317|CCMSLIB00000579838|CCMSLIB00000841911|CCMSLIB00005762821|CCMSLIB00005766072|CCMSLIB00005772364|CCMSLIB00005773431|CCMSLIB00005773776|CCMSLIB00005774313|CCMSLIB00005775046|CCMSLIB00005775909|CCMSLIB00005776109,15.99,1878,Drug_analog,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724239,related spectra of 'atorvastatin (delta mass:15.99)',CCMSLIB00000211304|CCMSLIB00000211317|CCMSLIB00000579838|CCMSLIB00000841911|CCMSLIB00005762821|CCMSLIB00005766072|CCMSLIB00005772295|CCMSLIB00005772364|CCMSLIB00005774313|CCMSLIB00005775046|CCMSLIB00005775909|CCMSLIB00005776109,15.99,1879,Drug_analog,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724240,related spectra of 'deferoxamine (delta mass:14.02)',CCMSLIB00003134607|CCMSLIB00003135047|CCMSLIB00003139590,14.02,1880,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724241,related spectra of 'deferoxamine (delta mass:14.02)',CCMSLIB00003134607|CCMSLIB00003135047,14.02,1881,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724242,related spectra of 'ceritinib (delta mass:20.03)',CCMSLIB00010132006|CCMSLIB00010132009,20.03,1882,Drug_analog,ceritinib,kinase inhibitor,oncology,non-small cell lung cancer (NSCLC),ALK tyrosine kinase receptor inhibitor,VERWOWGGCGHDQE-UHFFFAOYSA-N
CCMSLIB00012724243,related spectra of 'ergoloid (delta mass:-14.02)',CCMSLIB00000206149|CCMSLIB00005771134,-14.02,1883,Drug_analog,ergoloid,no_match,no_match,no_match,no_match,YLXBZBPHTNJZQE-UHFFFAOYSA-N
CCMSLIB00012724244,related spectra of 'lasalocid (delta mass:-29.97)',CCMSLIB00010139457|CCMSLIB00010139458|CCMSLIB00010139461|CCMSLIB00010148198|CCMSLIB00010148201,-29.97,1884,Drug_analog,lasalocid,other antibiotic|veterinary,infectious disease,coccidiosis,bacterial permeability inducer,BBMULGJBVDDDNI-OWKLGTHSSA-N
CCMSLIB00012724245,related spectra of 'reserpine (delta mass:-30.01)',CCMSLIB00000204826|CCMSLIB00000210228|CCMSLIB00005745884|CCMSLIB00006115905|CCMSLIB00006115907|CCMSLIB00006115908|CCMSLIB00006115910|CCMSLIB00006391549,-30.01,1885,Drug_analog,reserpine,catecholamine-depleting sympatholytic,cardiology,hypertension,vesicular monoamine transporter inhibitor,QEVHRUUCFGRFIF-UHFFFAOYSA-N|QEVHRUUCFGRFIF-MDEJGZGSSA-N
CCMSLIB00012724246,related spectra of 'framycetin (delta mass:-56.06)',CCMSLIB00010114511,-56.06,1886,Drug_analog,framycetin,aminoglycoside antibacterial,infectious disease,first-aid antibiotic|hepatic encephalopathy (HE)|intra-abdominal infections,bacterial 30S ribosomal subunit inhibitor,PGBHMTALBVVCIT-UHFFFAOYSA-N
CCMSLIB00012724247,related spectra of 'framycetin (delta mass:-56.06)',CCMSLIB00010114511,-56.06,1887,Drug_analog,framycetin,aminoglycoside antibacterial,infectious disease,first-aid antibiotic|hepatic encephalopathy (HE)|intra-abdominal infections,bacterial 30S ribosomal subunit inhibitor,PGBHMTALBVVCIT-UHFFFAOYSA-N
CCMSLIB00012724248,related spectra of 'framycetin (delta mass:-56.06)',CCMSLIB00010114511,-56.06,1888,Drug_analog,framycetin,aminoglycoside antibacterial,infectious disease,first-aid antibiotic|hepatic encephalopathy (HE)|intra-abdominal infections,bacterial 30S ribosomal subunit inhibitor,PGBHMTALBVVCIT-UHFFFAOYSA-N
CCMSLIB00012724249,related spectra of 'framycetin (delta mass:-56.06)',CCMSLIB00010114511|CCMSLIB00010125841,-56.06,1889,Drug_analog,framycetin,aminoglycoside antibacterial,infectious disease,first-aid antibiotic|hepatic encephalopathy (HE)|intra-abdominal infections,bacterial 30S ribosomal subunit inhibitor,PGBHMTALBVVCIT-UHFFFAOYSA-N
CCMSLIB00012724250,related spectra of 'framycetin (delta mass:-56.06)',CCMSLIB00010114511,-56.06,1890,Drug_analog,framycetin,aminoglycoside antibacterial,infectious disease,first-aid antibiotic|hepatic encephalopathy (HE)|intra-abdominal infections,bacterial 30S ribosomal subunit inhibitor,PGBHMTALBVVCIT-UHFFFAOYSA-N
CCMSLIB00012724251,"related spectra of 'deferoxamine (delta mass:1.01)', 'deferoxamine (delta mass:1.0)'",CCMSLIB00000531493,1,1891,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724252,"related spectra of 'montelukast (delta mass:1.99)', 'montelukast (delta mass:2.0)'",CCMSLIB00005773332|CCMSLIB00005773838|CCMSLIB00005775466,2,1892,Drug_analog,montelukast,leukotriene receptor antagonist (LTRA),pulmonary|allergy,asthma|allergic rhinitis|exercise-induced bronchoconstriction (EIB),leukotriene receptor antagonist,UCHDWCPVSPXUMX-UHFFFAOYSA-N
CCMSLIB00012724253,related spectra of 'proscillaridin (delta mass:58.0)',CCMSLIB00010129911|CCMSLIB00010129912|CCMSLIB00010129914,58.01,1893,Drug_analog,proscillaridin,no_match,cardiology|NA,congestive heart failure|cardiac arrythmia|NA,NA,MYEJFUXQJGHEQK-ALRJYLEOSA-N
CCMSLIB00012724254,"related spectra of 'deferoxamine (delta mass:29.98)', 'deferoxamine (delta mass:29.97)'",CCMSLIB00000079678|CCMSLIB00003139590,29.97,1894,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724255,related spectra of 'fosinopril (delta mass:27.05)',CCMSLIB00005777129,27.05,1895,Drug_analog,fosinopril,angiotensin converting enzyme inhibitor,cardiology|endocrinology,hypertension|congestive heart failure|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,BIDNLKIUORFRQP-FKDWWROVSA-N
CCMSLIB00012724256,related spectra of 'novobiocin (delta mass:-14.02)',CCMSLIB00010122464|CCMSLIB00010131322,-14.02,1896,Drug_analog,novobiocin,veterinary,infectious disease,mastitis|gram-positive bacterial infections,bacterial DNA gyrase inhibitor,YJQPYGGHQPGBLI-UHFFFAOYSA-N|YJQPYGGHQPGBLI-KGSXXDOSSA-N
CCMSLIB00012724257,related spectra of 'montelukast (delta mass:15.99)',CCMSLIB00000084941|CCMSLIB00005773332|CCMSLIB00005773838|CCMSLIB00005775466|CCMSLIB00005776867,15.99,1897,Drug_analog,montelukast,leukotriene receptor antagonist (LTRA),pulmonary|allergy,asthma|allergic rhinitis|exercise-induced bronchoconstriction (EIB),leukotriene receptor antagonist,UCHDWCPVSPXUMX-TZIWLTJVSA-N|UCHDWCPVSPXUMX-UHFFFAOYSA-N
CCMSLIB00012724258,related spectra of 'deferoxamine (delta mass:42.01)',CCMSLIB00000079678|CCMSLIB00000223884|CCMSLIB00000848497|CCMSLIB00003134607|CCMSLIB00003135047|CCMSLIB00003136339|CCMSLIB00003139590|CCMSLIB00005435927,42.01,1898,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724259,"related spectra of 'etoposide (delta mass:17.02)', 'etoposide (delta mass:17.03)'",CCMSLIB00000005537|CCMSLIB00000005538|CCMSLIB00000085936|CCMSLIB00005739317|CCMSLIB00005742829|CCMSLIB00005746510|CCMSLIB00005749450|CCMSLIB00010110964|CCMSLIB00010113121|CCMSLIB00010122299|CCMSLIB00010124445,17.03,1899,Drug_analog,etoposide,topoisomerase inhibitor,oncology|hematologic malignancy,non-small cell lung cancer (NSCLC)|testicular cancer|lymphoma|acute myeloid leukemia (AML)|ovarian cancer,topoisomerase inhibitor,VJJPUSNTGOMMGY-MRVIYFEKSA-N|VJJPUSNTGOMMGY-UHFFFAOYSA-N
CCMSLIB00012724260,related spectra of 'etoposide (delta mass:17.03)',CCMSLIB00000078056|CCMSLIB00000079249|CCMSLIB00000214242|CCMSLIB00000214246|CCMSLIB00000215727|CCMSLIB00000215731|CCMSLIB00005739317|CCMSLIB00005739912|CCMSLIB00005744607|CCMSLIB00005745040|CCMSLIB00005746510|CCMSLIB00005747471|CCMSLIB00005749450,17.03,1900,Drug_analog,etoposide,topoisomerase inhibitor,oncology|hematologic malignancy,non-small cell lung cancer (NSCLC)|testicular cancer|lymphoma|acute myeloid leukemia (AML)|ovarian cancer,topoisomerase inhibitor,VJJPUSNTGOMMGY-MRVIYFEKSA-N|VJJPUSNTGOMMGY-UHFFFAOYSA-N
CCMSLIB00012724261,"related spectra of 'etoposide (delta mass:17.02)', 'etoposide (delta mass:17.03)'",CCMSLIB00000005538|CCMSLIB00005749450|CCMSLIB00010113121,17.03,1901,Drug_analog,etoposide,topoisomerase inhibitor,oncology|hematologic malignancy,non-small cell lung cancer (NSCLC)|testicular cancer|lymphoma|acute myeloid leukemia (AML)|ovarian cancer,topoisomerase inhibitor,VJJPUSNTGOMMGY-MRVIYFEKSA-N
CCMSLIB00012724262,related spectra of 'etoposide (delta mass:17.03)',CCMSLIB00000078056|CCMSLIB00000079249|CCMSLIB00000085936|CCMSLIB00000214242|CCMSLIB00000214246|CCMSLIB00000215727|CCMSLIB00000215731|CCMSLIB00005738996|CCMSLIB00005739317|CCMSLIB00005739912|CCMSLIB00005742829|CCMSLIB00005744607|CCMSLIB00005745040|CCMSLIB00005746510|CCMSLIB00005747471|CCMSLIB00005749450|CCMSLIB00010122299|CCMSLIB00010124445,17.03,1902,Drug_analog,etoposide,topoisomerase inhibitor,oncology|hematologic malignancy,non-small cell lung cancer (NSCLC)|testicular cancer|lymphoma|acute myeloid leukemia (AML)|ovarian cancer,topoisomerase inhibitor,VJJPUSNTGOMMGY-MRVIYFEKSA-N|VJJPUSNTGOMMGY-UHFFFAOYSA-N
CCMSLIB00012724263,"related spectra of 'desosaminylazithromycin (delta mass:14.97)', 'desosaminylazithromycin (delta mass:14.96)'",CCMSLIB00000478608,14.96,1903,Drug_analog,desosaminylazithromycin,macrolide antimicrobial,infectious disease,pelvic inflammatory disease|pneumonia|urethritis|cervicitis|sinusitis,bacterial 50S ribosomal subunit inhibitor,PXDYILJJHOVNLO-NDJYQBQTSA-N
CCMSLIB00012724264,related spectra of 'reserpine (delta mass:-2.02)',CCMSLIB00000078194|CCMSLIB00000206359|CCMSLIB00000206360|CCMSLIB00000206361|CCMSLIB00005771180|CCMSLIB00005771209|CCMSLIB00005771477|CCMSLIB00010122306|CCMSLIB00010152343,-2.02,1904,Drug_analog,reserpine,catecholamine-depleting sympatholytic,cardiology,hypertension,vesicular monoamine transporter inhibitor,QEVHRUUCFGRFIF-MDEJGZGSSA-N|QEVHRUUCFGRFIF-UHFFFAOYSA-N
CCMSLIB00012724265,related spectra of 'desosaminylazithromycin (delta mass:18.01)',CCMSLIB00000478608,18.01,1905,Drug_analog,desosaminylazithromycin,macrolide antimicrobial,infectious disease,pelvic inflammatory disease|pneumonia|urethritis|cervicitis|sinusitis,bacterial 50S ribosomal subunit inhibitor,PXDYILJJHOVNLO-NDJYQBQTSA-N
CCMSLIB00012724480,related spectra of 'abacavir sulfate (delta mass:-40.032)',CCMSLIB00000078595,-40.03,2120,Drug_suspect,abacavir,HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI),infectious disease,human immunodeficiency virus (HIV-1),nucleoside reverse transcriptase inhibitor,MCGSCOLBFJQGHM-SCZZXKLOSA-N
CCMSLIB00012724267,related spectra of 'deferoxamine (delta mass:1.0)',CCMSLIB00001059066,1,1907,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724268,related spectra of 'deferoxamine (delta mass:1.01)',CCMSLIB00001059066,1,1908,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724269,"related spectra of 'diatrizoic acid (delta mass:-15.99)', 'diatrizoic acid (delta mass:1.01)'",CCMSLIB00003139191|CCMSLIB00003139215,-15.99|1.00,1909,Drug_analog,diatrizoic acid,radiographic contrast agent,radiology,contrast agent,NA,YVPYQUNUQOZFHG-UHFFFAOYSA-N
CCMSLIB00012724270,related spectra of 'rescinnamine (delta mass:-14.02)',CCMSLIB00000853201|CCMSLIB00004696213,-14.02,1910,Drug_analog,rescinnamine,rauwolfia alkaloids,cardiology,hypertension,angiotensin converting enzyme (ACE) inhibitor,SZLZWPPUNLXJEA-QEGASFHISA-N
CCMSLIB00012724271,related spectra of 'lasalocid (delta mass:14.02)',CCMSLIB00010139457|CCMSLIB00010139458|CCMSLIB00010139461|CCMSLIB00010148194|CCMSLIB00010148195|CCMSLIB00010148198|CCMSLIB00010148201,14.02,1911,Drug_analog,lasalocid,other antibiotic|veterinary,infectious disease,coccidiosis,bacterial permeability inducer,BBMULGJBVDDDNI-OWKLGTHSSA-N
CCMSLIB00012724272,related spectra of 'phorbol 12-myristate 13-acetate (delta mass:28.03)',CCMSLIB00010150305|CCMSLIB00010150308,28.03,1912,Drug_analog,phorbol 12-myristate 13-acetate,no_match,NA,NA,PKC activator,PHEDXBVPIONUQT-RGYGYFBISA-N
CCMSLIB00012724273,related spectra of 'deferoxamine (delta mass:14.97)',CCMSLIB00001059066,14.96,1913,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724274,"related spectra of 'diatrizoic acid (delta mass:18.01)', 'diatrizoic acid (delta mass:0.98)'",CCMSLIB00003139191|CCMSLIB00003139215,18.01|0.98,1914,Drug_analog,diatrizoic acid,radiographic contrast agent,radiology,contrast agent,NA,YVPYQUNUQOZFHG-UHFFFAOYSA-N
CCMSLIB00012724275,related spectra of 'monensin (delta mass:-36.02)',CCMSLIB00008851481,-36.02,1915,Drug_analog,monensin,veterinary,infectious disease,gastrointestinal parasites,bacterial permeability inducer,GAOZTHIDHYLHMS-KEOBGNEYSA-N
CCMSLIB00012724276,related spectra of 'lasalocid (delta mass:30.01)',CCMSLIB00010139457|CCMSLIB00010139458|CCMSLIB00010148194|CCMSLIB00010148195|CCMSLIB00010148198|CCMSLIB00010148201,30.01,1916,Drug_analog,lasalocid,other antibiotic|veterinary,infectious disease,coccidiosis,bacterial permeability inducer,BBMULGJBVDDDNI-OWKLGTHSSA-N
CCMSLIB00012724277,related spectra of 'hesperidin methylchalcone (delta mass:14.02)',CCMSLIB00010137447|CCMSLIB00010137448|CCMSLIB00010137451,14.02,1917,Drug_analog,hesperidin methylchalcone,no_match,no_match,no_match,no_match,FDHNLHLOJLLXDH-JIYHLSBYSA-N
CCMSLIB00012724278,related spectra of 'hesperidin methylchalcone (delta mass:14.02)',CCMSLIB00010137451,14.02,1918,Drug_analog,hesperidin methylchalcone,no_match,no_match,no_match,no_match,FDHNLHLOJLLXDH-JIYHLSBYSA-N
CCMSLIB00012724279,related spectra of 'rescinnamine (delta mass:16.0)',CCMSLIB00004696212|CCMSLIB00004696213,15.99,1919,Drug_analog,rescinnamine,rauwolfia alkaloids,cardiology,hypertension,angiotensin converting enzyme (ACE) inhibitor,SZLZWPPUNLXJEA-QEGASFHISA-N
CCMSLIB00012724280,related spectra of 'monensin (delta mass:-18.01)',CCMSLIB00008851481,-18.01,1920,Drug_analog,monensin,veterinary,infectious disease,gastrointestinal parasites,bacterial permeability inducer,GAOZTHIDHYLHMS-KEOBGNEYSA-N
CCMSLIB00012724281,related spectra of 'framycetin (delta mass:17.03)',CCMSLIB00010114511|CCMSLIB00010125841,17.03,1921,Drug_analog,framycetin,aminoglycoside antibacterial,infectious disease,first-aid antibiotic|hepatic encephalopathy (HE)|intra-abdominal infections,bacterial 30S ribosomal subunit inhibitor,PGBHMTALBVVCIT-UHFFFAOYSA-N
CCMSLIB00012724282,related spectra of 'framycetin (delta mass:17.03)',CCMSLIB00010114511,17.03,1922,Drug_analog,framycetin,aminoglycoside antibacterial,infectious disease,first-aid antibiotic|hepatic encephalopathy (HE)|intra-abdominal infections,bacterial 30S ribosomal subunit inhibitor,PGBHMTALBVVCIT-UHFFFAOYSA-N
CCMSLIB00012724283,related spectra of 'framycetin (delta mass:17.03)',CCMSLIB00010114511|CCMSLIB00010125841,17.03,1923,Drug_analog,framycetin,aminoglycoside antibacterial,infectious disease,first-aid antibiotic|hepatic encephalopathy (HE)|intra-abdominal infections,bacterial 30S ribosomal subunit inhibitor,PGBHMTALBVVCIT-UHFFFAOYSA-N
CCMSLIB00012724284,related spectra of 'framycetin (delta mass:17.03)',CCMSLIB00010114511,17.03,1924,Drug_analog,framycetin,aminoglycoside antibacterial,infectious disease,first-aid antibiotic|hepatic encephalopathy (HE)|intra-abdominal infections,bacterial 30S ribosomal subunit inhibitor,PGBHMTALBVVCIT-UHFFFAOYSA-N
CCMSLIB00012724285,related spectra of 'framycetin (delta mass:17.03)',CCMSLIB00010125841,17.03,1925,Drug_analog,framycetin,aminoglycoside antibacterial,infectious disease,first-aid antibiotic|hepatic encephalopathy (HE)|intra-abdominal infections,bacterial 30S ribosomal subunit inhibitor,PGBHMTALBVVCIT-UHFFFAOYSA-N
CCMSLIB00012724286,related spectra of 'framycetin (delta mass:17.03)',CCMSLIB00010114511,17.03,1926,Drug_analog,framycetin,aminoglycoside antibacterial,infectious disease,first-aid antibiotic|hepatic encephalopathy (HE)|intra-abdominal infections,bacterial 30S ribosomal subunit inhibitor,PGBHMTALBVVCIT-UHFFFAOYSA-N
CCMSLIB00012724287,related spectra of 'framycetin (delta mass:17.03)',CCMSLIB00010114511,17.03,1927,Drug_analog,framycetin,aminoglycoside antibacterial,infectious disease,first-aid antibiotic|hepatic encephalopathy (HE)|intra-abdominal infections,bacterial 30S ribosomal subunit inhibitor,PGBHMTALBVVCIT-UHFFFAOYSA-N
CCMSLIB00012724288,related spectra of 'framycetin (delta mass:17.03)',CCMSLIB00010114511,17.03,1928,Drug_analog,framycetin,aminoglycoside antibacterial,infectious disease,first-aid antibiotic|hepatic encephalopathy (HE)|intra-abdominal infections,bacterial 30S ribosomal subunit inhibitor,PGBHMTALBVVCIT-UHFFFAOYSA-N
CCMSLIB00012724289,related spectra of 'framycetin (delta mass:17.03)',CCMSLIB00010114511,17.03,1929,Drug_analog,framycetin,aminoglycoside antibacterial,infectious disease,first-aid antibiotic|hepatic encephalopathy (HE)|intra-abdominal infections,bacterial 30S ribosomal subunit inhibitor,PGBHMTALBVVCIT-UHFFFAOYSA-N
CCMSLIB00012724290,related spectra of 'framycetin (delta mass:17.03)',CCMSLIB00010114511,17.03,1930,Drug_analog,framycetin,aminoglycoside antibacterial,infectious disease,first-aid antibiotic|hepatic encephalopathy (HE)|intra-abdominal infections,bacterial 30S ribosomal subunit inhibitor,PGBHMTALBVVCIT-UHFFFAOYSA-N
CCMSLIB00012724291,related spectra of 'deferoxamine (delta mass:1.0)',CCMSLIB00003139883,1,1931,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724292,related spectra of 'deferoxamine (delta mass:1.0)',CCMSLIB00003139883,1,1932,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724293,related spectra of 'deferoxamine (delta mass:1.0)',CCMSLIB00003139883,1,1933,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724294,related spectra of 'deferoxamine (delta mass:1.0)',CCMSLIB00003139883,1,1934,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724295,related spectra of 'deferoxamine (delta mass:1.0)',CCMSLIB00003139883,1,1935,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724296,related spectra of 'deferoxamine (delta mass:1.0)',CCMSLIB00003139883,1,1936,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724297,related spectra of 'deferoxamine (delta mass:1.0)',CCMSLIB00003139883,1,1937,Drug_analog,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724298,related spectra of 'bromocriptine (delta mass:2.0)',CCMSLIB00010123783|CCMSLIB00010139262|CCMSLIB00010139263,2,1938,Drug_analog,bromocriptine,ergot derivative,endocrinology|neurology/psychiatry,hyperprolactinemia|Parkinson's Disease|acromegaly,dopamine receptor agonist,OZVBMTJYIDMWIL-AYFBDAFISA-N
CCMSLIB00012724299,related spectra of 'bromocriptine (delta mass:2.0)',CCMSLIB00010123783|CCMSLIB00010139262,2,1939,Drug_analog,bromocriptine,ergot derivative,endocrinology|neurology/psychiatry,hyperprolactinemia|Parkinson's Disease|acromegaly,dopamine receptor agonist,OZVBMTJYIDMWIL-AYFBDAFISA-N
CCMSLIB00012724300,"related spectra of 'fusafungine (delta mass:2.0)', 'fusafungine (delta mass:2.01)'",CCMSLIB00005721133|CCMSLIB00005723570,2,1940,Drug_analog,fusafungine,no_match,no_match,no_match,no_match,MIZMDSVSLSIMSC-VYLWARHZSA-N
CCMSLIB00012724301,related spectra of 'acarbose (delta mass:-17.03)',CCMSLIB00004721671|CCMSLIB00004721672,-17.03,1941,Drug_analog,acarbose,alpha glucosidase inhibitor,endocrinology,type 2 diabetes mellitus,glucosidase inhibitor,XUFXOAAUWZOOIT-UGEKTDRHSA-N
CCMSLIB00012724302,related spectra of 'oleandomycin (delta mass:-20.03)',CCMSLIB00004694151,-20.03,1942,Drug_analog,oleandomycin,macrolide antimicrobial,no_match,no_match,bacterial 50S ribosomal subunit inhibitor,RZPAKFUAFGMUPI-QESOVKLGSA-N
CCMSLIB00012724303,related spectra of 'hesperidin methylchalcone (delta mass:44.03)',CCMSLIB00010137449,44.03,1943,Drug_analog,hesperidin methylchalcone,no_match,no_match,no_match,no_match,FDHNLHLOJLLXDH-JIYHLSBYSA-N
CCMSLIB00012724481,related spectra of 'abacavir sulfate (delta mass:13.98)',CCMSLIB00000078595,13.98,2121,Drug_suspect,abacavir,HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI),infectious disease,human immunodeficiency virus (HIV-1),nucleoside reverse transcriptase inhibitor,MCGSCOLBFJQGHM-SCZZXKLOSA-N
CCMSLIB00012724305,related spectra of 'fusafungine (delta mass:29.98)',CCMSLIB00000846051|CCMSLIB00005727510,29.97,1945,Drug_analog,fusafungine,no_match,no_match,no_match,no_match,MIZMDSVSLSIMSC-VYLWARHZSA-N
CCMSLIB00012724306,related spectra of 'monensin (delta mass:-18.01)',CCMSLIB00008851484,-18.01,1946,Drug_analog,monensin,veterinary,infectious disease,gastrointestinal parasites,bacterial permeability inducer,GAOZTHIDHYLHMS-KEOBGNEYSA-N
CCMSLIB00012724307,related spectra of 'monensin (delta mass:-14.02)',CCMSLIB00008851484,-14.02,1947,Drug_analog,monensin,veterinary,infectious disease,gastrointestinal parasites,bacterial permeability inducer,GAOZTHIDHYLHMS-KEOBGNEYSA-N
CCMSLIB00012724308,related spectra of 'monensin (delta mass:-12.04)',CCMSLIB00004721557|CCMSLIB00004721558,-12.04,1948,Drug_analog,monensin,veterinary,infectious disease,gastrointestinal parasites,bacterial permeability inducer,ITGPEIOMPWTSAR-GJUJVRLTSA-N
CCMSLIB00012724309,related spectra of 'monensin (delta mass:-12.04)',CCMSLIB00004721557,-12.04,1949,Drug_analog,monensin,veterinary,infectious disease,gastrointestinal parasites,bacterial permeability inducer,ITGPEIOMPWTSAR-GJUJVRLTSA-N
CCMSLIB00012724310,related spectra of 'fusafungine (delta mass:28.03)',CCMSLIB00000846054|CCMSLIB00005723172,28.03,1950,Drug_analog,fusafungine,no_match,no_match,no_match,no_match,MIZMDSVSLSIMSC-VYLWARHZSA-N
CCMSLIB00012724311,"related spectra of 'acarbose (delta mass:1.99)', 'acarbose (delta mass:2.0)'",CCMSLIB00004721671,2,1951,Drug_analog,acarbose,alpha glucosidase inhibitor,endocrinology,type 2 diabetes mellitus,glucosidase inhibitor,XUFXOAAUWZOOIT-UGEKTDRHSA-N
CCMSLIB00012724312,"related spectra of 'fusafungine (delta mass:29.98)', 'fusafungine (delta mass:29.97)'",CCMSLIB00000846054|CCMSLIB00005723172,29.97,1952,Drug_analog,fusafungine,no_match,no_match,no_match,no_match,MIZMDSVSLSIMSC-VYLWARHZSA-N
CCMSLIB00012724313,related spectra of 'fusafungine (delta mass:29.98)',CCMSLIB00000846054|CCMSLIB00005723172,29.97,1953,Drug_analog,fusafungine,no_match,no_match,no_match,no_match,MIZMDSVSLSIMSC-VYLWARHZSA-N
CCMSLIB00012724314,related spectra of 'monensin (delta mass:1.0)',CCMSLIB00003136947,1,1954,Drug_analog,monensin,veterinary,infectious disease,gastrointestinal parasites,bacterial permeability inducer,GAOZTHIDHYLHMS-KEOBGNEYSA-N
CCMSLIB00012724315,related spectra of 'erythromycin (delta mass:-36.02)',CCMSLIB00000222303|CCMSLIB00010113483,-36.02,1955,Drug_analog,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-UHFFFAOYSA-N|ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012724316,related spectra of 'erythromycin (delta mass:-36.02)',CCMSLIB00000222303,-36.02,1956,Drug_analog,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-UHFFFAOYSA-N
CCMSLIB00012724317,related spectra of 'fusafungine (delta mass:43.99)',CCMSLIB00005723172,43.99,1957,Drug_analog,fusafungine,no_match,no_match,no_match,no_match,MIZMDSVSLSIMSC-VYLWARHZSA-N
CCMSLIB00012724318,related spectra of 'erythromycin (delta mass:-14.02)',CCMSLIB00003138877,-14.02,1958,Drug_analog,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012724319,related spectra of 'monensin (delta mass:14.02)',CCMSLIB00008851484,14.02,1959,Drug_analog,monensin,veterinary,infectious disease,gastrointestinal parasites,bacterial permeability inducer,GAOZTHIDHYLHMS-KEOBGNEYSA-N
CCMSLIB00012724320,"related spectra of 'clarithromycin (delta mass:-44.03)', 'clarithromycin (delta mass:-44.02)'",CCMSLIB00003137653,-44.03,1960,Drug_analog,clarithromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis,bacterial 50S ribosomal subunit inhibitor,AGOYDEPGAOXOCK-KCBOHYOISA-N
CCMSLIB00012724482,related spectra of 'abacavir sulfate (delta mass:27.995)',CCMSLIB00000078595,27.99,2122,Drug_suspect,abacavir,HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI),infectious disease,human immunodeficiency virus (HIV-1),nucleoside reverse transcriptase inhibitor,MCGSCOLBFJQGHM-SCZZXKLOSA-N
CCMSLIB00012724322,"related spectra of 'monensin (delta mass:14.02)', 'monensin (delta mass:14.01)'",CCMSLIB00003134545|CCMSLIB00003136947|CCMSLIB00005723245|CCMSLIB00005723246|CCMSLIB00005723247,14.02,1962,Drug_analog,monensin,veterinary,infectious disease,gastrointestinal parasites,bacterial permeability inducer,GAOZTHIDHYLHMS-KEOBGNEYSA-N
CCMSLIB00012724323,"related spectra of 'erythromycin (delta mass:-4.0)', 'clarithromycin (delta mass:-36.02)'",CCMSLIB00003137653|CCMSLIB00010149750,-4.00|-36.02,1963,Drug_analog,clarithromycin|erythromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis|listeria|respiratory tract infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,bacterial 50S ribosomal subunit inhibitor|protein synthesis inhibition by binding to 50S ribosomal subunit,AGOYDEPGAOXOCK-KCBOHYOISA-N|ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012724324,related spectra of 'monensin (delta mass:1.98)',CCMSLIB00004721564,1.98,1964,Drug_analog,monensin,veterinary,infectious disease,gastrointestinal parasites,bacterial permeability inducer,ITGPEIOMPWTSAR-GJUJVRLTSA-N
CCMSLIB00012724325,related spectra of 'monensin (delta mass:1.98)',CCMSLIB00004721564,1.98,1965,Drug_analog,monensin,veterinary,infectious disease,gastrointestinal parasites,bacterial permeability inducer,ITGPEIOMPWTSAR-GJUJVRLTSA-N
CCMSLIB00012724326,related spectra of 'monensin (delta mass:28.03)',CCMSLIB00008851484,28.03,1966,Drug_analog,monensin,veterinary,infectious disease,gastrointestinal parasites,bacterial permeability inducer,GAOZTHIDHYLHMS-KEOBGNEYSA-N
CCMSLIB00012724327,related spectra of 'spinosad (delta mass:-14.02)',CCMSLIB00001058649|CCMSLIB00001058908,-14.02,1967,Drug_analog,spinosad,other ectoparasiticides for systemic use|veterinary,infectious disease,flea,insecticide,SRJQTHAZUNRMPR-SFGMUSMWSA-N
CCMSLIB00012724328,"related spectra of 'erythromycin (delta mass:-16.0)', 'clarithromycin (delta mass:-30.01)'",CCMSLIB00000004872|CCMSLIB00000222303|CCMSLIB00003137653|CCMSLIB00005772340|CCMSLIB00005776922|CCMSLIB00005777146,-15.99|-30.01,1968,Drug_analog,clarithromycin|erythromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis|listeria|respiratory tract infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,bacterial 50S ribosomal subunit inhibitor|protein synthesis inhibition by binding to 50S ribosomal subunit,AGOYDEPGAOXOCK-KCBOHYOISA-N|ULGZDMOVFRHVEP-UHFFFAOYSA-N|ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012724329,"related spectra of 'erythromycin (delta mass:-16.0)', 'clarithromycin (delta mass:-30.01)'",CCMSLIB00003135296|CCMSLIB00006117146|CCMSLIB00006117148|CCMSLIB00006117149|CCMSLIB00010113483|CCMSLIB00010146700,-15.99|-30.01,1969,Drug_analog,erythromycin|clarithromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma|pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|otitis,protein synthesis inhibition by binding to 50S ribosomal subunit|bacterial 50S ribosomal subunit inhibitor,ULGZDMOVFRHVEP-RWJQBGPGSA-N|AGOYDEPGAOXOCK-KCBOHYOISA-N
CCMSLIB00012724330,related spectra of 'bcp31423 (delta mass:-14.02)',CCMSLIB00005772368|CCMSLIB00005772987|CCMSLIB00005773730|CCMSLIB00005775249,-14.02,1970,Drug_analog,n-desmethylclarithromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis,bacterial 50S ribosomal subunit inhibitor,CIJTVUQEURKBDL-UHFFFAOYSA-N
CCMSLIB00012724331,related spectra of 'erythromycin (delta mass:-14.02)',CCMSLIB00003135296|CCMSLIB00005772340|CCMSLIB00005776106|CCMSLIB00005776922,-14.02,1971,Drug_analog,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012724332,related spectra of 'clarithromycin (delta mass:-20.03)',CCMSLIB00000207357|CCMSLIB00000207358|CCMSLIB00000207364|CCMSLIB00010146700,-20.03,1972,Drug_analog,clarithromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis,bacterial 50S ribosomal subunit inhibitor,AGOYDEPGAOXOCK-AVDMLEEESA-N|AGOYDEPGAOXOCK-KCBOHYOISA-N
CCMSLIB00012724333,related spectra of '1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (delta mass:-17.97)',CCMSLIB00003136709,-17.97,1973,Drug_analog,1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)),no_match,no_match,no_match,no_match,PAZGBAOHGQRCBP-DDDNOICHSA-N
CCMSLIB00012724334,"related spectra of 'erythromycin (delta mass:13.98)', 'erythromycin (delta mass:-4.0)', 'erythromycin (delta mass:-1-4.01)', 'erythromycin (delta mass:--4.03)'",CCMSLIB00003135296|CCMSLIB00003137289|CCMSLIB00006117142|CCMSLIB00006117144|CCMSLIB00006117146|CCMSLIB00006117148|CCMSLIB00006117149|CCMSLIB00006685304|CCMSLIB00006685311|CCMSLIB00010113483|CCMSLIB00010149752|CCMSLIB00010149755,13.98|-3.99|14.02|-4.03,1974,Drug_analog,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012724335,"related spectra of 'clarithromycin (delta mass:-17.03)', 'erythromycin (delta mass:15.01)'",CCMSLIB00003137289|CCMSLIB00003138050|CCMSLIB00010149749|CCMSLIB00010149750,-17.03|15.01,1975,Drug_analog,erythromycin|clarithromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma|pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|otitis,protein synthesis inhibition by binding to 50S ribosomal subunit|bacterial 50S ribosomal subunit inhibitor,ULGZDMOVFRHVEP-RWJQBGPGSA-N|AGOYDEPGAOXOCK-KCBOHYOISA-N
CCMSLIB00012724336,"related spectra of 'erythromycin (delta mass:-2.02)', 'davercin (delta mass:-28.0)', 'erythromycin (delta mass:15.99)', 'erythromycin (delta mass:-2.01)', 'erythromycin (delta mass:16.0)', 'clarithromycin (delta mass:-16.03)'",CCMSLIB00000004872|CCMSLIB00000006291|CCMSLIB00000078509|CCMSLIB00000078998|CCMSLIB00000207357|CCMSLIB00000207358|CCMSLIB00000207363|CCMSLIB00000207364|CCMSLIB00003135296|CCMSLIB00003137289|CCMSLIB00003137653|CCMSLIB00003138877|CCMSLIB00005772340|CCMSLIB00005773712|CCMSLIB00005776106|CCMSLIB00005776922|CCMSLIB00005777178|CCMSLIB00006117142|CCMSLIB00006117144|CCMSLIB00006117146|CCMSLIB00006117148|CCMSLIB00006117149|CCMSLIB00006117164|CCMSLIB00006685304|CCMSLIB00006685311|CCMSLIB00010113483|CCMSLIB00010144512|CCMSLIB00010146700|CCMSLIB00010146701|CCMSLIB00010149749|CCMSLIB00010149752|CCMSLIB00010149757|CCMSLIB00010149760,-2.02|-27.99|15.99|-16.03,1976,Drug_analog,clarithromycin|erythromycin|davercin,macrolide antimicrobial|no_match,infectious disease|no_match,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis|listeria|respiratory tract infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma|no_match,bacterial 50S ribosomal subunit inhibitor|protein synthesis inhibition by binding to 50S ribosomal subunit|no_match,AGOYDEPGAOXOCK-KCBOHYOISA-N|ULGZDMOVFRHVEP-RWJQBGPGSA-N|AGOYDEPGAOXOCK-BVGAJGDJSA-N|AGOYDEPGAOXOCK-AVDMLEEESA-N|NKLGIWNNVDPGCA-ZDYKNUMJSA-N
CCMSLIB00012724337,"related spectra of 'clarithromycin (delta mass:-16.0)', 'azithromycin (delta mass:-17.03)', 'erythromycin (delta mass:-16.03)', 'clarithromycin (delta mass:-15.98)'",CCMSLIB00000078509|CCMSLIB00000207357|CCMSLIB00003138050|CCMSLIB00003138877|CCMSLIB00005777061,-15.99|-17.03|16.03,1977,Drug_analog,clarithromycin|erythromycin|azithromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis|listeria|respiratory tract infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma|urethritis|cervicitis,bacterial 50S ribosomal subunit inhibitor|protein synthesis inhibition by binding to 50S ribosomal subunit,AGOYDEPGAOXOCK-BVGAJGDJSA-N|AGOYDEPGAOXOCK-AVDMLEEESA-N|AGOYDEPGAOXOCK-KCBOHYOISA-N|ULGZDMOVFRHVEP-RWJQBGPGSA-N|MQTOSJVFKKJCRP-OHJWJPDZSA-N
CCMSLIB00012724338,related spectra of 'azithromycin (delta mass:-14.02)',CCMSLIB00000084786|CCMSLIB00005777061,-14.02,1978,Drug_analog,azithromycin,macrolide antimicrobial,infectious disease,pelvic inflammatory disease|pneumonia|urethritis|cervicitis|sinusitis,bacterial 50S ribosomal subunit inhibitor,MQTOSJVFKKJCRP-BICOPXKESA-N|MQTOSJVFKKJCRP-OHJWJPDZSA-N
CCMSLIB00012724339,related spectra of 'salinomycin (delta mass:2.02)',CCMSLIB00010139544,2.02,1979,Drug_analog,salinomycin,veterinary,infectious disease,coccidiosis,NA,KQXDHUJYNAXLNZ-XQSDOZFQSA-N
CCMSLIB00012724483,related spectra of 'abacavir sulfate (delta mass:79.957)',CCMSLIB00000078595,79.96,2123,Drug_suspect,abacavir,HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI),infectious disease,human immunodeficiency virus (HIV-1),nucleoside reverse transcriptase inhibitor,MCGSCOLBFJQGHM-SCZZXKLOSA-N
CCMSLIB00012724484,related spectra of 'abacavir sulfate (delta mass:176.032)',CCMSLIB00000078595,176.03,2124,Drug_suspect,abacavir,HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI),infectious disease,human immunodeficiency virus (HIV-1),nucleoside reverse transcriptase inhibitor,MCGSCOLBFJQGHM-SCZZXKLOSA-N
CCMSLIB00012724342,"related spectra of 'dimyristoylphosphatidylcholine (delta mass:37.95)', 'dimyristoylphosphatidylcholine (delta mass:37.96)'",CCMSLIB00006496380|CCMSLIB00006496399|CCMSLIB00006496438,37.95|37.96,1982,Drug_analog,dimyristoylphosphatidylcholine,no_match,no_match,no_match,no_match,CITHEXJVPOWHKC-UHFFFAOYSA-O
CCMSLIB00012724343,related spectra of 'rifaximin (delta mass:-42.01)',CCMSLIB00000562755|CCMSLIB00005773670|CCMSLIB00010137456,-42.01,1983,Drug_analog,rifaximin|rifaximin,rifamycin antibacterial,gastroenterology|infectious disease,diarrhea|irritable bowel syndrome|hepatic encephalopathy (HE),RNA synthesis inhibitor,NZCRJKRKKOLAOJ-XRCRFVBUSA-N
CCMSLIB00012724344,"related spectra of 'erythromycin (delta mass:27.99)', 'clarithromycin (delta mass:-4.03)'",CCMSLIB00000207357|CCMSLIB00000207358|CCMSLIB00000207363|CCMSLIB00000207364|CCMSLIB00010146700|CCMSLIB00010149749|CCMSLIB00010149750,27.99|-4.03,1984,Drug_analog,clarithromycin|erythromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis|listeria|respiratory tract infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,bacterial 50S ribosomal subunit inhibitor|protein synthesis inhibition by binding to 50S ribosomal subunit,AGOYDEPGAOXOCK-AVDMLEEESA-N|AGOYDEPGAOXOCK-KCBOHYOISA-N|ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012724345,related spectra of 'spinosad (delta mass:14.02)',CCMSLIB00001058649|CCMSLIB00001059017|CCMSLIB00005773749,14.02,1985,Drug_analog,spinosad,other ectoparasiticides for systemic use|veterinary,infectious disease,flea,insecticide,SRJQTHAZUNRMPR-SFGMUSMWSA-N|SRJQTHAZUNRMPR-UYQKXTDMSA-N
CCMSLIB00012724346,related spectra of '1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (delta mass:1.01)',CCMSLIB00003135216,1,1986,Drug_analog,1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)),no_match,no_match,no_match,no_match,PAZGBAOHGQRCBP-DDDNOICHSA-N
CCMSLIB00012724347,related spectra of '1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (delta mass:1.01)',CCMSLIB00003135409,1,1987,Drug_analog,1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)),no_match,no_match,no_match,no_match,PAZGBAOHGQRCBP-DDDNOICHSA-N
CCMSLIB00012724348,"related spectra of '1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (delta mass:1.0)', '1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (delta mass:1.01)'",CCMSLIB00003136874|CCMSLIB00003138763,1,1988,Drug_analog,1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)),no_match,no_match,no_match,no_match,PAZGBAOHGQRCBP-DDDNOICHSA-N
CCMSLIB00012724349,related spectra of '1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (delta mass:1.01)',CCMSLIB00003136874,1,1989,Drug_analog,1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)),no_match,no_match,no_match,no_match,PAZGBAOHGQRCBP-DDDNOICHSA-N
CCMSLIB00012724350,"related spectra of '1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (delta mass:2.02)', '1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (delta mass:2.01)', '1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (delta mass:2.0)'",CCMSLIB00003136709|CCMSLIB00003137677|CCMSLIB00003137979,2.02|2.00,1990,Drug_analog,1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)),no_match,no_match,no_match,no_match,PAZGBAOHGQRCBP-DDDNOICHSA-N
CCMSLIB00012724351,related spectra of '1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (delta mass:2.0)',CCMSLIB00003137677,2,1991,Drug_analog,1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)),no_match,no_match,no_match,no_match,PAZGBAOHGQRCBP-DDDNOICHSA-N
CCMSLIB00012724352,related spectra of '1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (delta mass:2.0)',CCMSLIB00003137677,2,1992,Drug_analog,1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)),no_match,no_match,no_match,no_match,PAZGBAOHGQRCBP-DDDNOICHSA-N
CCMSLIB00012724353,related spectra of '1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (delta mass:2.0)',CCMSLIB00003137677,2,1993,Drug_analog,1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)),no_match,no_match,no_match,no_match,PAZGBAOHGQRCBP-DDDNOICHSA-N
CCMSLIB00012724354,related spectra of '1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (delta mass:2.0)',CCMSLIB00003137677,2,1994,Drug_analog,1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)),no_match,no_match,no_match,no_match,PAZGBAOHGQRCBP-DDDNOICHSA-N
CCMSLIB00012724355,related spectra of '1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (delta mass:2.02)',CCMSLIB00003136709,2.02,1995,Drug_analog,1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)),no_match,no_match,no_match,no_match,PAZGBAOHGQRCBP-DDDNOICHSA-N
CCMSLIB00012724356,"related spectra of 'erythromycin (delta mass:34.01)', 'clarithromycin (delta mass:1.98)', 'erythromycin (delta mass:15.0)', 'erythromycin (delta mass:15.98)', 'erythromycin (delta mass:15.99)', 'clarithromycin (delta mass:1.99)', 'erythromycin (delta mass:16.0)'",CCMSLIB00000006288|CCMSLIB00000207357|CCMSLIB00000207358|CCMSLIB00000207363|CCMSLIB00000207364|CCMSLIB00000207365|CCMSLIB00000222303|CCMSLIB00003135296|CCMSLIB00003137289|CCMSLIB00003137653|CCMSLIB00004694442|CCMSLIB00004694443|CCMSLIB00005723243|CCMSLIB00005723244|CCMSLIB00005772340|CCMSLIB00005776106|CCMSLIB00005777178|CCMSLIB00006117142|CCMSLIB00006117144|CCMSLIB00006117146|CCMSLIB00006117148|CCMSLIB00006117149|CCMSLIB00006117160|CCMSLIB00006117162|CCMSLIB00006117167|CCMSLIB00010113483|CCMSLIB00010124808|CCMSLIB00010146700|CCMSLIB00010149754,34.01|1.98|15.00|15.99,1996,Drug_analog,erythromycin|clarithromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma|pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|otitis,protein synthesis inhibition by binding to 50S ribosomal subunit|bacterial 50S ribosomal subunit inhibitor,ULGZDMOVFRHVEP-RWJQBGPGSA-N|AGOYDEPGAOXOCK-AVDMLEEESA-N|ULGZDMOVFRHVEP-UHFFFAOYSA-N|AGOYDEPGAOXOCK-KCBOHYOISA-N
CCMSLIB00012724357,related spectra of 'azithromycin (delta mass:1.0)',CCMSLIB00005775616|CCMSLIB00005777061,1,1997,Drug_analog,azithromycin,macrolide antimicrobial,infectious disease,pelvic inflammatory disease|pneumonia|urethritis|cervicitis|sinusitis,bacterial 50S ribosomal subunit inhibitor,MQTOSJVFKKJCRP-OHJWJPDZSA-N
CCMSLIB00012724358,related spectra of 'midecamycin (delta mass:-56.03)',CCMSLIB00010133046|CCMSLIB00010133047|CCMSLIB00010133049,-56.03,1998,Drug_analog,midecamycin,macrolide antimicrobial,infectious disease,respiratory tract infections|ear infections|skin infections,protein synthesis inhibitor,DMUAPQTXSSNEDD-QALJCMCCSA-N
CCMSLIB00012724359,related spectra of 'midecamycin (delta mass:-56.03)',CCMSLIB00010133045|CCMSLIB00010133046|CCMSLIB00010133047|CCMSLIB00010133048|CCMSLIB00010133049,-56.03,1999,Drug_analog,midecamycin,macrolide antimicrobial,infectious disease,respiratory tract infections|ear infections|skin infections,protein synthesis inhibitor,DMUAPQTXSSNEDD-QALJCMCCSA-N
CCMSLIB00012724360,related spectra of 'midecamycin (delta mass:-56.03)',CCMSLIB00010133046|CCMSLIB00010133047|CCMSLIB00010133049,-56.03,2000,Drug_analog,midecamycin,macrolide antimicrobial,infectious disease,respiratory tract infections|ear infections|skin infections,protein synthesis inhibitor,DMUAPQTXSSNEDD-QALJCMCCSA-N
CCMSLIB00012725368,related spectra of 'abacavir (delta mass:-40.032)',CCMSLIB00010134211|CCMSLIB00010134212|CCMSLIB00010134213|CCMSLIB00010134214|CCMSLIB00010134215|CCMSLIB00010134216|CCMSLIB00010134217|CCMSLIB00010134218|CCMSLIB00010142710|CCMSLIB00010142711|CCMSLIB00010142712|CCMSLIB00010142713|CCMSLIB00010142714|CCMSLIB00010142715|CCMSLIB00010142716|CCMSLIB00010142717,-40.03,3008,Drug_suspect,abacavir,HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI),infectious disease,human immunodeficiency virus (HIV-1),nucleoside reverse transcriptase inhibitor,MCGSCOLBFJQGHM-SCZZXKLOSA-N
CCMSLIB00012724362,related spectra of '1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (delta mass:12.0)',CCMSLIB00003135216,12,2002,Drug_analog,1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)),no_match,no_match,no_match,no_match,PAZGBAOHGQRCBP-DDDNOICHSA-N
CCMSLIB00012724363,"related spectra of 'erythromycin (delta mass:28.03)', 'clarithromycin (delta mass:14.02)', 'clarithromycin (delta mass:14.01)'",CCMSLIB00000207357|CCMSLIB00000207358|CCMSLIB00000207359|CCMSLIB00000207363|CCMSLIB00000207364|CCMSLIB00000207365|CCMSLIB00000207366|CCMSLIB00004694442|CCMSLIB00004694443|CCMSLIB00005777178|CCMSLIB00006117142|CCMSLIB00006117160|CCMSLIB00006117162|CCMSLIB00006117164|CCMSLIB00006117166|CCMSLIB00006117167|CCMSLIB00006680141|CCMSLIB00010124808|CCMSLIB00010146700|CCMSLIB00010149754,28.03|14.02,2003,Drug_analog,clarithromycin|erythromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis|listeria|respiratory tract infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,bacterial 50S ribosomal subunit inhibitor|protein synthesis inhibition by binding to 50S ribosomal subunit,AGOYDEPGAOXOCK-AVDMLEEESA-N|ULGZDMOVFRHVEP-RWJQBGPGSA-N|AGOYDEPGAOXOCK-KCBOHYOISA-N
CCMSLIB00012724364,related spectra of 'clarithromycin n-oxide (delta mass:-1.98)',CCMSLIB00005732147,-1.98,2004,Drug_analog,clarithromycin n-oxide,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis,bacterial 50S ribosomal subunit inhibitor,KDRPFIWYMNONLJ-KCBOHYOISA-N
CCMSLIB00012724365,"related spectra of 'clarithromycin (delta mass:15.96)', 'erythromycin (delta mass:29.97)'",CCMSLIB00000078509|CCMSLIB00000078998|CCMSLIB00003135296|CCMSLIB00005772340|CCMSLIB00005776106|CCMSLIB00010113483,15.96|29.97,2005,Drug_analog,clarithromycin|erythromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis|listeria|respiratory tract infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,bacterial 50S ribosomal subunit inhibitor|protein synthesis inhibition by binding to 50S ribosomal subunit,AGOYDEPGAOXOCK-BVGAJGDJSA-N|AGOYDEPGAOXOCK-KCBOHYOISA-N|ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012724366,"related spectra of 'davercin (delta mass:4.03)', 'erythromycin (delta mass:30.01)', 'clarithromycin (delta mass:15.99)', 'clarithromycin (delta mass:16.0)', 'clarithromycin (delta mass:15.98)', 'azithromycin (delta mass:14.96)', 'clarithromycin (delta mass:15.97)'",CCMSLIB00000004872|CCMSLIB00000078509|CCMSLIB00000207344|CCMSLIB00000207345|CCMSLIB00000207350|CCMSLIB00000207351|CCMSLIB00000207357|CCMSLIB00000207359|CCMSLIB00000207363|CCMSLIB00000207365|CCMSLIB00000207366|CCMSLIB00003135296|CCMSLIB00003137653|CCMSLIB00003138050|CCMSLIB00004694442|CCMSLIB00004694443|CCMSLIB00005434451|CCMSLIB00005773712|CCMSLIB00005777061|CCMSLIB00005777146|CCMSLIB00005777178|CCMSLIB00006117142|CCMSLIB00006117144|CCMSLIB00006117146|CCMSLIB00006117148|CCMSLIB00006117149|CCMSLIB00006117160|CCMSLIB00006117162|CCMSLIB00006117164|CCMSLIB00006117166|CCMSLIB00006117167|CCMSLIB00006680141|CCMSLIB00006685304|CCMSLIB00010113483|CCMSLIB00010124808|CCMSLIB00010144512|CCMSLIB00010144513|CCMSLIB00010146700|CCMSLIB00010146701|CCMSLIB00010149754|CCMSLIB00010149755,4.03|30.01|15.99|14.96,2006,Drug_analog,clarithromycin|azithromycin|erythromycin|davercin,macrolide antimicrobial|no_match,infectious disease|no_match,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis|pelvic inflammatory disease|urethritis|cervicitis|listeria|respiratory tract infections|syphilis|amebiasis|chlamydia|diphtheria|erythrasma|no_match,bacterial 50S ribosomal subunit inhibitor|protein synthesis inhibition by binding to 50S ribosomal subunit|no_match,AGOYDEPGAOXOCK-KCBOHYOISA-N|AGOYDEPGAOXOCK-BVGAJGDJSA-N|MQTOSJVFKKJCRP-OHJWJPDZSA-N|AGOYDEPGAOXOCK-AVDMLEEESA-N|ULGZDMOVFRHVEP-RWJQBGPGSA-N|MQTOSJVFKKJCRP-BICOPXKESA-N|NKLGIWNNVDPGCA-ZDYKNUMJSA-N
CCMSLIB00012724367,related spectra of 'ginsenoside rg3 (delta mass:-2.02)',CCMSLIB00010137103|CCMSLIB00010137104|CCMSLIB00010137106,-2.02,2007,Drug_analog,ginsenoside rg3,no_match,NA,NA,angiogenesis inhibitor|apoptosis stimulant,RWXIFXNRCLMQCD-JBVRGBGGSA-N
CCMSLIB00012724368,related spectra of 'azithromycin (delta mass:18.01)',CCMSLIB00000207345|CCMSLIB00000207350|CCMSLIB00000207351|CCMSLIB00005434451,18.01,2008,Drug_analog,azithromycin,macrolide antimicrobial,infectious disease,pelvic inflammatory disease|pneumonia|urethritis|cervicitis|sinusitis,bacterial 50S ribosomal subunit inhibitor,MQTOSJVFKKJCRP-OHJWJPDZSA-N|MQTOSJVFKKJCRP-BICOPXKESA-N
CCMSLIB00012724369,related spectra of 'midecamycin (delta mass:-42.01)',CCMSLIB00010133045,-42.01,2009,Drug_analog,midecamycin,macrolide antimicrobial,infectious disease,respiratory tract infections|ear infections|skin infections,protein synthesis inhibitor,DMUAPQTXSSNEDD-QALJCMCCSA-N
CCMSLIB00012724370,related spectra of '1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (delta mass:28.03)',CCMSLIB00003136709,28.03,2010,Drug_analog,1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)),no_match,no_match,no_match,no_match,PAZGBAOHGQRCBP-DDDNOICHSA-N
CCMSLIB00012724371,related spectra of 'midecamycin (delta mass:-38.02)',CCMSLIB00010133045|CCMSLIB00010133046|CCMSLIB00010133047|CCMSLIB00010133049,-38.02,2011,Drug_analog,midecamycin,macrolide antimicrobial,infectious disease,respiratory tract infections|ear infections|skin infections,protein synthesis inhibitor,DMUAPQTXSSNEDD-QALJCMCCSA-N
CCMSLIB00012724372,related spectra of 'digoxin (delta mass:-2.02)',CCMSLIB00004706049,-2.02,2012,Drug_analog,digoxin,cardiac glycoside,cardiology,congestive heart failure|atrial fibrillation (AF),ATPase inhibitor,LTMHDMANZUZIPE-PUGKRICDSA-N
CCMSLIB00012724373,related spectra of 'digoxin (delta mass:-0.98)',CCMSLIB00004706049|CCMSLIB00004706050|CCMSLIB00004706051|CCMSLIB00010121632,-0.98,2013,Drug_analog,digoxin,cardiac glycoside,cardiology,congestive heart failure|atrial fibrillation (AF),ATPase inhibitor,LTMHDMANZUZIPE-PUGKRICDSA-N
CCMSLIB00012724374,"related spectra of 'gamithromycin (delta mass:4.0)', 'gamithromycin (delta mass:3.99)'",CCMSLIB00010137181|CCMSLIB00010137182|CCMSLIB00010137183|CCMSLIB00010137184,3.99,2014,Drug_analog,gamithromycin,veterinary,infectious disease,bovine respiratory disease (BRD),antibacterial,VWAMTBXLZPEDQO-UZSBJOJWSA-N
CCMSLIB00012724375,"related spectra of 'ginsenoside rg3 (delta mass:-0.98)', 'ginsenoside rg3 (delta mass:17.03)'",CCMSLIB00010137103|CCMSLIB00010137104|CCMSLIB00010137108,-0.98|17.03,2015,Drug_analog,ginsenoside rg3,no_match,NA,NA,angiogenesis inhibitor|apoptosis stimulant,RWXIFXNRCLMQCD-JBVRGBGGSA-N
CCMSLIB00012724376,"related spectra of 'midecamycin (delta mass:-28.03)', 'josamycin (delta mass:-42.01)'",CCMSLIB00010106266|CCMSLIB00010117604|CCMSLIB00010130229|CCMSLIB00010130231|CCMSLIB00010133045,-28.03|-42.01,2016,Drug_analog,josamycin|midecamycin,macrolide antimicrobial,infectious disease,gram-positive bacterial infections|respiratory tract infections|ear infections|skin infections,bacterial 50S ribosomal subunit inhibitor|protein synthesis inhibitor,XJSFLOJWULLJQS-NGVXBBESSA-N|DMUAPQTXSSNEDD-QALJCMCCSA-N
CCMSLIB00012724377,related spectra of 'salinomycin (delta mass:18.01)',CCMSLIB00004716630|CCMSLIB00010111110,18.01,2017,Drug_analog,salinomycin,veterinary,infectious disease,coccidiosis,NA,KQXDHUJYNAXLNZ-IBKCOUPJSA-N|KQXDHUJYNAXLNZ-XQSDOZFQSA-N
CCMSLIB00012724378,related spectra of 'cobicistat (delta mass:15.99)',CCMSLIB00010149420|CCMSLIB00010149421,15.99,2018,Drug_analog,cobicistat,CYP3A inhibitor,metabolism,atazanavir treatment|darunavir treatment,cytochrome P450 inhibitor,ZCIGNRJZKPOIKD-CQXVEOKZSA-N
CCMSLIB00012724379,"related spectra of 'tacrolimus (delta mass:-12.0)', 'pimecrolimus (delta mass:-17.97)'",CCMSLIB00000572577|CCMSLIB00005736390|CCMSLIB00010130721|CCMSLIB00010130722|CCMSLIB00010130723,-12.00|-17.97,2019,Drug_analog,tacrolimus|pimecrolimus,calcineurin inhibitor immunosuppressant,transplant|dermatology,organ rejection|atopic dermatitis|eczema,calcineurin inhibitor,QJJXYPPXXYFBGM-LFZNUXCKSA-N|QJJXYPPXXYFBGM-UHFFFAOYSA-N|KASDHRXLYQOAKZ-XDSKOBMDSA-N
CCMSLIB00012724380,"related spectra of '33069-62-4 (delta mass:-60.02)', '7-epitaxol (delta mass:-60.02)', 'paclitaxel (delta mass:-60.02)'",CCMSLIB00000005451|CCMSLIB00004713015|CCMSLIB00004721572|CCMSLIB00008851476|CCMSLIB00010125535|CCMSLIB00010138590|CCMSLIB00010138591|CCMSLIB00010138594|CCMSLIB00010142025|CCMSLIB00010142026|CCMSLIB00010142028,-60.02,2020,Drug_analog,paclitaxel|7-epitaxol|33069-62-4,microtubule inhibitor,oncology,ovarian cancer|breast cancer|non-small cell lung cancer (NSCLC),tubulin polymerization inhibitor,RCINICONZNJXQF-MZXODVADSA-N|RCINICONZNJXQF-LYTKHFMESA-N
CCMSLIB00012724381,related spectra of 'digoxin (delta mass:13.98)',CCMSLIB00004706049|CCMSLIB00010110292|CCMSLIB00010121632,13.98,2021,Drug_analog,digoxin,cardiac glycoside,cardiology,congestive heart failure|atrial fibrillation (AF),ATPase inhibitor,LTMHDMANZUZIPE-PUGKRICDSA-N
CCMSLIB00012724382,"related spectra of 'midecamycin (delta mass:-14.01)', 'josamycin (delta mass:-28.03)', 'midecamycin (delta mass:-14.02)'",CCMSLIB00010106266|CCMSLIB00010117604|CCMSLIB00010130229|CCMSLIB00010130230|CCMSLIB00010130231|CCMSLIB00010133045|CCMSLIB00010133046|CCMSLIB00010133048|CCMSLIB00010133049,-28.03|-14.02,2022,Drug_analog,josamycin|midecamycin,macrolide antimicrobial,infectious disease,gram-positive bacterial infections|respiratory tract infections|ear infections|skin infections,bacterial 50S ribosomal subunit inhibitor|protein synthesis inhibitor,XJSFLOJWULLJQS-NGVXBBESSA-N|DMUAPQTXSSNEDD-QALJCMCCSA-N
CCMSLIB00012724383,"related spectra of 'midecamycin (delta mass:-14.02)', 'josamycin (delta mass:-28.03)'",CCMSLIB00010106266|CCMSLIB00010117604|CCMSLIB00010133047,-14.02|-28.03,2023,Drug_analog,josamycin|midecamycin,macrolide antimicrobial,infectious disease,gram-positive bacterial infections|respiratory tract infections|ear infections|skin infections,bacterial 50S ribosomal subunit inhibitor|protein synthesis inhibitor,XJSFLOJWULLJQS-NGVXBBESSA-N|DMUAPQTXSSNEDD-QALJCMCCSA-N
CCMSLIB00012724384,related spectra of 'midecamycin (delta mass:-12.04)',CCMSLIB00010133046|CCMSLIB00010133047|CCMSLIB00010133049,-12.04,2024,Drug_analog,midecamycin,macrolide antimicrobial,infectious disease,respiratory tract infections|ear infections|skin infections,protein synthesis inhibitor,DMUAPQTXSSNEDD-QALJCMCCSA-N
CCMSLIB00012724385,related spectra of 'josamycin (delta mass:-14.02)',CCMSLIB00010106266,-14.02,2025,Drug_analog,josamycin,macrolide antimicrobial,infectious disease,gram-positive bacterial infections,bacterial 50S ribosomal subunit inhibitor,XJSFLOJWULLJQS-NGVXBBESSA-N
CCMSLIB00012724386,"related spectra of 'spiramycin i (delta mass:-28.03)', 'spiramycin (delta mass:-28.03)'",CCMSLIB00000572618|CCMSLIB00005734284,-28.03,2026,Drug_analog,spiramycin i|spiramycin,macrolide antimicrobial,infectious disease,toxoplasmosis|soft tissue infection,bacterial 50S ribosomal subunit inhibitor,ACTOXUHEUCPTEW-JMRHEKERSA-N
CCMSLIB00012724387,"related spectra of 'midecamycin (delta mass:3.99)', 'midecamycin (delta mass:4.0)'",CCMSLIB00010133045|CCMSLIB00010133046|CCMSLIB00010133049,3.99,2027,Drug_analog,midecamycin,macrolide antimicrobial,infectious disease,respiratory tract infections|ear infections|skin infections,protein synthesis inhibitor,DMUAPQTXSSNEDD-QALJCMCCSA-N
CCMSLIB00012724388,"related spectra of 'dirithromycin (delta mass:-14.01)', 'roxithromycin (delta mass:-15.99)'",CCMSLIB00005723229|CCMSLIB00005763768|CCMSLIB00005776923|CCMSLIB00006546680|CCMSLIB00006546700|CCMSLIB00006546821|CCMSLIB00006546841|CCMSLIB00006546931|CCMSLIB00010147255,-14.02|-15.99,2028,Drug_analog,dirithromycin|roxithromycin,macrolide antimicrobial,infectious disease,bronchitis|respiratory infections|respiratory tract infections|urinary tract infections|skin infections,bacterial 50S ribosomal subunit inhibitor,WLOHNSSYAXHWNR-DWIOZXRMSA-N|RXZBMPWDPOLZGW-HITVVWEBSA-N|RXZBMPWDPOLZGW-XMRMVWPWSA-N
CCMSLIB00012724389,related spectra of 'simvastatin (delta mass:-28.03)',CCMSLIB00005435691,-28.03,2029,Drug_analog,simvastatin,HMG-CoA reductase inhibitor (statin),endocrinology|cardiology|neurology/psychiatry,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,RYMZZMVNJRMUDD-HGQWONQESA-N
CCMSLIB00012724390,"related spectra of 'spiramycin (delta mass:-14.02)', 'spiramycin i (delta mass:-14.02)'",CCMSLIB00000572618|CCMSLIB00005734284,-14.02,2030,Drug_analog,spiramycin i|spiramycin,macrolide antimicrobial,infectious disease,toxoplasmosis|soft tissue infection,bacterial 50S ribosomal subunit inhibitor,ACTOXUHEUCPTEW-JMRHEKERSA-N
CCMSLIB00012724391,"related spectra of 'josamycin (delta mass:3.99)', 'josamycin (delta mass:4.0)'",CCMSLIB00010130228,3.99,2031,Drug_analog,josamycin,macrolide antimicrobial,infectious disease,gram-positive bacterial infections,bacterial 50S ribosomal subunit inhibitor,XJSFLOJWULLJQS-NGVXBBESSA-N
CCMSLIB00012724392,"related spectra of '7-epitaxol (delta mass:-18.01)', 'paclitaxel (delta mass:-18.01)'",CCMSLIB00000855151|CCMSLIB00004713015|CCMSLIB00004721572|CCMSLIB00008851476|CCMSLIB00010125535|CCMSLIB00010138590|CCMSLIB00010138591|CCMSLIB00010138592,-18.01,2032,Drug_analog,paclitaxel|7-epitaxol,microtubule inhibitor,oncology,ovarian cancer|breast cancer|non-small cell lung cancer (NSCLC),tubulin polymerization inhibitor,RCINICONZNJXQF-MZXODVADSA-N|RCINICONZNJXQF-LYTKHFMESA-N
CCMSLIB00012724393,"related spectra of '7-epitaxol (delta mass:-18.01)', '33069-62-4 (delta mass:-18.01)'",CCMSLIB00010138593|CCMSLIB00010138594|CCMSLIB00010142027,-18.01,2033,Drug_analog,7-epitaxol|33069-62-4,microtubule inhibitor,oncology,ovarian cancer|breast cancer|non-small cell lung cancer (NSCLC),tubulin polymerization inhibitor,RCINICONZNJXQF-LYTKHFMESA-N|RCINICONZNJXQF-MZXODVADSA-N
CCMSLIB00012724394,related spectra of 'josamycin (delta mass:-14.02)',CCMSLIB00010106267,-14.02,2034,Drug_analog,josamycin,macrolide antimicrobial,infectious disease,gram-positive bacterial infections,bacterial 50S ribosomal subunit inhibitor,XJSFLOJWULLJQS-NGVXBBESSA-N
CCMSLIB00012724395,related spectra of 'josamycin (delta mass:-14.02)',CCMSLIB00010106267,-14.02,2035,Drug_analog,josamycin,macrolide antimicrobial,infectious disease,gram-positive bacterial infections,bacterial 50S ribosomal subunit inhibitor,XJSFLOJWULLJQS-NGVXBBESSA-N
CCMSLIB00012724396,related spectra of 'josamycin (delta mass:-14.02)',CCMSLIB00010117605,-14.02,2036,Drug_analog,josamycin,macrolide antimicrobial,infectious disease,gram-positive bacterial infections,bacterial 50S ribosomal subunit inhibitor,XJSFLOJWULLJQS-NGVXBBESSA-N
CCMSLIB00012724397,related spectra of 'josamycin (delta mass:-14.02)',CCMSLIB00010106267,-14.02,2037,Drug_analog,josamycin,macrolide antimicrobial,infectious disease,gram-positive bacterial infections,bacterial 50S ribosomal subunit inhibitor,XJSFLOJWULLJQS-NGVXBBESSA-N
CCMSLIB00012724398,related spectra of 'josamycin (delta mass:-14.02)',CCMSLIB00010106267,-14.02,2038,Drug_analog,josamycin,macrolide antimicrobial,infectious disease,gram-positive bacterial infections,bacterial 50S ribosomal subunit inhibitor,XJSFLOJWULLJQS-NGVXBBESSA-N
CCMSLIB00012724399,"related spectra of 'midecamycin (delta mass:28.03)', 'josamycin (delta mass:14.02)'",CCMSLIB00010106266|CCMSLIB00010117604|CCMSLIB00010130229|CCMSLIB00010130231|CCMSLIB00010133045,28.03|14.02,2039,Drug_analog,josamycin|midecamycin,macrolide antimicrobial,infectious disease,gram-positive bacterial infections|respiratory tract infections|ear infections|skin infections,bacterial 50S ribosomal subunit inhibitor|protein synthesis inhibitor,XJSFLOJWULLJQS-NGVXBBESSA-N|DMUAPQTXSSNEDD-QALJCMCCSA-N
CCMSLIB00012724400,"related spectra of 'erythromycin ethyl succinate (delta mass:-18.01)', 'erythromycin ethylsuccinate (delta mass:-18.01)'",CCMSLIB00000077069|CCMSLIB00010152311|CCMSLIB00010152312|CCMSLIB00010152314|CCMSLIB00010152315|CCMSLIB00010152317|CCMSLIB00010152318,-18.01,2040,Drug_analog,erythromycin ethyl succinate|erythromycin ethylsuccinate,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,NSYZCCDSJNWWJL-YXOIYICCSA-N
CCMSLIB00012724401,"related spectra of 'spiramycin i (delta mass:12.0)', 'spiramycin (delta mass:12.0)'",CCMSLIB00000572618|CCMSLIB00005734284,12,2041,Drug_analog,spiramycin i|spiramycin,macrolide antimicrobial,infectious disease,toxoplasmosis|soft tissue infection,bacterial 50S ribosomal subunit inhibitor,ACTOXUHEUCPTEW-JMRHEKERSA-N
CCMSLIB00012724402,"related spectra of 'spiramycin i (delta mass:13.98)', 'spiramycin (delta mass:13.98)'",CCMSLIB00000572618|CCMSLIB00005734284|CCMSLIB00010115766,13.98,2042,Drug_analog,spiramycin i|spiramycin,macrolide antimicrobial,infectious disease,toxoplasmosis|soft tissue infection,bacterial 50S ribosomal subunit inhibitor,ACTOXUHEUCPTEW-JMRHEKERSA-N
CCMSLIB00012724403,"related spectra of 'spiramycin (delta mass:18.01)', 'spiramycin i (delta mass:18.01)'",CCMSLIB00000572618|CCMSLIB00004694217|CCMSLIB00005734284|CCMSLIB00010104431,18.01,2043,Drug_analog,spiramycin i|spiramycin,macrolide antimicrobial,infectious disease,toxoplasmosis|soft tissue infection,bacterial 50S ribosomal subunit inhibitor,ACTOXUHEUCPTEW-JMRHEKERSA-N
CCMSLIB00012724404,related spectra of 'josamycin (delta mass:14.02)',CCMSLIB00010106267,14.02,2044,Drug_analog,josamycin,macrolide antimicrobial,infectious disease,gram-positive bacterial infections,bacterial 50S ribosomal subunit inhibitor,XJSFLOJWULLJQS-NGVXBBESSA-N
CCMSLIB00012724405,related spectra of 'dioscin (delta mass:-2.02)',CCMSLIB00010133006|CCMSLIB00010133007|CCMSLIB00010133009|CCMSLIB00010133010,-2.02,2045,Drug_analog,dioscin,no_match,NA,NA,apoptosis stimulant,VNONINPVFQTJOC-ZGXDEBHDSA-N
CCMSLIB00012724406,"related spectra of 'erythromycin ethyl succinate (delta mass:13.98)', 'erythromycin ethylsuccinate (delta mass:14.02)', 'erythromycin ethylsuccinate (delta mass:13.98)'",CCMSLIB00000077069|CCMSLIB00010152312|CCMSLIB00010152314|CCMSLIB00010152315|CCMSLIB00010152317|CCMSLIB00010152318,13.98,2046,Drug_analog,erythromycin ethyl succinate|erythromycin ethylsuccinate,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,NSYZCCDSJNWWJL-YXOIYICCSA-N
CCMSLIB00012724407,related spectra of 'baicalin (delta mass:-14.02)',CCMSLIB00005746669,-14.02,2047,Drug_analog,baicalin,no_match,NA,NA,beta glucuronidase inhibitor,IKIIZLYTISPENI-ZFORQUDYSA-N
CCMSLIB00012724408,related spectra of 'dioscin (delta mass:13.98)',CCMSLIB00010133007|CCMSLIB00010133009,13.98,2048,Drug_analog,dioscin,no_match,NA,NA,apoptosis stimulant,VNONINPVFQTJOC-ZGXDEBHDSA-N
CCMSLIB00012724409,related spectra of 'dioscin (delta mass:15.99)',CCMSLIB00010133006|CCMSLIB00010133007|CCMSLIB00010133009,15.99,2049,Drug_analog,dioscin,no_match,NA,NA,apoptosis stimulant,VNONINPVFQTJOC-ZGXDEBHDSA-N
CCMSLIB00012724410,"related spectra of 'spiramycin (delta mass:42.01)', 'spiramycin i (delta mass:42.01)'",CCMSLIB00000572618|CCMSLIB00000572790|CCMSLIB00004694217|CCMSLIB00004694218|CCMSLIB00005731826|CCMSLIB00005734284|CCMSLIB00010115766,42.01,2050,Drug_analog,spiramycin i|spiramycin,macrolide antimicrobial,infectious disease,toxoplasmosis|soft tissue infection,bacterial 50S ribosomal subunit inhibitor,ACTOXUHEUCPTEW-JMRHEKERSA-N
CCMSLIB00012724411,related spectra of 'dioscin (delta mass:15.99)',CCMSLIB00010133011|CCMSLIB00010133012|CCMSLIB00010133013,15.99,2051,Drug_analog,dioscin,no_match,NA,NA,apoptosis stimulant,VNONINPVFQTJOC-ZGXDEBHDSA-N
CCMSLIB00012724412,related spectra of 'dioscin (delta mass:30.01)',CCMSLIB00010133011|CCMSLIB00010133013,30.01,2052,Drug_analog,dioscin,no_match,NA,NA,apoptosis stimulant,VNONINPVFQTJOC-ZGXDEBHDSA-N
CCMSLIB00012724413,related spectra of 'beta-cyclodextrin (delta mass:-162.05)',CCMSLIB00010149900,-162.05,2053,Drug_analog,beta-cyclodextrin,no_match,NA,NA,NA,WHGYBXFWUBPSRW-FOUAGVGXSA-N
CCMSLIB00012724414,related spectra of 'abacavir (delta mass:-40.03)',CCMSLIB00010134211|CCMSLIB00010134212|CCMSLIB00010134213|CCMSLIB00010134214|CCMSLIB00010134215|CCMSLIB00010134216|CCMSLIB00010134217|CCMSLIB00010134218|CCMSLIB00010142710|CCMSLIB00010142711|CCMSLIB00010142712|CCMSLIB00010142713|CCMSLIB00010142714|CCMSLIB00010142715|CCMSLIB00010142716|CCMSLIB00010142717,#N/A,2054,Drug_suspect,abacavir,HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI),infectious disease,human immunodeficiency virus (HIV-1),nucleoside reverse transcriptase inhibitor,MCGSCOLBFJQGHM-SCZZXKLOSA-N
CCMSLIB00012724415,related spectra of 'abacavir (delta mass:31.99)',CCMSLIB00010134211|CCMSLIB00010134212|CCMSLIB00010134213|CCMSLIB00010134214|CCMSLIB00010134215|CCMSLIB00010134216|CCMSLIB00010134217|CCMSLIB00010134218|CCMSLIB00010142710|CCMSLIB00010142711|CCMSLIB00010142712|CCMSLIB00010142713|CCMSLIB00010142714|CCMSLIB00010142715|CCMSLIB00010142716|CCMSLIB00010142717,#N/A,2055,Drug_suspect,abacavir,HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI),infectious disease,human immunodeficiency virus (HIV-1),nucleoside reverse transcriptase inhibitor,MCGSCOLBFJQGHM-SCZZXKLOSA-N
CCMSLIB00012724416,related spectra of 'beta-cyclodextrin (delta mass:17.03)',CCMSLIB00010149900,17.03,2056,Drug_analog,beta-cyclodextrin,no_match,NA,NA,NA,WHGYBXFWUBPSRW-FOUAGVGXSA-N
CCMSLIB00012724417,related spectra of 'beta-cyclodextrin (delta mass:18.01)',CCMSLIB00010149900,18.01,2057,Drug_analog,beta-cyclodextrin,no_match,NA,NA,NA,WHGYBXFWUBPSRW-FOUAGVGXSA-N
CCMSLIB00012724418,related spectra of 'beta-cyclodextrin (delta mass:36.02)',CCMSLIB00010149900,36.02,2058,Drug_analog,beta-cyclodextrin,no_match,NA,NA,NA,WHGYBXFWUBPSRW-FOUAGVGXSA-N
CCMSLIB00012724419,related spectra of 'cyclosporine (delta mass:28.03)',CCMSLIB00004721779|CCMSLIB00004721780,28.03,2059,Drug_analog,cyclosporine,calcineurin inhibitor immunosuppressant,rheumatology|dermatology|transplant,rheumatoid arthritis|psoriasis|organ rejection,calcineurin inhibitor,PMATZTZNYRCHOR-CGLBZJNRSA-N
CCMSLIB00012724420,"related spectra of '""lactose, anhydrous"" (delta mass:-15.995)'",CCMSLIB00010143804|CCMSLIB00010143805|CCMSLIB00010143806|CCMSLIB00010143807|CCMSLIB00010143808|CCMSLIB00010143809|CCMSLIB00010143810|CCMSLIB00010143811|CCMSLIB00010143812|CCMSLIB00010143813|CCMSLIB00010143814|CCMSLIB00010143815,-15.99,2060,Drug_suspect|Low_confidence,"lactose, anhydrous",no_match,no_match,no_match,no_match,DKXNBNKWCZZMJT-JVCRWLNRSA-N
CCMSLIB00012724421,"related spectra of '""lactose, anhydrous"" (delta mass:1.978)'",CCMSLIB00010143804|CCMSLIB00010143805|CCMSLIB00010143806|CCMSLIB00010143807|CCMSLIB00010143808|CCMSLIB00010143809|CCMSLIB00010143810|CCMSLIB00010143811|CCMSLIB00010143812|CCMSLIB00010143813|CCMSLIB00010143814|CCMSLIB00010143815,1.98,2061,Drug_suspect|Low_confidence,"lactose, anhydrous",no_match,no_match,no_match,no_match,DKXNBNKWCZZMJT-JVCRWLNRSA-N
CCMSLIB00012724422,"related spectra of '""lactose, anhydrous"" (delta mass:17.027)'",CCMSLIB00010143804|CCMSLIB00010143805|CCMSLIB00010143806|CCMSLIB00010143807|CCMSLIB00010143808|CCMSLIB00010143809|CCMSLIB00010143810|CCMSLIB00010143811|CCMSLIB00010143812|CCMSLIB00010143813|CCMSLIB00010143814|CCMSLIB00010143815,17.03,2062,Drug_suspect|Low_confidence,"lactose, anhydrous",no_match,no_match,no_match,no_match,DKXNBNKWCZZMJT-JVCRWLNRSA-N
CCMSLIB00012724423,related spectra of '(+)-ajmaline (delta mass:2.016)',CCMSLIB00010139174|CCMSLIB00010139175|CCMSLIB00010139176|CCMSLIB00010139177|CCMSLIB00010139178|CCMSLIB00010139179,2.02,2063,Drug_suspect,ajmaline,no_match,cardiology,Wolff-Parkinson-White Syndrome (WPW),sodium channel blocker,CJDRUOGAGYHKKD-RQBLFBSQSA-N
CCMSLIB00012724424,related spectra of '(s)-ketorolac (delta mass:-43.99)',CCMSLIB00010143678|CCMSLIB00010143679|CCMSLIB00010143680|CCMSLIB00010143681|CCMSLIB00010143682,-43.99,2064,Drug_suspect,ketorolac,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,rheumatoid arthritis|osteoarthritis|dysmenorrhea|muscle pain,cyclooxygenase inhibitor,OZWKMVRBQXNZKK-NSHDSACASA-N
CCMSLIB00012724425,related spectra of '(s)-ketorolac (delta mass:12.036)',CCMSLIB00010143678|CCMSLIB00010143679|CCMSLIB00010143680|CCMSLIB00010143681|CCMSLIB00010143682,12.04,2065,Drug_suspect,ketorolac,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,rheumatoid arthritis|osteoarthritis|dysmenorrhea|muscle pain,cyclooxygenase inhibitor,OZWKMVRBQXNZKK-NSHDSACASA-N
CCMSLIB00012724426,related spectra of '(s)-ketorolac (delta mass:14.016)',CCMSLIB00010143678|CCMSLIB00010143679|CCMSLIB00010143680|CCMSLIB00010143681|CCMSLIB00010143682,14.02,2066,Drug_suspect,ketorolac,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,rheumatoid arthritis|osteoarthritis|dysmenorrhea|muscle pain,cyclooxygenase inhibitor,OZWKMVRBQXNZKK-NSHDSACASA-N
CCMSLIB00012724427,related spectra of '0358_sulfamethazine (delta mass:0.984)',CCMSLIB00000579538,0.98,2067,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012724428,related spectra of '0358_sulfamethazine (delta mass:14.016)',CCMSLIB00000579538,14.02,2068,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012724429,related spectra of '0358_sulfamethazine (delta mass:27.995)',CCMSLIB00000579538,27.99,2069,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012724430,related spectra of '0358_sulfamethazine (delta mass:162.053)',CCMSLIB00000579538,162.05,2070,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012724431,"related spectra of '0465_10,11-dihydro-10,11-dihydroxycarbamazepine (delta mass:-2.016)'",CCMSLIB00000579630,-2.02,2071,Drug_suspect,dihydroxycarbazepine,mood stabilizer,neurology/psychiatry,seizures|trigeminal neuralgia,carboxamide antiepileptic,PRGQOPPDPVELEG-UHFFFAOYSA-N
CCMSLIB00012724432,related spectra of '0534_amitriptyline (delta mass:1.003)',CCMSLIB00000579660,1,2072,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724433,related spectra of '0534_amitriptyline (delta mass:15.995)',CCMSLIB00000579660,15.99,2073,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724434,related spectra of '0534_amitriptyline (delta mass:28.991)',CCMSLIB00000579660,28.99,2074,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724435,related spectra of '105827-78-9 (delta mass:1.003)',CCMSLIB00010145037|CCMSLIB00010145038|CCMSLIB00010145039|CCMSLIB00010145040|CCMSLIB00010145041,1,2075,Drug_suspect,imidacloprid,insecticide,infectious disease,fleas,acetylcholine receptor antagonist,YWTYJOPNNQFBPC-UHFFFAOYSA-N
CCMSLIB00012724436,related spectra of '105827-78-9 (delta mass:2.004)',CCMSLIB00010145037|CCMSLIB00010145038|CCMSLIB00010145039|CCMSLIB00010145040|CCMSLIB00010145041,2,2076,Drug_suspect,imidacloprid,insecticide,infectious disease,fleas,acetylcholine receptor antagonist,YWTYJOPNNQFBPC-UHFFFAOYSA-N
CCMSLIB00012724437,related spectra of '105827-78-9 (delta mass:15.995)',CCMSLIB00010145037|CCMSLIB00010145038|CCMSLIB00010145039|CCMSLIB00010145040|CCMSLIB00010145041,15.99,2077,Drug_suspect,imidacloprid,insecticide,infectious disease,fleas,acetylcholine receptor antagonist,YWTYJOPNNQFBPC-UHFFFAOYSA-N
CCMSLIB00012724438,related spectra of '2-acetamido-2-deoxy-d-mannopyranose (delta mass:-18.011)',CCMSLIB00010131499|CCMSLIB00010131500|CCMSLIB00010131501|CCMSLIB00010131502|CCMSLIB00010131503|CCMSLIB00010131504|CCMSLIB00010131505|CCMSLIB00010131506|CCMSLIB00010131507|CCMSLIB00010131508,-18.01,2078,Drug_suspect,2-acetamido-2-deoxy-d-mannopyranose,no_match,NA,NA,NA,OVRNDRQMDRJTHS-ZTVVOAFPSA-N
CCMSLIB00012724439,related spectra of '2-acetamido-2-deoxy-d-mannopyranose (delta mass:14.016)',CCMSLIB00010131499|CCMSLIB00010131500|CCMSLIB00010131501|CCMSLIB00010131502|CCMSLIB00010131503|CCMSLIB00010131504|CCMSLIB00010131505|CCMSLIB00010131506|CCMSLIB00010131507|CCMSLIB00010131508,14.02,2079,Drug_suspect,2-acetamido-2-deoxy-d-mannopyranose,no_match,NA,NA,NA,OVRNDRQMDRJTHS-ZTVVOAFPSA-N
CCMSLIB00012724440,related spectra of '2-acetamido-2-deoxy-d-mannopyranose (delta mass:18.01)',CCMSLIB00010131499|CCMSLIB00010131500|CCMSLIB00010131501|CCMSLIB00010131502|CCMSLIB00010131503|CCMSLIB00010131504|CCMSLIB00010131505|CCMSLIB00010131506|CCMSLIB00010131507|CCMSLIB00010131508,18.01,2080,Drug_suspect,2-acetamido-2-deoxy-d-mannopyranose,no_match,NA,NA,NA,OVRNDRQMDRJTHS-ZTVVOAFPSA-N
CCMSLIB00012724441,related spectra of '2-acetamido-2-deoxy-d-mannopyranose (delta mass:28.031)',CCMSLIB00010131499|CCMSLIB00010131500|CCMSLIB00010131501|CCMSLIB00010131502|CCMSLIB00010131503|CCMSLIB00010131504|CCMSLIB00010131505|CCMSLIB00010131506|CCMSLIB00010131507|CCMSLIB00010131508,28.03,2081,Drug_suspect,2-acetamido-2-deoxy-d-mannopyranose,no_match,NA,NA,NA,OVRNDRQMDRJTHS-ZTVVOAFPSA-N
CCMSLIB00012724442,"related spectra of '2-ethylhexyl 2-cyano-3,3-diphenylacrylate (delta mass:-2.016)'",CCMSLIB00000579921,-2.02,2082,Drug_suspect,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-UHFFFAOYSA-N
CCMSLIB00012724443,"related spectra of '2-ethylhexyl 2-cyano-3,3-diphenylacrylate (delta mass:17.027)'",CCMSLIB00000579921,17.03,2083,Drug_suspect,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-UHFFFAOYSA-N
CCMSLIB00012724444,"related spectra of '2-ethylhexyl 2-cyano-3,3-diphenylacrylate (delta mass:30.01)'",CCMSLIB00000579921,30.01,2084,Drug_suspect,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-UHFFFAOYSA-N
CCMSLIB00012724445,related spectra of '2361_pantoprazole (delta mass:-15.995)',CCMSLIB00000579370|CCMSLIB00000579654,-15.99,2085,Drug_suspect,pantoprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|erosive esophagitis (EE)|Zollinger-Ellison syndrome,ATPase inhibitor,IQPSEEYGBUAQFF-UHFFFAOYSA-N
CCMSLIB00012724446,related spectra of '2573_sertraline (delta mass:1.993)',CCMSLIB00000579705,2,2086,Drug_suspect,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012724447,related spectra of '29122-68-7 (delta mass:14.999)',NA,15,2087,Drug_suspect,NA,NA,NA,NA,NA,NA
CCMSLIB00012724448,"related spectra of '3-o-(2-methoxyethyl) 5-o-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate (delta mass:-14.016)'",CCMSLIB00000079086,-14.02,2088,Drug_suspect,nimodipine,dihydropyridine calcium channel blocker,neurology/psychiatry,subarachnoid hemorrhage|cerebral vasospasm,calcium channel blocker,UIAGMCDKSXEBJQ-UHFFFAOYSA-N
CCMSLIB00012724449,related spectra of '302776-68-7 (delta mass:-28.031)',CCMSLIB00010151335|CCMSLIB00010151336|CCMSLIB00010151337|CCMSLIB00010151338|CCMSLIB00010151339|CCMSLIB00010151340|CCMSLIB00010151341|CCMSLIB00010151342,-28.03,2089,Drug_suspect,302776-68-7,no_match,no_match,no_match,no_match,FDATWRLUYRHCJE-UHFFFAOYSA-N
CCMSLIB00012724450,related spectra of '317318-70-0 (delta mass:31.99)',CCMSLIB00010146783|CCMSLIB00010146784|CCMSLIB00010146785|CCMSLIB00010146786|CCMSLIB00010146787|CCMSLIB00010146788|CCMSLIB00010146789|CCMSLIB00010146790,31.99,2090,Drug_suspect,317318-70-0,no_match,NA,NA,PPAR receptor agonist,YDBLKRPLXZNVNB-UHFFFAOYSA-N
CCMSLIB00012724451,related spectra of '5-hydroxyomeprazole (delta mass:-14.016)',CCMSLIB00004679244,-14.02,2091,Drug_suspect,hydroxyomeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,CMZHQFXXAAIBKE-UHFFFAOYSA-N
CCMSLIB00012724452,related spectra of '5-hydroxyomeprazole (delta mass:-4.031)',CCMSLIB00004679244,-4.03,2092,Drug_suspect,hydroxyomeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,CMZHQFXXAAIBKE-UHFFFAOYSA-N
CCMSLIB00012724453,related spectra of '5-hydroxyomeprazole (delta mass:15.995)',CCMSLIB00004679244,15.99,2093,Drug_suspect,hydroxyomeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,CMZHQFXXAAIBKE-UHFFFAOYSA-N
CCMSLIB00012724454,related spectra of '5-hydroxyomeprazole (delta mass:27.995)',CCMSLIB00004679244,27.99,2094,Drug_suspect,hydroxyomeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,CMZHQFXXAAIBKE-UHFFFAOYSA-N
CCMSLIB00012724455,related spectra of '5-hydroxyomeprazole (delta mass:192.027)',CCMSLIB00004679244,192.03,2095,Drug_suspect,hydroxyomeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,CMZHQFXXAAIBKE-UHFFFAOYSA-N
CCMSLIB00012724456,"related spectra of '6,7-dimethoxy-3-{4-methoxy-6-methyl-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl}-1,3-dihydro-2-benzofuran-1-one (delta mass:37.958)'",CCMSLIB00005725047|CCMSLIB00005725048|CCMSLIB00005725049|CCMSLIB00005725050|CCMSLIB00005725051|CCMSLIB00005725052,37.96,2096,Drug_suspect,noscapine,opium alkaloids and derivatives,pulmonary,cough suppressant,bradykinin receptor antagonist|tubulin polymerization inhibitor,AKNNEGZIBPJZJG-UHFFFAOYSA-N
CCMSLIB00012724457,"related spectra of '6,7-dimethoxy-3-{4-methoxy-6-methyl-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl}-1,3-dihydro-2-benzofuran-1-one (delta mass:15.958)'",CCMSLIB00005725047|CCMSLIB00005725048|CCMSLIB00005725049|CCMSLIB00005725050|CCMSLIB00005725051|CCMSLIB00005725052,15.96,2097,Drug_suspect,noscapine,opium alkaloids and derivatives,pulmonary,cough suppressant,bradykinin receptor antagonist|tubulin polymerization inhibitor,AKNNEGZIBPJZJG-UHFFFAOYSA-N
CCMSLIB00012724458,"related spectra of '6,7-dimethoxy-3-{4-methoxy-6-methyl-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl}-1,3-dihydro-2-benzofuran-1-one (delta mass:15.995)'",CCMSLIB00005725047|CCMSLIB00005725048|CCMSLIB00005725049|CCMSLIB00005725050|CCMSLIB00005725051|CCMSLIB00005725052,15.99,2098,Drug_suspect,noscapine,opium alkaloids and derivatives,pulmonary,cough suppressant,bradykinin receptor antagonist|tubulin polymerization inhibitor,AKNNEGZIBPJZJG-UHFFFAOYSA-N
CCMSLIB00012724459,"related spectra of '6,7-dimethoxy-3-{4-methoxy-6-methyl-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl}-1,3-dihydro-2-benzofuran-1-one (delta mass:18.01)'",CCMSLIB00005725047|CCMSLIB00005725048|CCMSLIB00005725049|CCMSLIB00005725050|CCMSLIB00005725051|CCMSLIB00005725052,18.01,2099,Drug_suspect,noscapine,opium alkaloids and derivatives,pulmonary,cough suppressant,bradykinin receptor antagonist|tubulin polymerization inhibitor,AKNNEGZIBPJZJG-UHFFFAOYSA-N
CCMSLIB00012724460,"related spectra of '6,7-dimethoxy-3-{4-methoxy-6-methyl-2h,5h,6h,7h,8h-[1,3]dioxolo[4,5-g]isoquinolin-5-yl}-1,3-dihydro-2-benzofuran-1-one (delta mass:24.995)'",CCMSLIB00005725047|CCMSLIB00005725048|CCMSLIB00005725049|CCMSLIB00005725050|CCMSLIB00005725051|CCMSLIB00005725052,25,2100,Drug_suspect,noscapine,opium alkaloids and derivatives,pulmonary,cough suppressant,bradykinin receptor antagonist|tubulin polymerization inhibitor,AKNNEGZIBPJZJG-UHFFFAOYSA-N
CCMSLIB00012724461,related spectra of '69-53-4 (delta mass:12.0)',CCMSLIB00010135367|CCMSLIB00010135368|CCMSLIB00010135369|CCMSLIB00010135370|CCMSLIB00010135371|CCMSLIB00010143832|CCMSLIB00010143833|CCMSLIB00010143834|CCMSLIB00010143835|CCMSLIB00010143836|CCMSLIB00010143837|CCMSLIB00010143838|CCMSLIB00010143839,12,2101,Drug_suspect,69-53-4,penicillin class antibacterial,infectious disease,respiratory tract infections|meningitis|bacterial septicemia|endocarditis|urinary tract infections|gastrointestinal infections,bacterial cell wall synthesis inhibitor,AVKUERGKIZMTKX-NJBDSQKTSA-N
CCMSLIB00012724462,related spectra of '69-53-4 (delta mass:14.016)',CCMSLIB00010135367|CCMSLIB00010135368|CCMSLIB00010135369|CCMSLIB00010135370|CCMSLIB00010135371|CCMSLIB00010143832|CCMSLIB00010143833|CCMSLIB00010143834|CCMSLIB00010143835|CCMSLIB00010143836|CCMSLIB00010143837|CCMSLIB00010143838|CCMSLIB00010143839,14.02,2102,Drug_suspect,69-53-4,penicillin class antibacterial,infectious disease,respiratory tract infections|meningitis|bacterial septicemia|endocarditis|urinary tract infections|gastrointestinal infections,bacterial cell wall synthesis inhibitor,AVKUERGKIZMTKX-NJBDSQKTSA-N
CCMSLIB00012724463,related spectra of '69227-93-6 (delta mass:-56.062)',CCMSLIB00010133712|CCMSLIB00010133713|CCMSLIB00010133714|CCMSLIB00010133715|CCMSLIB00010133716,-56.06,2103,Drug_suspect,69227-93-6,no_match,no_match,no_match,no_match,NLEBIOOXCVAHBD-QKMCSOCLSA-N
CCMSLIB00012724464,related spectra of '69227-93-6 (delta mass:-42.047)',CCMSLIB00010133712|CCMSLIB00010133713|CCMSLIB00010133714|CCMSLIB00010133715|CCMSLIB00010133716,-42.05,2104,Drug_suspect,69227-93-6,no_match,no_match,no_match,no_match,NLEBIOOXCVAHBD-QKMCSOCLSA-N
CCMSLIB00012724465,related spectra of '69227-93-6 (delta mass:-28.031)',CCMSLIB00010133712|CCMSLIB00010133713|CCMSLIB00010133714|CCMSLIB00010133715|CCMSLIB00010133716,-28.03,2105,Drug_suspect,69227-93-6,no_match,no_match,no_match,no_match,NLEBIOOXCVAHBD-QKMCSOCLSA-N
CCMSLIB00012724466,related spectra of '69227-93-6 (delta mass:-17.026)',CCMSLIB00010133712|CCMSLIB00010133713|CCMSLIB00010133714|CCMSLIB00010133715|CCMSLIB00010133716,-17.03,2106,Drug_suspect,69227-93-6,no_match,no_match,no_match,no_match,NLEBIOOXCVAHBD-QKMCSOCLSA-N
CCMSLIB00012724467,related spectra of '69227-93-6 (delta mass:-14.016)',CCMSLIB00010133712|CCMSLIB00010133713|CCMSLIB00010133714|CCMSLIB00010133715|CCMSLIB00010133716,-14.02,2107,Drug_suspect,69227-93-6,no_match,no_match,no_match,no_match,NLEBIOOXCVAHBD-QKMCSOCLSA-N
CCMSLIB00012724468,related spectra of '69227-93-6 (delta mass:28.031)',CCMSLIB00010133712|CCMSLIB00010133713|CCMSLIB00010133714|CCMSLIB00010133715|CCMSLIB00010133716,28.03,2108,Drug_suspect,69227-93-6,no_match,no_match,no_match,no_match,NLEBIOOXCVAHBD-QKMCSOCLSA-N
CCMSLIB00012724469,related spectra of '69227-93-6 (delta mass:162.053)',CCMSLIB00010133712|CCMSLIB00010133713|CCMSLIB00010133714|CCMSLIB00010133715|CCMSLIB00010133716,162.05,2109,Drug_suspect,69227-93-6,no_match,no_match,no_match,no_match,NLEBIOOXCVAHBD-QKMCSOCLSA-N
CCMSLIB00012724470,"related spectra of '7-chloro-1-methyl-5-phenyl-3h-1,4-benzodiazepin-2-one (delta mass:15.995)'",CCMSLIB00000079136,15.99,2110,Drug_suspect,diazepam,benzodiazepine,neurology/psychiatry,seizures|anxiety|muscle spasms|spasticity|alcohol withdrawal,GABA-A receptor agonist,AAOVKJBEBIDNHE-UHFFFAOYSA-N
CCMSLIB00012724471,related spectra of '73573-88-3 (delta mass:12.036)',CCMSLIB00010147003|CCMSLIB00010147004|CCMSLIB00010147005|CCMSLIB00010147006|CCMSLIB00010147007,12.04,2111,Drug_suspect,73573-88-3,HMG-CoA reductase inhibitor (statin),NA,NA,HMGCR inhibitor,AJLFOPYRIVGYMJ-INTXDZFKSA-N
CCMSLIB00012724472,related spectra of '73573-88-3 (delta mass:15.995)',CCMSLIB00010147003|CCMSLIB00010147004|CCMSLIB00010147005|CCMSLIB00010147006|CCMSLIB00010147007,15.99,2112,Drug_suspect,73573-88-3,HMG-CoA reductase inhibitor (statin),NA,NA,HMGCR inhibitor,AJLFOPYRIVGYMJ-INTXDZFKSA-N
CCMSLIB00012724473,related spectra of '73573-88-3 (delta mass:31.99)',CCMSLIB00010147003|CCMSLIB00010147004|CCMSLIB00010147005|CCMSLIB00010147006|CCMSLIB00010147007,31.99,2113,Drug_suspect,73573-88-3,HMG-CoA reductase inhibitor (statin),NA,NA,HMGCR inhibitor,AJLFOPYRIVGYMJ-INTXDZFKSA-N
CCMSLIB00012724474,related spectra of '7365-44-8 (delta mass:42.01)',CCMSLIB00010132137|CCMSLIB00010132138|CCMSLIB00010132139|CCMSLIB00010132140|CCMSLIB00010132141,42.01,2114,Drug_suspect,7365-44-8,no_match,no_match,no_match,no_match,JOCBASBOOFNAJA-UHFFFAOYSA-N
CCMSLIB00012724475,"related spectra of '9-(4-aminophenyl)-3,7-dihydroxy-2,4,6-trimethyl-9-oxo-nonoic acid (candicidin related) (delta mass:-18.011)'",CCMSLIB00005463708,-18.01,2115,Drug_suspect,"9-(4'-aminophenyl)-3,7-dihydroxy-2,4,6-trimethyl-9-oxo-nonoic acid",polyene antifungal,infectious disease,vulvovaginal candidiasis,fungal ergosterol inhibitor,UHZAKFDEIOBYGZ-UHFFFAOYSA-N
CCMSLIB00012724476,related spectra of 'almitrine (delta mass:34.005)',CCMSLIB00010137012|CCMSLIB00010137013|CCMSLIB00010137014|CCMSLIB00010137015|CCMSLIB00010137016|CCMSLIB00010137017|CCMSLIB00010137018|CCMSLIB00010137019,34.01,2116,Drug_suspect,almitrine,no_match,pulmonary,chronic obstructive pulmonary disease (COPD),neurotransmitter agonist,OBDOVFRMEYHSQB-UHFFFAOYSA-N
CCMSLIB00012724477,related spectra of 'aripiprazole (delta mass:-2.016)',CCMSLIB00000079010,-2.02,2117,Drug_suspect,aripiprazole,atypical antipsychotic,neurology/psychiatry,depression|schizophrenia|bipolar disorder,D2 and 5-HT1A receptor partial agonist|5-HT2A receptor antagonist,CEUORZQYGODEFX-UHFFFAOYSA-N
CCMSLIB00012724478,related spectra of 'aripiprazole (delta mass:2.004)',CCMSLIB00000079010,2,2118,Drug_suspect,aripiprazole,atypical antipsychotic,neurology/psychiatry,depression|schizophrenia|bipolar disorder,D2 and 5-HT1A receptor partial agonist|5-HT2A receptor antagonist,CEUORZQYGODEFX-UHFFFAOYSA-N
CCMSLIB00012724479,related spectra of 'avermectin b1a (delta mass:28.031)',CCMSLIB00010152319|CCMSLIB00010152320|CCMSLIB00010152321|CCMSLIB00010152322|CCMSLIB00010152323,28.03,2119,Drug_suspect,avermectin b1a,no_match,no_match,no_match,antiparasitic,RRZXIRBKKLTSOM-XPNPUAGNSA-N
CCMSLIB00012725369,related spectra of 'abacavir (delta mass:13.98)',CCMSLIB00010134211|CCMSLIB00010134212|CCMSLIB00010134213|CCMSLIB00010134214|CCMSLIB00010134215|CCMSLIB00010134216|CCMSLIB00010134217|CCMSLIB00010134218|CCMSLIB00010142710|CCMSLIB00010142711|CCMSLIB00010142712|CCMSLIB00010142713|CCMSLIB00010142714|CCMSLIB00010142715|CCMSLIB00010142716|CCMSLIB00010142717,13.98,3009,Drug_suspect,abacavir,HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI),infectious disease,human immunodeficiency virus (HIV-1),nucleoside reverse transcriptase inhibitor,MCGSCOLBFJQGHM-SCZZXKLOSA-N
CCMSLIB00012725370,related spectra of 'abacavir (delta mass:18.01)',CCMSLIB00010134211|CCMSLIB00010134212|CCMSLIB00010134213|CCMSLIB00010134214|CCMSLIB00010134215|CCMSLIB00010134216|CCMSLIB00010134217|CCMSLIB00010134218|CCMSLIB00010142710|CCMSLIB00010142711|CCMSLIB00010142712|CCMSLIB00010142713|CCMSLIB00010142714|CCMSLIB00010142715|CCMSLIB00010142716|CCMSLIB00010142717,18.01,3010,Drug_suspect,abacavir,HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI),infectious disease,human immunodeficiency virus (HIV-1),nucleoside reverse transcriptase inhibitor,MCGSCOLBFJQGHM-SCZZXKLOSA-N
CCMSLIB00012725371,related spectra of 'abacavir (delta mass:27.995)',CCMSLIB00010134211|CCMSLIB00010134212|CCMSLIB00010134213|CCMSLIB00010134214|CCMSLIB00010134215|CCMSLIB00010134216|CCMSLIB00010134217|CCMSLIB00010134218|CCMSLIB00010142710|CCMSLIB00010142711|CCMSLIB00010142712|CCMSLIB00010142713|CCMSLIB00010142714|CCMSLIB00010142715|CCMSLIB00010142716|CCMSLIB00010142717,27.99,3011,Drug_suspect,abacavir,HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI),infectious disease,human immunodeficiency virus (HIV-1),nucleoside reverse transcriptase inhibitor,MCGSCOLBFJQGHM-SCZZXKLOSA-N
CCMSLIB00012725372,related spectra of 'abacavir (delta mass:79.957)',CCMSLIB00010134211|CCMSLIB00010134212|CCMSLIB00010134213|CCMSLIB00010134214|CCMSLIB00010134215|CCMSLIB00010134216|CCMSLIB00010134217|CCMSLIB00010134218|CCMSLIB00010142710|CCMSLIB00010142711|CCMSLIB00010142712|CCMSLIB00010142713|CCMSLIB00010142714|CCMSLIB00010142715|CCMSLIB00010142716|CCMSLIB00010142717,79.96,3012,Drug_suspect,abacavir,HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI),infectious disease,human immunodeficiency virus (HIV-1),nucleoside reverse transcriptase inhibitor,MCGSCOLBFJQGHM-SCZZXKLOSA-N
CCMSLIB00012725373,related spectra of 'abacavir (delta mass:176.032)',CCMSLIB00010134211|CCMSLIB00010134212|CCMSLIB00010134213|CCMSLIB00010134214|CCMSLIB00010134215|CCMSLIB00010134216|CCMSLIB00010134217|CCMSLIB00010134218|CCMSLIB00010142710|CCMSLIB00010142711|CCMSLIB00010142712|CCMSLIB00010142713|CCMSLIB00010142714|CCMSLIB00010142715|CCMSLIB00010142716|CCMSLIB00010142717,176.03,3013,Drug_suspect,abacavir,HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI),infectious disease,human immunodeficiency virus (HIV-1),nucleoside reverse transcriptase inhibitor,MCGSCOLBFJQGHM-SCZZXKLOSA-N
CCMSLIB00012724485,related spectra of 'alfuzosin hydrochloride (uroxatral) (delta mass:-28.031)',CCMSLIB00000078138,-28.03,2125,Drug_suspect,alfuzosin,alpha adrenergic blocker,urology,benign prostatic hyperplasia (BPH),adrenergic receptor antagonist,WNMJYKCGWZFFKR-UHFFFAOYSA-N
CCMSLIB00012724486,related spectra of 'alfuzosin hydrochloride (uroxatral) (delta mass:-14.016)',CCMSLIB00000078138,-14.02,2126,Drug_suspect,alfuzosin,alpha adrenergic blocker,urology,benign prostatic hyperplasia (BPH),adrenergic receptor antagonist,WNMJYKCGWZFFKR-UHFFFAOYSA-N
CCMSLIB00012724487,related spectra of 'amitriptyline (delta mass:0.984)',CCMSLIB00000078599,0.98,2127,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724488,related spectra of 'amitriptyline (delta mass:15.995)',CCMSLIB00000078599,15.99,2128,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724489,related spectra of 'amitryptiline (delta mass:-28.031)',CCMSLIB00003060623,-28.03,2129,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724490,related spectra of 'amitryptiline (delta mass:15.995)',CCMSLIB00003060623,15.99,2130,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724491,related spectra of 'atenolol [mostly precursor ion] (delta mass:14.999)',CCMSLIB00000077060,15,2131,Drug_suspect,atenolol,beta-adrenergic receptor inhibitor,cardiology,hypertension|angina pectoris|acute myocardial infarction,adrenergic receptor antagonist,NA
CCMSLIB00012724492,related spectra of 'avobenzone (delta mass:-27.995)',CCMSLIB00000077204|CCMSLIB00010141351|CCMSLIB00010141352|CCMSLIB00010141353|CCMSLIB00010141354|CCMSLIB00010141355,-27.99,2132,Drug_suspect,avobenzone|avobenzone,no_match,dermatology,cosmetic|sunscreen lotion,topical sunscreen agent,XNEFYCZVKIDDMS-UHFFFAOYSA-N
CCMSLIB00012724493,related spectra of 'avobenzone (delta mass:15.995)',CCMSLIB00000077204|CCMSLIB00010141351|CCMSLIB00010141352|CCMSLIB00010141353|CCMSLIB00010141354|CCMSLIB00010141355,15.99,2133,Drug_suspect,avobenzone|avobenzone,no_match,dermatology,cosmetic|sunscreen lotion,topical sunscreen agent,XNEFYCZVKIDDMS-UHFFFAOYSA-N
CCMSLIB00012724494,related spectra of 'azithromycin - dark web drugs (delta mass:-15.995)',CCMSLIB00005434451|CCMSLIB00005434452|CCMSLIB00005434453|CCMSLIB00005434454,-15.99,2134,Drug_suspect,azithromycin,macrolide antimicrobial,infectious disease,pelvic inflammatory disease|pneumonia|urethritis|cervicitis|sinusitis,bacterial 50S ribosomal subunit inhibitor,MQTOSJVFKKJCRP-BICOPXKESA-N
CCMSLIB00012724495,related spectra of 'azithromycin - dark web drugs (delta mass:-14.016)',CCMSLIB00005434451|CCMSLIB00005434452|CCMSLIB00005434453|CCMSLIB00005434454,-14.02,2135,Drug_suspect,azithromycin,macrolide antimicrobial,infectious disease,pelvic inflammatory disease|pneumonia|urethritis|cervicitis|sinusitis,bacterial 50S ribosomal subunit inhibitor,MQTOSJVFKKJCRP-BICOPXKESA-N
CCMSLIB00012724496,related spectra of 'azithromycin - dark web drugs (delta mass:14.016)',CCMSLIB00005434451|CCMSLIB00005434452|CCMSLIB00005434453|CCMSLIB00005434454,14.02,2136,Drug_suspect,azithromycin,macrolide antimicrobial,infectious disease,pelvic inflammatory disease|pneumonia|urethritis|cervicitis|sinusitis,bacterial 50S ribosomal subunit inhibitor,MQTOSJVFKKJCRP-BICOPXKESA-N
CCMSLIB00012724497,"related spectra of 'aztreonam (azactam, cayston) (delta mass:-79.958)'",CCMSLIB00000078169|CCMSLIB00000078170,-79.96,2137,Drug_suspect,aztreonam,monobactam antibacterial,infectious disease,urinary tract infections|respiratory tract infections|bacterial septicemia|skin infections|intra-abdominal infections|gynecologic infections,bacterial cell wall synthesis inhibitor,WZPBZJONDBGPKJ-DZIOLEBDSA-N
CCMSLIB00012724498,related spectra of 'benazepril hydrochloride (delta mass:14.016)',CCMSLIB00000078919,14.02,2138,Drug_suspect,benazepril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|myocardial infarction|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,XPCFTKFZXHTYIP-PMACEKPBSA-N
CCMSLIB00012724499,related spectra of 'bnc210 (delta mass:-56.062)',CCMSLIB00010131014|CCMSLIB00010131015|CCMSLIB00010131016|CCMSLIB00010131017|CCMSLIB00010131018,-56.06,2139,Drug_suspect,bnc210,no_match,no_match,no_match,no_match,BVRPESWOSNFUCJ-LKTVYLICSA-N
CCMSLIB00012724500,related spectra of 'bnc210 (delta mass:-39.012)',CCMSLIB00010131014|CCMSLIB00010131015|CCMSLIB00010131016|CCMSLIB00010131017|CCMSLIB00010131018,-39.01,2140,Drug_suspect,bnc210,no_match,no_match,no_match,no_match,BVRPESWOSNFUCJ-LKTVYLICSA-N
CCMSLIB00012724501,related spectra of 'bnc210 (delta mass:-16.031)',CCMSLIB00010131014|CCMSLIB00010131015|CCMSLIB00010131016|CCMSLIB00010131017|CCMSLIB00010131018,-16.03,2141,Drug_suspect,bnc210,no_match,no_match,no_match,no_match,BVRPESWOSNFUCJ-LKTVYLICSA-N
CCMSLIB00012724502,related spectra of 'bnc210 (delta mass:-12.036)',CCMSLIB00010131014|CCMSLIB00010131015|CCMSLIB00010131016|CCMSLIB00010131017|CCMSLIB00010131018,-12.04,2142,Drug_suspect,bnc210,no_match,no_match,no_match,no_match,BVRPESWOSNFUCJ-LKTVYLICSA-N
CCMSLIB00012724503,related spectra of 'bnc210 (delta mass:1.003)',CCMSLIB00010131014|CCMSLIB00010131015|CCMSLIB00010131016|CCMSLIB00010131017|CCMSLIB00010131018,1,2143,Drug_suspect,bnc210,no_match,no_match,no_match,no_match,BVRPESWOSNFUCJ-LKTVYLICSA-N
CCMSLIB00012724504,related spectra of 'bnc210 (delta mass:14.016)',CCMSLIB00010131014|CCMSLIB00010131015|CCMSLIB00010131016|CCMSLIB00010131017|CCMSLIB00010131018,14.02,2144,Drug_suspect,bnc210,no_match,no_match,no_match,no_match,BVRPESWOSNFUCJ-LKTVYLICSA-N
CCMSLIB00012724505,related spectra of 'baicalin (delta mass:28.031)',CCMSLIB00000078856|CCMSLIB00000078890|CCMSLIB00006716211|CCMSLIB00010147628|CCMSLIB00010147629|CCMSLIB00010147630|CCMSLIB00010147631|CCMSLIB00010147632,28.03,2145,Drug_suspect,baicalin|baicalin,no_match,NA|no_match,NA|no_match,beta glucuronidase inhibitor,IKIIZLYTISPENI-ZFORQUDYSA-N
CCMSLIB00012724506,related spectra of 'benazepril hydrochloride (delta mass:-28.031)',CCMSLIB00000078084,-28.03,2146,Drug_suspect,benazepril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|myocardial infarction|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,XPCFTKFZXHTYIP-PMACEKPBSA-N
CCMSLIB00012724507,related spectra of 'benzalkonium chloride (c12) (delta mass:28.031)',CCMSLIB00000531495,28.03,2147,Drug_suspect,benzalkonium,antiseptics and disinfectants,NA,antiseptic,antiseptic|preservative,CYDRXTMLKJDRQH-UHFFFAOYSA-N
CCMSLIB00012724508,related spectra of 'benzalkonium chloride (c12) (delta mass:13.98)',CCMSLIB00000531495,13.98,2148,Drug_suspect,benzalkonium,antiseptics and disinfectants,NA,antiseptic,antiseptic|preservative,CYDRXTMLKJDRQH-UHFFFAOYSA-N
CCMSLIB00012724509,related spectra of 'benzylpenicillin_20ev (delta mass:1.993)',CCMSLIB00005723212,2,2149,Drug_suspect,benzylpenicillin,penicillin class antibacterial,infectious disease,celluitis|meningitis|endocarditis|syphilis|pneumonia|bacterial septicemia,penicillin binding protein inhibitor,JGSARLDLIJGVTE-MBNYWOFBSA-N
CCMSLIB00012724510,related spectra of 'benzylpenicillin_20ev (delta mass:17.027)',CCMSLIB00005723212,17.03,2150,Drug_suspect,benzylpenicillin,penicillin class antibacterial,infectious disease,celluitis|meningitis|endocarditis|syphilis|pneumonia|bacterial septicemia,penicillin binding protein inhibitor,JGSARLDLIJGVTE-MBNYWOFBSA-N
CCMSLIB00012724511,related spectra of 'benzylpenicillin_20ev (delta mass:21.984)',CCMSLIB00005723212,21.98,2151,Drug_suspect,benzylpenicillin,penicillin class antibacterial,infectious disease,celluitis|meningitis|endocarditis|syphilis|pneumonia|bacterial septicemia,penicillin binding protein inhibitor,JGSARLDLIJGVTE-MBNYWOFBSA-N
CCMSLIB00012724512,related spectra of 'bilastine (delta mass:-28.031)',CCMSLIB00010152075|CCMSLIB00010152076|CCMSLIB00010152077|CCMSLIB00010152078|CCMSLIB00010152079,-28.03,2152,Drug_suspect,bilastine,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,ACCMWZWAEFYUGZ-UHFFFAOYSA-N
CCMSLIB00012724513,related spectra of 'carboxyomeprazole (delta mass:-14.016)',CCMSLIB00005721080,-14.02,2153,Drug_suspect,carboxyomeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,QRGFNZYFRUUYBG-UHFFFAOYSA-N
CCMSLIB00012724514,related spectra of 'carboxyomeprazole (delta mass:2.016)',CCMSLIB00005721080,2.02,2154,Drug_suspect,carboxyomeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,QRGFNZYFRUUYBG-UHFFFAOYSA-N
CCMSLIB00012724515,related spectra of 'carboxyomeprazole (delta mass:14.016)',CCMSLIB00005721080,14.02,2155,Drug_suspect,carboxyomeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,QRGFNZYFRUUYBG-UHFFFAOYSA-N
CCMSLIB00012724516,related spectra of 'carvedilol (delta mass:-14.016)',CCMSLIB00000078306|CCMSLIB00000078949|CCMSLIB00009919303,-14.02,2156,Drug_suspect,carvedilol|carvedilol,alpha adrenergic blocker|beta-adrenergic receptor inhibitor,cardiology,myocardial infarction|hypertension,adrenergic receptor antagonist,OGHNVEJMJSYVRP-UHFFFAOYSA-N
CCMSLIB00012724517,related spectra of 'carvedilol (delta mass:15.995)',CCMSLIB00000078306|CCMSLIB00000078949|CCMSLIB00009919303,15.99,2157,Drug_suspect,carvedilol|carvedilol,alpha adrenergic blocker|beta-adrenergic receptor inhibitor,cardiology,myocardial infarction|hypertension,adrenergic receptor antagonist,OGHNVEJMJSYVRP-UHFFFAOYSA-N
CCMSLIB00012724518,related spectra of 'cefprozil (delta mass:2.016)',CCMSLIB00000006323|CCMSLIB00000006324,2.02,2158,Drug_suspect,cefprozil,cephalosporin antibacterial,infectious disease,pharyngitis|tonsillitis|otitis|sinusitis|respiratory tract infections|skin infections|bronchitis,bacterial cell wall synthesis inhibitor,WDLWHQDACQUCJR-ZAMMOSSLSA-N
CCMSLIB00012724519,related spectra of 'celecoxib (delta mass:29.974)',CCMSLIB00000005554|CCMSLIB00000005555|CCMSLIB00000005556|CCMSLIB00000005557|CCMSLIB00000005558|CCMSLIB00000005559|CCMSLIB00000005560|CCMSLIB00000005561|CCMSLIB00000005562|CCMSLIB00000005563|CCMSLIB00000005564|CCMSLIB00000005565|CCMSLIB00000078076|CCMSLIB00000579523|CCMSLIB00000579792|CCMSLIB00000579815,29.97,2159,Drug_suspect,celecoxib,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis|ankylosing spondylitis|primary dysmenorrhea (PD),cyclooxygenase inhibitor,RZEKVGVHFLEQIL-UHFFFAOYSA-N|NA
CCMSLIB00012724520,related spectra of 'chloroquine (delta mass:15.995)',CCMSLIB00005723985,15.99,2160,Drug_suspect,chloroquine,antimalarial,infectious disease,malaria|amebiasis,antimalarial agent,WHTVZRBIWZFKQO-UHFFFAOYSA-N
CCMSLIB00012724521,related spectra of 'chlorpheniramine maleate (delta mass:-14.016)',CCMSLIB00000078301|CCMSLIB00000078302,-14.02,2161,Drug_suspect,chlorpheniramine,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,SOYKEARSMXGVTM-UHFFFAOYSA-N
CCMSLIB00012724522,related spectra of 'ciclesonide (delta mass:-18.011)',CCMSLIB00010138358|CCMSLIB00010138359|CCMSLIB00010138363|CCMSLIB00010138364|CCMSLIB00010138365|CCMSLIB00010138366|CCMSLIB00010138367|CCMSLIB00010138368|CCMSLIB00010138369|CCMSLIB00010138370,-18.01,2162,Drug_suspect,ciclesonide,corticosteroid,allergy|pulmonary,allergic rhinitis|asthma,glucocorticoid receptor agonist,LUKZNWIVRBCLON-GXOBDPJESA-N
CCMSLIB00012724523,related spectra of 'citalopram n-oxide (delta mass:-30.01)',CCMSLIB00000424942,-30.01,2163,Drug_suspect,citalopram n-oxide,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),DIOGFDCEWUUSBQ-UHFFFAOYSA-N
CCMSLIB00012724524,related spectra of 'clindamycin n-oxide (delta mass:-18.011)',CCMSLIB00005716877,-18.01,2164,Drug_suspect,clindamycin n-oxide,lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,BFVCXYLQNGCSNB-UHFFFAOYSA-N
CCMSLIB00012724525,related spectra of 'clindamycin n-oxide (delta mass:-14.016)',CCMSLIB00005716877,-14.02,2165,Drug_suspect,clindamycin n-oxide,lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,BFVCXYLQNGCSNB-UHFFFAOYSA-N
CCMSLIB00012724526,related spectra of 'clindamycin hydrochloride (dalacin) (delta mass:79.957)',CCMSLIB00000078472,79.96,2166,Drug_suspect,clindamycin,lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,KDLRVYVGXIQJDK-PSUNAQLJSA-N
CCMSLIB00012724527,related spectra of 'clindamycin sulfoxide (delta mass:-2.016)',CCMSLIB00005716876,-2.02,2167,Drug_suspect,clindamycin sulfoxide,lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,XSLGFIQRVCXUEU-NXMZTFJRSA-N
CCMSLIB00012724528,related spectra of 'clindamycin sulfoxide (delta mass:1.978)',CCMSLIB00005716876,1.98,2168,Drug_suspect,clindamycin sulfoxide,lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,XSLGFIQRVCXUEU-NXMZTFJRSA-N
CCMSLIB00012724529,related spectra of 'clindamycin sulfoxide (delta mass:13.98)',CCMSLIB00005716876,13.98,2169,Drug_suspect,clindamycin sulfoxide,lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,XSLGFIQRVCXUEU-NXMZTFJRSA-N
CCMSLIB00012724530,related spectra of 'clindamycin sulfoxide (delta mass:58.005)',CCMSLIB00005716876,58.01,2170,Drug_suspect,clindamycin sulfoxide,lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,XSLGFIQRVCXUEU-NXMZTFJRSA-N
CCMSLIB00012724531,related spectra of 'clindamycin sulfoxide (delta mass:79.957)',CCMSLIB00005716876,79.96,2171,Drug_suspect,clindamycin sulfoxide,lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,XSLGFIQRVCXUEU-NXMZTFJRSA-N
CCMSLIB00012724532,related spectra of 'clindamycin sulfoxide n-oxide (delta mass:-18.011)',CCMSLIB00005716880,-18.01,2172,Drug_suspect,clindamycin sulfoxide n-oxide,lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,IVIROPAKYIVJMP-UHFFFAOYSA-N
CCMSLIB00012724533,related spectra of 'clindamycin sulfoxide n-oxide (delta mass:-14.016)',CCMSLIB00005716880,-14.02,2173,Drug_suspect,clindamycin sulfoxide n-oxide,lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,IVIROPAKYIVJMP-UHFFFAOYSA-N
CCMSLIB00012724534,related spectra of 'clindamycin sulfoxide n-oxide (delta mass:-2.016)',CCMSLIB00005716880,-2.02,2174,Drug_suspect,clindamycin sulfoxide n-oxide,lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,IVIROPAKYIVJMP-UHFFFAOYSA-N
CCMSLIB00012724535,related spectra of 'clindamycin sulfoxide n-oxide (delta mass:42.01)',CCMSLIB00005716880,42.01,2175,Drug_suspect,clindamycin sulfoxide n-oxide,lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,IVIROPAKYIVJMP-UHFFFAOYSA-N
CCMSLIB00012724536,related spectra of 'clopidogrel (plavix) (delta mass:14.016)',CCMSLIB00000078139,14.02,2176,Drug_suspect,clopidogrel,P2Y12 platelet inhibitor,cardiology|neurology/psychiatry,myocardial infarction|stroke|peripheral artery disease (PAD)|acute coronary syndrome (ACS),purinergic receptor antagonist,GKTWGGQPFAXNFI-HNNXBMFYSA-N
CCMSLIB00012724537,related spectra of 'diphenoxylate (delta mass:-28.031)',CCMSLIB00000079112,-28.03,2177,Drug_suspect,diphenoxylate,antidiarrheal,gastroenterology,diarrhea,opioid receptor agonist,HYPPXZBJBPSRLK-UHFFFAOYSA-N
CCMSLIB00012724538,related spectra of 'dansylamide (delta mass:2.999)',CCMSLIB00010151063|CCMSLIB00010151064|CCMSLIB00010151065|CCMSLIB00010151066|CCMSLIB00010151067,3,2178,Drug_suspect,dansylamide,no_match,no_match,no_match,no_match,TYNBFJJKZPTRKS-UHFFFAOYSA-N
CCMSLIB00012723866,related spectra of 'amprenavir (delta mass:-88.05)',CCMSLIB00010143819|CCMSLIB00010143820|CCMSLIB00010143822|CCMSLIB00010143823,-88.05,1506,Drug_analog,amprenavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,YMARZQAQMVYCKC-OEMFJLHTSA-N
CCMSLIB00012724166,related spectra of 'darunavir (delta mass:-43.99)',CCMSLIB00005772118|CCMSLIB00005774111,-43.99,1806,Drug_analog,darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-HEXNFIEUSA-N
CCMSLIB00012724167,related spectra of 'darunavir (delta mass:-43.99)',CCMSLIB00000572866|CCMSLIB00005734048|CCMSLIB00010137589|CCMSLIB00010137590|CCMSLIB00010137592|CCMSLIB00010137593|CCMSLIB00010137595|CCMSLIB00010137596|CCMSLIB00010138287|CCMSLIB00010138288|CCMSLIB00010138290|CCMSLIB00010138291|CCMSLIB00010138293|CCMSLIB00010138294,-43.99,1807,Drug_analog,darunavir|darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-HEXNFIEUSA-N|CJBJHOAVZSMMDJ-UHFFFAOYSA-N
CCMSLIB00012724193,related spectra of 'darunavir (delta mass:14.02)',CCMSLIB00000572957|CCMSLIB00005731359|CCMSLIB00010137589|CCMSLIB00010137591|CCMSLIB00010137594|CCMSLIB00010138287|CCMSLIB00010138288,14.02,1833,Drug_analog,darunavir|darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-HEXNFIEUSA-N|CJBJHOAVZSMMDJ-UHFFFAOYSA-N
CCMSLIB00012724226,"related spectra of 'amprenavir (delta mass:58.01)', 'amprenavir (delta mass:58.0)'",CCMSLIB00000078220|CCMSLIB00010143816|CCMSLIB00010143817|CCMSLIB00010143819|CCMSLIB00010143820|CCMSLIB00010143822|CCMSLIB00010143823,58.01,1866,Drug_analog,amprenavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,YMARZQAQMVYCKC-OEMFJLHTSA-N
CCMSLIB00012724227,related spectra of 'darunavir (delta mass:15.99)',CCMSLIB00000572866|CCMSLIB00005734048|CCMSLIB00010137589|CCMSLIB00010137590|CCMSLIB00010138287|CCMSLIB00010138288,15.99,1867,Drug_analog,darunavir|darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-HEXNFIEUSA-N|CJBJHOAVZSMMDJ-UHFFFAOYSA-N
CCMSLIB00012724228,"related spectra of 'darunavir (delta mass:15.99)', 'darunavir (delta mass:16.0)'",CCMSLIB00000572957|CCMSLIB00005731359|CCMSLIB00010137589|CCMSLIB00010137590|CCMSLIB00010138287|CCMSLIB00010138288,15.99,1868,Drug_analog,darunavir|darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-HEXNFIEUSA-N|CJBJHOAVZSMMDJ-UHFFFAOYSA-N
CCMSLIB00012724230,related spectra of 'darunavir (delta mass:17.03)',CCMSLIB00010137592|CCMSLIB00010137593|CCMSLIB00010137595|CCMSLIB00010137596|CCMSLIB00010138290|CCMSLIB00010138291|CCMSLIB00010138293|CCMSLIB00010138294,17.03,1870,Drug_analog,darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-HEXNFIEUSA-N
CCMSLIB00012724547,related spectra of 'dasotraline (delta mass:-17.026)',CCMSLIB00010135530|CCMSLIB00010135531|CCMSLIB00010135532|CCMSLIB00010135533|CCMSLIB00010135534|CCMSLIB00010135576|CCMSLIB00010135577|CCMSLIB00010135578|CCMSLIB00010135579|CCMSLIB00010135580,-17.03,2187,Drug_suspect,dasotraline,no_match,NA,NA,dopamine-norepinephrine-serotonin reuptake inhibitor,SRPXSILJHWNFMK-MEDUHNTESA-N
CCMSLIB00012724548,related spectra of 'dasotraline (delta mass:43.991)',CCMSLIB00010135530|CCMSLIB00010135531|CCMSLIB00010135532|CCMSLIB00010135533|CCMSLIB00010135534|CCMSLIB00010135576|CCMSLIB00010135577|CCMSLIB00010135578|CCMSLIB00010135579|CCMSLIB00010135580,43.99,2188,Drug_suspect,dasotraline,no_match,NA,NA,dopamine-norepinephrine-serotonin reuptake inhibitor,SRPXSILJHWNFMK-MEDUHNTESA-N
CCMSLIB00012724549,related spectra of 'dasotraline (delta mass:58.005)',CCMSLIB00010135530|CCMSLIB00010135531|CCMSLIB00010135532|CCMSLIB00010135533|CCMSLIB00010135534|CCMSLIB00010135576|CCMSLIB00010135577|CCMSLIB00010135578|CCMSLIB00010135579|CCMSLIB00010135580,58.01,2189,Drug_suspect,dasotraline,no_match,NA,NA,dopamine-norepinephrine-serotonin reuptake inhibitor,SRPXSILJHWNFMK-MEDUHNTESA-N
CCMSLIB00012724550,related spectra of 'denatonium (delta mass:13.98)',CCMSLIB00010151223|CCMSLIB00010151224|CCMSLIB00010151225|CCMSLIB00010151226|CCMSLIB00010151227|CCMSLIB00010151228|CCMSLIB00010151229|CCMSLIB00010151230,13.98,2190,Drug_suspect,denatonium,no_match,NA,NA,NA,ZFQMTVNLDNXRNQ-UHFFFAOYSA-O
CCMSLIB00012724551,related spectra of 'descladinoseazithromycin (delta mass:-15.995)',CCMSLIB00000478608,-15.99,2191,Drug_suspect,desosaminylazithromycin,macrolide antimicrobial,infectious disease,pelvic inflammatory disease|pneumonia|urethritis|cervicitis|sinusitis,bacterial 50S ribosomal subunit inhibitor,PXDYILJJHOVNLO-NDJYQBQTSA-N
CCMSLIB00012724552,related spectra of 'descladinoseazithromycin (delta mass:-14.016)',CCMSLIB00000478608,-14.02,2192,Drug_suspect,desosaminylazithromycin,macrolide antimicrobial,infectious disease,pelvic inflammatory disease|pneumonia|urethritis|cervicitis|sinusitis,bacterial 50S ribosomal subunit inhibitor,PXDYILJJHOVNLO-NDJYQBQTSA-N
CCMSLIB00012724553,related spectra of 'descladinoseazithromycin (delta mass:14.016)',CCMSLIB00000478608,14.02,2193,Drug_suspect,desosaminylazithromycin,macrolide antimicrobial,infectious disease,pelvic inflammatory disease|pneumonia|urethritis|cervicitis|sinusitis,bacterial 50S ribosomal subunit inhibitor,PXDYILJJHOVNLO-NDJYQBQTSA-N
CCMSLIB00012724554,related spectra of 'descladinoseazithromycin (delta mass:18.01)',CCMSLIB00000478608,18.01,2194,Drug_suspect,desosaminylazithromycin,macrolide antimicrobial,infectious disease,pelvic inflammatory disease|pneumonia|urethritis|cervicitis|sinusitis,bacterial 50S ribosomal subunit inhibitor,PXDYILJJHOVNLO-NDJYQBQTSA-N
CCMSLIB00012724555,related spectra of 'desferrioxamine b + al (m-2h+al) (delta mass:14.963)',CCMSLIB00000072100|CCMSLIB00000075313|CCMSLIB00000531493|CCMSLIB00001059065|CCMSLIB00003739979|CCMSLIB00005435926,14.96,2195,Drug_suspect,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724556,related spectra of 'desferrioxamine b + al (m-2h+al) (delta mass:27.995)',CCMSLIB00000072100|CCMSLIB00000075313|CCMSLIB00000531493|CCMSLIB00001059065|CCMSLIB00003739979|CCMSLIB00005435926,27.99,2196,Drug_suspect,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724557,related spectra of 'desferrioxamine b + al (m-2h+al) (delta mass:28.991)',CCMSLIB00000072100|CCMSLIB00000075313|CCMSLIB00000531493|CCMSLIB00001059065|CCMSLIB00003739979|CCMSLIB00005435926,28.99,2197,Drug_suspect,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724558,related spectra of 'desloratadine (delta mass:15.995)',CCMSLIB00000078622|CCMSLIB00000078623|CCMSLIB00000579607|CCMSLIB00010143022|CCMSLIB00010143023|CCMSLIB00010143024|CCMSLIB00010143025|CCMSLIB00010143026|CCMSLIB00010143027|CCMSLIB00010143028|CCMSLIB00010143029,15.99,2198,Drug_suspect,desloratadine|desloratadine,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria|pruritus,histamine receptor antagonist,JAUOIFJMECXRGI-UHFFFAOYSA-N
CCMSLIB00012724559,related spectra of 'desvenlafaxine (delta mass:-18.011)',CCMSLIB00010132018|CCMSLIB00010132019|CCMSLIB00010132020|CCMSLIB00010132021|CCMSLIB00010132022|CCMSLIB00010132023|CCMSLIB00010132024|CCMSLIB00010132025|CCMSLIB00010132026|CCMSLIB00010132027|CCMSLIB00010132028|CCMSLIB00010132029|CCMSLIB00010132030|CCMSLIB00010135602|CCMSLIB00010135603|CCMSLIB00010135604|CCMSLIB00010135605|CCMSLIB00010135606|CCMSLIB00010135607|CCMSLIB00010135608|CCMSLIB00010135609|CCMSLIB00010135610|CCMSLIB00010135611|CCMSLIB00010135612|CCMSLIB00010135613|CCMSLIB00010135614,-18.01,2199,Drug_suspect,desvenlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression,serotonin and norepinephrine reuptake inhibitor (SNRI),KYYIDSXMWOZKMP-UHFFFAOYSA-N
CCMSLIB00012724560,related spectra of 'desvenlafaxine (delta mass:-3.995)',CCMSLIB00010132018|CCMSLIB00010132019|CCMSLIB00010132020|CCMSLIB00010132021|CCMSLIB00010132022|CCMSLIB00010132023|CCMSLIB00010132024|CCMSLIB00010132025|CCMSLIB00010132026|CCMSLIB00010132027|CCMSLIB00010132028|CCMSLIB00010132029|CCMSLIB00010132030|CCMSLIB00010135602|CCMSLIB00010135603|CCMSLIB00010135604|CCMSLIB00010135605|CCMSLIB00010135606|CCMSLIB00010135607|CCMSLIB00010135608|CCMSLIB00010135609|CCMSLIB00010135610|CCMSLIB00010135611|CCMSLIB00010135612|CCMSLIB00010135613|CCMSLIB00010135614,-3.99,2200,Drug_suspect,desvenlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression,serotonin and norepinephrine reuptake inhibitor (SNRI),KYYIDSXMWOZKMP-UHFFFAOYSA-N
CCMSLIB00012724561,related spectra of 'desvenlafaxine (delta mass:176.032)',CCMSLIB00010132018|CCMSLIB00010132019|CCMSLIB00010132020|CCMSLIB00010132021|CCMSLIB00010132022|CCMSLIB00010132023|CCMSLIB00010132024|CCMSLIB00010132025|CCMSLIB00010132026|CCMSLIB00010132027|CCMSLIB00010132028|CCMSLIB00010132029|CCMSLIB00010132030|CCMSLIB00010135602|CCMSLIB00010135603|CCMSLIB00010135604|CCMSLIB00010135605|CCMSLIB00010135606|CCMSLIB00010135607|CCMSLIB00010135608|CCMSLIB00010135609|CCMSLIB00010135610|CCMSLIB00010135611|CCMSLIB00010135612|CCMSLIB00010135613|CCMSLIB00010135614,176.03,2201,Drug_suspect,desvenlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression,serotonin and norepinephrine reuptake inhibitor (SNRI),KYYIDSXMWOZKMP-UHFFFAOYSA-N
CCMSLIB00012724562,related spectra of 'dextromethorphan (delta mass:15.995)',CCMSLIB00004679246|CCMSLIB00009919494,15.99,2202,Drug_suspect,dextromethorphan|dextromethorphan,uncompetitive NMDA receptor antagonist|sigma-1 agonist,pulmonary,cough suppressant,glutamate receptor antagonist|sigma receptor agonist,MKXZASYAUGDDCJ-NJAFHUGGSA-N
CCMSLIB00012724563,related spectra of 'diltiazem hcl (tiazac) (delta mass:-56.027)',CCMSLIB00000078321,-56.03,2203,Drug_suspect,diltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,HSUGRBWQSSZJOP-RTWAWAEBSA-N
CCMSLIB00012724564,related spectra of 'diltiazem hcl (tiazac) (delta mass:-26.016)',CCMSLIB00000078321,-26.02,2204,Drug_suspect,diltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,HSUGRBWQSSZJOP-RTWAWAEBSA-N
CCMSLIB00012724565,related spectra of 'diltiazem hcl (tiazac) (delta mass:-14.016)',CCMSLIB00000078321,-14.02,2205,Drug_suspect,diltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,HSUGRBWQSSZJOP-RTWAWAEBSA-N
CCMSLIB00012724566,related spectra of 'diphenhydramine n-glucose (delta mass:-30.01)',CCMSLIB00005877199,-30.01,2206,Drug_suspect,diphenhydramine n-glucose,histamine-1 (H1) inhibitor,allergy,seasonal allergy|allergic rashes|urticaria,histamine receptor antagonist,OECMWWMYKNJXHL-OCAHFIFXSA-N
CCMSLIB00012724567,related spectra of 'diphenhydramine n-glucose (delta mass:15.958)',CCMSLIB00005877199,15.96,2207,Drug_suspect,diphenhydramine n-glucose,histamine-1 (H1) inhibitor,allergy,seasonal allergy|allergic rashes|urticaria,histamine receptor antagonist,OECMWWMYKNJXHL-OCAHFIFXSA-N
CCMSLIB00012724568,related spectra of 'diphenhydramine-n-glucuronide (delta mass:-43.99)',CCMSLIB00004680092,-43.99,2208,Drug_suspect,diphenhydramine-n-glucuronide,histamine-1 (H1) inhibitor,allergy,seasonal allergy|allergic rashes|urticaria,histamine receptor antagonist,OAIGZXXQYIJBLR-VAUIJEFBSA-O
CCMSLIB00012724569,related spectra of 'diphenhydramine-n-glucuronide (delta mass:2.016)',CCMSLIB00004680092,2.02,2209,Drug_suspect,diphenhydramine-n-glucuronide,histamine-1 (H1) inhibitor,allergy,seasonal allergy|allergic rashes|urticaria,histamine receptor antagonist,OAIGZXXQYIJBLR-VAUIJEFBSA-O
CCMSLIB00012724570,related spectra of 'diphenhydramine-n-glucuronide (delta mass:15.995)',CCMSLIB00004680092,15.99,2210,Drug_suspect,diphenhydramine-n-glucuronide,histamine-1 (H1) inhibitor,allergy,seasonal allergy|allergic rashes|urticaria,histamine receptor antagonist,OAIGZXXQYIJBLR-VAUIJEFBSA-O
CCMSLIB00012724231,related spectra of 'darunavir (delta mass:20.03)',CCMSLIB00005774111|CCMSLIB00005776851,20.03,1871,Drug_analog,darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-HEXNFIEUSA-N
CCMSLIB00012724572,related spectra of 'edoxaban (delta mass:-14.016)',CCMSLIB00010132797|CCMSLIB00010132798|CCMSLIB00010132799|CCMSLIB00010132800|CCMSLIB00010132801|CCMSLIB00010147315|CCMSLIB00010147316|CCMSLIB00010147317|CCMSLIB00010147318|CCMSLIB00010147319|CCMSLIB00010147320|CCMSLIB00010147321|CCMSLIB00010147322,-14.02,2212,Drug_suspect,edoxaban,factor Xa inhibitor,hematology|cardiology,stroke|pulmonary embolism (PE)|systemic embolism|deep vein thrombosis (DVT)|atrial fibrillation (AF),coagulation factor inhibitor,HGVDHZBSSITLCT-JLJPHGGASA-N
CCMSLIB00012724573,related spectra of 'edta (delta mass:-58.006)',CCMSLIB00010145114|CCMSLIB00010145115|CCMSLIB00010145116|CCMSLIB00010145117|CCMSLIB00010145118,-58.01,2213,Drug_suspect|Background/QAQC,edta,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N
CCMSLIB00012724574,related spectra of 'edta (delta mass:-30.01)',CCMSLIB00010145114|CCMSLIB00010145115|CCMSLIB00010145116|CCMSLIB00010145117|CCMSLIB00010145118,-30.01,2214,Drug_suspect|Background/QAQC,edta,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N
CCMSLIB00012724575,related spectra of 'edta (delta mass:-29.975)',CCMSLIB00010145114|CCMSLIB00010145115|CCMSLIB00010145116|CCMSLIB00010145117|CCMSLIB00010145118,-29.97,2215,Drug_suspect|Background/QAQC,edta,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N
CCMSLIB00012724576,related spectra of 'edta (delta mass:57.022)',CCMSLIB00010145114|CCMSLIB00010145115|CCMSLIB00010145116|CCMSLIB00010145117|CCMSLIB00010145118,57.02,2216,Drug_suspect|Background/QAQC,edta,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N
CCMSLIB00012724266,related spectra of 'lopinavir (delta mass:-18.01)',CCMSLIB00000006307|CCMSLIB00005776948|CCMSLIB00005777193,-18.01,1906,Drug_analog,lopinavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,KJHKTHWMRKYKJE-SUGCFTRWSA-N
CCMSLIB00012724578,related spectra of 'enrofloxacin (delta mass:-14.016)',CCMSLIB00000079094|CCMSLIB00000079095,-14.02,2218,Drug_suspect,enrofloxacin,fluoroquinolone antimicrobial|veterinary,infectious disease,gram-negative bacterial infections,bacterial DNA gyrase inhibitor,SPFYMRJSYKOXGV-UHFFFAOYSA-N
CCMSLIB00012724579,related spectra of 'escitalopram oxalate (delta mass:-14.016)',CCMSLIB00000078913,-14.02,2219,Drug_suspect,escitalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-FQEVSTJZSA-N
CCMSLIB00012724580,related spectra of 'escitalopram oxalate (delta mass:15.995)',CCMSLIB00000078913,15.99,2220,Drug_suspect,escitalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-FQEVSTJZSA-N
CCMSLIB00012724304,"related spectra of 'saquinavir (delta mass:-2.02)', 'saquinavir (delta mass:-2.01)'",CCMSLIB00000085050|CCMSLIB00000085067|CCMSLIB00003137648|CCMSLIB00003138824,-2.02,1944,Drug_analog,saquinavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,QWAXKHKRTORLEM-UGJKXSETSA-N
CCMSLIB00012724321,"related spectra of 'ritonavir (delta mass:-15.98)', 'ritonavir (delta mass:-15.97)'",CCMSLIB00000078032|CCMSLIB00000079259|CCMSLIB00005772706|CCMSLIB00005773498|CCMSLIB00005775952|CCMSLIB00005776971,-15.98|-15.97,1961,Drug_analog,ritonavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,NCDNCNXCDXHOMX-XGKFQTDJSA-N
CCMSLIB00012724340,"related spectra of 'ritonavir (delta mass:16.0)', 'ritonavir (delta mass:15.99)'",CCMSLIB00000005595|CCMSLIB00000078032|CCMSLIB00000079259|CCMSLIB00000209757|CCMSLIB00000209759|CCMSLIB00005772706|CCMSLIB00005773291|CCMSLIB00005773498|CCMSLIB00005775329|CCMSLIB00005775952|CCMSLIB00010141703|CCMSLIB00010141704|CCMSLIB00010141707,15.99,1980,Drug_analog,ritonavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,NCDNCNXCDXHOMX-XGKFQTDJSA-N|NCDNCNXCDXHOMX-FDEOAKKQSA-N
CCMSLIB00012724341,related spectra of 'atazanavir (delta mass:31.99)',CCMSLIB00000572851|CCMSLIB00005733646|CCMSLIB00005776089,31.99,1981,Drug_analog,atazanavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,AXRYRYVKAWYZBR-GASGPIRDSA-N|AXRYRYVKAWYZBR-UHFFFAOYSA-N
CCMSLIB00012724585,related spectra of 'enniatin b (delta mass:-28.031)',CCMSLIB00005723570|CCMSLIB00005725548,-28.03,2225,Drug_suspect,fusafungine,no_match,no_match,no_match,no_match,MIZMDSVSLSIMSC-VYLWARHZSA-N
CCMSLIB00012724586,related spectra of 'enniatin b (delta mass:-14.016)',CCMSLIB00005723570|CCMSLIB00005725548,-14.02,2226,Drug_suspect,fusafungine,no_match,no_match,no_match,no_match,MIZMDSVSLSIMSC-VYLWARHZSA-N
CCMSLIB00012724587,related spectra of 'enniatin b (delta mass:15.975)',CCMSLIB00005723570|CCMSLIB00005725548,15.97,2227,Drug_suspect,fusafungine,no_match,no_match,no_match,no_match,MIZMDSVSLSIMSC-VYLWARHZSA-N
CCMSLIB00012724588,related spectra of 'enrofloxacin (delta mass:-14.016)',CCMSLIB00000078564|CCMSLIB00000078565|CCMSLIB00010135789|CCMSLIB00010135790|CCMSLIB00010135791|CCMSLIB00010135792|CCMSLIB00010135793|CCMSLIB00010135794|CCMSLIB00010135795|CCMSLIB00010135796,-14.02,2228,Drug_suspect,enrofloxacin|enrofloxacin,fluoroquinolone antimicrobial|veterinary,infectious disease,gram-negative bacterial infections,bacterial DNA gyrase inhibitor,SPFYMRJSYKOXGV-UHFFFAOYSA-N
CCMSLIB00012724589,related spectra of 'eplerenone (delta mass:43.043)',CCMSLIB00000004469|CCMSLIB00000004470|CCMSLIB00000004471|CCMSLIB00000004472|CCMSLIB00000004473|CCMSLIB00000004474|CCMSLIB00000004475|CCMSLIB00000004476|CCMSLIB00000004477|CCMSLIB00000078245|CCMSLIB00010145689|CCMSLIB00010145690|CCMSLIB00010145691|CCMSLIB00010145692|CCMSLIB00010145693,43.04,2229,Drug_suspect,eplerenone|eplerenone,aldosterone antagonist,cardiology,congestive heart failure|hypertension,aldosterone antagonist,JUKPWJGBANNWMW-VWBFHTRKSA-N
CCMSLIB00012724590,related spectra of 'eprinomectin solution (delta mass:-36.021)',CCMSLIB00010142887|CCMSLIB00010142888|CCMSLIB00010142889|CCMSLIB00010142890|CCMSLIB00010142891|CCMSLIB00010142892|CCMSLIB00010142893|CCMSLIB00010142894,-36.02,2230,Drug_suspect,eprinomectin solution,avermectins|veterinary,infectious disease,gastrointestinal roundworms|lungworms,benzodiazepine receptor agonist,ZKWQQXZUCOBISE-AMPAAKTKSA-N
CCMSLIB00012724591,related spectra of 'erythromycin_20ev (delta mass:15.995)',CCMSLIB00005723242,15.99,2231,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012724592,related spectra of 'escitalopram (delta mass:-16.031)',CCMSLIB00009919487|CCMSLIB00010142216|CCMSLIB00010142217|CCMSLIB00010142218|CCMSLIB00010142219|CCMSLIB00010142220|CCMSLIB00010142221|CCMSLIB00010142222|CCMSLIB00010142223,-16.03,2232,Drug_suspect,escitalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-FQEVSTJZSA-N
CCMSLIB00012724593,related spectra of 'escitalopram (delta mass:-14.016)',CCMSLIB00009919487|CCMSLIB00010142216|CCMSLIB00010142217|CCMSLIB00010142218|CCMSLIB00010142219|CCMSLIB00010142220|CCMSLIB00010142221|CCMSLIB00010142222|CCMSLIB00010142223,-14.02,2233,Drug_suspect,escitalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-FQEVSTJZSA-N
CCMSLIB00012724594,related spectra of 'escitalopram (delta mass:15.995)',CCMSLIB00009919487|CCMSLIB00010142216|CCMSLIB00010142217|CCMSLIB00010142218|CCMSLIB00010142219|CCMSLIB00010142220|CCMSLIB00010142221|CCMSLIB00010142222|CCMSLIB00010142223,15.99,2234,Drug_suspect,escitalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-FQEVSTJZSA-N
CCMSLIB00012724595,related spectra of 'escitalopram oxalate (delta mass:-14.016)',CCMSLIB00000078645,-14.02,2235,Drug_suspect,escitalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-FQEVSTJZSA-N
CCMSLIB00012724596,related spectra of 'esomeprazolena (delta mass:-15.995)',CCMSLIB00000006484|CCMSLIB00000006485|CCMSLIB00000006486,-15.99,2236,Drug_suspect,esomeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,SUBDBMMJDZJVOS-UHFFFAOYSA-N
CCMSLIB00012724597,related spectra of 'esomeprazolena (delta mass:-14.016)',CCMSLIB00000006484|CCMSLIB00000006485|CCMSLIB00000006486,-14.02,2237,Drug_suspect,esomeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,SUBDBMMJDZJVOS-UHFFFAOYSA-N
CCMSLIB00012724598,related spectra of 'esomeprazolena (delta mass:43.991)',CCMSLIB00000006484|CCMSLIB00000006485|CCMSLIB00000006486,43.99,2238,Drug_suspect,esomeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,SUBDBMMJDZJVOS-UHFFFAOYSA-N
CCMSLIB00012724599,related spectra of 'esomeprazolena (delta mass:192.027)',CCMSLIB00000006484|CCMSLIB00000006485|CCMSLIB00000006486,192.03,2239,Drug_suspect,esomeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,SUBDBMMJDZJVOS-UHFFFAOYSA-N
CCMSLIB00012724600,related spectra of 'ethylenediaminetetraacetic acid edta (delta mass:-58.006)',CCMSLIB00005435779|CCMSLIB00005435780,-58.01,2240,Drug_suspect|Background/QAQC,edta,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N
CCMSLIB00012724601,related spectra of 'ethylenediaminetetraacetic acid edta (delta mass:57.022)',CCMSLIB00005435779|CCMSLIB00005435780,57.02,2241,Drug_suspect|Background/QAQC,edta,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N
CCMSLIB00012724602,related spectra of 'febuxostat (delta mass:14.016)',CCMSLIB00000004822|CCMSLIB00000004823|CCMSLIB00000004824|CCMSLIB00000004825|CCMSLIB00000004826|CCMSLIB00000004827|CCMSLIB00000004828|CCMSLIB00000004829|CCMSLIB00000004830|CCMSLIB00000004831|CCMSLIB00000004832|CCMSLIB00010140724|CCMSLIB00010140725|CCMSLIB00010140726|CCMSLIB00010140727|CCMSLIB00010140728|CCMSLIB00010140729|CCMSLIB00010140730|CCMSLIB00010140731,14.02,2242,Drug_suspect,febuxostat|febuxostat,xanthine oxidase inhibitor,rheumatology,hyperuricemia|gout,xanthine oxidase inhibitor,BQSJTQLCZDPROO-UHFFFAOYSA-N|NA
CCMSLIB00012724603,related spectra of 'febuxostat (delta mass:15.995)',CCMSLIB00000004822|CCMSLIB00000004823|CCMSLIB00000004824|CCMSLIB00000004825|CCMSLIB00000004826|CCMSLIB00000004827|CCMSLIB00000004828|CCMSLIB00000004829|CCMSLIB00000004830|CCMSLIB00000004831|CCMSLIB00000004832|CCMSLIB00010140724|CCMSLIB00010140725|CCMSLIB00010140726|CCMSLIB00010140727|CCMSLIB00010140728|CCMSLIB00010140729|CCMSLIB00010140730|CCMSLIB00010140731,15.99,2243,Drug_suspect,febuxostat|febuxostat,xanthine oxidase inhibitor,rheumatology,hyperuricemia|gout,xanthine oxidase inhibitor,BQSJTQLCZDPROO-UHFFFAOYSA-N|NA
CCMSLIB00012724604,related spectra of 'febuxostat (delta mass:29.974)',CCMSLIB00000004822|CCMSLIB00000004823|CCMSLIB00000004824|CCMSLIB00000004825|CCMSLIB00000004826|CCMSLIB00000004827|CCMSLIB00000004828|CCMSLIB00000004829|CCMSLIB00000004830|CCMSLIB00000004831|CCMSLIB00000004832|CCMSLIB00010140724|CCMSLIB00010140725|CCMSLIB00010140726|CCMSLIB00010140727|CCMSLIB00010140728|CCMSLIB00010140729|CCMSLIB00010140730|CCMSLIB00010140731,29.97,2244,Drug_suspect,febuxostat|febuxostat,xanthine oxidase inhibitor,rheumatology,hyperuricemia|gout,xanthine oxidase inhibitor,BQSJTQLCZDPROO-UHFFFAOYSA-N|NA
CCMSLIB00012724605,related spectra of 'febuxostat (uloric) (delta mass:14.016)',CCMSLIB00000078184,14.02,2245,Drug_suspect,febuxostat,xanthine oxidase inhibitor,rheumatology,hyperuricemia|gout,xanthine oxidase inhibitor,BQSJTQLCZDPROO-UHFFFAOYSA-N
CCMSLIB00012724606,related spectra of 'febuxostat (uloric) (delta mass:15.995)',CCMSLIB00000078184,15.99,2246,Drug_suspect,febuxostat,xanthine oxidase inhibitor,rheumatology,hyperuricemia|gout,xanthine oxidase inhibitor,BQSJTQLCZDPROO-UHFFFAOYSA-N
CCMSLIB00012724607,related spectra of 'febuxostat (uloric) (delta mass:29.974)',CCMSLIB00000078184,29.97,2247,Drug_suspect,febuxostat,xanthine oxidase inhibitor,rheumatology,hyperuricemia|gout,xanthine oxidase inhibitor,BQSJTQLCZDPROO-UHFFFAOYSA-N
CCMSLIB00012724608,related spectra of 'ferrioxamine b [m+fe-2h] (delta mass:-1.98)',CCMSLIB00000531492|CCMSLIB00001059066,-1.98,2248,Drug_suspect,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724609,related spectra of 'ferrioxamine b [m+fe-2h] (delta mass:28.031)',CCMSLIB00000531492|CCMSLIB00001059066,28.03,2249,Drug_suspect,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012724610,related spectra of 'glimepiride (delta mass:15.995)',CCMSLIB00000079242|CCMSLIB00000079243,15.99,2250,Drug_suspect,glimepiride,sulfonylurea,endocrinology,type 2 diabetes mellitus,insulin secretagogue,WIGIZIANZCJQQY-UHFFFAOYSA-N
CCMSLIB00012724611,related spectra of 'ginkgolide a (delta mass:0.984)',CCMSLIB00010144971|CCMSLIB00010144972|CCMSLIB00010144973|CCMSLIB00010144974|CCMSLIB00010144975|CCMSLIB00010145261|CCMSLIB00010145262|CCMSLIB00010145263|CCMSLIB00010145264|CCMSLIB00010145265,0.98,2251,Drug_suspect,ginkgolide a,no_match,NA,NA,GABA receptor antagonist,FPUXKXIZEIDQKW-UHFFFAOYSA-N
CCMSLIB00012724612,related spectra of 'glipizide (glucotrol) (delta mass:-2.016)',CCMSLIB00000078249|CCMSLIB00000078250,-2.02,2252,Drug_suspect,glipizide,sulfonylurea,endocrinology,type 2 diabetes mellitus,insulin secretagogue,ZJJXGWJIGJFDTL-UHFFFAOYSA-N
CCMSLIB00012724613,related spectra of 'glipizide (glucotrol) (delta mass:15.995)',CCMSLIB00000078249|CCMSLIB00000078250,15.99,2253,Drug_suspect,glipizide,sulfonylurea,endocrinology,type 2 diabetes mellitus,insulin secretagogue,ZJJXGWJIGJFDTL-UHFFFAOYSA-N
CCMSLIB00012724614,related spectra of 'glyburide (diabeta) (delta mass:15.995)',CCMSLIB00000078251|CCMSLIB00000078252,15.99,2254,Drug_suspect,glyburide,sulfonylurea,endocrinology,type 2 diabetes mellitus,ATP channel blocker|insulin secretagogue,ZNNLBTZKUZBEKO-UHFFFAOYSA-N
CCMSLIB00012724615,related spectra of 'golotimod (delta mass:-58.006)',CCMSLIB00010133730|CCMSLIB00010133731|CCMSLIB00010133732|CCMSLIB00010133733|CCMSLIB00010133734,-58.01,2255,Drug_suspect|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012724616,related spectra of 'golotimod (delta mass:-44.986)',CCMSLIB00010133730|CCMSLIB00010133731|CCMSLIB00010133732|CCMSLIB00010133733|CCMSLIB00010133734,-44.99,2256,Drug_suspect|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012724617,related spectra of 'golotimod (delta mass:-42.01)',CCMSLIB00010133730|CCMSLIB00010133731|CCMSLIB00010133732|CCMSLIB00010133733|CCMSLIB00010133734,-42.01,2257,Drug_suspect|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012724618,related spectra of 'golotimod (delta mass:-27.995)',CCMSLIB00010133730|CCMSLIB00010133731|CCMSLIB00010133732|CCMSLIB00010133733|CCMSLIB00010133734,-27.99,2258,Drug_suspect|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012724619,related spectra of 'golotimod (delta mass:-18.011)',CCMSLIB00010133730|CCMSLIB00010133731|CCMSLIB00010133732|CCMSLIB00010133733|CCMSLIB00010133734,-18.01,2259,Drug_suspect|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012724620,related spectra of 'golotimod (delta mass:-14.016)',CCMSLIB00010133730|CCMSLIB00010133731|CCMSLIB00010133732|CCMSLIB00010133733|CCMSLIB00010133734,-14.02,2260,Drug_suspect|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012724621,related spectra of 'golotimod (delta mass:-0.984)',CCMSLIB00010133730|CCMSLIB00010133731|CCMSLIB00010133732|CCMSLIB00010133733|CCMSLIB00010133734,-0.98,2261,Drug_suspect|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012724622,related spectra of 'golotimod (delta mass:42.01)',CCMSLIB00010133730|CCMSLIB00010133731|CCMSLIB00010133732|CCMSLIB00010133733|CCMSLIB00010133734,42.01,2262,Drug_suspect|Low_confidence,golotimod,no_match,no_match,no_match,no_match,CATMPQFFVNKDEY-YPMHNXCESA-N
CCMSLIB00012724623,related spectra of 'griseofulvin (delta mass:14.016)',CCMSLIB00000077081|CCMSLIB00000077082|CCMSLIB00004684925|CCMSLIB00004684926|CCMSLIB00004684927|CCMSLIB00004684928|CCMSLIB00004692129|CCMSLIB00004692130|CCMSLIB00004692131|CCMSLIB00004692132|CCMSLIB00004692133|CCMSLIB00004692134|CCMSLIB00004692135|CCMSLIB00004692136|CCMSLIB00004692137|CCMSLIB00004692138|CCMSLIB00004692139|CCMSLIB00004692140|CCMSLIB00008851495,14.02,2263,Drug_suspect,griseofulvin,tubulin inhibiting agent,infectious disease,ringworm|tinea pedis|fungal infections,tubulin polymerization inhibitor,DDUHZTYCFQRHIY-RBHXEPJQSA-N
CCMSLIB00012724624,related spectra of 'guanosine-5_-monophosphate (delta mass:-79.967)',NA,-79.97,2264,Drug_suspect,NA,NA,NA,NA,NA,NA
CCMSLIB00012724625,related spectra of 'guanosine-5_-monophosphate (delta mass:-15.995)',NA,-15.99,2265,Drug_suspect,NA,NA,NA,NA,NA,NA
CCMSLIB00012724626,related spectra of 'higenamine (delta mass:-15.995)',CCMSLIB00006439218|CCMSLIB00006439219|CCMSLIB00006439296|CCMSLIB00006439297|CCMSLIB00006439374|CCMSLIB00006439375|CCMSLIB00006439446|CCMSLIB00006439447|CCMSLIB00006439515|CCMSLIB00006439516|CCMSLIB00006516423|CCMSLIB00006516447|CCMSLIB00006516466|CCMSLIB00006516489|CCMSLIB00006516701|CCMSLIB00006516718|CCMSLIB00006516737|CCMSLIB00006516756|CCMSLIB00006516962|CCMSLIB00006516980|CCMSLIB00006516998|CCMSLIB00006517019|CCMSLIB00006517203|CCMSLIB00006517216|CCMSLIB00006517231|CCMSLIB00006517244|CCMSLIB00006517403|CCMSLIB00006517416|CCMSLIB00006517435|CCMSLIB00006517448|CCMSLIB00010144236|CCMSLIB00010144237|CCMSLIB00010144238|CCMSLIB00010144239|CCMSLIB00010144240|CCMSLIB00010144241|CCMSLIB00010144242,-15.99,2266,Drug_suspect,higenamine|higenamine,no_match,NA,NA,adrenergic receptor agonist,WZRCQWQRFZITDX-UHFFFAOYSA-N
CCMSLIB00012724627,related spectra of 'hispidulin (delta mass:12.0)',CCMSLIB00010143730|CCMSLIB00010143731|CCMSLIB00010143732|CCMSLIB00010143733|CCMSLIB00010143734|CCMSLIB00010143735|CCMSLIB00010143736|CCMSLIB00010143737,12,2267,Drug_suspect,hispidulin,no_match,no_match,no_match,no_match,IHFBPDAQLQOCBX-UHFFFAOYSA-N
CCMSLIB00012724628,related spectra of 'hydroxyzine 2hcl (delta mass:-88.053)',CCMSLIB00000078630,-88.05,2268,Drug_suspect,hydroxyzine,histamine-1 (H1) inhibitor,neurology/psychiatry|allergy,anxiety|urticaria|itching,histamine H1 receptor inverse agonist,ZQDWXGKKHFNSQK-UHFFFAOYSA-N
CCMSLIB00012724629,related spectra of 'hydroxyzine 2hcl (delta mass:-44.026)',CCMSLIB00000078630,-44.03,2269,Drug_suspect,hydroxyzine,histamine-1 (H1) inhibitor,neurology/psychiatry|allergy,anxiety|urticaria|itching,histamine H1 receptor inverse agonist,ZQDWXGKKHFNSQK-UHFFFAOYSA-N
CCMSLIB00012724630,related spectra of 'hydroxyzine 2hcl (delta mass:16.031)',CCMSLIB00000078630,16.03,2270,Drug_suspect,hydroxyzine,histamine-1 (H1) inhibitor,neurology/psychiatry|allergy,anxiety|urticaria|itching,histamine H1 receptor inverse agonist,ZQDWXGKKHFNSQK-UHFFFAOYSA-N
CCMSLIB00012724631,related spectra of 'indacaterol (delta mass:-18.011)',CCMSLIB00010131239|CCMSLIB00010131240|CCMSLIB00010131241|CCMSLIB00010131242|CCMSLIB00010131243|CCMSLIB00010131244|CCMSLIB00010131245|CCMSLIB00010131246|CCMSLIB00010131247|CCMSLIB00010131248|CCMSLIB00010131249|CCMSLIB00010131250|CCMSLIB00010131251|CCMSLIB00010136393|CCMSLIB00010136394|CCMSLIB00010136395|CCMSLIB00010136396|CCMSLIB00010136397|CCMSLIB00010136398|CCMSLIB00010136399|CCMSLIB00010136400|CCMSLIB00010136401|CCMSLIB00010136402|CCMSLIB00010136403|CCMSLIB00010136404|CCMSLIB00010136405,-18.01,2271,Drug_suspect,indacaterol,beta-2 adrenergic agonist,pulmonary,chronic obstructive pulmonary disease (COPD),adrenergic receptor agonist,QZZUEBNBZAPZLX-QFIPXVFZSA-N
CCMSLIB00012724632,related spectra of 'indacaterol maleate (delta mass:-18.011)',CCMSLIB00000078574,-18.01,2272,Drug_suspect,indacaterol,beta-2 adrenergic agonist,pulmonary,chronic obstructive pulmonary disease (COPD),adrenergic receptor agonist,QZZUEBNBZAPZLX-QFIPXVFZSA-N
CCMSLIB00012724633,related spectra of 'ivacaftor (vx-770) (delta mass:13.98)',CCMSLIB00000078023,13.98,2273,Drug_suspect,ivacaftor,cystic fibrosis transmembrane conductance regulator (CFTR) potentiator,pulmonary|genetics,cystic fibrosis,CFTR channel potentiator,PURKAOJPTOLRMP-UHFFFAOYSA-N
CCMSLIB00012724634,related spectra of 'ivacaftor (vx-770) (delta mass:15.995)',CCMSLIB00000078023,15.99,2274,Drug_suspect,ivacaftor,cystic fibrosis transmembrane conductance regulator (CFTR) potentiator,pulmonary|genetics,cystic fibrosis,CFTR channel potentiator,PURKAOJPTOLRMP-UHFFFAOYSA-N
CCMSLIB00012724635,related spectra of 'ivacaftor (vx-770) (delta mass:29.974)',CCMSLIB00000078023,29.97,2275,Drug_suspect,ivacaftor,cystic fibrosis transmembrane conductance regulator (CFTR) potentiator,pulmonary|genetics,cystic fibrosis,CFTR channel potentiator,PURKAOJPTOLRMP-UHFFFAOYSA-N
CCMSLIB00012724636,related spectra of 'levocetirizine (delta mass:-44.026)',CCMSLIB00000079138,-44.03,2276,Drug_suspect,levocetirizine,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,ZKLPARSLTMPFCP-OAQYLSRUSA-N
CCMSLIB00012724637,related spectra of 'lansoprazole (delta mass:-15.995)',CCMSLIB00000006481|CCMSLIB00000006482|CCMSLIB00000006483|CCMSLIB00000078113|CCMSLIB00000078114,-15.99,2277,Drug_suspect,lansoprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|erosive esophagitis (EE)|gastrointestinal ulcers|Zollinger-Ellison syndrome,ATPase inhibitor,MJIHNNLFOKEZEW-UHFFFAOYSA-N
CCMSLIB00012724638,related spectra of 'levocetirizine (delta mass:-58.006)',CCMSLIB00000081597|CCMSLIB00010134357|CCMSLIB00010134358|CCMSLIB00010134359|CCMSLIB00010134360|CCMSLIB00010134361,-58.01,2278,Drug_suspect,levocetirizine|levocetirizine,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,ZKLPARSLTMPFCP-OAQYLSRUSA-N
CCMSLIB00012724639,related spectra of 'levocetirizine (delta mass:-44.026)',CCMSLIB00000081597|CCMSLIB00010134357|CCMSLIB00010134358|CCMSLIB00010134359|CCMSLIB00010134360|CCMSLIB00010134361,-44.03,2279,Drug_suspect,levocetirizine|levocetirizine,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,ZKLPARSLTMPFCP-OAQYLSRUSA-N
CCMSLIB00012724640,related spectra of 'levocetirizine (delta mass:15.995)',CCMSLIB00000081597|CCMSLIB00010134357|CCMSLIB00010134358|CCMSLIB00010134359|CCMSLIB00010134360|CCMSLIB00010134361,15.99,2280,Drug_suspect,levocetirizine|levocetirizine,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,ZKLPARSLTMPFCP-OAQYLSRUSA-N
CCMSLIB00012724641,related spectra of 'levocetirizine (delta mass:21.984)',CCMSLIB00000081597|CCMSLIB00010134357|CCMSLIB00010134358|CCMSLIB00010134359|CCMSLIB00010134360|CCMSLIB00010134361,21.98,2281,Drug_suspect,levocetirizine|levocetirizine,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,ZKLPARSLTMPFCP-OAQYLSRUSA-N
CCMSLIB00012724642,related spectra of 'lincomycin a (delta mass:-29.994)',CCMSLIB00004721938,-29.99,2282,Drug_suspect,lincomycin,lincosamide antibacterial,infectious disease,gram-positive bacterial infections,protein synthesis inhibitor by binding 50S ribosomal subunit,OJMMVQQUTAEWLP-KIDUDLJLSA-N
CCMSLIB00012724643,related spectra of 'lincomycin a (delta mass:-14.016)',CCMSLIB00004721938,-14.02,2283,Drug_suspect,lincomycin,lincosamide antibacterial,infectious disease,gram-positive bacterial infections,protein synthesis inhibitor by binding 50S ribosomal subunit,OJMMVQQUTAEWLP-KIDUDLJLSA-N
CCMSLIB00012724644,related spectra of 'lincomycin a (delta mass:15.995)',CCMSLIB00004721938,15.99,2284,Drug_suspect,lincomycin,lincosamide antibacterial,infectious disease,gram-positive bacterial infections,protein synthesis inhibitor by binding 50S ribosomal subunit,OJMMVQQUTAEWLP-KIDUDLJLSA-N
CCMSLIB00012724361,related spectra of 'ritonavir (delta mass:15.99)',CCMSLIB00000078031|CCMSLIB00005774145,15.99,2001,Drug_analog,ritonavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,NCDNCNXCDXHOMX-XGKFQTDJSA-N
CCMSLIB00012724539,related spectra of 'darunavir (delta mass:-43.99)',CCMSLIB00010137589|CCMSLIB00010137590|CCMSLIB00010137591|CCMSLIB00010137592|CCMSLIB00010137593|CCMSLIB00010137594|CCMSLIB00010137595|CCMSLIB00010137596|CCMSLIB00010138287|CCMSLIB00010138288|CCMSLIB00010138289|CCMSLIB00010138290|CCMSLIB00010138291|CCMSLIB00010138292|CCMSLIB00010138293|CCMSLIB00010138294,-43.99,2179,Drug_suspect,darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-HEXNFIEUSA-N
CCMSLIB00012724540,related spectra of 'darunavir (delta mass:-2.016)',CCMSLIB00010137589|CCMSLIB00010137590|CCMSLIB00010137591|CCMSLIB00010137592|CCMSLIB00010137593|CCMSLIB00010137594|CCMSLIB00010137595|CCMSLIB00010137596|CCMSLIB00010138287|CCMSLIB00010138288|CCMSLIB00010138289|CCMSLIB00010138290|CCMSLIB00010138291|CCMSLIB00010138292|CCMSLIB00010138293|CCMSLIB00010138294,-2.02,2180,Drug_suspect,darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-HEXNFIEUSA-N
CCMSLIB00012724648,related spectra of 'losartan (delta mass:-2.016)',CCMSLIB00000579704|CCMSLIB00003061260|CCMSLIB00009919309,-2.02,2288,Drug_suspect,losartan|losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012724649,related spectra of 'losartan (delta mass:15.975)',CCMSLIB00000579704|CCMSLIB00003061260|CCMSLIB00009919309,15.97,2289,Drug_suspect,losartan|losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012724650,related spectra of 'losartan (delta mass:15.995)',CCMSLIB00000579704|CCMSLIB00003061260|CCMSLIB00009919309,15.99,2290,Drug_suspect,losartan|losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012724651,related spectra of 'losartan carboxaldehyde [exp3179] (delta mass:4.032)',CCMSLIB00003061262,4.03,2291,Drug_suspect,losartan carboxaldehyde,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,FQZSMTSTFMNWQF-UHFFFAOYSA-N
CCMSLIB00012724652,related spectra of 'losartan carboxaldehyde [exp3179] (delta mass:18.01)',CCMSLIB00003061262,18.01,2292,Drug_suspect,losartan carboxaldehyde,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,FQZSMTSTFMNWQF-UHFFFAOYSA-N
CCMSLIB00012724653,related spectra of 'losartan carboxylic acid [exp3174] (delta mass:-31.991)',CCMSLIB00003061261,-31.99,2293,Drug_suspect,losartan carboxylic acid,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,ZEUXAIYYDDCIRX-UHFFFAOYSA-N
CCMSLIB00012724654,related spectra of 'losartan carboxylic acid [exp3174] (delta mass:2.016)',CCMSLIB00003061261,2.02,2294,Drug_suspect,losartan carboxylic acid,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,ZEUXAIYYDDCIRX-UHFFFAOYSA-N
CCMSLIB00012724655,related spectra of 'losartan carboxylic acid [exp3174] (delta mass:15.995)',CCMSLIB00003061261,15.99,2295,Drug_suspect,losartan carboxylic acid,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,ZEUXAIYYDDCIRX-UHFFFAOYSA-N
CCMSLIB00012724656,related spectra of 'mls000028587-01!meloxicam (delta mass:15.995)',CCMSLIB00000085616,15.99,2296,Drug_suspect,meloxicam,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis,cyclooxygenase inhibitor,ZRVUJXDFFKFLMG-UHFFFAOYSA-N
CCMSLIB00012724657,related spectra of 'mls000069729-01!603-50-9 (delta mass:-42.01)',CCMSLIB00000085931,-42.01,2297,Drug_suspect,bisacodyl,stimulant laxative,gastroenterology,constipation,laxative,KHOITXIGCFIULA-UHFFFAOYSA-N
CCMSLIB00012724658,related spectra of 'mls000766281-01! (delta mass:14.016)',CCMSLIB00000080570,14.02,2298,Drug_suspect,galantamine,cholinesterase inhibitor,neurology/psychiatry,senile dementia,acetylcholinesterase inhibitor,ASUTZQLVASHGKV-UHFFFAOYSA-N
CCMSLIB00012724659,related spectra of 'mls000766281-01! (delta mass:15.995)',CCMSLIB00000080570,15.99,2299,Drug_suspect,galantamine,cholinesterase inhibitor,neurology/psychiatry,senile dementia,acetylcholinesterase inhibitor,ASUTZQLVASHGKV-UHFFFAOYSA-N
CCMSLIB00012724660,related spectra of 'mls000863291-01! (delta mass:-56.062)',CCMSLIB00000085413,-56.06,2300,Drug_suspect,itraconazole,azole antifungal,infectious disease,onychomycosis|histoplasmosis|blastomycosis|aspergillosis,lanosterol 14-alpha-demethylase inhibitor,VHVPQPYKVGDNFY-ZPGVKDDISA-N
CCMSLIB00012724661,related spectra of 'mls001076668-01!benazepril hydrochloride (delta mass:-28.031)',CCMSLIB00000085360,-28.03,2301,Drug_suspect,benazepril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|myocardial infarction|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,XPCFTKFZXHTYIP-PMACEKPBSA-N
CCMSLIB00012724662,related spectra of 'mls001148257-01!(+)-cis-diltiazem hydrochloride (delta mass:-56.027)',CCMSLIB00000085377,-56.03,2302,Drug_suspect,diltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,HSUGRBWQSSZJOP-RTWAWAEBSA-N
CCMSLIB00012724663,related spectra of 'mls001148257-01!(+)-cis-diltiazem hydrochloride (delta mass:-28.031)',CCMSLIB00000085377,-28.03,2303,Drug_suspect,diltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,HSUGRBWQSSZJOP-RTWAWAEBSA-N
CCMSLIB00012724664,related spectra of 'mls001148257-01!(+)-cis-diltiazem hydrochloride (delta mass:176.032)',CCMSLIB00000085377,176.03,2304,Drug_suspect,diltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,HSUGRBWQSSZJOP-RTWAWAEBSA-N
CCMSLIB00012724665,related spectra of 'mls001165756-01!fexofenadine (delta mass:-14.016)',CCMSLIB00000085405,-14.02,2305,Drug_suspect,fexofenadine,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,RWTNPBWLLIMQHL-GDLZYMKVSA-N
CCMSLIB00012724666,related spectra of 'mls001240224-01!sildenafil (delta mass:-14.016)',CCMSLIB00000085187|CCMSLIB00000085188,-14.02,2306,Drug_suspect,sildenafil,phosphodiesterase-5 (PDE-5) inhibitor,urology|cardiology,erectile dysfunction|pulmonary arterial hypertension (PAH),phosphodiesterase inhibitor,BNRNXUUZRGQAQC-UHFFFAOYSA-N
CCMSLIB00012724667,related spectra of 'mls001240224-01!sildenafil (delta mass:-13.98)',CCMSLIB00000085187|CCMSLIB00000085188,-13.98,2307,Drug_suspect,sildenafil,phosphodiesterase-5 (PDE-5) inhibitor,urology|cardiology,erectile dysfunction|pulmonary arterial hypertension (PAH),phosphodiesterase inhibitor,BNRNXUUZRGQAQC-UHFFFAOYSA-N
CCMSLIB00012724668,related spectra of 'mls001333745-01!13292-46-1 (delta mass:-56.027)',CCMSLIB00000085828,-56.03,2308,Drug_suspect,rifampicin,rifamycin antibacterial,infectious disease,tuberculosis|meningitis,RNA polymerase inhibitor,JQXXHWHPUNPDRT-WLSIYKJHSA-N
CCMSLIB00012724669,related spectra of 'mls001333745-01!13292-46-1 (delta mass:-42.01)',CCMSLIB00000085828,-42.01,2309,Drug_suspect,rifampicin,rifamycin antibacterial,infectious disease,tuberculosis|meningitis,RNA polymerase inhibitor,JQXXHWHPUNPDRT-WLSIYKJHSA-N
CCMSLIB00012724670,related spectra of 'mls001333745-01!13292-46-1 (delta mass:-14.016)',CCMSLIB00000085828,-14.02,2310,Drug_suspect,rifampicin,rifamycin antibacterial,infectious disease,tuberculosis|meningitis,RNA polymerase inhibitor,JQXXHWHPUNPDRT-WLSIYKJHSA-N
CCMSLIB00012724671,related spectra of 'mls001333745-01!13292-46-1 (delta mass:15.995)',CCMSLIB00000085828,15.99,2311,Drug_suspect,rifampicin,rifamycin antibacterial,infectious disease,tuberculosis|meningitis,RNA polymerase inhibitor,JQXXHWHPUNPDRT-WLSIYKJHSA-N
CCMSLIB00012724672,related spectra of 'mls001361394-01!111470-99-6 (delta mass:15.995)',CCMSLIB00000085674,15.99,2312,Drug_suspect,amlodipine,dihydropyridine calcium channel blocker,cardiology,hypertension|chronic stable angina|vasospastic angina|coronary artery disease (CAD),calcium channel blocker,HTIQEAQVCYTUBX-UHFFFAOYSA-N
CCMSLIB00012724673,related spectra of 'mls001401408-01!escitalopram oxalate (delta mass:-14.016)',CCMSLIB00000085257,-14.02,2313,Drug_suspect,escitalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-FQEVSTJZSA-N
CCMSLIB00012724674,related spectra of 'mls001401453-01!zolpidem tartrate (delta mass:15.995)',CCMSLIB00000085387,15.99,2314,Drug_suspect,zolpidem,gamma-aminobutyric acid (GABA)-ergic agonist,neurology/psychiatry,insomnia,GABA-A receptor agonist,ZAFYATHCZYHLPB-UHFFFAOYSA-N
CCMSLIB00012724675,related spectra of 'mls001401453-01!zolpidem tartrate (delta mass:29.974)',CCMSLIB00000085387,29.97,2315,Drug_suspect,zolpidem,gamma-aminobutyric acid (GABA)-ergic agonist,neurology/psychiatry,insomnia,GABA-A receptor agonist,ZAFYATHCZYHLPB-UHFFFAOYSA-N
CCMSLIB00012724676,related spectra of 'mls002153815-01! (delta mass:-28.031)',CCMSLIB00000085940,-28.03,2316,Drug_suspect,cyclobenzaprine,muscle relaxant,neurology/psychiatry,muscle spasms,adrenergic receptor agonist|serotonin receptor agonist,JURKNVYFZMSNLP-UHFFFAOYSA-N
CCMSLIB00012724677,related spectra of 'mls002153855-01!norcyclobenzaprine303-50-4 (delta mass:-14.016)',CCMSLIB00000085637,-14.02,2317,Drug_suspect,norcyclobenzaprine,muscle relaxant,neurology/psychiatry,muscle spasms,adrenergic receptor agonist|serotonin receptor agonist,XECQQDXTQRYYBH-UHFFFAOYSA-N
CCMSLIB00012724678,related spectra of 'mls002222270-01! (delta mass:15.995)',CCMSLIB00000085168,15.99,2318,Drug_suspect,mesoridazine,phenothiazine,neurology/psychiatry,schizophrenia,dopamine receptor antagonist,SLVMESMUVMCQIY-UHFFFAOYSA-N
CCMSLIB00012724679,related spectra of 'mmv688775 (delta mass:176.032)',CCMSLIB00004722095,176.03,2319,Drug_suspect,rifampicin,rifamycin antibacterial,infectious disease,tuberculosis|meningitis,RNA polymerase inhibitor,JQXXHWHPUNPDRT-MTOCILLGSA-N
CCMSLIB00012724680,related spectra of 'maraviroc (delta mass:15.995)',CCMSLIB00000004788|CCMSLIB00000004789|CCMSLIB00000004790|CCMSLIB00000004791|CCMSLIB00000004792|CCMSLIB00000004793|CCMSLIB00000004794|CCMSLIB00000004795|CCMSLIB00000004796|CCMSLIB00000078380|CCMSLIB00000078381|CCMSLIB00010143857|CCMSLIB00010143858|CCMSLIB00010143859|CCMSLIB00010143860|CCMSLIB00010143861,15.99,2320,Drug_suspect,maraviroc|maraviroc,CCR5 co-receptor antagonist,infectious disease,human immunodeficiency virus (HIV-1),CC chemokine receptor antagonist,GSNHKUDZZFZSJB-HLMSNRGBSA-N|GSNHKUDZZFZSJB-QYOOZWMWSA-N
CCMSLIB00012724681,related spectra of 'maraviroc (delta mass:21.984)',CCMSLIB00000004788|CCMSLIB00000004789|CCMSLIB00000004790|CCMSLIB00000004791|CCMSLIB00000004792|CCMSLIB00000004793|CCMSLIB00000004794|CCMSLIB00000004795|CCMSLIB00000004796|CCMSLIB00000078380|CCMSLIB00000078381|CCMSLIB00010143857|CCMSLIB00010143858|CCMSLIB00010143859|CCMSLIB00010143860|CCMSLIB00010143861,21.98,2321,Drug_suspect,maraviroc|maraviroc,CCR5 co-receptor antagonist,infectious disease,human immunodeficiency virus (HIV-1),CC chemokine receptor antagonist,GSNHKUDZZFZSJB-HLMSNRGBSA-N|GSNHKUDZZFZSJB-QYOOZWMWSA-N
CCMSLIB00012724682,related spectra of 'massbank: acepromazine (delta mass:2.016)',CCMSLIB00000205981|CCMSLIB00000205982|CCMSLIB00000205983|CCMSLIB00000205984|CCMSLIB00000205985|CCMSLIB00005771245|CCMSLIB00005771293|CCMSLIB00005771381|CCMSLIB00005771527|CCMSLIB00005771591,2.02,2322,Drug_suspect,acepromazine,phenothiazine|veterinary,neurology/psychiatry,sedative,dopamine receptor antagonist,NA|NOSIYYJFMPDDSA-UHFFFAOYSA-N
CCMSLIB00012724683,related spectra of 'massbank: acepromazine (delta mass:15.995)',CCMSLIB00000205981|CCMSLIB00000205982|CCMSLIB00000205983|CCMSLIB00000205984|CCMSLIB00000205985|CCMSLIB00005771245|CCMSLIB00005771293|CCMSLIB00005771381|CCMSLIB00005771527|CCMSLIB00005771591,15.99,2323,Drug_suspect,acepromazine,phenothiazine|veterinary,neurology/psychiatry,sedative,dopamine receptor antagonist,NA|NOSIYYJFMPDDSA-UHFFFAOYSA-N
CCMSLIB00012724684,related spectra of 'massbank: ampicillin (delta mass:12.0)',CCMSLIB00000206021|CCMSLIB00000206022|CCMSLIB00000206023|CCMSLIB00000206024|CCMSLIB00000206025|CCMSLIB00005771186|CCMSLIB00005771194|CCMSLIB00005771246|CCMSLIB00005771257|CCMSLIB00005771279,12,2324,Drug_suspect,ampicillin,penicillin class antibacterial,infectious disease,respiratory tract infections|meningitis|bacterial septicemia|endocarditis|urinary tract infections|gastrointestinal infections,bacterial cell wall synthesis inhibitor,AVKUERGKIZMTKX-UHFFFAOYSA-N
CCMSLIB00012724685,related spectra of 'massbank: oxaprozin (delta mass:14.016)',CCMSLIB00000206287|CCMSLIB00000206288|CCMSLIB00000206289|CCMSLIB00000206290|CCMSLIB00000206291|CCMSLIB00005771152|CCMSLIB00005771221|CCMSLIB00005771348|CCMSLIB00005771476|CCMSLIB00005771579,14.02,2325,Drug_suspect,oxaprozin,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis,cyclooxygenase inhibitor,OFPXSFXSNFPTHF-UHFFFAOYSA-N
CCMSLIB00012724686,related spectra of 'massbank: prednisolone (delta mass:-18.011)',CCMSLIB00000206327|CCMSLIB00000206328|CCMSLIB00000206329|CCMSLIB00000206330|CCMSLIB00000206331|CCMSLIB00005771167|CCMSLIB00005771178|CCMSLIB00005771361|CCMSLIB00005771416|CCMSLIB00005771567,-18.01,2326,Drug_suspect,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-UHFFFAOYSA-N
CCMSLIB00012724687,related spectra of 'massbank: prednisolone (delta mass:-15.995)',CCMSLIB00000206327|CCMSLIB00000206328|CCMSLIB00000206329|CCMSLIB00000206330|CCMSLIB00000206331|CCMSLIB00005771167|CCMSLIB00005771178|CCMSLIB00005771361|CCMSLIB00005771416|CCMSLIB00005771567,-15.99,2327,Drug_suspect,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-UHFFFAOYSA-N
CCMSLIB00012724688,related spectra of 'massbank: prednisolone (delta mass:-14.016)',CCMSLIB00000206327|CCMSLIB00000206328|CCMSLIB00000206329|CCMSLIB00000206330|CCMSLIB00000206331|CCMSLIB00005771167|CCMSLIB00005771178|CCMSLIB00005771361|CCMSLIB00005771416|CCMSLIB00005771567,-14.02,2328,Drug_suspect,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-UHFFFAOYSA-N
CCMSLIB00012724689,related spectra of 'massbank: prednisolone (delta mass:2.016)',CCMSLIB00000206327|CCMSLIB00000206328|CCMSLIB00000206329|CCMSLIB00000206330|CCMSLIB00000206331|CCMSLIB00005771167|CCMSLIB00005771178|CCMSLIB00005771361|CCMSLIB00005771416|CCMSLIB00005771567,2.02,2329,Drug_suspect,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-UHFFFAOYSA-N
CCMSLIB00012724690,related spectra of 'massbank: prednisolone (delta mass:79.957)',CCMSLIB00000206327|CCMSLIB00000206328|CCMSLIB00000206329|CCMSLIB00000206330|CCMSLIB00000206331|CCMSLIB00005771167|CCMSLIB00005771178|CCMSLIB00005771361|CCMSLIB00005771416|CCMSLIB00005771567,79.96,2330,Drug_suspect,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-UHFFFAOYSA-N
CCMSLIB00012724691,related spectra of 'massbank: streptomycin (delta mass:18.01)',CCMSLIB00000206377|CCMSLIB00000206378|CCMSLIB00000206379|CCMSLIB00000206380|CCMSLIB00000206381|CCMSLIB00005771106|CCMSLIB00005771137|CCMSLIB00005771154|CCMSLIB00005771303|CCMSLIB00005771334,18.01,2331,Drug_suspect,streptomycin,aminoglycoside antibacterial,infectious disease,tuberculosis|gram-negative bacterial infections,bacterial 30S ribosomal subunit inhibitor,NA|UCSJYZPVAKXKNQ-UHFFFAOYSA-N
CCMSLIB00012724692,"related spectra of 'massbank: sulfamethoxazole|4-amino-n-(5-methyl-1,2-oxazol-3-yl)benzene-1-sulfonamide (delta mass:14.016)'",CCMSLIB00005753343|CCMSLIB00005753354|CCMSLIB00005753373|CCMSLIB00005753498|CCMSLIB00005753514|CCMSLIB00005753529|CCMSLIB00005753588|CCMSLIB00005753601|CCMSLIB00005753625|CCMSLIB00005753677|CCMSLIB00005753689|CCMSLIB00005753696|CCMSLIB00005753729|CCMSLIB00005753750|CCMSLIB00005753758|CCMSLIB00005753814|CCMSLIB00005753824|CCMSLIB00005753888|CCMSLIB00005753907|CCMSLIB00005753928|CCMSLIB00005753964|CCMSLIB00005753990|CCMSLIB00005754000|CCMSLIB00005754022|CCMSLIB00005754024|CCMSLIB00005754033|CCMSLIB00005754054|CCMSLIB00005754131|CCMSLIB00005754144|CCMSLIB00005754156|CCMSLIB00005754191|CCMSLIB00005754382|CCMSLIB00005754399|CCMSLIB00005754400|CCMSLIB00005754473|CCMSLIB00005754499|CCMSLIB00005754526|CCMSLIB00005754628|CCMSLIB00005754630|CCMSLIB00005754841|CCMSLIB00005754884|CCMSLIB00005754899|CCMSLIB00005754900|CCMSLIB00005754912|CCMSLIB00005755088,14.02,2332,Drug_suspect|Low_confidence,sulfamethoxazole,sulfonamide antimicrobial,infectious disease,pneumonia|enteritis|urinary tract infections,PABA antagonist,JLKIGFTWXXRPMT-UHFFFAOYSA-N
CCMSLIB00012724693,"related spectra of 'massbank:au100802 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:27.995)'",CCMSLIB00005775958,27.99,2333,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012724694,"related spectra of 'massbank:au100803 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:27.995)'",CCMSLIB00005774974,27.99,2334,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012724695,"related spectra of 'massbank:au100806 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:-1.98)'",CCMSLIB00005776263,-1.98,2335,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012724696,"related spectra of 'massbank:au100806 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:0.984)'",CCMSLIB00005776263,0.98,2336,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012724697,"related spectra of 'massbank:au100806 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:1.003)'",CCMSLIB00005776263,1,2337,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012724698,"related spectra of 'massbank:au100806 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:1.993)'",CCMSLIB00005776263,2,2338,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012724699,"related spectra of 'massbank:au100806 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:2.004)'",CCMSLIB00005776263,2,2339,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012724700,"related spectra of 'massbank:au100806 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:21.984)'",CCMSLIB00005776263,21.98,2340,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012724701,"related spectra of 'massbank:au100806 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:27.995)'",CCMSLIB00005776263,27.99,2341,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012724702,"related spectra of 'massbank:au100806 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:162.053)'",CCMSLIB00005776263,162.05,2342,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012724703,"related spectra of 'massbank:au101702 sulfamethizole|4-amino-n-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide (delta mass:27.995)'",CCMSLIB00005774906,27.99,2343,Drug_suspect|Background/QAQC,sulfamethizole,sulfonamide antimicrobial,infectious disease,urinary tract infections,bacterial antifolate,VACCAVUAMIDAGB-UHFFFAOYSA-N
CCMSLIB00012724704,"related spectra of 'massbank:au101702 sulfamethizole|4-amino-n-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide (delta mass:43.043)'",CCMSLIB00005774906,43.04,2344,Drug_suspect|Background/QAQC,sulfamethizole,sulfonamide antimicrobial,infectious disease,urinary tract infections,bacterial antifolate,VACCAVUAMIDAGB-UHFFFAOYSA-N
CCMSLIB00012724705,"related spectra of 'massbank:au105301 clarithromycin|(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-y (delta mass:-17.026)'",CCMSLIB00005777178,-17.03,2345,Drug_suspect,clarithromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis,bacterial 50S ribosomal subunit inhibitor,AGOYDEPGAOXOCK-KCBOHYOISA-N
CCMSLIB00012724706,"related spectra of 'massbank:au105301 clarithromycin|(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-y (delta mass:1.993)'",CCMSLIB00005777178,2,2346,Drug_suspect,clarithromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis,bacterial 50S ribosomal subunit inhibitor,AGOYDEPGAOXOCK-KCBOHYOISA-N
CCMSLIB00012724707,"related spectra of 'massbank:au105301 clarithromycin|(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-y (delta mass:14.016)'",CCMSLIB00005777178,14.02,2347,Drug_suspect,clarithromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis,bacterial 50S ribosomal subunit inhibitor,AGOYDEPGAOXOCK-KCBOHYOISA-N
CCMSLIB00012724708,"related spectra of 'massbank:au105301 clarithromycin|(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-y (delta mass:15.958)'",CCMSLIB00005777178,15.96,2348,Drug_suspect,clarithromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis,bacterial 50S ribosomal subunit inhibitor,AGOYDEPGAOXOCK-KCBOHYOISA-N
CCMSLIB00012724709,"related spectra of 'massbank:au105301 clarithromycin|(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-y (delta mass:15.995)'",CCMSLIB00005777178,15.99,2349,Drug_suspect,clarithromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis,bacterial 50S ribosomal subunit inhibitor,AGOYDEPGAOXOCK-KCBOHYOISA-N
CCMSLIB00012724710,"related spectra of 'massbank:au105308 clarithromycin|(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-y (delta mass:-14.016)'",CCMSLIB00005776726,-14.02,2350,Drug_suspect,clarithromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis,bacterial 50S ribosomal subunit inhibitor,AGOYDEPGAOXOCK-KCBOHYOISA-N
CCMSLIB00012724711,"related spectra of 'massbank:au105308 clarithromycin|(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-y (delta mass:15.995)'",CCMSLIB00005776726,15.99,2351,Drug_suspect,clarithromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis,bacterial 50S ribosomal subunit inhibitor,AGOYDEPGAOXOCK-KCBOHYOISA-N
CCMSLIB00012724712,"related spectra of 'massbank:au105310 clarithromycin|(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-y (delta mass:15.995)'",CCMSLIB00005777146,15.99,2352,Drug_suspect,clarithromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis,bacterial 50S ribosomal subunit inhibitor,AGOYDEPGAOXOCK-KCBOHYOISA-N
CCMSLIB00012724713,"related spectra of 'massbank:au105406 erythromycin|(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2- (delta mass:-14.016)'",CCMSLIB00005772340,-14.02,2353,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012724714,related spectra of 'massbank:au106203 fenbendazole|methyl n-(6-phenylsulfanyl-1h-benzimidazol-2-yl)carbamate (delta mass:15.995)',CCMSLIB00005776062,15.99,2354,Drug_suspect,fenbendazole,anthelminticveterinary,infectious disease,gastrointestinal parasites|gastrointestinal roundworms,tubulin polymerization inhibitor,HDDSHPAODJUKPD-UHFFFAOYSA-N
CCMSLIB00012724715,related spectra of 'massbank:au106203 fenbendazole|methyl n-(6-phenylsulfanyl-1h-benzimidazol-2-yl)carbamate (delta mass:31.99)',CCMSLIB00005776062,31.99,2355,Drug_suspect,fenbendazole,anthelminticveterinary,infectious disease,gastrointestinal parasites|gastrointestinal roundworms,tubulin polymerization inhibitor,HDDSHPAODJUKPD-UHFFFAOYSA-N
CCMSLIB00012724716,related spectra of 'massbank:au106203 fenbendazole|methyl n-(6-phenylsulfanyl-1h-benzimidazol-2-yl)carbamate (delta mass:79.957)',CCMSLIB00005776062,79.96,2356,Drug_suspect,fenbendazole,anthelminticveterinary,infectious disease,gastrointestinal parasites|gastrointestinal roundworms,tubulin polymerization inhibitor,HDDSHPAODJUKPD-UHFFFAOYSA-N
CCMSLIB00012724717,"related spectra of 'massbank:au107608 methylprednisolone|methylprednisolone|(6s,8s,9s,10r,11s,13s,14s,17r)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-one (delta mass:13.98)'",CCMSLIB00005774642,13.98,2357,Drug_suspect,methylprednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,VHRSUDSXCMQTMA-PJHHCJLFSA-N
CCMSLIB00012724718,"related spectra of 'massbank:au107608 methylprednisolone|methylprednisolone|(6s,8s,9s,10r,11s,13s,14s,17r)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-one (delta mass:15.995)'",CCMSLIB00005774642,15.99,2358,Drug_suspect,methylprednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,VHRSUDSXCMQTMA-PJHHCJLFSA-N
CCMSLIB00012724719,"related spectra of 'massbank:au112901 atorvastatin|(3r,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid (delta mass:-76.031)'",CCMSLIB00005775909,-76.03,2359,Drug_suspect,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724720,"related spectra of 'massbank:au112901 atorvastatin|(3r,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid (delta mass:-44.026)'",CCMSLIB00005775909,-44.03,2360,Drug_suspect,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724721,"related spectra of 'massbank:au112901 atorvastatin|(3r,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid (delta mass:-43.99)'",CCMSLIB00005775909,-43.99,2361,Drug_suspect,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724722,"related spectra of 'massbank:au112901 atorvastatin|(3r,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid (delta mass:-18.011)'",CCMSLIB00005775909,-18.01,2362,Drug_suspect,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724723,"related spectra of 'massbank:au112901 atorvastatin|(3r,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid (delta mass:-2.016)'",CCMSLIB00005775909,-2.02,2363,Drug_suspect,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724724,"related spectra of 'massbank:au112901 atorvastatin|(3r,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid (delta mass:15.975)'",CCMSLIB00005775909,15.97,2364,Drug_suspect,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724725,"related spectra of 'massbank:au112901 atorvastatin|(3r,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid (delta mass:15.995)'",CCMSLIB00005775909,15.99,2365,Drug_suspect,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724726,"related spectra of 'massbank:au112901 atorvastatin|(3r,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid (delta mass:192.027)'",CCMSLIB00005775909,192.03,2366,Drug_suspect,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724727,"related spectra of 'massbank:au112904 atorvastatin|atorvastatin|(3r,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid (delta mass:-30.01)'",CCMSLIB00005775046,-30.01,2367,Drug_suspect,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724728,"related spectra of 'massbank:au112904 atorvastatin|atorvastatin|(3r,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid (delta mass:15.995)'",CCMSLIB00005775046,15.99,2368,Drug_suspect,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012724729,related spectra of 'massbank:au117901 rifaximin (delta mass:-42.01)',CCMSLIB00005773670,-42.01,2369,Drug_suspect,rifaximin,rifamycin antibacterial,gastroenterology|infectious disease,diarrhea|irritable bowel syndrome|hepatic encephalopathy (HE),RNA synthesis inhibitor,NZCRJKRKKOLAOJ-XRCRFVBUSA-N
CCMSLIB00012724730,related spectra of 'massbank:au117901 rifaximin (delta mass:-14.016)',CCMSLIB00005773670,-14.02,2370,Drug_suspect,rifaximin,rifamycin antibacterial,gastroenterology|infectious disease,diarrhea|irritable bowel syndrome|hepatic encephalopathy (HE),RNA synthesis inhibitor,NZCRJKRKKOLAOJ-XRCRFVBUSA-N
CCMSLIB00012724731,"related spectra of 'massbank:au150002 sertraline|(1s,4s)-4-(3,4-dichlorophenyl)-n-methyl-1,2,3,4-tetrahydronaphthalen-1-amine (delta mass:1.993)'",CCMSLIB00005774363,2,2371,Drug_suspect,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012724732,"related spectra of 'massbank:au150002 sertraline|(1s,4s)-4-(3,4-dichlorophenyl)-n-methyl-1,2,3,4-tetrahydronaphthalen-1-amine (delta mass:2.004)'",CCMSLIB00005774363,2,2372,Drug_suspect,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012724733,"related spectra of 'massbank:au150002 sertraline|(1s,4s)-4-(3,4-dichlorophenyl)-n-methyl-1,2,3,4-tetrahydronaphthalen-1-amine (delta mass:15.995)'",CCMSLIB00005774363,15.99,2373,Drug_suspect,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012724734,"related spectra of 'massbank:au150002 sertraline|(1s,4s)-4-(3,4-dichlorophenyl)-n-methyl-1,2,3,4-tetrahydronaphthalen-1-amine (delta mass:29.974)'",CCMSLIB00005774363,29.97,2374,Drug_suspect,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012724735,"related spectra of 'massbank:au150002 sertraline|(1s,4s)-4-(3,4-dichlorophenyl)-n-methyl-1,2,3,4-tetrahydronaphthalen-1-amine (delta mass:43.991)'",CCMSLIB00005774363,43.99,2375,Drug_suspect,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012724736,"related spectra of 'massbank:au150003 sertraline|(1s,4s)-4-(3,4-dichlorophenyl)-n-methyl-1,2,3,4-tetrahydronaphthalen-1-amine (delta mass:15.995)'",CCMSLIB00005772508,15.99,2376,Drug_suspect,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012724737,"related spectra of 'massbank:au150003 sertraline|(1s,4s)-4-(3,4-dichlorophenyl)-n-methyl-1,2,3,4-tetrahydronaphthalen-1-amine (delta mass:29.974)'",CCMSLIB00005772508,29.97,2377,Drug_suspect,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012724738,"related spectra of 'massbank:au150003 sertraline|(1s,4s)-4-(3,4-dichlorophenyl)-n-methyl-1,2,3,4-tetrahydronaphthalen-1-amine (delta mass:43.991)'",CCMSLIB00005772508,43.99,2378,Drug_suspect,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012724739,"related spectra of 'massbank:au150003 sertraline|(1s,4s)-4-(3,4-dichlorophenyl)-n-methyl-1,2,3,4-tetrahydronaphthalen-1-amine (delta mass:192.027)'",CCMSLIB00005772508,192.03,2379,Drug_suspect,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012724740,"related spectra of 'massbank:au150004 sertraline|(1s,4s)-4-(3,4-dichlorophenyl)-n-methyl-1,2,3,4-tetrahydronaphthalen-1-amine (delta mass:43.991)'",CCMSLIB00005772120,43.99,2380,Drug_suspect,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012724741,"related spectra of 'massbank:au150006 sertraline|(1s,4s)-4-(3,4-dichlorophenyl)-n-methyl-1,2,3,4-tetrahydronaphthalen-1-amine (delta mass:15.995)'",CCMSLIB00005776039,15.99,2381,Drug_suspect,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012724742,"related spectra of 'massbank:au150006 sertraline|(1s,4s)-4-(3,4-dichlorophenyl)-n-methyl-1,2,3,4-tetrahydronaphthalen-1-amine (delta mass:43.991)'",CCMSLIB00005776039,43.99,2382,Drug_suspect,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012724743,"related spectra of 'massbank:au150006 sertraline|(1s,4s)-4-(3,4-dichlorophenyl)-n-methyl-1,2,3,4-tetrahydronaphthalen-1-amine (delta mass:192.027)'",CCMSLIB00005776039,192.03,2383,Drug_suspect,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012724744,"related spectra of 'massbank:au150403 amitriptyline|n,n-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine (delta mass:-0.984)'",CCMSLIB00005773705,-0.98,2384,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724745,"related spectra of 'massbank:au150403 amitriptyline|n,n-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine (delta mass:1.003)'",CCMSLIB00005773705,1,2385,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724746,"related spectra of 'massbank:au150404 amitriptyline|n,n-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine (delta mass:-28.031)'",CCMSLIB00005776364,-28.03,2386,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724747,"related spectra of 'massbank:au150406 amitriptyline|3-(5,6-dihydrodibenzo[2,1-b:2`,1`-f][7]annulen-11-ylidene)-n,n-dimethylpropan-1-amine (delta mass:-0.984)'",CCMSLIB00005775830,-0.98,2387,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724748,"related spectra of 'massbank:au150406 amitriptyline|3-(5,6-dihydrodibenzo[2,1-b:2`,1`-f][7]annulen-11-ylidene)-n,n-dimethylpropan-1-amine (delta mass:1.003)'",CCMSLIB00005775830,1,2388,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724749,"related spectra of 'massbank:au150406 amitriptyline|3-(5,6-dihydrodibenzo[2,1-b:2`,1`-f][7]annulen-11-ylidene)-n,n-dimethylpropan-1-amine (delta mass:15.995)'",CCMSLIB00005775830,15.99,2389,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724750,related spectra of 'massbank:au151306 citalopram|1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3h-2-benzofuran-5-carbonitrile (delta mass:-28.031)',CCMSLIB00005772827,-28.03,2390,Drug_suspect,citalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-UHFFFAOYSA-N
CCMSLIB00012724751,related spectra of 'massbank:au151306 citalopram|1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3h-2-benzofuran-5-carbonitrile (delta mass:-14.016)',CCMSLIB00005772827,-14.02,2391,Drug_suspect,citalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-UHFFFAOYSA-N
CCMSLIB00012724752,related spectra of 'massbank:au154606 norketamine|2-amino-2-(2-chlorophenyl)cyclohexan-1-one (delta mass:2.004)',CCMSLIB00005773240,2,2392,Drug_suspect,norketamine,general anesthetic,neurology/psychiatry,anesthesia,NMDA receptor antagonist,BEQZHFIKTBVCAU-UHFFFAOYSA-N
CCMSLIB00012724753,related spectra of 'massbank:au154606 norketamine|2-amino-2-(2-chlorophenyl)cyclohexan-1-one (delta mass:2.999)',CCMSLIB00005773240,3,2393,Drug_suspect,norketamine,general anesthetic,neurology/psychiatry,anesthesia,NMDA receptor antagonist,BEQZHFIKTBVCAU-UHFFFAOYSA-N
CCMSLIB00012724754,related spectra of 'massbank:au154606 norketamine|2-amino-2-(2-chlorophenyl)cyclohexan-1-one (delta mass:30.01)',CCMSLIB00005773240,30.01,2394,Drug_suspect,norketamine,general anesthetic,neurology/psychiatry,anesthesia,NMDA receptor antagonist,BEQZHFIKTBVCAU-UHFFFAOYSA-N
CCMSLIB00012724755,related spectra of 'massbank:au154606 norketamine|2-amino-2-(2-chlorophenyl)cyclohexan-1-one (delta mass:58.005)',CCMSLIB00005773240,58.01,2395,Drug_suspect,norketamine,general anesthetic,neurology/psychiatry,anesthesia,NMDA receptor antagonist,BEQZHFIKTBVCAU-UHFFFAOYSA-N
CCMSLIB00012724756,"related spectra of 'massbank:au156603 norsertraline|desmethylsertraline|(1s,4s)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine (delta mass:-17.026)'",CCMSLIB00005777221,-17.03,2396,Drug_suspect,desmethylsertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),SRPXSILJHWNFMK-ZBEGNZNMSA-N
CCMSLIB00012724757,"related spectra of 'massbank:au156603 norsertraline|desmethylsertraline|(1s,4s)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine (delta mass:192.027)'",CCMSLIB00005777221,192.03,2397,Drug_suspect,desmethylsertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),SRPXSILJHWNFMK-ZBEGNZNMSA-N
CCMSLIB00012724758,"related spectra of 'massbank:au156604 norsertraline|desmethylsertraline|(1s,4s)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine (delta mass:-17.026)'",CCMSLIB00005774419,-17.03,2398,Drug_suspect,desmethylsertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),SRPXSILJHWNFMK-ZBEGNZNMSA-N
CCMSLIB00012724759,related spectra of 'massbank:au158606 ketamine|2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one (delta mass:43.991)',CCMSLIB00005773368,43.99,2399,Drug_suspect,ketamine,general anesthetic,neurology/psychiatry,anesthesia,NMDA receptor antagonist,YQEZLKZALYSWHR-UHFFFAOYSA-N
CCMSLIB00012724760,related spectra of 'massbank:au158606 ketamine|2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one (delta mass:58.005)',CCMSLIB00005773368,58.01,2400,Drug_suspect,ketamine,general anesthetic,neurology/psychiatry,anesthesia,NMDA receptor antagonist,YQEZLKZALYSWHR-UHFFFAOYSA-N
CCMSLIB00012724761,"related spectra of 'massbank:au160003 clozapine|3-chloro-6-(4-methylpiperazin-1-yl)-5h-benzo[b][1,4]benzodiazepine (delta mass:45.985)'",CCMSLIB00005775779,45.99,2401,Drug_suspect,clozapine,atypical antipsychotic,neurology/psychiatry,schizophrenia,dopamine receptor antagonist|serotonin receptor antagonist,ZUXABONWMNSFBN-UHFFFAOYSA-N
CCMSLIB00012724762,"related spectra of 'massbank:au160209 oxycodone|(4r,4as,7ar,12bs)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one (delta mass:-14.016)'",CCMSLIB00005774854,-14.02,2402,Drug_suspect,oxycodone,opioid agonist,neurology/psychiatry,pain,opioid receptor agonist,BRUQQQPBMZOVGD-XFKAJCMBSA-N
CCMSLIB00012724763,"related spectra of 'massbank:au161103 nordiazepam|7-chloro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one (delta mass:15.995)'",CCMSLIB00005774967,15.99,2403,Drug_suspect,nordazepam,benzodiazepine,neurology/psychiatry,seizures|anxiety|muscle spasms|spasticity|alcohol withdrawal,GABA-A receptor agonist,AKPLHCDWDRPJGD-UHFFFAOYSA-N
CCMSLIB00012724764,related spectra of 'massbank:au201303 n4-acetylsulfadiazine|n-acetyl sulfadiazine|n-[4-(pyrimidin-2-ylsulfamoyl)phenyl]acetamide (delta mass:15.995)',CCMSLIB00005773222,15.99,2404,Drug_suspect,n-acetyl sulfadiazine,sulfonamide antibacterial,infectious disease,malaria|meningitis|urinary tract infections|conjunctivitis|trachoma|chancroid,bacterial antifolate,NJIZUWGMNCUKGU-UHFFFAOYSA-N
CCMSLIB00012724765,"related spectra of 'massbank:au202008 n-desmethyl clarithromycin|14-ethyl-12,13-dihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-6-[3-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetra (delta mass:15.995)'",CCMSLIB00005772368,15.99,2405,Drug_suspect,n-desmethylclarithromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis,bacterial 50S ribosomal subunit inhibitor,CIJTVUQEURKBDL-UHFFFAOYSA-N
CCMSLIB00012724766,"related spectra of 'massbank:au202010 n-desmethyl clarithromycin|14-ethyl-12,13-dihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-6-[3-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetra (delta mass:15.995)'",CCMSLIB00005773059,15.99,2406,Drug_suspect,n-desmethylclarithromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis,bacterial 50S ribosomal subunit inhibitor,CIJTVUQEURKBDL-UHFFFAOYSA-N
CCMSLIB00012724767,related spectra of 'massbank:au202503 atenolol acid|metoprolol acid|2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetic acid (delta mass:14.016)',CCMSLIB00005775449,14.02,2407,Drug_suspect,metoprolol acid,beta-adrenergic receptor inhibitor,cardiology,hypertension|angina pectoris|myocardial infarction,adrenergic receptor antagonist,PUQIRTNPJRFRCZ-UHFFFAOYSA-N
CCMSLIB00012724768,related spectra of 'massbank:au205603 fenofibric acid|2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (delta mass:-43.99)',CCMSLIB00005773924,-43.99,2408,Drug_suspect,fenofibric acid,fibrates|peroxisome proliferator-activated receptor (PPAR) alpha agonist,cardiology|endocrinology,hypertriglyceridemia|hypercholesterolemia|hyperlipidemia,PPAR receptor agonist,MQOBSOSZFYZQOK-UHFFFAOYSA-N
CCMSLIB00012724769,related spectra of 'massbank:au205603 fenofibric acid|2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (delta mass:14.016)',CCMSLIB00005773924,14.02,2409,Drug_suspect,fenofibric acid,fibrates|peroxisome proliferator-activated receptor (PPAR) alpha agonist,cardiology|endocrinology,hypertriglyceridemia|hypercholesterolemia|hyperlipidemia,PPAR receptor agonist,MQOBSOSZFYZQOK-UHFFFAOYSA-N
CCMSLIB00012724770,related spectra of 'massbank:au205603 fenofibric acid|2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (delta mass:15.995)',CCMSLIB00005773924,15.99,2410,Drug_suspect,fenofibric acid,fibrates|peroxisome proliferator-activated receptor (PPAR) alpha agonist,cardiology|endocrinology,hypertriglyceridemia|hypercholesterolemia|hyperlipidemia,PPAR receptor agonist,MQOBSOSZFYZQOK-UHFFFAOYSA-N
CCMSLIB00012724771,related spectra of 'massbank:au205603 fenofibric acid|2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (delta mass:21.984)',CCMSLIB00005773924,21.98,2411,Drug_suspect,fenofibric acid,fibrates|peroxisome proliferator-activated receptor (PPAR) alpha agonist,cardiology|endocrinology,hypertriglyceridemia|hypercholesterolemia|hyperlipidemia,PPAR receptor agonist,MQOBSOSZFYZQOK-UHFFFAOYSA-N
CCMSLIB00012724772,"related spectra of 'massbank:au209410 irbesartan|2-butyl-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one (delta mass:-28.031)'",CCMSLIB00005772775,-28.03,2412,Drug_suspect,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012724773,"related spectra of 'massbank:au209410 irbesartan|2-butyl-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one (delta mass:-2.016)'",CCMSLIB00005772775,-2.02,2413,Drug_suspect,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012724774,"related spectra of 'massbank:au209410 irbesartan|2-butyl-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one (delta mass:13.98)'",CCMSLIB00005772775,13.98,2414,Drug_suspect,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012724775,"related spectra of 'massbank:au209410 irbesartan|2-butyl-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one (delta mass:15.995)'",CCMSLIB00005772775,15.99,2415,Drug_suspect,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012724776,"related spectra of 'massbank:au209410 irbesartan|2-butyl-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one (delta mass:29.974)'",CCMSLIB00005772775,29.97,2416,Drug_suspect,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012724777,"related spectra of 'massbank:au209410 irbesartan|2-butyl-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one (delta mass:31.99)'",CCMSLIB00005772775,31.99,2417,Drug_suspect,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012724778,related spectra of 'massbank:au212403 cetirizine|levocetirizine|2-[2-[4-[(r)-(4-chlorophenyl)-phenylmethyl]piperazin-1-ium-1-yl]ethoxy]acetate (delta mass:2.004)',CCMSLIB00005774496,2,2418,Drug_suspect,levocetirizine|cetirizine,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,ZKLPARSLTMPFCP-OAQYLSRUSA-N
CCMSLIB00012724779,related spectra of 'massbank:au212404 cetirizine|levocetirizine|2-[2-[4-[(r)-(4-chlorophenyl)-phenylmethyl]piperazin-1-ium-1-yl]ethoxy]acetate (delta mass:-44.026)',CCMSLIB00005775156,-44.03,2419,Drug_suspect,cetirizine|levocetirizine,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,ZKLPARSLTMPFCP-OAQYLSRUSA-N
CCMSLIB00012724541,related spectra of 'darunavir (delta mass:15.995)',CCMSLIB00010137589|CCMSLIB00010137590|CCMSLIB00010137591|CCMSLIB00010137592|CCMSLIB00010137593|CCMSLIB00010137594|CCMSLIB00010137595|CCMSLIB00010137596|CCMSLIB00010138287|CCMSLIB00010138288|CCMSLIB00010138289|CCMSLIB00010138290|CCMSLIB00010138291|CCMSLIB00010138292|CCMSLIB00010138293|CCMSLIB00010138294,15.99,2181,Drug_suspect,darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-HEXNFIEUSA-N
CCMSLIB00012724542,related spectra of 'darunavir (delta mass:29.974)',CCMSLIB00010137589|CCMSLIB00010137590|CCMSLIB00010137591|CCMSLIB00010137592|CCMSLIB00010137593|CCMSLIB00010137594|CCMSLIB00010137595|CCMSLIB00010137596|CCMSLIB00010138287|CCMSLIB00010138288|CCMSLIB00010138289|CCMSLIB00010138290|CCMSLIB00010138291|CCMSLIB00010138292|CCMSLIB00010138293|CCMSLIB00010138294,29.97,2182,Drug_suspect,darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-HEXNFIEUSA-N
CCMSLIB00012724543,related spectra of 'darunavir (delta mass:162.053)',CCMSLIB00010137589|CCMSLIB00010137590|CCMSLIB00010137591|CCMSLIB00010137592|CCMSLIB00010137593|CCMSLIB00010137594|CCMSLIB00010137595|CCMSLIB00010137596|CCMSLIB00010138287|CCMSLIB00010138288|CCMSLIB00010138289|CCMSLIB00010138290|CCMSLIB00010138291|CCMSLIB00010138292|CCMSLIB00010138293|CCMSLIB00010138294,162.05,2183,Drug_suspect,darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-HEXNFIEUSA-N
CCMSLIB00012724544,related spectra of 'darunavir ethanolate (prezista) (delta mass:-2.016)',CCMSLIB00000078211|CCMSLIB00000078212,-2.02,2184,Drug_suspect,darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-HEXNFIEUSA-N
CCMSLIB00012724545,related spectra of 'darunavir ethanolate (prezista) (delta mass:15.995)',CCMSLIB00000078211|CCMSLIB00000078212,15.99,2185,Drug_suspect,darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-HEXNFIEUSA-N
CCMSLIB00012724546,related spectra of 'darunavir ethanolate (prezista) (delta mass:176.032)',CCMSLIB00000078211|CCMSLIB00000078212,176.03,2186,Drug_suspect,darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-HEXNFIEUSA-N
CCMSLIB00012724645,related spectra of 'lopinavir (delta mass:-18.011)',CCMSLIB00000006305|CCMSLIB00000006306|CCMSLIB00000006307|CCMSLIB00000006308|CCMSLIB00000006309|CCMSLIB00000006310|CCMSLIB00000006311|CCMSLIB00000006312|CCMSLIB00000006313,-18.01,2285,Drug_suspect,lopinavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,KJHKTHWMRKYKJE-SUGCFTRWSA-N
CCMSLIB00012724646,related spectra of 'lopinavir (delta mass:13.98)',CCMSLIB00000006305|CCMSLIB00000006306|CCMSLIB00000006307|CCMSLIB00000006308|CCMSLIB00000006309|CCMSLIB00000006310|CCMSLIB00000006311|CCMSLIB00000006312|CCMSLIB00000006313,13.98,2286,Drug_suspect,lopinavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,KJHKTHWMRKYKJE-SUGCFTRWSA-N
CCMSLIB00012724647,related spectra of 'lopinavir (delta mass:15.995)',CCMSLIB00000006305|CCMSLIB00000006306|CCMSLIB00000006307|CCMSLIB00000006308|CCMSLIB00000006309|CCMSLIB00000006310|CCMSLIB00000006311|CCMSLIB00000006312|CCMSLIB00000006313,15.99,2287,Drug_suspect,lopinavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,KJHKTHWMRKYKJE-SUGCFTRWSA-N
CCMSLIB00012724780,"related spectra of 'massbank:au214804 atazanavir|methyl n-[(2s)-1-[2-[(2s,3s)-2-hydroxy-3-[[(2s)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl] (delta mass:-15.995)'",CCMSLIB00005772952,-15.99,2420,Drug_suspect,atazanavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,AXRYRYVKAWYZBR-GASGPIRDSA-N
CCMSLIB00012724781,"related spectra of 'massbank:au214804 atazanavir|methyl n-[(2s)-1-[2-[(2s,3s)-2-hydroxy-3-[[(2s)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl] (delta mass:-12.036)'",CCMSLIB00005772952,-12.04,2421,Drug_suspect,atazanavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,AXRYRYVKAWYZBR-GASGPIRDSA-N
CCMSLIB00012724782,"related spectra of 'massbank:au214804 atazanavir|methyl n-[(2s)-1-[2-[(2s,3s)-2-hydroxy-3-[[(2s)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl] (delta mass:-4.031)'",CCMSLIB00005772952,-4.03,2422,Drug_suspect,atazanavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,AXRYRYVKAWYZBR-GASGPIRDSA-N
CCMSLIB00012724783,"related spectra of 'massbank:au214804 atazanavir|methyl n-[(2s)-1-[2-[(2s,3s)-2-hydroxy-3-[[(2s)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl] (delta mass:11.964)'",CCMSLIB00005772952,11.96,2423,Drug_suspect,atazanavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,AXRYRYVKAWYZBR-GASGPIRDSA-N
CCMSLIB00012724793,"related spectra of 'massbank:au220210 praziquantel|2-(cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1h-pyrazino[2,1-a]isoquinolin-4-one (delta mass:-2.016)'",CCMSLIB00005775754,-2.02,2433,Drug_suspect,praziquantel,anthelmintic,infectious disease,gastrointestinal parasites|cystic hydatid disease|schistosomiasis,anthelmintic agent,FSVJFNAIGNNGKK-UHFFFAOYSA-N
CCMSLIB00012724794,"related spectra of 'massbank:au220304 pioglitazone|5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione (delta mass:15.995)'",CCMSLIB00005774772,15.99,2434,Drug_suspect,pioglitazone,peroxisome proliferator-activated receptor (PPAR) gamma agonist,endocrinology,type 2 diabetes mellitus,insulin sensitizer|PPAR receptor agonist,HYAFETHFCAUJAY-UHFFFAOYSA-N
CCMSLIB00012724795,"related spectra of 'massbank:au220304 pioglitazone|5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione (delta mass:29.974)'",CCMSLIB00005774772,29.97,2435,Drug_suspect,pioglitazone,peroxisome proliferator-activated receptor (PPAR) gamma agonist,endocrinology,type 2 diabetes mellitus,insulin sensitizer|PPAR receptor agonist,HYAFETHFCAUJAY-UHFFFAOYSA-N
CCMSLIB00012724796,"related spectra of 'massbank:au226006 verapamil|2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile (delta mass:-28.031)'",CCMSLIB00005776170,-28.03,2436,Drug_suspect,verapamil,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris|arrhythmia,calcium channel blocker,SGTNSNPWRIOYBX-UHFFFAOYSA-N
CCMSLIB00012724797,"related spectra of 'massbank:au227104 trazodone|2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one (delta mass:15.995)'",CCMSLIB00005773584,15.99,2437,Drug_suspect,trazodone,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,PHLBKPHSAVXXEF-UHFFFAOYSA-N
CCMSLIB00012724798,"related spectra of 'massbank:au227104 trazodone|2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one (delta mass:34.005)'",CCMSLIB00005773584,34.01,2438,Drug_suspect,trazodone,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,PHLBKPHSAVXXEF-UHFFFAOYSA-N
CCMSLIB00012724799,"related spectra of 'massbank:au227106 trazodone|2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one (delta mass:1.993)'",CCMSLIB00005772451,2,2439,Drug_suspect,trazodone,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,PHLBKPHSAVXXEF-UHFFFAOYSA-N
CCMSLIB00012724800,"related spectra of 'massbank:au227106 trazodone|2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one (delta mass:2.999)'",CCMSLIB00005772451,3,2440,Drug_suspect,trazodone,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,PHLBKPHSAVXXEF-UHFFFAOYSA-N
CCMSLIB00012724801,"related spectra of 'massbank:au227106 trazodone|2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one (delta mass:15.995)'",CCMSLIB00005772451,15.99,2441,Drug_suspect,trazodone,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,PHLBKPHSAVXXEF-UHFFFAOYSA-N
CCMSLIB00012724802,"related spectra of 'massbank:au227106 trazodone|2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one (delta mass:34.005)'",CCMSLIB00005772451,34.01,2442,Drug_suspect,trazodone,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,PHLBKPHSAVXXEF-UHFFFAOYSA-N
CCMSLIB00012724803,"related spectra of 'massbank:au227106 trazodone|2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one (delta mass:45.985)'",CCMSLIB00005772451,45.99,2443,Drug_suspect,trazodone,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,PHLBKPHSAVXXEF-UHFFFAOYSA-N
CCMSLIB00012724804,related spectra of 'massbank:au228004 losartan|[2-butyl-5-chloro-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol (delta mass:-20.026)',CCMSLIB00005774716,-20.03,2444,Drug_suspect,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012724805,related spectra of 'massbank:au228004 losartan|[2-butyl-5-chloro-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol (delta mass:-18.011)',CCMSLIB00005774716,-18.01,2445,Drug_suspect,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012724806,related spectra of 'massbank:au228004 losartan|[2-butyl-5-chloro-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol (delta mass:15.995)',CCMSLIB00005774716,15.99,2446,Drug_suspect,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012724807,related spectra of 'massbank:au228004 losartan|[2-butyl-5-chloro-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol (delta mass:43.043)',CCMSLIB00005774716,43.04,2447,Drug_suspect,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012724784,"related spectra of 'massbank:au214804 atazanavir|methyl n-[(2s)-1-[2-[(2s,3s)-2-hydroxy-3-[[(2s)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl] (delta mass:15.995)'",CCMSLIB00005772952,15.99,2424,Drug_suspect,atazanavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,AXRYRYVKAWYZBR-GASGPIRDSA-N
CCMSLIB00012724785,"related spectra of 'massbank:au214804 atazanavir|methyl n-[(2s)-1-[2-[(2s,3s)-2-hydroxy-3-[[(2s)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl] (delta mass:29.974)'",CCMSLIB00005772952,29.97,2425,Drug_suspect,atazanavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,AXRYRYVKAWYZBR-GASGPIRDSA-N
CCMSLIB00012724810,"related spectra of 'massbank:au229004 desacetyldiltiazem|(2s,3s)-5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4-one (delta mass:-14.016)'",CCMSLIB00005775914,-14.02,2450,Drug_suspect,deacetyldiltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,NZHUXMZTSSZXSB-MOPGFXCFSA-N
CCMSLIB00012724811,"related spectra of 'massbank:au229004 desacetyldiltiazem|(2s,3s)-5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4-one (delta mass:192.027)'",CCMSLIB00005775914,192.03,2451,Drug_suspect,deacetyldiltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,NZHUXMZTSSZXSB-MOPGFXCFSA-N
CCMSLIB00012724812,"related spectra of 'massbank:au229006 desacetyldiltiazem|(2s,3s)-5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4-one (delta mass:-28.031)'",CCMSLIB00005772298,-28.03,2452,Drug_suspect,deacetyldiltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,NZHUXMZTSSZXSB-MOPGFXCFSA-N
CCMSLIB00012724813,"related spectra of 'massbank:au229006 desacetyldiltiazem|(2s,3s)-5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4-one (delta mass:-14.016)'",CCMSLIB00005772298,-14.02,2453,Drug_suspect,deacetyldiltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,NZHUXMZTSSZXSB-MOPGFXCFSA-N
CCMSLIB00012724814,"related spectra of 'massbank:au229006 desacetyldiltiazem|(2s,3s)-5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4-one (delta mass:13.98)'",CCMSLIB00005772298,13.98,2454,Drug_suspect,deacetyldiltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,NZHUXMZTSSZXSB-MOPGFXCFSA-N
CCMSLIB00012724815,"related spectra of 'massbank:au229006 desacetyldiltiazem|(2s,3s)-5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4-one (delta mass:15.995)'",CCMSLIB00005772298,15.99,2455,Drug_suspect,deacetyldiltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,NZHUXMZTSSZXSB-MOPGFXCFSA-N
CCMSLIB00012724816,"related spectra of 'massbank:au229006 desacetyldiltiazem|(2s,3s)-5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4-one (delta mass:27.995)'",CCMSLIB00005772298,27.99,2456,Drug_suspect,deacetyldiltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,NZHUXMZTSSZXSB-MOPGFXCFSA-N
CCMSLIB00012724817,related spectra of 'massbank:au235606 celecoxib|4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide (delta mass:29.974)',CCMSLIB00005773640,29.97,2457,Drug_suspect,celecoxib,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis|ankylosing spondylitis|primary dysmenorrhea (PD),cyclooxygenase inhibitor,RZEKVGVHFLEQIL-UHFFFAOYSA-N
CCMSLIB00012724818,related spectra of 'massbank:au235659 celecoxib|4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide (delta mass:2.999)',CCMSLIB00005775351,3,2458,Drug_suspect,celecoxib,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis|ankylosing spondylitis|primary dysmenorrhea (PD),cyclooxygenase inhibitor,RZEKVGVHFLEQIL-UHFFFAOYSA-N
CCMSLIB00012724819,related spectra of 'massbank:au235659 celecoxib|4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide (delta mass:43.991)',CCMSLIB00005775351,43.99,2459,Drug_suspect,celecoxib,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis|ankylosing spondylitis|primary dysmenorrhea (PD),cyclooxygenase inhibitor,RZEKVGVHFLEQIL-UHFFFAOYSA-N
CCMSLIB00012724786,"related spectra of 'massbank:au214804 atazanavir|methyl n-[(2s)-1-[2-[(2s,3s)-2-hydroxy-3-[[(2s)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl] (delta mass:31.99)'",CCMSLIB00005772952,31.99,2426,Drug_suspect,atazanavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,AXRYRYVKAWYZBR-GASGPIRDSA-N
CCMSLIB00012724787,"related spectra of 'massbank:au214804 atazanavir|methyl n-[(2s)-1-[2-[(2s,3s)-2-hydroxy-3-[[(2s)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl] (delta mass:63.981)'",CCMSLIB00005772952,63.98,2427,Drug_suspect,atazanavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,AXRYRYVKAWYZBR-GASGPIRDSA-N
CCMSLIB00012724822,related spectra of 'massbank:au236503 torasemide|torsemide|1-[4-(3-methylanilino)pyridin-3-yl]sulfonyl-3-propan-2-ylurea (delta mass:-14.016)',CCMSLIB00005773297,-14.02,2462,Drug_suspect,torasemide,loop diuretic,cardiology|nephrology,edema|hypertension|congestive heart failure|renal failure,electrolyte reabsorption inhibitor|thromboxane receptor antagonist,NGBFQHCMQULJNZ-UHFFFAOYSA-N
CCMSLIB00012724823,"related spectra of 'massbank:au239460 canrenone|(9s,14s)-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1h-cyclopenta[a]phenanthrene-17,5`-oxolane]-2`,3-dione (delta mass:-56.062)'",CCMSLIB00005774283,-56.06,2463,Drug_suspect,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012724824,"related spectra of 'massbank:au239460 canrenone|(9s,14s)-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1h-cyclopenta[a]phenanthrene-17,5`-oxolane]-2`,3-dione (delta mass:-28.031)'",CCMSLIB00005774283,-28.03,2464,Drug_suspect,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012724825,"related spectra of 'massbank:au239460 canrenone|(9s,14s)-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1h-cyclopenta[a]phenanthrene-17,5`-oxolane]-2`,3-dione (delta mass:-27.995)'",CCMSLIB00005774283,-27.99,2465,Drug_suspect,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012724826,"related spectra of 'massbank:au239460 canrenone|(9s,14s)-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1h-cyclopenta[a]phenanthrene-17,5`-oxolane]-2`,3-dione (delta mass:-14.016)'",CCMSLIB00005774283,-14.02,2466,Drug_suspect,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012724827,"related spectra of 'massbank:au239460 canrenone|(9s,14s)-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1h-cyclopenta[a]phenanthrene-17,5`-oxolane]-2`,3-dione (delta mass:14.016)'",CCMSLIB00005774283,14.02,2467,Drug_suspect,canrenone,aldosterone antagonist,endocrinology|cardiology,hyperaldosteronism|congestive heart failure|edema|hypertension|hypokalemia,mineralocorticoid receptor antagonist,UJVLDDZCTMKXJK-AFDHUMPMSA-N
CCMSLIB00012724828,"related spectra of 'massbank:au239704 17alpha-hydroxyprogesterone|17alpha-hydroxypregn-4-ene-3,20-dione|17-acetyl-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-3-one (delta mass:-15.995)'",CCMSLIB00005772150,-15.99,2468,Drug_suspect|Low_confidence,hydroxyprogesterone caproate,progestin,obstetrics/gynecology,spontaneous preterm birth,progesterone receptor agonist,DBPWSSGDRRHUNT-UHFFFAOYSA-N
CCMSLIB00012724829,related spectra of 'massbank:au241506 warfarin|4-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-2-one (delta mass:15.995)',CCMSLIB00005775428,15.99,2469,Drug_suspect,warfarin,vitamin K antagonist,hematology|cardiology,deep vein thrombosis (DVT)|pulmonary embolism (PE)|atrial fibrillation (AF)|myocardial infarction|thromboembolism,vitamin K antagonist,PJVWKTKQMONHTI-UHFFFAOYSA-N
CCMSLIB00012724830,"related spectra of 'massbank:au250102 octocrylene|2-ethylhexyl 2-cyano-3,3-diphenylprop-2-enoate (delta mass:17.027)'",CCMSLIB00005776664,17.03,2470,Drug_suspect,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-UHFFFAOYSA-N
CCMSLIB00012724831,"related spectra of 'massbank:au250104 octocrylene|2-ethylhexyl 2-cyano-3,3-diphenylprop-2-enoate (delta mass:17.027)'",CCMSLIB00005774938,17.03,2471,Drug_suspect,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-UHFFFAOYSA-N
CCMSLIB00012724832,"related spectra of 'massbank:au250104 octocrylene|2-ethylhexyl 2-cyano-3,3-diphenylprop-2-enoate (delta mass:30.01)'",CCMSLIB00005774938,30.01,2472,Drug_suspect,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-UHFFFAOYSA-N
CCMSLIB00012724833,"related spectra of 'massbank:au250106 octocrylene|2-ethylhexyl 2-cyano-3,3-diphenylprop-2-enoate (delta mass:0.984)'",CCMSLIB00005775977,0.98,2473,Drug_suspect,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-UHFFFAOYSA-N
CCMSLIB00012724834,"related spectra of 'massbank:au250106 octocrylene|2-ethylhexyl 2-cyano-3,3-diphenylprop-2-enoate (delta mass:17.027)'",CCMSLIB00005775977,17.03,2474,Drug_suspect,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-UHFFFAOYSA-N
CCMSLIB00012724835,related spectra of 'massbank:au250201 octyl-methoxycinnamate|octinoxate|2-ethylhexyl (e)-3-(4-methoxyphenyl)prop-2-enoate (delta mass:17.027)',CCMSLIB00005775317,17.03,2475,Drug_suspect,octinoxate,no_match,dermatology,sunscreen lotion,NA,YBGZDTIWKVFICR-JLHYYAGUSA-N
CCMSLIB00012724836,related spectra of 'massbank:au250204 octyl-methoxycinnamate|octinoxate|2-ethylhexyl (e)-3-(4-methoxyphenyl)prop-2-enoate (delta mass:-12.036)',CCMSLIB00005772366,-12.04,2476,Drug_suspect,octinoxate,no_match,dermatology,sunscreen lotion,NA,YBGZDTIWKVFICR-JLHYYAGUSA-N
CCMSLIB00012724837,related spectra of 'massbank:au250204 octyl-methoxycinnamate|octinoxate|2-ethylhexyl (e)-3-(4-methoxyphenyl)prop-2-enoate (delta mass:-11.964)',CCMSLIB00005772366,-11.96,2477,Drug_suspect,octinoxate,no_match,dermatology,sunscreen lotion,NA,YBGZDTIWKVFICR-JLHYYAGUSA-N
CCMSLIB00012724838,related spectra of 'massbank:au250206 octyl-methoxycinnamate|octinoxate|2-ethylhexyl (e)-3-(4-methoxyphenyl)prop-2-enoate (delta mass:17.027)',CCMSLIB00005773706,17.03,2478,Drug_suspect,octinoxate,no_match,dermatology,sunscreen lotion,NA,YBGZDTIWKVFICR-JLHYYAGUSA-N
CCMSLIB00012724839,"related spectra of 'massbank:au250405 loperamide|4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-n,n-dimethyl-2,2-diphenylbutanamide (delta mass:-28.031)'",CCMSLIB00005774074,-28.03,2479,Drug_suspect,loperamide,opioid agonist,gastroenterology,diarrhea,opioid receptor agonist,RDOIQAHITMMDAJ-UHFFFAOYSA-N
CCMSLIB00012724840,"related spectra of 'massbank:au250405 loperamide|4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-n,n-dimethyl-2,2-diphenylbutanamide (delta mass:-14.016)'",CCMSLIB00005774074,-14.02,2480,Drug_suspect,loperamide,opioid agonist,gastroenterology,diarrhea,opioid receptor agonist,RDOIQAHITMMDAJ-UHFFFAOYSA-N
CCMSLIB00012724841,"related spectra of 'massbank:au250503 promethazin|promethazine|n,n-dimethyl-1-phenothiazin-10-ylpropan-2-amine (delta mass:-14.016)'",CCMSLIB00005775560,-14.02,2481,Drug_suspect,promethazine,phenothiazine,neurology/psychiatry|allergy|gastroenterology,sedative|allergic rhinitis|motion sickness|nausea|vomiting|allergic conditions,histamine receptor antagonist,PWWVAXIEGOYWEE-UHFFFAOYSA-N
CCMSLIB00012724842,"related spectra of 'massbank:au263506 spinosyn a|spinosad factor a|(1s,2r,5s,7r,9r,10s,14r,15s,19s)-15-[(2r,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-14-methyl-7-[(2r,3r,4r,5s,6s)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-ox (delta mass:-14.016)'",CCMSLIB00005773749,-14.02,2482,Drug_suspect,spinosad,other ectoparasiticides for systemic use|veterinary,infectious disease,flea,insecticide,SRJQTHAZUNRMPR-UYQKXTDMSA-N
CCMSLIB00012724843,"related spectra of 'massbank:au266606 trimethoprim|5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine (delta mass:14.016)'",CCMSLIB00005773209,14.02,2483,Drug_suspect,trimethoprim,dihydrofolate reductase inhibitor antibacterial,infectious disease,urinary tract infections|ear infections|gastrointestinal infections,dihydrofolate reductase inhibitor,IEDVJHCEMCRBQM-UHFFFAOYSA-N
CCMSLIB00012724844,"related spectra of 'massbank:au267102 diphenhydramine|2-benzhydryloxy-n,n-dimethylethanamine (delta mass:15.995)'",CCMSLIB00005773092,15.99,2484,Drug_suspect,diphenhydramine,histamine-1 (H1) inhibitor,allergy,seasonal allergy|allergic rashes|urticaria,histamine receptor antagonist,ZZVUWRFHKOJYTH-UHFFFAOYSA-N
CCMSLIB00012724845,"related spectra of 'massbank:au267103 diphenhydramine|2-benzhydryloxy-n,n-dimethylethanamine (delta mass:-14.016)'",CCMSLIB00005772811,-14.02,2485,Drug_suspect,diphenhydramine,histamine-1 (H1) inhibitor,allergy,seasonal allergy|allergic rashes|urticaria,histamine receptor antagonist,ZZVUWRFHKOJYTH-UHFFFAOYSA-N
CCMSLIB00012724846,"related spectra of 'massbank:au267103 diphenhydramine|2-benzhydryloxy-n,n-dimethylethanamine (delta mass:15.995)'",CCMSLIB00005772811,15.99,2486,Drug_suspect,diphenhydramine,histamine-1 (H1) inhibitor,allergy,seasonal allergy|allergic rashes|urticaria,histamine receptor antagonist,ZZVUWRFHKOJYTH-UHFFFAOYSA-N
CCMSLIB00012724847,"related spectra of 'massbank:au267104 diphenhydramine|2-benzhydryloxy-n,n-dimethylethanamine (delta mass:-14.016)'",CCMSLIB00005774769,-14.02,2487,Drug_suspect,diphenhydramine,histamine-1 (H1) inhibitor,allergy,seasonal allergy|allergic rashes|urticaria,histamine receptor antagonist,ZZVUWRFHKOJYTH-UHFFFAOYSA-N
CCMSLIB00012724848,"related spectra of 'massbank:au267106 diphenhydramine|2-benzhydryloxy-n,n-dimethylethanamine (delta mass:15.995)'",CCMSLIB00005772901,15.99,2488,Drug_suspect,diphenhydramine,histamine-1 (H1) inhibitor,allergy,seasonal allergy|allergic rashes|urticaria,histamine receptor antagonist,ZZVUWRFHKOJYTH-UHFFFAOYSA-N
CCMSLIB00012724849,related spectra of 'massbank:au269803 mycophenolic acid|(e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1h-2-benzofuran-5-yl)-4-methylhex-4-enoic acid (delta mass:-18.011)',CCMSLIB00005775082,-18.01,2489,Drug_suspect,mycophenolic acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-RUDMXATFSA-N
CCMSLIB00012724850,related spectra of 'massbank:au269803 mycophenolic acid|(e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1h-2-benzofuran-5-yl)-4-methylhex-4-enoic acid (delta mass:21.984)',CCMSLIB00005775082,21.98,2490,Drug_suspect,mycophenolic acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-RUDMXATFSA-N
CCMSLIB00012724851,related spectra of 'massbank:au269803 mycophenolic acid|(e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1h-2-benzofuran-5-yl)-4-methylhex-4-enoic acid (delta mass:28.031)',CCMSLIB00005775082,28.03,2491,Drug_suspect,mycophenolic acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-RUDMXATFSA-N
CCMSLIB00012724852,related spectra of 'massbank:au269803 mycophenolic acid|(e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1h-2-benzofuran-5-yl)-4-methylhex-4-enoic acid (delta mass:176.032)',CCMSLIB00005775082,176.03,2492,Drug_suspect,mycophenolic acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-RUDMXATFSA-N
CCMSLIB00012724853,"related spectra of 'massbank:au271506 tamoxifen|2-[4-[(z)-1,2-diphenylbut-1-enyl]phenoxy]-n,n-dimethylethanamine (delta mass:-14.016)'",CCMSLIB00005777055,-14.02,2493,Drug_suspect,tamoxifen,estrogen agonist/antagonist,oncology,breast cancer,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),NKANXQFJJICGDU-QPLCGJKRSA-N
CCMSLIB00012724854,related spectra of 'massbank:au271803 enalapril|(2s)-1-[(2s)-2-[[(2s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid (delta mass:15.995)',CCMSLIB00005772614,15.99,2494,Drug_suspect,enalapril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,GBXSMTUPTTWBMN-XIRDDKMYSA-N
CCMSLIB00012724855,related spectra of 'massbank:au274104 hydroxychloroquine|2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol (delta mass:13.98)',CCMSLIB00005776717,13.98,2495,Drug_suspect,hydroxychloroquine,antirheumatic|antimalarial,infectious disease|rheumatology,malaria|rheumatoid arthritis|lupus,antimalarial agent,XXSMGPRMXLTPCZ-UHFFFAOYSA-N
CCMSLIB00012724856,related spectra of 'massbank:au274106 hydroxychloroquine|2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol (delta mass:-28.031)',CCMSLIB00005774546,-28.03,2496,Drug_suspect,hydroxychloroquine,antirheumatic|antimalarial,infectious disease|rheumatology,malaria|rheumatoid arthritis|lupus,antimalarial agent,XXSMGPRMXLTPCZ-UHFFFAOYSA-N
CCMSLIB00012724857,related spectra of 'massbank:au274106 hydroxychloroquine|2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol (delta mass:13.98)',CCMSLIB00005774546,13.98,2497,Drug_suspect,hydroxychloroquine,antirheumatic|antimalarial,infectious disease|rheumatology,malaria|rheumatoid arthritis|lupus,antimalarial agent,XXSMGPRMXLTPCZ-UHFFFAOYSA-N
CCMSLIB00012724858,related spectra of 'massbank:au274503 montelukast|uchdwcpvspxumx-uhfffaoysa-n|2-[1-[[1-[3-[2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid (delta mass:15.975)',CCMSLIB00005773332,15.97,2498,Drug_suspect,montelukast,leukotriene receptor antagonist (LTRA),pulmonary|allergy,asthma|allergic rhinitis|exercise-induced bronchoconstriction (EIB),leukotriene receptor antagonist,UCHDWCPVSPXUMX-UHFFFAOYSA-N
CCMSLIB00012724859,related spectra of 'massbank:au274503 montelukast|uchdwcpvspxumx-uhfffaoysa-n|2-[1-[[1-[3-[2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid (delta mass:15.995)',CCMSLIB00005773332,15.99,2499,Drug_suspect,montelukast,leukotriene receptor antagonist (LTRA),pulmonary|allergy,asthma|allergic rhinitis|exercise-induced bronchoconstriction (EIB),leukotriene receptor antagonist,UCHDWCPVSPXUMX-UHFFFAOYSA-N
CCMSLIB00012724860,related spectra of 'massbank:au274504 montelukast|uchdwcpvspxumx-uhfffaoysa-n|2-[1-[[1-[3-[2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid (delta mass:15.995)',CCMSLIB00005776867,15.99,2500,Drug_suspect,montelukast,leukotriene receptor antagonist (LTRA),pulmonary|allergy,asthma|allergic rhinitis|exercise-induced bronchoconstriction (EIB),leukotriene receptor antagonist,UCHDWCPVSPXUMX-UHFFFAOYSA-N
CCMSLIB00012724861,related spectra of 'massbank:au274506 montelukast|uchdwcpvspxumx-uhfffaoysa-n|2-[1-[[1-[3-[2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid (delta mass:15.995)',CCMSLIB00005775466,15.99,2501,Drug_suspect,montelukast,leukotriene receptor antagonist (LTRA),pulmonary|allergy,asthma|allergic rhinitis|exercise-induced bronchoconstriction (EIB),leukotriene receptor antagonist,UCHDWCPVSPXUMX-UHFFFAOYSA-N
CCMSLIB00012724862,"related spectra of 'massbank:au274704 ziprasidone|5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one (delta mass:31.99)'",CCMSLIB00005776391,31.99,2502,Drug_suspect,ziprasidone,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,MVWVFYHBGMAFLY-UHFFFAOYSA-N
CCMSLIB00012724863,"related spectra of 'massbank:au281002 6a_methylprednisolone|methylprednisolone|(6s,8s,9s,10r,11s,13s,14s,17r)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-one (delta mass:13.98)'",CCMSLIB00005774455,13.98,2503,Drug_suspect,methylprednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,VHRSUDSXCMQTMA-PJHHCJLFSA-N
CCMSLIB00012724864,"related spectra of 'massbank:au283003 desonide|(1s,2s,4r,8s,9s,11s,12s,13r)-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one (delta mass:-40.032)'",CCMSLIB00005775479,-40.03,2504,Drug_suspect,desonide,corticosteroid,dermatology,corticosteroid-responsive dermatoses,glucocorticoid receptor agonist,WBGKWQHBNHJJPZ-LECWWXJVSA-N
CCMSLIB00012724865,"related spectra of 'massbank:au283003 desonide|(1s,2s,4r,8s,9s,11s,12s,13r)-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one (delta mass:-18.011)'",CCMSLIB00005775479,-18.01,2505,Drug_suspect,desonide,corticosteroid,dermatology,corticosteroid-responsive dermatoses,glucocorticoid receptor agonist,WBGKWQHBNHJJPZ-LECWWXJVSA-N
CCMSLIB00012724866,"related spectra of 'massbank:au283003 desonide|(1s,2s,4r,8s,9s,11s,12s,13r)-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one (delta mass:-14.016)'",CCMSLIB00005775479,-14.02,2506,Drug_suspect,desonide,corticosteroid,dermatology,corticosteroid-responsive dermatoses,glucocorticoid receptor agonist,WBGKWQHBNHJJPZ-LECWWXJVSA-N
CCMSLIB00012724867,"related spectra of 'massbank:au283003 desonide|(1s,2s,4r,8s,9s,11s,12s,13r)-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one (delta mass:13.98)'",CCMSLIB00005775479,13.98,2507,Drug_suspect,desonide,corticosteroid,dermatology,corticosteroid-responsive dermatoses,glucocorticoid receptor agonist,WBGKWQHBNHJJPZ-LECWWXJVSA-N
CCMSLIB00012724868,"related spectra of 'massbank:au283003 desonide|(1s,2s,4r,8s,9s,11s,12s,13r)-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one (delta mass:42.01)'",CCMSLIB00005775479,42.01,2508,Drug_suspect,desonide,corticosteroid,dermatology,corticosteroid-responsive dermatoses,glucocorticoid receptor agonist,WBGKWQHBNHJJPZ-LECWWXJVSA-N
CCMSLIB00012724869,"related spectra of 'massbank:au283104 fluticasone propionate|[(6s,8s,9r,10s,11s,13s,14s,16r,17r)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17- (delta mass:1.003)'",CCMSLIB00005772951,1,2509,Drug_suspect,fluticasone propionate,corticosteroid,dermatology|pulmonary|allergy,corticosteroid-responsive dermatoses|asthma|COPD|allergic rhinitis|nonallergic rhinitis,glucocorticoid receptor agonist,WMWTYOKRWGGJOA-CENSZEJFSA-N
CCMSLIB00012724870,"related spectra of 'massbank:ea018110 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide|4-amino-n-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide (delta mass:2.004)'",CCMSLIB00000207281,2,2510,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012724871,"related spectra of 'massbank:ea018355 sulfadimethoxine|4-amino-n-(2,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide (delta mass:1.003)'",CCMSLIB00005730395,1,2511,Drug_suspect|Background/QAQC,sulfadimethoxine,sulfonamide antimicrobial|veterinary,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,dihydropteroate synthetase inhibitor,ZZORFUFYDOWNEF-UHFFFAOYSA-N
CCMSLIB00012724872,"related spectra of 'massbank:ea019009 azithromycin|(2r,3s,4r,5r,8r,10r,11r,13s,14r)-11-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl] (delta mass:-15.995)'",CCMSLIB00000207350,-15.99,2512,Drug_suspect,azithromycin,macrolide antimicrobial,infectious disease,pelvic inflammatory disease|pneumonia|urethritis|cervicitis|sinusitis,bacterial 50S ribosomal subunit inhibitor,MQTOSJVFKKJCRP-OHJWJPDZSA-N
CCMSLIB00012724873,"related spectra of 'massbank:ea019102 clarithromycin|6-o-methylerythromycin|(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyl- (delta mass:-36.021)'",CCMSLIB00000207357,-36.02,2513,Drug_suspect,clarithromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis,bacterial 50S ribosomal subunit inhibitor,AGOYDEPGAOXOCK-AVDMLEEESA-N
CCMSLIB00012724874,"related spectra of 'massbank:ea019102 clarithromycin|6-o-methylerythromycin|(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyl- (delta mass:-30.01)'",CCMSLIB00000207357,-30.01,2514,Drug_suspect,clarithromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis,bacterial 50S ribosomal subunit inhibitor,AGOYDEPGAOXOCK-AVDMLEEESA-N
CCMSLIB00012724875,"related spectra of 'massbank:ea019102 clarithromycin|6-o-methylerythromycin|(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyl- (delta mass:-18.011)'",CCMSLIB00000207357,-18.01,2515,Drug_suspect,clarithromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis,bacterial 50S ribosomal subunit inhibitor,AGOYDEPGAOXOCK-AVDMLEEESA-N
CCMSLIB00012724876,"related spectra of 'massbank:ea019102 clarithromycin|6-o-methylerythromycin|(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyl- (delta mass:14.016)'",CCMSLIB00000207357,14.02,2516,Drug_suspect,clarithromycin,macrolide antimicrobial,infectious disease,pharyngitis|tonsillitis|sinusitis|bronchitis|pneumonia|skin infections|otitis,bacterial 50S ribosomal subunit inhibitor,AGOYDEPGAOXOCK-AVDMLEEESA-N
CCMSLIB00012724877,"related spectra of 'massbank:ea019910 trimethoprim|2,4-diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine (delta mass:14.016)'",CCMSLIB00000207449,14.02,2517,Drug_suspect,trimethoprim,dihydrofolate reductase inhibitor antibacterial,infectious disease,urinary tract infections|ear infections|gastrointestinal infections,dihydrofolate reductase inhibitor,IEDVJHCEMCRBQM-UHFFFAOYSA-N
CCMSLIB00012724878,related spectra of 'massbank:ea023409 sulfapyridine|2-sulfapyridine|4-amino-n-(2-pyridinyl)benzenesulfonamide (delta mass:42.01)',CCMSLIB00000207633,42.01,2518,Drug_suspect,sulfapyridine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,GECHUMIMRBOMGK-UHFFFAOYSA-N
CCMSLIB00012724879,"related spectra of 'massbank:ea024103 iopamidol|1,3-benzenedicarboxamide, n,n'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-((2-hydroxy-1-oxopropyl)amino)-2,4,6-triiodo-|1-n,3-n-bis(1,3-dihydroxypropan-2-yl)-5-(2-hydroxypropanoylamino)-2,4,6-t (delta mass:17.027)'",CCMSLIB00000207683,17.03,2519,Drug_suspect,iopamidol,radiographic contrast agent,radiology,contrast agent,radiopaque medium,XQZXYNRDCRIARQ-UHFFFAOYSA-N
CCMSLIB00012724880,"related spectra of 'massbank:ea024504 n4-acetylsulfadimethoxine|n-[4-[(4,6-dimethoxy-2-pyrimidinyl)sulfamoyl]phenyl]acetamide (delta mass:-14.016)'",CCMSLIB00000207725,-14.02,2520,Drug_suspect|Background/QAQC,n(4)-acetylsulfadimethoxine,sulfonamide antimicrobial|veterinary,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,dihydropteroate synthetase inhibitor,DQWIIKBKAIPUPY-UHFFFAOYSA-N
CCMSLIB00012724881,related spectra of 'massbank:ea024810 n4-acetylsulfadiazine|n-[4-(2-pyrimidinylsulfamoyl)phenyl]acetamide (delta mass:-0.984)',CCMSLIB00000207759,-0.98,2521,Drug_suspect,n-acetyl sulfadiazine,sulfonamide antibacterial,infectious disease,malaria|meningitis|urinary tract infections|conjunctivitis|trachoma|chancroid,bacterial antifolate,NJIZUWGMNCUKGU-UHFFFAOYSA-N
CCMSLIB00012724882,"related spectra of 'massbank:ea029909 n4-acetylsulfamethoxazole|n-[4-[(5-methyl-1,2-oxazol-3-yl)sulfamoyl]phenyl]acetamide (delta mass:14.016)'",CCMSLIB00000208226,14.02,2522,Drug_suspect,acetylsulfamethoxazole,sulfonamide antimicrobial,infectious disease,pneumonia|enteritis|urinary tract infections,PABA antagonist,GXPIUNZCALHVBA-UHFFFAOYSA-N
CCMSLIB00012724883,related spectra of 'massbank:ea069704 atenolol acid|metoprolol acid|4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetic acid (delta mass:14.016)',CCMSLIB00000208971,14.02,2523,Drug_suspect,metoprolol acid,beta-adrenergic receptor inhibitor,cardiology,hypertension|angina pectoris|myocardial infarction,adrenergic receptor antagonist,PUQIRTNPJRFRCZ-UHFFFAOYSA-N
CCMSLIB00012724884,related spectra of 'massbank:ea069714 atenolol acid|metoprolol acid|4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetic acid (delta mass:14.016)',CCMSLIB00000208991,14.02,2524,Drug_suspect,metoprolol acid,beta-adrenergic receptor inhibitor,cardiology,hypertension|angina pectoris|myocardial infarction,adrenergic receptor antagonist,PUQIRTNPJRFRCZ-UHFFFAOYSA-N
CCMSLIB00012724885,related spectra of 'massbank:ea103405 n-desmethylvenlafaxine|1-[1-(4-methoxyphenyl)-2-(methylamino)ethyl]-1-cyclohexanol (delta mass:-3.995)',CCMSLIB00000209371,-3.99,2525,Drug_suspect,n-desmethylvenlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,MKAFOJAJJMUXLW-UHFFFAOYSA-N
CCMSLIB00012724886,"related spectra of 'massbank:ea103811 4-formylaminoantipyrine|n-(1,5-dimethyl-3-oxidanylidene-2-phenyl-pyrazol-4-yl)methanamide (delta mass:14.016)'",CCMSLIB00000209413,14.02,2526,Drug_suspect,4-formylaminoantipyrine,other analgesics and antipyretics,neurology/psychiatry,pain relief,cyclooxygenase inhibitor,WSJBSKRPKADYRQ-UHFFFAOYSA-N
CCMSLIB00012724887,related spectra of 'massbank:ea105304 o-desmethylvenlafaxine|desvenlafaxine|4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol (delta mass:176.032)',CCMSLIB00000209427,176.03,2527,Drug_suspect,desvenlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression,serotonin and norepinephrine reuptake inhibitor (SNRI),KYYIDSXMWOZKMP-UHFFFAOYSA-N
CCMSLIB00012724888,related spectra of 'massbank:ea256110 gabapentin|1-(aminomethyl)cyclohexaneacetic acid| 2-[1-(aminomethyl)cyclohexyl]acetic acid (delta mass:15.995)',CCMSLIB00000209584,15.99,2528,Drug_suspect|Low_confidence,gabapentin,antiepileptic drug (AED),neurology/psychiatry,neuropathic pain|shingles|seizures|restless leg syndrome,calcium channel blocker,UGJMXCAKCUNAIE-UHFFFAOYSA-N
CCMSLIB00012724889,related spectra of 'massbank:ea256110 gabapentin|1-(aminomethyl)cyclohexaneacetic acid| 2-[1-(aminomethyl)cyclohexyl]acetic acid (delta mass:42.01)',CCMSLIB00000209584,42.01,2529,Drug_suspect|Low_confidence,gabapentin,antiepileptic drug (AED),neurology/psychiatry,neuropathic pain|shingles|seizures|restless leg syndrome,calcium channel blocker,UGJMXCAKCUNAIE-UHFFFAOYSA-N
CCMSLIB00012724788,"related spectra of 'massbank:au217909 darunavir|[(3as,4r,6ar)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] n-[(2s,3r)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate (delta mass:15.995)'",CCMSLIB00005772118,15.99,2428,Drug_suspect,darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-HEXNFIEUSA-N
CCMSLIB00012724891,"related spectra of 'massbank:ea262110 methylprednisolone|(6alpha,11beta)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|(6s,8s,9s,10r,11s,13s,14s,17r)-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-6,10,13-trimethyl-7,8,9,11,12,14,15, (delta mass:-2.016)'",CCMSLIB00000209927,-2.02,2531,Drug_suspect,methylprednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,VHRSUDSXCMQTMA-PJHHCJLFSA-N
CCMSLIB00012724892,"related spectra of 'massbank:ea262110 methylprednisolone|(6alpha,11beta)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione|(6s,8s,9s,10r,11s,13s,14s,17r)-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-6,10,13-trimethyl-7,8,9,11,12,14,15, (delta mass:13.98)'",CCMSLIB00000209927,13.98,2532,Drug_suspect,methylprednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,VHRSUDSXCMQTMA-PJHHCJLFSA-N
CCMSLIB00012724893,"related spectra of 'massbank:ea263704 d617|verapamil metabolite d617|2-(3,4-dimethoxyphenyl)-2-isopropyl-5-(methylamino)valeronitrile (delta mass:-14.016)'",CCMSLIB00000209971,-14.02,2533,Drug_suspect,d-617 (verapamil metabolite),nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris|arrhythmia,calcium channel blocker,WLOBUUJURNEQCL-UHFFFAOYSA-N
CCMSLIB00012724894,"related spectra of 'massbank:ea263705 d617|verapamil metabolite d617|2-(3,4-dimethoxyphenyl)-2-isopropyl-5-(methylamino)valeronitrile (delta mass:-14.016)'",CCMSLIB00000209973,-14.02,2534,Drug_suspect,d-617 (verapamil metabolite),nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris|arrhythmia,calcium channel blocker,WLOBUUJURNEQCL-UHFFFAOYSA-N
CCMSLIB00012724895,"related spectra of 'massbank:ea267611 lamotrigine|6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine (delta mass:1.003)'",CCMSLIB00000210214,1,2535,Drug_suspect,lamotrigine,antiepileptic drug (AED)|mood stabilizer,neurology/psychiatry,epilepsy|bipolar disorder,serotonin receptor antagonist|sodium channel blocker,PYZRQGJRPPTADH-UHFFFAOYSA-N
CCMSLIB00012724896,"related spectra of 'massbank:ea270914 imidacloprid|n-[1-[(6-chloranylpyridin-3-yl)methyl]-4,5-dihydroimidazol-2-yl]nitramide (delta mass:2.004)'",CCMSLIB00000210421,2,2536,Drug_suspect,imidacloprid,insecticide,infectious disease,fleas,acetylcholine receptor antagonist,YWTYJOPNNQFBPC-UHFFFAOYSA-N
CCMSLIB00012724897,"related spectra of 'massbank:ea277403 irbesartan|8-butyl-7-[4-[2-(2h-tetrazol-5-yl)phenyl]benzyl]-7,9-diazaspiro[4.4]non-8-en-6-one (delta mass:-2.016)'",CCMSLIB00000210858,-2.02,2537,Drug_suspect,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012724898,"related spectra of 'massbank:ea277403 irbesartan|8-butyl-7-[4-[2-(2h-tetrazol-5-yl)phenyl]benzyl]-7,9-diazaspiro[4.4]non-8-en-6-one (delta mass:13.98)'",CCMSLIB00000210858,13.98,2538,Drug_suspect,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012724899,"related spectra of 'massbank:ea277403 irbesartan|8-butyl-7-[4-[2-(2h-tetrazol-5-yl)phenyl]benzyl]-7,9-diazaspiro[4.4]non-8-en-6-one (delta mass:15.995)'",CCMSLIB00000210858,15.99,2539,Drug_suspect,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012724900,"related spectra of 'massbank:ea277403 irbesartan|8-butyl-7-[4-[2-(2h-tetrazol-5-yl)phenyl]benzyl]-7,9-diazaspiro[4.4]non-8-en-6-one (delta mass:29.974)'",CCMSLIB00000210858,29.97,2540,Drug_suspect,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012724901,"related spectra of 'massbank:ea277403 irbesartan|8-butyl-7-[4-[2-(2h-tetrazol-5-yl)phenyl]benzyl]-7,9-diazaspiro[4.4]non-8-en-6-one (delta mass:31.99)'",CCMSLIB00000210858,31.99,2541,Drug_suspect,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012724902,"related spectra of 'massbank:ea280204 rosuvastatin|(e,3r,5r)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid (delta mass:14.016)'",CCMSLIB00000211136,14.02,2542,Drug_suspect,rosuvastatin,HMG-CoA reductase inhibitor (statin),endocrinology|cardiology|neurology/psychiatry,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,BPRHUIZQVSMCRT-YXWZHEERSA-N
CCMSLIB00012724903,"related spectra of 'massbank:ea280210 rosuvastatin|(e,3r,5r)-7-[4-(4-fluorophenyl)-2-(methyl-methylsulfonylamino)-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid (delta mass:14.016)'",CCMSLIB00000211149,14.02,2543,Drug_suspect,rosuvastatin,HMG-CoA reductase inhibitor (statin),endocrinology|cardiology|neurology/psychiatry,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,BPRHUIZQVSMCRT-YXWZHEERSA-N
CCMSLIB00012724904,related spectra of 'massbank:ea280811 mycophenolic acid| (e)-6-(4-hydroxy-3-keto-6-methoxy-7-methyl-phthalan-5-yl)-4-methyl-hex-4-enoic acid (delta mass:-18.011)',CCMSLIB00000211262,-18.01,2544,Drug_suspect,mycophenolic acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-RUDMXATFSA-N
CCMSLIB00012724905,"related spectra of 'massbank:ea281704 cocaine| (1s,3s,4r,5r)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylic acid methyl ester (delta mass:15.995)'",CCMSLIB00000211401,15.99,2545,Drug_suspect,cocaine,central nervous system stimulant,drug of abuse,psychostimulant,monoamine transporter inhibitor,ZPUCINDJVBIVPJ-UHFFFAOYSA-N
CCMSLIB00012724906,"related spectra of 'massbank:ea281710 cocaine| (1s,3s,4r,5r)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylic acid methyl ester (delta mass:-42.01)'",CCMSLIB00000211410,-42.01,2546,Drug_suspect,cocaine,central nervous system stimulant,drug of abuse,psychostimulant,monoamine transporter inhibitor,ZPUCINDJVBIVPJ-UHFFFAOYSA-N
CCMSLIB00012724907,"related spectra of 'massbank:ea282104 amitriptyline|3-(10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethyl-1-propanamine (delta mass:15.995)'",CCMSLIB00000211508,15.99,2547,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724908,"related spectra of 'massbank:ea282105 amitriptyline|3-(10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethyl-1-propanamine (delta mass:15.995)'",CCMSLIB00000211510,15.99,2548,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724909,"related spectra of 'massbank:ea282106 amitriptyline|3-(10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethyl-1-propanamine (delta mass:0.984)'",CCMSLIB00000211512,0.98,2549,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724910,"related spectra of 'massbank:ea282106 amitriptyline|3-(10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethyl-1-propanamine (delta mass:14.016)'",CCMSLIB00000211512,14.02,2550,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724911,"related spectra of 'massbank:ea282109 amitriptyline|3-(10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethyl-1-propanamine (delta mass:15.995)'",CCMSLIB00000211519,15.99,2551,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724912,"related spectra of 'massbank:ea282110 amitriptyline|3-(10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethyl-1-propanamine (delta mass:-4.031)'",CCMSLIB00000211521,-4.03,2552,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724913,"related spectra of 'massbank:ea282110 amitriptyline|3-(10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethyl-1-propanamine (delta mass:-0.984)'",CCMSLIB00000211521,-0.98,2553,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724914,"related spectra of 'massbank:ea282110 amitriptyline|3-(10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethyl-1-propanamine (delta mass:0.984)'",CCMSLIB00000211521,0.98,2554,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724915,"related spectra of 'massbank:ea282110 amitriptyline|3-(10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethyl-1-propanamine (delta mass:1.003)'",CCMSLIB00000211521,1,2555,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724916,"related spectra of 'massbank:ea282110 amitriptyline|3-(10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethyl-1-propanamine (delta mass:15.995)'",CCMSLIB00000211521,15.99,2556,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724917,"related spectra of 'massbank:ea282111 amitriptyline|3-(10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethyl-1-propanamine (delta mass:0.984)'",CCMSLIB00000211523,0.98,2557,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724918,"related spectra of 'massbank:ea282111 amitriptyline|3-(10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethyl-1-propanamine (delta mass:13.98)'",CCMSLIB00000211523,13.98,2558,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724919,"related spectra of 'massbank:ea282111 amitriptyline|3-(10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethyl-1-propanamine (delta mass:15.995)'",CCMSLIB00000211523,15.99,2559,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724920,"related spectra of 'massbank:ea282112 amitriptyline|3-(10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethyl-1-propanamine (delta mass:-28.031)'",CCMSLIB00000211525,-28.03,2560,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724921,"related spectra of 'massbank:ea282112 amitriptyline|3-(10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethyl-1-propanamine (delta mass:-4.031)'",CCMSLIB00000211525,-4.03,2561,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724922,"related spectra of 'massbank:ea282112 amitriptyline|3-(10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethyl-1-propanamine (delta mass:1.003)'",CCMSLIB00000211525,1,2562,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724923,"related spectra of 'massbank:ea282112 amitriptyline|3-(10,11-dihydro-5h-dibenzo[a,d][7]annulen-5-ylidene)-n,n-dimethyl-1-propanamine (delta mass:15.995)'",CCMSLIB00000211525,15.99,2563,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724924,related spectra of 'massbank:ea282407 dextromethorphan|dxm|(14alpha)-3-methoxy-17-methylmorphinan (delta mass:15.995)',CCMSLIB00000211598,15.99,2564,Drug_suspect,dextromethorphan,uncompetitive NMDA receptor antagonist|sigma-1 agonist,pulmonary,cough suppressant,glutamate receptor antagonist|sigma receptor agonist,MKXZASYAUGDDCJ-KBAYOESNSA-N
CCMSLIB00012724925,related spectra of 'massbank:ea282603 ketamine|2-(2-chlorophenyl)-2-(methylamino)-1-cyclohexanone (delta mass:1.993)',CCMSLIB00000211643,2,2565,Drug_suspect,ketamine,general anesthetic,neurology/psychiatry,anesthesia,NMDA receptor antagonist,YQEZLKZALYSWHR-UHFFFAOYSA-N
CCMSLIB00012724926,related spectra of 'massbank:ea282603 ketamine|2-(2-chlorophenyl)-2-(methylamino)-1-cyclohexanone (delta mass:12.0)',CCMSLIB00000211643,12,2566,Drug_suspect,ketamine,general anesthetic,neurology/psychiatry,anesthesia,NMDA receptor antagonist,YQEZLKZALYSWHR-UHFFFAOYSA-N
CCMSLIB00012724927,related spectra of 'massbank:ea282605 ketamine|2-(2-chlorophenyl)-2-(methylamino)-1-cyclohexanone (delta mass:1.978)',CCMSLIB00000211647,1.98,2567,Drug_suspect,ketamine,general anesthetic,neurology/psychiatry,anesthesia,NMDA receptor antagonist,YQEZLKZALYSWHR-UHFFFAOYSA-N
CCMSLIB00012724928,related spectra of 'massbank:ea282605 ketamine|2-(2-chlorophenyl)-2-(methylamino)-1-cyclohexanone (delta mass:1.993)',CCMSLIB00000211647,2,2568,Drug_suspect,ketamine,general anesthetic,neurology/psychiatry,anesthesia,NMDA receptor antagonist,YQEZLKZALYSWHR-UHFFFAOYSA-N
CCMSLIB00012724929,related spectra of 'massbank:ea282611 ketamine|2-(2-chlorophenyl)-2-(methylamino)-1-cyclohexanone (delta mass:2.004)',CCMSLIB00000211660,2,2569,Drug_suspect,ketamine,general anesthetic,neurology/psychiatry,anesthesia,NMDA receptor antagonist,YQEZLKZALYSWHR-UHFFFAOYSA-N
CCMSLIB00012724930,related spectra of 'massbank:ea282611 ketamine|2-(2-chlorophenyl)-2-(methylamino)-1-cyclohexanone (delta mass:13.98)',CCMSLIB00000211660,13.98,2570,Drug_suspect,ketamine,general anesthetic,neurology/psychiatry,anesthesia,NMDA receptor antagonist,YQEZLKZALYSWHR-UHFFFAOYSA-N
CCMSLIB00012724931,related spectra of 'massbank:ea282611 ketamine|2-(2-chlorophenyl)-2-(methylamino)-1-cyclohexanone (delta mass:15.995)',CCMSLIB00000211660,15.99,2571,Drug_suspect,ketamine,general anesthetic,neurology/psychiatry,anesthesia,NMDA receptor antagonist,YQEZLKZALYSWHR-UHFFFAOYSA-N
CCMSLIB00012724932,"related spectra of 'massbank:eq022902 octocrylene|[(2r)-2-ethylhexyl] 2-cyano-3,3-diphenylprop-2-enoate (delta mass:17.027)'",CCMSLIB00005734697,17.03,2572,Drug_suspect,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-LJQANCHMSA-N
CCMSLIB00012724933,"related spectra of 'massbank:eq022903 octocrylene|[(2r)-2-ethylhexyl] 2-cyano-3,3-diphenylprop-2-enoate (delta mass:17.027)'",CCMSLIB00005734462,17.03,2573,Drug_suspect,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-LJQANCHMSA-N
CCMSLIB00012724934,"related spectra of 'massbank:eq022903 octocrylene|[(2r)-2-ethylhexyl] 2-cyano-3,3-diphenylprop-2-enoate (delta mass:30.01)'",CCMSLIB00005734462,30.01,2574,Drug_suspect,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-LJQANCHMSA-N
CCMSLIB00012724935,"related spectra of 'massbank:eq279402 losartan|[2-butyl-5-chloranyl-3-[[4-[2-(2h-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol (delta mass:15.995)'",CCMSLIB00005736096,15.99,2575,Drug_suspect,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012724789,"related spectra of 'massbank:au219204 ritonavir|1,3-thiazol-5-ylmethyl n-[(2s,3s,5s)-3-hydroxy-5-[[(2s)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate (delta mass:-15.979)'",CCMSLIB00005775952,-15.98,2429,Drug_suspect,ritonavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,NCDNCNXCDXHOMX-XGKFQTDJSA-N
CCMSLIB00012724790,"related spectra of 'massbank:au219204 ritonavir|1,3-thiazol-5-ylmethyl n-[(2s,3s,5s)-3-hydroxy-5-[[(2s)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate (delta mass:15.995)'",CCMSLIB00005775952,15.99,2430,Drug_suspect,ritonavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,NCDNCNXCDXHOMX-XGKFQTDJSA-N
CCMSLIB00012724791,"related spectra of 'massbank:au219204 ritonavir|1,3-thiazol-5-ylmethyl n-[(2s,3s,5s)-3-hydroxy-5-[[(2s)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate (delta mass:176.032)'",CCMSLIB00005775952,176.03,2431,Drug_suspect,ritonavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,NCDNCNXCDXHOMX-XGKFQTDJSA-N
CCMSLIB00012724792,"related spectra of 'massbank:au219234 ritonavir|1,3-thiazol-5-ylmethyl n-[(2s,3s,5s)-3-hydroxy-5-[[(2s)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate (delta mass:-14.016)'",CCMSLIB00005774145,-14.02,2432,Drug_suspect,ritonavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,NCDNCNXCDXHOMX-XGKFQTDJSA-N
CCMSLIB00012724808,"related spectra of 'massbank:au228803 lopinavir|(2s)-n-[(2s,4s,5s)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide (delta mass:-2.016)'",CCMSLIB00005775758,-2.02,2448,Drug_suspect,lopinavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,KJHKTHWMRKYKJE-SUGCFTRWSA-N
CCMSLIB00012724941,"related spectra of 'massbank:eq301701 diltiazem|1,5-benzothiazepin-4(5h)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, (2s-cis)-|[5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxidanylidene-2,3-dihydro-1 (delta mass:-42.01)'",CCMSLIB00005730493,-42.01,2581,Drug_suspect,diltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,HSUGRBWQSSZJOP-UHFFFAOYSA-N
CCMSLIB00012724942,"related spectra of 'massbank:eq301701 diltiazem|1,5-benzothiazepin-4(5h)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, (2s-cis)-|[5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxidanylidene-2,3-dihydro-1 (delta mass:-14.016)'",CCMSLIB00005730493,-14.02,2582,Drug_suspect,diltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,HSUGRBWQSSZJOP-UHFFFAOYSA-N
CCMSLIB00012724943,"related spectra of 'massbank:eq301702 diltiazem|1,5-benzothiazepin-4(5h)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, (2s-cis)-|[5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxidanylidene-2,3-dihydro-1 (delta mass:-14.016)'",CCMSLIB00005736434,-14.02,2583,Drug_suspect,diltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,HSUGRBWQSSZJOP-UHFFFAOYSA-N
CCMSLIB00012724944,"related spectra of 'massbank:eq301702 diltiazem|1,5-benzothiazepin-4(5h)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, (2s-cis)-|[5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxidanylidene-2,3-dihydro-1 (delta mass:15.995)'",CCMSLIB00005736434,15.99,2584,Drug_suspect,diltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,HSUGRBWQSSZJOP-UHFFFAOYSA-N
CCMSLIB00012724945,"related spectra of 'massbank:eq307052 chloramphenicol|clm|2,2-bis(chloranyl)-n-[(1r,2r)-1-(4-nitrophenyl)-1,3-bis(oxidanyl)propan-2-yl]ethanamide (delta mass:3.995)'",CCMSLIB00005736199,3.99,2585,Drug_suspect,chloramphenicol,amphenicol class antibacterial,infectious disease,meningitis|cholera|bacterial conjunctivitis,bacterial 50S ribosomal subunit inhibitor,WIIZWVCIJKGZOK-RKDXNWHRSA-N
CCMSLIB00012724946,related spectra of 'massbank:eq307304 ofloxacin|dl-8280 (delta mass:-43.99)',CCMSLIB00005732545,-43.99,2586,Drug_suspect,ofloxacin,fluoroquinolone antimicrobial,infectious disease,pneumonia|sinusitis|bronchitis|skin infections|prostatitis|urinary tract infections|pyelonephritis|anthrax|plague|gram-negative bacterial infections|gram-positive bacterial infections,bacterial DNA gyrase inhibitor,GSDSWSVVBLHKDQ-UHFFFAOYSA-N
CCMSLIB00012724947,related spectra of 'massbank:eq307304 ofloxacin|dl-8280 (delta mass:-14.016)',CCMSLIB00005732545,-14.02,2587,Drug_suspect,ofloxacin,fluoroquinolone antimicrobial,infectious disease,pneumonia|sinusitis|bronchitis|skin infections|prostatitis|urinary tract infections|pyelonephritis|anthrax|plague|gram-negative bacterial infections|gram-positive bacterial infections,bacterial DNA gyrase inhibitor,GSDSWSVVBLHKDQ-UHFFFAOYSA-N
CCMSLIB00012724948,"related spectra of 'massbank:eq307703 spiramycin|2-[(4r,5s,6s,7r,9r,10r,16r)-6-[4-(dimethylamino)-5-[4,6-dimethyl-4,5-bis(oxidanyl)oxan-2-yl]oxy-6-methyl-3-oxidanyl-oxan-2-yl]oxy-10-[5-(dimethylamino)-6-methyl-oxan-2-yl]oxy-5-methoxy-9,16 (delta mass:12.0)'",CCMSLIB00005731826,12,2588,Drug_suspect,spiramycin,macrolide antimicrobial,infectious disease,toxoplasmosis|soft tissue infection,bacterial 50S ribosomal subunit inhibitor,ACTOXUHEUCPTEW-JMRHEKERSA-N
CCMSLIB00012724949,"related spectra of 'massbank:eq307703 spiramycin|2-[(4r,5s,6s,7r,9r,10r,16r)-6-[4-(dimethylamino)-5-[4,6-dimethyl-4,5-bis(oxidanyl)oxan-2-yl]oxy-6-methyl-3-oxidanyl-oxan-2-yl]oxy-10-[5-(dimethylamino)-6-methyl-oxan-2-yl]oxy-5-methoxy-9,16 (delta mass:18.01)'",CCMSLIB00005731826,18.01,2589,Drug_suspect,spiramycin,macrolide antimicrobial,infectious disease,toxoplasmosis|soft tissue infection,bacterial 50S ribosomal subunit inhibitor,ACTOXUHEUCPTEW-JMRHEKERSA-N
CCMSLIB00012724950,"related spectra of 'massbank:eq308302 amoxicillin|amoxicillin anhydrous|(2s,5r,6r)-6-[[(2r)-2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (delta mass:-17.026)'",CCMSLIB00005733092,-17.03,2590,Drug_suspect,amoxicillin,penicillin class antibacterial,infectious disease,skin infections|duodenal ulcer disease|gonorrhea|ear infections|throat infections|genitourinary tract infections|respiratory tract infections,penicillin binding protein inhibitor,LSQZJLSUYDQPKJ-NJBDSQKTSA-N
CCMSLIB00012724951,"related spectra of 'massbank:eq308352 amoxicillin|amoxicillin anhydrous|(2s,5r,6r)-6-[[(2r)-2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (delta mass:-43.99)'",CCMSLIB00005732214,-43.99,2591,Drug_suspect,amoxicillin,penicillin class antibacterial,infectious disease,skin infections|duodenal ulcer disease|gonorrhea|ear infections|throat infections|genitourinary tract infections|respiratory tract infections,penicillin binding protein inhibitor,LSQZJLSUYDQPKJ-NJBDSQKTSA-N
CCMSLIB00012724952,"related spectra of 'massbank:eq313701 lansoprazole|2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1h-benzimidazole (delta mass:-15.995)'",CCMSLIB00005732129,-15.99,2592,Drug_suspect,lansoprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|erosive esophagitis (EE)|gastrointestinal ulcers|Zollinger-Ellison syndrome,ATPase inhibitor,MJIHNNLFOKEZEW-UHFFFAOYSA-N
CCMSLIB00012724953,"related spectra of 'massbank:eq313802 lorazepam|2h-1,4-benzodiazepin-2-one, 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-|7-chloranyl-5-(2-chlorophenyl)-3-oxidanyl-1,3-dihydro-1,4-benzodiazepin-2-one (delta mass:1.993)'",CCMSLIB00005730698,2,2593,Drug_suspect,lorazepam,benzodiazepine,neurology/psychiatry,anxiety|seizures|insomnia|anesthesia,GABA-A receptor agonist,DIWRORZWFLOCLC-UHFFFAOYSA-N
CCMSLIB00012724954,"related spectra of 'massbank:eq314001 nystatin|(1s,3r,4r,7r,9r,11r,15s,16r,17r,18s,19e,21e,25e,27e,29e,31e,33r,35s,36r,37s)-33-[(3-amino-3,6-dideoxy-?-d-mannopyranosyl)oxy]-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-di (delta mass:14.016)'",CCMSLIB00005730009,14.02,2594,Drug_suspect,nystatin,polyene antifungal,infectious disease,esophageal candidiasis|skin candida|yeast infection|oral candidiasis,fungal ergosterol inhibitor,VQOXZBDYSJBXMA-UHFFFAOYSA-N
CCMSLIB00012724955,"related spectra of 'massbank:eq320603 nafcillin|(2s,5r,6r)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (delta mass:18.01)'",CCMSLIB00005733626,18.01,2595,Drug_suspect,nafcillin,penicillin class antibacterial,infectious disease,gram-positive bacterial infections,bacterial cell wall synthesis inhibitor,GPXLMGHLHQJAGZ-JTDSTZFVSA-N
CCMSLIB00012724956,related spectra of 'massbank:eq327302 pramoxine|4-[3-(4-butoxyphenoxy)propyl]morpholine (delta mass:15.995)',CCMSLIB00005735097,15.99,2596,Drug_suspect,pramoxine,anesthetics for topical use,neurology/psychiatry,local anesthetic,topical anesthetic,DQKXQSGTHWVTAD-UHFFFAOYSA-N
CCMSLIB00012724957,related spectra of 'massbank:eq327302 pramoxine|4-[3-(4-butoxyphenoxy)propyl]morpholine (delta mass:29.974)',CCMSLIB00005735097,29.97,2597,Drug_suspect,pramoxine,anesthetics for topical use,neurology/psychiatry,local anesthetic,topical anesthetic,DQKXQSGTHWVTAD-UHFFFAOYSA-N
CCMSLIB00012724809,"related spectra of 'massbank:au228804 lopinavir|(2s)-n-[(2s,4s,5s)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide (delta mass:-2.016)'",CCMSLIB00005776948,-2.02,2449,Drug_suspect,lopinavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,KJHKTHWMRKYKJE-SUGCFTRWSA-N
CCMSLIB00012724959,related spectra of 'massbank:eq362701 lacosamide|n2-acetyl-n-benzyl-o-methyl-d-serinamide|2-acetamido-n-benzyl-3-methoxypropanamide (delta mass:-14.016)',CCMSLIB00005735123,-14.02,2599,Drug_suspect,lacosamide,other antiepileptics,neurology/psychiatry,seizures,sodium channel modulator,VPPJLAIAVCUEMN-UHFFFAOYSA-N
CCMSLIB00012724960,related spectra of 'massbank:eq362701 lacosamide|n2-acetyl-n-benzyl-o-methyl-d-serinamide|2-acetamido-n-benzyl-3-methoxypropanamide (delta mass:15.995)',CCMSLIB00005735123,15.99,2600,Drug_suspect,lacosamide,other antiepileptics,neurology/psychiatry,seizures,sodium channel modulator,VPPJLAIAVCUEMN-UHFFFAOYSA-N
CCMSLIB00012724961,"related spectra of 'massbank:eq362902 delta9-tetrahydrocannabinol|delta9-thc|6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol (delta mass:-28.031)'",CCMSLIB00005736746,-28.03,2601,Drug_suspect,dronabinol,cannabinoid,gastroenterology|neurology/psychiatry,anorexia|weight loss|nausea|vomiting,cannabinoid receptor agonist,CYQFCXCEBYINGO-UHFFFAOYSA-N
CCMSLIB00012724962,"related spectra of 'massbank:eq367603 doxepine|doxepin|3-(6h-benzo[c][1]benzoxepin-11-ylidene)-n,n-dimethylpropan-1-amine (delta mass:-14.016)'",CCMSLIB00005735291,-14.02,2602,Drug_suspect,doxepin,tricyclic antidepressant (TCA),neurology/psychiatry,depression|anxiety,histamine receptor antagonist,ODQWQRRAPPTVAG-UHFFFAOYSA-N
CCMSLIB00012724963,"related spectra of 'massbank:eq369203 nortriptyline|3-(5,6-dihydrodibenzo[2,1-b:2`,1`-f][7]annulen-11-ylidene)-n-methylpropan-1-amine (delta mass:-14.016)'",CCMSLIB00005730683,-14.02,2603,Drug_suspect,nortriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression,tricyclic antidepressant,PHVGLTMQBUFIQQ-UHFFFAOYSA-N
CCMSLIB00012724964,"related spectra of 'massbank:eq369203 nortriptyline|3-(5,6-dihydrodibenzo[2,1-b:2`,1`-f][7]annulen-11-ylidene)-n-methylpropan-1-amine (delta mass:29.995)'",CCMSLIB00005730683,29.99,2604,Drug_suspect,nortriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression,tricyclic antidepressant,PHVGLTMQBUFIQQ-UHFFFAOYSA-N
CCMSLIB00012724965,"related spectra of 'massbank:eq369203 nortriptyline|3-(5,6-dihydrodibenzo[2,1-b:2`,1`-f][7]annulen-11-ylidene)-n-methylpropan-1-amine (delta mass:30.01)'",CCMSLIB00005730683,30.01,2605,Drug_suspect,nortriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression,tricyclic antidepressant,PHVGLTMQBUFIQQ-UHFFFAOYSA-N
CCMSLIB00012724966,"related spectra of 'massbank:eq369204 nortriptyline|3-(5,6-dihydrodibenzo[2,1-b:2`,1`-f][7]annulen-11-ylidene)-n-methylpropan-1-amine (delta mass:30.01)'",CCMSLIB00005736187,30.01,2606,Drug_suspect,nortriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression,tricyclic antidepressant,PHVGLTMQBUFIQQ-UHFFFAOYSA-N
CCMSLIB00012724967,related spectra of 'massbank:fio00344 praziquantel (delta mass:-12.036)',CCMSLIB00000214089|CCMSLIB00000215570,-12.04,2607,Drug_suspect,praziquantel,anthelmintic,infectious disease,gastrointestinal parasites|cystic hydatid disease|schistosomiasis,anthelmintic agent,FSVJFNAIGNNGKK-UHFFFAOYSA-N
CCMSLIB00012724968,related spectra of 'massbank:fio00344 praziquantel (delta mass:15.995)',CCMSLIB00000214089|CCMSLIB00000215570,15.99,2608,Drug_suspect,praziquantel,anthelmintic,infectious disease,gastrointestinal parasites|cystic hydatid disease|schistosomiasis,anthelmintic agent,FSVJFNAIGNNGKK-UHFFFAOYSA-N
CCMSLIB00012724969,related spectra of 'massbank:fio00474 amitryptiline (delta mass:15.975)',CCMSLIB00000214320|CCMSLIB00000215807,15.97,2609,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724970,related spectra of 'massbank:fio00474 amitryptiline (delta mass:15.995)',CCMSLIB00000214320|CCMSLIB00000215807,15.99,2610,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724971,related spectra of 'massbank:fio00475 amitryptiline (delta mass:-28.031)',CCMSLIB00000214322|CCMSLIB00000215809,-28.03,2611,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724972,related spectra of 'massbank:fio00475 amitryptiline (delta mass:-4.031)',CCMSLIB00000214322|CCMSLIB00000215809,-4.03,2612,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724973,related spectra of 'massbank:fio00475 amitryptiline (delta mass:-2.016)',CCMSLIB00000214322|CCMSLIB00000215809,-2.02,2613,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724974,related spectra of 'massbank:fio00475 amitryptiline (delta mass:-0.984)',CCMSLIB00000214322|CCMSLIB00000215809,-0.98,2614,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724975,related spectra of 'massbank:fio00475 amitryptiline (delta mass:0.984)',CCMSLIB00000214322|CCMSLIB00000215809,0.98,2615,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724976,related spectra of 'massbank:fio00475 amitryptiline (delta mass:1.003)',CCMSLIB00000214322|CCMSLIB00000215809,1,2616,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724977,related spectra of 'massbank:fio00475 amitryptiline (delta mass:13.98)',CCMSLIB00000214322|CCMSLIB00000215809,13.98,2617,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724978,related spectra of 'massbank:fio00475 amitryptiline (delta mass:15.975)',CCMSLIB00000214322|CCMSLIB00000215809,15.97,2618,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724979,related spectra of 'massbank:fio00475 amitryptiline (delta mass:15.995)',CCMSLIB00000214322|CCMSLIB00000215809,15.99,2619,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724980,related spectra of 'massbank:fio00475 amitryptiline (delta mass:28.031)',CCMSLIB00000214322|CCMSLIB00000215809,28.03,2620,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724981,related spectra of 'massbank:fio00476 amitryptiline (delta mass:-28.031)',CCMSLIB00000214324|CCMSLIB00000215811,-28.03,2621,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724982,related spectra of 'massbank:fio00476 amitryptiline (delta mass:-2.016)',CCMSLIB00000214324|CCMSLIB00000215811,-2.02,2622,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724983,related spectra of 'massbank:fio00476 amitryptiline (delta mass:-0.984)',CCMSLIB00000214324|CCMSLIB00000215811,-0.98,2623,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724984,related spectra of 'massbank:fio00476 amitryptiline (delta mass:0.984)',CCMSLIB00000214324|CCMSLIB00000215811,0.98,2624,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724985,related spectra of 'massbank:fio00476 amitryptiline (delta mass:1.003)',CCMSLIB00000214324|CCMSLIB00000215811,1,2625,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724986,related spectra of 'massbank:fio00476 amitryptiline (delta mass:2.004)',CCMSLIB00000214324|CCMSLIB00000215811,2,2626,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724987,related spectra of 'massbank:fio00476 amitryptiline (delta mass:15.995)',CCMSLIB00000214324|CCMSLIB00000215811,15.99,2627,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012724988,related spectra of 'massbank:fio00897 mycophenolic-acid (delta mass:-18.011)',CCMSLIB00005777982,-18.01,2628,Drug_suspect,mycophenolic-acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-UHFFFAOYSA-N
CCMSLIB00012724989,related spectra of 'massbank:fio01037 xanthotoxin (delta mass:-13.98)',CCMSLIB00005777930,-13.98,2629,Drug_suspect,methoxsalen,photoactivated radical generator|psoralen,dermatology,psoriasis,DNA synthesis inhibitor,QXKHYNVANLEOEG-UHFFFAOYSA-N
CCMSLIB00012724990,related spectra of 'massbank:fio01037 xanthotoxin (delta mass:12.036)',CCMSLIB00005777930,12.04,2630,Drug_suspect,methoxsalen,photoactivated radical generator|psoralen,dermatology,psoriasis,DNA synthesis inhibitor,QXKHYNVANLEOEG-UHFFFAOYSA-N
CCMSLIB00012724991,related spectra of 'massbank:fio01106 carbamazepine (delta mass:45.985)',CCMSLIB00005777760,45.99,2631,Drug_suspect,carbamazepine,mood stabilizer,neurology/psychiatry,seizures|trigeminal neuralgia,carboxamide antiepileptic,FFGPTBGBLSHEPO-UHFFFAOYSA-N
CCMSLIB00012724992,related spectra of 'massbank:lqb00468 pc 28:0 (delta mass:-42.01)',CCMSLIB00005736934,-42.01,2632,Drug_suspect,dimyristoylphosphatidylcholine,no_match,no_match,no_match,no_match,CITHEXJVPOWHKC-UHFFFAOYSA-O
CCMSLIB00012724993,related spectra of 'massbank:lqb00468 pc 28:0 (delta mass:-28.031)',CCMSLIB00005736934,-28.03,2633,Drug_suspect,dimyristoylphosphatidylcholine,no_match,no_match,no_match,no_match,CITHEXJVPOWHKC-UHFFFAOYSA-O
CCMSLIB00012724994,related spectra of 'massbank:lqb00468 pc 28:0 (delta mass:14.016)',CCMSLIB00005736934,14.02,2634,Drug_suspect,dimyristoylphosphatidylcholine,no_match,no_match,no_match,no_match,CITHEXJVPOWHKC-UHFFFAOYSA-O
CCMSLIB00012724995,related spectra of 'massbank:lqb00468 pc 28:0 (delta mass:30.01)',CCMSLIB00005736934,30.01,2635,Drug_suspect,dimyristoylphosphatidylcholine,no_match,no_match,no_match,no_match,CITHEXJVPOWHKC-UHFFFAOYSA-O
CCMSLIB00012724996,"related spectra of 'massbank:lu006002 imidacloprid|n-[1-[(6-chloro-3-pyridinyl)methyl]-4,5-dihydroimidazol-2-yl]nitramide|n-[1-[(6-chloropyridin-3-yl)methyl]-4,5-dihydroimidazol-2-yl]nitramide (delta mass:1.003)'",CCMSLIB00005762340,1,2636,Drug_suspect,imidacloprid,insecticide,infectious disease,fleas,acetylcholine receptor antagonist,YWTYJOPNNQFBPC-UHFFFAOYSA-N
CCMSLIB00012724997,"related spectra of 'massbank:lu006002 imidacloprid|n-[1-[(6-chloro-3-pyridinyl)methyl]-4,5-dihydroimidazol-2-yl]nitramide|n-[1-[(6-chloropyridin-3-yl)methyl]-4,5-dihydroimidazol-2-yl]nitramide (delta mass:15.995)'",CCMSLIB00005762340,15.99,2637,Drug_suspect,imidacloprid,insecticide,infectious disease,fleas,acetylcholine receptor antagonist,YWTYJOPNNQFBPC-UHFFFAOYSA-N
CCMSLIB00012724998,"related spectra of 'massbank:lu017303 phenolphthalein|3,3-bis(4-hydroxyphenyl)-2-benzofuran-1-one (delta mass:14.016)'",CCMSLIB00005760483,14.02,2638,Drug_suspect,phenolphthalein,no_match,NA,NA,indicator dye,KJFMBFZCATUALV-UHFFFAOYSA-N
CCMSLIB00012724999,"related spectra of 'massbank:lu017303 phenolphthalein|3,3-bis(4-hydroxyphenyl)-2-benzofuran-1-one (delta mass:27.047)'",CCMSLIB00005760483,27.05,2639,Drug_suspect,phenolphthalein,no_match,NA,NA,indicator dye,KJFMBFZCATUALV-UHFFFAOYSA-N
CCMSLIB00012725000,related spectra of 'massbank:lu022003 labetalol|2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide (delta mass:15.995)',CCMSLIB00005764589,15.99,2640,Drug_suspect,labetalol,beta-adrenergic receptor inhibitor,cardiology,hypertension,adrenergic receptor antagonist,SGUAFYQXFOLMHL-UHFFFAOYSA-N
CCMSLIB00012725001,"related spectra of 'massbank:lu035804 atorvastatin|(3r,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid (delta mass:15.995)'",CCMSLIB00005760904,15.99,2641,Drug_suspect,atorvastatin,HMG-CoA reductase inhibitor (statin),neurology/psychiatry|cardiology|endocrinology,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,XUKUURHRXDUEBC-KAYWLYCHSA-N
CCMSLIB00012725002,"related spectra of 'massbank:lu037802 amiodarone|(2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone (delta mass:15.995)'",CCMSLIB00005763929,15.99,2642,Drug_suspect,amiodarone,antiarrhythmic,cardiology,ventricular arrhythmias,potassium channel blocker,IYIKLHRQXLHMJQ-UHFFFAOYSA-N
CCMSLIB00012725003,"related spectra of 'massbank:lu037802 amiodarone|(2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone (delta mass:29.974)'",CCMSLIB00005763929,29.97,2643,Drug_suspect,amiodarone,antiarrhythmic,cardiology,ventricular arrhythmias,potassium channel blocker,IYIKLHRQXLHMJQ-UHFFFAOYSA-N
CCMSLIB00012725004,"related spectra of 'massbank:lu037803 amiodarone|(2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone (delta mass:13.98)'",CCMSLIB00005764299,13.98,2644,Drug_suspect,amiodarone,antiarrhythmic,cardiology,ventricular arrhythmias,potassium channel blocker,IYIKLHRQXLHMJQ-UHFFFAOYSA-N
CCMSLIB00012725005,related spectra of 'massbank:lu043802 oxfendazole|methyl n-[6-(benzenesulfinyl)-1h-benzimidazol-2-yl]carbamate (delta mass:15.995)',CCMSLIB00005760054,15.99,2645,Drug_suspect,oxfendazole,benzimidazoles and related substances|veterinary,infectious disease,lungworms|tapeworm|gastrointestinal roundworms,anthelmintic agent,BEZZFPOZAYTVHN-UHFFFAOYSA-N
CCMSLIB00012725006,related spectra of 'massbank:lu046702 glipizide|n-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide (delta mass:15.995)',CCMSLIB00005760254,15.99,2646,Drug_suspect,glipizide,sulfonylurea,endocrinology,type 2 diabetes mellitus,insulin secretagogue,ZJJXGWJIGJFDTL-UHFFFAOYSA-N
CCMSLIB00012725007,"related spectra of 'massbank:lu048702 meloxicam|4-hydroxy-2-methyl-n-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide (delta mass:15.995)'",CCMSLIB00005765037,15.99,2647,Drug_suspect,meloxicam,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis,cyclooxygenase inhibitor,ZRVUJXDFFKFLMG-UHFFFAOYSA-N
CCMSLIB00012725008,"related spectra of 'massbank:lu048702 meloxicam|4-hydroxy-2-methyl-n-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide (delta mass:29.974)'",CCMSLIB00005765037,29.97,2648,Drug_suspect,meloxicam,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis,cyclooxygenase inhibitor,ZRVUJXDFFKFLMG-UHFFFAOYSA-N
CCMSLIB00012725009,related spectra of 'massbank:lu053503 cetirizine|2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid (delta mass:-58.006)',CCMSLIB00005759946,-58.01,2649,Drug_suspect,cetirizine,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,ZKLPARSLTMPFCP-UHFFFAOYSA-N
CCMSLIB00012725010,related spectra of 'massbank:lu053503 cetirizine|2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid (delta mass:21.984)',CCMSLIB00005759946,21.98,2650,Drug_suspect,cetirizine,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,ZKLPARSLTMPFCP-UHFFFAOYSA-N
CCMSLIB00012725011,"related spectra of 'massbank:lu063804 triamterene|6-phenylpteridine-2,4,7-triamine (delta mass:15.995)'",CCMSLIB00005764668,15.99,2651,Drug_suspect,triamterene,potassium-sparing diuretic,cardiology,hypokalemia|hypertension|edema,sodium channel blocker,FNYLWPVRPXGIIP-UHFFFAOYSA-N
CCMSLIB00012725012,"related spectra of 'massbank:lu083504 maprotiline|n-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine (delta mass:0.984)'",CCMSLIB00005760130,0.98,2652,Drug_suspect|Low_confidence,maprotiline,non-selective monoamine reuptake inhibitors,neurology/psychiatry,depression|dysthymic disorder,norepinephrine reputake inhibitor|tricyclic antidepressant,QSLMDECMDJKHMQ-UHFFFAOYSA-N
CCMSLIB00012725013,"related spectra of 'massbank:lu083504 maprotiline|n-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine (delta mass:14.016)'",CCMSLIB00005760130,14.02,2653,Drug_suspect|Low_confidence,maprotiline,non-selective monoamine reuptake inhibitors,neurology/psychiatry,depression|dysthymic disorder,norepinephrine reputake inhibitor|tricyclic antidepressant,QSLMDECMDJKHMQ-UHFFFAOYSA-N
CCMSLIB00012725014,related spectra of 'massbank:lu090402 methylprednisolone (delta mass:2.016)',CCMSLIB00005764667,2.02,2654,Drug_suspect,methylprednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,VHRSUDSXCMQTMA-PJHHCJLFSA-N
CCMSLIB00012725015,"related spectra of 'massbank:lu094303 amitriptyline|n,n-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine (delta mass:1.003)'",CCMSLIB00005761267,1,2655,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012725016,related spectra of 'massbank:lu101703 2-ethylhexyl 4-(dimethylamino)benzoate (delta mass:-42.047)',CCMSLIB00005765720,-42.05,2656,Drug_suspect,padimate o,no_match,no_match,no_match,no_match,WYWZRNAHINYAEF-UHFFFAOYSA-N
CCMSLIB00012725017,related spectra of 'massbank:lu101703 2-ethylhexyl 4-(dimethylamino)benzoate (delta mass:-14.016)',CCMSLIB00005765720,-14.02,2657,Drug_suspect,padimate o,no_match,no_match,no_match,no_match,WYWZRNAHINYAEF-UHFFFAOYSA-N
CCMSLIB00012725018,"related spectra of 'massbank:lu102102 8-methoxypsoralen|methoxsalen|9-methoxyfuro[3,2-g]chromen-7-one (delta mass:14.016)'",CCMSLIB00005765755,14.02,2658,Drug_suspect,methoxsalen,photoactivated radical generator|psoralen,dermatology,psoriasis,DNA synthesis inhibitor,QXKHYNVANLEOEG-UHFFFAOYSA-N
CCMSLIB00012725019,related spectra of 'massbank:lu104703 sulfasalazine|2-hydroxy-5-[[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid (delta mass:-18.011)',CCMSLIB00005761266,-18.01,2659,Drug_suspect,sulfasalazine,aminosalicylate,gastroenterology|rheumatology,ulcerative colitis|Crohn's disease|rheumatoid arthritis,cyclooxygenase inhibitor,NCEXYHBECQHGNR-UHFFFAOYSA-N
CCMSLIB00012725020,related spectra of 'massbank:lu104752 sulfasalazine|2-hydroxy-5-[[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid (delta mass:12.0)',CCMSLIB00005766956,12,2660,Drug_suspect,sulfasalazine,aminosalicylate,gastroenterology|rheumatology,ulcerative colitis|Crohn's disease|rheumatoid arthritis,cyclooxygenase inhibitor,NCEXYHBECQHGNR-UHFFFAOYSA-N
CCMSLIB00012725021,"related spectra of 'massbank:lu130903 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:-76.031)'",CCMSLIB00005766542,-76.03,2661,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725022,"related spectra of 'massbank:lu130903 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:1.003)'",CCMSLIB00005766542,1,2662,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725023,"related spectra of 'massbank:lu130903 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:15.995)'",CCMSLIB00005766542,15.99,2663,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725024,related spectra of 'massbank:msj00169 alpha-tocopherol|vitamin e (delta mass:-16.031)',CCMSLIB00005777334,-16.03,2664,Drug_suspect,tocofersolan,vitamins,metabolism,vitamin E deficiency,antioxidant|vitamin E,GVJHHUAWPYXKBD-IEOSBIPESA-N
CCMSLIB00012725025,related spectra of 'massbank:msj00169 alpha-tocopherol|vitamin e (delta mass:15.012)',CCMSLIB00005777334,15.01,2665,Drug_suspect,tocofersolan,vitamins,metabolism,vitamin E deficiency,antioxidant|vitamin E,GVJHHUAWPYXKBD-IEOSBIPESA-N
CCMSLIB00012725026,"related spectra of 'massbank:na002775 yohimbine|methyl (1s,15r,18s,19r,20s)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate (delta mass:42.01)'",CCMSLIB00005768391,42.01,2666,Drug_suspect,yohimbine,drugs used in erectile dysfunction,urology,erectile dysfunction,adrenergic receptor antagonist,BLGXFZZNTVWLAY-SCYLSFHTSA-N
CCMSLIB00012725027,related spectra of 'massbank:pr307644 icariin|3-[(6-deoxy-alpha-l-mannopyranosyl)oxy]-7-(beta-d-glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-4h-1-benzopyran-4-one (delta mass:21.984)',CCMSLIB00005742554,21.98,2667,Drug_suspect,icariin,no_match,NA,NA,phosphodiesterase inhibitor,TZJALUIVHRYQQB-XLRXWWTNSA-N
CCMSLIB00012725028,related spectra of 'massbank:tue00082 atenolol (delta mass:14.999)',CCMSLIB00005755105,15,2668,Drug_suspect,atenolol,beta-adrenergic receptor inhibitor,cardiology,hypertension|angina pectoris|acute myocardial infarction,adrenergic receptor antagonist,METKIMKYRPQLGS-UHFFFAOYSA-N
CCMSLIB00012725029,related spectra of 'massbank:tue00812 venlafaxine (delta mass:-18.011)',CCMSLIB00005755186,-18.01,2669,Drug_suspect,venlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,PNVNVHUZROJLTJ-UHFFFAOYSA-N
CCMSLIB00012725030,related spectra of 'massbank:tue00822 o-desmethylvenlafaxine (delta mass:-18.011)',CCMSLIB00005755108,-18.01,2670,Drug_suspect,desvenlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression,serotonin and norepinephrine reuptake inhibitor (SNRI),KYYIDSXMWOZKMP-UHFFFAOYSA-N
CCMSLIB00012725031,related spectra of 'massbank:tue00822 o-desmethylvenlafaxine (delta mass:-3.995)',CCMSLIB00005755108,-3.99,2671,Drug_suspect,desvenlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression,serotonin and norepinephrine reuptake inhibitor (SNRI),KYYIDSXMWOZKMP-UHFFFAOYSA-N
CCMSLIB00012725032,related spectra of 'massbank:tue00822 o-desmethylvenlafaxine (delta mass:176.032)',CCMSLIB00005755108,176.03,2672,Drug_suspect,desvenlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression,serotonin and norepinephrine reuptake inhibitor (SNRI),KYYIDSXMWOZKMP-UHFFFAOYSA-N
CCMSLIB00012725033,related spectra of 'massbank:uf404201 warfarin|coumafene (delta mass:15.995)',CCMSLIB00000223519,15.99,2673,Drug_suspect,warfarin,vitamin K antagonist,hematology|cardiology,deep vein thrombosis (DVT)|pulmonary embolism (PE)|atrial fibrillation (AF)|myocardial infarction|thromboembolism,vitamin K antagonist,PJVWKTKQMONHTI-UHFFFAOYSA-N
CCMSLIB00012725034,"related spectra of 'massbank:uf407901 paroxetine|3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine (delta mass:2.016)'",CCMSLIB00000223641,2.02,2674,Drug_suspect,paroxetine,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|generalized anxiety disorder (GAD)|panic disorders|posttraumatic stress disorder|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),AHOUBRCZNHFOSL-UHFFFAOYSA-N
CCMSLIB00012725035,related spectra of 'massbank:uf408802 sulfapyridine|2-sulfapyridine|4-amino-n-(2-pyridinyl)benzenesulfonamide (delta mass:15.995)',CCMSLIB00000223677,15.99,2675,Drug_suspect,sulfapyridine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,GECHUMIMRBOMGK-UHFFFAOYSA-N
CCMSLIB00012725036,related spectra of 'massbank:uf408802 sulfapyridine|2-sulfapyridine|4-amino-n-(2-pyridinyl)benzenesulfonamide (delta mass:42.01)',CCMSLIB00000223677,42.01,2676,Drug_suspect,sulfapyridine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,GECHUMIMRBOMGK-UHFFFAOYSA-N
CCMSLIB00012725037,"related spectra of 'massbank:uf409901 sulfamethazine|sulfadimidin|4-amino-n-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide (delta mass:-3.985)'",CCMSLIB00000223720,-3.99,2677,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725038,"related spectra of 'massbank:uf409901 sulfamethazine|sulfadimidin|4-amino-n-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide (delta mass:-2.016)'",CCMSLIB00000223720,-2.02,2678,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725039,"related spectra of 'massbank:uf409901 sulfamethazine|sulfadimidin|4-amino-n-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide (delta mass:2.004)'",CCMSLIB00000223720,2,2679,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725040,"related spectra of 'massbank:uf409901 sulfamethazine|sulfadimidin|4-amino-n-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide (delta mass:27.995)'",CCMSLIB00000223720,27.99,2680,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725041,"related spectra of 'massbank:uf409901 sulfamethazine|sulfadimidin|4-amino-n-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide (delta mass:162.053)'",CCMSLIB00000223720,162.05,2681,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725042,related spectra of 'massbank:uf411801 citalopram|1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3h-2-benzofuran-5-carbonitrile (delta mass:-28.031)',CCMSLIB00000223791,-28.03,2682,Drug_suspect,citalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-UHFFFAOYSA-N
CCMSLIB00012725043,related spectra of 'massbank:uf411801 citalopram|1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3h-2-benzofuran-5-carbonitrile (delta mass:-16.031)',CCMSLIB00000223791,-16.03,2683,Drug_suspect,citalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-UHFFFAOYSA-N
CCMSLIB00012725044,related spectra of 'massbank:uf411801 citalopram|1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3h-2-benzofuran-5-carbonitrile (delta mass:-14.016)',CCMSLIB00000223791,-14.02,2684,Drug_suspect,citalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-UHFFFAOYSA-N
CCMSLIB00012725045,related spectra of 'massbank:uf411801 citalopram|1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3h-2-benzofuran-5-carbonitrile (delta mass:15.995)',CCMSLIB00000223791,15.99,2685,Drug_suspect,citalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-UHFFFAOYSA-N
CCMSLIB00012725046,related spectra of 'massbank:ut001011 phosphatidylcholine 16:0-16:0 (delta mass:-28.031)',CCMSLIB00005752372,-28.03,2686,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725047,related spectra of 'massbank:ut001011 phosphatidylcholine 16:0-16:0 (delta mass:-26.016)',CCMSLIB00005752372,-26.02,2687,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725048,related spectra of 'massbank:ut001011 phosphatidylcholine 16:0-16:0 (delta mass:0.984)',CCMSLIB00005752372,0.98,2688,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725049,related spectra of 'massbank:ut001011 phosphatidylcholine 16:0-16:0 (delta mass:1.003)',CCMSLIB00005752372,1,2689,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725050,related spectra of 'massbank:ut001011 phosphatidylcholine 16:0-16:0 (delta mass:2.004)',CCMSLIB00005752372,2,2690,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725051,related spectra of 'massbank:ut001011 phosphatidylcholine 16:0-16:0 (delta mass:2.016)',CCMSLIB00005752372,2.02,2691,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725052,related spectra of 'massbank:ut001011 phosphatidylcholine 16:0-16:0 (delta mass:12.036)',CCMSLIB00005752372,12.04,2692,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725053,related spectra of 'massbank:ut001011 phosphatidylcholine 16:0-16:0 (delta mass:14.016)',CCMSLIB00005752372,14.02,2693,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725054,related spectra of 'massbank:ut001011 phosphatidylcholine 16:0-16:0 (delta mass:28.031)',CCMSLIB00005752372,28.03,2694,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725055,related spectra of 'massbank:ut001747 phosphatidylcholine 16:0-16:0 (delta mass:-26.016)',CCMSLIB00005751921,-26.02,2695,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725056,related spectra of 'massbank:ut001747 phosphatidylcholine 16:0-16:0 (delta mass:-13.98)',CCMSLIB00005751921,-13.98,2696,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725057,related spectra of 'massbank:ut001747 phosphatidylcholine 16:0-16:0 (delta mass:2.016)',CCMSLIB00005751921,2.02,2697,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725058,related spectra of 'massbank:ut001747 phosphatidylcholine 16:0-16:0 (delta mass:12.036)',CCMSLIB00005751921,12.04,2698,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725059,related spectra of 'massbank:ut001747 phosphatidylcholine 16:0-16:0 (delta mass:14.016)',CCMSLIB00005751921,14.02,2699,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725060,related spectra of 'massbank:ut001747 phosphatidylcholine 16:0-16:0 (delta mass:15.995)',CCMSLIB00005751921,15.99,2700,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725061,related spectra of 'massbank:ut001747 phosphatidylcholine 16:0-16:0 (delta mass:28.031)',CCMSLIB00005751921,28.03,2701,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725062,related spectra of 'massbank:ut002028 phosphatidylcholine 16:0-16:0 (delta mass:-13.98)',CCMSLIB00005752766,-13.98,2702,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725063,related spectra of 'massbank:ut002028 phosphatidylcholine 16:0-16:0 (delta mass:-2.016)',CCMSLIB00005752766,-2.02,2703,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725064,related spectra of 'massbank:ut002756 phosphatidylcholine 16:0-16:0 (delta mass:-2.016)',CCMSLIB00005751911,-2.02,2704,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725065,related spectra of 'massbank:ut002756 phosphatidylcholine 16:0-16:0 (delta mass:12.036)',CCMSLIB00005751911,12.04,2705,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725066,related spectra of 'massbank:ut002756 phosphatidylcholine 16:0-16:0 (delta mass:21.984)',CCMSLIB00005751911,21.98,2706,Drug_suspect,colfosceril palmitate,lung surfactants,pulmonary,respiratory distress syndrome (RDS),pulmonary surfactant,KILNVBDSWZSGLL-UHFFFAOYSA-O
CCMSLIB00012725067,related spectra of 'massbankeu:sm818901 losartan|[2-butyl-5-chloro-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol (delta mass:-18.011)',CCMSLIB00000841586,-18.01,2707,Drug_suspect,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012725068,related spectra of 'massbankeu:sm818901 losartan|[2-butyl-5-chloro-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol (delta mass:12.036)',CCMSLIB00000841586,12.04,2708,Drug_suspect,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012725069,related spectra of 'massbankeu:sm818901 losartan|[2-butyl-5-chloro-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol (delta mass:15.995)',CCMSLIB00000841586,15.99,2709,Drug_suspect,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012725070,related spectra of 'massbankeu:sm818901 losartan|[2-butyl-5-chloro-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol (delta mass:176.032)',CCMSLIB00000841586,176.03,2710,Drug_suspect,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012725071,"related spectra of 'massbankeu:sm833651 pantoprazole|6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1h-benzimidazole (delta mass:-15.995)'",CCMSLIB00000841678,-15.99,2711,Drug_suspect,pantoprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|erosive esophagitis (EE)|Zollinger-Ellison syndrome,ATPase inhibitor,IQPSEEYGBUAQFF-UHFFFAOYSA-N
CCMSLIB00012725072,"related spectra of 'massbankeu:sm850301 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:0.984)'",CCMSLIB00000841836,0.98,2712,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725073,"related spectra of 'massbankeu:sm850301 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:1.993)'",CCMSLIB00000841836,2,2713,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725074,"related spectra of 'massbankeu:sm850301 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:2.004)'",CCMSLIB00000841836,2,2714,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725075,"related spectra of 'massbankeu:sm850301 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:15.995)'",CCMSLIB00000841836,15.99,2715,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725076,"related spectra of 'massbankeu:sm850301 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:27.995)'",CCMSLIB00000841836,27.99,2716,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725077,"related spectra of 'massbankeu:sm850301 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:28.031)'",CCMSLIB00000841836,28.03,2717,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725078,"related spectra of 'massbankeu:sm850301 sulfamethazine|4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (delta mass:162.053)'",CCMSLIB00000841836,162.05,2718,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725079,"related spectra of 'massbankeu:sm859002 acetyl-sulfamethoxazole|n-[4-[(5-methyl-1,2-oxazol-3-yl)sulfamoyl]phenyl]acetamide (delta mass:-14.016)'",CCMSLIB00000841909,-14.02,2719,Drug_suspect,acetylsulfamethoxazole,sulfonamide antimicrobial,infectious disease,pneumonia|enteritis|urinary tract infections,PABA antagonist,GXPIUNZCALHVBA-UHFFFAOYSA-N
CCMSLIB00012725080,"related spectra of 'massbankeu:sm859203 amitriptyline|3-(5,6-dihydrodibenzo[2,1-b:2`,1`-f][7]annulen-11-ylidene)-n,n-dimethylpropan-1-amine (delta mass:1.003)'",CCMSLIB00000841910,1,2720,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012725081,related spectra of 'massbankeu:sm860801 valsartan|(2s)-3-methyl-2-[pentanoyl-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid (delta mass:-18.011)',CCMSLIB00000841928,-18.01,2721,Drug_suspect,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012725082,related spectra of 'massbankeu:sm860801 valsartan|(2s)-3-methyl-2-[pentanoyl-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid (delta mass:-2.016)',CCMSLIB00000841928,-2.02,2722,Drug_suspect,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012725083,related spectra of 'massbankeu:sm860801 valsartan|(2s)-3-methyl-2-[pentanoyl-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid (delta mass:17.027)',CCMSLIB00000841928,17.03,2723,Drug_suspect,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012725084,related spectra of 'massbankeu:sm860801 valsartan|(2s)-3-methyl-2-[pentanoyl-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid (delta mass:29.974)',CCMSLIB00000841928,29.97,2724,Drug_suspect,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012725085,related spectra of 'matrine (delta mass:15.995)',CCMSLIB00010147062|CCMSLIB00010147063|CCMSLIB00010147064|CCMSLIB00010147065|CCMSLIB00010147066|CCMSLIB00010147067|CCMSLIB00010147068|CCMSLIB00010147069,15.99,2725,Drug_suspect,matrine,no_match,NA,NA,opioid receptor agonist,ZSBXGIUJOOQZMP-JLNYLFASSA-N
CCMSLIB00012725086,related spectra of 'meloxicam (mobic) (delta mass:15.995)',CCMSLIB00000077137,15.99,2726,Drug_suspect,meloxicam,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis,cyclooxygenase inhibitor,ZRVUJXDFFKFLMG-UHFFFAOYSA-N
CCMSLIB00012725087,related spectra of 'meloxicam (mobic) (delta mass:29.974)',CCMSLIB00000077137,29.97,2727,Drug_suspect,meloxicam,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis,cyclooxygenase inhibitor,ZRVUJXDFFKFLMG-UHFFFAOYSA-N
CCMSLIB00012725088,"related spectra of 'mirtazapine (remeron, avanza) (delta mass:13.98)'",CCMSLIB00000078388|CCMSLIB00000078389,13.98,2728,Drug_suspect,mirtazapine,other antidepressants,neurology/psychiatry,depression,adrenergic receptor antagonist|serotonin receptor antagonist,RONZAEMNMFQXRA-UHFFFAOYSA-N
CCMSLIB00012725089,related spectra of 'moxifloxacin (delta mass:13.98)',CCMSLIB00000081725,13.98,2729,Drug_suspect,moxifloxacin,fluoroquinolone antimicrobial,infectious disease,sinusitis|bronchitis|pneumonia|skin infections|intra-abdominal infections,bacterial DNA gyrase inhibitor,FABPRXSRWADJSP-MEDUHNTESA-N
CCMSLIB00012725090,related spectra of 'mycophenolic acid_130117 (delta mass:-18.011)',CCMSLIB00000478521,-18.01,2730,Drug_suspect,mycophenolic acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-RUDMXATFSA-N
CCMSLIB00012725091,related spectra of 'mycophenolic acid_130117 (delta mass:2.016)',CCMSLIB00000478521,2.02,2731,Drug_suspect,mycophenolic acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-RUDMXATFSA-N
CCMSLIB00012725092,related spectra of 'mycophenolic acid_130117 (delta mass:28.031)',CCMSLIB00000478521,28.03,2732,Drug_suspect,mycophenolic acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-RUDMXATFSA-N
CCMSLIB00012725093,related spectra of 'mycophenolic acid_130117 (delta mass:176.032)',CCMSLIB00000478521,176.03,2733,Drug_suspect,mycophenolic acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-RUDMXATFSA-N
CCMSLIB00012725094,related spectra of 'n-acetyl mesalazine (delta mass:14.016)',CCMSLIB00000579422|CCMSLIB00000579593,14.02,2734,Drug_suspect,n-acetyl mesalazine,aminosalicylate,gastroenterology,ulcerative colitis,cyclooxygenase inhibitor|lipoxygenase inhibitor|prostanoid receptor antagonist,GEFDRROBUCULOD-UHFFFAOYSA-N
CCMSLIB00012725095,related spectra of 'n-acetyl mesalazine (delta mass:28.031)',CCMSLIB00000579422|CCMSLIB00000579593,28.03,2735,Drug_suspect,n-acetyl mesalazine,aminosalicylate,gastroenterology,ulcerative colitis,cyclooxygenase inhibitor|lipoxygenase inhibitor|prostanoid receptor antagonist,GEFDRROBUCULOD-UHFFFAOYSA-N
CCMSLIB00012725096,related spectra of 'n-desmethylclindamycin (delta mass:-2.016)',CCMSLIB00005716875,-2.02,2736,Drug_suspect,"methyl 7-chloro-6,7,8-trideoxy-6-[[[(2s,4r)-4beta-propyl-2alpha-pyrrolidinyl]carbonyl]amino]-1-thio-l-threo-alpha-d-galacto-octopyranoside",lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,HDBHHHCDEYATPY-UHFFFAOYSA-N
CCMSLIB00012725097,related spectra of 'n-desmethylclindamycin (delta mass:12.0)',CCMSLIB00005716875,12,2737,Drug_suspect,"methyl 7-chloro-6,7,8-trideoxy-6-[[[(2s,4r)-4beta-propyl-2alpha-pyrrolidinyl]carbonyl]amino]-1-thio-l-threo-alpha-d-galacto-octopyranoside",lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,HDBHHHCDEYATPY-UHFFFAOYSA-N
CCMSLIB00012725098,related spectra of 'n-desmethylclindamycin (delta mass:27.995)',CCMSLIB00005716875,27.99,2738,Drug_suspect,"methyl 7-chloro-6,7,8-trideoxy-6-[[[(2s,4r)-4beta-propyl-2alpha-pyrrolidinyl]carbonyl]amino]-1-thio-l-threo-alpha-d-galacto-octopyranoside",lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,HDBHHHCDEYATPY-UHFFFAOYSA-N
CCMSLIB00012725099,related spectra of 'n-desmethylclindamycin (delta mass:31.99)',CCMSLIB00005716875,31.99,2739,Drug_suspect,"methyl 7-chloro-6,7,8-trideoxy-6-[[[(2s,4r)-4beta-propyl-2alpha-pyrrolidinyl]carbonyl]amino]-1-thio-l-threo-alpha-d-galacto-octopyranoside",lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,HDBHHHCDEYATPY-UHFFFAOYSA-N
CCMSLIB00012725100,related spectra of 'n-desmethylclindamycin sulfoxide (delta mass:12.0)',CCMSLIB00005716878,12,2740,Drug_suspect,n-desmethylclindamycin sulfoxide,lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,RKZYQAJFAZGGKD-UHFFFAOYSA-N
CCMSLIB00012725101,related spectra of 'n-desmethylclindamycin sulfoxide (delta mass:15.995)',CCMSLIB00005716878,15.99,2741,Drug_suspect,n-desmethylclindamycin sulfoxide,lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,RKZYQAJFAZGGKD-UHFFFAOYSA-N
CCMSLIB00012725102,related spectra of 'n-desmethylclindamycin sulfoxide (delta mass:27.995)',CCMSLIB00005716878,27.99,2742,Drug_suspect,n-desmethylclindamycin sulfoxide,lincosamide antibacterial,infectious disease,respiratory tract infections|pneumonia|skin infections|gynecologic infections|intra-abdominal infections|bacterial septicemia|bone and joint infections,bacterial 50S ribosomal subunit inhibitor,RKZYQAJFAZGGKD-UHFFFAOYSA-N
CCMSLIB00012725103,"related spectra of 'ncgc00015878-07!methyl 18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate (delta mass:2.016)'",CCMSLIB00000848723,2.02,2743,Drug_suspect,yohimbine,drugs used in erectile dysfunction,urology,erectile dysfunction,adrenergic receptor antagonist,BLGXFZZNTVWLAY-UHFFFAOYSA-N
CCMSLIB00012725104,"related spectra of 'ncgc00015878-07!methyl 18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate (delta mass:15.995)'",CCMSLIB00000848723,15.99,2744,Drug_suspect,yohimbine,drugs used in erectile dysfunction,urology,erectile dysfunction,adrenergic receptor antagonist,BLGXFZZNTVWLAY-UHFFFAOYSA-N
CCMSLIB00012725105,"related spectra of 'ncgc00015878-08_c21h26n2o3_methyl (16alpha,17alpha)-17-hydroxyyohimban-16-carboxylate (delta mass:1.978)'",CCMSLIB00000854883|CCMSLIB00000854885,1.98,2745,Drug_suspect,yohimbine,drugs used in erectile dysfunction,urology,erectile dysfunction,adrenergic receptor antagonist,BLGXFZZNTVWLAY-UHFFFAOYSA-N
CCMSLIB00012725106,related spectra of 'ncgc00179585-04_c35h42n2o9_cinnaloid (delta mass:15.995)',CCMSLIB00000853201,15.99,2746,Drug_suspect,rescinnamine,rauwolfia alkaloids,cardiology,hypertension,angiotensin converting enzyme (ACE) inhibitor,SZLZWPPUNLXJEA-QEGASFHISA-N
CCMSLIB00012725107,"related spectra of 'ncgc00180529-03!(3s,6r,9s,12r,15s,18r)-4,10,16-trimethyl-3,6,9,12,15,18-hexa(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone [iin-based on: ccmslib00000846051] (delta mass:-14.016)'",CCMSLIB00005723171|CCMSLIB00005723172|CCMSLIB00005723173|CCMSLIB00005723174,-14.02,2747,Drug_suspect,fusafungine,no_match,no_match,no_match,no_match,MIZMDSVSLSIMSC-VYLWARHZSA-N
CCMSLIB00012725108,"related spectra of 'ncgc00180529-03!(3s,6r,9s,12r,15s,18r)-4,10,16-trimethyl-3,6,9,12,15,18-hexa(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone [iin-based on: ccmslib00000846051] (delta mass:28.031)'",CCMSLIB00005723171|CCMSLIB00005723172|CCMSLIB00005723173|CCMSLIB00005723174,28.03,2748,Drug_suspect,fusafungine,no_match,no_match,no_match,no_match,MIZMDSVSLSIMSC-VYLWARHZSA-N
CCMSLIB00012725109,"related spectra of 'ncgc00180529-03!(3s,6r,9s,12r,15s,18r)-4,10,16-trimethyl-3,6,9,12,15,18-hexa(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone [iin-based on: ccmslib00000846051] (delta mass:29.974)'",CCMSLIB00005723171|CCMSLIB00005723172|CCMSLIB00005723173|CCMSLIB00005723174,29.97,2749,Drug_suspect,fusafungine,no_match,no_match,no_match,no_match,MIZMDSVSLSIMSC-VYLWARHZSA-N
CCMSLIB00012725110,"related spectra of 'ncgc00180529-03!(3s,6r,9s,12r,15s,18r)-4,10,16-trimethyl-3,6,9,12,15,18-hexa(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone [iin-based on: ccmslib00000846051] (delta mass:43.991)'",CCMSLIB00005723171|CCMSLIB00005723172|CCMSLIB00005723173|CCMSLIB00005723174,43.99,2750,Drug_suspect,fusafungine,no_match,no_match,no_match,no_match,MIZMDSVSLSIMSC-VYLWARHZSA-N
CCMSLIB00012725111,"related spectra of 'ncgc00385066-01!2-[(1s,6s)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol (delta mass:-28.031)'",CCMSLIB00000848975,-28.03,2751,Drug_suspect,cannabidiol,cannabinoid,neurology/psychiatry,Lennox-Gastaut syndrome|Dravet syndrome|seizures|pain,cannabinoid receptor modulator,QHMBSVQNZZTUGM-MSOLQXFVSA-N
CCMSLIB00012725112,"related spectra of 'ncgc00385066-01!2-[(1s,6s)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol (delta mass:18.01)'",CCMSLIB00000848975,18.01,2752,Drug_suspect,cannabidiol,cannabinoid,neurology/psychiatry,Lennox-Gastaut syndrome|Dravet syndrome|seizures|pain,cannabinoid receptor modulator,QHMBSVQNZZTUGM-MSOLQXFVSA-N
CCMSLIB00012725113,"related spectra of 'ncgc00385454-01_c20h26n2o2_ajmalan-17,21-diol, (17r,21alpha)- (delta mass:2.016)'",CCMSLIB00000851795,2.02,2753,Drug_suspect,ajmaline,no_match,cardiology,Wolff-Parkinson-White Syndrome (WPW),sodium channel blocker,CJDRUOGAGYHKKD-RPVHCMHVSA-N
CCMSLIB00012725114,related spectra of 'nelarabine (delta mass:-15.011)',CCMSLIB00000005883|CCMSLIB00000005884|CCMSLIB00000005885|CCMSLIB00010140555|CCMSLIB00010140556|CCMSLIB00010140557|CCMSLIB00010140558|CCMSLIB00010140559,-15.01,2754,Drug_suspect,nelarabine|nelarabine,nucleoside metabolic inhibitor,hematologic malignancy,acute lymphoblastic leukemia (ALL),DNA synthesis inhibitor|T cell inhibitor,IXOXBSCIXZEQEQ-UHTZMRCNSA-N
CCMSLIB00012725115,related spectra of 'nelarabine (delta mass:13.98)',CCMSLIB00000005883|CCMSLIB00000005884|CCMSLIB00000005885|CCMSLIB00010140555|CCMSLIB00010140556|CCMSLIB00010140557|CCMSLIB00010140558|CCMSLIB00010140559,13.98,2755,Drug_suspect,nelarabine|nelarabine,nucleoside metabolic inhibitor,hematologic malignancy,acute lymphoblastic leukemia (ALL),DNA synthesis inhibitor|T cell inhibitor,IXOXBSCIXZEQEQ-UHTZMRCNSA-N
CCMSLIB00012725116,related spectra of 'norfloxacin (norxacin) (delta mass:27.995)',CCMSLIB00000078174|CCMSLIB00000078175,27.99,2756,Drug_suspect,norfloxacin,fluoroquinolone antimicrobial,infectious disease,urinary tract infections|gonorrhea|prostatitis,bacterial DNA gyrase inhibitor,OGJPXUAPXNRGGI-UHFFFAOYSA-N
CCMSLIB00012725117,related spectra of 'norverapamil (delta mass:-14.016)',CCMSLIB00009919351|CCMSLIB00010130543|CCMSLIB00010130544|CCMSLIB00010130545|CCMSLIB00010130546|CCMSLIB00010130547|CCMSLIB00010130548|CCMSLIB00010130549|CCMSLIB00010130550,-14.02,2757,Drug_suspect,norverapamil,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris|arrhythmia,calcium channel blocker,UPKQNCPKPOLASS-UHFFFAOYSA-N
CCMSLIB00012725118,related spectra of 'norverapamil (delta mass:15.995)',CCMSLIB00009919351|CCMSLIB00010130543|CCMSLIB00010130544|CCMSLIB00010130545|CCMSLIB00010130546|CCMSLIB00010130547|CCMSLIB00010130548|CCMSLIB00010130549|CCMSLIB00010130550,15.99,2758,Drug_suspect,norverapamil,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris|arrhythmia,calcium channel blocker,UPKQNCPKPOLASS-UHFFFAOYSA-N
CCMSLIB00012725119,related spectra of 'norverapamil (delta mass:176.032)',CCMSLIB00009919351|CCMSLIB00010130543|CCMSLIB00010130544|CCMSLIB00010130545|CCMSLIB00010130546|CCMSLIB00010130547|CCMSLIB00010130548|CCMSLIB00010130549|CCMSLIB00010130550,176.03,2759,Drug_suspect,norverapamil,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris|arrhythmia,calcium channel blocker,UPKQNCPKPOLASS-UHFFFAOYSA-N
CCMSLIB00012725120,related spectra of 'olmesartan medoxomil (delta mass:-18.011)',CCMSLIB00000079017,-18.01,2760,Drug_suspect,olmesartan medoxomil,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,UQGKUQLKSCSZGY-UHFFFAOYSA-N
CCMSLIB00012725121,related spectra of 'olmesartan medoxomil (delta mass:28.031)',CCMSLIB00000079017,28.03,2761,Drug_suspect,olmesartan medoxomil,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,UQGKUQLKSCSZGY-UHFFFAOYSA-N
CCMSLIB00012725122,related spectra of 'octocrylene (delta mass:17.027)',CCMSLIB00000077208,17.03,2762,Drug_suspect,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-UHFFFAOYSA-N
CCMSLIB00012725123,related spectra of 'octocrylene (delta mass:30.01)',CCMSLIB00000077208,30.01,2763,Drug_suspect,octocrylene,no_match,dermatology,sunscreen lotion,NA,FMJSMJQBSVNSBF-UHFFFAOYSA-N
CCMSLIB00012725124,related spectra of 'ofloxacin (delta mass:-14.016)',CCMSLIB00000076983|CCMSLIB00000076984|CCMSLIB00000081724,-14.02,2764,Drug_suspect,ofloxacin,fluoroquinolone antimicrobial,infectious disease,pneumonia|sinusitis|bronchitis|skin infections|prostatitis|urinary tract infections|pyelonephritis|anthrax|plague|gram-negative bacterial infections|gram-positive bacterial infections,bacterial DNA gyrase inhibitor,GSDSWSVVBLHKDQ-UHFFFAOYSA-N
CCMSLIB00012725125,related spectra of 'omeprazole (delta mass:192.027)',CCMSLIB00000579449|CCMSLIB00004679253,192.03,2765,Drug_suspect,omeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,SUBDBMMJDZJVOS-UHFFFAOYSA-N
CCMSLIB00012725126,"related spectra of 'ondansetron aka ""9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1h-carbazol-4-one"" (delta mass:15.995)'",CCMSLIB00000079015,15.99,2766,Drug_suspect,ondansetron,serotonin-3 (5-HT3) receptor antagonist,gastroenterology,nausea|vomiting,serotonin receptor antagonist,FELGMEQIXOGIFQ-UHFFFAOYSA-N
CCMSLIB00012725127,related spectra of 'oxfendazole (delta mass:15.995)',CCMSLIB00000078305|CCMSLIB00010151563|CCMSLIB00010151564|CCMSLIB00010151565|CCMSLIB00010151566|CCMSLIB00010151567,15.99,2767,Drug_suspect,oxfendazole|oxfendazole,benzimidazoles and related substances|veterinary,infectious disease,lungworms|tapeworm|gastrointestinal roundworms,anthelmintic agent,BEZZFPOZAYTVHN-UHFFFAOYSA-N
CCMSLIB00012725128,related spectra of 'oxymatrine (delta mass:-2.016)',CCMSLIB00005778375|CCMSLIB00006439216|CCMSLIB00006439217|CCMSLIB00006439294|CCMSLIB00006439295|CCMSLIB00006439372|CCMSLIB00006439373|CCMSLIB00006439444|CCMSLIB00006439445|CCMSLIB00006439513|CCMSLIB00006439514|CCMSLIB00006516421|CCMSLIB00006516422|CCMSLIB00006516445|CCMSLIB00006516446|CCMSLIB00006516464|CCMSLIB00006516465|CCMSLIB00006516487|CCMSLIB00006516488|CCMSLIB00006516699|CCMSLIB00006516700|CCMSLIB00006516716|CCMSLIB00006516717|CCMSLIB00006516735|CCMSLIB00006516736|CCMSLIB00006516754|CCMSLIB00006516755|CCMSLIB00006516961|CCMSLIB00006516978|CCMSLIB00006516979|CCMSLIB00006516997|CCMSLIB00006517018|CCMSLIB00006517202|CCMSLIB00006517215|CCMSLIB00006517230|CCMSLIB00006517243|CCMSLIB00006517402|CCMSLIB00006517414|CCMSLIB00006517415|CCMSLIB00006517434|CCMSLIB00006517446|CCMSLIB00006517447|CCMSLIB00010133989|CCMSLIB00010133990|CCMSLIB00010133991|CCMSLIB00010133992|CCMSLIB00010133994|CCMSLIB00010133995,-2.02,2768,Drug_suspect,oxymatrine|oxymatrine,no_match,NA,NA,NA,XVPBINOPNYFXID-LHDUFFHYSA-N|NA
CCMSLIB00012725129,related spectra of 'oxymatrine (delta mass:15.995)',CCMSLIB00005778375|CCMSLIB00006439216|CCMSLIB00006439217|CCMSLIB00006439294|CCMSLIB00006439295|CCMSLIB00006439372|CCMSLIB00006439373|CCMSLIB00006439444|CCMSLIB00006439445|CCMSLIB00006439513|CCMSLIB00006439514|CCMSLIB00006516421|CCMSLIB00006516422|CCMSLIB00006516445|CCMSLIB00006516446|CCMSLIB00006516464|CCMSLIB00006516465|CCMSLIB00006516487|CCMSLIB00006516488|CCMSLIB00006516699|CCMSLIB00006516700|CCMSLIB00006516716|CCMSLIB00006516717|CCMSLIB00006516735|CCMSLIB00006516736|CCMSLIB00006516754|CCMSLIB00006516755|CCMSLIB00006516961|CCMSLIB00006516978|CCMSLIB00006516979|CCMSLIB00006516997|CCMSLIB00006517018|CCMSLIB00006517202|CCMSLIB00006517215|CCMSLIB00006517230|CCMSLIB00006517243|CCMSLIB00006517402|CCMSLIB00006517414|CCMSLIB00006517415|CCMSLIB00006517434|CCMSLIB00006517446|CCMSLIB00006517447|CCMSLIB00010133989|CCMSLIB00010133990|CCMSLIB00010133991|CCMSLIB00010133992|CCMSLIB00010133994|CCMSLIB00010133995,15.99,2769,Drug_suspect,oxymatrine|oxymatrine,no_match,NA,NA,NA,XVPBINOPNYFXID-LHDUFFHYSA-N|NA
CCMSLIB00012725130,related spectra of 'piperonyl butoxide (delta mass:28.031)',CCMSLIB00010146985|CCMSLIB00010146986|CCMSLIB00010146987|CCMSLIB00010146988|CCMSLIB00010146989|CCMSLIB00010146998|CCMSLIB00010146999,28.03,2770,Drug_suspect,piperonyl butoxide,no_match,infectious disease,lice,cytochrome P450 inhibitor,FIPWRIJSWJWJAI-UHFFFAOYSA-N
CCMSLIB00012725131,related spectra of 'prednisolone hemisuccinate (delta mass:-18.011)',CCMSLIB00010144769|CCMSLIB00010144770|CCMSLIB00010144771|CCMSLIB00010144772|CCMSLIB00010144773|CCMSLIB00010144774|CCMSLIB00010144775|CCMSLIB00010144776|CCMSLIB00010144777|CCMSLIB00010144778|CCMSLIB00010144779|CCMSLIB00010144780|CCMSLIB00010144781,-18.01,2771,Drug_suspect,prednisolone hemisuccinate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,APGDTXUMTIZLCJ-CGVGKPPMSA-N
CCMSLIB00012725132,related spectra of 'prednisolone hemisuccinate (delta mass:18.01)',CCMSLIB00010144769|CCMSLIB00010144770|CCMSLIB00010144771|CCMSLIB00010144772|CCMSLIB00010144773|CCMSLIB00010144774|CCMSLIB00010144775|CCMSLIB00010144776|CCMSLIB00010144777|CCMSLIB00010144778|CCMSLIB00010144779|CCMSLIB00010144780|CCMSLIB00010144781,18.01,2772,Drug_suspect,prednisolone hemisuccinate,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,APGDTXUMTIZLCJ-CGVGKPPMSA-N
CCMSLIB00012725133,related spectra of 'pesticide1_carbaryl_c12h11no2_1-naphthyl methylcarbamate (delta mass:15.012)',CCMSLIB00001058720,15.01,2773,Drug_suspect,carbaryl,insecticide,NA,insect pests,acetylcholinesterase inhibitor,CVXBEEMKQHEXEN-UHFFFAOYSA-N
CCMSLIB00012725134,"related spectra of 'pesticide4_boscalid_c18h12cl2n2o_3-pyridinecarboxamide, 2-chloro-n-(4'-chloro[1,1'-biphenyl]-2-yl)- (delta mass:-56.062)'",CCMSLIB00001058347|CCMSLIB00001058363|CCMSLIB00001058507|CCMSLIB00001058508|CCMSLIB00001058748|CCMSLIB00001058753|CCMSLIB00001058945|CCMSLIB00001058947,-56.06,2774,Drug_suspect,boscalid,no_match,no_match,no_match,no_match,WYEMLYFITZORAB-UHFFFAOYSA-N
CCMSLIB00012725135,"related spectra of 'pesticide4_boscalid_c18h12cl2n2o_3-pyridinecarboxamide, 2-chloro-n-(4'-chloro[1,1'-biphenyl]-2-yl)- (delta mass:21.984)'",CCMSLIB00001058347|CCMSLIB00001058363|CCMSLIB00001058507|CCMSLIB00001058508|CCMSLIB00001058748|CCMSLIB00001058753|CCMSLIB00001058945|CCMSLIB00001058947,21.98,2775,Drug_suspect,boscalid,no_match,no_match,no_match,no_match,WYEMLYFITZORAB-UHFFFAOYSA-N
CCMSLIB00012725136,"related spectra of 'pesticide4_eprinomectin_c50h75no14_(1'r,2s,4's,5s,6r,8'r,10'e,12's,13's,14'e,16'e,20'r,21'r,24's)-6-[(2r)-2-butanyl]-21',24'-dihydroxy-5,11',13',22'-tetramethyl-2'-oxo-5,6-dihydrospiro[pyran-2,6'-[3,7,19]trioxatetracyclo[15.6.1.1~4,8~.0~20,24~]pentacosa[10,14,16,22]tetraen]-12'-yl 4-o-(4-acetamido-2,4,6-trideoxy-3-o-methyl-alpha-l-arabino-hexopyranosyl)-2,6-dideoxy-3-o-methyl-alpha-l-arabino-hexopyranoside (delta mass:-18.011)'",CCMSLIB00001058402|CCMSLIB00001058636|CCMSLIB00001058637|CCMSLIB00001058870|CCMSLIB00001058872|CCMSLIB00001059015,-18.01,2776,Drug_suspect,eprinomectin,avermectins|veterinary,infectious disease,gastrointestinal roundworms|lungworms,benzodiazepine receptor agonist,ZKWQQXZUCOBISE-UHFFFAOYSA-N
CCMSLIB00012725137,related spectra of 'pesticide4_piperonyl butoxide_c19h30o5_butacide (delta mass:28.031)',CCMSLIB00001058601|CCMSLIB00001058606|CCMSLIB00001058840|CCMSLIB00001058997|CCMSLIB00001058999,28.03,2777,Drug_suspect,piperonyl butoxide,no_match,infectious disease,lice,cytochrome P450 inhibitor,FIPWRIJSWJWJAI-UHFFFAOYSA-N
CCMSLIB00012725138,related spectra of 'pioglitazone (delta mass:15.995)',CCMSLIB00010131176|CCMSLIB00010131177|CCMSLIB00010131178|CCMSLIB00010131179|CCMSLIB00010131180|CCMSLIB00010131181|CCMSLIB00010131182|CCMSLIB00010131183|CCMSLIB00010150257|CCMSLIB00010150258|CCMSLIB00010150259|CCMSLIB00010150260|CCMSLIB00010150261|CCMSLIB00010150262|CCMSLIB00010150263|CCMSLIB00010150264,15.99,2778,Drug_suspect,pioglitazone,peroxisome proliferator-activated receptor (PPAR) gamma agonist,endocrinology,type 2 diabetes mellitus,insulin sensitizer|PPAR receptor agonist,HYAFETHFCAUJAY-UHFFFAOYSA-N
CCMSLIB00012725139,related spectra of 'piroxicam (feldene) (delta mass:15.995)',CCMSLIB00000078247|CCMSLIB00000078248,15.99,2779,Drug_suspect,piroxicam,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis,cyclooxygenase inhibitor,QYSPLQLAKJAUJT-UHFFFAOYSA-N
CCMSLIB00012725140,related spectra of 'quetiapine hemifumarate (delta mass:-44.026)',CCMSLIB00000079141,-44.03,2780,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725141,related spectra of 'quetiapine hemifumarate (delta mass:15.995)',CCMSLIB00000079141,15.99,2781,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725142,related spectra of 'quinapril hydrochloride (delta mass:-28.031)',CCMSLIB00000077139|CCMSLIB00000077140|CCMSLIB00000077141,-28.03,2782,Drug_suspect|Low_confidence,quinapril,angiotensin converting enzyme inhibitor,cardiology,hypertension|congestive heart failure,angiotensin converting enzyme inhibitor,JSDRRTOADPPCHY-HSQYWUDLSA-N
CCMSLIB00012725143,related spectra of 'quetiapine sulfoxide (delta mass:-88.053)',CCMSLIB00010135507|CCMSLIB00010135508|CCMSLIB00010135509|CCMSLIB00010135510|CCMSLIB00010135511|CCMSLIB00010135512|CCMSLIB00010135513|CCMSLIB00010135514,-88.05,2783,Drug_suspect,quetiapine sulfoxide,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,FXJNLPUSSHEDON-UHFFFAOYSA-N
CCMSLIB00012725144,related spectra of 'quetiapine sulfoxide (delta mass:-44.026)',CCMSLIB00010135507|CCMSLIB00010135508|CCMSLIB00010135509|CCMSLIB00010135510|CCMSLIB00010135511|CCMSLIB00010135512|CCMSLIB00010135513|CCMSLIB00010135514,-44.03,2784,Drug_suspect,quetiapine sulfoxide,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,FXJNLPUSSHEDON-UHFFFAOYSA-N
CCMSLIB00012725145,related spectra of 'quetiapine sulfoxide (delta mass:-26.016)',CCMSLIB00010135507|CCMSLIB00010135508|CCMSLIB00010135509|CCMSLIB00010135510|CCMSLIB00010135511|CCMSLIB00010135512|CCMSLIB00010135513|CCMSLIB00010135514,-26.02,2785,Drug_suspect,quetiapine sulfoxide,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,FXJNLPUSSHEDON-UHFFFAOYSA-N
CCMSLIB00012725146,related spectra of 'quetiapine sulfoxide (delta mass:13.98)',CCMSLIB00010135507|CCMSLIB00010135508|CCMSLIB00010135509|CCMSLIB00010135510|CCMSLIB00010135511|CCMSLIB00010135512|CCMSLIB00010135513|CCMSLIB00010135514,13.98,2786,Drug_suspect,quetiapine sulfoxide,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,FXJNLPUSSHEDON-UHFFFAOYSA-N
CCMSLIB00012725147,related spectra of 'quetiapine sulfoxide (delta mass:15.995)',CCMSLIB00010135507|CCMSLIB00010135508|CCMSLIB00010135509|CCMSLIB00010135510|CCMSLIB00010135511|CCMSLIB00010135512|CCMSLIB00010135513|CCMSLIB00010135514,15.99,2787,Drug_suspect,quetiapine sulfoxide,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,FXJNLPUSSHEDON-UHFFFAOYSA-N
CCMSLIB00012725148,related spectra of 'quetiapine sulfoxide (delta mass:176.032)',CCMSLIB00010135507|CCMSLIB00010135508|CCMSLIB00010135509|CCMSLIB00010135510|CCMSLIB00010135511|CCMSLIB00010135512|CCMSLIB00010135513|CCMSLIB00010135514,176.03,2788,Drug_suspect,quetiapine sulfoxide,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,FXJNLPUSSHEDON-UHFFFAOYSA-N
CCMSLIB00012725149,related spectra of 'quetiapine fumarate (seroquel) (delta mass:-16.031)',CCMSLIB00000078279,-16.03,2789,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725150,related spectra of 'quetiapine fumarate (seroquel) (delta mass:13.98)',CCMSLIB00000078279,13.98,2790,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725151,related spectra of 'quetiapinefumarate (delta mass:13.98)',CCMSLIB00000006401|CCMSLIB00000006402|CCMSLIB00000006403|CCMSLIB00000006404|CCMSLIB00000006405|CCMSLIB00000006406|CCMSLIB00000006407|CCMSLIB00000006408|CCMSLIB00000006409,13.98,2791,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,ZNPNOVHKCAAQCG-UHFFFAOYSA-N
CCMSLIB00012725152,related spectra of 'rifampicin (delta mass:-42.01)',CCMSLIB00000076971,-42.01,2792,Drug_suspect,rifampicin,rifamycin antibacterial,infectious disease,tuberculosis|meningitis,RNA polymerase inhibitor,JQXXHWHPUNPDRT-WLSIYKJHSA-N
CCMSLIB00012725153,related spectra of 'rifampicin (delta mass:176.032)',CCMSLIB00000076971,176.03,2793,Drug_suspect,rifampicin,rifamycin antibacterial,infectious disease,tuberculosis|meningitis,RNA polymerase inhibitor,JQXXHWHPUNPDRT-WLSIYKJHSA-N
CCMSLIB00012725154,related spectra of 'rifaximin (delta mass:-42.01)',CCMSLIB00000079274|CCMSLIB00000079275,-42.01,2794,Drug_suspect,rifaximin,rifamycin antibacterial,gastroenterology|infectious disease,diarrhea|irritable bowel syndrome|hepatic encephalopathy (HE),RNA synthesis inhibitor,NZCRJKRKKOLAOJ-XRCRFVBUSA-N
CCMSLIB00012725155,related spectra of 'rifaximin (delta mass:-14.016)',CCMSLIB00000079274|CCMSLIB00000079275,-14.02,2795,Drug_suspect,rifaximin,rifamycin antibacterial,gastroenterology|infectious disease,diarrhea|irritable bowel syndrome|hepatic encephalopathy (HE),RNA synthesis inhibitor,NZCRJKRKKOLAOJ-XRCRFVBUSA-N
CCMSLIB00012725156,related spectra of 'rifaximin (delta mass:14.016)',CCMSLIB00000079274|CCMSLIB00000079275,14.02,2796,Drug_suspect,rifaximin,rifamycin antibacterial,gastroenterology|infectious disease,diarrhea|irritable bowel syndrome|hepatic encephalopathy (HE),RNA synthesis inhibitor,NZCRJKRKKOLAOJ-XRCRFVBUSA-N
CCMSLIB00012725157,related spectra of 'radafaxine (delta mass:-18.011)',CCMSLIB00010131545|CCMSLIB00010131546|CCMSLIB00010131548|CCMSLIB00010131549|CCMSLIB00010131553|CCMSLIB00010131554|CCMSLIB00010131555|CCMSLIB00010131556|CCMSLIB00010131557|CCMSLIB00010131579|CCMSLIB00010131580|CCMSLIB00010131581|CCMSLIB00010131582|CCMSLIB00010131583|CCMSLIB00010131584|CCMSLIB00010131585|CCMSLIB00010131586|CCMSLIB00010131587|CCMSLIB00010131588|CCMSLIB00010131589|CCMSLIB00010131590|CCMSLIB00010131591|CCMSLIB00010131656|CCMSLIB00010131657|CCMSLIB00010131658|CCMSLIB00010131659|CCMSLIB00010131660|CCMSLIB00010131661|CCMSLIB00010131662|CCMSLIB00010131663|CCMSLIB00010131664|CCMSLIB00010131665,-18.01,2797,Drug_suspect,hydroxybupropion,no_match,NA,NA,dopamine-norepinephrine reuptake inhibitor,RCOBKSKAZMVBHT-TVQRCGJNSA-N
CCMSLIB00012725158,related spectra of 'radafaxine (delta mass:0.984)',CCMSLIB00010131545|CCMSLIB00010131546|CCMSLIB00010131548|CCMSLIB00010131549|CCMSLIB00010131553|CCMSLIB00010131554|CCMSLIB00010131555|CCMSLIB00010131556|CCMSLIB00010131557|CCMSLIB00010131579|CCMSLIB00010131580|CCMSLIB00010131581|CCMSLIB00010131582|CCMSLIB00010131583|CCMSLIB00010131584|CCMSLIB00010131585|CCMSLIB00010131586|CCMSLIB00010131587|CCMSLIB00010131588|CCMSLIB00010131589|CCMSLIB00010131590|CCMSLIB00010131591|CCMSLIB00010131656|CCMSLIB00010131657|CCMSLIB00010131658|CCMSLIB00010131659|CCMSLIB00010131660|CCMSLIB00010131661|CCMSLIB00010131662|CCMSLIB00010131663|CCMSLIB00010131664|CCMSLIB00010131665,0.98,2798,Drug_suspect,hydroxybupropion,no_match,NA,NA,dopamine-norepinephrine reuptake inhibitor,RCOBKSKAZMVBHT-TVQRCGJNSA-N
CCMSLIB00012725159,related spectra of 'radafaxine (delta mass:1.993)',CCMSLIB00010131545|CCMSLIB00010131546|CCMSLIB00010131548|CCMSLIB00010131549|CCMSLIB00010131553|CCMSLIB00010131554|CCMSLIB00010131555|CCMSLIB00010131556|CCMSLIB00010131557|CCMSLIB00010131579|CCMSLIB00010131580|CCMSLIB00010131581|CCMSLIB00010131582|CCMSLIB00010131583|CCMSLIB00010131584|CCMSLIB00010131585|CCMSLIB00010131586|CCMSLIB00010131587|CCMSLIB00010131588|CCMSLIB00010131589|CCMSLIB00010131590|CCMSLIB00010131591|CCMSLIB00010131656|CCMSLIB00010131657|CCMSLIB00010131658|CCMSLIB00010131659|CCMSLIB00010131660|CCMSLIB00010131661|CCMSLIB00010131662|CCMSLIB00010131663|CCMSLIB00010131664|CCMSLIB00010131665,2,2799,Drug_suspect,hydroxybupropion,no_match,NA,NA,dopamine-norepinephrine reuptake inhibitor,RCOBKSKAZMVBHT-TVQRCGJNSA-N
CCMSLIB00012725160,related spectra of 'radafaxine (delta mass:2.999)',CCMSLIB00010131545|CCMSLIB00010131546|CCMSLIB00010131548|CCMSLIB00010131549|CCMSLIB00010131553|CCMSLIB00010131554|CCMSLIB00010131555|CCMSLIB00010131556|CCMSLIB00010131557|CCMSLIB00010131579|CCMSLIB00010131580|CCMSLIB00010131581|CCMSLIB00010131582|CCMSLIB00010131583|CCMSLIB00010131584|CCMSLIB00010131585|CCMSLIB00010131586|CCMSLIB00010131587|CCMSLIB00010131588|CCMSLIB00010131589|CCMSLIB00010131590|CCMSLIB00010131591|CCMSLIB00010131656|CCMSLIB00010131657|CCMSLIB00010131658|CCMSLIB00010131659|CCMSLIB00010131660|CCMSLIB00010131661|CCMSLIB00010131662|CCMSLIB00010131663|CCMSLIB00010131664|CCMSLIB00010131665,3,2800,Drug_suspect,hydroxybupropion,no_match,NA,NA,dopamine-norepinephrine reuptake inhibitor,RCOBKSKAZMVBHT-TVQRCGJNSA-N
CCMSLIB00012725161,related spectra of 'radafaxine (delta mass:15.995)',CCMSLIB00010131545|CCMSLIB00010131546|CCMSLIB00010131548|CCMSLIB00010131549|CCMSLIB00010131553|CCMSLIB00010131554|CCMSLIB00010131555|CCMSLIB00010131556|CCMSLIB00010131557|CCMSLIB00010131579|CCMSLIB00010131580|CCMSLIB00010131581|CCMSLIB00010131582|CCMSLIB00010131583|CCMSLIB00010131584|CCMSLIB00010131585|CCMSLIB00010131586|CCMSLIB00010131587|CCMSLIB00010131588|CCMSLIB00010131589|CCMSLIB00010131590|CCMSLIB00010131591|CCMSLIB00010131656|CCMSLIB00010131657|CCMSLIB00010131658|CCMSLIB00010131659|CCMSLIB00010131660|CCMSLIB00010131661|CCMSLIB00010131662|CCMSLIB00010131663|CCMSLIB00010131664|CCMSLIB00010131665,15.99,2801,Drug_suspect,hydroxybupropion,no_match,NA,NA,dopamine-norepinephrine reuptake inhibitor,RCOBKSKAZMVBHT-TVQRCGJNSA-N
CCMSLIB00012725162,related spectra of 'ravuconazole (delta mass:-15.979)',CCMSLIB00010131773|CCMSLIB00010131774|CCMSLIB00010131775|CCMSLIB00010131776|CCMSLIB00010131777,-15.98,2802,Drug_suspect,ravuconazole,no_match,NA,NA,sterol demethylase inhibitor,OPAHEYNNJWPQPX-RCDICMHDSA-N
CCMSLIB00012725163,related spectra of 'rifamycin s (delta mass:15.975)',CCMSLIB00000001651|CCMSLIB00000001653|CCMSLIB00000478607,15.97,2803,Drug_suspect,rifamycin,rifamycin antibacterial,infectious disease,travelers' diarrhea|gram-positive bacterial infection|gram-negative bacterial infection,DNA directed RNA polymerase inhibitor,BTVYFIMKUHNOBZ-ODRIEIDWSA-N
CCMSLIB00012725164,related spectra of 'rifaximin (xifaxan) (delta mass:-42.01)',CCMSLIB00000078289|CCMSLIB00000078290,-42.01,2804,Drug_suspect,rifaximin,rifamycin antibacterial,gastroenterology|infectious disease,diarrhea|irritable bowel syndrome|hepatic encephalopathy (HE),RNA synthesis inhibitor,NZCRJKRKKOLAOJ-XRCRFVBUSA-N
CCMSLIB00012725165,related spectra of 'rifaximin (xifaxan) (delta mass:-14.016)',CCMSLIB00000078289|CCMSLIB00000078290,-14.02,2805,Drug_suspect,rifaximin,rifamycin antibacterial,gastroenterology|infectious disease,diarrhea|irritable bowel syndrome|hepatic encephalopathy (HE),RNA synthesis inhibitor,NZCRJKRKKOLAOJ-XRCRFVBUSA-N
CCMSLIB00012724890,"related spectra of 'massbank:ea258010 ritonavir| 1,3-thiazol-5-ylmethyl n-[(2s,5s)-3-hydroxy-5-[[3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate (delta mass:15.995)'",CCMSLIB00000209759,15.99,2530,Drug_suspect,ritonavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,NCDNCNXCDXHOMX-FDEOAKKQSA-N
CCMSLIB00012724936,"related spectra of 'massbank:eq301602 darunavir|n-[(1s,2r)-1-benzyl-2-hydroxy-3-[isobutyl(sulfanilyl)amino]propyl]carbamic acid [(3as,4r,6ar)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] ester (delta mass:-43.99)'",CCMSLIB00005734048,-43.99,2576,Drug_suspect,darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-UHFFFAOYSA-N
CCMSLIB00012725168,related spectra of 's-methylglutathione (delta mass:14.016)',CCMSLIB00010131524|CCMSLIB00010131525|CCMSLIB00010131526|CCMSLIB00010131527|CCMSLIB00010131528|CCMSLIB00010131529|CCMSLIB00010131530|CCMSLIB00010131531,14.02,2808,Drug_suspect,s-methylglutathione,no_match,no_match,no_match,no_match,QTQDDTSVRVWHMO-BQBZGAKWSA-N
CCMSLIB00012725169,related spectra of 'sulfadoxine (delta mass:-2.016)',CCMSLIB00010140230|CCMSLIB00010140231|CCMSLIB00010140232|CCMSLIB00010140233|CCMSLIB00010140234,-2.02,2809,Drug_suspect|Background/QAQC,sulfadoxine,sulfonamide,infectious disease,malaria,dihydropteroate synthase inhibitor,PJSFRIWCGOHTNF-UHFFFAOYSA-N
CCMSLIB00012725170,related spectra of 'sulfadoxine (delta mass:1.003)',CCMSLIB00010140230|CCMSLIB00010140231|CCMSLIB00010140232|CCMSLIB00010140233|CCMSLIB00010140234,1,2810,Drug_suspect|Background/QAQC,sulfadoxine,sulfonamide,infectious disease,malaria,dihydropteroate synthase inhibitor,PJSFRIWCGOHTNF-UHFFFAOYSA-N
CCMSLIB00012725171,related spectra of 'sulfadoxine (delta mass:1.993)',CCMSLIB00010140230|CCMSLIB00010140231|CCMSLIB00010140232|CCMSLIB00010140233|CCMSLIB00010140234,2,2811,Drug_suspect|Background/QAQC,sulfadoxine,sulfonamide,infectious disease,malaria,dihydropteroate synthase inhibitor,PJSFRIWCGOHTNF-UHFFFAOYSA-N
CCMSLIB00012725172,related spectra of 'sulfadoxine (delta mass:2.004)',CCMSLIB00010140230|CCMSLIB00010140231|CCMSLIB00010140232|CCMSLIB00010140233|CCMSLIB00010140234,2,2812,Drug_suspect|Background/QAQC,sulfadoxine,sulfonamide,infectious disease,malaria,dihydropteroate synthase inhibitor,PJSFRIWCGOHTNF-UHFFFAOYSA-N
CCMSLIB00012725173,related spectra of 'sulfadoxine (delta mass:2.016)',CCMSLIB00010140230|CCMSLIB00010140231|CCMSLIB00010140232|CCMSLIB00010140233|CCMSLIB00010140234,2.02,2813,Drug_suspect|Background/QAQC,sulfadoxine,sulfonamide,infectious disease,malaria,dihydropteroate synthase inhibitor,PJSFRIWCGOHTNF-UHFFFAOYSA-N
CCMSLIB00012725174,related spectra of 'sulfisomidine (delta mass:2.004)',CCMSLIB00010150209|CCMSLIB00010150210|CCMSLIB00010150211|CCMSLIB00010150212|CCMSLIB00010150213,2,2814,Drug_suspect|Low_confidence,sulfisomidine,no_match,NA,NA,antibacterial,YZMCKZRAOLZXAZ-UHFFFAOYSA-N
CCMSLIB00012725175,related spectra of 'sulfisomidine (delta mass:14.016)',CCMSLIB00010150209|CCMSLIB00010150210|CCMSLIB00010150211|CCMSLIB00010150212|CCMSLIB00010150213,14.02,2815,Drug_suspect|Low_confidence,sulfisomidine,no_match,NA,NA,antibacterial,YZMCKZRAOLZXAZ-UHFFFAOYSA-N
CCMSLIB00012725176,related spectra of 'sulfisomidine (delta mass:162.053)',CCMSLIB00010150209|CCMSLIB00010150210|CCMSLIB00010150211|CCMSLIB00010150212|CCMSLIB00010150213,162.05,2816,Drug_suspect|Low_confidence,sulfisomidine,no_match,NA,NA,antibacterial,YZMCKZRAOLZXAZ-UHFFFAOYSA-N
CCMSLIB00012725177,related spectra of 'silodosin (delta mass:-58.042)',CCMSLIB00010140112|CCMSLIB00010140113|CCMSLIB00010140114|CCMSLIB00010140115|CCMSLIB00010140116|CCMSLIB00010140117|CCMSLIB00010140118|CCMSLIB00010140119,-58.04,2817,Drug_suspect,silodosin,alpha adrenergic blocker,urology,benign prostatic hyperplasia (BPH),adrenergic receptor antagonist,PNCPYILNMDWPEY-QGZVFWFLSA-N
CCMSLIB00012725178,related spectra of 'silodosin (delta mass:13.98)',CCMSLIB00010140112|CCMSLIB00010140113|CCMSLIB00010140114|CCMSLIB00010140115|CCMSLIB00010140116|CCMSLIB00010140117|CCMSLIB00010140118|CCMSLIB00010140119,13.98,2818,Drug_suspect,silodosin,alpha adrenergic blocker,urology,benign prostatic hyperplasia (BPH),adrenergic receptor antagonist,PNCPYILNMDWPEY-QGZVFWFLSA-N
CCMSLIB00012725179,related spectra of 'simvastatin backbone ion (delta mass:-29.975)',CCMSLIB00005435703,-29.97,2819,Drug_suspect,simvastatin backbone ion,HMG-CoA reductase inhibitor (statin),endocrinology|cardiology|neurology/psychiatry,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,NA
CCMSLIB00012725180,related spectra of 'simvastatin backbone ion (delta mass:14.016)',CCMSLIB00005435703,14.02,2820,Drug_suspect,simvastatin backbone ion,HMG-CoA reductase inhibitor (statin),endocrinology|cardiology|neurology/psychiatry,hypercholesterolemia|coronary heart disease|myocardial infarction|stroke|hyperlipidemia|atherosclerosis,HMGCR inhibitor,NA
CCMSLIB00012725181,related spectra of 'solifenacin (delta mass:15.995)',CCMSLIB00010140060|CCMSLIB00010140061|CCMSLIB00010140062|CCMSLIB00010140063|CCMSLIB00010140064|CCMSLIB00010140065|CCMSLIB00010140066|CCMSLIB00010140067|CCMSLIB00010141210|CCMSLIB00010141211|CCMSLIB00010141212|CCMSLIB00010141213|CCMSLIB00010141214,15.99,2821,Drug_suspect,solifenacin,anticholinergic,urology,urinary incontinence|urinary frequency,acetylcholine receptor antagonist,FBOUYBDGKBSUES-VXKWHMMOSA-N
CCMSLIB00012725182,related spectra of 'spectral match to (+)-.alpha.-tocopherol from nist14 (delta mass:1.003)',CCMSLIB00003135122|CCMSLIB00003136309|CCMSLIB00003136792|CCMSLIB00003138013,1,2822,Drug_suspect,tocofersolan,vitamins,metabolism,vitamin E deficiency,antioxidant|vitamin E,GVJHHUAWPYXKBD-IEOSBIPESA-N
CCMSLIB00012725183,related spectra of 'spectral match to .beta.-estradiol 3-benzoate from nist14 (delta mass:17.027)',CCMSLIB00003134645|CCMSLIB00003134651|CCMSLIB00003135377|CCMSLIB00003136395|CCMSLIB00003138449|CCMSLIB00003140040|CCMSLIB00003140226,17.03,2823,Drug_suspect|Low_confidence,estradiol benzoate,estrogen,obstetrics/gynecology,contraceptive|menopause symptoms,estrogen receptor agonist,UYIFTLBWAOGQBI-BZDYCCQFSA-N
CCMSLIB00012725184,related spectra of 'spectral match to .beta.-estradiol 3-benzoate from nist14 (delta mass:15.995)',CCMSLIB00003134645|CCMSLIB00003134651|CCMSLIB00003135377|CCMSLIB00003136395|CCMSLIB00003138449|CCMSLIB00003140040|CCMSLIB00003140226,15.99,2824,Drug_suspect|Low_confidence,estradiol benzoate,estrogen,obstetrics/gynecology,contraceptive|menopause symptoms,estrogen receptor agonist,UYIFTLBWAOGQBI-BZDYCCQFSA-N
CCMSLIB00012725185,related spectra of 'spectral match to 1-hexadecylpyridinium from nist14 (delta mass:-21.984)',CCMSLIB00003134747|CCMSLIB00003135734|CCMSLIB00003137637,-21.98,2825,Drug_suspect,cetylpyridinium,antiseptics and disinfectants,dental,gingivitis|mouth inflammation,antiseptic,NEUSVAOJNUQRTM-UHFFFAOYSA-N
CCMSLIB00012725186,related spectra of 'spectral match to 1-hexadecylpyridinium from nist14 (delta mass:29.974)',CCMSLIB00003134747|CCMSLIB00003135734|CCMSLIB00003137637,29.97,2826,Drug_suspect,cetylpyridinium,antiseptics and disinfectants,dental,gingivitis|mouth inflammation,antiseptic,NEUSVAOJNUQRTM-UHFFFAOYSA-N
CCMSLIB00012725187,related spectra of 'spectral match to 2-hydroxy-4-methoxybenzophenone from nist14 (delta mass:1.003)',CCMSLIB00003135062|CCMSLIB00003135866|CCMSLIB00003137818,1,2827,Drug_suspect,oxybenzone,no_match,dermatology,sunscreen lotion,lipase inhibitor,DXGLGDHPHMLXJC-UHFFFAOYSA-N
CCMSLIB00012725188,related spectra of 'spectral match to 2-hydroxy-4-methoxybenzophenone from nist14 (delta mass:14.016)',CCMSLIB00003135062|CCMSLIB00003135866|CCMSLIB00003137818,14.02,2828,Drug_suspect,oxybenzone,no_match,dermatology,sunscreen lotion,lipase inhibitor,DXGLGDHPHMLXJC-UHFFFAOYSA-N
CCMSLIB00012725189,related spectra of 'spectral match to amiodarone from nist14 (delta mass:-28.031)',CCMSLIB00003138500,-28.03,2829,Drug_suspect,amiodarone,antiarrhythmic,cardiology,ventricular arrhythmias,potassium channel blocker,IYIKLHRQXLHMJQ-UHFFFAOYSA-N
CCMSLIB00012725190,related spectra of 'spectral match to amiodarone from nist14 (delta mass:13.98)',CCMSLIB00003138500,13.98,2830,Drug_suspect,amiodarone,antiarrhythmic,cardiology,ventricular arrhythmias,potassium channel blocker,IYIKLHRQXLHMJQ-UHFFFAOYSA-N
CCMSLIB00012725191,related spectra of 'spectral match to amitriptyline from nist14 (delta mass:1.003)',CCMSLIB00003134726|CCMSLIB00003134977|CCMSLIB00003136124|CCMSLIB00003136711|CCMSLIB00003138900,1,2831,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N|NA
CCMSLIB00012725192,related spectra of 'spectral match to amitriptyline from nist14 (delta mass:15.995)',CCMSLIB00003134726|CCMSLIB00003134977|CCMSLIB00003136124|CCMSLIB00003136711|CCMSLIB00003138900,15.99,2832,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N|NA
CCMSLIB00012725193,related spectra of 'spectral match to ampicillin from nist14 (delta mass:12.0)',CCMSLIB00003134964|CCMSLIB00003135533|CCMSLIB00003136777|CCMSLIB00003136795|CCMSLIB00003136826|CCMSLIB00003136856|CCMSLIB00003137057|CCMSLIB00003137135|CCMSLIB00003137167|CCMSLIB00003137197|CCMSLIB00003138124|CCMSLIB00003138564|CCMSLIB00003138994|CCMSLIB00003139459|CCMSLIB00003139621|CCMSLIB00003139940,12,2833,Drug_suspect,ampicillin,penicillin class antibacterial,infectious disease,respiratory tract infections|meningitis|bacterial septicemia|endocarditis|urinary tract infections|gastrointestinal infections,bacterial cell wall synthesis inhibitor,AVKUERGKIZMTKX-NJBDSQKTSA-N
CCMSLIB00012725194,related spectra of 'spectral match to artesunate from nist14 (delta mass:-100.016)',CCMSLIB00003135856|CCMSLIB00003136469,-100.02,2834,Drug_suspect,artesunate,antimalarial,infectious disease,malaria,DNA synthesis inhibitor,FIHJKUPKCHIPAT-AHIGJZGOSA-N
CCMSLIB00012725195,related spectra of 'spectral match to avobenzone from nist14 (delta mass:-27.995)',CCMSLIB00003134632|CCMSLIB00003136058|CCMSLIB00003139344|CCMSLIB00003139700|CCMSLIB00003139723,-27.99,2835,Drug_suspect,avobenzone,no_match,dermatology,cosmetic|sunscreen lotion,topical sunscreen agent,XNEFYCZVKIDDMS-UHFFFAOYSA-N
CCMSLIB00012725196,related spectra of 'spectral match to avobenzone from nist14 (delta mass:15.995)',CCMSLIB00003134632|CCMSLIB00003136058|CCMSLIB00003139344|CCMSLIB00003139700|CCMSLIB00003139723,15.99,2836,Drug_suspect,avobenzone,no_match,dermatology,cosmetic|sunscreen lotion,topical sunscreen agent,XNEFYCZVKIDDMS-UHFFFAOYSA-N
CCMSLIB00012725197,related spectra of 'spectral match to baicalin from nist14 (delta mass:2.016)',CCMSLIB00003137233|CCMSLIB00003138563|CCMSLIB00003138770|CCMSLIB00003138915|CCMSLIB00003139314|CCMSLIB00003139334,2.02,2837,Drug_suspect,baicalin,no_match,NA,NA,beta glucuronidase inhibitor,IKIIZLYTISPENI-ZFORQUDYSA-N
CCMSLIB00012725198,related spectra of 'spectral match to baicalin from nist14 (delta mass:14.016)',CCMSLIB00003137233|CCMSLIB00003138563|CCMSLIB00003138770|CCMSLIB00003138915|CCMSLIB00003139314|CCMSLIB00003139334,14.02,2838,Drug_suspect,baicalin,no_match,NA,NA,beta glucuronidase inhibitor,IKIIZLYTISPENI-ZFORQUDYSA-N
CCMSLIB00012725199,related spectra of 'spectral match to baicalin from nist14 (delta mass:27.995)',CCMSLIB00003137233|CCMSLIB00003138563|CCMSLIB00003138770|CCMSLIB00003138915|CCMSLIB00003139314|CCMSLIB00003139334,27.99,2839,Drug_suspect,baicalin,no_match,NA,NA,beta glucuronidase inhibitor,IKIIZLYTISPENI-ZFORQUDYSA-N
CCMSLIB00012725200,related spectra of 'spectral match to baicalin from nist14 (delta mass:-40.032)',CCMSLIB00003137233|CCMSLIB00003138563|CCMSLIB00003138770|CCMSLIB00003138915|CCMSLIB00003139314|CCMSLIB00003139334,-40.03,2840,Drug_suspect,baicalin,no_match,NA,NA,beta glucuronidase inhibitor,IKIIZLYTISPENI-ZFORQUDYSA-N
CCMSLIB00012725201,related spectra of 'spectral match to baicalin from nist14 (delta mass:-11.964)',CCMSLIB00003137233|CCMSLIB00003138563|CCMSLIB00003138770|CCMSLIB00003138915|CCMSLIB00003139314|CCMSLIB00003139334,-11.96,2841,Drug_suspect,baicalin,no_match,NA,NA,beta glucuronidase inhibitor,IKIIZLYTISPENI-ZFORQUDYSA-N
CCMSLIB00012725202,related spectra of 'spectral match to benzyldodecyldimethylammonium from nist14 (delta mass:-28.031)',CCMSLIB00003135025|CCMSLIB00003136025|CCMSLIB00003136054|CCMSLIB00003136390|CCMSLIB00003137084|CCMSLIB00003138424|CCMSLIB00003138447|CCMSLIB00003138572|CCMSLIB00003139649,-28.03,2842,Drug_suspect,benzalkonium,antiseptics and disinfectants,NA,antiseptic,antiseptic|preservative,CYDRXTMLKJDRQH-UHFFFAOYSA-N
CCMSLIB00012725203,related spectra of 'spectral match to benzyldodecyldimethylammonium from nist14 (delta mass:1.003)',CCMSLIB00003135025|CCMSLIB00003136025|CCMSLIB00003136054|CCMSLIB00003136390|CCMSLIB00003137084|CCMSLIB00003138424|CCMSLIB00003138447|CCMSLIB00003138572|CCMSLIB00003139649,1,2843,Drug_suspect,benzalkonium,antiseptics and disinfectants,NA,antiseptic,antiseptic|preservative,CYDRXTMLKJDRQH-UHFFFAOYSA-N
CCMSLIB00012725204,related spectra of 'spectral match to benzyldodecyldimethylammonium from nist14 (delta mass:1.943)',CCMSLIB00003135025|CCMSLIB00003136025|CCMSLIB00003136054|CCMSLIB00003136390|CCMSLIB00003137084|CCMSLIB00003138424|CCMSLIB00003138447|CCMSLIB00003138572|CCMSLIB00003139649,1.94,2844,Drug_suspect,benzalkonium,antiseptics and disinfectants,NA,antiseptic,antiseptic|preservative,CYDRXTMLKJDRQH-UHFFFAOYSA-N
CCMSLIB00012725205,related spectra of 'spectral match to benzyldodecyldimethylammonium from nist14 (delta mass:28.031)',CCMSLIB00003135025|CCMSLIB00003136025|CCMSLIB00003136054|CCMSLIB00003136390|CCMSLIB00003137084|CCMSLIB00003138424|CCMSLIB00003138447|CCMSLIB00003138572|CCMSLIB00003139649,28.03,2845,Drug_suspect,benzalkonium,antiseptics and disinfectants,NA,antiseptic,antiseptic|preservative,CYDRXTMLKJDRQH-UHFFFAOYSA-N
CCMSLIB00012725206,related spectra of 'spectral match to benzyldodecyldimethylammonium from nist14 (delta mass:29.974)',CCMSLIB00003135025|CCMSLIB00003136025|CCMSLIB00003136054|CCMSLIB00003136390|CCMSLIB00003137084|CCMSLIB00003138424|CCMSLIB00003138447|CCMSLIB00003138572|CCMSLIB00003139649,29.97,2846,Drug_suspect,benzalkonium,antiseptics and disinfectants,NA,antiseptic,antiseptic|preservative,CYDRXTMLKJDRQH-UHFFFAOYSA-N
CCMSLIB00012725207,related spectra of 'spectral match to cetirizine from nist14 (delta mass:-44.026)',CCMSLIB00003136875,-44.03,2847,Drug_suspect,cetirizine,histamine-1 (H1) inhibitor,allergy,allergic rhinitis|urticaria,histamine receptor antagonist,ZKLPARSLTMPFCP-UHFFFAOYSA-N
CCMSLIB00012725208,related spectra of 'spectral match to citalopram from metlin (delta mass:-14.016)',CCMSLIB00003140190,-14.02,2848,Drug_suspect,citalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-UHFFFAOYSA-N
CCMSLIB00012725209,related spectra of 'spectral match to citalopram from metlin (delta mass:15.995)',CCMSLIB00003140190,15.99,2849,Drug_suspect,citalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-UHFFFAOYSA-N
CCMSLIB00012725210,"related spectra of 'spectral match to cyanidin 3,5-diglucoside from nist14 (delta mass:-1.98)'",CCMSLIB00003137671|CCMSLIB00003139593,-1.98,2850,Drug_suspect,indocyanine green,diagnostic dye,radiology,vascular imaging agent,contrast agent,RDFLLVCQYHQOBU-ZOTFFYTFSA-O
CCMSLIB00012725211,"related spectra of 'spectral match to cyanidin 3,5-diglucoside from nist14 (delta mass:13.98)'",CCMSLIB00003137671|CCMSLIB00003139593,13.98,2851,Drug_suspect,indocyanine green,diagnostic dye,radiology,vascular imaging agent,contrast agent,RDFLLVCQYHQOBU-ZOTFFYTFSA-O
CCMSLIB00012725212,related spectra of 'spectral match to cyclobenzaprine from nist14 (delta mass:18.01)',CCMSLIB00003136482|CCMSLIB00003137759|CCMSLIB00003139608,18.01,2852,Drug_suspect,cyclobenzaprine,muscle relaxant,neurology/psychiatry,muscle spasms,adrenergic receptor agonist|serotonin receptor agonist,JURKNVYFZMSNLP-UHFFFAOYSA-N
CCMSLIB00012725213,related spectra of 'spectral match to desferrioxamine from nist14 (delta mass:-44.026)',CCMSLIB00003134607|CCMSLIB00003134671|CCMSLIB00003135047|CCMSLIB00003135563|CCMSLIB00003135712|CCMSLIB00003135891|CCMSLIB00003136339|CCMSLIB00003137069|CCMSLIB00003138086|CCMSLIB00003139590|CCMSLIB00003139877,-44.03,2853,Drug_suspect,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012725214,related spectra of 'spectral match to desferrioxamine from nist14 (delta mass:-43.04)',CCMSLIB00003134607|CCMSLIB00003134671|CCMSLIB00003135047|CCMSLIB00003135563|CCMSLIB00003135712|CCMSLIB00003135891|CCMSLIB00003136339|CCMSLIB00003137069|CCMSLIB00003138086|CCMSLIB00003139590|CCMSLIB00003139877,-43.04,2854,Drug_suspect,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012725215,related spectra of 'spectral match to desferrioxamine from nist14 (delta mass:-30.01)',CCMSLIB00003134607|CCMSLIB00003134671|CCMSLIB00003135047|CCMSLIB00003135563|CCMSLIB00003135712|CCMSLIB00003135891|CCMSLIB00003136339|CCMSLIB00003137069|CCMSLIB00003138086|CCMSLIB00003139590|CCMSLIB00003139877,-30.01,2855,Drug_suspect,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012725216,related spectra of 'spectral match to desferrioxamine from nist14 (delta mass:-14.016)',CCMSLIB00003134607|CCMSLIB00003134671|CCMSLIB00003135047|CCMSLIB00003135563|CCMSLIB00003135712|CCMSLIB00003135891|CCMSLIB00003136339|CCMSLIB00003137069|CCMSLIB00003138086|CCMSLIB00003139590|CCMSLIB00003139877,-14.02,2856,Drug_suspect,deferoxamine,iron chelator,hematology,acute iron intoxication|iron overload,chelating agent,UBQYURCVBFRUQT-UHFFFAOYSA-N
CCMSLIB00012725217,related spectra of 'spectral match to desmethylketamine from nist14 (delta mass:1.993)',CCMSLIB00003139502,2,2857,Drug_suspect,ketamine metabolite,general anesthetic,neurology/psychiatry,anesthesia,NMDA receptor antagonist,NA
CCMSLIB00012725218,related spectra of 'spectral match to desmethylketamine from nist14 (delta mass:2.004)',CCMSLIB00003139502,2,2858,Drug_suspect,ketamine metabolite,general anesthetic,neurology/psychiatry,anesthesia,NMDA receptor antagonist,NA
CCMSLIB00012725219,related spectra of 'spectral match to diatrizoic acid from nist14 (delta mass:14.016)',CCMSLIB00003139191|CCMSLIB00003139215,14.02,2859,Drug_suspect,diatrizoic acid,radiographic contrast agent,radiology,contrast agent,NA,YVPYQUNUQOZFHG-UHFFFAOYSA-N
CCMSLIB00012725220,related spectra of 'spectral match to diethyltoluamide from nist14 (delta mass:29.974)',CCMSLIB00003135871|CCMSLIB00003137365,29.97,2860,Drug_suspect,diethyltoluamide,other insecticides and repellents,NA,NA,ionotropic receptor IR40a activator,MMOXZBCLCQITDF-UHFFFAOYSA-N
CCMSLIB00012725221,related spectra of 'spectral match to diltiazem from nist14 (delta mass:-14.016)',CCMSLIB00003135470|CCMSLIB00003135521,-14.02,2861,Drug_suspect,diltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,HSUGRBWQSSZJOP-RTWAWAEBSA-N
CCMSLIB00012725222,related spectra of 'spectral match to dioctyl sulfosuccinate from nist14 (delta mass:15.995)',CCMSLIB00003135991|CCMSLIB00003136961|CCMSLIB00003139039,15.99,2862,Drug_suspect,docusate sodium,"softeners, emollients",gastroenterology,constipation,laxative,HNSDLXPSAYFUHK-UHFFFAOYSA-N
CCMSLIB00012725223,related spectra of 'spectral match to eicosapentaenoic acid ethyl ester from nist14 (delta mass:-56.062)',CCMSLIB00003135591|CCMSLIB00003137858|CCMSLIB00003138718,-56.06,2863,Drug_suspect,icosapent ethyl,other lipid modifying agents,cardiology,hypertriglyceridemia,cholesterol inhibitor,SSQPWTVBQMWLSZ-AAQCHOMXSA-N
CCMSLIB00012725224,related spectra of 'spectral match to epirubicin from nist14 (delta mass:-18.011)',CCMSLIB00003139661,-18.01,2864,Drug_suspect,epirubicin,anthracycline topoisomerase inhibitor,hematologic malignancy|oncology,acute lymphoblastic leukemia (ALL)|acute myeloid leukemia (AML)|Wilm's tumor|breast cancer|ovarian cancer|Hodgkin's lymphoma|bladder cancer|multiple myeloma,topoisomerase inhibitor,AOJJSUZBOXZQNB-VTZDEGQISA-N
CCMSLIB00012725225,related spectra of 'spectral match to epirubicin from nist14 (delta mass:-14.016)',CCMSLIB00003139661,-14.02,2865,Drug_suspect,epirubicin,anthracycline topoisomerase inhibitor,hematologic malignancy|oncology,acute lymphoblastic leukemia (ALL)|acute myeloid leukemia (AML)|Wilm's tumor|breast cancer|ovarian cancer|Hodgkin's lymphoma|bladder cancer|multiple myeloma,topoisomerase inhibitor,AOJJSUZBOXZQNB-VTZDEGQISA-N
CCMSLIB00012725226,related spectra of 'spectral match to epirubicin from nist14 (delta mass:18.01)',CCMSLIB00003139661,18.01,2866,Drug_suspect,epirubicin,anthracycline topoisomerase inhibitor,hematologic malignancy|oncology,acute lymphoblastic leukemia (ALL)|acute myeloid leukemia (AML)|Wilm's tumor|breast cancer|ovarian cancer|Hodgkin's lymphoma|bladder cancer|multiple myeloma,topoisomerase inhibitor,AOJJSUZBOXZQNB-VTZDEGQISA-N
CCMSLIB00012725227,related spectra of 'spectral match to erythromycin from nist14 (delta mass:-14.016)',CCMSLIB00003135296|CCMSLIB00003137289|CCMSLIB00003138877,-14.02,2867,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725228,related spectra of 'spectral match to erythromycin from nist14 (delta mass:13.98)',CCMSLIB00003135296|CCMSLIB00003137289|CCMSLIB00003138877,13.98,2868,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725229,related spectra of 'spectral match to erythromycin from nist14 (delta mass:28.031)',CCMSLIB00003135296|CCMSLIB00003137289|CCMSLIB00003138877,28.03,2869,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725230,related spectra of 'spectral match to erythromycin from nist14 (delta mass:-176.105)',CCMSLIB00003135296|CCMSLIB00003137289|CCMSLIB00003138877,-176.1,2870,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725231,related spectra of 'spectral match to erythromycin from nist14 (delta mass:-18.011)',CCMSLIB00003135296|CCMSLIB00003137289|CCMSLIB00003138877,-18.01,2871,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725232,related spectra of 'spectral match to erythromycin from nist14 (delta mass:-15.995)',CCMSLIB00003135296|CCMSLIB00003137289|CCMSLIB00003138877,-15.99,2872,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725233,related spectra of 'spectral match to erythromycin from nist14 (delta mass:-14.016)',CCMSLIB00003135296|CCMSLIB00003137289|CCMSLIB00003138877,-14.02,2873,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725234,related spectra of 'spectral match to erythromycin from nist14 (delta mass:-3.995)',CCMSLIB00003137289|CCMSLIB00003138877,-3.99,2874,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725235,related spectra of 'spectral match to erythromycin from nist14 (delta mass:2.016)',CCMSLIB00003135296|CCMSLIB00003137289|CCMSLIB00003138877,2.02,2875,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725236,related spectra of 'spectral match to erythromycin from nist14 (delta mass:3.995)',CCMSLIB00003135296|CCMSLIB00003137289|CCMSLIB00003138877,3.99,2876,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725237,related spectra of 'spectral match to erythromycin from nist14 (delta mass:14.016)',CCMSLIB00003135296|CCMSLIB00003137289|CCMSLIB00003138877,14.02,2877,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725238,related spectra of 'spectral match to erythromycin from nist14 (delta mass:15.995)',CCMSLIB00003135296|CCMSLIB00003137289|CCMSLIB00003138877,15.99,2878,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725239,related spectra of 'spectral match to erythromycin from nist14 (delta mass:31.99)',CCMSLIB00003135296|CCMSLIB00003137289|CCMSLIB00003138877,31.99,2879,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725240,related spectra of 'spectral match to erythromycin from nist14 (delta mass:34.005)',CCMSLIB00003135296|CCMSLIB00003137289|CCMSLIB00003138877,34.01,2880,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725241,related spectra of 'spectral match to erythromycin from nist14 (delta mass:61.053)',CCMSLIB00003135296|CCMSLIB00003137289|CCMSLIB00003138877,61.05,2881,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725242,related spectra of 'spectral match to ethylenediaminetetraacetic acid from nist14 (delta mass:-58.006)',CCMSLIB00003134529|CCMSLIB00003134779|CCMSLIB00003135454|CCMSLIB00003135498|CCMSLIB00003139410,-58.01,2882,Drug_suspect|Background/QAQC,edta,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N
CCMSLIB00012725243,related spectra of 'spectral match to ethylenediaminetetraacetic acid from nist14 (delta mass:-30.01)',CCMSLIB00003134529|CCMSLIB00003134779|CCMSLIB00003135454|CCMSLIB00003135498|CCMSLIB00003139410,-30.01,2883,Drug_suspect|Background/QAQC,edta,lead chelator|anticoagulant,critical care,metal toxicity,chelating agent,KCXVZYZYPLLWCC-UHFFFAOYSA-N
CCMSLIB00012725244,related spectra of 'spectral match to gabapentin from nist14 (delta mass:-58.042)',CCMSLIB00003137859|CCMSLIB00003137885|CCMSLIB00003137913,-58.04,2884,Drug_suspect|Low_confidence,gabapentin,antiepileptic drug (AED),neurology/psychiatry,neuropathic pain|shingles|seizures|restless leg syndrome,calcium channel blocker,UGJMXCAKCUNAIE-UHFFFAOYSA-N
CCMSLIB00012725245,related spectra of 'spectral match to gabapentin from nist14 (delta mass:21.984)',CCMSLIB00003137859|CCMSLIB00003137885|CCMSLIB00003137913,21.98,2885,Drug_suspect|Low_confidence,gabapentin,antiepileptic drug (AED),neurology/psychiatry,neuropathic pain|shingles|seizures|restless leg syndrome,calcium channel blocker,UGJMXCAKCUNAIE-UHFFFAOYSA-N
CCMSLIB00012725246,related spectra of 'spectral match to gabapentin from nist14 (delta mass:61.053)',CCMSLIB00003137859|CCMSLIB00003137885|CCMSLIB00003137913,61.05,2886,Drug_suspect|Low_confidence,gabapentin,antiepileptic drug (AED),neurology/psychiatry,neuropathic pain|shingles|seizures|restless leg syndrome,calcium channel blocker,UGJMXCAKCUNAIE-UHFFFAOYSA-N
CCMSLIB00012725247,related spectra of 'spectral match to hepc from nist14 (delta mass:-4.031)',CCMSLIB00003134569|CCMSLIB00003139798,-4.03,2887,Drug_suspect|Low_confidence,miltefosine,antileishmanial drug,infectious disease,leishmaniasis,membrane integrity inhibitor,PQLXHQMOHUQAKB-UHFFFAOYSA-O
CCMSLIB00012725248,related spectra of 'spectral match to hepc from nist14 (delta mass:-2.016)',CCMSLIB00003134569|CCMSLIB00003139798,-2.02,2888,Drug_suspect|Low_confidence,miltefosine,antileishmanial drug,infectious disease,leishmaniasis,membrane integrity inhibitor,PQLXHQMOHUQAKB-UHFFFAOYSA-O
CCMSLIB00012725249,related spectra of 'spectral match to hepc from nist14 (delta mass:1.003)',CCMSLIB00003134569|CCMSLIB00003139798,1,2889,Drug_suspect|Low_confidence,miltefosine,antileishmanial drug,infectious disease,leishmaniasis,membrane integrity inhibitor,PQLXHQMOHUQAKB-UHFFFAOYSA-O
CCMSLIB00012725250,related spectra of 'spectral match to hydroxychloroquine from nist14 (delta mass:13.98)',CCMSLIB00003136088|CCMSLIB00003136145|CCMSLIB00003136264,13.98,2890,Drug_suspect,hydroxychloroquine,antirheumatic|antimalarial,infectious disease|rheumatology,malaria|rheumatoid arthritis|lupus,antimalarial agent,XXSMGPRMXLTPCZ-UHFFFAOYSA-N
CCMSLIB00012725251,related spectra of 'spectral match to loperamide from nist14 (delta mass:-28.031)',CCMSLIB00003138788|CCMSLIB00003140249,-28.03,2891,Drug_suspect,loperamide,opioid agonist,gastroenterology,diarrhea,opioid receptor agonist,RDOIQAHITMMDAJ-UHFFFAOYSA-N
CCMSLIB00012725252,related spectra of 'spectral match to loperamide from nist14 (delta mass:-14.016)',CCMSLIB00003138788|CCMSLIB00003140249,-14.02,2892,Drug_suspect,loperamide,opioid agonist,gastroenterology,diarrhea,opioid receptor agonist,RDOIQAHITMMDAJ-UHFFFAOYSA-N
CCMSLIB00012725253,related spectra of 'spectral match to lorazepam from nist14 (delta mass:1.993)',CCMSLIB00003134640,2,2893,Drug_suspect,lorazepam,benzodiazepine,neurology/psychiatry,anxiety|seizures|insomnia|anesthesia,GABA-A receptor agonist,DIWRORZWFLOCLC-UHFFFAOYSA-N
CCMSLIB00012725254,related spectra of 'spectral match to lorazepam from nist14 (delta mass:2.999)',CCMSLIB00003134640,3,2894,Drug_suspect,lorazepam,benzodiazepine,neurology/psychiatry,anxiety|seizures|insomnia|anesthesia,GABA-A receptor agonist,DIWRORZWFLOCLC-UHFFFAOYSA-N
CCMSLIB00012725255,related spectra of 'spectral match to meloxicam from nist14 (delta mass:29.974)',CCMSLIB00003135226|CCMSLIB00003136594,29.97,2895,Drug_suspect,meloxicam,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis,cyclooxygenase inhibitor,ZRVUJXDFFKFLMG-UHFFFAOYSA-N
CCMSLIB00012725256,related spectra of 'spectral match to mestranol from nist14 (delta mass:-12.036)',CCMSLIB00003140010,-12.04,2896,Drug_suspect,mestranol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist,IMSSROKUHAOUJS-MJCUULBUSA-N
CCMSLIB00012725257,related spectra of 'spectral match to mestranol from nist14 (delta mass:27.995)',CCMSLIB00003140010,27.99,2897,Drug_suspect,mestranol,estrogen,obstetrics/gynecology,contraceptive,estrogen receptor agonist,IMSSROKUHAOUJS-MJCUULBUSA-N
CCMSLIB00012725258,related spectra of 'spectral match to nifenazone from nist14 (delta mass:4.032)',CCMSLIB00003137539,4.03,2898,Drug_suspect,nifenazone,salicylic acid preparations,dermatology,acne vulgaris (AV)|warts|psoriasis|corns,cyclooxygenase inhibitor|prostanoid receptor antagonist,YGSDEFSMJLZEOE-UHFFFAOYSA-N
CCMSLIB00012725259,related spectra of 'spectral match to nortriptyline from nist14 (delta mass:30.01)',CCMSLIB00003135401|CCMSLIB00003136095|CCMSLIB00003138588,30.01,2899,Drug_suspect,nortriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression,tricyclic antidepressant,PHVGLTMQBUFIQQ-UHFFFAOYSA-N
CCMSLIB00012725260,related spectra of 'spectral match to ofloxacin from nist14 (delta mass:-14.016)',CCMSLIB00003135908,-14.02,2900,Drug_suspect,ofloxacin,fluoroquinolone antimicrobial,infectious disease,pneumonia|sinusitis|bronchitis|skin infections|prostatitis|urinary tract infections|pyelonephritis|anthrax|plague|gram-negative bacterial infections|gram-positive bacterial infections,bacterial DNA gyrase inhibitor,GSDSWSVVBLHKDQ-UHFFFAOYSA-N
CCMSLIB00012725261,related spectra of 'spectral match to penicillamine disulfide from nist14 (delta mass:27.995)',CCMSLIB00003137618,27.99,2901,Drug_suspect|Low_confidence,d-penicillamine disulfide,antirheumatic,metabolism|rheumatology|genetics,Wilson's disease|rheumatoid arthritis|cystinuria,chelating agent,POYPKGFSZHXASD-WDSKDSINSA-N
CCMSLIB00012725262,related spectra of 'spectral match to pindolol from nist14 (delta mass:28.031)',CCMSLIB00003134568,28.03,2902,Drug_suspect,pindolol,beta-adrenergic receptor inhibitor,cardiology,hypertension,adrenergic receptor antagonist,NA
CCMSLIB00012725263,related spectra of 'spectral match to quetiapine from metlin (delta mass:-88.053)',CCMSLIB00003134541,-88.05,2903,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725264,related spectra of 'spectral match to quetiapine from metlin (delta mass:-44.026)',CCMSLIB00003134541,-44.03,2904,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725265,related spectra of 'spectral match to quetiapine from metlin (delta mass:-16.031)',CCMSLIB00003134541,-16.03,2905,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725266,related spectra of 'spectral match to quetiapine from metlin (delta mass:-2.016)',CCMSLIB00003134541,-2.02,2906,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725267,related spectra of 'spectral match to quetiapine from metlin (delta mass:13.98)',CCMSLIB00003134541,13.98,2907,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725268,related spectra of 'spectral match to quetiapine from metlin (delta mass:15.995)',CCMSLIB00003134541,15.99,2908,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725269,related spectra of 'spectral match to quetiapine from nist14 (delta mass:-44.026)',CCMSLIB00003140182,-44.03,2909,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725270,related spectra of 'spectral match to quetiapine from nist14 (delta mass:13.98)',CCMSLIB00003140182,13.98,2910,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725271,related spectra of 'spectral match to quetiapine from nist14 (delta mass:15.995)',CCMSLIB00003140182,15.99,2911,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725272,related spectra of 'spectral match to sulfadimethoxine from nist14 (delta mass:-90.048)',CCMSLIB00003134657|CCMSLIB00003134693|CCMSLIB00003135764|CCMSLIB00003135842|CCMSLIB00003136358|CCMSLIB00003137321|CCMSLIB00003137512|CCMSLIB00003138002|CCMSLIB00003138091|CCMSLIB00003138703|CCMSLIB00003138866|CCMSLIB00003138938|CCMSLIB00003138961,-90.05,2912,Drug_suspect|Background/QAQC,sulfadimethoxine,sulfonamide antimicrobial|veterinary,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,dihydropteroate synthetase inhibitor,ZZORFUFYDOWNEF-UHFFFAOYSA-N
CCMSLIB00012725273,related spectra of 'spectral match to sulfadimethoxine from nist14 (delta mass:-3.985)',CCMSLIB00003134657|CCMSLIB00003134693|CCMSLIB00003135764|CCMSLIB00003135842|CCMSLIB00003136358|CCMSLIB00003137321|CCMSLIB00003137512|CCMSLIB00003138002|CCMSLIB00003138091|CCMSLIB00003138703|CCMSLIB00003138866|CCMSLIB00003138938|CCMSLIB00003138961,-3.99,2913,Drug_suspect|Background/QAQC,sulfadimethoxine,sulfonamide antimicrobial|veterinary,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,dihydropteroate synthetase inhibitor,ZZORFUFYDOWNEF-UHFFFAOYSA-N
CCMSLIB00012725274,related spectra of 'spectral match to sulfadimethoxine from nist14 (delta mass:1.003)',CCMSLIB00003134657|CCMSLIB00003134693|CCMSLIB00003135764|CCMSLIB00003135842|CCMSLIB00003136358|CCMSLIB00003137321|CCMSLIB00003137512|CCMSLIB00003138002|CCMSLIB00003138091|CCMSLIB00003138703|CCMSLIB00003138866|CCMSLIB00003138938|CCMSLIB00003138961,1,2914,Drug_suspect|Background/QAQC,sulfadimethoxine,sulfonamide antimicrobial|veterinary,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,dihydropteroate synthetase inhibitor,ZZORFUFYDOWNEF-UHFFFAOYSA-N
CCMSLIB00012725275,related spectra of 'spectral match to sulfadimethoxine from nist14 (delta mass:1.993)',CCMSLIB00003134657|CCMSLIB00003134693|CCMSLIB00003135764|CCMSLIB00003135842|CCMSLIB00003136358|CCMSLIB00003137321|CCMSLIB00003137512|CCMSLIB00003138002|CCMSLIB00003138091|CCMSLIB00003138703|CCMSLIB00003138866|CCMSLIB00003138938|CCMSLIB00003138961,2,2915,Drug_suspect|Background/QAQC,sulfadimethoxine,sulfonamide antimicrobial|veterinary,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,dihydropteroate synthetase inhibitor,ZZORFUFYDOWNEF-UHFFFAOYSA-N
CCMSLIB00012725276,related spectra of 'spectral match to sulfadimethoxine from nist14 (delta mass:2.004)',CCMSLIB00003134657|CCMSLIB00003134693|CCMSLIB00003135764|CCMSLIB00003135842|CCMSLIB00003136358|CCMSLIB00003137321|CCMSLIB00003137512|CCMSLIB00003138002|CCMSLIB00003138091|CCMSLIB00003138703|CCMSLIB00003138866|CCMSLIB00003138938|CCMSLIB00003138961,2,2916,Drug_suspect|Background/QAQC,sulfadimethoxine,sulfonamide antimicrobial|veterinary,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,dihydropteroate synthetase inhibitor,ZZORFUFYDOWNEF-UHFFFAOYSA-N
CCMSLIB00012725277,related spectra of 'spectral match to sulfadimethoxine from nist14 (delta mass:2.016)',CCMSLIB00003134657|CCMSLIB00003134693|CCMSLIB00003135764|CCMSLIB00003135842|CCMSLIB00003136358|CCMSLIB00003137321|CCMSLIB00003137512|CCMSLIB00003138002|CCMSLIB00003138091|CCMSLIB00003138703|CCMSLIB00003138866|CCMSLIB00003138938|CCMSLIB00003138961,2.02,2917,Drug_suspect|Background/QAQC,sulfadimethoxine,sulfonamide antimicrobial|veterinary,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,dihydropteroate synthetase inhibitor,ZZORFUFYDOWNEF-UHFFFAOYSA-N
CCMSLIB00012725278,related spectra of 'spectral match to sulfadimethoxine from nist14 (delta mass:2.999)',CCMSLIB00003134657|CCMSLIB00003134693|CCMSLIB00003135764|CCMSLIB00003135842|CCMSLIB00003136358|CCMSLIB00003137321|CCMSLIB00003137512|CCMSLIB00003138002|CCMSLIB00003138091|CCMSLIB00003138703|CCMSLIB00003138866|CCMSLIB00003138938|CCMSLIB00003138961,3,2918,Drug_suspect|Background/QAQC,sulfadimethoxine,sulfonamide antimicrobial|veterinary,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,dihydropteroate synthetase inhibitor,ZZORFUFYDOWNEF-UHFFFAOYSA-N
CCMSLIB00012725279,related spectra of 'spectral match to sulfadoxin from nist14 (delta mass:2.004)',CCMSLIB00003135183|CCMSLIB00003135483|CCMSLIB00003135695|CCMSLIB00003135919|CCMSLIB00003137993|CCMSLIB00003138192|CCMSLIB00003138817|CCMSLIB00003139177,2,2919,Drug_suspect|Background/QAQC,sulfadoxine,sulfonamide,infectious disease,malaria,dihydropteroate synthase inhibitor,PJSFRIWCGOHTNF-UHFFFAOYSA-N
CCMSLIB00012725280,related spectra of 'spectral match to sulfamethazine from nist14 (delta mass:2.004)',CCMSLIB00003135019|CCMSLIB00003135048|CCMSLIB00003136257|CCMSLIB00003136955|CCMSLIB00003137995|CCMSLIB00003138861,2,2920,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725281,related spectra of 'spectral match to sulfamethazine from nist14 (delta mass:27.995)',CCMSLIB00003135019|CCMSLIB00003135048|CCMSLIB00003136257|CCMSLIB00003136955|CCMSLIB00003137995|CCMSLIB00003138861,27.99,2921,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725282,related spectra of 'spectral match to sulfamethizole from nist14 (delta mass:1.993)',CCMSLIB00003135796|CCMSLIB00003137228|CCMSLIB00003137765|CCMSLIB00003138135|CCMSLIB00003139855,2,2922,Drug_suspect|Background/QAQC,sulfamethizole,sulfonamide antimicrobial,infectious disease,urinary tract infections,bacterial antifolate,VACCAVUAMIDAGB-UHFFFAOYSA-N
CCMSLIB00012725283,related spectra of 'spectral match to sulfamethizole from nist14 (delta mass:2.999)',CCMSLIB00003135796|CCMSLIB00003137228|CCMSLIB00003137765|CCMSLIB00003138135|CCMSLIB00003139855,3,2923,Drug_suspect|Background/QAQC,sulfamethizole,sulfonamide antimicrobial,infectious disease,urinary tract infections,bacterial antifolate,VACCAVUAMIDAGB-UHFFFAOYSA-N
CCMSLIB00012725284,related spectra of 'spectral match to sulfamethizole from nist14 (delta mass:14.016)',CCMSLIB00003135796|CCMSLIB00003137228|CCMSLIB00003137765|CCMSLIB00003138135|CCMSLIB00003139855,14.02,2924,Drug_suspect|Background/QAQC,sulfamethizole,sulfonamide antimicrobial,infectious disease,urinary tract infections,bacterial antifolate,VACCAVUAMIDAGB-UHFFFAOYSA-N
CCMSLIB00012725285,related spectra of 'spectral match to sulfamethizole from nist14 (delta mass:15.995)',CCMSLIB00003135796|CCMSLIB00003137228|CCMSLIB00003137765|CCMSLIB00003138135|CCMSLIB00003139855,15.99,2925,Drug_suspect|Background/QAQC,sulfamethizole,sulfonamide antimicrobial,infectious disease,urinary tract infections,bacterial antifolate,VACCAVUAMIDAGB-UHFFFAOYSA-N
CCMSLIB00012725286,related spectra of 'spectral match to sulfamethizole from nist14 (delta mass:27.995)',CCMSLIB00003135796|CCMSLIB00003137228|CCMSLIB00003137765|CCMSLIB00003138135|CCMSLIB00003139855,27.99,2926,Drug_suspect|Background/QAQC,sulfamethizole,sulfonamide antimicrobial,infectious disease,urinary tract infections,bacterial antifolate,VACCAVUAMIDAGB-UHFFFAOYSA-N
CCMSLIB00012725287,related spectra of 'spectral match to sulindac sulfone from nist14 (delta mass:-31.991)',CCMSLIB00003137137,-31.99,2927,Drug_suspect,exisulind,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis|ankylosing spondylitis,cyclooxygenase inhibitor,MVGSNCBCUWPVDA-MFOYZWKCSA-N
CCMSLIB00012725288,related spectra of 'spectral match to terbinafine from nist14 (delta mass:-14.016)',CCMSLIB00003138916|CCMSLIB00003139293,-14.02,2928,Drug_suspect,terbinafine,allylamine antifungal,infectious disease,tinea pedis|tinea cruris|tinea corporis,fungal squalene epoxidase inhibitor,DOMXUEMWDBAQBQ-WEVVVXLNSA-N
CCMSLIB00012725289,related spectra of 'spectral match to terbinafine from nist14 (delta mass:1.978)',CCMSLIB00003138916|CCMSLIB00003139293,1.98,2929,Drug_suspect,terbinafine,allylamine antifungal,infectious disease,tinea pedis|tinea cruris|tinea corporis,fungal squalene epoxidase inhibitor,DOMXUEMWDBAQBQ-WEVVVXLNSA-N
CCMSLIB00012725290,related spectra of 'spectral match to terbinafine from nist14 (delta mass:15.975)',CCMSLIB00003138916|CCMSLIB00003139293,15.97,2930,Drug_suspect,terbinafine,allylamine antifungal,infectious disease,tinea pedis|tinea cruris|tinea corporis,fungal squalene epoxidase inhibitor,DOMXUEMWDBAQBQ-WEVVVXLNSA-N
CCMSLIB00012725291,related spectra of 'spectral match to terbinafine from nist14 (delta mass:15.995)',CCMSLIB00003138916|CCMSLIB00003139293,15.99,2931,Drug_suspect,terbinafine,allylamine antifungal,infectious disease,tinea pedis|tinea cruris|tinea corporis,fungal squalene epoxidase inhibitor,DOMXUEMWDBAQBQ-WEVVVXLNSA-N
CCMSLIB00012725292,related spectra of 'spectral match to terbinafine from nist14 (delta mass:29.974)',CCMSLIB00003138916|CCMSLIB00003139293,29.97,2932,Drug_suspect,terbinafine,allylamine antifungal,infectious disease,tinea pedis|tinea cruris|tinea corporis,fungal squalene epoxidase inhibitor,DOMXUEMWDBAQBQ-WEVVVXLNSA-N
CCMSLIB00012725293,related spectra of 'spectral match to terbinafine from nist14 (delta mass:31.99)',CCMSLIB00003138916|CCMSLIB00003139293,31.99,2933,Drug_suspect,terbinafine,allylamine antifungal,infectious disease,tinea pedis|tinea cruris|tinea corporis,fungal squalene epoxidase inhibitor,DOMXUEMWDBAQBQ-WEVVVXLNSA-N
CCMSLIB00012725294,related spectra of 'spectral match to thymidine from nist14 (delta mass:-14.016)',CCMSLIB00003135045|CCMSLIB00003136510|CCMSLIB00003137624|CCMSLIB00003138747|CCMSLIB00003139902|CCMSLIB00003139908,-14.02,2934,Drug_suspect,telbivudine,HBV nucleoside analog reverse transcriptase inhibitor (HBV-NRTI),infectious disease,hepatitis B,DNA polymerase inhibitor,IQFYYKKMVGJFEH-XLPZGREQSA-N
CCMSLIB00012725295,related spectra of 'spectral match to thymidine from nist14 (delta mass:-0.984)',CCMSLIB00003135045|CCMSLIB00003136510|CCMSLIB00003137624|CCMSLIB00003138747|CCMSLIB00003139902|CCMSLIB00003139908,-0.98,2935,Drug_suspect,telbivudine,HBV nucleoside analog reverse transcriptase inhibitor (HBV-NRTI),infectious disease,hepatitis B,DNA polymerase inhibitor,IQFYYKKMVGJFEH-XLPZGREQSA-N
CCMSLIB00012725296,related spectra of 'spectral match to trazodone from nist14 (delta mass:2.004)',CCMSLIB00003134509|CCMSLIB00003135035|CCMSLIB00003136788|CCMSLIB00003139444|CCMSLIB00003139478,2,2936,Drug_suspect,trazodone,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,NA|PHLBKPHSAVXXEF-UHFFFAOYSA-N
CCMSLIB00012725297,related spectra of 'spectral match to trazodone from nist14 (delta mass:15.995)',CCMSLIB00003134509|CCMSLIB00003135035|CCMSLIB00003136788|CCMSLIB00003139444|CCMSLIB00003139478,15.99,2937,Drug_suspect,trazodone,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,NA|PHLBKPHSAVXXEF-UHFFFAOYSA-N
CCMSLIB00012725298,related spectra of 'spectral match to tylosin from nist14 (delta mass:1.003)',CCMSLIB00003136011,1,2938,Drug_suspect,tylosin,macrolide antimicrobial|veterinary,infectious disease,gram-positive bacterial infections|colitis,protein synthesis inhibitor,WBPYTXDJUQJLPQ-VMXQISHHSA-N
CCMSLIB00012725299,related spectra of 'spectral match to valsartan from nist14 (delta mass:-18.011)',CCMSLIB00003138031,-18.01,2939,Drug_suspect,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012725300,related spectra of 'spectral match to valsartan from nist14 (delta mass:-4.954)',CCMSLIB00003138031,-4.96,2940,Drug_suspect,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012725301,related spectra of 'spectral match to valsartan from nist14 (delta mass:-2.016)',CCMSLIB00003138031,-2.02,2941,Drug_suspect,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012725302,related spectra of 'spectral match to valsartan from nist14 (delta mass:15.995)',CCMSLIB00003138031,15.99,2942,Drug_suspect,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012725303,related spectra of 'spectral match to vecuronium cation from nist14 (delta mass:-42.01)',CCMSLIB00003137713|CCMSLIB00003140215,-42.01,2943,Drug_suspect,vecuronium,nondepolarizing neuromuscular blocker,neurology/psychiatry,muscle relaxant,acetylcholine receptor antagonist,BGSZAXLLHYERSY-XQIGCQGXSA-N
CCMSLIB00012725304,related spectra of 'spectral match to vecuronium cation from nist14 (delta mass:-12.036)',CCMSLIB00003137713|CCMSLIB00003140215,-12.04,2944,Drug_suspect,vecuronium,nondepolarizing neuromuscular blocker,neurology/psychiatry,muscle relaxant,acetylcholine receptor antagonist,BGSZAXLLHYERSY-XQIGCQGXSA-N
CCMSLIB00012725305,related spectra of 'spectral match to vecuronium cation from nist14 (delta mass:-12.036)',CCMSLIB00003137713|CCMSLIB00003140215,-12.04,2945,Drug_suspect,vecuronium,nondepolarizing neuromuscular blocker,neurology/psychiatry,muscle relaxant,acetylcholine receptor antagonist,BGSZAXLLHYERSY-XQIGCQGXSA-N
CCMSLIB00012725306,related spectra of 'spectral match to xylazine from nist14 (delta mass:1.003)',CCMSLIB00003135849|CCMSLIB00003136075|CCMSLIB00003138760|CCMSLIB00003138762|CCMSLIB00003139129|CCMSLIB00003139963,1,2946,Drug_suspect,xylazine,other hypnotics and sedatives|veterinary,neurology/psychiatry,anesthetic,adrenergic receptor agonist,BPICBUSOMSTKRF-UHFFFAOYSA-N
CCMSLIB00012725307,related spectra of 'spectral match to xylazine from nist14 (delta mass:2.004)',CCMSLIB00003135849|CCMSLIB00003136075|CCMSLIB00003138760|CCMSLIB00003138762|CCMSLIB00003139129|CCMSLIB00003139963,2,2947,Drug_suspect,xylazine,other hypnotics and sedatives|veterinary,neurology/psychiatry,anesthetic,adrenergic receptor agonist,BPICBUSOMSTKRF-UHFFFAOYSA-N
CCMSLIB00012725308,related spectra of 'streptomycin_50ev (delta mass:-14.016)',CCMSLIB00005723217,-14.02,2948,Drug_suspect,streptomycin,aminoglycoside antibacterial,infectious disease,tuberculosis|gram-negative bacterial infections,bacterial 30S ribosomal subunit inhibitor,UCSJYZPVAKXKNQ-HZYVHMACSA-N
CCMSLIB00012725309,related spectra of 'sulfachloropyridazine (delta mass:1.993)',CCMSLIB00010146859|CCMSLIB00010146860|CCMSLIB00010146861|CCMSLIB00010146862|CCMSLIB00010146863,2,2949,Drug_suspect|Background/QAQC,sulfachloropyridazine,sulfonamide antimicrobial|veterinary,infectious disease,urinary tract infections,bacterial antifolate,XOXHILFPRYWFOD-UHFFFAOYSA-N
CCMSLIB00012725310,related spectra of 'sulfachloropyridazine (delta mass:2.999)',CCMSLIB00010146859|CCMSLIB00010146860|CCMSLIB00010146861|CCMSLIB00010146862|CCMSLIB00010146863,3,2950,Drug_suspect|Background/QAQC,sulfachloropyridazine,sulfonamide antimicrobial|veterinary,infectious disease,urinary tract infections,bacterial antifolate,XOXHILFPRYWFOD-UHFFFAOYSA-N
CCMSLIB00012725311,related spectra of 'sulfachloropyridazine (delta mass:12.036)',CCMSLIB00010146859|CCMSLIB00010146860|CCMSLIB00010146861|CCMSLIB00010146862|CCMSLIB00010146863,12.04,2951,Drug_suspect|Background/QAQC,sulfachloropyridazine,sulfonamide antimicrobial|veterinary,infectious disease,urinary tract infections,bacterial antifolate,XOXHILFPRYWFOD-UHFFFAOYSA-N
CCMSLIB00012725312,related spectra of 'sulfachloropyridazine (delta mass:27.995)',CCMSLIB00010146859|CCMSLIB00010146860|CCMSLIB00010146861|CCMSLIB00010146862|CCMSLIB00010146863,27.99,2952,Drug_suspect|Background/QAQC,sulfachloropyridazine,sulfonamide antimicrobial|veterinary,infectious disease,urinary tract infections,bacterial antifolate,XOXHILFPRYWFOD-UHFFFAOYSA-N
CCMSLIB00012725313,related spectra of 'sulfamethazine (delta mass:27.995)',CCMSLIB00000078582|CCMSLIB00003060629|CCMSLIB00003060630,27.99,2953,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N|NA
CCMSLIB00012725314,related spectra of 'tadalafil (delta mass:2.016)',CCMSLIB00000078956,2.02,2954,Drug_suspect,tadalafil,phosphodiesterase-5 (PDE-5) inhibitor,urology,erectile dysfunction|benign prostatic hyperplasia|pulmonary arterial hypertension (PAH),phosphodiesterase inhibitor,WOXKDUGGOYFFRN-IIBYNOLFSA-N
CCMSLIB00012725315,related spectra of 'tadalafil (delta mass:2.016)',CCMSLIB00004684429|CCMSLIB00004684430|CCMSLIB00004684431|CCMSLIB00004684432|CCMSLIB00004691229|CCMSLIB00004691230|CCMSLIB00004691231|CCMSLIB00004691232|CCMSLIB00004691233|CCMSLIB00004691234|CCMSLIB00004691235|CCMSLIB00004691236|CCMSLIB00004691237|CCMSLIB00010150669|CCMSLIB00010150670|CCMSLIB00010150671|CCMSLIB00010150672|CCMSLIB00010150673,2.02,2955,Drug_suspect,tadalafil|tadalafil,phosphodiesterase-5 (PDE-5) inhibitor,urology,erectile dysfunction|benign prostatic hyperplasia|pulmonary arterial hypertension (PAH),phosphodiesterase inhibitor,WOXKDUGGOYFFRN-IIBYNOLFSA-N|NA
CCMSLIB00012725316,related spectra of 'tamoxifen (delta mass:-14.016)',CCMSLIB00000077066|CCMSLIB00000579719,-14.02,2956,Drug_suspect,tamoxifen,estrogen agonist/antagonist,oncology,breast cancer,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),NKANXQFJJICGDU-QPLCGJKRSA-N
CCMSLIB00012725317,related spectra of 'tecadenoson (delta mass:-14.016)',CCMSLIB00010148099|CCMSLIB00010148100|CCMSLIB00010148101|CCMSLIB00010148102|CCMSLIB00010148103,-14.02,2957,Drug_suspect,tecadenoson,no_match,NA,NA,adenosine receptor agonist,OESBDSFYJMDRJY-BAYCTPFLSA-N
CCMSLIB00012725318,related spectra of 'temazepam (delta mass:14.016)',CCMSLIB00000579696|CCMSLIB00009919533,14.02,2958,Drug_suspect,temazepam|temazepam,benzodiazepine,neurology/psychiatry,insomnia,GABA-A receptor agonist,SEQDDYPDSLOBDC-UHFFFAOYSA-N
CCMSLIB00012725319,related spectra of 'temazepam (delta mass:176.032)',CCMSLIB00000579696|CCMSLIB00009919533,176.03,2959,Drug_suspect,temazepam|temazepam,benzodiazepine,neurology/psychiatry,insomnia,GABA-A receptor agonist,SEQDDYPDSLOBDC-UHFFFAOYSA-N
CCMSLIB00012725320,related spectra of 'terazosin (delta mass:-14.016)',CCMSLIB00000077132|CCMSLIB00000079158,-14.02,2960,Drug_suspect,terazosin,alpha adrenergic blocker,urology|cardiology,benign prostatic hyperplasia (BPH)|hypertension,adrenergic receptor antagonist,VCKUSRYTPJJLNI-UHFFFAOYSA-N
CCMSLIB00012725321,related spectra of 'terazosin (delta mass:31.99)',CCMSLIB00000077132|CCMSLIB00000079158,31.99,2961,Drug_suspect,terazosin,alpha adrenergic blocker,urology|cardiology,benign prostatic hyperplasia (BPH)|hypertension,adrenergic receptor antagonist,VCKUSRYTPJJLNI-UHFFFAOYSA-N
CCMSLIB00012725322,related spectra of 'tetracaine hydrochloride (pontocaine) (delta mass:-14.016)',CCMSLIB00000078514,-14.02,2962,Drug_suspect,tetracaine,ester local anesthetic,neurology/psychiatry,anesthetic,membrane integrity inhibitor,GKCBAIGFKIBETG-UHFFFAOYSA-N
CCMSLIB00012725323,related spectra of 'tetracaine hydrochloride (pontocaine) (delta mass:-12.036)',CCMSLIB00000078514,-12.04,2963,Drug_suspect,tetracaine,ester local anesthetic,neurology/psychiatry,anesthetic,membrane integrity inhibitor,GKCBAIGFKIBETG-UHFFFAOYSA-N
CCMSLIB00012725324,related spectra of 'tilarginine (delta mass:13.98)',CCMSLIB00010144106|CCMSLIB00010144107|CCMSLIB00010144108|CCMSLIB00010144109|CCMSLIB00010144110,13.98,2964,Drug_suspect,tilarginine,no_match,NA,NA,nitric oxide synthase inhibitor,NTNWOCRCBQPEKQ-YFKPBYRVSA-N
CCMSLIB00012725325,related spectra of 'tobramycin 1-n- or 3- n-formyl (delta mass:-27.995)',CCMSLIB00003142424,-27.99,2965,Drug_suspect,tobramycin 1-n- or 3- n-formyl,aminoglycoside antibacterial,infectious disease,bacterial septicemia|respiratory tract infections|meningitis|skin infections|urinary tract infections,bacterial 30S ribosomal subunit inhibitor,WRKRRZYETOSMBY-ZMYKPOSGSA-N
CCMSLIB00012725326,"related spectra of 'tobramycin, n-propionyl derivative likely (delta mass:-56.027)'",CCMSLIB00003142427|CCMSLIB00003142428,-56.03,2966,Drug_suspect,"tobramycin, n-propionyl derivative likely",aminoglycoside antibacterial,infectious disease,bacterial septicemia|respiratory tract infections|meningitis|skin infections|urinary tract infections,bacterial 30S ribosomal subunit inhibitor,XMVDIYAEPSBCDQ-HXNOWKDOSA-N
CCMSLIB00012725327,related spectra of 'topiramate (delta mass:2.004)',CCMSLIB00000005578|CCMSLIB00000005579|CCMSLIB00000005580|CCMSLIB00000005581|CCMSLIB00000005582|CCMSLIB00000005583|CCMSLIB00000078147|CCMSLIB00004684743|CCMSLIB00004684744|CCMSLIB00004684745|CCMSLIB00004684746|CCMSLIB00009919534,2,2967,Drug_suspect,topiramate|topiramate,other antiepileptics,neurology/psychiatry,epilepsy|migraine headache|seizures,carbonic anhydrase inhibitor|glutamate receptor antagonist|kainate receptor antagonist,KJADKKWYZYXHBB-XBWDGYHZSA-N
CCMSLIB00012725328,related spectra of 'torasemide (delta mass:-14.016)',CCMSLIB00000579369|CCMSLIB00000579641|CCMSLIB00010150195|CCMSLIB00010150196|CCMSLIB00010150197|CCMSLIB00010150198|CCMSLIB00010150199|CCMSLIB00010150200|CCMSLIB00010150201|CCMSLIB00010150202,-14.02,2968,Drug_suspect,torasemide|torasemide,loop diuretic,cardiology|nephrology,edema|hypertension|congestive heart failure|renal failure,electrolyte reabsorption inhibitor|thromboxane receptor antagonist,NGBFQHCMQULJNZ-UHFFFAOYSA-N
CCMSLIB00012725329,related spectra of 'trazodone hydrochloride (desyrel) (delta mass:2.004)',CCMSLIB00000078519,2,2969,Drug_suspect,trazodone,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,PHLBKPHSAVXXEF-UHFFFAOYSA-N
CCMSLIB00012725330,related spectra of 'tricaprylin  (delta mass:-17.026)',CCMSLIB00000479745,-17.03,2970,Drug_suspect,tricaprylin,no_match,dermatology,cosmetic,NA,VLPFTAMPNXLGLX-UHFFFAOYSA-N
CCMSLIB00012725331,related spectra of 'tricaprylin  (delta mass:4.955)',CCMSLIB00000479745,4.96,2971,Drug_suspect,tricaprylin,no_match,dermatology,cosmetic,NA,VLPFTAMPNXLGLX-UHFFFAOYSA-N
CCMSLIB00012725332,related spectra of 'tricaprylin  (delta mass:28.031)',CCMSLIB00000479745,28.03,2972,Drug_suspect,tricaprylin,no_match,dermatology,cosmetic,NA,VLPFTAMPNXLGLX-UHFFFAOYSA-N
CCMSLIB00012725333,related spectra of 'tricaprylin  (delta mass:42.01)',CCMSLIB00000479745,42.01,2973,Drug_suspect,tricaprylin,no_match,dermatology,cosmetic,NA,VLPFTAMPNXLGLX-UHFFFAOYSA-N
CCMSLIB00012725334,related spectra of 'trospium (delta mass:-30.01)',CCMSLIB00010139337|CCMSLIB00010139338|CCMSLIB00010139339|CCMSLIB00010139340|CCMSLIB00010139341|CCMSLIB00010139342|CCMSLIB00010139343|CCMSLIB00010139344|CCMSLIB00010139345|CCMSLIB00010139346|CCMSLIB00010139347|CCMSLIB00010139348|CCMSLIB00010139349|CCMSLIB00010139350|CCMSLIB00010139351|CCMSLIB00010139352,-30.01,2974,Drug_suspect,trospium,anticholinergic,urology,urinary incontinence|urinary frequency,acetylcholine receptor antagonist,OYYDSUSKLWTMMQ-AIZNXBIQSA-N
CCMSLIB00012725335,related spectra of 'trospium (delta mass:2.004)',CCMSLIB00010139337|CCMSLIB00010139338|CCMSLIB00010139339|CCMSLIB00010139340|CCMSLIB00010139341|CCMSLIB00010139342|CCMSLIB00010139343|CCMSLIB00010139344|CCMSLIB00010139345|CCMSLIB00010139346|CCMSLIB00010139347|CCMSLIB00010139348|CCMSLIB00010139349|CCMSLIB00010139350|CCMSLIB00010139351|CCMSLIB00010139352,2,2975,Drug_suspect,trospium,anticholinergic,urology,urinary incontinence|urinary frequency,acetylcholine receptor antagonist,OYYDSUSKLWTMMQ-AIZNXBIQSA-N
CCMSLIB00012725336,related spectra of 'trospium (delta mass:15.012)',CCMSLIB00010139337|CCMSLIB00010139338|CCMSLIB00010139339|CCMSLIB00010139340|CCMSLIB00010139341|CCMSLIB00010139342|CCMSLIB00010139343|CCMSLIB00010139344|CCMSLIB00010139345|CCMSLIB00010139346|CCMSLIB00010139347|CCMSLIB00010139348|CCMSLIB00010139349|CCMSLIB00010139350|CCMSLIB00010139351|CCMSLIB00010139352,15.01,2976,Drug_suspect,trospium,anticholinergic,urology,urinary incontinence|urinary frequency,acetylcholine receptor antagonist,OYYDSUSKLWTMMQ-AIZNXBIQSA-N
CCMSLIB00012725337,related spectra of 'trospium (delta mass:21.984)',CCMSLIB00010139337|CCMSLIB00010139338|CCMSLIB00010139339|CCMSLIB00010139340|CCMSLIB00010139341|CCMSLIB00010139342|CCMSLIB00010139343|CCMSLIB00010139344|CCMSLIB00010139345|CCMSLIB00010139346|CCMSLIB00010139347|CCMSLIB00010139348|CCMSLIB00010139349|CCMSLIB00010139350|CCMSLIB00010139351|CCMSLIB00010139352,21.98,2977,Drug_suspect,trospium,anticholinergic,urology,urinary incontinence|urinary frequency,acetylcholine receptor antagonist,OYYDSUSKLWTMMQ-AIZNXBIQSA-N
CCMSLIB00012725338,related spectra of 'trospium (delta mass:27.047)',CCMSLIB00010139337|CCMSLIB00010139338|CCMSLIB00010139339|CCMSLIB00010139340|CCMSLIB00010139341|CCMSLIB00010139342|CCMSLIB00010139343|CCMSLIB00010139344|CCMSLIB00010139345|CCMSLIB00010139346|CCMSLIB00010139347|CCMSLIB00010139348|CCMSLIB00010139349|CCMSLIB00010139350|CCMSLIB00010139351|CCMSLIB00010139352,27.05,2978,Drug_suspect,trospium,anticholinergic,urology,urinary incontinence|urinary frequency,acetylcholine receptor antagonist,OYYDSUSKLWTMMQ-AIZNXBIQSA-N
CCMSLIB00012725339,related spectra of 'trospium (delta mass:27.995)',CCMSLIB00010139337|CCMSLIB00010139338|CCMSLIB00010139339|CCMSLIB00010139340|CCMSLIB00010139341|CCMSLIB00010139342|CCMSLIB00010139343|CCMSLIB00010139344|CCMSLIB00010139345|CCMSLIB00010139346|CCMSLIB00010139347|CCMSLIB00010139348|CCMSLIB00010139349|CCMSLIB00010139350|CCMSLIB00010139351|CCMSLIB00010139352,27.99,2979,Drug_suspect,trospium,anticholinergic,urology,urinary incontinence|urinary frequency,acetylcholine receptor antagonist,OYYDSUSKLWTMMQ-AIZNXBIQSA-N
CCMSLIB00012725340,related spectra of 'trospium (delta mass:29.974)',CCMSLIB00010139337|CCMSLIB00010139338|CCMSLIB00010139339|CCMSLIB00010139340|CCMSLIB00010139341|CCMSLIB00010139342|CCMSLIB00010139343|CCMSLIB00010139344|CCMSLIB00010139345|CCMSLIB00010139346|CCMSLIB00010139347|CCMSLIB00010139348|CCMSLIB00010139349|CCMSLIB00010139350|CCMSLIB00010139351|CCMSLIB00010139352,29.97,2980,Drug_suspect,trospium,anticholinergic,urology,urinary incontinence|urinary frequency,acetylcholine receptor antagonist,OYYDSUSKLWTMMQ-AIZNXBIQSA-N
CCMSLIB00012725341,related spectra of 'trospium (delta mass:42.01)',CCMSLIB00010139337|CCMSLIB00010139338|CCMSLIB00010139339|CCMSLIB00010139340|CCMSLIB00010139341|CCMSLIB00010139342|CCMSLIB00010139343|CCMSLIB00010139344|CCMSLIB00010139345|CCMSLIB00010139346|CCMSLIB00010139347|CCMSLIB00010139348|CCMSLIB00010139349|CCMSLIB00010139350|CCMSLIB00010139351|CCMSLIB00010139352,42.01,2981,Drug_suspect,trospium,anticholinergic,urology,urinary incontinence|urinary frequency,acetylcholine receptor antagonist,OYYDSUSKLWTMMQ-AIZNXBIQSA-N
CCMSLIB00012725342,related spectra of 'trospium (delta mass:43.043)',CCMSLIB00010139337|CCMSLIB00010139338|CCMSLIB00010139339|CCMSLIB00010139340|CCMSLIB00010139341|CCMSLIB00010139342|CCMSLIB00010139343|CCMSLIB00010139344|CCMSLIB00010139345|CCMSLIB00010139346|CCMSLIB00010139347|CCMSLIB00010139348|CCMSLIB00010139349|CCMSLIB00010139350|CCMSLIB00010139351|CCMSLIB00010139352,43.04,2982,Drug_suspect,trospium,anticholinergic,urology,urinary incontinence|urinary frequency,acetylcholine receptor antagonist,OYYDSUSKLWTMMQ-AIZNXBIQSA-N
CCMSLIB00012725343,related spectra of 'trospium (delta mass:43.991)',CCMSLIB00010139337|CCMSLIB00010139338|CCMSLIB00010139339|CCMSLIB00010139340|CCMSLIB00010139341|CCMSLIB00010139342|CCMSLIB00010139343|CCMSLIB00010139344|CCMSLIB00010139345|CCMSLIB00010139346|CCMSLIB00010139347|CCMSLIB00010139348|CCMSLIB00010139349|CCMSLIB00010139350|CCMSLIB00010139351|CCMSLIB00010139352,43.99,2983,Drug_suspect,trospium,anticholinergic,urology,urinary incontinence|urinary frequency,acetylcholine receptor antagonist,OYYDSUSKLWTMMQ-AIZNXBIQSA-N
CCMSLIB00012725344,related spectra of 'trospium (delta mass:61.053)',CCMSLIB00010139337|CCMSLIB00010139338|CCMSLIB00010139339|CCMSLIB00010139340|CCMSLIB00010139341|CCMSLIB00010139342|CCMSLIB00010139343|CCMSLIB00010139344|CCMSLIB00010139345|CCMSLIB00010139346|CCMSLIB00010139347|CCMSLIB00010139348|CCMSLIB00010139349|CCMSLIB00010139350|CCMSLIB00010139351|CCMSLIB00010139352,61.05,2984,Drug_suspect,trospium,anticholinergic,urology,urinary incontinence|urinary frequency,acetylcholine receptor antagonist,OYYDSUSKLWTMMQ-AIZNXBIQSA-N
CCMSLIB00012725345,related spectra of 'trospium (delta mass:162.053)',CCMSLIB00010139337|CCMSLIB00010139338|CCMSLIB00010139339|CCMSLIB00010139340|CCMSLIB00010139341|CCMSLIB00010139342|CCMSLIB00010139343|CCMSLIB00010139344|CCMSLIB00010139345|CCMSLIB00010139346|CCMSLIB00010139347|CCMSLIB00010139348|CCMSLIB00010139349|CCMSLIB00010139350|CCMSLIB00010139351|CCMSLIB00010139352,162.05,2985,Drug_suspect,trospium,anticholinergic,urology,urinary incontinence|urinary frequency,acetylcholine receptor antagonist,OYYDSUSKLWTMMQ-AIZNXBIQSA-N
CCMSLIB00012725346,related spectra of 'valsartan (delta mass:15.995)',CCMSLIB00000079130|CCMSLIB00000079131|CCMSLIB00006680041|CCMSLIB00006680061|CCMSLIB00006685043|CCMSLIB00006685062|CCMSLIB00006685093|CCMSLIB00006685103|CCMSLIB00006685115|CCMSLIB00006685220,15.99,2986,Drug_suspect,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012725347,related spectra of 'valsartan (delta mass:15.995)',CCMSLIB00000079130|CCMSLIB00000079131|CCMSLIB00006680041|CCMSLIB00006680061|CCMSLIB00006685043|CCMSLIB00006685062|CCMSLIB00006685093|CCMSLIB00006685103|CCMSLIB00006685115|CCMSLIB00006685220,15.99,2987,Drug_suspect,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012725348,related spectra of 'verapamil (delta mass:-28.031)',CCMSLIB00006679994|CCMSLIB00006680023|CCMSLIB00006684334|CCMSLIB00006684925|CCMSLIB00006685124|CCMSLIB00006685206|CCMSLIB00006685212|CCMSLIB00006685239|CCMSLIB00010143478|CCMSLIB00010143479|CCMSLIB00010143480|CCMSLIB00010143481|CCMSLIB00010143482|CCMSLIB00010143483|CCMSLIB00010143484|CCMSLIB00010143485,-28.03,2988,Drug_suspect,verapamil|verapamil,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris|arrhythmia,calcium channel blocker,SGTNSNPWRIOYBX-UHFFFAOYSA-N
CCMSLIB00012725349,related spectra of 'vortioxetine (delta mass:15.975)',CCMSLIB00010132979|CCMSLIB00010132980|CCMSLIB00010132981|CCMSLIB00010132982|CCMSLIB00010132983|CCMSLIB00010132984|CCMSLIB00010132985|CCMSLIB00010132986|CCMSLIB00010141006|CCMSLIB00010141007|CCMSLIB00010141008|CCMSLIB00010141009|CCMSLIB00010141010|CCMSLIB00010141011|CCMSLIB00010141012|CCMSLIB00010141013,15.97,2989,Drug_suspect,vortioxetine,other antidepressants,neurology/psychiatry,depression,serotonin receptor agonist|serotonin receptor antagonist,YQNWZWMKLDQSAC-UHFFFAOYSA-N
CCMSLIB00012725350,related spectra of 'vortioxetine (delta mass:15.995)',CCMSLIB00010132979|CCMSLIB00010132980|CCMSLIB00010132981|CCMSLIB00010132982|CCMSLIB00010132983|CCMSLIB00010132984|CCMSLIB00010132985|CCMSLIB00010132986|CCMSLIB00010141006|CCMSLIB00010141007|CCMSLIB00010141008|CCMSLIB00010141009|CCMSLIB00010141010|CCMSLIB00010141011|CCMSLIB00010141012|CCMSLIB00010141013,15.99,2990,Drug_suspect,vortioxetine,other antidepressants,neurology/psychiatry,depression,serotonin receptor agonist|serotonin receptor antagonist,YQNWZWMKLDQSAC-UHFFFAOYSA-N
CCMSLIB00012725351,related spectra of 'valaciclovir (delta mass:30.01)',CCMSLIB00010011933|CCMSLIB00010135856|CCMSLIB00010135857|CCMSLIB00010135858|CCMSLIB00010135859|CCMSLIB00010135860,30.01,2991,Drug_suspect,valaciclovir|valaciclovir,nucleoside analog HSV DNA polymerase inhibitor|VZV DNA polymerase inhibitor,infectious disease,shingles|virus herpes simplex (HSV),DNA polymerase inhibitor,HDOVUKNUBWVHOX-QMMMGPOBSA-N
CCMSLIB00012725352,related spectra of 'valganciclovir (delta mass:-30.01)',CCMSLIB00010151505|CCMSLIB00010151506|CCMSLIB00010151507|CCMSLIB00010151508|CCMSLIB00010151509|CCMSLIB00010151510|CCMSLIB00010151511|CCMSLIB00010151512,-30.01,2992,Drug_suspect,valganciclovir,nucleoside analog antiviral,infectious disease,cytomegalovirus (CMV),DNA synthesis inhibitor,WPVFJKSGQUFQAP-GKAPJAKFSA-N
CCMSLIB00012725353,related spectra of 'vidarabine (delta mass:45.985)',CCMSLIB00010133129|CCMSLIB00010133130|CCMSLIB00010133131|CCMSLIB00010133132|CCMSLIB00010133133|CCMSLIB00010140026|CCMSLIB00010140027|CCMSLIB00010140028|CCMSLIB00010140029|CCMSLIB00010140030,45.99,2993,Drug_suspect,vidarabine,adenosine receptor agonist,cardiology,Wolff-Parkinson-White Syndrome (WPW)|supraventricular tachycardia,adenosine receptor agonist,OIRDTQYFTABQOQ-UHTZMRCNSA-N
CCMSLIB00012725354,related spectra of 'vinburnine (delta mass:1.003)',CCMSLIB00010140955|CCMSLIB00010140956|CCMSLIB00010140957|CCMSLIB00010140958|CCMSLIB00010140959|CCMSLIB00010140960|CCMSLIB00010140961,1,2994,Drug_suspect,vinburnine,other peripheral vasodilators,NA,NA,adrenergic receptor antagonist,WYJAPUKIYAZSEM-MOPGFXCFSA-N
CCMSLIB00012725355,related spectra of 'voriconazole (delta mass:15.995)',CCMSLIB00000005584|CCMSLIB00000005585|CCMSLIB00000005586|CCMSLIB00000005587|CCMSLIB00000005588|CCMSLIB00000005589|CCMSLIB00000005590|CCMSLIB00000005591|CCMSLIB00000005592|CCMSLIB00000078151|CCMSLIB00010135167|CCMSLIB00010135168|CCMSLIB00010135169|CCMSLIB00010135170|CCMSLIB00010135171|CCMSLIB00010135172|CCMSLIB00010135173|CCMSLIB00010135174,15.99,2995,Drug_suspect,voriconazole|voriconazole,azole antifungal,infectious disease,esophageal candidiasis|aspergillosis|fungal infections,lanosterol 14-alpha-demethylase inhibitor,BCEHBSKCWLPMDN-MGPLVRAMSA-N
CCMSLIB00012725356,related spectra of 'voriconazole (delta mass:43.991)',CCMSLIB00000005584|CCMSLIB00000005585|CCMSLIB00000005586|CCMSLIB00000005587|CCMSLIB00000005588|CCMSLIB00000005589|CCMSLIB00000005590|CCMSLIB00000005591|CCMSLIB00000005592|CCMSLIB00000078151|CCMSLIB00010135167|CCMSLIB00010135168|CCMSLIB00010135169|CCMSLIB00010135170|CCMSLIB00010135171|CCMSLIB00010135172|CCMSLIB00010135173|CCMSLIB00010135174,43.99,2996,Drug_suspect,voriconazole|voriconazole,azole antifungal,infectious disease,esophageal candidiasis|aspergillosis|fungal infections,lanosterol 14-alpha-demethylase inhibitor,BCEHBSKCWLPMDN-MGPLVRAMSA-N
CCMSLIB00012725357,related spectra of 'yohimbine (delta mass:-58.006)',CCMSLIB00000424794|CCMSLIB00004680087|CCMSLIB00009919324|CCMSLIB00010142751|CCMSLIB00010142752|CCMSLIB00010142753|CCMSLIB00010142754|CCMSLIB00010142755|CCMSLIB00010142756|CCMSLIB00010142757|CCMSLIB00010142758,-58.01,2997,Drug_suspect,yohimbine|yohimbine,drugs used in erectile dysfunction,urology,erectile dysfunction,adrenergic receptor antagonist,BLGXFZZNTVWLAY-SCYLSFHTSA-N
CCMSLIB00012725358,related spectra of 'yohimbine (delta mass:30.01)',CCMSLIB00000424794|CCMSLIB00004680087|CCMSLIB00009919324|CCMSLIB00010142751|CCMSLIB00010142752|CCMSLIB00010142753|CCMSLIB00010142754|CCMSLIB00010142755|CCMSLIB00010142756|CCMSLIB00010142757|CCMSLIB00010142758,30.01,2998,Drug_suspect,yohimbine|yohimbine,drugs used in erectile dysfunction,urology,erectile dysfunction,adrenergic receptor antagonist,BLGXFZZNTVWLAY-SCYLSFHTSA-N
CCMSLIB00012725359,related spectra of 'ziprasidone (delta mass:31.99)',CCMSLIB00000579633|CCMSLIB00009919369|CCMSLIB00010139989|CCMSLIB00010139990|CCMSLIB00010139991|CCMSLIB00010139992|CCMSLIB00010139993|CCMSLIB00010141215|CCMSLIB00010141216|CCMSLIB00010141217|CCMSLIB00010141218|CCMSLIB00010141219,31.99,2999,Drug_suspect,ziprasidone|ziprasidone,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,MVWVFYHBGMAFLY-UHFFFAOYSA-N
CCMSLIB00012725360,related spectra of '[2-(carbamoyloxymethyl)-2-methylpentyl] n-propan-2-ylcarbamate (delta mass:15.995)',CCMSLIB00000077018,15.99,3000,Drug_suspect,carisoprodol,muscle relaxant,neurology/psychiatry,painful musculoskeletal conditions,GABA receptor modulator,OFZCIYFFPZCNJE-UHFFFAOYSA-N
CCMSLIB00012725361,related spectra of '[2-(carbamoyloxymethyl)-2-methylpentyl] n-propan-2-ylcarbamate (delta mass:176.032)',CCMSLIB00000077018,176.03,3001,Drug_suspect,carisoprodol,muscle relaxant,neurology/psychiatry,painful musculoskeletal conditions,GABA receptor modulator,OFZCIYFFPZCNJE-UHFFFAOYSA-N
CCMSLIB00012725362,related spectra of '[putative] omeprazole sulfide 5-carboxylic acid (delta mass:-43.99)',CCMSLIB00004679262,-43.99,3002,Drug_suspect,omeprazole sulfide 5-carboxylic acid,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,NA
CCMSLIB00012725363,related spectra of '[putative] omeprazole sulfide 5-carboxylic acid (delta mass:-29.975)',CCMSLIB00004679262,-29.97,3003,Drug_suspect,omeprazole sulfide 5-carboxylic acid,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,NA
CCMSLIB00012725364,related spectra of '[putative] omeprazole sulfide 5-carboxylic acid (delta mass:-14.016)',CCMSLIB00004679262,-14.02,3004,Drug_suspect,omeprazole sulfide 5-carboxylic acid,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,NA
CCMSLIB00012725365,related spectra of '[putative] omeprazole sulfide 5-carboxylic acid (delta mass:-13.98)',CCMSLIB00004679262,-13.98,3005,Drug_suspect,omeprazole sulfide 5-carboxylic acid,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,NA
CCMSLIB00012725366,related spectra of '[putative] omeprazole sulfide 5-carboxylic acid (delta mass:-2.016)',CCMSLIB00004679262,-2.02,3006,Drug_suspect,omeprazole sulfide 5-carboxylic acid,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,NA
CCMSLIB00012725367,related spectra of '[putative] omeprazole sulfide 5-carboxylic acid (delta mass:15.995)',CCMSLIB00004679262,15.99,3007,Drug_suspect,omeprazole sulfide 5-carboxylic acid,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,NA
CCMSLIB00012724937,"related spectra of 'massbank:eq301602 darunavir|n-[(1s,2r)-1-benzyl-2-hydroxy-3-[isobutyl(sulfanilyl)amino]propyl]carbamic acid [(3as,4r,6ar)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] ester (delta mass:-2.016)'",CCMSLIB00005734048,-2.02,2577,Drug_suspect,darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-UHFFFAOYSA-N
CCMSLIB00012724938,"related spectra of 'massbank:eq301602 darunavir|n-[(1s,2r)-1-benzyl-2-hydroxy-3-[isobutyl(sulfanilyl)amino]propyl]carbamic acid [(3as,4r,6ar)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] ester (delta mass:15.995)'",CCMSLIB00005734048,15.99,2578,Drug_suspect,darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-UHFFFAOYSA-N
CCMSLIB00012724939,"related spectra of 'massbank:eq301602 darunavir|n-[(1s,2r)-1-benzyl-2-hydroxy-3-[isobutyl(sulfanilyl)amino]propyl]carbamic acid [(3as,4r,6ar)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] ester (delta mass:29.974)'",CCMSLIB00005734048,29.97,2579,Drug_suspect,darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-UHFFFAOYSA-N
CCMSLIB00012724940,"related spectra of 'massbank:eq301602 darunavir|n-[(1s,2r)-1-benzyl-2-hydroxy-3-[isobutyl(sulfanilyl)amino]propyl]carbamic acid [(3as,4r,6ar)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] ester (delta mass:162.053)'",CCMSLIB00005734048,162.05,2580,Drug_suspect,darunavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,CJBJHOAVZSMMDJ-UHFFFAOYSA-N
CCMSLIB00012725166,related spectra of 'ritonavir (delta mass:15.995)',CCMSLIB00000005593|CCMSLIB00000005594|CCMSLIB00000005595|CCMSLIB00000005596|CCMSLIB00000005597|CCMSLIB00000005598|CCMSLIB00000078031|CCMSLIB00000078032|CCMSLIB00000078033,15.99,2806,Drug_suspect,ritonavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,NCDNCNXCDXHOMX-XGKFQTDJSA-N
CCMSLIB00012725167,related spectra of 'ritonavir (delta mass:31.99)',CCMSLIB00000005593|CCMSLIB00000005594|CCMSLIB00000005595|CCMSLIB00000005596|CCMSLIB00000005597|CCMSLIB00000005598|CCMSLIB00000078031|CCMSLIB00000078032|CCMSLIB00000078033,31.99,2807,Drug_suspect,ritonavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,NCDNCNXCDXHOMX-XGKFQTDJSA-N
CCMSLIB00012725374,related spectra of 'alfuzosin (delta mass:-28.031)',CCMSLIB00010142243|CCMSLIB00010142244|CCMSLIB00010142245|CCMSLIB00010142246|CCMSLIB00010142247|CCMSLIB00010142248|CCMSLIB00010142249|CCMSLIB00010142250|CCMSLIB00010151022|CCMSLIB00010151023|CCMSLIB00010151024|CCMSLIB00010151025|CCMSLIB00010151026,-28.03,3014,Drug_suspect,alfuzosin,alpha adrenergic blocker,urology,benign prostatic hyperplasia (BPH),adrenergic receptor antagonist,WNMJYKCGWZFFKR-UHFFFAOYSA-N
CCMSLIB00012725375,related spectra of 'alfuzosin (delta mass:-14.016)',CCMSLIB00010142243|CCMSLIB00010142244|CCMSLIB00010142245|CCMSLIB00010142246|CCMSLIB00010142247|CCMSLIB00010142248|CCMSLIB00010142249|CCMSLIB00010142250|CCMSLIB00010151022|CCMSLIB00010151023|CCMSLIB00010151024|CCMSLIB00010151025|CCMSLIB00010151026,-14.02,3015,Drug_suspect,alfuzosin,alpha adrenergic blocker,urology,benign prostatic hyperplasia (BPH),adrenergic receptor antagonist,WNMJYKCGWZFFKR-UHFFFAOYSA-N
CCMSLIB00012725376,related spectra of 'amiodarone (delta mass:13.98)',CCMSLIB00010151163|CCMSLIB00010151164|CCMSLIB00010151165|CCMSLIB00010151166|CCMSLIB00010151167|CCMSLIB00010151168|CCMSLIB00010151169|CCMSLIB00010151170,13.98,3016,Drug_suspect,amiodarone,antiarrhythmic,cardiology,ventricular arrhythmias,potassium channel blocker,IYIKLHRQXLHMJQ-UHFFFAOYSA-N
CCMSLIB00012725377,related spectra of 'amiodarone (delta mass:15.995)',CCMSLIB00010151163|CCMSLIB00010151164|CCMSLIB00010151165|CCMSLIB00010151166|CCMSLIB00010151167|CCMSLIB00010151168|CCMSLIB00010151169|CCMSLIB00010151170,15.99,3017,Drug_suspect,amiodarone,antiarrhythmic,cardiology,ventricular arrhythmias,potassium channel blocker,IYIKLHRQXLHMJQ-UHFFFAOYSA-N
CCMSLIB00012725378,related spectra of 'amiodarone (delta mass:29.974)',CCMSLIB00010151163|CCMSLIB00010151164|CCMSLIB00010151165|CCMSLIB00010151166|CCMSLIB00010151167|CCMSLIB00010151168|CCMSLIB00010151169|CCMSLIB00010151170,29.97,3018,Drug_suspect,amiodarone,antiarrhythmic,cardiology,ventricular arrhythmias,potassium channel blocker,IYIKLHRQXLHMJQ-UHFFFAOYSA-N
CCMSLIB00012725379,related spectra of 'amitriptyline (delta mass:-28.031)',CCMSLIB00010131287|CCMSLIB00010131288|CCMSLIB00010131289|CCMSLIB00010131290|CCMSLIB00010131291|CCMSLIB00010131292|CCMSLIB00010131293|CCMSLIB00010131294,-28.03,3019,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012725380,related spectra of 'amitriptyline (delta mass:-4.031)',CCMSLIB00010131287|CCMSLIB00010131288|CCMSLIB00010131289|CCMSLIB00010131290|CCMSLIB00010131291|CCMSLIB00010131292|CCMSLIB00010131293|CCMSLIB00010131294,-4.03,3020,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012725381,related spectra of 'amitriptyline (delta mass:-2.016)',CCMSLIB00010131287|CCMSLIB00010131288|CCMSLIB00010131289|CCMSLIB00010131290|CCMSLIB00010131291|CCMSLIB00010131292|CCMSLIB00010131293|CCMSLIB00010131294,-2.02,3021,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012725382,related spectra of 'amitriptyline (delta mass:-0.984)',CCMSLIB00010131287|CCMSLIB00010131288|CCMSLIB00010131289|CCMSLIB00010131290|CCMSLIB00010131291|CCMSLIB00010131292|CCMSLIB00010131293|CCMSLIB00010131294,-0.98,3022,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012725383,related spectra of 'amitriptyline (delta mass:0.984)',CCMSLIB00010131287|CCMSLIB00010131288|CCMSLIB00010131289|CCMSLIB00010131290|CCMSLIB00010131291|CCMSLIB00010131292|CCMSLIB00010131293|CCMSLIB00010131294,0.98,3023,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012725384,related spectra of 'amitriptyline (delta mass:1.003)',CCMSLIB00010131287|CCMSLIB00010131288|CCMSLIB00010131289|CCMSLIB00010131290|CCMSLIB00010131291|CCMSLIB00010131292|CCMSLIB00010131293|CCMSLIB00010131294,1,3024,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012725385,related spectra of 'amitriptyline (delta mass:13.98)',CCMSLIB00010131287|CCMSLIB00010131288|CCMSLIB00010131289|CCMSLIB00010131290|CCMSLIB00010131291|CCMSLIB00010131292|CCMSLIB00010131293|CCMSLIB00010131294,13.98,3025,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012725386,related spectra of 'amitriptyline (delta mass:14.016)',CCMSLIB00010131287|CCMSLIB00010131288|CCMSLIB00010131289|CCMSLIB00010131290|CCMSLIB00010131291|CCMSLIB00010131292|CCMSLIB00010131293|CCMSLIB00010131294,14.02,3026,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012725387,related spectra of 'amitriptyline (delta mass:15.995)',CCMSLIB00010131287|CCMSLIB00010131288|CCMSLIB00010131289|CCMSLIB00010131290|CCMSLIB00010131291|CCMSLIB00010131292|CCMSLIB00010131293|CCMSLIB00010131294,15.99,3027,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012725388,related spectra of 'amitriptyline (delta mass:28.031)',CCMSLIB00010131287|CCMSLIB00010131288|CCMSLIB00010131289|CCMSLIB00010131290|CCMSLIB00010131291|CCMSLIB00010131292|CCMSLIB00010131293|CCMSLIB00010131294,28.03,3028,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012725389,related spectra of 'amitriptyline (delta mass:28.991)',CCMSLIB00010131287|CCMSLIB00010131288|CCMSLIB00010131289|CCMSLIB00010131290|CCMSLIB00010131291|CCMSLIB00010131292|CCMSLIB00010131293|CCMSLIB00010131294,28.99,3029,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012725390,related spectra of 'amitriptyline (delta mass:176.032)',CCMSLIB00010131287|CCMSLIB00010131288|CCMSLIB00010131289|CCMSLIB00010131290|CCMSLIB00010131291|CCMSLIB00010131292|CCMSLIB00010131293|CCMSLIB00010131294,176.03,3030,Drug_suspect|Background/QAQC,amitriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression|chronic pain,norepinephrine reuptake inhibitor|serotonin reuptake inhibitor,KRMDCWKBEZIMAB-UHFFFAOYSA-N
CCMSLIB00012725391,related spectra of 'amoxicillin (delta mass:-17.026)',CCMSLIB00010143995|CCMSLIB00010143996|CCMSLIB00010143997|CCMSLIB00010143998|CCMSLIB00010143999|CCMSLIB00010150291|CCMSLIB00010150292|CCMSLIB00010150293|CCMSLIB00010150294|CCMSLIB00010150295|CCMSLIB00010151513|CCMSLIB00010151514|CCMSLIB00010151515|CCMSLIB00010151516|CCMSLIB00010151517,-17.03,3031,Drug_suspect,amoxicillin,penicillin class antibacterial,infectious disease,skin infections|duodenal ulcer disease|gonorrhea|ear infections|throat infections|genitourinary tract infections|respiratory tract infections,penicillin binding protein inhibitor,LSQZJLSUYDQPKJ-NJBDSQKTSA-N
CCMSLIB00012725392,related spectra of 'amprenavir (delta mass:-88.053)',CCMSLIB00010143816|CCMSLIB00010143817|CCMSLIB00010143818|CCMSLIB00010143819|CCMSLIB00010143820|CCMSLIB00010143821|CCMSLIB00010143822|CCMSLIB00010143823,-88.05,3032,Drug_suspect,amprenavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,YMARZQAQMVYCKC-OEMFJLHTSA-N
CCMSLIB00012725393,related spectra of 'amprenavir (delta mass:31.99)',CCMSLIB00010143816|CCMSLIB00010143817|CCMSLIB00010143818|CCMSLIB00010143819|CCMSLIB00010143820|CCMSLIB00010143821|CCMSLIB00010143822|CCMSLIB00010143823,31.99,3033,Drug_suspect,amprenavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,YMARZQAQMVYCKC-OEMFJLHTSA-N
CCMSLIB00012725394,related spectra of 'amprenavir (delta mass:176.032)',CCMSLIB00010143816|CCMSLIB00010143817|CCMSLIB00010143818|CCMSLIB00010143819|CCMSLIB00010143820|CCMSLIB00010143821|CCMSLIB00010143822|CCMSLIB00010143823,176.03,3034,Drug_suspect,amprenavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,YMARZQAQMVYCKC-OEMFJLHTSA-N
CCMSLIB00012725395,related spectra of 'aztreonam (chimeric precursor selection) (delta mass:-79.958)',CCMSLIB00010130079|CCMSLIB00010130080|CCMSLIB00010130081,-79.96,3035,Drug_suspect,aztreonam (chimeric precursor selection),monobactam antibacterial,infectious disease,urinary tract infections|respiratory tract infections|bacterial septicemia|skin infections|intra-abdominal infections|gynecologic infections,bacterial cell wall synthesis inhibitor,WZPBZJONDBGPKJ-VEHQQRBSSA-N
CCMSLIB00012725396,related spectra of 'baclofen (delta mass:-17.026)',CCMSLIB00010139490|CCMSLIB00010139491|CCMSLIB00010139492|CCMSLIB00010139493|CCMSLIB00010139494,-17.03,3036,Drug_suspect,baclofen,gamma-aminobutyric acid (GABA)-ergic agonist,neurology/psychiatry,multiple sclerosis|spasms,benzodiazepine receptor agonist,KPYSYYIEGFHWSV-UHFFFAOYSA-N
CCMSLIB00012725397,related spectra of 'baicalein (delta mass:18.01)',CCMSLIB00004687629|CCMSLIB00004705242|CCMSLIB00004705243|CCMSLIB00004705244|CCMSLIB00004705245|CCMSLIB00004705246|CCMSLIB00004705247|CCMSLIB00004705248|CCMSLIB00004705249|CCMSLIB00004705250|CCMSLIB00004718210|CCMSLIB00004718211|CCMSLIB00004718212|CCMSLIB00004718213|CCMSLIB00004718214|CCMSLIB00004718215|CCMSLIB00010136230|CCMSLIB00010136231|CCMSLIB00010136232|CCMSLIB00010136233|CCMSLIB00010136234,18.01,3037,Drug_suspect,baicalein|baicalein,no_match,no_match,no_match,no_match,FXNFHKRTJBSTCS-UHFFFAOYSA-N
CCMSLIB00012725398,related spectra of 'benazepril (delta mass:-28.031)',CCMSLIB00010133142|CCMSLIB00010133143|CCMSLIB00010133144|CCMSLIB00010133145|CCMSLIB00010133146|CCMSLIB00010133147|CCMSLIB00010133148|CCMSLIB00010133149,-28.03,3038,Drug_suspect,benazepril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|myocardial infarction|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,XPCFTKFZXHTYIP-PMACEKPBSA-N
CCMSLIB00012725399,related spectra of 'benazepril (delta mass:14.016)',CCMSLIB00010133142|CCMSLIB00010133143|CCMSLIB00010133144|CCMSLIB00010133145|CCMSLIB00010133146|CCMSLIB00010133147|CCMSLIB00010133148|CCMSLIB00010133149,14.02,3039,Drug_suspect,benazepril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|myocardial infarction|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,XPCFTKFZXHTYIP-PMACEKPBSA-N
CCMSLIB00012725400,related spectra of 'benzethonium (delta mass:15.995)',CCMSLIB00010129859|CCMSLIB00010129860|CCMSLIB00010129861|CCMSLIB00010129862|CCMSLIB00010129863|CCMSLIB00010129864|CCMSLIB00010129865|CCMSLIB00010129866,15.99,3040,Drug_suspect,benzethonium,antiseptics and disinfectants,infectious disease,first-aid antiseptic,disruption of cell membranes,SIYLLGKDQZGJHK-UHFFFAOYSA-N
CCMSLIB00012725401,related spectra of 'benzethonium (delta mass:29.974)',CCMSLIB00010129859|CCMSLIB00010129860|CCMSLIB00010129861|CCMSLIB00010129862|CCMSLIB00010129863|CCMSLIB00010129864|CCMSLIB00010129865|CCMSLIB00010129866,29.97,3041,Drug_suspect,benzethonium,antiseptics and disinfectants,infectious disease,first-aid antiseptic,disruption of cell membranes,SIYLLGKDQZGJHK-UHFFFAOYSA-N
CCMSLIB00012725402,related spectra of 'benzethonium (delta mass:30.01)',CCMSLIB00010129859|CCMSLIB00010129860|CCMSLIB00010129861|CCMSLIB00010129862|CCMSLIB00010129863|CCMSLIB00010129864|CCMSLIB00010129865|CCMSLIB00010129866,30.01,3042,Drug_suspect,benzethonium,antiseptics and disinfectants,infectious disease,first-aid antiseptic,disruption of cell membranes,SIYLLGKDQZGJHK-UHFFFAOYSA-N
CCMSLIB00012725403,related spectra of 'berberine (delta mass:-12.0)',CCMSLIB00010132403|CCMSLIB00010132404|CCMSLIB00010132405|CCMSLIB00010132406|CCMSLIB00010132407|CCMSLIB00010132408|CCMSLIB00010132409|CCMSLIB00010132410|CCMSLIB00010144708|CCMSLIB00010144709|CCMSLIB00010144710|CCMSLIB00010144711|CCMSLIB00010144712|CCMSLIB00010144713|CCMSLIB00010144714|CCMSLIB00010144715,-12,3043,Drug_suspect,berberine,no_match,NA,NA,LDL receptor activator,YBHILYKTIRIUTE-UHFFFAOYSA-N
CCMSLIB00012725404,related spectra of 'berberine (delta mass:14.016)',CCMSLIB00010132403|CCMSLIB00010132404|CCMSLIB00010132405|CCMSLIB00010132406|CCMSLIB00010132407|CCMSLIB00010132408|CCMSLIB00010132409|CCMSLIB00010132410|CCMSLIB00010144708|CCMSLIB00010144709|CCMSLIB00010144710|CCMSLIB00010144711|CCMSLIB00010144712|CCMSLIB00010144713|CCMSLIB00010144714|CCMSLIB00010144715,14.02,3044,Drug_suspect,berberine,no_match,NA,NA,LDL receptor activator,YBHILYKTIRIUTE-UHFFFAOYSA-N
CCMSLIB00012725405,related spectra of 'buspirone (delta mass:15.995)',CCMSLIB00010147589|CCMSLIB00010147590|CCMSLIB00010147591|CCMSLIB00010147592|CCMSLIB00010147593|CCMSLIB00010147594|CCMSLIB00010147595|CCMSLIB00010147596,15.99,3045,Drug_suspect,buspirone,anxiolytics,neurology/psychiatry,generalized anxiety disorder (GAD),serotonin receptor agonist,QWCRAEMEVRGPNT-UHFFFAOYSA-N
CCMSLIB00012725406,related spectra of 'carbamazepine (delta mass:45.985)',CCMSLIB00010131213|CCMSLIB00010131214|CCMSLIB00010131215|CCMSLIB00010131216|CCMSLIB00010131217,45.99,3046,Drug_suspect,carbamazepine,mood stabilizer,neurology/psychiatry,seizures|trigeminal neuralgia,carboxamide antiepileptic,FFGPTBGBLSHEPO-UHFFFAOYSA-N
CCMSLIB00012725407,related spectra of 'carvedilol (delta mass:-14.016)',CCMSLIB00010152218|CCMSLIB00010152219|CCMSLIB00010152220|CCMSLIB00010152221|CCMSLIB00010152222|CCMSLIB00010152223|CCMSLIB00010152224|CCMSLIB00010152225,-14.02,3047,Drug_suspect,carvedilol,alpha adrenergic blocker|beta-adrenergic receptor inhibitor,cardiology,myocardial infarction|hypertension,adrenergic receptor antagonist,OGHNVEJMJSYVRP-UHFFFAOYSA-N
CCMSLIB00012725408,related spectra of 'carvedilol (delta mass:15.995)',CCMSLIB00010152218|CCMSLIB00010152219|CCMSLIB00010152220|CCMSLIB00010152221|CCMSLIB00010152222|CCMSLIB00010152223|CCMSLIB00010152224|CCMSLIB00010152225,15.99,3048,Drug_suspect,carvedilol,alpha adrenergic blocker|beta-adrenergic receptor inhibitor,cardiology,myocardial infarction|hypertension,adrenergic receptor antagonist,OGHNVEJMJSYVRP-UHFFFAOYSA-N
CCMSLIB00012725409,related spectra of 'cefotaxime (delta mass:-60.021)',CCMSLIB00010141156|CCMSLIB00010141157|CCMSLIB00010141158|CCMSLIB00010141159|CCMSLIB00010141160|CCMSLIB00010147328|CCMSLIB00010147329|CCMSLIB00010147330|CCMSLIB00010147331|CCMSLIB00010147332,-60.02,3049,Drug_suspect,cefotaxime,cephalosporin antibacterial,infectious disease,respiratory tract infections|bone and joint infections|pelvic inflammatory disease|intra-abdominal infections|skin infections|meningitis|urinary tract infections|bacterial septicemia|gynecologic infections,bacterial cell wall synthesis inhibitor,GPRBEKHLDVQUJE-QSWIMTSFSA-N
CCMSLIB00012725410,related spectra of 'cilostazol (delta mass:-2.016)',CCMSLIB00010145463|CCMSLIB00010145464|CCMSLIB00010145465|CCMSLIB00010145466|CCMSLIB00010145467,-2.02,3050,Drug_suspect,cilostazol,phosphodiesterase-3 inhibitor,cardiology,claudication,phosphodiesterase inhibitor,RRGUKTPIGVIEKM-UHFFFAOYSA-N
CCMSLIB00012725411,related spectra of 'ciprofloxacin (delta mass:-43.99)',CCMSLIB00010141390|CCMSLIB00010141391|CCMSLIB00010141392|CCMSLIB00010141393,-43.99,3051,Drug_suspect,ciprofloxacin,fluoroquinolone antimicrobial,infectious disease,gram-positive bacterial infections|gram-negative bacterial infections,bacterial DNA gyrase inhibitor,MYSWGUAQZAJSOK-UHFFFAOYSA-N
CCMSLIB00012725412,related spectra of 'ciprofloxacin (delta mass:14.016)',CCMSLIB00010141390|CCMSLIB00010141391|CCMSLIB00010141392|CCMSLIB00010141393,14.02,3052,Drug_suspect,ciprofloxacin,fluoroquinolone antimicrobial,infectious disease,gram-positive bacterial infections|gram-negative bacterial infections,bacterial DNA gyrase inhibitor,MYSWGUAQZAJSOK-UHFFFAOYSA-N
CCMSLIB00012725413,related spectra of 'ciprofloxacin (delta mass:15.995)',CCMSLIB00010141390|CCMSLIB00010141391|CCMSLIB00010141392|CCMSLIB00010141393,15.99,3053,Drug_suspect,ciprofloxacin,fluoroquinolone antimicrobial,infectious disease,gram-positive bacterial infections|gram-negative bacterial infections,bacterial DNA gyrase inhibitor,MYSWGUAQZAJSOK-UHFFFAOYSA-N
CCMSLIB00012725414,related spectra of 'citalopram (delta mass:-28.031)',CCMSLIB00010142659|CCMSLIB00010142660|CCMSLIB00010142661|CCMSLIB00010142662|CCMSLIB00010142663|CCMSLIB00010142664|CCMSLIB00010142665|CCMSLIB00010142666,-28.03,3054,Drug_suspect,citalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-UHFFFAOYSA-N
CCMSLIB00012725415,related spectra of 'citalopram (delta mass:-14.016)',CCMSLIB00010142659|CCMSLIB00010142660|CCMSLIB00010142661|CCMSLIB00010142662|CCMSLIB00010142663|CCMSLIB00010142664|CCMSLIB00010142665|CCMSLIB00010142666,-14.02,3055,Drug_suspect,citalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-UHFFFAOYSA-N
CCMSLIB00012725416,related spectra of 'citalopram (delta mass:15.995)',CCMSLIB00010142659|CCMSLIB00010142660|CCMSLIB00010142661|CCMSLIB00010142662|CCMSLIB00010142663|CCMSLIB00010142664|CCMSLIB00010142665|CCMSLIB00010142666,15.99,3056,Drug_suspect,citalopram,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,selective serotonin reuptake inhibitor (SSRI),WSEQXVZVJXJVFP-UHFFFAOYSA-N
CCMSLIB00012725417,related spectra of 'clopidogrel (delta mass:14.016)',CCMSLIB00000077124|CCMSLIB00010139569|CCMSLIB00010139570|CCMSLIB00010139571|CCMSLIB00010139572|CCMSLIB00010139573|CCMSLIB00010139574|CCMSLIB00010139575|CCMSLIB00010139576|CCMSLIB00010142037|CCMSLIB00010142038|CCMSLIB00010142039|CCMSLIB00010142040|CCMSLIB00010142041,14.02,3057,Drug_suspect,clopidogrel,P2Y12 platelet inhibitor,cardiology|neurology/psychiatry,myocardial infarction|stroke|peripheral artery disease (PAD)|acute coronary syndrome (ACS),purinergic receptor antagonist,GKTWGGQPFAXNFI-HNNXBMFYSA-N
CCMSLIB00012725418,related spectra of 'cyclobenzaprine (delta mass:-28.031)',CCMSLIB00010151698|CCMSLIB00010151699|CCMSLIB00010151700|CCMSLIB00010151701|CCMSLIB00010151702|CCMSLIB00010151703|CCMSLIB00010151704|CCMSLIB00010151705,-28.03,3058,Drug_suspect,cyclobenzaprine,muscle relaxant,neurology/psychiatry,muscle spasms,adrenergic receptor agonist|serotonin receptor agonist,JURKNVYFZMSNLP-UHFFFAOYSA-N
CCMSLIB00012725419,related spectra of 'cyclobenzaprine (delta mass:3.995)',CCMSLIB00010151698|CCMSLIB00010151699|CCMSLIB00010151700|CCMSLIB00010151701|CCMSLIB00010151702|CCMSLIB00010151703|CCMSLIB00010151704|CCMSLIB00010151705,3.99,3059,Drug_suspect,cyclobenzaprine,muscle relaxant,neurology/psychiatry,muscle spasms,adrenergic receptor agonist|serotonin receptor agonist,JURKNVYFZMSNLP-UHFFFAOYSA-N
CCMSLIB00012725420,related spectra of 'cyclobenzaprine (delta mass:18.01)',CCMSLIB00010151698|CCMSLIB00010151699|CCMSLIB00010151700|CCMSLIB00010151701|CCMSLIB00010151702|CCMSLIB00010151703|CCMSLIB00010151704|CCMSLIB00010151705,18.01,3060,Drug_suspect,cyclobenzaprine,muscle relaxant,neurology/psychiatry,muscle spasms,adrenergic receptor agonist|serotonin receptor agonist,JURKNVYFZMSNLP-UHFFFAOYSA-N
CCMSLIB00012725421,related spectra of 'cyclobenzaprine (delta mass:176.032)',CCMSLIB00010151698|CCMSLIB00010151699|CCMSLIB00010151700|CCMSLIB00010151701|CCMSLIB00010151702|CCMSLIB00010151703|CCMSLIB00010151704|CCMSLIB00010151705,176.03,3061,Drug_suspect,cyclobenzaprine,muscle relaxant,neurology/psychiatry,muscle spasms,adrenergic receptor agonist|serotonin receptor agonist,JURKNVYFZMSNLP-UHFFFAOYSA-N
CCMSLIB00012725422,related spectra of 'desethyl piperacillin (delta mass:28.031)',CCMSLIB00000424811,28.03,3062,Drug_suspect,desethyl piperacillin,penicillin class antibacterial,infectious disease,intra-abdominal infections|skin infections|pelvic inflammatory disease|pneumonia|gram-positive bacterial infections|gram-negative bacterial infections,bacterial cell wall synthesis inhibitor,MKBNTPDMOZKDSO-ZIVKBKJYSA-N
CCMSLIB00012725423,related spectra of 'dexlansoprazole (delta mass:-15.995)',CCMSLIB00010136973|CCMSLIB00010136974|CCMSLIB00010136975|CCMSLIB00010136976|CCMSLIB00010136977,-15.99,3063,Drug_suspect,dexlansoprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|erosive esophagitis (EE)|gastrointestinal ulcers|Zollinger-Ellison syndrome,ATPase inhibitor,MJIHNNLFOKEZEW-RUZDIDTESA-N
CCMSLIB00012725424,related spectra of 'dibucaine (delta mass:-28.031)',CCMSLIB00010138121|CCMSLIB00010138122|CCMSLIB00010138123|CCMSLIB00010138124|CCMSLIB00010138125|CCMSLIB00010138126|CCMSLIB00010138127|CCMSLIB00010138128|CCMSLIB00010143313|CCMSLIB00010143314|CCMSLIB00010143315|CCMSLIB00010143316|CCMSLIB00010143317|CCMSLIB00010143318|CCMSLIB00010143319|CCMSLIB00010143320,-28.03,3064,Drug_suspect,dibucaine,amide local anesthetic,neurology/psychiatry,local anesthetic,sodium channel blocker,PUFQVTATUTYEAL-UHFFFAOYSA-N
CCMSLIB00012725425,related spectra of 'dibutyl phthalate (delta mass:-14.016)',CCMSLIB00010152591|CCMSLIB00010152592|CCMSLIB00010152593|CCMSLIB00010152594|CCMSLIB00010152595|CCMSLIB00010152596|CCMSLIB00010152597|CCMSLIB00010152598|CCMSLIB00010152599,-14.02,3065,Drug_suspect,dibutyl phthalate,no_match,NA,NA,NA,DOIRQSBPFJWKBE-UHFFFAOYSA-N
CCMSLIB00012725426,related spectra of 'dibutyl phthalate (delta mass:21.984)',CCMSLIB00010152591|CCMSLIB00010152592|CCMSLIB00010152593|CCMSLIB00010152594|CCMSLIB00010152595|CCMSLIB00010152596|CCMSLIB00010152597|CCMSLIB00010152598|CCMSLIB00010152599,21.98,3066,Drug_suspect,dibutyl phthalate,no_match,NA,NA,NA,DOIRQSBPFJWKBE-UHFFFAOYSA-N
CCMSLIB00012725427,related spectra of 'dibutyl phthalate (delta mass:28.031)',CCMSLIB00010152591|CCMSLIB00010152592|CCMSLIB00010152593|CCMSLIB00010152594|CCMSLIB00010152595|CCMSLIB00010152596|CCMSLIB00010152597|CCMSLIB00010152598|CCMSLIB00010152599,28.03,3067,Drug_suspect,dibutyl phthalate,no_match,NA,NA,NA,DOIRQSBPFJWKBE-UHFFFAOYSA-N
CCMSLIB00012725428,related spectra of 'diltiazem (delta mass:-56.027)',CCMSLIB00009919323|CCMSLIB00010145989|CCMSLIB00010145990|CCMSLIB00010145991|CCMSLIB00010145992|CCMSLIB00010145993,-56.03,3068,Drug_suspect,diltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,HSUGRBWQSSZJOP-RTWAWAEBSA-N
CCMSLIB00012725429,related spectra of 'diltiazem (delta mass:-28.031)',CCMSLIB00009919323|CCMSLIB00010145989|CCMSLIB00010145990|CCMSLIB00010145991|CCMSLIB00010145992|CCMSLIB00010145993,-28.03,3069,Drug_suspect,diltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,HSUGRBWQSSZJOP-RTWAWAEBSA-N
CCMSLIB00012725430,related spectra of 'diltiazem (delta mass:-26.016)',CCMSLIB00009919323|CCMSLIB00010145989|CCMSLIB00010145990|CCMSLIB00010145991|CCMSLIB00010145992|CCMSLIB00010145993,-26.02,3070,Drug_suspect,diltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,HSUGRBWQSSZJOP-RTWAWAEBSA-N
CCMSLIB00012725431,related spectra of 'diltiazem (delta mass:-14.016)',CCMSLIB00009919323|CCMSLIB00010145989|CCMSLIB00010145990|CCMSLIB00010145991|CCMSLIB00010145992|CCMSLIB00010145993,-14.02,3071,Drug_suspect,diltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,HSUGRBWQSSZJOP-RTWAWAEBSA-N
CCMSLIB00012725432,related spectra of 'diltiazem (delta mass:176.032)',CCMSLIB00009919323|CCMSLIB00010145989|CCMSLIB00010145990|CCMSLIB00010145991|CCMSLIB00010145992|CCMSLIB00010145993,176.03,3072,Drug_suspect,diltiazem,nondihydropyridine calcium channel blocker,cardiology,hypertension|angina pectoris,calcium channel blocker,HSUGRBWQSSZJOP-RTWAWAEBSA-N
CCMSLIB00012725433,related spectra of 'domperidone (delta mass:2.999)',CCMSLIB00010134111|CCMSLIB00010134112|CCMSLIB00010134113|CCMSLIB00010134114|CCMSLIB00010134115,3,3073,Drug_suspect,domperidone,propulsives,gastroenterology,indigestion|epigastric pain|nausea|vomiting,dopamine receptor antagonist,FGXWKSZFVQUSTL-UHFFFAOYSA-N
CCMSLIB00012725434,related spectra of 'domperidone (delta mass:15.995)',CCMSLIB00010134111|CCMSLIB00010134112|CCMSLIB00010134113|CCMSLIB00010134114|CCMSLIB00010134115,15.99,3074,Drug_suspect,domperidone,propulsives,gastroenterology,indigestion|epigastric pain|nausea|vomiting,dopamine receptor antagonist,FGXWKSZFVQUSTL-UHFFFAOYSA-N
CCMSLIB00012725435,related spectra of 'doxapram (delta mass:15.995)',CCMSLIB00010143321|CCMSLIB00010143322|CCMSLIB00010143323|CCMSLIB00010143324|CCMSLIB00010143325|CCMSLIB00010143326|CCMSLIB00010143327|CCMSLIB00010143328,15.99,3075,Drug_suspect,doxapram,respiratory stimulant,pulmonary|critical care,respiratory depression|central nervous system depression|acute hypercapnia (AHC),potassium channel blocker,XFDJYSQDBULQSI-UHFFFAOYSA-N
CCMSLIB00012725436,related spectra of 'doxepin (delta mass:-14.016)',CCMSLIB00010144039|CCMSLIB00010144040|CCMSLIB00010144041|CCMSLIB00010144042|CCMSLIB00010144043|CCMSLIB00010144044|CCMSLIB00010144045|CCMSLIB00010144046,-14.02,3076,Drug_suspect,doxepin,tricyclic antidepressant (TCA),neurology/psychiatry,depression|anxiety,histamine receptor antagonist,ODQWQRRAPPTVAG-GZTJUZNOSA-N
CCMSLIB00012725437,related spectra of 'emamectin b1a (delta mass:-36.021)',CCMSLIB00010141998|CCMSLIB00010141999|CCMSLIB00010142000|CCMSLIB00010142001|CCMSLIB00010142002|CCMSLIB00010142003|CCMSLIB00010142004|CCMSLIB00010142005,-36.02,3077,Drug_suspect,emamectin b1a,no_match,no_match,no_match,no_match,CXEGAUYXQAKHKJ-NSBHKLITSA-N
CCMSLIB00012725438,related spectra of 'emamectin b1a (delta mass:-18.011)',CCMSLIB00010141998|CCMSLIB00010141999|CCMSLIB00010142000|CCMSLIB00010142001|CCMSLIB00010142002|CCMSLIB00010142003|CCMSLIB00010142004|CCMSLIB00010142005,-18.01,3078,Drug_suspect,emamectin b1a,no_match,no_match,no_match,no_match,CXEGAUYXQAKHKJ-NSBHKLITSA-N
CCMSLIB00012725439,related spectra of 'emamectin b1a (delta mass:-14.016)',CCMSLIB00010141998|CCMSLIB00010141999|CCMSLIB00010142000|CCMSLIB00010142001|CCMSLIB00010142002|CCMSLIB00010142003|CCMSLIB00010142004|CCMSLIB00010142005,-14.02,3079,Drug_suspect,emamectin b1a,no_match,no_match,no_match,no_match,CXEGAUYXQAKHKJ-NSBHKLITSA-N
CCMSLIB00012725440,related spectra of 'emamectin b1a (delta mass:14.016)',CCMSLIB00010141998|CCMSLIB00010141999|CCMSLIB00010142000|CCMSLIB00010142001|CCMSLIB00010142002|CCMSLIB00010142003|CCMSLIB00010142004|CCMSLIB00010142005,14.02,3080,Drug_suspect,emamectin b1a,no_match,no_match,no_match,no_match,CXEGAUYXQAKHKJ-NSBHKLITSA-N
CCMSLIB00012725441,related spectra of 'emamectin b1a (delta mass:18.01)',CCMSLIB00010141998|CCMSLIB00010141999|CCMSLIB00010142000|CCMSLIB00010142001|CCMSLIB00010142002|CCMSLIB00010142003|CCMSLIB00010142004|CCMSLIB00010142005,18.01,3081,Drug_suspect,emamectin b1a,no_match,no_match,no_match,no_match,CXEGAUYXQAKHKJ-NSBHKLITSA-N
CCMSLIB00012725442,related spectra of 'emamectin b1a (delta mass:58.005)',CCMSLIB00010141998|CCMSLIB00010141999|CCMSLIB00010142000|CCMSLIB00010142001|CCMSLIB00010142002|CCMSLIB00010142003|CCMSLIB00010142004|CCMSLIB00010142005,58.01,3082,Drug_suspect,emamectin b1a,no_match,no_match,no_match,no_match,CXEGAUYXQAKHKJ-NSBHKLITSA-N
CCMSLIB00012725443,related spectra of 'enalapril (delta mass:15.995)',CCMSLIB00010134495|CCMSLIB00010134496|CCMSLIB00010134497|CCMSLIB00010134498|CCMSLIB00010134499|CCMSLIB00010134500|CCMSLIB00010134501|CCMSLIB00010134502,15.99,3083,Drug_suspect,enalapril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|diabetic nephropathy|chronic kidney disease,angiotensin converting enzyme inhibitor,GBXSMTUPTTWBMN-XIRDDKMYSA-N
CCMSLIB00012725444,related spectra of 'erythromycin (delta mass:-176.105)',CCMSLIB00010149749|CCMSLIB00010149750|CCMSLIB00010149751|CCMSLIB00010149752|CCMSLIB00010149753|CCMSLIB00010149754|CCMSLIB00010149755|CCMSLIB00010149756|CCMSLIB00010149757|CCMSLIB00010149758|CCMSLIB00010149759|CCMSLIB00010149760|CCMSLIB00010149761,-176.1,3084,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725445,related spectra of 'erythromycin (delta mass:-14.016)',CCMSLIB00010149749|CCMSLIB00010149750|CCMSLIB00010149751|CCMSLIB00010149752|CCMSLIB00010149753|CCMSLIB00010149754|CCMSLIB00010149755|CCMSLIB00010149756|CCMSLIB00010149757|CCMSLIB00010149758|CCMSLIB00010149759|CCMSLIB00010149760|CCMSLIB00010149761,-14.02,3085,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725446,related spectra of 'erythromycin (delta mass:-3.995)',CCMSLIB00010149749|CCMSLIB00010149750|CCMSLIB00010149751|CCMSLIB00010149752|CCMSLIB00010149753|CCMSLIB00010149754|CCMSLIB00010149755|CCMSLIB00010149756|CCMSLIB00010149757|CCMSLIB00010149758|CCMSLIB00010149759|CCMSLIB00010149760|CCMSLIB00010149761,-3.99,3086,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725447,related spectra of 'erythromycin (delta mass:2.016)',CCMSLIB00010149749|CCMSLIB00010149750|CCMSLIB00010149751|CCMSLIB00010149752|CCMSLIB00010149753|CCMSLIB00010149754|CCMSLIB00010149755|CCMSLIB00010149756|CCMSLIB00010149757|CCMSLIB00010149758|CCMSLIB00010149759|CCMSLIB00010149760|CCMSLIB00010149761,2.02,3087,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725448,related spectra of 'erythromycin (delta mass:3.995)',CCMSLIB00010149749|CCMSLIB00010149750|CCMSLIB00010149751|CCMSLIB00010149752|CCMSLIB00010149753|CCMSLIB00010149754|CCMSLIB00010149755|CCMSLIB00010149756|CCMSLIB00010149757|CCMSLIB00010149758|CCMSLIB00010149759|CCMSLIB00010149760|CCMSLIB00010149761,3.99,3088,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725449,related spectra of 'erythromycin (delta mass:14.016)',CCMSLIB00010149749|CCMSLIB00010149750|CCMSLIB00010149751|CCMSLIB00010149752|CCMSLIB00010149753|CCMSLIB00010149754|CCMSLIB00010149755|CCMSLIB00010149756|CCMSLIB00010149757|CCMSLIB00010149758|CCMSLIB00010149759|CCMSLIB00010149760|CCMSLIB00010149761,14.02,3089,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725450,related spectra of 'erythromycin (delta mass:28.031)',CCMSLIB00010149749|CCMSLIB00010149750|CCMSLIB00010149751|CCMSLIB00010149752|CCMSLIB00010149753|CCMSLIB00010149754|CCMSLIB00010149755|CCMSLIB00010149756|CCMSLIB00010149757|CCMSLIB00010149758|CCMSLIB00010149759|CCMSLIB00010149760|CCMSLIB00010149761,28.03,3090,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725451,related spectra of 'erythromycin (delta mass:31.99)',CCMSLIB00010149749|CCMSLIB00010149750|CCMSLIB00010149751|CCMSLIB00010149752|CCMSLIB00010149753|CCMSLIB00010149754|CCMSLIB00010149755|CCMSLIB00010149756|CCMSLIB00010149757|CCMSLIB00010149758|CCMSLIB00010149759|CCMSLIB00010149760|CCMSLIB00010149761,31.99,3091,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725452,related spectra of 'erythromycin (delta mass:61.053)',CCMSLIB00010149749|CCMSLIB00010149750|CCMSLIB00010149751|CCMSLIB00010149752|CCMSLIB00010149753|CCMSLIB00010149754|CCMSLIB00010149755|CCMSLIB00010149756|CCMSLIB00010149757|CCMSLIB00010149758|CCMSLIB00010149759|CCMSLIB00010149760|CCMSLIB00010149761,61.05,3092,Drug_suspect,erythromycin,macrolide antimicrobial,infectious disease,listeria|respiratory tract infections|skin infections|syphilis|amebiasis|pelvic inflammatory disease|chlamydia|diphtheria|erythrasma,protein synthesis inhibition by binding to 50S ribosomal subunit,ULGZDMOVFRHVEP-RWJQBGPGSA-N
CCMSLIB00012725453,related spectra of 'famotidine (delta mass:15.995)',CCMSLIB00010131234|CCMSLIB00010131235|CCMSLIB00010131236|CCMSLIB00010131237|CCMSLIB00010131238,15.99,3093,Drug_suspect,famotidine,histamine-2 (H2) receptor antagonist,gastroenterology,heartburn|gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|gastric ulcers,histamine receptor antagonist,XUFQPHANEAPEMJ-UHFFFAOYSA-N
CCMSLIB00012725454,related spectra of 'fenbendazole (delta mass:15.995)',CCMSLIB00010140535|CCMSLIB00010140536|CCMSLIB00010140537|CCMSLIB00010140538|CCMSLIB00010140539,15.99,3094,Drug_suspect,fenbendazole,anthelminticveterinary,infectious disease,gastrointestinal parasites|gastrointestinal roundworms,tubulin polymerization inhibitor,HDDSHPAODJUKPD-UHFFFAOYSA-N
CCMSLIB00012725455,related spectra of 'fenbendazole (delta mass:31.99)',CCMSLIB00010140535|CCMSLIB00010140536|CCMSLIB00010140537|CCMSLIB00010140538|CCMSLIB00010140539,31.99,3095,Drug_suspect,fenbendazole,anthelminticveterinary,infectious disease,gastrointestinal parasites|gastrointestinal roundworms,tubulin polymerization inhibitor,HDDSHPAODJUKPD-UHFFFAOYSA-N
CCMSLIB00012725456,related spectra of 'fenbendazole (delta mass:79.957)',CCMSLIB00010140535|CCMSLIB00010140536|CCMSLIB00010140537|CCMSLIB00010140538|CCMSLIB00010140539,79.96,3096,Drug_suspect,fenbendazole,anthelminticveterinary,infectious disease,gastrointestinal parasites|gastrointestinal roundworms,tubulin polymerization inhibitor,HDDSHPAODJUKPD-UHFFFAOYSA-N
CCMSLIB00012725457,related spectra of 'gabapentin (delta mass:15.995)',CCMSLIB00010132417|CCMSLIB00010132418|CCMSLIB00010132419|CCMSLIB00010132420|CCMSLIB00010132421|CCMSLIB00010132422|CCMSLIB00010132423|CCMSLIB00010132424|CCMSLIB00010132425|CCMSLIB00010132426|CCMSLIB00010132427|CCMSLIB00010132428|CCMSLIB00010132429|CCMSLIB00010137473|CCMSLIB00010137474|CCMSLIB00010137475|CCMSLIB00010137476|CCMSLIB00010137477|CCMSLIB00010137478|CCMSLIB00010137479|CCMSLIB00010137480|CCMSLIB00010137481|CCMSLIB00010137482,15.99,3097,Drug_suspect|Low_confidence,gabapentin,antiepileptic drug (AED),neurology/psychiatry,neuropathic pain|shingles|seizures|restless leg syndrome,calcium channel blocker,UGJMXCAKCUNAIE-UHFFFAOYSA-N
CCMSLIB00012725458,related spectra of 'gabapentin (delta mass:42.01)',CCMSLIB00010132417|CCMSLIB00010132418|CCMSLIB00010132419|CCMSLIB00010132420|CCMSLIB00010132421|CCMSLIB00010132422|CCMSLIB00010132423|CCMSLIB00010132424|CCMSLIB00010132425|CCMSLIB00010132426|CCMSLIB00010132427|CCMSLIB00010132428|CCMSLIB00010132429|CCMSLIB00010137473|CCMSLIB00010137474|CCMSLIB00010137475|CCMSLIB00010137476|CCMSLIB00010137477|CCMSLIB00010137478|CCMSLIB00010137479|CCMSLIB00010137480|CCMSLIB00010137481|CCMSLIB00010137482,42.01,3098,Drug_suspect|Low_confidence,gabapentin,antiepileptic drug (AED),neurology/psychiatry,neuropathic pain|shingles|seizures|restless leg syndrome,calcium channel blocker,UGJMXCAKCUNAIE-UHFFFAOYSA-N
CCMSLIB00012725459,related spectra of 'galanthamine (delta mass:14.016)',CCMSLIB00006392980|CCMSLIB00006392981|CCMSLIB00006393027|CCMSLIB00006393074|CCMSLIB00006393120|CCMSLIB00006393121|CCMSLIB00006393168|CCMSLIB00006393169|CCMSLIB00006393216|CCMSLIB00006393217|CCMSLIB00006393263|CCMSLIB00006393264|CCMSLIB00006393308|CCMSLIB00006393309|CCMSLIB00006393356|CCMSLIB00006393357|CCMSLIB00006393401|CCMSLIB00006393402|CCMSLIB00006393448|CCMSLIB00006393449|CCMSLIB00006393495|CCMSLIB00006393496|CCMSLIB00006393541|CCMSLIB00006393542|CCMSLIB00006393587|CCMSLIB00006393588|CCMSLIB00006393632|CCMSLIB00006393633|CCMSLIB00006393678|CCMSLIB00006393679|CCMSLIB00006393721|CCMSLIB00006393722|CCMSLIB00006393765|CCMSLIB00006393766|CCMSLIB00006393808|CCMSLIB00006393809|CCMSLIB00006393855|CCMSLIB00006393856|CCMSLIB00006562483|CCMSLIB00006562507|CCMSLIB00006562531|CCMSLIB00006562555|CCMSLIB00006562579|CCMSLIB00006562587|CCMSLIB00006562611|CCMSLIB00006562635|CCMSLIB00006562659|CCMSLIB00006562683|CCMSLIB00006562691|CCMSLIB00006562715|CCMSLIB00006562739|CCMSLIB00006562763|CCMSLIB00006562787|CCMSLIB00006562795|CCMSLIB00006562819|CCMSLIB00006562843|CCMSLIB00006562867|CCMSLIB00006562891|CCMSLIB00006562899|CCMSLIB00006562923|CCMSLIB00006562947|CCMSLIB00006562971|CCMSLIB00006562996|CCMSLIB00006563004|CCMSLIB00006563028|CCMSLIB00006563052|CCMSLIB00006563076|CCMSLIB00006563100|CCMSLIB00006563108|CCMSLIB00006563132|CCMSLIB00006563156|CCMSLIB00006563180|CCMSLIB00006563204|CCMSLIB00006563212|CCMSLIB00006563236|CCMSLIB00006563260|CCMSLIB00006563284|CCMSLIB00006563308|CCMSLIB00006563316|CCMSLIB00006563340|CCMSLIB00006563364|CCMSLIB00006563388|CCMSLIB00006563412|CCMSLIB00006563420|CCMSLIB00006563444|CCMSLIB00006563468|CCMSLIB00006563492|CCMSLIB00006563516|CCMSLIB00010140160|CCMSLIB00010140161|CCMSLIB00010140162|CCMSLIB00010140163|CCMSLIB00010140164|CCMSLIB00010140165|CCMSLIB00010140166|CCMSLIB00010140167|CCMSLIB00010142804|CCMSLIB00010142805|CCMSLIB00010142806|CCMSLIB00010142807|CCMSLIB00010142808,14.02,3099,Drug_suspect,galantamine|galanthamine,cholinesterase inhibitor,neurology/psychiatry,senile dementia,acetylcholinesterase inhibitor,ASUTZQLVASHGKV-JDFRZJQESA-N
CCMSLIB00012725460,related spectra of 'glipizide (delta mass:-2.016)',CCMSLIB00010148879|CCMSLIB00010148880|CCMSLIB00010148881|CCMSLIB00010148882|CCMSLIB00010148883|CCMSLIB00010148884|CCMSLIB00010148885|CCMSLIB00010148886,-2.02,3100,Drug_suspect,glipizide,sulfonylurea,endocrinology,type 2 diabetes mellitus,insulin secretagogue,ZJJXGWJIGJFDTL-UHFFFAOYSA-N
CCMSLIB00012725461,related spectra of 'glipizide (delta mass:15.995)',CCMSLIB00010148879|CCMSLIB00010148880|CCMSLIB00010148881|CCMSLIB00010148882|CCMSLIB00010148883|CCMSLIB00010148884|CCMSLIB00010148885|CCMSLIB00010148886,15.99,3101,Drug_suspect,glipizide,sulfonylurea,endocrinology,type 2 diabetes mellitus,insulin secretagogue,ZJJXGWJIGJFDTL-UHFFFAOYSA-N
CCMSLIB00012725462,related spectra of 'hydrocortisone hemisuccinate (delta mass:-18.011)',CCMSLIB00010133124|CCMSLIB00010133125|CCMSLIB00010133126|CCMSLIB00010133127|CCMSLIB00010133128,-18.01,3102,Drug_suspect,hydrocortisone hemisuccinate,corticosteroid,endocrinology|rheumatology|allergy|gastroenterology|dermatology|pulmonary|ophtalmology,allergic reaction|rheumatoid arthritis|gastrointestinal disease|dermatologic disease|ophthalmic disease|respiratory disease,glucocorticoid receptor agonist,VWQWXZAWFPZJDA-CGVGKPPMSA-N
CCMSLIB00012725463,related spectra of 'hydroxychloroquine (delta mass:-28.031)',CCMSLIB00010138313|CCMSLIB00010138314|CCMSLIB00010138315|CCMSLIB00010138316|CCMSLIB00010138317|CCMSLIB00010138318|CCMSLIB00010138319|CCMSLIB00010138320,-28.03,3103,Drug_suspect,hydroxychloroquine,antirheumatic|antimalarial,infectious disease|rheumatology,malaria|rheumatoid arthritis|lupus,antimalarial agent,XXSMGPRMXLTPCZ-UHFFFAOYSA-N
CCMSLIB00012725464,related spectra of 'hydroxychloroquine (delta mass:13.98)',CCMSLIB00010138313|CCMSLIB00010138314|CCMSLIB00010138315|CCMSLIB00010138316|CCMSLIB00010138317|CCMSLIB00010138318|CCMSLIB00010138319|CCMSLIB00010138320,13.98,3104,Drug_suspect,hydroxychloroquine,antirheumatic|antimalarial,infectious disease|rheumatology,malaria|rheumatoid arthritis|lupus,antimalarial agent,XXSMGPRMXLTPCZ-UHFFFAOYSA-N
CCMSLIB00012725465,related spectra of 'irbesartan (delta mass:-28.031)',CCMSLIB00010131632|CCMSLIB00010131633|CCMSLIB00010131634|CCMSLIB00010131635|CCMSLIB00010131636|CCMSLIB00010131637|CCMSLIB00010131638|CCMSLIB00010131639,-28.03,3105,Drug_suspect,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012725466,related spectra of 'irbesartan (delta mass:-2.016)',CCMSLIB00010131632|CCMSLIB00010131633|CCMSLIB00010131634|CCMSLIB00010131635|CCMSLIB00010131636|CCMSLIB00010131637|CCMSLIB00010131638|CCMSLIB00010131639,-2.02,3106,Drug_suspect,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012725467,related spectra of 'irbesartan (delta mass:13.98)',CCMSLIB00010131632|CCMSLIB00010131633|CCMSLIB00010131634|CCMSLIB00010131635|CCMSLIB00010131636|CCMSLIB00010131637|CCMSLIB00010131638|CCMSLIB00010131639,13.98,3107,Drug_suspect,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012725468,related spectra of 'irbesartan (delta mass:15.995)',CCMSLIB00010131632|CCMSLIB00010131633|CCMSLIB00010131634|CCMSLIB00010131635|CCMSLIB00010131636|CCMSLIB00010131637|CCMSLIB00010131638|CCMSLIB00010131639,15.99,3108,Drug_suspect,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012725469,related spectra of 'irbesartan (delta mass:29.974)',CCMSLIB00010131632|CCMSLIB00010131633|CCMSLIB00010131634|CCMSLIB00010131635|CCMSLIB00010131636|CCMSLIB00010131637|CCMSLIB00010131638|CCMSLIB00010131639,29.97,3109,Drug_suspect,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012725470,related spectra of 'irbesartan (delta mass:31.99)',CCMSLIB00010131632|CCMSLIB00010131633|CCMSLIB00010131634|CCMSLIB00010131635|CCMSLIB00010131636|CCMSLIB00010131637|CCMSLIB00010131638|CCMSLIB00010131639,31.99,3110,Drug_suspect,irbesartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,YOSHYTLCDANDAN-UHFFFAOYSA-N
CCMSLIB00012725471,related spectra of 'lasalocid (delta mass:-43.99)',CCMSLIB00010139447|CCMSLIB00010139448|CCMSLIB00010139449|CCMSLIB00010139450|CCMSLIB00010139451|CCMSLIB00010139452|CCMSLIB00010139453|CCMSLIB00010139454|CCMSLIB00010139455|CCMSLIB00010139456|CCMSLIB00010139457|CCMSLIB00010139458|CCMSLIB00010139459|CCMSLIB00010139460|CCMSLIB00010139461|CCMSLIB00010139462|CCMSLIB00010139463|CCMSLIB00010139464|CCMSLIB00010139465|CCMSLIB00010139466|CCMSLIB00010148179|CCMSLIB00010148180|CCMSLIB00010148181|CCMSLIB00010148182|CCMSLIB00010148183|CCMSLIB00010148184|CCMSLIB00010148185|CCMSLIB00010148186|CCMSLIB00010148187|CCMSLIB00010148188|CCMSLIB00010148189|CCMSLIB00010148190|CCMSLIB00010148191|CCMSLIB00010148192|CCMSLIB00010148193|CCMSLIB00010148194|CCMSLIB00010148195|CCMSLIB00010148196|CCMSLIB00010148197|CCMSLIB00010148198|CCMSLIB00010148199|CCMSLIB00010148200|CCMSLIB00010148201|CCMSLIB00010148202|CCMSLIB00010148203|CCMSLIB00010148204|CCMSLIB00010148205|CCMSLIB00010148206,-43.99,3111,Drug_suspect,lasalocid,other antibiotic|veterinary,infectious disease,coccidiosis,bacterial permeability inducer,BBMULGJBVDDDNI-OWKLGTHSSA-N
CCMSLIB00012725472,related spectra of 'lasalocid (delta mass:-29.975)',CCMSLIB00010139447|CCMSLIB00010139448|CCMSLIB00010139449|CCMSLIB00010139450|CCMSLIB00010139451|CCMSLIB00010139452|CCMSLIB00010139453|CCMSLIB00010139454|CCMSLIB00010139455|CCMSLIB00010139456|CCMSLIB00010139457|CCMSLIB00010139458|CCMSLIB00010139459|CCMSLIB00010139460|CCMSLIB00010139461|CCMSLIB00010139462|CCMSLIB00010139463|CCMSLIB00010139464|CCMSLIB00010139465|CCMSLIB00010139466|CCMSLIB00010148179|CCMSLIB00010148180|CCMSLIB00010148181|CCMSLIB00010148182|CCMSLIB00010148183|CCMSLIB00010148184|CCMSLIB00010148185|CCMSLIB00010148186|CCMSLIB00010148187|CCMSLIB00010148188|CCMSLIB00010148189|CCMSLIB00010148190|CCMSLIB00010148191|CCMSLIB00010148192|CCMSLIB00010148193|CCMSLIB00010148194|CCMSLIB00010148195|CCMSLIB00010148196|CCMSLIB00010148197|CCMSLIB00010148198|CCMSLIB00010148199|CCMSLIB00010148200|CCMSLIB00010148201|CCMSLIB00010148202|CCMSLIB00010148203|CCMSLIB00010148204|CCMSLIB00010148205|CCMSLIB00010148206,-29.97,3112,Drug_suspect,lasalocid,other antibiotic|veterinary,infectious disease,coccidiosis,bacterial permeability inducer,BBMULGJBVDDDNI-OWKLGTHSSA-N
CCMSLIB00012725473,related spectra of 'lasalocid (delta mass:15.995)',CCMSLIB00010139447|CCMSLIB00010139448|CCMSLIB00010139449|CCMSLIB00010139450|CCMSLIB00010139451|CCMSLIB00010139452|CCMSLIB00010139453|CCMSLIB00010139454|CCMSLIB00010139455|CCMSLIB00010139456|CCMSLIB00010139457|CCMSLIB00010139458|CCMSLIB00010139459|CCMSLIB00010139460|CCMSLIB00010139461|CCMSLIB00010139462|CCMSLIB00010139463|CCMSLIB00010139464|CCMSLIB00010139465|CCMSLIB00010139466|CCMSLIB00010148179|CCMSLIB00010148180|CCMSLIB00010148181|CCMSLIB00010148182|CCMSLIB00010148183|CCMSLIB00010148184|CCMSLIB00010148185|CCMSLIB00010148186|CCMSLIB00010148187|CCMSLIB00010148188|CCMSLIB00010148189|CCMSLIB00010148190|CCMSLIB00010148191|CCMSLIB00010148192|CCMSLIB00010148193|CCMSLIB00010148194|CCMSLIB00010148195|CCMSLIB00010148196|CCMSLIB00010148197|CCMSLIB00010148198|CCMSLIB00010148199|CCMSLIB00010148200|CCMSLIB00010148201|CCMSLIB00010148202|CCMSLIB00010148203|CCMSLIB00010148204|CCMSLIB00010148205|CCMSLIB00010148206,15.99,3113,Drug_suspect,lasalocid,other antibiotic|veterinary,infectious disease,coccidiosis,bacterial permeability inducer,BBMULGJBVDDDNI-OWKLGTHSSA-N
CCMSLIB00012725474,related spectra of 'lasalocid (delta mass:28.031)',CCMSLIB00010139447|CCMSLIB00010139448|CCMSLIB00010139449|CCMSLIB00010139450|CCMSLIB00010139451|CCMSLIB00010139452|CCMSLIB00010139453|CCMSLIB00010139454|CCMSLIB00010139455|CCMSLIB00010139456|CCMSLIB00010139457|CCMSLIB00010139458|CCMSLIB00010139459|CCMSLIB00010139460|CCMSLIB00010139461|CCMSLIB00010139462|CCMSLIB00010139463|CCMSLIB00010139464|CCMSLIB00010139465|CCMSLIB00010139466|CCMSLIB00010148179|CCMSLIB00010148180|CCMSLIB00010148181|CCMSLIB00010148182|CCMSLIB00010148183|CCMSLIB00010148184|CCMSLIB00010148185|CCMSLIB00010148186|CCMSLIB00010148187|CCMSLIB00010148188|CCMSLIB00010148189|CCMSLIB00010148190|CCMSLIB00010148191|CCMSLIB00010148192|CCMSLIB00010148193|CCMSLIB00010148194|CCMSLIB00010148195|CCMSLIB00010148196|CCMSLIB00010148197|CCMSLIB00010148198|CCMSLIB00010148199|CCMSLIB00010148200|CCMSLIB00010148201|CCMSLIB00010148202|CCMSLIB00010148203|CCMSLIB00010148204|CCMSLIB00010148205|CCMSLIB00010148206,28.03,3114,Drug_suspect,lasalocid,other antibiotic|veterinary,infectious disease,coccidiosis,bacterial permeability inducer,BBMULGJBVDDDNI-OWKLGTHSSA-N
CCMSLIB00012725475,related spectra of 'lasalocid (delta mass:30.01)',CCMSLIB00010139447|CCMSLIB00010139448|CCMSLIB00010139449|CCMSLIB00010139450|CCMSLIB00010139451|CCMSLIB00010139452|CCMSLIB00010139453|CCMSLIB00010139454|CCMSLIB00010139455|CCMSLIB00010139456|CCMSLIB00010139457|CCMSLIB00010139458|CCMSLIB00010139459|CCMSLIB00010139460|CCMSLIB00010139461|CCMSLIB00010139462|CCMSLIB00010139463|CCMSLIB00010139464|CCMSLIB00010139465|CCMSLIB00010139466|CCMSLIB00010148179|CCMSLIB00010148180|CCMSLIB00010148181|CCMSLIB00010148182|CCMSLIB00010148183|CCMSLIB00010148184|CCMSLIB00010148185|CCMSLIB00010148186|CCMSLIB00010148187|CCMSLIB00010148188|CCMSLIB00010148189|CCMSLIB00010148190|CCMSLIB00010148191|CCMSLIB00010148192|CCMSLIB00010148193|CCMSLIB00010148194|CCMSLIB00010148195|CCMSLIB00010148196|CCMSLIB00010148197|CCMSLIB00010148198|CCMSLIB00010148199|CCMSLIB00010148200|CCMSLIB00010148201|CCMSLIB00010148202|CCMSLIB00010148203|CCMSLIB00010148204|CCMSLIB00010148205|CCMSLIB00010148206,30.01,3115,Drug_suspect,lasalocid,other antibiotic|veterinary,infectious disease,coccidiosis,bacterial permeability inducer,BBMULGJBVDDDNI-OWKLGTHSSA-N
CCMSLIB00012725476,related spectra of 'lincomycin (delta mass:-29.994)',CCMSLIB00010138460|CCMSLIB00010138461|CCMSLIB00010138462|CCMSLIB00010138463|CCMSLIB00010138464|CCMSLIB00010138465|CCMSLIB00010138466|CCMSLIB00010138467,-29.99,3116,Drug_suspect,lincomycin,lincosamide antibacterial,infectious disease,gram-positive bacterial infections,protein synthesis inhibitor by binding 50S ribosomal subunit,OJMMVQQUTAEWLP-KIDUDLJLSA-N
CCMSLIB00012725477,related spectra of 'lincomycin (delta mass:-14.016)',CCMSLIB00010138460|CCMSLIB00010138461|CCMSLIB00010138462|CCMSLIB00010138463|CCMSLIB00010138464|CCMSLIB00010138465|CCMSLIB00010138466|CCMSLIB00010138467,-14.02,3117,Drug_suspect,lincomycin,lincosamide antibacterial,infectious disease,gram-positive bacterial infections,protein synthesis inhibitor by binding 50S ribosomal subunit,OJMMVQQUTAEWLP-KIDUDLJLSA-N
CCMSLIB00012725478,related spectra of 'lincomycin (delta mass:15.995)',CCMSLIB00010138460|CCMSLIB00010138461|CCMSLIB00010138462|CCMSLIB00010138463|CCMSLIB00010138464|CCMSLIB00010138465|CCMSLIB00010138466|CCMSLIB00010138467,15.99,3118,Drug_suspect,lincomycin,lincosamide antibacterial,infectious disease,gram-positive bacterial infections,protein synthesis inhibitor by binding 50S ribosomal subunit,OJMMVQQUTAEWLP-KIDUDLJLSA-N
CCMSLIB00012725479,related spectra of 'lincomycin (delta mass:31.99)',CCMSLIB00010138460|CCMSLIB00010138461|CCMSLIB00010138462|CCMSLIB00010138463|CCMSLIB00010138464|CCMSLIB00010138465|CCMSLIB00010138466|CCMSLIB00010138467,31.99,3119,Drug_suspect,lincomycin,lincosamide antibacterial,infectious disease,gram-positive bacterial infections,protein synthesis inhibitor by binding 50S ribosomal subunit,OJMMVQQUTAEWLP-KIDUDLJLSA-N
CCMSLIB00012725480,related spectra of 'loperamide (delta mass:-28.031)',CCMSLIB00010138129|CCMSLIB00010138130|CCMSLIB00010138131|CCMSLIB00010138132|CCMSLIB00010138133|CCMSLIB00010138134|CCMSLIB00010138135|CCMSLIB00010138136,-28.03,3120,Drug_suspect,loperamide,opioid agonist,gastroenterology,diarrhea,opioid receptor agonist,RDOIQAHITMMDAJ-UHFFFAOYSA-N
CCMSLIB00012725481,related spectra of 'loperamide (delta mass:-14.016)',CCMSLIB00010138129|CCMSLIB00010138130|CCMSLIB00010138131|CCMSLIB00010138132|CCMSLIB00010138133|CCMSLIB00010138134|CCMSLIB00010138135|CCMSLIB00010138136,-14.02,3121,Drug_suspect,loperamide,opioid agonist,gastroenterology,diarrhea,opioid receptor agonist,RDOIQAHITMMDAJ-UHFFFAOYSA-N
CCMSLIB00012725482,related spectra of 'losartan (delta mass:-18.011)',CCMSLIB00010129972|CCMSLIB00010129973|CCMSLIB00010129974|CCMSLIB00010129975|CCMSLIB00010129976|CCMSLIB00010129985|CCMSLIB00010129986|CCMSLIB00010129987|CCMSLIB00010129988|CCMSLIB00010129989|CCMSLIB00010139536|CCMSLIB00010139537|CCMSLIB00010139538|CCMSLIB00010139539|CCMSLIB00010139540,-18.01,3122,Drug_suspect,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012725483,related spectra of 'losartan (delta mass:12.036)',CCMSLIB00010129972|CCMSLIB00010129973|CCMSLIB00010129974|CCMSLIB00010129975|CCMSLIB00010129976|CCMSLIB00010129985|CCMSLIB00010129986|CCMSLIB00010129987|CCMSLIB00010129988|CCMSLIB00010129989|CCMSLIB00010139536|CCMSLIB00010139537|CCMSLIB00010139538|CCMSLIB00010139539|CCMSLIB00010139540,12.04,3123,Drug_suspect,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012725484,related spectra of 'losartan (delta mass:15.995)',CCMSLIB00010129972|CCMSLIB00010129973|CCMSLIB00010129974|CCMSLIB00010129975|CCMSLIB00010129976|CCMSLIB00010129985|CCMSLIB00010129986|CCMSLIB00010129987|CCMSLIB00010129988|CCMSLIB00010129989|CCMSLIB00010139536|CCMSLIB00010139537|CCMSLIB00010139538|CCMSLIB00010139539|CCMSLIB00010139540,15.99,3124,Drug_suspect,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012725485,related spectra of 'losartan (delta mass:176.032)',CCMSLIB00010129972|CCMSLIB00010129973|CCMSLIB00010129974|CCMSLIB00010129975|CCMSLIB00010129976|CCMSLIB00010129985|CCMSLIB00010129986|CCMSLIB00010129987|CCMSLIB00010129988|CCMSLIB00010129989|CCMSLIB00010139536|CCMSLIB00010139537|CCMSLIB00010139538|CCMSLIB00010139539|CCMSLIB00010139540,176.03,3125,Drug_suspect,losartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|diabetic nephropathy,angiotensin receptor antagonist,PSIFNNKUMBGKDQ-UHFFFAOYSA-N
CCMSLIB00012725486,related spectra of 'meloxicam (delta mass:15.995)',CCMSLIB00010143110|CCMSLIB00010143111|CCMSLIB00010143112|CCMSLIB00010143113|CCMSLIB00010143114|CCMSLIB00010143115|CCMSLIB00010143116|CCMSLIB00010143117,15.99,3126,Drug_suspect,meloxicam,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis,cyclooxygenase inhibitor,ZRVUJXDFFKFLMG-UHFFFAOYSA-N
CCMSLIB00012725487,related spectra of 'meloxicam (delta mass:29.974)',CCMSLIB00010143110|CCMSLIB00010143111|CCMSLIB00010143112|CCMSLIB00010143113|CCMSLIB00010143114|CCMSLIB00010143115|CCMSLIB00010143116|CCMSLIB00010143117,29.97,3127,Drug_suspect,meloxicam,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis,cyclooxygenase inhibitor,ZRVUJXDFFKFLMG-UHFFFAOYSA-N
CCMSLIB00012725488,related spectra of 'methylprednisolone (delta mass:-2.016)',CCMSLIB00010152452|CCMSLIB00010152453|CCMSLIB00010152454|CCMSLIB00010152455|CCMSLIB00010152456|CCMSLIB00010152457|CCMSLIB00010152458,-2.02,3128,Drug_suspect,methylprednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,VHRSUDSXCMQTMA-PJHHCJLFSA-N
CCMSLIB00012725489,related spectra of 'methylprednisolone (delta mass:2.016)',CCMSLIB00010152452|CCMSLIB00010152453|CCMSLIB00010152454|CCMSLIB00010152455|CCMSLIB00010152456|CCMSLIB00010152457|CCMSLIB00010152458,2.02,3129,Drug_suspect,methylprednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,VHRSUDSXCMQTMA-PJHHCJLFSA-N
CCMSLIB00012725490,related spectra of 'methylprednisolone (delta mass:13.98)',CCMSLIB00010152452|CCMSLIB00010152453|CCMSLIB00010152454|CCMSLIB00010152455|CCMSLIB00010152456|CCMSLIB00010152457|CCMSLIB00010152458,13.98,3130,Drug_suspect,methylprednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,VHRSUDSXCMQTMA-PJHHCJLFSA-N
CCMSLIB00012725491,related spectra of 'methylprednisolone (delta mass:15.995)',CCMSLIB00010152452|CCMSLIB00010152453|CCMSLIB00010152454|CCMSLIB00010152455|CCMSLIB00010152456|CCMSLIB00010152457|CCMSLIB00010152458,15.99,3131,Drug_suspect,methylprednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,VHRSUDSXCMQTMA-PJHHCJLFSA-N
CCMSLIB00012725492,related spectra of 'mycophenolic acid (delta mass:-18.011)',CCMSLIB00010145940|CCMSLIB00010145941|CCMSLIB00010145942|CCMSLIB00010145943|CCMSLIB00010145944,-18.01,3132,Drug_suspect,mycophenolic acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-RUDMXATFSA-N
CCMSLIB00012725493,related spectra of 'mycophenolic acid (delta mass:2.016)',CCMSLIB00010145940|CCMSLIB00010145941|CCMSLIB00010145942|CCMSLIB00010145943|CCMSLIB00010145944,2.02,3133,Drug_suspect,mycophenolic acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-RUDMXATFSA-N
CCMSLIB00012725494,related spectra of 'mycophenolic acid (delta mass:21.984)',CCMSLIB00010145940|CCMSLIB00010145941|CCMSLIB00010145942|CCMSLIB00010145943|CCMSLIB00010145944,21.98,3134,Drug_suspect,mycophenolic acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-RUDMXATFSA-N
CCMSLIB00012725495,related spectra of 'mycophenolic acid (delta mass:28.031)',CCMSLIB00010145940|CCMSLIB00010145941|CCMSLIB00010145942|CCMSLIB00010145943|CCMSLIB00010145944,28.03,3135,Drug_suspect,mycophenolic acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-RUDMXATFSA-N
CCMSLIB00012725496,related spectra of 'mycophenolic acid (delta mass:176.032)',CCMSLIB00010145940|CCMSLIB00010145941|CCMSLIB00010145942|CCMSLIB00010145943|CCMSLIB00010145944,176.03,3136,Drug_suspect,mycophenolic acid,antimetabolite immunosuppressant,transplant,organ rejection,inosine-5'-monophosphatase dehydrogenase inhibitor,HPNSFSBZBAHARI-RUDMXATFSA-N
CCMSLIB00012725497,related spectra of 'norfloxacin (delta mass:27.995)',CCMSLIB00010133415|CCMSLIB00010133416|CCMSLIB00010133417|CCMSLIB00010133418|CCMSLIB00010133419|CCMSLIB00010133420|CCMSLIB00010133421|CCMSLIB00010133422,27.99,3137,Drug_suspect,norfloxacin,fluoroquinolone antimicrobial,infectious disease,urinary tract infections|gonorrhea|prostatitis,bacterial DNA gyrase inhibitor,OGJPXUAPXNRGGI-UHFFFAOYSA-N
CCMSLIB00012725498,related spectra of 'nortriptyline (delta mass:-14.016)',CCMSLIB00010138445|CCMSLIB00010138446|CCMSLIB00010138447|CCMSLIB00010138448|CCMSLIB00010138449,-14.02,3138,Drug_suspect,nortriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression,tricyclic antidepressant,PHVGLTMQBUFIQQ-UHFFFAOYSA-N
CCMSLIB00012725499,related spectra of 'nortriptyline (delta mass:15.012)',CCMSLIB00010138445|CCMSLIB00010138446|CCMSLIB00010138447|CCMSLIB00010138448|CCMSLIB00010138449,15.01,3139,Drug_suspect,nortriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression,tricyclic antidepressant,PHVGLTMQBUFIQQ-UHFFFAOYSA-N
CCMSLIB00012725500,related spectra of 'nortriptyline (delta mass:27.995)',CCMSLIB00010138445|CCMSLIB00010138446|CCMSLIB00010138447|CCMSLIB00010138448|CCMSLIB00010138449,27.99,3140,Drug_suspect,nortriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression,tricyclic antidepressant,PHVGLTMQBUFIQQ-UHFFFAOYSA-N
CCMSLIB00012725501,related spectra of 'nortriptyline (delta mass:30.01)',CCMSLIB00010138445|CCMSLIB00010138446|CCMSLIB00010138447|CCMSLIB00010138448|CCMSLIB00010138449,30.01,3141,Drug_suspect,nortriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression,tricyclic antidepressant,PHVGLTMQBUFIQQ-UHFFFAOYSA-N
CCMSLIB00012725502,related spectra of 'nortriptyline (delta mass:42.01)',CCMSLIB00010138445|CCMSLIB00010138446|CCMSLIB00010138447|CCMSLIB00010138448|CCMSLIB00010138449,42.01,3142,Drug_suspect,nortriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression,tricyclic antidepressant,PHVGLTMQBUFIQQ-UHFFFAOYSA-N
CCMSLIB00012725503,related spectra of 'noscapine (delta mass:15.958)',CCMSLIB00010152459|CCMSLIB00010152460|CCMSLIB00010152461|CCMSLIB00010152462|CCMSLIB00010152463|CCMSLIB00010152464|CCMSLIB00010152465|CCMSLIB00010152466,15.96,3143,Drug_suspect,noscapine,opium alkaloids and derivatives,pulmonary,cough suppressant,bradykinin receptor antagonist|tubulin polymerization inhibitor,AKNNEGZIBPJZJG-MSOLQXFVSA-N
CCMSLIB00012725504,related spectra of 'noscapine (delta mass:15.995)',CCMSLIB00010152459|CCMSLIB00010152460|CCMSLIB00010152461|CCMSLIB00010152462|CCMSLIB00010152463|CCMSLIB00010152464|CCMSLIB00010152465|CCMSLIB00010152466,15.99,3144,Drug_suspect,noscapine,opium alkaloids and derivatives,pulmonary,cough suppressant,bradykinin receptor antagonist|tubulin polymerization inhibitor,AKNNEGZIBPJZJG-MSOLQXFVSA-N
CCMSLIB00012725505,related spectra of 'noscapine (delta mass:18.01)',CCMSLIB00010152459|CCMSLIB00010152460|CCMSLIB00010152461|CCMSLIB00010152462|CCMSLIB00010152463|CCMSLIB00010152464|CCMSLIB00010152465|CCMSLIB00010152466,18.01,3145,Drug_suspect,noscapine,opium alkaloids and derivatives,pulmonary,cough suppressant,bradykinin receptor antagonist|tubulin polymerization inhibitor,AKNNEGZIBPJZJG-MSOLQXFVSA-N
CCMSLIB00012725506,related spectra of 'noscapine (delta mass:24.995)',CCMSLIB00010152459|CCMSLIB00010152460|CCMSLIB00010152461|CCMSLIB00010152462|CCMSLIB00010152463|CCMSLIB00010152464|CCMSLIB00010152465|CCMSLIB00010152466,25,3146,Drug_suspect,noscapine,opium alkaloids and derivatives,pulmonary,cough suppressant,bradykinin receptor antagonist|tubulin polymerization inhibitor,AKNNEGZIBPJZJG-MSOLQXFVSA-N
CCMSLIB00012725507,related spectra of 'ofloxacin (delta mass:-43.99)',CCMSLIB00010142006|CCMSLIB00010142007|CCMSLIB00010142008|CCMSLIB00010142009|CCMSLIB00010142010,-43.99,3147,Drug_suspect,ofloxacin,fluoroquinolone antimicrobial,infectious disease,pneumonia|sinusitis|bronchitis|skin infections|prostatitis|urinary tract infections|pyelonephritis|anthrax|plague|gram-negative bacterial infections|gram-positive bacterial infections,bacterial DNA gyrase inhibitor,GSDSWSVVBLHKDQ-UHFFFAOYSA-N
CCMSLIB00012725508,related spectra of 'ofloxacin (delta mass:-14.016)',CCMSLIB00010142006|CCMSLIB00010142007|CCMSLIB00010142008|CCMSLIB00010142009|CCMSLIB00010142010,-14.02,3148,Drug_suspect,ofloxacin,fluoroquinolone antimicrobial,infectious disease,pneumonia|sinusitis|bronchitis|skin infections|prostatitis|urinary tract infections|pyelonephritis|anthrax|plague|gram-negative bacterial infections|gram-positive bacterial infections,bacterial DNA gyrase inhibitor,GSDSWSVVBLHKDQ-UHFFFAOYSA-N
CCMSLIB00012725509,related spectra of 'omeprazole (delta mass:-15.995)',CCMSLIB00010138450|CCMSLIB00010138451|CCMSLIB00010138452|CCMSLIB00010138453|CCMSLIB00010138454|CCMSLIB00010138455|CCMSLIB00010138456|CCMSLIB00010138457|CCMSLIB00010138458|CCMSLIB00010138459|CCMSLIB00010142822|CCMSLIB00010142823|CCMSLIB00010142824|CCMSLIB00010142825|CCMSLIB00010142826,-15.99,3149,Drug_suspect,omeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,SUBDBMMJDZJVOS-UHFFFAOYSA-N
CCMSLIB00012725510,related spectra of 'omeprazole (delta mass:-14.016)',CCMSLIB00010138450|CCMSLIB00010138451|CCMSLIB00010138452|CCMSLIB00010138453|CCMSLIB00010138454|CCMSLIB00010138455|CCMSLIB00010138456|CCMSLIB00010138457|CCMSLIB00010138458|CCMSLIB00010138459|CCMSLIB00010142822|CCMSLIB00010142823|CCMSLIB00010142824|CCMSLIB00010142825|CCMSLIB00010142826,-14.02,3150,Drug_suspect,omeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,SUBDBMMJDZJVOS-UHFFFAOYSA-N
CCMSLIB00012725511,related spectra of 'omeprazole (delta mass:43.991)',CCMSLIB00010138450|CCMSLIB00010138451|CCMSLIB00010138452|CCMSLIB00010138453|CCMSLIB00010138454|CCMSLIB00010138455|CCMSLIB00010138456|CCMSLIB00010138457|CCMSLIB00010138458|CCMSLIB00010138459|CCMSLIB00010142822|CCMSLIB00010142823|CCMSLIB00010142824|CCMSLIB00010142825|CCMSLIB00010142826,43.99,3151,Drug_suspect,omeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,SUBDBMMJDZJVOS-UHFFFAOYSA-N
CCMSLIB00012725512,related spectra of 'omeprazole (delta mass:192.027)',CCMSLIB00010138450|CCMSLIB00010138451|CCMSLIB00010138452|CCMSLIB00010138453|CCMSLIB00010138454|CCMSLIB00010138455|CCMSLIB00010138456|CCMSLIB00010138457|CCMSLIB00010138458|CCMSLIB00010138459|CCMSLIB00010142822|CCMSLIB00010142823|CCMSLIB00010142824|CCMSLIB00010142825|CCMSLIB00010142826,192.03,3152,Drug_suspect,omeprazole,proton pump inhibitor,gastroenterology,gastroesophageal reflux disease (GERD)|Zollinger-Ellison syndrome|peptic ulcer disease (PUD),ATPase inhibitor,SUBDBMMJDZJVOS-UHFFFAOYSA-N
CCMSLIB00012725513,related spectra of 'ondansetron (delta mass:15.995)',CCMSLIB00010143990|CCMSLIB00010143991|CCMSLIB00010143992|CCMSLIB00010143993|CCMSLIB00010143994,15.99,3153,Drug_suspect,ondansetron,serotonin-3 (5-HT3) receptor antagonist,gastroenterology,nausea|vomiting,serotonin receptor antagonist,FELGMEQIXOGIFQ-UHFFFAOYSA-N
CCMSLIB00012725514,related spectra of 'oxaprozin (delta mass:14.016)',CCMSLIB00010132210|CCMSLIB00010132211|CCMSLIB00010132212|CCMSLIB00010132213|CCMSLIB00010132214|CCMSLIB00010132215|CCMSLIB00010132216|CCMSLIB00010132217,14.02,3154,Drug_suspect,oxaprozin,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis,cyclooxygenase inhibitor,OFPXSFXSNFPTHF-UHFFFAOYSA-N
CCMSLIB00012725515,related spectra of 'phenolphthalein (delta mass:14.016)',CCMSLIB00010149124|CCMSLIB00010149125|CCMSLIB00010149126|CCMSLIB00010149127|CCMSLIB00010149128,14.02,3155,Drug_suspect,phenolphthalein,no_match,NA,NA,indicator dye,KJFMBFZCATUALV-UHFFFAOYSA-N
CCMSLIB00012725516,related spectra of 'phenolphthalein (delta mass:27.047)',CCMSLIB00010149124|CCMSLIB00010149125|CCMSLIB00010149126|CCMSLIB00010149127|CCMSLIB00010149128,27.05,3156,Drug_suspect,phenolphthalein,no_match,NA,NA,indicator dye,KJFMBFZCATUALV-UHFFFAOYSA-N
CCMSLIB00012725517,related spectra of 'piperacillin (delta mass:-28.031)',CCMSLIB00010151522|CCMSLIB00010151523|CCMSLIB00010151524|CCMSLIB00010151525|CCMSLIB00010151526,-28.03,3157,Drug_suspect,piperacillin,penicillin class antibacterial,infectious disease,intra-abdominal infections|skin infections|pelvic inflammatory disease|pneumonia|gram-positive bacterial infections|gram-negative bacterial infections,bacterial cell wall synthesis inhibitor,IVBHGBMCVLDMKU-GXNBUGAJSA-N
CCMSLIB00012725518,related spectra of 'piperacillin (delta mass:15.012)',CCMSLIB00010151522|CCMSLIB00010151523|CCMSLIB00010151524|CCMSLIB00010151525|CCMSLIB00010151526,15.01,3158,Drug_suspect,piperacillin,penicillin class antibacterial,infectious disease,intra-abdominal infections|skin infections|pelvic inflammatory disease|pneumonia|gram-positive bacterial infections|gram-negative bacterial infections,bacterial cell wall synthesis inhibitor,IVBHGBMCVLDMKU-GXNBUGAJSA-N
CCMSLIB00012725519,related spectra of 'piperacillin (delta mass:17.027)',CCMSLIB00010151522|CCMSLIB00010151523|CCMSLIB00010151524|CCMSLIB00010151525|CCMSLIB00010151526,17.03,3159,Drug_suspect,piperacillin,penicillin class antibacterial,infectious disease,intra-abdominal infections|skin infections|pelvic inflammatory disease|pneumonia|gram-positive bacterial infections|gram-negative bacterial infections,bacterial cell wall synthesis inhibitor,IVBHGBMCVLDMKU-GXNBUGAJSA-N
CCMSLIB00012725520,related spectra of 'prednisolone (delta mass:-36.021)',CCMSLIB00010134088|CCMSLIB00010134089|CCMSLIB00010134090|CCMSLIB00010134091|CCMSLIB00010134092|CCMSLIB00010134093|CCMSLIB00010134094|CCMSLIB00010134095|CCMSLIB00010134096|CCMSLIB00010134097,-36.02,3160,Drug_suspect,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012725521,related spectra of 'prednisolone (delta mass:-18.011)',CCMSLIB00010134088|CCMSLIB00010134089|CCMSLIB00010134090|CCMSLIB00010134091|CCMSLIB00010134092|CCMSLIB00010134093|CCMSLIB00010134094|CCMSLIB00010134095|CCMSLIB00010134096|CCMSLIB00010134097,-18.01,3161,Drug_suspect,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012725522,related spectra of 'prednisolone (delta mass:-15.995)',CCMSLIB00010134088|CCMSLIB00010134089|CCMSLIB00010134090|CCMSLIB00010134091|CCMSLIB00010134092|CCMSLIB00010134093|CCMSLIB00010134094|CCMSLIB00010134095|CCMSLIB00010134096|CCMSLIB00010134097,-15.99,3162,Drug_suspect,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012725523,related spectra of 'prednisolone (delta mass:-14.016)',CCMSLIB00010134088|CCMSLIB00010134089|CCMSLIB00010134090|CCMSLIB00010134091|CCMSLIB00010134092|CCMSLIB00010134093|CCMSLIB00010134094|CCMSLIB00010134095|CCMSLIB00010134096|CCMSLIB00010134097,-14.02,3163,Drug_suspect,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012725524,related spectra of 'prednisolone (delta mass:2.016)',CCMSLIB00010134088|CCMSLIB00010134089|CCMSLIB00010134090|CCMSLIB00010134091|CCMSLIB00010134092|CCMSLIB00010134093|CCMSLIB00010134094|CCMSLIB00010134095|CCMSLIB00010134096|CCMSLIB00010134097,2.02,3164,Drug_suspect,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012725525,related spectra of 'prednisolone (delta mass:79.957)',CCMSLIB00010134088|CCMSLIB00010134089|CCMSLIB00010134090|CCMSLIB00010134091|CCMSLIB00010134092|CCMSLIB00010134093|CCMSLIB00010134094|CCMSLIB00010134095|CCMSLIB00010134096|CCMSLIB00010134097,79.96,3165,Drug_suspect,prednisolone,corticosteroid,dermatology|pulmonary|endocrinology|oncology|rheumatology|gastroenterology|allergy|hematologic malignancy|transplant|ophthalmology|neurology/psychiatry,serious conditions where primarily anti-inflammatory and immunosuppressive effects are intended,glucocorticoid receptor agonist,OIGNJSKKLXVSLS-VWUMJDOOSA-N
CCMSLIB00012725526,related spectra of 'protriptyline (delta mass:-14.016)',CCMSLIB00010137913|CCMSLIB00010137914|CCMSLIB00010137915|CCMSLIB00010137916|CCMSLIB00010137917|CCMSLIB00010137918|CCMSLIB00010137919|CCMSLIB00010137920,-14.02,3166,Drug_suspect,protriptyline,tricyclic antidepressant (TCA),neurology/psychiatry,depression,tricyclic antidepressant,BWPIARFWQZKAIA-UHFFFAOYSA-N
CCMSLIB00012725527,related spectra of 'quetiapine (delta mass:-88.053)',CCMSLIB00010139368|CCMSLIB00010139369|CCMSLIB00010139370|CCMSLIB00010139371|CCMSLIB00010139372|CCMSLIB00010139373|CCMSLIB00010139374|CCMSLIB00010139375|CCMSLIB00010145183|CCMSLIB00010145184|CCMSLIB00010145185|CCMSLIB00010145186|CCMSLIB00010145187|CCMSLIB00010145188|CCMSLIB00010145189|CCMSLIB00010145190,-88.05,3167,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725528,related spectra of 'quetiapine (delta mass:-44.026)',CCMSLIB00010139368|CCMSLIB00010139369|CCMSLIB00010139370|CCMSLIB00010139371|CCMSLIB00010139372|CCMSLIB00010139373|CCMSLIB00010139374|CCMSLIB00010139375|CCMSLIB00010145183|CCMSLIB00010145184|CCMSLIB00010145185|CCMSLIB00010145186|CCMSLIB00010145187|CCMSLIB00010145188|CCMSLIB00010145189|CCMSLIB00010145190,-44.03,3168,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725529,related spectra of 'quetiapine (delta mass:-16.031)',CCMSLIB00010139368|CCMSLIB00010139369|CCMSLIB00010139370|CCMSLIB00010139371|CCMSLIB00010139372|CCMSLIB00010139373|CCMSLIB00010139374|CCMSLIB00010139375|CCMSLIB00010145183|CCMSLIB00010145184|CCMSLIB00010145185|CCMSLIB00010145186|CCMSLIB00010145187|CCMSLIB00010145188|CCMSLIB00010145189|CCMSLIB00010145190,-16.03,3169,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725530,related spectra of 'quetiapine (delta mass:-2.016)',CCMSLIB00010139368|CCMSLIB00010139369|CCMSLIB00010139370|CCMSLIB00010139371|CCMSLIB00010139372|CCMSLIB00010139373|CCMSLIB00010139374|CCMSLIB00010139375|CCMSLIB00010145183|CCMSLIB00010145184|CCMSLIB00010145185|CCMSLIB00010145186|CCMSLIB00010145187|CCMSLIB00010145188|CCMSLIB00010145189|CCMSLIB00010145190,-2.02,3170,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725531,related spectra of 'quetiapine (delta mass:13.98)',CCMSLIB00010139368|CCMSLIB00010139369|CCMSLIB00010139370|CCMSLIB00010139371|CCMSLIB00010139372|CCMSLIB00010139373|CCMSLIB00010139374|CCMSLIB00010139375|CCMSLIB00010145183|CCMSLIB00010145184|CCMSLIB00010145185|CCMSLIB00010145186|CCMSLIB00010145187|CCMSLIB00010145188|CCMSLIB00010145189|CCMSLIB00010145190,13.98,3171,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725532,related spectra of 'quetiapine (delta mass:15.995)',CCMSLIB00010139368|CCMSLIB00010139369|CCMSLIB00010139370|CCMSLIB00010139371|CCMSLIB00010139372|CCMSLIB00010139373|CCMSLIB00010139374|CCMSLIB00010139375|CCMSLIB00010145183|CCMSLIB00010145184|CCMSLIB00010145185|CCMSLIB00010145186|CCMSLIB00010145187|CCMSLIB00010145188|CCMSLIB00010145189|CCMSLIB00010145190,15.99,3172,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725533,related spectra of 'quetiapine (delta mass:27.995)',CCMSLIB00010139368|CCMSLIB00010139369|CCMSLIB00010139370|CCMSLIB00010139371|CCMSLIB00010139372|CCMSLIB00010139373|CCMSLIB00010139374|CCMSLIB00010139375|CCMSLIB00010145183|CCMSLIB00010145184|CCMSLIB00010145185|CCMSLIB00010145186|CCMSLIB00010145187|CCMSLIB00010145188|CCMSLIB00010145189|CCMSLIB00010145190,27.99,3173,Drug_suspect,quetiapine,atypical antipsychotic,neurology/psychiatry,schizophrenia|bipolar disorder,dopamine receptor antagonist|serotonin receptor antagonist,URKOMYMAXPYINW-UHFFFAOYSA-N
CCMSLIB00012725534,related spectra of 'quinapril (delta mass:-28.031)',CCMSLIB00010144659|CCMSLIB00010144660|CCMSLIB00010144661|CCMSLIB00010144662|CCMSLIB00010144663,-28.03,3174,Drug_suspect,quinapril,angiotensin converting enzyme inhibitor,cardiology,hypertension|congestive heart failure,angiotensin converting enzyme inhibitor,JSDRRTOADPPCHY-HSQYWUDLSA-N
CCMSLIB00012725535,related spectra of 'ramipril (delta mass:-28.031)',CCMSLIB00010138468|CCMSLIB00010138469|CCMSLIB00010138470|CCMSLIB00010138471|CCMSLIB00010138472,-28.03,3175,Drug_suspect,ramipril,angiotensin converting enzyme inhibitor,cardiology|nephrology,hypertension|congestive heart failure|diabetic nephropathy,angiotensin converting enzyme inhibitor,HDACQVRGBOVJII-JBDAPHQKSA-N
CCMSLIB00012725536,related spectra of 'reserpine (delta mass:-14.016)',CCMSLIB00006391044|CCMSLIB00006391045|CCMSLIB00006391090|CCMSLIB00006391091|CCMSLIB00006391137|CCMSLIB00006391138|CCMSLIB00006391184|CCMSLIB00006391185|CCMSLIB00006391230|CCMSLIB00006391231|CCMSLIB00006391276|CCMSLIB00006391277|CCMSLIB00006391322|CCMSLIB00006391323|CCMSLIB00006391368|CCMSLIB00006391369|CCMSLIB00006391412|CCMSLIB00006391413|CCMSLIB00006391457|CCMSLIB00006391458|CCMSLIB00006391503|CCMSLIB00006391504|CCMSLIB00006391549|CCMSLIB00006391550|CCMSLIB00006391594|CCMSLIB00006391595|CCMSLIB00006391639|CCMSLIB00006391640|CCMSLIB00006391683|CCMSLIB00006391684|CCMSLIB00006391727|CCMSLIB00006391728|CCMSLIB00006391770|CCMSLIB00006391771|CCMSLIB00006391813|CCMSLIB00006391814|CCMSLIB00006391854|CCMSLIB00006391855|CCMSLIB00006391897|CCMSLIB00006391898|CCMSLIB00006441498|CCMSLIB00006441499|CCMSLIB00006441548|CCMSLIB00006441549|CCMSLIB00006441598|CCMSLIB00006441599|CCMSLIB00006441648|CCMSLIB00006441649|CCMSLIB00006441697|CCMSLIB00006441698|CCMSLIB00006441747|CCMSLIB00006441748|CCMSLIB00006441797|CCMSLIB00006441798|CCMSLIB00006441845|CCMSLIB00006441846|CCMSLIB00006441891|CCMSLIB00006441892|CCMSLIB00006441932|CCMSLIB00006441933|CCMSLIB00006523056|CCMSLIB00006523057|CCMSLIB00006523082|CCMSLIB00006523083|CCMSLIB00006523107|CCMSLIB00006523108|CCMSLIB00006523132|CCMSLIB00006523133|CCMSLIB00006523249|CCMSLIB00006523250|CCMSLIB00006523272|CCMSLIB00006523296|CCMSLIB00006523297|CCMSLIB00006523323|CCMSLIB00006523384|CCMSLIB00006523399|CCMSLIB00006523415|CCMSLIB00006523467|CCMSLIB00006523520|CCMSLIB00006523521|CCMSLIB00006523543|CCMSLIB00006523556|CCMSLIB00006560412|CCMSLIB00006560436|CCMSLIB00006560460|CCMSLIB00006560484|CCMSLIB00006560516|CCMSLIB00006560540|CCMSLIB00006560564|CCMSLIB00006560588|CCMSLIB00006560620|CCMSLIB00006560644|CCMSLIB00006560668|CCMSLIB00006560692|CCMSLIB00006560724|CCMSLIB00006560748|CCMSLIB00006560772|CCMSLIB00006560796|CCMSLIB00006560828|CCMSLIB00006560852|CCMSLIB00006560876|CCMSLIB00006560900|CCMSLIB00006560932|CCMSLIB00006560956|CCMSLIB00006560980|CCMSLIB00006561004|CCMSLIB00006561036|CCMSLIB00006561060|CCMSLIB00006561084|CCMSLIB00006561108|CCMSLIB00006561140|CCMSLIB00006561164|CCMSLIB00006561188|CCMSLIB00006561212|CCMSLIB00006561244|CCMSLIB00006561268|CCMSLIB00006561292|CCMSLIB00006561316|CCMSLIB00006561348|CCMSLIB00006561372|CCMSLIB00006561396|CCMSLIB00006561420|CCMSLIB00010149780|CCMSLIB00010149781|CCMSLIB00010149782|CCMSLIB00010149783|CCMSLIB00010149784|CCMSLIB00010149785|CCMSLIB00010149786|CCMSLIB00010149787|CCMSLIB00010152342|CCMSLIB00010152343|CCMSLIB00010152344|CCMSLIB00010152345|CCMSLIB00010152346|CCMSLIB00010152347|CCMSLIB00010152348|CCMSLIB00010152349,-14.02,3176,Drug_suspect,reserpine,catecholamine-depleting sympatholytic,cardiology,hypertension,vesicular monoamine transporter inhibitor,QEVHRUUCFGRFIF-MDEJGZGSSA-N|NA
CCMSLIB00012725537,related spectra of 'ritonavir (delta mass:-15.979)',CCMSLIB00010141703|CCMSLIB00010141704|CCMSLIB00010141705|CCMSLIB00010141706|CCMSLIB00010141707,-15.98,3177,Drug_suspect,ritonavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,NCDNCNXCDXHOMX-XGKFQTDJSA-N
CCMSLIB00012725538,related spectra of 'ritonavir (delta mass:15.995)',CCMSLIB00010141703|CCMSLIB00010141704|CCMSLIB00010141705|CCMSLIB00010141706|CCMSLIB00010141707,15.99,3178,Drug_suspect,ritonavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,NCDNCNXCDXHOMX-XGKFQTDJSA-N
CCMSLIB00012725539,related spectra of 'ritonavir (delta mass:31.99)',CCMSLIB00010141703|CCMSLIB00010141704|CCMSLIB00010141705|CCMSLIB00010141706|CCMSLIB00010141707,31.99,3179,Drug_suspect,ritonavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,NCDNCNXCDXHOMX-XGKFQTDJSA-N
CCMSLIB00012725540,related spectra of 'ritonavir (delta mass:176.032)',CCMSLIB00010141703|CCMSLIB00010141704|CCMSLIB00010141705|CCMSLIB00010141706|CCMSLIB00010141707,176.03,3180,Drug_suspect,ritonavir,HIV protease inhibitor,infectious disease,human immunodeficiency virus (HIV-1),HIV protease inhibitor,NCDNCNXCDXHOMX-XGKFQTDJSA-N
CCMSLIB00012725541,related spectra of 'rotenone (delta mass:-42.047)',CCMSLIB00010131098|CCMSLIB00010131099|CCMSLIB00010131100|CCMSLIB00010131101|CCMSLIB00010131102,-42.05,3181,Drug_suspect,rotenone,no_match,no_match,no_match,no_match,JUVIOZPCNVVQFO-HBGVWJBISA-N
CCMSLIB00012725542,related spectra of 'sertraline (delta mass:1.993)',CCMSLIB00010136153|CCMSLIB00010136154|CCMSLIB00010136155|CCMSLIB00010136156|CCMSLIB00010136157,2,3182,Drug_suspect,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012725543,related spectra of 'sertraline (delta mass:2.004)',CCMSLIB00010136153|CCMSLIB00010136154|CCMSLIB00010136155|CCMSLIB00010136156|CCMSLIB00010136157,2,3183,Drug_suspect,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012725544,related spectra of 'sertraline (delta mass:15.995)',CCMSLIB00010136153|CCMSLIB00010136154|CCMSLIB00010136155|CCMSLIB00010136156|CCMSLIB00010136157,15.99,3184,Drug_suspect,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012725545,related spectra of 'sertraline (delta mass:29.974)',CCMSLIB00010136153|CCMSLIB00010136154|CCMSLIB00010136155|CCMSLIB00010136156|CCMSLIB00010136157,29.97,3185,Drug_suspect,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012725546,related spectra of 'sertraline (delta mass:43.991)',CCMSLIB00010136153|CCMSLIB00010136154|CCMSLIB00010136155|CCMSLIB00010136156|CCMSLIB00010136157,43.99,3186,Drug_suspect,sertraline,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression|obsessive compulsive disorder (OCD)|panic disorders|posttraumatic stress disorder|premenstrual syndrome|social anxiety disorder,selective serotonin reuptake inhibitor (SSRI),VGKDLMBJGBXTGI-SJCJKPOMSA-N
CCMSLIB00012725547,related spectra of 'sulfamethazine (delta mass:-3.985)',CCMSLIB00010143272|CCMSLIB00010143273|CCMSLIB00010143274|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143277|CCMSLIB00010143278|CCMSLIB00010143279,-3.99,3187,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725548,related spectra of 'sulfamethazine (delta mass:-2.016)',CCMSLIB00010143272|CCMSLIB00010143273|CCMSLIB00010143274|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143277|CCMSLIB00010143278|CCMSLIB00010143279,-2.02,3188,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725549,related spectra of 'sulfamethazine (delta mass:0.984)',CCMSLIB00010143272|CCMSLIB00010143273|CCMSLIB00010143274|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143277|CCMSLIB00010143278|CCMSLIB00010143279,0.98,3189,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725550,related spectra of 'sulfamethazine (delta mass:1.003)',CCMSLIB00010143272|CCMSLIB00010143273|CCMSLIB00010143274|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143277|CCMSLIB00010143278|CCMSLIB00010143279,1,3190,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725551,related spectra of 'sulfamethazine (delta mass:2.004)',CCMSLIB00010143272|CCMSLIB00010143273|CCMSLIB00010143274|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143277|CCMSLIB00010143278|CCMSLIB00010143279,2,3191,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725552,related spectra of 'sulfamethazine (delta mass:2.016)',CCMSLIB00010143272|CCMSLIB00010143273|CCMSLIB00010143274|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143277|CCMSLIB00010143278|CCMSLIB00010143279,2.02,3192,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725553,related spectra of 'sulfamethazine (delta mass:14.016)',CCMSLIB00010143272|CCMSLIB00010143273|CCMSLIB00010143274|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143277|CCMSLIB00010143278|CCMSLIB00010143279,14.02,3193,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725554,related spectra of 'sulfamethazine (delta mass:15.995)',CCMSLIB00010143272|CCMSLIB00010143273|CCMSLIB00010143274|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143277|CCMSLIB00010143278|CCMSLIB00010143279,15.99,3194,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725555,related spectra of 'sulfamethazine (delta mass:21.984)',CCMSLIB00010143272|CCMSLIB00010143273|CCMSLIB00010143274|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143277|CCMSLIB00010143278|CCMSLIB00010143279,21.98,3195,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725556,related spectra of 'sulfamethazine (delta mass:27.995)',CCMSLIB00010143272|CCMSLIB00010143273|CCMSLIB00010143274|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143277|CCMSLIB00010143278|CCMSLIB00010143279,27.99,3196,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725557,related spectra of 'sulfamethazine (delta mass:28.031)',CCMSLIB00010143272|CCMSLIB00010143273|CCMSLIB00010143274|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143277|CCMSLIB00010143278|CCMSLIB00010143279,28.03,3197,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725558,related spectra of 'sulfamethazine (delta mass:162.053)',CCMSLIB00010143272|CCMSLIB00010143273|CCMSLIB00010143274|CCMSLIB00010143275|CCMSLIB00010143276|CCMSLIB00010143277|CCMSLIB00010143278|CCMSLIB00010143279,162.05,3198,Drug_suspect|Background/QAQC,sulfamethazine,sulfonamide antimicrobial,infectious disease,gram-negative bacterial infections|gram-positive bacterial infections,PABA antagonist,ASWVTGNCAZCNNR-UHFFFAOYSA-N
CCMSLIB00012725559,related spectra of 'sulfamethizole (delta mass:1.993)',CCMSLIB00010136741|CCMSLIB00010136742|CCMSLIB00010136743|CCMSLIB00010136744|CCMSLIB00010136745,2,3199,Drug_suspect|Background/QAQC,sulfamethizole,sulfonamide antimicrobial,infectious disease,urinary tract infections,bacterial antifolate,VACCAVUAMIDAGB-UHFFFAOYSA-N
CCMSLIB00012725560,related spectra of 'sulfamethizole (delta mass:2.999)',CCMSLIB00010136741|CCMSLIB00010136742|CCMSLIB00010136743|CCMSLIB00010136744|CCMSLIB00010136745,3,3200,Drug_suspect|Background/QAQC,sulfamethizole,sulfonamide antimicrobial,infectious disease,urinary tract infections,bacterial antifolate,VACCAVUAMIDAGB-UHFFFAOYSA-N
CCMSLIB00012725561,related spectra of 'sulfamethizole (delta mass:15.995)',CCMSLIB00010136741|CCMSLIB00010136742|CCMSLIB00010136743|CCMSLIB00010136744|CCMSLIB00010136745,15.99,3201,Drug_suspect|Background/QAQC,sulfamethizole,sulfonamide antimicrobial,infectious disease,urinary tract infections,bacterial antifolate,VACCAVUAMIDAGB-UHFFFAOYSA-N
CCMSLIB00012725562,related spectra of 'sulfamethizole (delta mass:27.995)',CCMSLIB00010136741|CCMSLIB00010136742|CCMSLIB00010136743|CCMSLIB00010136744|CCMSLIB00010136745,27.99,3202,Drug_suspect|Background/QAQC,sulfamethizole,sulfonamide antimicrobial,infectious disease,urinary tract infections,bacterial antifolate,VACCAVUAMIDAGB-UHFFFAOYSA-N
CCMSLIB00012725563,related spectra of 'sulfamethizole (delta mass:43.043)',CCMSLIB00010136741|CCMSLIB00010136742|CCMSLIB00010136743|CCMSLIB00010136744|CCMSLIB00010136745,43.04,3203,Drug_suspect|Background/QAQC,sulfamethizole,sulfonamide antimicrobial,infectious disease,urinary tract infections,bacterial antifolate,VACCAVUAMIDAGB-UHFFFAOYSA-N
CCMSLIB00012725564,related spectra of 'sulindac (delta mass:14.016)',CCMSLIB00010142068|CCMSLIB00010142069|CCMSLIB00010142070|CCMSLIB00010142071|CCMSLIB00010142072,14.02,3204,Drug_suspect,sulindac,nonsteroidal anti-inflammatory drug,rheumatology|neurology/psychiatry,osteoarthritis|rheumatoid arthritis|ankylosing spondylitis,cyclooxygenase inhibitor,MLKXDPUZXIRXEP-MFOYZWKCSA-N
CCMSLIB00012725565,related spectra of 'tamoxifen (delta mass:-14.016)',CCMSLIB00010140068|CCMSLIB00010140069|CCMSLIB00010140070|CCMSLIB00010140071|CCMSLIB00010140072|CCMSLIB00010140073|CCMSLIB00010140074|CCMSLIB00010140075|CCMSLIB00010148578|CCMSLIB00010148579|CCMSLIB00010148580|CCMSLIB00010148581|CCMSLIB00010148582|CCMSLIB00010148583|CCMSLIB00010148584|CCMSLIB00010148585,-14.02,3205,Drug_suspect,tamoxifen,estrogen agonist/antagonist,oncology,breast cancer,estrogen receptor antagonist|selective estrogen receptor modulator (SERM),NKANXQFJJICGDU-QPLCGJKRSA-N
CCMSLIB00012725566,related spectra of 'terazosin (delta mass:-14.016)',CCMSLIB00010152477|CCMSLIB00010152478|CCMSLIB00010152479|CCMSLIB00010152480|CCMSLIB00010152481|CCMSLIB00010152482|CCMSLIB00010152483|CCMSLIB00010152484,-14.02,3206,Drug_suspect,terazosin,alpha adrenergic blocker,urology|cardiology,benign prostatic hyperplasia (BPH)|hypertension,adrenergic receptor antagonist,VCKUSRYTPJJLNI-UHFFFAOYSA-N
CCMSLIB00012725567,related spectra of 'terazosin (delta mass:31.99)',CCMSLIB00010152477|CCMSLIB00010152478|CCMSLIB00010152479|CCMSLIB00010152480|CCMSLIB00010152481|CCMSLIB00010152482|CCMSLIB00010152483|CCMSLIB00010152484,31.99,3207,Drug_suspect,terazosin,alpha adrenergic blocker,urology|cardiology,benign prostatic hyperplasia (BPH)|hypertension,adrenergic receptor antagonist,VCKUSRYTPJJLNI-UHFFFAOYSA-N
CCMSLIB00012725568,related spectra of 'terbinafine (delta mass:-14.016)',CCMSLIB00010136030|CCMSLIB00010136031|CCMSLIB00010136032|CCMSLIB00010136033|CCMSLIB00010136034|CCMSLIB00010137415|CCMSLIB00010137416|CCMSLIB00010137417|CCMSLIB00010137418|CCMSLIB00010137419|CCMSLIB00010137420|CCMSLIB00010137421|CCMSLIB00010137422,-14.02,3208,Drug_suspect,terbinafine,allylamine antifungal,infectious disease,tinea pedis|tinea cruris|tinea corporis,fungal squalene epoxidase inhibitor,DOMXUEMWDBAQBQ-WEVVVXLNSA-N
CCMSLIB00012725569,related spectra of 'terbinafine (delta mass:1.978)',CCMSLIB00010136030|CCMSLIB00010136031|CCMSLIB00010136032|CCMSLIB00010136033|CCMSLIB00010136034|CCMSLIB00010137415|CCMSLIB00010137416|CCMSLIB00010137417|CCMSLIB00010137418|CCMSLIB00010137419|CCMSLIB00010137420|CCMSLIB00010137421|CCMSLIB00010137422,1.98,3209,Drug_suspect,terbinafine,allylamine antifungal,infectious disease,tinea pedis|tinea cruris|tinea corporis,fungal squalene epoxidase inhibitor,DOMXUEMWDBAQBQ-WEVVVXLNSA-N
CCMSLIB00012725570,related spectra of 'terbinafine (delta mass:15.958)',CCMSLIB00010136030|CCMSLIB00010136031|CCMSLIB00010136032|CCMSLIB00010136033|CCMSLIB00010136034|CCMSLIB00010137415|CCMSLIB00010137416|CCMSLIB00010137417|CCMSLIB00010137418|CCMSLIB00010137419|CCMSLIB00010137420|CCMSLIB00010137421|CCMSLIB00010137422,15.96,3210,Drug_suspect,terbinafine,allylamine antifungal,infectious disease,tinea pedis|tinea cruris|tinea corporis,fungal squalene epoxidase inhibitor,DOMXUEMWDBAQBQ-WEVVVXLNSA-N
CCMSLIB00012725571,related spectra of 'terbinafine (delta mass:15.995)',CCMSLIB00010136030|CCMSLIB00010136031|CCMSLIB00010136032|CCMSLIB00010136033|CCMSLIB00010136034|CCMSLIB00010137415|CCMSLIB00010137416|CCMSLIB00010137417|CCMSLIB00010137418|CCMSLIB00010137419|CCMSLIB00010137420|CCMSLIB00010137421|CCMSLIB00010137422,15.99,3211,Drug_suspect,terbinafine,allylamine antifungal,infectious disease,tinea pedis|tinea cruris|tinea corporis,fungal squalene epoxidase inhibitor,DOMXUEMWDBAQBQ-WEVVVXLNSA-N
CCMSLIB00012725572,related spectra of 'terbinafine (delta mass:29.974)',CCMSLIB00010136030|CCMSLIB00010136031|CCMSLIB00010136032|CCMSLIB00010136033|CCMSLIB00010136034|CCMSLIB00010137415|CCMSLIB00010137416|CCMSLIB00010137417|CCMSLIB00010137418|CCMSLIB00010137419|CCMSLIB00010137420|CCMSLIB00010137421|CCMSLIB00010137422,29.97,3212,Drug_suspect,terbinafine,allylamine antifungal,infectious disease,tinea pedis|tinea cruris|tinea corporis,fungal squalene epoxidase inhibitor,DOMXUEMWDBAQBQ-WEVVVXLNSA-N
CCMSLIB00012725573,related spectra of 'terbinafine (delta mass:31.99)',CCMSLIB00010136030|CCMSLIB00010136031|CCMSLIB00010136032|CCMSLIB00010136033|CCMSLIB00010136034|CCMSLIB00010137415|CCMSLIB00010137416|CCMSLIB00010137417|CCMSLIB00010137418|CCMSLIB00010137419|CCMSLIB00010137420|CCMSLIB00010137421|CCMSLIB00010137422,31.99,3213,Drug_suspect,terbinafine,allylamine antifungal,infectious disease,tinea pedis|tinea cruris|tinea corporis,fungal squalene epoxidase inhibitor,DOMXUEMWDBAQBQ-WEVVVXLNSA-N
CCMSLIB00012725574,related spectra of 'testosterone propionate (delta mass:-27.995)',CCMSLIB00010138235|CCMSLIB00010138236|CCMSLIB00010138237|CCMSLIB00010138238|CCMSLIB00010138239,-27.99,3214,Drug_suspect|Low_confidence,testosterone propionate,androgen,endocrinology,hypogonadism,androgen receptor agonist,PDMMFKSKQVNJMI-BLQWBTBKSA-N
CCMSLIB00012725575,related spectra of 'thioridazine (delta mass:-14.016)',CCMSLIB00010143030|CCMSLIB00010143031|CCMSLIB00010143032|CCMSLIB00010143033|CCMSLIB00010143034|CCMSLIB00010143035|CCMSLIB00010143036|CCMSLIB00010143037,-14.02,3215,Drug_suspect,thioridazine,phenothiazine,neurology/psychiatry,schizophrenia,dopamine receptor antagonist,KLBQZWRITKRQQV-UHFFFAOYSA-N
CCMSLIB00012725576,related spectra of 'thioridazine (delta mass:31.99)',CCMSLIB00010143030|CCMSLIB00010143031|CCMSLIB00010143032|CCMSLIB00010143033|CCMSLIB00010143034|CCMSLIB00010143035|CCMSLIB00010143036|CCMSLIB00010143037,31.99,3216,Drug_suspect,thioridazine,phenothiazine,neurology/psychiatry,schizophrenia,dopamine receptor antagonist,KLBQZWRITKRQQV-UHFFFAOYSA-N
CCMSLIB00012725577,related spectra of 'trazodone (delta mass:2.999)',CCMSLIB00010148306|CCMSLIB00010148307|CCMSLIB00010148308|CCMSLIB00010148309|CCMSLIB00010148310|CCMSLIB00010148311|CCMSLIB00010148312|CCMSLIB00010148313,3,3217,Drug_suspect,trazodone,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,PHLBKPHSAVXXEF-UHFFFAOYSA-N
CCMSLIB00012725578,related spectra of 'trazodone (delta mass:15.995)',CCMSLIB00010148306|CCMSLIB00010148307|CCMSLIB00010148308|CCMSLIB00010148309|CCMSLIB00010148310|CCMSLIB00010148311|CCMSLIB00010148312|CCMSLIB00010148313,15.99,3218,Drug_suspect,trazodone,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,PHLBKPHSAVXXEF-UHFFFAOYSA-N
CCMSLIB00012725579,related spectra of 'trazodone (delta mass:34.005)',CCMSLIB00010148306|CCMSLIB00010148307|CCMSLIB00010148308|CCMSLIB00010148309|CCMSLIB00010148310|CCMSLIB00010148311|CCMSLIB00010148312|CCMSLIB00010148313,34.01,3219,Drug_suspect,trazodone,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,PHLBKPHSAVXXEF-UHFFFAOYSA-N
CCMSLIB00012725580,related spectra of 'trazodone (delta mass:45.985)',CCMSLIB00010148306|CCMSLIB00010148307|CCMSLIB00010148308|CCMSLIB00010148309|CCMSLIB00010148310|CCMSLIB00010148311|CCMSLIB00010148312|CCMSLIB00010148313,45.99,3220,Drug_suspect,trazodone,selective serotonin reuptake inhibitor (SSRI),neurology/psychiatry,depression,adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor,PHLBKPHSAVXXEF-UHFFFAOYSA-N
CCMSLIB00012725581,related spectra of 'triamterene (delta mass:15.995)',CCMSLIB00010129837|CCMSLIB00010129838|CCMSLIB00010129839|CCMSLIB00010129840|CCMSLIB00010129841|CCMSLIB00010129842,15.99,3221,Drug_suspect,triamterene,potassium-sparing diuretic,cardiology,hypokalemia|hypertension|edema,sodium channel blocker,FNYLWPVRPXGIIP-UHFFFAOYSA-N
CCMSLIB00012725582,related spectra of 'trimebutine (delta mass:-14.016)',CCMSLIB00010151014|CCMSLIB00010151015|CCMSLIB00010151016|CCMSLIB00010151017|CCMSLIB00010151018|CCMSLIB00010151019|CCMSLIB00010151020|CCMSLIB00010151021,-14.02,3222,Drug_suspect,trimebutine,drugs for functional gastrointestinal disorders,gastroenterology,irritable bowel syndrome,opioid receptor agonist,LORDFXWUHHSAQU-UHFFFAOYSA-N
CCMSLIB00012725583,related spectra of 'trimethoprim (delta mass:14.016)',CCMSLIB00010131218|CCMSLIB00010131219|CCMSLIB00010131220|CCMSLIB00010131221|CCMSLIB00010131222|CCMSLIB00010131223|CCMSLIB00010131224|CCMSLIB00010131225,14.02,3223,Drug_suspect,trimethoprim,dihydrofolate reductase inhibitor antibacterial,infectious disease,urinary tract infections|ear infections|gastrointestinal infections,dihydrofolate reductase inhibitor,IEDVJHCEMCRBQM-UHFFFAOYSA-N
CCMSLIB00012725584,related spectra of 'urapidil (delta mass:-14.016)',CCMSLIB00010137163|CCMSLIB00010137164|CCMSLIB00010137165|CCMSLIB00010137166|CCMSLIB00010137167|CCMSLIB00010144750|CCMSLIB00010144751|CCMSLIB00010144752|CCMSLIB00010144753|CCMSLIB00010144754|CCMSLIB00010144755|CCMSLIB00010144756|CCMSLIB00010144757,-14.02,3224,Drug_suspect,urapidil,alpha adrenergic blocker,cardiology,hypertension,adrenergic receptor antagonist,ICMGLRUYEQNHPF-UHFFFAOYSA-N
CCMSLIB00012725585,related spectra of 'urapidil (delta mass:15.995)',CCMSLIB00010137163|CCMSLIB00010137164|CCMSLIB00010137165|CCMSLIB00010137166|CCMSLIB00010137167|CCMSLIB00010144750|CCMSLIB00010144751|CCMSLIB00010144752|CCMSLIB00010144753|CCMSLIB00010144754|CCMSLIB00010144755|CCMSLIB00010144756|CCMSLIB00010144757,15.99,3225,Drug_suspect,urapidil,alpha adrenergic blocker,cardiology,hypertension,adrenergic receptor antagonist,ICMGLRUYEQNHPF-UHFFFAOYSA-N
CCMSLIB00012725586,related spectra of 'valsartan (delta mass:-18.011)',CCMSLIB00010140221|CCMSLIB00010140222|CCMSLIB00010140223|CCMSLIB00010140224|CCMSLIB00010140225|CCMSLIB00010147620|CCMSLIB00010147621|CCMSLIB00010147622|CCMSLIB00010147623|CCMSLIB00010147624|CCMSLIB00010147625|CCMSLIB00010147626|CCMSLIB00010147627,-18.01,3226,Drug_suspect,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012725587,related spectra of 'valsartan (delta mass:-4.954)',CCMSLIB00010140221|CCMSLIB00010140222|CCMSLIB00010140223|CCMSLIB00010140224|CCMSLIB00010140225|CCMSLIB00010147620|CCMSLIB00010147621|CCMSLIB00010147622|CCMSLIB00010147623|CCMSLIB00010147624|CCMSLIB00010147625|CCMSLIB00010147626|CCMSLIB00010147627,-4.96,3227,Drug_suspect,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012725588,related spectra of 'valsartan (delta mass:-2.016)',CCMSLIB00010140221|CCMSLIB00010140222|CCMSLIB00010140223|CCMSLIB00010140224|CCMSLIB00010140225|CCMSLIB00010147620|CCMSLIB00010147621|CCMSLIB00010147622|CCMSLIB00010147623|CCMSLIB00010147624|CCMSLIB00010147625|CCMSLIB00010147626|CCMSLIB00010147627,-2.02,3228,Drug_suspect,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012725589,related spectra of 'valsartan (delta mass:15.995)',CCMSLIB00010140221|CCMSLIB00010140222|CCMSLIB00010140223|CCMSLIB00010140224|CCMSLIB00010140225|CCMSLIB00010147620|CCMSLIB00010147621|CCMSLIB00010147622|CCMSLIB00010147623|CCMSLIB00010147624|CCMSLIB00010147625|CCMSLIB00010147626|CCMSLIB00010147627,15.99,3229,Drug_suspect,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012725590,related spectra of 'valsartan (delta mass:17.027)',CCMSLIB00010140221|CCMSLIB00010140222|CCMSLIB00010140223|CCMSLIB00010140224|CCMSLIB00010140225|CCMSLIB00010147620|CCMSLIB00010147621|CCMSLIB00010147622|CCMSLIB00010147623|CCMSLIB00010147624|CCMSLIB00010147625|CCMSLIB00010147626|CCMSLIB00010147627,17.03,3230,Drug_suspect,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012725591,related spectra of 'valsartan (delta mass:29.974)',CCMSLIB00010140221|CCMSLIB00010140222|CCMSLIB00010140223|CCMSLIB00010140224|CCMSLIB00010140225|CCMSLIB00010147620|CCMSLIB00010147621|CCMSLIB00010147622|CCMSLIB00010147623|CCMSLIB00010147624|CCMSLIB00010147625|CCMSLIB00010147626|CCMSLIB00010147627,29.97,3231,Drug_suspect,valsartan,angiotensin II receptor blocker,cardiology|nephrology,hypertension|congestive heart failure|chronic kidney disease|diabetic nephropaty,angiotensin receptor antagonist,ACWBQPMHZXGDFX-QFIPXVFZSA-N
CCMSLIB00012725592,related spectra of 'venlafaxine (delta mass:-18.011)',CCMSLIB00010130533|CCMSLIB00010130534|CCMSLIB00010130535|CCMSLIB00010130536|CCMSLIB00010130537,-18.01,3232,Drug_suspect,venlafaxine,serotonin and norepinephrine reuptake inhibitor (SNRI),neurology/psychiatry,depression|generalized anxiety disorder (GAD)|panic disorders|social anxiety disorder,serotonin and norepinephrine reuptake inhibitor,PNVNVHUZROJLTJ-UHFFFAOYSA-N
CCMSLIB00012725593,related spectra of 'vinorelbine??tartrate (delta mass:29.974)',CCMSLIB00000079270|CCMSLIB00000079271,29.97,3233,Drug_suspect,vinorelbine,vinca alkaloid,oncology,non-small cell lung cancer (NSCLC),tubulin polymerization inhibitor,GBABOYUKABKIAF-IELIFDKJSA-N
CCMSLIB00012725594,related spectra of 'yohimbine a (delta mass:2.016)',CCMSLIB00000007128|CCMSLIB00000007129|CCMSLIB00000007130|CCMSLIB00000007131,2.02,3234,Drug_suspect,yohimbine,drugs used in erectile dysfunction,urology,erectile dysfunction,adrenergic receptor antagonist,NA